Please wait...
| ID | PMID | YEAR | Sequence | MAP | Name | C-ter MOD | N-ter MOD | Linear/Cyclic | Stereo-Chemistry | Modified | Length | Fuction | Activity | RBCs Source | Origin | Experimental structure | Non-Hemolytic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10660589 | 2000 | ALWKTLLKKVLKAAAKAALN | S4-(1-20) | Free | Free | Linear | L | None | 20 | Antimicrobial | LC50 =5±1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWMTLLKKVLKAAAK | S4-(1-16) | Free | Free | Linear | L | None | 16 | Antimicrobial | LC50 =23±1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWMTLLKKVLK | S4-(1-12) | Free | Free | Linear | L | None | 12 | Antimicrobial | LC50 =100μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | TLLKKVLKAAAK | S4-(5-16) | Free | Free | Linear | L | None | 12 | Antimicrobial | LC50 >80μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | KVLKAAAKAALNAVLVGANA | S4-(9-28) | Free | Free | Linear | L | None | 20 | Antimicrobial | LC50 =24±1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | AAAKAALNAVLVGANA | S4-(13-28) | Free | Free | Linear | L | None | 16 | Antimicrobial | LC50 =40μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKVLKAAAK | K4-S4-(1-16) | Free | Free | Linear | L | None | 16 | Antimicrobial | LC50 =57±3μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKVLKAAAK{ct:Amid} | K4-S4-(1-16)a | Amidation | Free | Linear | L | None | 16 | Antimicrobial | LC50 =10±0.5μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKVLKAAA{ct:Amid} | K4-S4-(1-15)a | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 =20±1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKVLKA{ct:Amid} | K4-S4-(1-13)a | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LC50 =57±3μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKV{ct:Amid} | K4-S4-(1-10)a | Amidation | Free | Linear | L | None | 10 | Antimicrobial | LC50 >100μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 15149180 | 2004 | {conj:lauric acid}YGAAKKAAKAAKKAAKAA | AKK | Free | Conjugated with lauric acid | Linear | L | None | 18 | Antimicrobial | <15% hemolysis at 500μM | Human | Synthetic peptide | α-helix | NA | ||
| 15149180 | 2004 | {conj:lauric acid}YGAKAKAAKAAKAKAAKA | KAK | Free | Conjugated with lauric acid | Linear | L | None | 18 | Antimicrobial | <15% hemolysis at 500μM | Human | Synthetic peptide | α-helix | NA | ||
| 15149180 | 2004 | {conj:lauric acid}KLFKRHLKWKII{ct:Amid} | SC4 | Amidation | Conjugated with lauric acid | Linear | L | None | 12 | Antimicrobial | <15% hemolysis at 500μM | Human | Synthetic peptide | α-helix | NA | ||
| 18243710 | 2008 | DAACAAHCLWR{ct:Amid} | DHWR | Amidation | Free | Linear | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | NA | NA | ||
| 18243710 | 2008 | DAACAAHCLWR{cyc:N-C}{ct:Amid} | DHWRox | Amidation | Free | Cyclic | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 18243710 | 2008 | DAACAAKCLWR{ct:Amid} | DKWR | Amidation | Free | Linear | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 18243710 | 2008 | DAACAAKCLWR{cyc:N-C}{ct:Amid} | DKWRox | Amidation | Free | Cyclic | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 18243710 | 2008 | KAACAAHCLWR{ct:Amid} | KHWR | Amidation | Free | Linear | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 18243710 | 2008 | KAACAAHCLWR{cyc:N-C}{ct:Amid} | KHWRox | Amidation | Free | Cyclic | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 18243710 | 2008 | KAACAAKCLWR{ct:Amid} | KKWR | Amidation | Free | Linear | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 18243710 | 2008 | KAACAAKCLWR{cyc:N-C}{ct:Amid} | KKWRox | Amidation | Free | Cyclic | L | None | 11 | Antimicrobial | HC50 >200μg/ml | Human | α-helical domain of Tenecin 1,an insect defensin | α-helix | NA | ||
| 10924341 | 2000 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 100μg/ml | Rat | Indolicidin of bovine neutrophil | NA | NA | ||
| 10924341 | 2000 | ILPWKLPLLPLRR{ct:Amid} | IL4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0% hemolysis at 100μg/ml | Rat | Indolicidin analog of bovine neutrophil | NA | Non-hemolytic | ||
| 10924341 | 2000 | ILPLKLPWLPLRR{ct:Amid} | IL8 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0% hemolysis at 100μg/ml | Rat | Indolicidin analog of bovine neutrophil | NA | Non-hemolytic | ||
| 10924341 | 2000 | ILPLKLPLLPWRR{ct:Amid} | IL11 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0% hemolysis at 100μg/ml | Rat | Indolicidin analog of bovine neutrophil | NA | Non-hemolytic | ||
| 11087404 | 2000 | RRWCFRVCYRGFCYRKCR{ct:Amid} | PM1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 21.3μg/ml | Human | Polyphemusin variants (horseshoe crab Limulus Polyphemus) | NA | NA | ||
| 11087404 | 2000 | RRWCFRVCYRGRFCYRKCR{ct:Amid} | PV5 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 42.6μg/ml | Human | Polyphemusin variants (horseshoe crab Limulus Polyphemus) | NA | NA | ||
| 11087404 | 2000 | RRWCFRVCYKGFCRYKCR{ct:Amid} | PV7 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 85μg/ml | Human | Polyphemusin variants (horseshoe crab Limulus Polyphemus) | NA | NA | ||
| 11087404 | 2000 | FRWCFRVCYKGRCRYKCR{ct:Amid} | PV8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 85μg/ml | Human | Polyphemusin variants (horseshoe crab Limulus Polyphemus) | NA | NA | ||
| 11467858 | 2001 | RGLRRLGRKIAHGVKKY{ct:Amid} | SMAP-29(1–17) | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 100μM (non-hemolytic) | Human | Cathelecidin derivative SMAP-29 derivative (sheep myeloid mRNA) | NA | Non-hemolytic | ||
| 11467858 | 2001 | RKLRRLKRKIAHKVKKY{ct:Amid} | [K2,7,13]-SMAP-29(1–17) | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 100μM (non-hemolytic) | Human | Cathelecidin derivative SMAP-29 derivative (sheep myeloid mRNA) | NA | Non-hemolytic | ||
| 18942691 | 2008 | GFLSILKKVLPKVMAHMK{ct:Amid} | MEP | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 >100μM | Rat | Melectin isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLKKVMAHMK{ct:Amid} | MEP-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 =27.3μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLKVMAHMK{ct:Amid} | MEP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | LC50 =22.9μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLAKVMAHMK{ct:Amid} | MEP-3 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 =29.7μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLGKVMAHMK{ct:Amid} | MEP-4 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 =41.1μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | VLPKVMAHMK{ct:Amid} | MEP-8 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | LC50 >100μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLP{ct:Amid} | MEP-9 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | LC50 >100μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVL{ct:Amid} | MEP-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | LC50 >100μM | Rat | Melectin analog isolated from the venom of the cleptoparasitic bee Melecta albifrons | NA | NA | ||
| 20153801 | 2010 | FLLFPLMCKIQGKC | Japonicin-1Npa | Free | Free | Linear | L | None | 14 | Antimicrobial | 1.92% hemolysis at 80μg/ml | Human | Japonicin-1 (skin of Xizang plateau frog Nanorana parkeri) | NA | NA | ||
| 20153801 | 2010 | FVLPLVMCKILRKC | Japonicin-1Npb | Free | Free | Linear | L | None | 14 | Antimicrobial | 3.40% hemolysis at 80μg/ml | Human | Japonicin-1 (skin of Xizang plateau frog Nanorana parkeri) | NA | NA | ||
| 20153801 | 2010 | GWANTLKNVAGGLCKITGAA | Parkerin | Free | Free | Linear | L | None | 20 | Antimicrobial | 2.36% hemolysis at 80μg/ml | Human | Parkerin (skin of Xizang plateau frog Nanorana parkeri) | NA | NA | ||
| 17145799 | 2007 | RWRWRWRWRW{ct:Amid} | (RW)5 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | HD50 =76μM | Sheep | Synthetic peptide (Phage display libraries) | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid} | Peptide 1 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 3.1 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}{cyc:N-C}{ct:Amid} | Peptide 2 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 1.6 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:ACPC}-L-{nnr:APC}-K-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:APC}-L-{nnr:ACPC}-L-{nnr:ACPC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid} | Peptide 3 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 100 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}{cyc:N-C}{ct:Amid} | Peptide 4 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 100 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}{cyc:N-C}{ct:Amid} | Peptide 5 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 1.6 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-F-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-F-{nnr:APC}-F-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}{cyc:N-C}{ct:Amid} | Peptide 6 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 1.6 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-A-{nnr:APC}-A-{nnr:ACPC}-K-{nnr:ACPC}-A-{nnr:APC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid} | Peptide 7 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at >400 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-L-{nnr:ACPC}-A-{nnr:APC}-A-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:ACPC}-K-{nnr:ACPC}-A-{nnr:APC}{cyc:N-C}{ct:Amid} | Peptide 8 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 100 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:ACPC}-A-{nnr:APC}-K-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:APC}-A-{nnr:ACPC}-A-{nnr:ACPC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid} | Peptide 9 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at >400 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17389605 | 2007 | KISKKIMRTFLRRILTGKK{ct:Amid} | NK19a | Amidation | Free | Linear | L | None | 19 | Antimicrobial and Cytotoxic | ~9% hemolysis at 100μg/ml | Human | Synthetic peptide variants based on the NK-2 lysin | α-helix | NA | ||
| 17389605 | 2007 | RILRGVSRRIMRRILTGRR{ct:Amid} | NK19b-KR | Amidation | Free | Linear | L | None | 19 | Antimicrobial and Cytotoxic | ~8% hemolysis at 100μg/ml | Human | Synthetic peptide variants based on the NK-2 lysin | α-helix | NA | ||
| 17394119 | 2007 | KWKLFKKIGAVLKVL | CAMEL0 | Free | Free | Linear | L | None | 15 | Antimicrobial | ~30% hemolysis at 100μM | Mouse | Cecropin–melittin hybrid (Synthetic peptide) | type I β-turn from Leu4-Lys7,followed by a helix at the C-terminus. | NA | ||
| 17394119 | 2007 | KWKLFKK-{nnr:ΔF}-GAVLKVL | CAMELΔ Phe1 | Free | Free | Linear | L | ΔF = α,β-dehydrophenylalanine (ΔPhe) | 15 | Antimicrobial | ~25% hemolysis at 100μM | Mouse | Cecropin–melittin hybrid (Synthetic peptide) | type I β-turn from Leu4-Lys7,followed by a helix at the C-terminus. | NA | ||
| 17394119 | 2007 | KWKL-{nnr:ΔF}-KKIGAV-{nnr:ΔF}-KVL | CAMELΔ Phe2 | Free | Free | Linear | L | ΔF = α,β-dehydrophenylalanine (ΔPhe) | 15 | Antimicrobial | ~90% hemolysis at 100μM | Mouse | Cecropin–melittin hybrid (Synthetic peptide) | type I β-turn from Leu4-Lys7,followed by a helix at the C-terminus. | NA | ||
| 17394119 | 2007 | KWKL-{nnr:ΔF}-KK-{nnr:ΔF}-GAV-{nnr:ΔF}-KVL | CAMELΔ Phe3 | Free | Free | Linear | L | ΔF = α,β-dehydrophenylalanine (ΔPhe) | 15 | Antimicrobial | >60% hemolysis at 100μM | Mouse | Cecropin–melittin hybrid (Synthetic peptide) | type I β-turn from Leu4-Lys7,followed by a helix at the C-terminus. | NA | ||
| 17451843 | 2007 | FLPIVGKLLSGLL{ct:Amid} | Temporin-1Csa | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =75μM | Human | Temporin analog (skin secretions of Rana cascadae) | NA | NA | ||
| 17451843 | 2007 | FLPIIGKLLSGLL{ct:Amid} | Temporin-1CSb | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =95μM | Human | Temporin analog (skin secretions of Rana cascadae) | NA | NA | ||
| 17451843 | 2007 | FLPLVTGLLSGLL{ct:Amid} | Temporin-1CSc | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 >300μM | Human | Temporin analog (skin secretions of Rana cascadae) | NA | NA | ||
| 17451843 | 2007 | NFLGTLVNLAKKIL{ct:Amid} | Temporin-1CSd | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 =50μM | Human | Temporin analog (skin secretions of Rana cascadae) | NA | NA | ||
| 18186149 | 2008 | KKKKKKAAFAAWAAFDA{cyc:N-C}{ct:Amid} | 7K-F18-1D17 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC =650μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{cyc:N-C}{ct:Amid} | 6k-f17 | Amidation | Free | Cyclic | D | None | 17 | Antimicrobial | MHC =325μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKAAFALWAAFAA{cyc:N-C}{ct:Amid} | 6K-F17-1L11 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC =81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKAAFALWLAFAA{cyc:N-C}{ct:Amid} | 6K-F17-2L11,13 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKAAFLAWALFAA{cyc:N-C}{ct:Amid} | 6K-F17-2L10,14 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}L{d}L{d}{cyc:N-C}{ct:Amid} | 6k-f17-2l16,17 | Amidation | Free | Cyclic | D | None | 17 | Antimicrobial | MHC <81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKALFAAWAAFLA{cyc:N-C}{ct:Amid} | 6K-F17-2L8,16 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKLLFAAWAAFAA{cyc:N-C}{ct:Amid} | 6K-F17-2L7,8 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKALFALWLAFAA{cyc:N-C}{ct:Amid} | 6K-F17-3L8,11,13 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <<81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKAAFALWLAFLA{cyc:N-C}{ct:Amid} | 6K-F17-3L11,13,16 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <<81μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | KKKKKKALFALWLAFLA{cyc:N-C}{ct:Amid} | 6K-F17-4L8,11,13,16 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | MHC <<81μM | Human | Synthetic peptide | random coil | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCVGR | PC1 | Free | Free | Linear | L | None | 18 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGGLCYCRRRFCVCVGR | PC3 | Free | Free | Linear | L | None | 18 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRGWICFCVGR | PC4 | Free | Free | Linear | L | None | 18 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRPRFCVCVGR | PC5 | Free | Free | Linear | L | None | 18 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLAYCRRRFCVAVGR | PC9 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0-3% hemolysis upto 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | No β-hairpin present | NA | ||
| 18455267 | 2008 | RGGRLCYARRRFAVCVGR | PC10 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0-3% hemolysis upto 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | No β-hairpin present | NA | ||
| 18455267 | 2008 | LCYCRRRFCVCVGR | PC11 | Free | Free | Linear | L | None | 14 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RCYCRRRFCVCVGR | PC12 | Free | Free | Linear | L | None | 14 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCV | PC13 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCICV | PC14 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCR | PC15 | Free | Free | Linear | L | None | 16 | Antimicrobial | 3-6% hemolysis at 80μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RCYCRRRFCVCR | PC16 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCVCV | PC17 | Free | Free | Linear | L | None | 12 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYARRRFAVCV | PC18 | Free | Free | Linear | L | None | 12 | Antimicrobial | 3-6% hemolysis at 80μg/ml | Human | Protegrin analogues from the procrine leukocytes | No β-hairpin present | NA | ||
| 18455267 | 2008 | RCYARRRFAVCR | PC18 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | No β-hairpin present | NA | ||
| 18455267 | 2008 | LAYCRRRFCVAV | PC20 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | No β-hairpin present | NA | ||
| 18455267 | 2008 | RAYCRRRFCVAR | PC21 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | No β-hairpin present | NA | ||
| 18455267 | 2008 | CYCRRRFCVCVGR | PC37 | Free | Free | Linear | L | None | 13 | Antimicrobial | 3-6% hemolysis at 80μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVC | PC45 | Free | Free | Linear | L | None | 15 | Antimicrobial | 3-6% hemolysis at 80μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYTRRRFTVCV | PC64 | Free | Free | Linear | L | None | 12 | Antimicrobial | 3-6% hemolysis at 80μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LTYCRRRFCVTV | PC64a | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYTRPRFTVCV | PC65 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYTFRPRFVCV | PC69 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYTFRGRFVCV | PC70 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | CYCRRRFCVCV | PC71 | Free | Free | Linear | L | None | 11 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCVC | PC72 | Free | Free | Linear | L | None | 11 | Antimicrobial | 6-12% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | CYCRRRFCVC | PC73 | Free | Free | Linear | L | None | 10 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | CYCFRRFCVC | PC74 | Free | Free | Linear | L | None | 10 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRRCVCV | PC77 | Free | Free | Linear | L | None | 12 | Antimicrobial | 3-6% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCFRRRCVCV | PC78 | Free | Free | Linear | L | None | 12 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRFRRCVCV | PC79 | Free | Free | Linear | L | None | 12 | Antimicrobial | 3-6% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRFRCVCV | PC80 | Free | Free | Linear | L | None | 12 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | YCYCRRRFCVCVGR | PC91 | Free | Free | Linear | L | None | 14 | Antimicrobial | 25-50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | TCYCRRRFCVCVGR | PC92 | Free | Free | Linear | L | None | 14 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | ACYCRRRFCVCVGR | PC93 | Free | Free | Linear | L | None | 14 | Antimicrobial | 25-50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | VCYCRRRFCVCVGR | PC94 | Free | Free | Linear | L | None | 14 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | ICYCRRRFCVCVGR | PC95 | Free | Free | Linear | L | None | 14 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | FCYCRRRFCVCVGR | PC96 | Free | Free | Linear | L | None | 14 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | WCYCRRRFCVCVGR | PC97 | Free | Free | Linear | L | None | 14 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | ECYCRRRFCVCVGR | PC98 | Free | Free | Linear | L | None | 14 | Antimicrobial | 3-6% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCY | PC100 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCT | PC101 | Free | Free | Linear | L | None | 16 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCA | PC102 | Free | Free | Linear | L | None | 16 | Antimicrobial | 25-50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCL | PC103 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCI | PC104 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCF | PC105 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCW | PC106 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RGGRLCYCRRRFCVCE | PC107 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RLCYTRGRFTVCV | PC109 | Free | Free | Linear | L | None | 13 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYTRGRFTVCVR | PC110 | Free | Free | Linear | L | None | 13 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | RLCYTRGRFTVCVR | PC111 | Free | Free | Linear | L | None | 14 | Antimicrobial | 12-25% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCHHHFCVCV | PC112 | Free | Free | Linear | L | None | 12 | Antimicrobial | 6-12% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYTHHHFTVCV | PC113 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCYCV | PC146 | Free | Free | Linear | L | None | 12 | Antimicrobial | 6-12% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCFCV | PC147 | Free | Free | Linear | L | None | 12 | Antimicrobial | >50% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCTCV | PC148 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCGCV | PC149 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0-3% hemolysis at 80 μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18455267 | 2008 | LCYCRRRFCWCV | PC150 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25-50% hemolysis at 80μg/ml | Human | Protegrin analogues from the procrine leukocytes | β-hairpin | NA | ||
| 18566844 | 2008 | GRRRRSVQWCA | hLF(1–11) | Free | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolysis at ≥200μM | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 18566844 | 2008 | FQWQRNMRKVR | hLF(21–31) | Free | Free | Linear | L | None | 11 | Antimicrobial | >2-3% at ≥16μM | Human | Synthetic peptide | NA | NA | ||
| 18566844 | 2008 | KVAKQEKKKKKTGRAKRR | UBI 18–35 | Free | Free | Linear | L | None | 18 | Antimicrobial | >2-3% at ≥20μM | Human | Synthetic peptide derived from Ubiquicidin | NA | NA | ||
| 18566844 | 2008 | TGRAKRRMQYNRR | UBI 29–41 | Free | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis at ≥200μM | Human | Synthetic peptide derived from Ubiquicidin | NA | Non-hemolytic | ||
| 18566844 | 2008 | LLLFLLKKRKKRKY | dhvar5 | Free | Free | Linear | L | None | 14 | Antimicrobial | >2-3% at ≥16μM | Human | Synthetic peptide | NA | NA | ||
| 18570895 | 2008 | LRQSQFVGSR{ct:Amid} | Urechistachykinins I | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 0% hemolysis at 3-100 μM (non-hemolytic) | Human | Neuropeptide derived from Urechis unicinctus | NA | Non-hemolytic | ||
| 18570895 | 2008 | AAGMGFFGAR{ct:Amid} | Urechistachykinins II | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 0% hemolysis at 3-100 μM (non-hemolytic) | Human | Neuropeptide derived from Urechis unicinctus | NA | Non-hemolytic | ||
| 18752624 | 2008 | MDFIIDIIKKIVGLFTGK | H2C | Free | Free | Linear | L | None | 18 | Cytotoxic | HD50 =4.79±0.09mM | Sheep | Synergistic hemolysins (Staphylococcus cohnii) | NA | NA | ||
| 18752624 | 2008 | MDFIIDIIKKIVGLFTGK | H2C | Free | Free | Linear | L | None | 18 | Cytotoxic | HD50 =8.76±2.08mM | Rabbit | Synergistic hemolysins (Staphylococcus cohnii) | NA | NA | ||
| 18752624 | 2008 | MDFIIDIIKKIVGLFTGK | H2C | Free | Free | Linear | L | None | 18 | Cytotoxic | HD50 =2.00±0.12mM | Guinea-pig | Synergistic hemolysins (Staphylococcus cohnii) | NA | NA | ||
| 18752624 | 2008 | MDFIIDIIKKIVGLFTGK | H2C | Free | Free | Linear | L | None | 18 | Cytotoxic | HD50 =5.35±0.60mM | Dog | Synergistic hemolysins (Staphylococcus cohnii) | NA | NA | ||
| 18752624 | 2008 | MDFIIDIIKKIVGLFTGK | H2C | Free | Free | Linear | L | None | 18 | Cytotoxic | HD50 =6.34±3.54mM | Human | Synergistic hemolysins (Staphylococcus cohnii) | NA | NA | ||
| 18852279 | 2008 | KWKLFKKIGAVLKVL{nt:Acet}{ct:Amid} | CM15 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 45% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 18852279 | 2008 | KWKKFKKIGAVLKVL{nt:Acet}{ct:Amid} | K4 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 21% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 18852279 | 2008 | KWKLFKKIGKVLKVL{nt:Acet}{ct:Amid} | K10 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 67% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 18852279 | 2008 | KWKLFKKIGAVLKKL{nt:Acet}{ct:Amid} | K14 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 4% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 18852279 | 2008 | KWKKFKKIGKVLKVL{nt:Acet}{ct:Amid} | K410 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 9% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 18852279 | 2008 | KWKKFKKIGAVLKKL{nt:Acet}{ct:Amid} | K414 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 3% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 18852279 | 2008 | KWKLFKKIGKVLKKL{nt:Acet}{ct:Amid} | K1014 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 8% hemolysis at 64μM | Human | Lysine-enriched analogs of the cecropin-mellitin hybrid | α-helix | NA | ||
| 19104020 | 2009 | KLALKLALKALKAALKLA{ct:Amid} | KLAL | Amidation | Free | Linear | L | None | 18 | Antimicrobial | EC50 =13.1μM | Human | Synthetic peptide | α-helix | NA | ||
| 19104020 | 2009 | KLALKLALKALKAALKLA{nt:Acet}{ct:Amid} | Ac-KLAL | Amidation | Acetylation | Linear | L | None | 18 | Antimicrobial | EC50 =9.1μM | Human | Synthetic peptide | α-helix | NA | ||
| 18695936 | 2009 | GRILSFIKGLAEHL{ct:Amid} | Eumenine mastoparan-OD | Amidation | Free | Linear | L | None | 14 | Hemolytic | >40% hemolysis at 50μM | Sheep | Venom of a Vespid solitary wasp, Orancistrocerus drewseni drewseni | α-helix | NA | ||
| 18695936 | 2009 | ILGIITSLLKSL{ct:Amid} | Orancis-Protonectin | Amidation | Free | Linear | L | None | 12 | Hemolytic | ~80% hemolysis at 50μM | Sheep | Venom of a Vespid solitary wasp, Orancistrocerus drewseni drewseni | α-helix | NA | ||
| 18695936 | 2009 | INLKALAALAKKIL{ct:Amid} | Mastoparan | Amidation | Free | Linear | L | None | 14 | Hemolytic | <10% hemolysis at 50μM | Sheep | Black-bellied hornet (Vespa basalis, Vespinae) venom | α-helix | NA | ||
| 19132829 | 2009 | V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antimicrobial | HC50=21.1(±2.6)μM | Sheep | Gramicidin S (Bacillus brevis) | β-sheet structure | NA | ||
| 19132829 | 2009 | V{nnr:O}L-{nnr:hpa}-PV{nnr:O}L-{nnr:hpa}-P{cyc:N-C} | GS1 | Free | Free | Cyclic | Mix | O = L-Ornithine, Hpa = homophenylalanine | 10 | Antimicrobial | HC50=7.0(±0.3)μM | Sheep | Gramicidin S analogue (Bacillus brevis) | β-sheet structure | NA | ||
| 19132829 | 2009 | V{nnr:O}L-{nnr:1-nal}-PV{nnr:O}L-{nnr:1-nal}-P{cyc:N-C} | GS2 | Free | Free | Cyclic | Mix | O = L-Ornithine, 1-Nal = 1-naphthylalanine | 10 | Antimicrobial | HC50=5.0(±0.1)μM | Sheep | Gramicidin S analogue (Bacillus brevis) | β-sheet structure | NA | ||
| 19132829 | 2009 | V{nnr:O}L-{nnr:2-nal}-PV{nnr:O}L-{nnr:2-nal}-P{cyc:N-C} | GS3 | Free | Free | Cyclic | Mix | O = L-Ornithine, 2-Nal = 2-naphthylalanine | 10 | Antimicrobial | HC50=7.1(±3.5)μM | Sheep | Gramicidin S analogue (Bacillus brevis) | β-sheet structure | NA | ||
| 19132829 | 2009 | V{nnr:O}L-{nnr:dip}-PV{nnr:O}L-{nnr:dip}-P{cyc:N-C} | GS4 | Free | Free | Cyclic | Mix | O = L-Ornithine, Dip = β,β-diphenylalanine | 10 | Antimicrobial | HC50=8.6(±1.1)μM | Sheep | Gramicidin S analogue (Bacillus brevis) | β-sheet structure | NA | ||
| 19132829 | 2009 | V{nnr:O}L-{nnr:flg}-PV{nnr:O}L-{nnr:flg}-P{cyc:N-C} | GS5 | Free | Free | Cyclic | Mix | O = L-Ornithine, Flg = fluorenylglycine | 10 | Antimicrobial | HC50=6.2(±0.3)μM | Sheep | Gramicidin S analogue (Bacillus brevis) | β-sheet structure | NA | ||
| 19132829 | 2009 | V{nnr:O}L-{nnr:tic}-PV{nnr:O}L-{nnr:tic}-P{cyc:N-C} | GS6 | Free | Free | Cyclic | Mix | O = L-Ornithine, Tic = 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | 10 | Antimicrobial | HC50 >50 μM | Sheep | Gramicidin S analogue (Bacillus brevis) | β-sheet structure | NA | ||
| 19330556 | 2009 | GIHDILKYGKPS | Myxinidin | Free | Free | Linear | L | None | 12 | Antimicrobial | 0% hemolysis at 1-500μg/ml (non-hemolytic) | Rabbit | Epidermal mucus extract of hagfish (Myxine glutinosa L.) | NA | Non-hemolytic | ||
| 19345214 | 2009 | ELLKAVRLIK | Rev-NIS | Free | Free | Linear | L | None | 10 | Antifungal | 0% hemolysis at 1-100μM (non-hemolytic) | Human | Rev (HIV-1) | helical | Non-hemolytic | ||
| 19399781 | 2009 | {nnr:Aib}-GL-{nnr:Aib}-GGL-{nnr:Aib}-GI-LOL{nt:Acet}{ct:leucinol} | Trichogin GA IV | 1,2-aminoalcohol, Lol (leucinol) | Acetylated by lipol (n-octanoyl) | Linear | L | Aib = α-aminoisobutyric acid | 11 | Antifungal and Antibacterial | 2% hemolysis at 15 μM | Human | Trichogin GA IV (Trichoderma longibrachiatum) | mixed 310/α-helical | NA | ||
| 19399781 | 2009 | {nnr:Aib}-GL-{nnr:Aib}-GGL-{nnr:Aib}-GIL{nt:Acet}{ct:Methoxy(Ome)} | Tric-OMe | Methoxy (Ome) | Acetylated by lipol (n-octanoyl) | Linear | L | Aib = α-aminoisobutyric acid | 11 | Antifungal and Antibacterial | 2% hemolysis at 15 μM | Human | Trichogin GA IV analogue (Trichoderma longibrachiatum) | mixed 310/α-helical | NA | ||
| 19445503 | 2009 | RRGWVLDLVLYYGRR | VDVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.02 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLDLVLYYGRR | VDVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.05 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLDLVLYYGRR | VDVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.07 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLDLVLYYGRR | VDVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.02 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLDLVLYYGRR | VDVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.09 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLDLVLYYGRR | VDVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.27 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLYYGRR | VAVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLYYGRR | VAVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.0 fractions hemolysis at 5.0 μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLYYGRR | VAVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.05 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLYYGRR | VAVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLYYGRR | VAVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.19 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLYYGRR | VAVY | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.4 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLRYGRR | VAVR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLRYGRR | VAVR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.02 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLRYGRR | VAVR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.19 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLRYGRR | VAVR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLRYGRR | VAVR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.15 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVLRYGRR | VAVR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.28 fractions hemolysis in 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALYLRYGRR | VAYR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALYLRYGRR | VAYR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.02 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALYLRYGRR | VAYR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.08 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALYLRYGRR | VAYR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.01 fracions Hemoysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALYLRYGRR | VAYR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.2 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALYLRYGRR | VAYR | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.25 fractions hemolyis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLRLALAY | VRAA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.0 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLRLALAY | VRAA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.03 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLRLALAY | VRAA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.08 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLRLALAY | VRAA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLRLALAY | VRAA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.1 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLRLALAY | VRAA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.14 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWALRLVLAY | ARVA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.02 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWALRLVLAY | ARVA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.05 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWALRLVLAY | ARVA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.06 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWALRLVLAY | ARVA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.05 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWALRLVLAY | ARVA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.12 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWALRLVLAY | ARVA | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.18 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWRLVLALVY | RVAV | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.0 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWRLVLALVY | RVAV | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.0 fractions hemolysis 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWRLVLALVY | RVAV | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.05 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWRLVLALVY | RVAV | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.01 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWRLVLALVY | RVAV | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.18 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWRLVLALVY | RVAV | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.3 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WYLTLTLGYGRR | YTTG | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.02 fractions hemolysis at 0.5μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WYLTLTLGYGRR | YTTG | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.02 fractions hemolysis at 5.0μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WYLTLTLGYGRR | YTTG | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.07 fractions hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WYLTLTLGYGRR | YTTG | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.02 fractions hemolysis at 0.5μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WYLTLTLGYGRR | YTTG | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.15 fractions hemolysis at 5.0μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | WYLTLTLGYGRR | YTTG | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.45 fractions hemolysis at 15μM | Human | Synthetic peptide | β-sheet structure | NA | ||
| 19445503 | 2009 | RRGWVLALVL{d}RYGRR | dVAVR | Free | Free | Linear | Mix | None | 15 | Antimicrobial | 5±6 % hemolysis at 15μM | Human | Synthetic peptide | β-sheet | NA | ||
| 19445503 | 2009 | RRGWVLALVL{d}RYGRR | dVAVR | Free | Free | Linear | Mix | None | 15 | Antimicrobial | 0 % hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet | NA | ||
| 19445503 | 2009 | RRGWVLALYL{d}RYGRR | dVAYR | Free | Free | Linear | Mix | None | 15 | Antimicrobial | 5±3% hemolysis at 15μM | Human | Synthetic peptide | β-sheet | NA | ||
| 19445503 | 2009 | RRGWVLALYL{d}RYGRR | dVAYR | Free | Free | Linear | Mix | None | 15 | Antimicrobial | 15±20% hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet | NA | ||
| 19445503 | 2009 | RRGWALRLVL{d}AY | dARVA | Free | Free | Linear | Mix | None | 12 | Antimicrobial | 4% hemolysis at 15μM | Human | Synthetic peptide | β-sheet | NA | ||
| 19445503 | 2009 | RRGWALRLVL{d}AY | dARVA | Free | Free | Linear | Mix | None | 12 | Antimicrobial | 10±12 % hemolysis at 15μM | Sheep | Synthetic peptide | β-sheet | NA | ||
| 19479741 | 2009 | VGKTWIKVIRGIGKSKIKWQ | Bactrocerin 1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 1-50μM (non-hemolytic) | Mouse | Immunized dipteran insect, Bactrocera dorsalis | random coil | Non-hemolytic | ||
| 19524300 | 2009 | RFGRFLRKIRRFRPK | C1-15 | Free | Free | Linear | L | None | 15 | Immunomodulatory and antimicrobial | 0% hemolysis at 40μM (non-hemolytic) | Chicken | Host defense peptide cathelicidin-2 (CATH-2) analog (Chicken ) | Helical | Non-hemolytic | ||
| 19524300 | 2009 | FRPKVTITIQGSARF{ct:Amid} | C12-26 | Amidation | Free | Linear | L | None | 15 | Immunomodulatory and antimicrobial | 0% hemolysis at 40μM | Chicken | Host defense peptide cathelicidin-2 (CATH-2) analog (Chicken ) | Helical | Non-hemolytic | ||
| 19544481 | 2009 | KKLLKWLKKLL{ct:Amid} | L5K5W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 7.26% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLKKLL{ct:Amid} | L5K5W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5.76% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLKKLL{ct:Amid} | L5K5W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4.72% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLKKLL{ct:Amid} | L5K5W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5.07% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLKKLL{ct:Amid} | L5K5W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4.78% hemolysis at12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLKKLL{ct:Amid} | L5K5W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5.30% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLLKLL{ct:Amid} | L6K4W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 57.58% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLLKLL{ct:Amid} | L6K4W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 14.92% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLLKLL{ct:Amid} | L6K4W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 7.38% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLLKLL{ct:Amid} | L6K4W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5.01% hemolysis at25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLLKLL{ct:Amid} | L6K4W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4.96% hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | KKLLKWLLKLL{ct:Amid} | L6K4W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4.73% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKLLKWLLKLL{ct:Amid} | L7K3W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 64.43% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKLLKWLLKLL{ct:Amid} | L7K3W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 34.29% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKLLKWLLKLL{ct:Amid} | L7K3W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 17.58% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKLLKWLLKLL{ct:Amid} | L7K3W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 14.99% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKLLKWLLKLL{ct:Amid} | L7K3W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 6.51% hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKLLKWLLKLL{ct:Amid} | L7K3W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5.13% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKLLKWLLKLLK{ct:Amid} | L7K5W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 47.72% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKLLKWLLKLLK{ct:Amid} | L7K5W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 20.86% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKLLKWLLKLLK{ct:Amid} | L7K5W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 12.80% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKLLKWLLKLLK{ct:Amid} | L7K5W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10.78% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKLLKWLLKLLK{ct:Amid} | L7K5W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5.31% hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LKKLLKWLLKLLK{ct:Amid} | L7K5W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5.07% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKLLKWLLKLLK{ct:Amid} | L8K4W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 36.37% hemolysis at 200μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKLLKWLLKLLK{ct:Amid} | L8K4W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10.90% hemolysis at 100μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKLLKWLLKLLK{ct:Amid} | L8K4W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 7.61% hemolysis at 50μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKLLKWLLKLLK{ct:Amid} | L8K4W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5.24% hemolysis at 25μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKLLKWLLKLLK{ct:Amid} | L8K4W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5.24% hemolysis at 12.5μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19544481 | 2009 | LLKLLKWLLKLLK{ct:Amid} | L8K4W7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.44% hemolysis at 6.3μg/ml | Human | Synthetic peptide | helical | NA | ||
| 19576903 | 2009 | ILPWKWPWWPWRR{ct:Amid} | IL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 64μM | Human | Indolicidin (bovine) | NA | NA | ||
| 19576903 | 2009 | ILPWKWKWWPWRR{ct:Amid} | IL-K7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 41.8% hemolysis at 64μM | Human | Indolicidin analog (bovine) | NA | NA | ||
| 19576903 | 2009 | ILPWKWPFFPWRR{ct:Amid} | IL-F89 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 21.4% hemolysis at 64μM | Human | Indolicidin analog (bovine) | NA | NA | ||
| 19576903 | 2009 | ILPWKWKFFPWRR{ct:Amid} | IL-K7F89 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10% hemolysis at 64μM | Human | Indolicidin analog (bovine) | NA | NA | ||
| 19576903 | 2009 | ILPFKFPFFPFRR{ct:Amid} | IL-F | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.3% hemolysis at 64μM | Human | Indolicidin analog (bovine) | NA | NA | ||
| 19703772 | 2009 | KLLLKLWLKLLK{nt:Acet}{ct:Amid} | KL1 | Amidation | Acetylation | Linear | L | None | 12 | Antibacterial | 100% hemolysis at >50μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 19703772 | 2009 | K{nnr:Ψ[CH2NH]}LLLKLWLKLLK{nt:Acet}{ct:Amid} | KL2 | Amidation | Acetylation | Linear | L | nnr:Ψ[CH2NH] | 12 | Antibacterial | 100% hemolysis at 150μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 19703772 | 2009 | KLLLKLWL{Ψ[CH2NH]}KLLK{nt:Acet}{ct:Amid} | KL3 | Amidation | Acetylation | Linear | L | nnr:Ψ[CH2NH] | 12 | Antibacterial | Low hemolysis upto 200μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 19635451 | 2010 | GIGAVLKVLALISWIKRKR{ct:Amid} | Mel-H | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 28% hemolysis at 0.4μM | Human | Melittin analog (venom of European honey bee) | α-helix | NA | ||
| 19635451 | 2010 | GIGAVLKVLALISWIKRKR{ct:Amid} | Mel-H | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 42% hemolysis at 23μM | Human | Melittin analog (venom of European honey bee) | α-helix | NA | ||
| 19635451 | 2010 | GIGAV{d}LKV{d}LAL{d}ISWIK{d}RKR{ct:Amid} | Mel-dH | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | 5% hemolysis at 0.4μM | Human | Melittin analog (venom of European honey bee) | α-helix | NA | ||
| 19635451 | 2010 | GIGAV{d}LKV{d}LAL{d}ISWIK{d}RKR{ct:Amid} | Mel-dH | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | 12 % hemolysis at 23μM | Human | Melittin analog (venom of European honey bee) | α-helix | NA | ||
| 20176897 | 2010 | G-{nnr:ΔF}-RK-{nnr:ΔF}-HK-{nnr:ΔF}-WA{nt:Acet}{ct:Amid} | ΔFm | Amidation | Acetylation | Linear | L | ΔF = α,β-didehydrophenylalanine | 10 | Antibacterial | 0% hemolysis upto 1358μg/ml (non-hemolytic) | Human | Synthetic peptide | Helical | Non-hemolytic | ||
| 20176897 | 2010 | G-{nnr:ΔF}-RK-{nnr:ΔF}-KA-{nnr:ΔF}-WH{nt:Acet}{ct:Amid} | ΔFmscr | Amidation | Acetylation | Linear | L | ΔF = α,β-didehydrophenylalanine | 10 | Antibacterial | 0% hemolysis upto 679μg/ml (non-hemolytic) | Human | Synthetic peptide | helical | Non-hemolytic | ||
| 20195659 | 2011 | IDWLKLGKMVMDVL{ct:Amid} | Polybia MP3 | Amidation | Free | Linear | L | None | 14 | Antibacterial | EC50 =50 μM | Rabbit | Venom sac of the Polybia paulista | helical | NA | ||
| 20195659 | 2011 | INWLKLGKMVIDAL{ct:Amid} | Polybia MP2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | EC50 =50 μM | Rabbit | Venom sac of the Polybia paulista | helical | NA | ||
| 20195659 | 2011 | IDWKKLLDAAKQIL{ct:Amid} | Polybia MP1 | Amidation | Free | Linear | L | None | 14 | Antibacterial | Non-hemolytic | Rabbit | Venom sac of the Polybia paulista | helical | NA | ||
| 20195659 | 2011 | INWKKLLDAAKQIL{ct:Amid} | Polybia N2-MP1 | Amidation | Free | Linear | L | None | 14 | Antibacterial | EC50 =26 μM | Rabbit | Venom sac of the Polybia paulista | helical | NA | ||
| 20196123 | 2010 | ILPWKWPWWPWRR{ct:Amid} | Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 50μM | Human | Indolicidin (bovine) | Random-coil | NA | ||
| 20196123 | 2010 | ILPLKWPWWPWRR{ct:Amid} | [L4]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 73% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKLPWWPWRR{ct:Amid} | [L6]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 88% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPLWPWRR{ct:Amid} | [L8]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 63% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPWLPWRR{ct:Amid} | [L9]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 6% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPWWPLRR{ct:Amid} | [L11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 13% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPLKLPLLPLRR{ct:Amid} | [L4,6,8,9,11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPFKFPFFPFRR{ct:Amid} | [F4,6,8,9,11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 6% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPYKYPYYPYRR{ct:Amid} | [Y4,6,8,9,11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 4% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPLKLPWWPWRR{ct:Amid} | [L4,6]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 8% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPKKKPWWPWRR{ct:Amid} | [K4,6]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 8% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPLLPWRR{ct:Amid} | [L8,9]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 18% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPYLPWRR{ct:Amid} | [Y8,L9]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 60% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPKLPWRR{ct:Amid} | [K8,L9]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | Non-hemolytic | ||
| 20196123 | 2010 | ILPWKWPWLPLRR{ct:Amid} | [L9,11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 3% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPWLPYRR{ct:Amid} | [L9,Y11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 12% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPWLPKRR{ct:Amid} | [L9,K11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 3% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPKKWPKLPWRR{ct:Amid} | [K4,8,L9]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 7% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKKPKLPWRR{ct:Amid} | [K6,8,L9]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 11% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPWLPWKK{ct:Amid} | [L9,K12,13]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 8% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | RRWPWWPWKWPLI{ct:Amid} | Retro-Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 36% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | RRWPLLPWKWPLI{ct:Amid} | Retro-[L8,9]Indb | Amidation | Free | Linear | L | None | 13 | Antibacterial | 11% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | RRWPLKPWKKPLI{ct:Amid} | Retro-[K4,8,L9]Indb | Amidation | Free | Linear | L | None | 13 | Antibacterial | 9% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | RRWPLKPKKWPLI{ct:Amid} | Retro-[K6,8,L9]Indb | Amidation | Free | Linear | L | None | 13 | Antibacterial | 7% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20237682 | 2010 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC = 3.0x10-5 g/ml | Human | Indolicidin (bovine neutrophils) | α Helical and β Sheet | NA | ||
| 20237682 | 2010 | ILPWKWPWWPARR{ct:Amid} | Δ5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC = 2.8x10-3 g/ml | Human | Indolicidin derivative (bovine neutrophils) | α Helical and β Sheet | NA | ||
| 20237682 | 2010 | ILPWKWPWAPARR{ct:Amid} | Δ45 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC = >2.6 x 10-3 g/ml | Human | Indolicidin derivative (bovine neutrophils) | α Helical and β Sheet | NA | ||
| 20237682 | 2010 | ILPWKWPAAPARR{ct:Amid} | Δ345 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC = >6.7x10-3 g/ml | Human | Indolicidin derivative (bovine neutrophils) | NA | NA | ||
| 20237682 | 2010 | ILPWKAPAAPARR{ct:Amid} | Δ2345 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC = >6.4x10-3 g/ml | Human | Indolicidin derivative (bovine neutrophils) | NA | NA | ||
| 20237682 | 2010 | ILPAKAPAAPARR{ct:Amid} | Δ12345 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC = >6.8x10-3 g/ml | Human | Indolicidin derivative (bovine neutrophils) | NA | NA | ||
| 20449481 | 2010 | V{nnr:O}LLF{d}PV{nnr:O}LF{d}P{cyc:N-C} | 2HBr (1) | Free | Free | Cyclic | Mix | O = L-Ornithine | 11 | Antimicrobial | 100% hemolysis at 100μM | Sheep | Gramacidin S (Bacillus brevis ) | antiparallel β-sheet | NA | ||
| 20449481 | 2010 | V{nnr:O}LAF{d}PV{nnr:O}LF{d}P{cyc:N-C} | 2HBr (2) | Free | Free | Cyclic | Mix | O = L-Ornithine | 11 | Antimicrobial | 50% hemolysis at 100μM | Sheep | Gramacidin S (Bacillus brevis ) | antiparallel β-sheet | NA | ||
| 20449481 | 2010 | V{nnr:O}L{nnr:O}F{d}PV{nnr:O}LF{d}P{cyc:N-C} | 3HBr (3) | Free | Free | Cyclic | Mix | O = L-Ornithine | 11 | Antimicrobial | 10% hemolysis at 100μM | Sheep | Gramacidin S (Bacillus brevis ) | antiparallel β-sheet | NA | ||
| 20449481 | 2010 | V{nnr:O}LKF{d}PV{nnr:O}LF{d}P{cyc:N-C} | 3HBr (4) | Free | Free | Cyclic | Mix | O = L-Ornithine | 11 | Antimicrobial | 10% hemolysis at 100μM | Sheep | Gramacidin S (Bacillus brevis ) | antiparallel β-sheet | NA | ||
| 20449481 | 2010 | V{nnr:O}LRF{d}PV{nnr:O}LF{d}P{cyc:N-C} | 3HCl (5) | Free | Free | Cyclic | Mix | O = L-Ornithine | 11 | Antimicrobial | 15% hemolysis at 100μM | Sheep | Gramacidin S (Bacillus brevis ) | antiparallel β-sheet | NA | ||
| 20499256 | 2010 | GFLSILKKVLPKVMAHMK{ct:Amid} | MEP | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 >100μM | Rat | Melectin from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSILKKVLPKV-{nnr:Met(O)}-AH-{nnr:Met(O)}-K{ct:Amid} | [Met (O)14,17] MEP | Amidation | Free | Linear | L | Met(O) = methionine sulfoxide | 18 | Antimicrobial | LC50 >200μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSILKKVLPKV-{nnr:Met(O2)}-AH-{nnr:Met(O2)}-K{ct:Amid} | [Met (O2)14,17] MEP | Amidation | Free | Linear | L | Met(O2) = methionine sulfone | 18 | Antimicrobial | LC50 >200μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSILKKVLPKV-{nnr:Nle}-AH-{nnr:Nle}-K{ct:Amid} | [Nle14,17] MEP | Amidation | Free | Linear | L | Nle = Norleucine | 18 | Antimicrobial | LC50 =50μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSLLKKVLPKV-Met-AH-{nnr:Nle}-K{ct:Amid} | [Nle17] MEP | Amidation | Free | Linear | L | Nle = Norleucine | 18 | Antimicrobial | LC50 =80μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSILKKVLPKV-{nnr:Nle}-AH-{nnr:Met(O)}-K{ct:Amid} | [Nle14, Met(O)17] MEP | Amidation | Free | Linear | L | Nle = Norleucine, Met(O) = methionine sulfoxide | 18 | Antimicrobial | LC50 >200μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSILKKVLPKV-{nnr:Nle}-AH-Met-K{ct:Amid} | [Nle14] MEP | Amidation | Free | Linear | L | Nle = Norleucine | 18 | Antimicrobial | LC50 =56.3μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSIVKKVLPKV-{nnr:Nle}-AH-{nnr:Met(O)}-K{ct:Amid} | [Val6, Nle14, Met(O)17] MEP | Amidation | Free | Linear | L | Nle = Norleucine, Met(O) = methionine sulfoxide | 18 | Antimicrobial | LC50 >200μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20499256 | 2010 | GFLSIVKKVLPKV-{nnr:Nle}-AH-Met(O)-K{ct:Amid} | [Val6, Nle14] MEP | Amidation | Free | Linear | L | Nle = Norleucine | 18 | Antimicrobial | LC50 >200μM | Rat | Melectin derivative from venom of the cleptoparasitic bee Melecta albifrons | α Helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | CA(1-7)M(2-9) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =40.2μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K1 (Me3) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =77.2μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K3 (Me3) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =85.6μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K6 (Me3) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =157.6μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K7 (Me3) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =164.0μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K13 (Me3) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =157.4μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K1,3 (Me3)2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =105.0μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K3,6 (Me3)2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =117.3μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K6,7 (Me3)2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =134.0μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K1,13 (Me3)2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 =82.6μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20617807 | 2010 | KWKLFKKIGAVLKVL{ct:Amid} | K1,3,6,7,13 (Me3)5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | HD50 >200μM | Sheep | Cecropin A-melittin hybrid | α-helix | NA | ||
| 20665599 | 2010 | KLKKLLKKWLKLLKKLLK{ct:Amid} | K9L8W | Amidation | Free | Linear | L | None | 18 | Antifungal | HC50 =14μM | Human | Synthetic peptide | α-helix | NA | ||
| 20665599 | 2010 | KL{d}KK{d}LL{d}KK{d}WL{d}KL{d}LK{d}KL{d}LK{d}{ct:Amid} | D9-K9L8W | Amidation | Free | Linear | Mix | None | 18 | Antifungal | HC50 <800μM | Human | Synthetic peptide | α-helix | NA | ||
| 20690652 | 2010 | KNLRRIIRKGIHIIKKYF | Novicidin | Free | Free | Linear | L | None | 18 | Antimicrobial | IC50 >50μM | Human | Peptide derived from ovispirin, a cationic peptide which originated from the ovine cathelicidin SMAP-29 | Helical | NA | ||
| 20728940 | 2010 | PAICQRAEIEACILL | Δ8-22 | Free | Free | Linear | L | None | 15 | Inhibitor of complement pathway | 100% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | NA | NA | ||
| 20927512 | 2011 | LGFGTFVLMLLGLVVELIK | TMDSP | Free | Free | Linear | L | None | 19 | Antibacterial | Mild hemolytic activity at 50μM | Sheep | Tmp1 (goat skin surface metagenome) | α Helix | NA | ||
| 21110126 | 2011 | FLGWLFKWASK{ct:Amid} | GA-W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =25μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FLGWLFKWAWK{ct:Amid} | GA-W3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =50μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FLWWLFKWAWK{ct:Amid} | GA-W4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =25μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FLGWLFKWAKK{ct:Amid} | GA-K3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =50μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FLKWLFKWAKK{ct:Amid} | GA-K4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =6.3μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FLKWLFKWLKK{ct:Amid} | GA-K4L | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =12.5μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FAKWAFKWAKK{ct:Amid} | GA-K4A | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC ≥200μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21110126 | 2011 | FAKWAFKWLKK{ct:Amid} | GA-K4AL | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC ≥200μg/ml | Human | Brevinin-1EMa analog (skin of a species of Korean frog Glandirana emeljanovi) | α-helix | NA | ||
| 21184776 | 2011 | NAGSLLSGWG | Leucrocin II | Free | Free | Linear | L | None | 10 | Antibacterial | 91.73% hemolysis at 10μg | Human | Leucrocin (serum and plasma of Crocodylus siamensis) | 44.44% Extended strand 55.56% Random coil | NA | ||
| 21184776 | 2011 | NAGSLLSGWG | Leucrocin II | Free | Free | Linear | L | None | 10 | Antibacterial | 11.63% hemolysis at 6.0μg | Human | Leucrocin (serum and plasma of Crocodylus siamensis) | 45.44% Extended strand 55.56% Random coil | NA | ||
| 14709550 | 2004 | K{d}GGGK{d}WGGK{d}GGK{d}{nt:Palmitoylation}{ct:Amid} | PA-D-G | Amidation | Palmitoylation | Linear | Mix | None | 12 | Antifungal and Antibacterial | >75% hemolysis at 100µM | Human | Synthetic peptide | Random coils | NA | ||
| 14709550 | 2004 | KAA{d}A{d}KWAA{d}KA{d}AK{nt:Palmitoylation}{ct:Amid} | PA-D-A | Amidation | Palmitoylation | Linear | Mix | None | 12 | Antifungal and Antibacterial | <25% hemolysis at 100µM | Human | Synthetic peptide | Random coils | NA | ||
| 14709550 | 2004 | KVV{d}V{d}KWVV{d}KV{d}VK{nt:Palmitoylation}{ct:Amid} | PA-D-V | Amidation | Palmitoylation | Linear | Mix | None | 12 | Antifungal and Antibacterial | 100% hemolysis at 100µM | Human | Synthetic peptide | β-aggregates | NA | ||
| 14709550 | 2004 | KLL{d}L{d}KWLL{d}KL{d}LK{nt:Palmitoylation}{ct:Amid} | PA-D-L | Amidation | Palmitoylation | Linear | Mix | None | 12 | Antifungal and Antibacterial | >75% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKLLKLLKKLLK{ct:Amid} | KLW | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50% hemolysis at 50µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKLLKLLKKLLK{ct:Amid} | KLW | Amidation | Free | Linear | L | None | 18 | Antimicrobial | >50% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKPLKLLKKLLK{ct:Amid} | KLW-L9P | Amidation | Free | Linear | L | None | 18 | Antimicrobial | <10% hemolysis at 50µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKPLKLLKKLLK{ct:Amid} | KLW-L9P | Amidation | Free | Linear | L | None | 18 | Antimicrobial | ~10% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKP{d}LKLLKKLLK{ct:Amid} | KLW-L9p | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | <5 % hemolysis at 50µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKP{d}LKLLKKLLK{ct:Amid} | KLW-L9p | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | ~5% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKLLPLLKKLLK{ct:Amid} | KLW-K11P | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50% hemolysis at 50µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKLLPLLKKLLK{ct:Amid} | KLW-K11P | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKLLP{d}LLKKLLK{ct:Amid} | KLW-K11p | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | <20% hemolysis at 50µM | Human | Synthetic peptide | α-helical | NA | ||
| 14733952 | 2004 | KWKKLLKKLLP{d}LLKKLLK{ct:Amid} | KLW-K11p | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | >30% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 15009528 | 2004 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14KD4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =125 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLL{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14LD4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =5 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLF{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14FD4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =2 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLY{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14YD4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =5 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLN{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14ND4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =62 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTTG | HM1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 46% hemolysis at 100µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTTG | HM1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 30% hemolysis at 50µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 86% hemolysis at 100µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 69% hemolysis at 50µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 98% hemolysis at 100µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 83% hemolysis at 50µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15052574 | 2004 | I/LNWLKLGKAIIDAI/L{ct:Amid} | Agelaia-MP | Amidation | Free | Linear | L | None | 14 | Inflammatory | 75% hemolysis at 1 x10-6 M | Rat | Mastoparan (venom of the wasp Agelaia pallipes pallipes) | NA | NA | ||
| 15150833 | 2004 | INWLKLGKMVIDAL{ct:Amid} | 13a | Amidation | Free | Linear | L | None | 14 | Inflammatory | 100% hemolysis at 6.2x10-5 M | Rat | Mastoparan (venom of the social wasp Polybia paulista) | NA | NA | ||
| 15150833 | 2004 | IDWLKLGKMVMDVL{ct:Amid} | 13b | Amidation | Free | Linear | L | None | 14 | Inflammatory | 100% hemolysis at 6.2x10-5 M | Rat | Mastoparan (venom of the social wasp Polybia paulista) | NA | NA | ||
| 15225564 | 2004 | ILGTILGLLKGL{ct:Amid} | Protonectin | Amidation | Free | Linear | L | None | 12 | Chemotactic | >40% hemolysis at 10-4 M | Rat | Mastoparan (venom of the neotropical social wasp Agelaia pallipes pallipes) | NA | NA | ||
| 15225564 | 2004 | INWLKLGKAIIDAL{ct:Amid} | Agelaia-MP | Amidation | Free | Linear | L | None | 14 | Mast cell degranulating toxin | ~90% hemolysis at 10-4 M | Rat | Mastoparan (venom of the neotropical social wasp Agelaia pallipes pallipes) | NA | NA | ||
| 15298176 | 2004 | LFGVLAKVAAHVVPAIAEHF{ct:Amid} | [∆1]Mac | Amidation | Free | Linear | L | None | 20 | Antibacterial | ~10% hemolysis at 100µM | Rabbit | Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata) | α-helical | NA | ||
| 15325526 | 2005 | FLPIIGQLLSGLL{ct:Amid} | Temporin-1AUa | Amidation | Free | Linear | L | None | 13 | Antimicrobial | HC50 >300µM | Human | Temporin-1 from skin secretions of the Northern red-legged frog Rana aurora aurora | NA | NA | ||
| 15581688 | 2005 | INWKKMAAATALKMI{ct:Amid} | MP | Amidation | Free | Linear | L | None | 15 | Hemolytic | 40% hemolysis at 10µM | Rat | Venom of the Neotropical social wasp Protopolybia exigua (Saussure) | α-helical | NA | ||
| 15581688 | 2005 | INWLKLGKKVSAIL{ct:Amid} | MPI | Amidation | Free | Linear | L | None | 14 | Hemolytic | 40% hemolysis at 10µM | Rat | Venom of the Neotropical social wasp Protopolybia indica (Saussure) | α-helical | NA | ||
| 15616319 | 2005 | QRSVSNAATRVCRTGRSRW | G13 | Free | Free | Linear | L | None | 19 | Antibiotic | 20% hemolysis 100µM | Rabbit | Granulysin-Derived Peptides | α-helical | NA | ||
| 15616319 | 2005 | GRSRWRDVCRNFMRR | G14 | Free | Free | Linear | L | None | 15 | Antibiotic | 40% hemolysis 100µM | Rabbit | Granulysin-Derived Peptides | α-helical | NA | ||
| 15616319 | 2005 | GQSQWRDVCRNFMRR | G15 | Free | Free | Linear | L | None | 15 | Antibiotic | ~40% hemolysis 100µM | Rabbit | Granulysin-Derived Peptides | α-helical | NA | ||
| 15629533 | 2005 | STIGDLVKWIIDTVNKFTKK | Peptide n-20 | Free | Free | Linear | L | None | 20 | Hemolytic | ~100% hemolysis at 20µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 15629533 | 2005 | IGDLVKWIIDTVNKFTKK | Peptide n-18 | Free | Free | Linear | L | None | 18 | Hemolytic | <50% hemolysis at 30µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 15629533 | 2005 | DLVKWIIDTVNKFTKK | Peptide n-16 | Free | Free | Linear | L | None | 16 | Hemolytic | <25% hemolysis at 30µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 15639237 | 2005 | GLGSVFGRLARILGRVIPKV{ct:Amid} | P1 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 20% hemolysis at 10µM | Human | Ant venom toxin pilosulin (Myrmecia pilosula) | α-helical | NA | ||
| 15639237 | 2005 | GLLSKFGRLARKLARVIPKV{ct:Amid} | P2 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 15% hemolysis at 10µM | Human | Ant venom toxin pilosulin (Myrmecia pilosula) | α-helical | NA | ||
| 15639237 | 2005 | GLGSVFGRLARILGRVIPKV{ct:Amid} | P1 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 100% hemolysis at 100µM | Human | Ant venom toxin pilosulin (Myrmecia pilosula) | α-helical | NA | ||
| 15639237 | 2005 | GLLSKFGRLARKLARVIPKV{ct:Amid} | P2 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 40% hemolysis at 100µM | Human | Ant venom toxin pilosulin (Myrmecia pilosula) | α-helical | NA | ||
| 15752569 | 2005 | FLSLIPHAINAVSAIAKHN{ct:Amid} | PS-1 | Amidation | Free | Linear | L | None | 19 | Antibacterial and Antiprotozoan | 1.98% hemolysis at 64µM | Human | Skin secretion of the Brazilian tree-frogs, Phyllomedusa hypochondrialis and Phyllomedusa oreades | α-helical | NA | ||
| 15752569 | 2005 | FLSLIPHAINAVSTLVHHF{ct:Amid} | PS-2 | Amidation | Free | Linear | L | None | 19 | Antibacterial and Antiprotozoan | 2.05% hemolysis at 64µM | Human | Skin secretion of the Brazilian tree-frogs, Phyllomedusa hypochondrialis and Phyllomedusa oreades | α-helical | NA | ||
| 15822124 | 2005 | FRKLFRVYSNFLRGKLKL{nt:Acet}{ct:Amid} | P1buy | Amidation | Acetylation | Linear | L | None | 18 | Hemolytic | 62% hemolysis at 10µM | Rat | Protein Data Bank (PDB, 1buy) | α-helical | NA | ||
| 15822124 | 2005 | WYSEMKRNVQRLERAIEE{nt:Acet}{ct:Amid} | P1c3c | Amidation | Acetylation | Linear | L | None | 18 | Hemolytic | 18% hemolysis at 10µM | Rat | Protein Data Bank (PDB, 1c3c) | α-helical | NA | ||
| 15822124 | 2005 | RDAKELVELFFEEIRRAL{nt:Acet}{ct:Amid} | P1ihf | Amidation | Acetylation | Linear | L | None | 18 | Hemolytic | 46% hemolysis at 10µM | Rat | Protein Data Bank (PDB, 1ihf) | α-helical | NA | ||
| 15822124 | 2005 | KQLIRFLKRLDRNLWGLA{nt:Acet}{ct:Amid} | P1ill | Amidation | Acetylation | Linear | L | None | 18 | Hemolytic | 48% hemolysis at 10µM | Rat | Protein Data Bank (PDB, 1ill) | α-helical | NA | ||
| 16137634 | 2005 | RQIKIWFQNRRMKWKK{ct:Amid} | pAntp(43–58) | Amidation | Free | Linear | L | None | 16 | CPP | 20.0±1.8% hemolysis at 50µM | Bovine | Penetratin (fragment of Antennapedia homeodomain) | NA | NA | ||
| 16137634 | 2005 | GRKKRRQRRRPPQ{ct:Amid} | pTAT(48–60) | Amidation | Free | Linear | L | None | 13 | CPP | 11.2±1.5% hemolysis at 50µM | Bovine | Fragment of transcription factor coded by theTat protein (HIV virus) | NA | NA | ||
| 16137634 | 2005 | LLIILRRRIRKQAHAHSK{ct:Amid} | pVEC(615–632) | Amidation | Free | Linear | L | None | 18 | CPP | 18.1±0.3% hemolysis at 50µM | Bovine | Vascular endothelial cadherin protein (Murine) | NA | NA | ||
| 16137634 | 2005 | KLALKLALKALKAALKLA{ct:Amid} | MAP | Amidation | Free | Linear | L | None | 18 | CPP | 20.9±1.8% hemolysis at 50µM | Bovine | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLLKKLLKLLKKLLK{ct:Amid} | KLW | Amidation | Free | Linear | L | None | 18 | Antimicrobial | >50% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 16142907 | 2005 | KWKKLLKK{nnr:a}LKLLKKLLK{ct:Amid} | KLW-L9-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 16142907 | 2005 | KWKKLLKKL{nnr:a}KLLKKLLK{ct:Amid} | KLW-L10-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | 20% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLLKKLL{nnr:a}LLKKLLK{ct:Amid} | KLW-K11-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | ~50% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLL{nnr:a}KLL{nnr:a}LLKKLLK{ct:Amid} | KLW-K7,11-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | ~30% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLLKKLLKLLKKLLK{ct:Amid} | KLW | Amidation | Free | Linear | L | None | 18 | Antimicrobial | <50% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLLKK{nnr:a}LKLLKKLLK{ct:Amid} | KLW-L9-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | >5% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLLKKL{nnr:a}KLLKKLLK{ct:Amid} | KLW-L10-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | 10-15% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLLKKLL{nnr:a}LLKKLLK{ct:Amid} | KLW-K11-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | ~50% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLL{nnr:a}KLL{nnr:a}LLKKLLK{ct:Amid} | KLW-K7,11-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | 10-15% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16226345 | 2006 | DAACAAHCLWR{ct:Amid} | L1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 100% hemolysis at 50μg/ml | Human | Synthetic peptide | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}CRRLCYKQRCVTYCRGR{ct:Amid} | Gomesin | Amidation | Free | Linear | L | Z = pyroglutamic acid | 18 | Antimicrobial | At 100µM less than 10% hemolysis | Human | Gomesin(Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16235231 | 2006 | {nnr:Z}DRRLSYKQRSVTYORGR{cyc:N-C}{ct:Amid} | cyclo(2-15)[Asp2 Ser6,11, Orn15]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | ~10% hemolysis at 100µM | Human | Analog of Gomesin (Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16235231 | 2006 | {nnr:Z}SRRLDYKQROVTYSRGR{cyc:N-C}{ct:Amid} | cyclo(6-11)[Ser2,15, Asp6, Orn11]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | ~10% hemolysis at 100µM | Human | Analog of Gomesin (Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16235231 | 2006 | {nnr:Z}CRRLDYKQROVTYCRGR{cyc:N-C}{ct:Amid} | Bicyclo(2-15, 6-11)[Cys2, 15, Asp6, Orn11]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | >30% hemolysis at 100µM | Human | Analog of Gomesin (Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16235231 | 2006 | {nnr:Z}CRRLDYKQRBVTYCRGR{cyc:N-C}{ct:Amid} | Bicyclo(2-15, 6-11)[Cys2, 15, Asp6, Dap11]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | >30% hemolysis at 100µM | Human | Analog of Gomesin (Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16235231 | 2006 | {nnr:Z}DRRLCYKQRCVTYORGR{cyc:N-C}{ct:Amid} | Bicyclo(2-15, 6-11)[Asp2, Cys6, 11, Orn15]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | ~15% hemolysis at 100µM | Human | Analog of Gomesin (Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16235231 | 2006 | {nnr:Z}DRRLCYKQRCVTYBRGR{cyc:N-C}{ct:Amid} | Bicyclo(2-15, 6-11)[Asp2, Cys6, Dap15]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | ~15% hemolysis at 100µM | Human | Analog of Gomesin (Acanthoscurria gomesiana) | α-helical and β-sheet | NA | ||
| 16460028 | 2006 | GASLSFKILKTVLEALGNV | EqTII11-29 | Free | Free | Linear | L | None | 19 | Hemolytic | 10% hemolysis at 25µM | Human | Actinoporin from sea anaemone Actinia equina L | NA | NA | ||
| 16616888 | 2006 | FQWQRNIRKVR{nt:acylation (CH3-(CH2)10-CO-NH-)}{ct:Amid} | C12LF11 | Amidation | acylation (CH3-(CH2)10-CO-NH-) | Linear | L | None | 11 | Antimicrobial | 0.25% hemolysis at 100µg/ml | Human | N-lauryl-derivative of LF11(human lactoferrin) | NA | NA | ||
| 16730857 | 2006 | KLKLKFKLKQ{cyc:N-C} | BPC10L | Free | Free | Cyclic | L | None | 10 | Antibacterial | 81 ± 5.3% hemolysis at 360µM | Human | Synthetic peptide | NA | NA | ||
| 16730857 | 2006 | KLKLKF{d}KLKQ{cyc:N-C} | BPC10D | Free | Free | Cyclic | Mix | None | 10 | Hemolytic | 42± 6.8% hemolysis at 360µM | Human | Synthetic peptide | NA | NA | ||
| 16762455 | 2006 | LNLKGIFKKVASLLT | Eumenitin | Free | Free | Linear | L | None | 15 | Antimicrobial | 20% hemolysis at 1mM | Human | Eumenitin isolated from the venom of the solitary eumenine wasp Eumenes rubronotatus | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLLKKLL{ct:Amid} | M17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ~63% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKPLKLLKKLL{ct:Amid} | M17P | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0-5% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLLKKLL{ct:Amid} | M17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ~63% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKPLKLLKKLL{ct:Amid} | M17P | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 4% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16940084 | 2006 | QRLFQVKGRR | PBP 10 | Free | Free | Linear | L | None | 10 | Antibacterial | >40% hemolysis at 40 µM | Human | Derived from the polyphosphoinositide binding site of gelsolin | NA | NA | ||
| 16997878 | 2006 | VRRFPWWWPFLRR | Tritrpticin | Free | Free | Linear | L | None | 13 | Antimicrobial | EC50 = 380µg/ml | Human | Tritrpticin from cathelicidin family of antimicrobial peptides | NA | NA | ||
| 16997878 | 2006 | VRRFPWWWPFLRR{ct:Amid} | Tritrp1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 = 190µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VKKFPWWWPFLKK{ct:Amid} | Tritrp2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 >1000µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VRRFAWWWAFLRR{ct:Amid} | Tritrp3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 = 60µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VRRFPYYYPFLRR{ct:Amid} | Tritrp4 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 >1000µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VRRYPWWWPYLRR{ct:Amid} | Tritrp5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 = 220µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VRRFPFFFPFLRR{ct:Amid} | Tritrp6 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 >1000µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VRRFAWWWPFLRR{ct:Amid} | Tritrp7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 >1000µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | VRRFPWWWAFLRR{ct:Amid} | Tritrp8 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 =354µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 16997878 | 2006 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | EC50 =310µg/ml | Human | Tritrpticin Analogs | NA | NA | ||
| 17067722 | 2006 | IGGIISFFKRLF | Gs B | Free | Free | Linear | L | None | 12 | Antibacterial | <10 HU/mg | Horse | Grammistins (Pogonoperca punctata) | NA | NA | ||
| 17142988 | 2006 | INWLKLGKKILGAI{ct:Amid} | Pm-R1 | Amidation | Free | Linear | L | None | 14 | Hemolytic | 24 % of hemolysis at 50mM | Sheep | Kinins derivative (Polistes rothneyi iwatai) | NA | NA | ||
| 17142988 | 2006 | LNFKALAALAKKIL{ct:Amid} | Pm-R2 | Amidation | Free | Linear | L | None | 14 | Hemolytic | 23 % of hemolysis at 50mM | Sheep | Kinins derivative (Polistes rothneyi iwatai) | NA | NA | ||
| 17142988 | 2006 | IAWLKLGKGILGAL{ct:Amid} | Pm-R3 | Amidation | Free | Linear | L | None | 14 | Hemolytic | 36 % of hemolysis at 50mM | Sheep | Kinins derivative (Polistes rothneyi iwatai) | NA | NA | ||
| 17142988 | 2006 | ILGTILGLLKGL{ct:Amid} | Polistes-protonectin | Amidation | Free | Linear | L | None | 12 | Hemolytic | 97 % of hemolysis at 50mM | Sheep | Kinins derivative (Polistes rothneyi iwatai) | NA | NA | ||
| 17142988 | 2006 | IALKALAALAKKIL{ct:Amid} | Mastparan | Amidation | Free | Linear | L | None | 14 | Hemolytic | 18 % of hemolysis at 50mM | Sheep | Mastoparans family | NA | NA | ||
| 17176094 | 2006 | RGGRLCYCRRRFCVCVGR{ct:Amid} | PG-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | ~100% hemolysis at above 100µg/ml | Human | Protegrins analog (porcine) | NA | NA | ||
| 17176094 | 2006 | RGGRLTYTRP{d}RFTVTVGR{ct:Amid} | TTpTT | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | ~10% hemolysis at above 100µg/ml | Human | Protegrins analog (porcine) | NA | NA | ||
| 17176094 | 2006 | RGGRLVYTR{nnr:p*}RFTVIVGR{ct:Amid} | TTp*TT | Amidation | Free | Linear | Mix | p* = amino-functionalized D-proline | 18 | Antimicrobial | ~20% hemolysis at above 100µg/ml | Human | Protegrins analog (porcine) | NA | NA | ||
| 17176094 | 2006 | RGGRLCYTRP{d}RFTVCVGR{ct:Amid} | CTpTC | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | ~60% hemolysis at above 100µg/ml | Human | Protegrins analog (porcine) | NA | NA | ||
| 17547385 | 2007 | ELMNS{nnr:Tic}{nnr:Oic}GKLGK{nnr:Tic}{nnr:Oic}ELMS{ct:Amid} | Peptide-8 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 18 | Antibiotic | 23% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | ELMNS{nnr:Tic}{nnr:Oic}GKLGK{nnr:Tic}{nnr:Oic}ELMS{ct:Amid} | Peptide-8 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 18 | Antibiotic | 23% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | ELS{nnr:Tic}{nnr:Oic}GKG{nnr:Tic}{nnr:Oic}LKES{ct:Amid} | Peptide-9 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 14 | Antibiotic | 23% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | ELS{nnr:Tic}{nnr:Oic}GKG{nnr:Tic}{nnr:Oic}LKES{ct:Amid} | Peptide-9 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 14 | Antibiotic | 23% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-23 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 14% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-23 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 14% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{ct:Amid} | Peptide-26 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 33.4% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{ct:Amid} | Peptide-26 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 14.3% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | KL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{ct:Amid} | Peptide-27 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 43.6% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | KL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{ct:Amid} | Peptide-27 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 24.9% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-28 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 15 | Antibiotic | 86.8% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-28 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 15 | Antibiotic | 50% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}{nnr:Oic}{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-29 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, GABA= γ-aminobutyric acid | 19 | Antibiotic | 10.8% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}{nnr:Oic}{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-29 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, GABA= γ-aminobutyric acid | 19 | Antibiotic | 1% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | G{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}G{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-30 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 15 | Antibiotic | 26.7% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | G{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}G{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-30 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 15 | Antibiotic | 9.2% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Oic}GK{nnr:Oic}GF{nnr:Oic}GKKKKK{nt:Acet}{ct:Amid} | Peptide-31 | Amidation | Acetylation | Linear | L | Oic = octahydroindolecarboxylic acid | 15 | Antibiotic | 5.9% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Oic}GK{nnr:Oic}GF{nnr:Oic}GKKKKK{nt:Acet}{ct:Amid} | Peptide-31 | Amidation | Acetylation | Linear | L | Oic = octahydroindolecarboxylic acid | 15 | Antibiotic | 3.2% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}GK{nnr:Tic}GF{nnr:Tic}GK{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-32 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid | 16 | Antibiotic | 6% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}GK{nnr:Tic}GF{nnr:Tic}GK{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-32 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid | 16 | Antibiotic | 4.9% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}GGK{nnr:Tic}GGF{nnr:Tic}GGK{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-33 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid | 19 | Antibiotic | 5.70% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}GGK{nnr:Tic}GGF{nnr:Tic}GGK{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-33 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid | 19 | Antibiotic | 3.80% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GFG-{nnr:Oic}-GKG-{nnr:Oic}-GFG-{nnr:Oic}-GKGKKKK{nt:Acet}{ct:Amid} | Peptide-34 | Amidation | Acetylation | Linear | L | Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 3.30% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GFG{nnr:Oic}GKG{nnr:Oic}GFG{nnr:Oic}GKGKKKK{nt:Acet}{ct:Amid} | Peptide-34 | Amidation | Acetylation | Linear | L | Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 3.3% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GFF{nnr:Oic}GKF{nnr:Oic}GFF{nnr:Oic}GKFKKKK{nt:Acet}{ct:Amid} | Peptide-35 | Amidation | Acetylation | Linear | L | Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 27.30% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GFF{nnr:Oic}GKF{nnr:Oic}GFF{nnr:Oic}GKFKKKK{nt:Acet}{ct:Amid} | Peptide-35 | Amidation | Acetylation | Linear | L | Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 8.9% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-36 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine | 19 | Antibiotic | 24.4% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-36 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine | 19 | Antibiotic | 7.4% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:Ahx}F{nnr:Tic}{nnr:Oic}{nnr:Ahx}K{nnr:Tic}{nnr:Oic}{nnr:Ahx}F{nnr:Tic}{nnr:Oic}{nnr:Ahx}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-37 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, Ahx = 6-aminohexanoic acid | 19 | Antibiotic | 44.7% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:Ahx}F{nnr:Tic}{nnr:Oic}{nnr:Ahx}K{nnr:Tic}{nnr:Oic}{nnr:Ahx}F{nnr:Tic}{nnr:Oic}{nnr:Ahx}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-37 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, Ahx = 6-aminohexanoic acid | 19 | Antibiotic | 26.6% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKKKK{nt:Acet}{ct:Amid} | Peptide-38 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 17 | Antibiotic | 41.3% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKKKK{nt:Acet}{ct:Amid} | Peptide-38 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 17 | Antibiotic | 33.5% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKKK{nt:Acet}{ct:Amid} | Peptide-39 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 20 | Antibiotic | 24.9% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKKK{nt:Acet}{ct:Amid} | Peptide-39 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 20 | Antibiotic | 18.9% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}{nnr:Oic}{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}KKKKK{nt:Acet}{ct:Amid} | Peptide-40 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, GABA= γ-aminobutyric acid | 18 | Antibiotic | 29.7% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}{nnr:Oic}{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}KKKKK{nt:Acet}{ct:Amid} | Peptide-40 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, GABA= γ-aminobutyric acid | 18 | Antibiotic | 10.5% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17560323 | 2007 | HFLGTLVNLAKKIL{ct:Amid} | Temporin-1DRa | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 65µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | KFLGTLVNLAKKIL{ct:Amid} | Lys-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | LKLGTLVNLAKKIL{ct:Amid} | Lys-2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFKGTLVNLAKKIL{ct:Amid} | Lys-3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLKTLVNLAKKIL{ct:Amid} | Lys-4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 42µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLKLVNLAKKIL{ct:Amid} | Lys-5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 100µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTKVNLAKKIL{ct:Amid} | Lys-6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLKNLAKKIL{ct:Amid} | Lys-7 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 330µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVKLAKKIL{ct:Amid} | Lys-8 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 38µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNKAKKIL{ct:Amid} | Lys-9 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLKKKIL{ct:Amid} | Lys-10 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAKKKL{ct:Amid} | Lys-13 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAKKIK{ct:Amid} | Lys-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLK{d}TLVNLAKKIL{ct:Amid} | D-Lys-4 | Amidation | Free | Linear | Mix | None | 14 | Antimicrobial | LD50 = 110µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLK{d}LVNLAKKIL{ct:Amid} | D-Lys-5 | Amidation | Free | Linear | Mix | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLK{d}NLAKKIL{ct:Amid} | D-Lys-7 | Amidation | Free | Linear | Mix | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVKLAKKIL{ct:Amid} | D-Lys-8 | Amidation | Free | Linear | Mix | None | 14 | Antimicrobial | LD50 = 385µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAK{d}KIL{ct:Amid} | D-Lys-11 | Amidation | Free | Linear | Mix | None | 14 | Antimicrobial | LD50 = 210µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAKK{d}IL{ct:Amid} | D-Lys-12 | Amidation | Free | Linear | Mix | None | 14 | Antimicrobial | LD50 = 500µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAKKIL{ct:Amid} | Chg-9 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 12µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAKKIL{ct:Amid} | Chg-13 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 16µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17560323 | 2007 | HFLLTLVNLAKKIL{ct:Amid} | Chg-9, Chg-13 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LD50 = 100µM | Human | Analogs of temporin-1DRa | NA | NA | ||
| 17826814 | 2007 | SLTFEVLDKVLGELGKVSRK | St I 12–31 | Free | Free | Linear | L | None | 20 | Hemolytic | Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is ~0.004 min-1 | Human | Sticholysin (Stichodactyla helianthus) | NA | NA | ||
| 17826814 | 2007 | SLTFQVLDKVLEELGKVSRK | St II 11–30 | Free | Free | Linear | L | None | 20 | Hemolytic | Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is ~0.002 min-1 | Human | Sticholysin (Stichodactyla helianthus) | NA | NA | ||
| 17961502 | 2007 | AKKVFKRLRKLFKKI | HPC2A3 | Free | Free | Linear | L | None | 15 | Antimicrobial | 4.5% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 17961502 | 2007 | FKRLKKLFKKIWNWK | HPA3NT3 | Free | Free | Linear | L | None | 15 | Antimicrobial | 11.62% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 17961502 | 2007 | FKRLEKLFKKIWNWK | HPA3NT2 | Free | Free | Linear | L | None | 15 | Antimicrobial | 14.92% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 17961502 | 2007 | FKRLKKLFSKIWNWK | HPA3NT1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 9.65% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 17961502 | 2007 | FKRLEKLFSKIWNWK | HPA3NT0 | Free | Free | Linear | L | None | 15 | Antimicrobial | 4.70% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 17961502 | 2007 | WKKVFKRLEKLFSKIWNWK | HPA3A1 | Free | Free | Linear | L | None | 19 | Antimicrobial | 94.69% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 17961502 | 2007 | AKKVFKRLEKLFSKIWNWK | HPA3 | Free | Free | Linear | L | None | 19 | Antimicrobial | 23.11% hemolysis at 100µM | Human | HP(2-20) analog (Helicobacter pylori) | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKFL{ct:Amid} | BP76 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 3±1% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKVL{nt:Benzoylation}{ct:Amid} | BP31 | Amidation | Benzoylation | Linear | L | None | 11 | Hemolytic | 34±9.2% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKWL{ct:Amid} | BP52 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 51±4.8% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | FKLFKKILKFL{ct:Amid} | BP66 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 9±2.2% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKFL{nt:Acet}{ct:Amid} | BP77 | Amidation | Acetylation | Linear | L | None | 11 | Hemolytic | 6±0.6% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKFL{nt:Tosylation}{ct:Amid} | BP78 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 40±4.0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | LKLFKKILKFL{ct:Amid} | BP81 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 10±1.3% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 3±0.1% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKYL{nt:Tosylation}{ct:Amid} | BP102 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 40±3.5% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKYL{nt:Benzoylation}{ct:Amid} | BP103 | Amidation | Benzoylation | Linear | L | None | 11 | Hemolytic | 42±4.7% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | LKLFKKILKYL{ct:Amid} | BP105 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 14±1.6% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | YKLFKKILKKL{nt:Tosylation}{ct:Amid} | BP121 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 22±1.3% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKKL{nt:Tosylation}{ct:Amid} | BP125 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 2±0.7% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKKL{nt:Benzoylation}{ct:Amid} | BP126 | Amidation | Benzoylation | Linear | L | None | 11 | Hemolytic | 2±0.4% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKFL{ct:Amid} | BP76 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 34±2.1% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKVL{nt:Benzoylation}{ct:Amid} | BP31 | Amidation | Benzoylation | Linear | L | None | 11 | Hemolytic | 71±2.3% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKWL{ct:Amid} | BP52 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 84±6.5% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | FKLFKKILKFL{ct:Amid} | BP66 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 63±5.9% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKFL{nt:Acet}{ct:Amid} | BP77 | Amidation | Acetylation | Linear | L | None | 11 | Hemolytic | 40±3.8% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKFL{nt:Tosylation}{ct:Amid} | BP78 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 85±7.4% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | LKLFKKILKFL{ct:Amid} | BP81 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 65±1.5% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 22±2.8% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKYL{nt:Tosylation}{ct:Amid} | BP102 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 79±6.5% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKYL{nt:Benzoylation}{ct:Amid} | BP103 | Amidation | Benzoylation | Linear | L | None | 11 | Hemolytic | 83±13.5% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | LKLFKKILKYL{ct:Amid} | BP105 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 91±6.2% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | YKLFKKILKKL{nt:Tosylation}{ct:Amid} | BP121 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 81±3.7% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKKL{ct:Amid} | BP125 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 8±1.6% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKKL{ct:Amid} | BP126 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 14±2.9% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17981364 | 2007 | SLLSLINKLIT | Decoralin | Free | Free | Linear | L | None | 11 | Hemolytic | 50-60% hemolysis at 10-3 M | Mouse | Decoralin (Oreumenes decoratus) | NA | NA | ||
| 17981364 | 2007 | SLLSLINKLIT{ct:Amid} | Decoralin-NH2 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 100% hemolysis at 10-3 M | Mouse | Decoralin analog (Oreumenes decoratus) | NA | NA | ||
| 17981364 | 2007 | SLLSLINKLIT{ct:Amid} | Decoralin-NH2 | Amidation | Free | Linear | L | None | 11 | Hemolytic | EC50 = 80 µM | Human | Decoralin analog (Oreumenes decoratus) | NA | NA | ||
| 17688900 | 2007 | FLSLALAALPKFLCLVFKKC | Brevinin-1DYa | Free | Free | Linear | L | None | 20 | Antibacterial | LC50 <5 µM | Human | brevinin family (Rana dybowskii) | NA | NA | ||
| 17688900 | 2007 | FLSLALAALPKLFCLIFKKC | Brevinin-1DYb | Free | Free | Linear | L | None | 20 | Antibacterial | LC50 <5 µM | Human | brevinin family (Rana dybowskii) | NA | NA | ||
| 17688900 | 2007 | FLPLLLAGLPKLLCLFFKKC | Brevinin-1DYc | Free | Free | Linear | L | None | 20 | Antibacterial | LC50 <5 µM | Human | brevinin family (Rana dybowskii) | NA | NA | ||
| 15052574 | 2004 | I/LLGTILGLLKGI/L{ct:Amid} | Agelaia-CP | Amidation | Free | Linear | L | None | 15 | Inflammatory | 0% hemolysis at 1x10-5 M (non-hemolytic) | Rat | Mastoparan (Agelaia pallipes pallipes) | NA | Non-hemolytic | ||
| 15055772 | 2004 | KWKLFKKIPKFLHLAKKF{ct:Amid} | P18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | Non-hemolytic | Human | cecropin A-magainin 2 hybrid | NA | Non-hemolytic | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLKVLTTG | HP(2-9)-ME(1-12) | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLKVLTWG | HM2 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Analog of HP(2-9)-ME(1-12) | NA | Non-hemolytic | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLKVLKKG | HM5 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Analog of HP(2-9)-ME(1-12) | NA | Non-hemolytic | ||
| 15196144 | 2004 | FKCRRWQWRMKKLG | LFB(17–30) | Free | Free | Linear | L | None | 14 | Fungicidal | 0% hemolysis at 100µM (non-hemolytic) | Human | Human lactoferrin | NA | Non-hemolytic | ||
| 15196144 | 2004 | KRLFKKLLFSLRKY | Dhvar 4 | Free | Free | Linear | L | None | 14 | Fungicidal | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 15196144 | 2004 | KRLFRRWQWRMKKY | JH8194 | Free | Free | Linear | L | None | 14 | Fungicidal | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 15196144 | 2004 | KRLFRRLLFSMKKY | JH8195 | Free | Free | Linear | L | None | 14 | Fungicidal | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 15196144 | 2004 | FKCKKVVISLRRY | JH8944 | Free | Free | Linear | L | None | 13 | Fungicidal | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 15298176 | 2004 | FGVLAKVAAHVVPAIAEHF{ct:Amid} | [∆1,2]Mac | Amidation | Free | Linear | L | None | 19 | Antibacterial | 0%hemolysis at 100µM (non-hemolytic) | Rabbit | Analog of Maculatin 1.1 (Mac) | NA | Non-hemolytic | ||
| 15581688 | 2005 | INWKAIIEAAKQAL{ct:Amid} | MP II | Amidation | Free | Linear | L | None | 14 | Hemolytic | No hemolysis at 10µM (non-hemolytic) | Rat | Mastoparan (Parapolybia indica) | NA | Non-hemolytic | ||
| 15581688 | 2005 | INWLKLGKAVIDAL{ct:Amid} | MP III | Amidation | Free | Linear | L | None | 14 | Hemolytic | No hemolysis at 10µM (non-hemolytic) | Rat | Mastoparan (Parapolybia indica) | NA | Non-hemolytic | ||
| 15616319 | 2005 | GRDYRTSLTIVQKLKKMVD | G1 | Free | Free | Linear | L | None | 19 | Antimicrobial | No hemolysis at 10µM (non-hemolytic) | Rabbit | Granulysin-Derived Peptides | NA | Non-hemolytic | ||
| 15616319 | 2005 | RDVCRNFMRR | G11 | Free | Free | Linear | L | None | 10 | Antimicrobial | No hemolysis at 10µM (non-hemolytic) | Rabbit | Granulysin-Derived Peptides | NA | Non-hemolytic | ||
| 15616319 | 2005 | QRSVSNAATRVCRT | G10 | Free | Free | Linear | L | None | 14 | Antimicrobial | No hemolysis at 10µM (non-hemolytic) | Rabbit | Granulysin-Derived Peptides | NA | Non-hemolytic | ||
| 15616319 | 2005 | QSRVIQGLVAGETAQQICED | G21 | Free | Free | Linear | L | None | 20 | Antimicrobial | No hemolysis at 10µM (non-hemolytic) | Rabbit | Granulysin-Derived Peptides | NA | Non-hemolytic | ||
| 15822124 | 2005 | NRLARHFRDIAGRVNQRL{nt:Acet}{ct:Amid} | P1c9k | Amidation | Acetylation | Linear | L | None | 18 | Hemolytic | Non-hemolytic | Rat | Protein Data Bank (PDB) | NA | Non-hemolytic | ||
| 15822124 | 2005 | LKDVEEAQQKIINIIRRL{nt:Acet}{ct:Amid} | P1qc7 | Amidation | Acetylation | Linear | L | None | 18 | Hemolytic | Non-hemolytic | Rat | Protein Data Bank (PDB) | NA | Non-hemolytic | ||
| 15949628 | 2005 | EWGRRCCGWGPGRRYCVRWC{cyc:N-C} | Ib-AMP1 | Free | Free | Cyclic | L | None | 20 | Antimicrobial | no hemolysis upto 100μM (non-hemolytic) | Rabbit | Synthetic peptide (Impatiens balsamina) | NA | Non-hemolytic | ||
| 15949628 | 2005 | EWGRRCCGWGPGRRYCRRWC{cyc:N-C} | Ib-AMP4 | Free | Free | Cyclic | L | None | 20 | Antimicrobial | no hemolysis upto 100μM (non-hemolytic) | Rabbit | Synthetic peptide (Impatiens balsamina) | NA | Non-hemolytic | ||
| 15980334 | 2005 | QAKIRVRLSA | M4 | Free | Free | Linear | L | None | 10 | Antimicrobial | <1% hemolysis at 120μg/ml | Human | Synthetic peptide | NA | NA | ||
| 15980334 | 2005 | QKKIRVRLSA | M6 | Free | Free | Linear | L | None | 10 | Antimicrobial | <1% hemolysis at 120μg/ml | Human | Synthetic peptide | NA | NA | ||
| 16142907 | 2005 | KWKKLLKK{nnr:a}LKL{nnr:a}KKLLK{ct:Amid} | KLW-L9,13-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 16226345 | 2006 | DAACAAKCLWR{ct:Amid} | L2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolysis at 200μg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 16226345 | 2006 | KAACAAHCLWR{ct:Amid} | L3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolysis at 200μg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 16226345 | 2006 | KAACAAKCLWR{ct:Amid} | L4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolysis at 200μg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 16344012 | 2006 | KWKLFKKIGIGKFLHSAKKF{ct:Amid} | CA-MA | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | CA-MA (Hyalaphora cecropia and Xenopus laevis) | NA | Non-hemolytic | ||
| 16344012 | 2006 | KWKKLLKKPLLKKLLKKL{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | CA-MA analog | NA | Non-hemolytic | ||
| 16616888 | 2006 | FQWQRNIRKVR{ct:Amid} | LF11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | Non-hemolytic | Human | N-lauryl-derivative of LF11(human lactoferrin) | NA | Non-hemolytic | ||
| 16730859 | 2006 | QADFQKVVAGVANALAHRYH | β126-145 | Free | Free | Linear | L | None | 20 | Antibacterial | Non-hemolytic | Bovine | Bovine hemoglobin | NA | Non-hemolytic | ||
| 16963159 | 2006 | FLSLIPHAINAVSAIAKHF{ct:Amid} | PS-7 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | No hemolysis at 6µM (non-hemolytic) | Human | Phylloseptin (Phyllomedusa hypochondrialis) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKLFSKIQNDK | HP (2–20) | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | KVFKRLEKLFSKIQNDK | HPN1(4–20) | Free | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | FKRLEKLFSKIQNDK | HPN2(6–20) | Free | Free | Linear | L | None | 16 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | RLEKLFSKIQNDK | HPN3(8–20) | Free | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKLFSKIQN | HPC1(2–18) | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKLFSKI | HPC2(2–16) | Free | Free | Linear | L | None | 15 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKLFS | HPC3(2–14) | Free | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | KVFKRLEKLFSKI | HPN1C2(4–16) | Free | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | KVFKRLEKLFS | HPN1C3(4–14) | Free | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKLFSKIQNWK | HPA1 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKLFSKIWNDK | HPA2 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVFKRLEKSFSKIQNDK | HPA4 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 17961502 | 2007 | AKKVSKRLEKLFSKIQNDK | HPA5 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | HP(2-20) analog (Helicobacter pylori) | NA | Non-hemolytic | ||
| 20015460 | 2010 | GVIKSVLKGVAKTVALGML{ct:Amid} | B2RP | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 = 280 µM | Human | Skin secretions of the South-East Asian frog Hylarana erythraea (Ranidae) | NA | NA | ||
| 17888907 | 2008 | KWCFRVCYRGICYRRC | Tachyplesin-I | Free | Free | Linear | L | None | 16 | Antimicrobial | 10% hemolysis 100µM | Human | Synthetic peptide | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAAKALVKTVLF{ct:Amid} | Ascaphin-8 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 = 55µM | Human | Ascaphin-8 (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKLLLKGAAKALVKTVLF{ct:Amid} | Lys-4 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 = 24µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKKAAKALVKTVLF{ct:Amid} | Lys-8 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 = 11µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAKKALVKTVLF{ct:Amid} | Lys-10 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 >500µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAAKALKKTVLF{ct:Amid} | Lys-14 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 >500µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAAKALVKTVK{d}F{ct:Amid} | Lys-18 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 >500µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKK{d}LLKGAAKALVKTVLF{ct:Amid} | D-Lys-4 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | LD50 = 300µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKK{d}AAKALVKTVLF{ct:Amid} | D-Lys-8 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | LD50 = 150µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAK{d}KALVKTVLF{ct:Amid} | D-Lys-10 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | LD50 >500 µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAAKALVKTVLF{ct:Amid} | D-Lys-14 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | LD50 >500 µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAAKALVKTVK{d}F{ct:Amid} | D-Lys-18 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | LD50 >500 µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GFKDLLKGAAKALVKAVLF{ct:Amid} | Ala-16 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LD50 = 22µM | Human | Ascaphin-8 analog (Ascaphus truei) | NA | NA | ||
| 18554256 | 2008 | GLLGPLLKIAAKVGSNLL{ct:Amid} | XT-7 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 140µM | Human | XT-7 (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | KLLGPLLKIAAKVGSNLL{ct:Amid} | Lys-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 400µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLKPLLKIAAKVGSNLL{ct:Amid} | Lys-4 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 >500µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLGKLLKIAAKVGSNLL{ct:Amid} | Lys-5 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 15µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLGPLLKIAKKVGSNLL{ct:Amid} | Lys-11 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 350µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLGPLLKIAAKVGKNLL{ct:Amid} | Lys-15 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 110µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLGPLLKIAAKVGSKLL{ct:Amid} | Lys-16 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 80µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLGPLLKIAAKVGKKLL{ct:Amid} | Lys-15, Lys-16 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 60µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLGKLLKIAAKVGKKLL{ct:Amid} | Lys-5, Lys-15, Lys-16 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 25µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 18554256 | 2008 | GLLKKLLKIAAKVGKKLL{ct:Amid} | Lys-4, Lys-5,Lys-15, Lys-16 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LD50 = 25µM | Human | XT-7 analog (Xenopus tropicalis) | NA | NA | ||
| 11478963 | 2001 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Hypotensive | 80-85% hemolysis at 15 µM | Guinea-pig | MP-B (Vespa basalis) | NA | NA | ||
| 11478963 | 2001 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Hypotensive | 81-85% hemolysis at 15 µM | Guinea-pig | MP-B (Vespa basalis) | NA | NA | ||
| 11478963 | 2001 | L{d}K{d}L{d}K{d}S{d}I{d}V{d}S{d}W{d}A{d}K{d}K{d}V{d}L{d}{ct:Amid} | D-MP-B | Amidation | Free | Linear | D | None | 14 | Hypotensive | 82-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | L{d}K{d}L{d}K{d}S{d}I{d}V{d}S{d}W{d}A{d}K{d}K{d}V{d}L{d}{ct:Amid} | D-MP-B | Amidation | Free | Linear | D | None | 14 | Hypotensive | 83-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | LK{d}LKSIVSWAKKVL{ct:Amid} | [D-Lys2]-MP-B | Amidation | Free | Linear | Mix | None | 14 | Hypotensive | 84-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | LK{d}LKSIVSWAKKVL{ct:Amid} | [D-Lys2]-MP-B | Amidation | Free | Linear | Mix | None | 14 | Hypotensive | 85-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | LKLK{d}SIVSWAKKVL{ct:Amid} | [D-Lys4]-MP-B | Amidation | Free | Linear | Mix | None | 14 | Hypotensive | 86-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | LKLK{d}SIVSWAKKVL{ct:Amid} | [D-Lys4]-MP-B | Amidation | Free | Linear | Mix | None | 14 | Hypotensive | 87-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | LKLKSIVSWAK{d}K{d}VL{ct:Amid} | [D-Lys11,12]-MP-B | Amidation | Free | Linear | Mix | None | 14 | Hypotensive | 88-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | LKLKSIVSWAK{d}K{d}VL{ct:Amid} | [D-Lys11,12]-MP-B | Amidation | Free | Linear | Mix | None | 14 | Hypotensive | 89-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11520071 | 2001 | ILGKIWEGIKSLF{ct:Amid} | IsCT | Amidation | Free | Linear | L | None | 13 | Cytotoxic | 30-40% hemolysis at 50 µM | Sheep | Scorpion Opisthacanthus madagascariensis | NA | NA | ||
| 11520071 | 2001 | ILGKIWEGIKSLF{ct:Amid} | IsCT | Amidation | Free | Linear | L | None | 13 | Cytotoxic | 50-60% hemolysis at 100 µM | Sheep | Scorpion Opisthacanthus madagascariensis | NA | NA | ||
| 15003829 | 2004 | FLSLALAALPKLFCLIFKKC | Brevinin-1PRa | Free | Free | Linear | L | None | 20 | Antimicrobial | HC50 = 7µM | Human | Rana pirica (brevinin-2) | NA | NA | ||
| 15003829 | 2004 | ILPILGNLLNGLL{ct:Amid} | Temporin-1PRa | Amidation | Free | Linear | L | None | 13 | Antimicrobial | HC50 >300µM | Human | Rana pirica (brevinin-2) | NA | NA | ||
| 15003829 | 2004 | ILPILGNLLNSLL{ct:Amid} | Temporin-1PRb | Amidation | Free | Linear | L | None | 13 | Antimicrobial | HC50 >300µM | Human | Rana pirica (brevinin-2) | NA | NA | ||
| 21871946 | 2012 | FVDLKKIANIINSIF{ct:Amid} | Temporin-1CEa | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 60% hemolysis at 100 µM | Human | Rana chensinensis | NA | NA | ||
| 21871946 | 2012 | FVDLKKIANIINSIF{ct:Amid} | Temporin-1CEa | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 100% hemolysis at 200 µM | Human | Rana chensinensis | NA | NA | ||
| 21924309 | 2011 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Antioxidant | Non-hemolytic | Human | MP-B (Vespa basalis) | NA | Non-hemolytic | ||
| 21924309 | 2011 | LKWKSIVSWAKKVL{ct:Amid} | MP-B-1 | Amidation | Free | Linear | L | None | 14 | Antioxidant | Non-hemolytic | Human | MP-B analog (Vespa basalis) | NA | Non-hemolytic | ||
| 21924309 | 2011 | LKLKNIVSWAKKVL{ct:Amid} | MP-B-2 | Amidation | Free | Linear | L | None | 14 | Antioxidant | Non-hemolytic | Human | MP-B analog (Vespa basalis) | NA | Non-hemolytic | ||
| 21924309 | 2011 | LKLKSIVSYAKKVL{ct:Amid} | MP-B-3 | Amidation | Free | Linear | L | None | 14 | Antioxidant | Non-hemolytic | Human | MP-B analog (Vespa basalis) | NA | Non-hemolytic | ||
| 10631295 | 2000 | KLKLKLKLKLK{nt:Dansylation}{ct:Amid} | (KL)5K | Amidation | Dansylation | Linear | L | None | 11 | Antimicrobial | 60% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10631295 | 2000 | KLKLKLKLKLKLKLK{nt:Dansylation}{ct:Amid} | (KL)6K | Amidation | Dansylation | Linear | L | None | 13 | Antimicrobial | ~90% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10631295 | 2000 | KLLKLLLKLLLKLLK{nt:Dansylation}{ct:Amid} | (KL)7K | Amidation | Dansylation | Linear | L | None | 15 | Antimicrobial | ~90% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10667861 | 2000 | INLKALAALAKKIL{ct:Amid} | MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 68.2% hemolysis at 100µM | Human | Mastoparan B isolated from the venom of the hornet Vespa basalis | NA | NA | ||
| 10667861 | 2000 | INLKALAALAKKIL{ct:Amid} | MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 37.9% hemolysis at 50µM | Human | Mastoparan B (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKAKSIVSWAKKVL{ct:Amid} | [Ala3] MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 13.8% hemolysis at 100µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKAKSIVSWAKKVL{ct:Amid} | [Ala3] MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 11.9% hemolysis at 50µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKLASIVSWAKKVL{ct:Amid} | [Ala4]MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 93.4% hemolysis at 100µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKLASIVSWAKKVL{ct:Amid} | [Ala4]MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 60.1% hemolysis at 50µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKLKSIVSAAKKVL{ct:Amid} | [Ala9]MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 6.0% hemolysis at 100µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKLKSIVSAAKKVL{ct:Amid} | [Ala9]MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 8.5% hemolysis at 50µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKLKSIVSWAKAVL{ct:Amid} | [Ala12]MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 66.2% hemolysis at 100µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10667861 | 2000 | LKLKSIVSWAKAVL{ct:Amid} | [Ala12]MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 59.1% hemolysis at 50µM | Human | Mastoparan B analog (Vespa basalis) | NA | NA | ||
| 10675500 | 2000 | KWKLFKKIGIGKFLHSAKKF{ct:Amid} | CA-MA | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Cecropin A(Hyalophora cecropia), Magainin 2(Xenopus laevis) | NA | Non-hemolytic | ||
| 10675500 | 2000 | KWKLFKKIKFLHSAKKF{ct:Amid} | CA-MA1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Cecropin A(Hyalophora cecropia), Magainin 2(Xenopus laevis) | NA | Non-hemolytic | ||
| 10675500 | 2000 | KWKLFKKIPKFLHSAKKF{ct:Amid} | CA-MA2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Cecropin A(Hyalophora cecropia), Magainin 2(Xenopus laevis) | NA | Non-hemolytic | ||
| 10675500 | 2000 | KWKLFKKIGPGKFLHSAKKF{ct:Amid} | CA-MA3 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100µM (non-hemolytic) | Human | Cecropin A(Hyalophora cecropia), Magainin 2(Xenopus laevis) | NA | Non-hemolytic | ||
| 10817697 | 2000 | EGRERDHELRHRRHHHQSPK{ct:Amid} | MUC7 D1 | Amidation | Free | Linear | L | None | 20 | Antifungal | <10% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 10819172 | 2000 | KLLLKLLLKLLK{ct:Amid} | S1 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 100% hemolysis at 200µg/ml | Mouse | Synthetic peptide | NA | NA | ||
| 10819172 | 2000 | KLLΨ[CH2OCONH]LKLLLKLLK{ct:Amid} | SC1 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 100% hemolysis at 200µg/ml | Mouse | Synthetic peptide | NA | NA | ||
| 10819172 | 2000 | KLLΨ[CH2OCONH]LKLLLΨ[CH2OCONH]KLLK{ct:Amid} | SC2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | ~90% hemolysis at 200µg/ml | Mouse | Synthetic peptide | NA | NA | ||
| 20237682 | 2010 | ILPWKWPWWPWRR{ct:Amid} | Δ0 (Indolicidin) | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC 3.0*10-3 g ml-1 | Human | Indolicidin(Bovine neutrophils) | NA | NA | ||
| 20237682 | 2010 | ILPWKWPWWPARR{ct:Amid} | Δ5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC 2.8*10-3 g ml-1 | Human | Indolicidin derivatives(Bovine neutrophils) | NA | NA | ||
| 20237682 | 2010 | ILPWKWPWAPARR{ct:Amid} | Δ45 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >2.6*10-3 g ml-1 | Human | Indolicidin derivatives(Bovine neutrophils) | NA | NA | ||
| 20237682 | 2010 | ILPWKWPAAPARR{ct:Amid} | Δ345 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >6.7*10-3 g ml-1 | Human | Indolicidin derivatives(Bovine neutrophils) | NA | NA | ||
| 20237682 | 2010 | ILPWKAPAAPARR{ct:Amid} | Δ2345 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >6.4*10-3 g ml-1 | Human | Indolicidin derivatives(Bovine neutrophils) | NA | Non-hemolytic | ||
| 20237682 | 2010 | ILPAKAPAAPARR{ct:Amid} | Δ12345 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >6.8*10-3 g ml-1 | Human | Indolicidin derivatives(Bovine neutrophils) | NA | Non-hemolytic | ||
| 20798581 | 2010 | KKAAHVGKHVGKAALTHYL{ct:Amid} | Ple (7-25) | Amidation | Free | Linear | L | None | 19 | Antifungal | 0% hemolysis at 100µM (non-hemolytic) | Human | Pleurocidin analogs (Pleuronectes americanus) | NA | Non-hemolytic | ||
| 20798581 | 2010 | GWGSFFKKAAHVGKHVGKA{ct:Amid} | Ple (1-19) | Amidation | Free | Linear | L | None | 19 | Antifungal | 0% hemolysis at 100µM (non-hemolytic) | Human | Pleurocidin analogs (Pleuronectes americanus) | NA | Non-hemolytic | ||
| 21168911 | 2011 | FFRRFFRRFFRR{ct:Amid} | (FFRR)3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | HC50 > 500 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | AARRAARRAARR{ct:Amid} | (AARR)3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | HC50 > 500 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | LLRRLLRRLLRR{ct:Amid} | (LLRR)3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | HC50 > 500 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | LLKKLLKKLLKK{ct:Amid} | (LLKK)3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | HC50 > 500 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | FFRRFFRRFFRRFFRR{ct:Amid} | (FFRR)4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | HC50 > ~26 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | LLRRLLRRLLRRLLRR{ct:Amid} | (LLRR)4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | HC50 > ~12 | Human | Synthetic peptide | NA | NA | ||
| 21168911 | 2011 | LLKKLLKKLLKKLLKK{ct:Amid} | (LLKK)4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | HC50 > ~24 | Human | Synthetic peptide | NA | NA | ||
| 21184791 | 2011 | GRILSFIKGLAEHL{ct:Amid} | OdVP1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | ILGIITSLLKSL{ct:Amid} | OdVP2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | EC50 = 31 (23–41)µM | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | NA | ||
| 21184791 | 2011 | KDLHTVVSAILQAL{ct:Amid} | OdVP3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | LDPKVVQSLL{ct:Amid} | OdVP4 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | INLKGLIKKVASLLT | EpVP1 | Free | Free | Linear | L | None | 15 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | FDLLGLVKKVASAL{ct:Amid} | EpVP2a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | FDLLGLVKSVVSAL{ct:Amid} | EpVP2b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | EC50 = 64 (68–70)µM | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | NA | ||
| 21184791 | 2011 | AINPKSVQSLL{ct:Amid} | EpVP3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | INPKSVQSLL{ct:Amid} | EpVP3S | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | LSPAVMASLA{ct:Amid} | EpVP4a | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | LSPAAMASLA{ct:Amid} | EpVP4b | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | VHVPPICSHRECRK | EpVP5 | Free | Free | Linear | L | None | 14 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 21184791 | 2011 | FGPVIGLLSGILKSLL | EpVP6 | Free | Free | Linear | L | None | 16 | Antimicrobial | Non-hemolytic | Human | Venom peptides (Orancistrocerus drewseni, Eumenes pomiformis) | NA | Non-hemolytic | ||
| 23430306 | 2013 | LRRLWLRANRL | LRR-1 | Free | Free | Linear | L | None | 11 | Antibacterial | 0% hemolysis at 128µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 16730966 | 2006 | KRFKQDGGWSHWSPWSS | KRF17 | Free | Free | Linear | L | None | 17 | Antimicrobial | ~3% hemolysis at 60µM | Human | Synthetic peptide | NA | NA | ||
| 22464970 | 2012 | KWFRVYRGIYRRR{ct:Amid} | CDT | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis at 200µg/ml (non-hemolytic) | Human | Tachyplesin-1(Tachypleus tridentatus) | NA | Non-hemolytic | ||
| 22484288 | 2012 | FLFSLIPHAIGGLISAFK | AamAP1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolysis at 10µM | Horse | AamAP1 from the venom of the North African scorpion, Androctonus amoreuxi | NA | NA | ||
| 22484288 | 2012 | FLFSLIPHAIGGLISAFK | AamAP1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 100µM | Horse | AamAP1 from the venom of the North African scorpion, Androctonus amoreuxi | NA | NA | ||
| 22484288 | 2012 | FPFSLIPHAIGGLISAIK | AamAP2 | Free | Free | Linear | L | None | 18 | Antimicrobial | 19% hemolysis at 10µM | Horse | AamAP2 from the venom of the North African scorpion, Androctonus amoreuxi | NA | NA | ||
| 22484288 | 2012 | FPFSLIPHAIGGLISAIK | AamAP2 | Free | Free | Linear | L | None | 18 | Antimicrobial | 75% hemolysis at 100µM | Horse | AamAP2 from the venom of the North African scorpion, Androctonus amoreuxi | NA | NA | ||
| 22484288 | 2012 | FLFSLIPKAIGGLISAFK | AamAP-S1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 17.8% hemolysis at 10µM | Horse | AamAP1 analog (Androctonus amoreuxi) | NA | NA | ||
| 22484288 | 2012 | FLFSLIPKAIGGLISAFK | AamAP-S1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 53% hemolysis at 100µM | Horse | AamAP1 analog (Androctonus amoreuxi) | NA | NA | ||
| 11168889 | 2000 | PKLLKTFLSKWIG | SPFK | Free | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 30 µg/mL | Rat | Synthetic peptide | NA | NA | ||
| 11168889 | 2000 | GIWKSLFTKLLKG | Retro SPFK (RSac) | Free | Free | Linear | L | None | 13 | Antimicrobial | 95-100% hemolysis at 60 µg/mL | Rat | Synthetic peptide | NA | NA | ||
| 11168889 | 2000 | GIWKSLFTKLLKG{ct:Amid} | Retro SPFK amide (RSam) | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 95-100% hemolysis at 60 µg/mL | Rat | Synthetic peptide | NA | NA | ||
| 11168889 | 2000 | PKLL{d}KTFL{d}SKWIG | Diastereo SPFK (DSac) | Free | Free | Linear | Mix | None | 13 | Antimicrobial | ~10% hemolsis at 60 µg/mL | Rat | Synthetic peptide | NA | NA | ||
| 11168889 | 2000 | PKLL{d}ETFL{d}SKWIG{ct:Amid} | Diastereo SPFK amide (DSam) | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | ~40 % hemolysis at 60 µg/mL | Rat | Synthetic peptide | NA | NA | ||
| 11279030 | 2001 | FIGTALGIASAIPAIVKLFK{ct:Amid} | Ponericin-W6 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and Insecticidal | zone of inhibition (3 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | FIGTALGIASAIPAIVKLFK{ct:Amid} | Ponericin-W6 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and Insecticidal | zone of inhibition (1 mm) at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GLVDVLGKVGGLIKKLLP{ct:Amid} | Ponericin-G6 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GLVDVLGKVGGLIKKLLP{ct:Amid} | Ponericin-G6 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P19(9|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 19 | Antimicrobial | 30% hemolysis at 10μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P19(9|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 19 | Antimicrobial | 70% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P17(9|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 17 | Antimicrobial | 15% hemolysis at 10μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P17(9|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 17 | Antimicrobial | 35% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P15(7|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 15 | Antimicrobial | 5% hemolysis at 10μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P15(7|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 15 | Antimicrobial | 30% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-GY{ct:Amid} | P14(7|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 14 | Antimicrobial | 10% hemolysis at 10μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-GY{ct:Amid} | P14(7|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 14 | Antimicrobial | 30% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P13(7|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 13 | Antimicrobial | 5% hemolysis at 10μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Nle}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-GY{ct:Amid} | P13(7|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 13 | Antimicrobial | 25% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Aib}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Nle}-GY{ct:Amid} | P13(5|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 13 | Antimicrobial | 12% hemolysis at 10μM | Human | Synthetic peptide | NA | NA | ||
| 11683882 | 2001 | G-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Aib}-{nnr:Orn}-{nnr:Orn}-{nnr:Nle}-{nnr:Nle}-{nnr:Orn}-GY{ct:Amid} | P14(6|B) | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid, Nle = norleucine, Orn = ornithine | 14 | Antimicrobial | 70% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 11995990 | 2001 | FLPLIGRVLSGIL{ct:Amid} | Temporin A (TA) | Amidation | Free | Linear | L | None | 13 | Antifungal | 0% hemolysis at 14 µM | Human | Temporin A isolated from the skin of Rana temporaria | NA | NA | ||
| 11995990 | 2001 | FLPLIGRVLSGIL{ct:Amid} | Temporin A (TA) | Amidation | Free | Linear | L | None | 13 | Antifungal | 100% hemolysis at 225 µM | Human | Temporin A isolated from the skin of Rana temporaria | NA | NA | ||
| 11995990 | 2001 | KWKLFKKLPLIGRVL{ct:Amid} | CA(1-7)TA(2-9)NH2 (CATA) | Amidation | Free | Linear | L | None | 15 | Antifungal | 0% hemolysis at 14 µM | Human | Cecropin A-temporin A hybrid | NA | NA | ||
| 11995990 | 2001 | KWKLFKKLPLIGRVL{ct:Amid} | CA(1-7)TA(2-9)NH2 (CATA) | Amidation | Free | Linear | L | None | 15 | Antifungal | 100% hemolysis at 225 µM | Human | Cecropin A-temporin A hybrid | NA | NA | ||
| 12005420 | 2001 | KWKFKKIPKFLHLAKKF{ct:Amid} | P18 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12005420 | 2001 | KWKLFKKILKFLHLAKKF{ct:Amid} | [L9]-P18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 88.6% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKISKFLHLAKKF{ct:Amid} | [S9]-P18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50.4% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | WKLFKKIPKFLHLAKKF{ct:Amid} | N-1 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 10.1% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | FKLFKKIPKFLHLAKKF{ct:Amid} | N-2 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 0.6% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWFKKIPKFLHLAKKF{ct:Amid} | N-3 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 1.8% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | WFKKIPKFLHLAKKF{ct:Amid} | N-4 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 1.5% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | WKKIPKFLHLAKKF{ct:Amid} | N-5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12005420 | 2001 | KWFKKIPKFLHLLKKF{ct:Amid} | N-3L | Amidation | Free | Linear | L | None | 16 | Antibacterial | 27.3% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | WFKKIPKFLHLLKKF{ct:Amid} | N-4L | Amidation | Free | Linear | L | None | 15 | Antibacterial | 28.8% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | WKKIPKFLHLLKKF{ct:Amid} | N-5L | Amidation | Free | Linear | L | None | 14 | Antibacterial | 9.4% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKIPFLHLAKKF{ct:Amid} | C-1 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 30.3% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKIPKFLHLAKK{ct:Amid} | C-2 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 19.8% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKIPLHLAKKF{ct:Amid} | C-3 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 4.7% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKIPKFLHLAK{ct:Amid} | C-4 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12005420 | 2001 | KWKLFKKIPHLAKKF{ct:Amid} | C-5 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12005420 | 2001 | KWKLFKKIPKFLHLA{ct:Amid} | C-6 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 6.7% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKIPLAKKF{ct:Amid} | C-7 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12005420 | 2001 | KWKLFKKIPKFLHL{ct:Amid} | C-8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12005420 | 2001 | KWKLFKKIPLKKF{ct:Amid} | C-9 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 6.2% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKIPKFLH{ct:Amid} | C-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 7.6% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 11932493 | 2002 | KNLRRIIRKIIHIIKKYG | Ovispirin-1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 70.2% hemolysis at 80 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 11932493 | 2002 | KNLRRIIRKIIHIIKKYG | Ovispirin-1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 55.0% hemolysis at 40 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 11932493 | 2002 | KNLRRIIRKGIHIIKKYG | Novispirin G-10 | Free | Free | Linear | L | None | 18 | Antimicrobial | 2.5% hemolysis at 80 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 11932493 | 2002 | KNLRRIIRKGIHIIKKYG | Novispirin G-10 | Free | Free | Linear | L | None | 18 | Antimicrobial | 1.8% hemolysis at 40µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11932493 | 2002 | KNLRRITRKIIHIIKKYG | Novispirin T-7 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10.0% hemolysis at 80 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 11932493 | 2002 | KNLRRITRKIIHIIKKYG | Novispirin T-7 | Free | Free | Linear | L | None | 18 | Antimicrobial | 3.0% hemolysis at 80 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 12054688 | 2002 | ILGKIWEGIKSLF{ct:Amid} | IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | ~30% hemolysis at 200μM | Sheep | IsCT (Isolated from the venom of scorpion Opisthacanthus madagascariensis) | NA | NA | ||
| 12054688 | 2002 | ILGKIWEGIKS | IsCTf | Free | Free | Linear | L | None | 11 | Antibacterial and Antifungal | ~0% hemolysis at 200μM (non-hemolytic) | Sheep | IsCT analogs (Isolated from the venom of scorpion Opisthacanthus madagascariensis) | NA | Non-hemolytic | ||
| 12054688 | 2002 | IFGAIWNGIKSLF{ct:Amid} | IsCT2 | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | <20% hemolysis at 200μM | Sheep | IsCT analogs (Isolated from the venom of scorpion Opisthacanthus madagascariensis) | NA | NA | ||
| 12054688 | 2002 | IFGAIWNGIKS | IsCT2f | Free | Free | Linear | L | None | 11 | Antibacterial and Antifungal | ~0% hemolysis at 200μM (non-hemolytic) | Sheep | IsCT analogs (Isolated from the venom of scorpion Opisthacanthus madagascariensis) | NA | Non-hemolytic | ||
| 12110678 | 2002 | LKLLKKLLKKLLKLL{ct:Amid} | Amphipathic-1L | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 12110678 | 2002 | KLKLLKLLKLLKLLK{ct:Amid} | Scrambled-4L | Amidation | Free | Linear | L | None | 15 | Antibacterial | 82% hemolysis at 100 µM | Human | Synthetic peptide | NA | NA | ||
| 12110678 | 2002 | KKKLLLLLLLLLKKK{ct:Amid} | Segregated-5L | Amidation | Free | Linear | L | None | 15 | Antibacterial | 66% hemolysis at 100 µM | Human | Synthetic peptide | NA | NA | ||
| 12110678 | 2002 | LKL{d}LKK{d}LL{d}K{d}KLLK{d}LL{ct:Amid} | Amphipathic-1D | Amidation | Free | Linear | Mix | None | 15 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12110678 | 2002 | LLK{d}KLL{d}KL{d}L{d}LKLL{d}KK{ct:Amid} | Amphipathic-2D | Amidation | Free | Linear | Mix | None | 15 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12110678 | 2002 | LLK{d}LLK{d}KL{d}L{d}KKLL{d}KL{ct:Amid} | Amphipathic-3D | Amidation | Free | Linear | Mix | None | 15 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12110678 | 2002 | KLK{d}LLK{d}LL{d}K{d}LLKL{d}LK{ct:Amid} | Scrambled-4D | Amidation | Free | Linear | Mix | None | 15 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12110678 | 2002 | KKK{d}LLL{d}LL{d}L{d}LLLK{d}KK{ct:Amid} | Scrambled-5D | Amidation | Free | Linear | Mix | None | 15 | Antibacterial | 3% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12110678 | 2002 | LLL{d}LLK{d}KK{d}K{d}KKLL{d}LL{ct:Amid} | Scrambled-6D | Amidation | Free | Linear | Mix | None | 15 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12207877 | 2002 | VRRFPWWWPFLRR | Tritrpticin | Free | Free | Linear | L | None | 13 | Antibacterial and Antifungal | >80% hemolysis at 200µg/ml | Human | Tritrpticin | NA | NA | ||
| 12207877 | 2002 | VRRFGWWWGFLRR | TPG | Free | Free | Linear | L | None | 13 | Antibacterial and Antifungal | >60% hemolysis at 200µg/ml | Human | Tritrpticin analogs | NA | NA | ||
| 12207877 | 2002 | VRRFAWWWAFLRR | TPA | Free | Free | Linear | L | None | 13 | Antibacterial and Antifungal | ~ 90% hemolysis at 200µg/ml | Human | Tritrpticin analogs | NA | NA | ||
| 12207877 | 2002 | VRRFPFFFPFLRR | TWF | Free | Free | Linear | L | None | 13 | Antibacterial and Antifungal | 0% hemolysis at 200µg/ml (non-hemolytic) | Human | Tritrpticin analogs | NA | Non-hemolytic | ||
| 12207877 | 2002 | VRRFPAAAPFLRR | TWA | Free | Free | Linear | L | None | 13 | Antibacterial and Antifungal | 0% hemolysis at 200µg/ml (non-hemolytic) | Human | Tritrpticin analogs | NA | Non-hemolytic | ||
| 12207877 | 2002 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | ~ 80% hemolysis at 200µg/ml | Human | Indolicidin | NA | NA | ||
| 12297012 | 2002 | GSKKPVPIIYCNRRGKCQRM | Th1 | Free | Free | Linear | L | None | 20 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin analogs (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12297012 | 2002 | GSKKPVPIIYCNRRTKCQRM | Th2 | Free | Free | Linear | L | None | 20 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin analogs (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12297012 | 2002 | GSKKPVPIIYCNRRKCQRM | Th3 | Free | Free | Linear | L | None | 19 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin analogs (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12384369 | 2002 | KKKAAAFAAWAAFAKKK{ct:Amid} | F17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKAAAFAAWAAFAKKK{ct:Amid} | F17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKAAAFAAWAAFAKKK{ct:Amid} | F17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKAAAFAAWAAFAKKK{ct:Amid} | F17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRAAF{d}AAW{d}AAF{d}AARRR{ct:Amid} | F17-R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRAAFAAWAAFAARRR{ct:Amid} | F17-R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRAAFAAWAAFAARRR{ct:Amid} | F17-R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRAAFAAWAAFAARRR{ct:Amid} | F17-R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAWAAFAA{ct:Amid} | F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 1% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAWAAFAA{ct:Amid} | F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAWAAFAA{ct:Amid} | F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAWAAFAA{ct:Amid} | F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid} | All-D F17-6K | Amidation | Free | Linear | D | None | 17 | Antimicrobial | 2% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid} | All-D F17-6K | Amidation | Free | Linear | D | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid} | All-D F17-6K | Amidation | Free | Linear | D | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid} | All-D F17-6K | Amidation | Free | Linear | D | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRRRRAAFAAWAAFAA{ct:Amid} | F17-6R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 3% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRRRRAAFAAWAAFAA{ct:Amid} | F17-6R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 1% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRRRRAAFAAWAAFAA{ct:Amid} | F17-6R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 26% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | RRRRRRAAFAAWAAFAA{ct:Amid} | F17-6R | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 14% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAAFWAAAAF{ct:Amid} | KAFW | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 1% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAAFWAAAAF{ct:Amid} | KAFW | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAAFWAAAAF{ct:Amid} | KAFW | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAAFWAAAAF{ct:Amid} | KAFW | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAFAAFAA{ct:Amid} | 3F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAFAAFAA{ct:Amid} | 3F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAFAAFAA{ct:Amid} | 3F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAFAAFAAFAA{ct:Amid} | 3F17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAWAAWAAWAA{ct:Amid} | W17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAWAAWAAWAA{ct:Amid} | W17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAWAAWAAWAA{ct:Amid} | W17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAWAAWAAWAA{ct:Amid} | W17-6K | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12404639 | 2002 | LRLKYRRFKYRV{cyc:N-C} | Mimetic 1 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 27% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12404639 | 2002 | LRLQYRRFQYRV{cyc:N-C} | Mimetic 2 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 27% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12404639 | 2002 | LRLEYRRFEYRV{cyc:N-C} | Mimetic 3 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 14% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12404639 | 2002 | LRLKKRRWKYRV{cyc:N-C} | Mimetic 4 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 1% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12404639 | 2002 | LRLKKRRWKYRV{cyc:N-C} | Mimetic 5 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 13% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12404639 | 2002 | LCLKKRRWKYCV{cyc:N-C} | Mimetic 6 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 3% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12404639 | 2002 | LRCKKRRWKCRV{cyc:N-C} | Mimetic 7 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 1% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12581207 | 2003 | FIGLLISAGKAIHDLIRRRH{ct:Amid} | Chrysophsin-3 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 100% hemolysis at 5 μM | Human | Synthetic peptide | NA | NA | ||
| 12681513 | 2003 | KKFPWWWPFKK | SYM11KK | Free | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolysis at 200 μg/ml (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12681513 | 2003 | VKKFPWWWPFLKK | TRK | Free | Free | Linear | L | None | 13 | Antimicrobial | 1% hemolysis at 200 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 12681513 | 2003 | RRFPWWWPFRR | SYM11 | Free | Free | Linear | L | None | 11 | Antimicrobial | ~60% hemolysis at 200 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 12712499 | 2003 | V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLY{d}PVKLY{d}P{cyc:N-C} | GS10 | Free | Free | Cyclic | Mix | None | 10 | Antibacterial and Antifungal | 100% hemolysis at 51–100 µg/mL | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKY{d}PKVKLY{d}P{cyc:N-C} | GS12 | Free | Free | Cyclic | Mix | None | 12 | Antibacterial and Antifungal | 100% hemolysis at >150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at <15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | V{d}KLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14V1 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/m | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VK{d}LKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K2 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/m | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKL{d}KVY{d}PLKVKLY{d}P{cyc:N-C} | GS14L3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at <15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at >150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKV{d}Y{d}PLKVKLY{d}P{cyc:N-C} | GS14V5 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 100–150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVYPLKVKLY{d}P{cyc:N-C} | GS14Y6 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/m | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}P{d}L{d}KVKLY{d}P{cyc:N-C} | GS14P7 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at <15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PL{d}KVKLY{d}P{cyc:N-C} | GS14L8 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLK{d}VKLY{d}P{cyc:N-C} | GS14K9 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 51–100 µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLKV{d}KLY{d}P{cyc:N-C} | GS14V10 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at <15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLKVK{d}LY{d}P{cyc:N-C} | GS14K11 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 100–150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLKVKL{d}Y{d}P{cyc:N-C} | GS14L12 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLKVKLYP{cyc:N-C} | GS14Y13 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at < 15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLKVKLY{d}P{d}{cyc:N-C} | GS14P14 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at < 15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKKLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 K3L4 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 100–150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | LKLK{d}LF{d}PLKLKLF{d}P{cyc:N-C} | GS14K4 Y2/F2, V3/L3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at < 15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | LKLK{d}LY{d}PLKLKLY{d}P{cyc:N-C} | GS14K4 V3/L3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLK{d}VF{d}PLKVKLF{d}P{cyc:N-C} | GS14K4 Y2/F2 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at > 150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | AKLK{d}AY{d}PLKAKLY{d}P{cyc:N-C} | GS14K4 V3/A3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at > 150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKAK{d}VY{d}PAKVKAY{d}P{cyc:N-C} | GS14K4 L3/A3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at > 150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | AKAK{d}AY{d}PAKAKAY{d}P{cyc:N-C} | GS14K4 V3L3/A6 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at > 150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12963031 | 2003 | KKVADKVLLLKQLRIMRL | Spinigerin (4–21) | Free | Free | Linear | L | None | 18 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Spinigerin truncate isolated from the fungus-growing termite Pseudacanthotermes spiniger | NA | Non-hemolytic | ||
| 14514057 | 2003 | KWKLFKKIGIGKFLHSAKKF{ct:Amid} | CA-MA | Amidation | Free | Linear | L | None | 20 | Antibacterial and Antitumor | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14514057 | 2003 | KWKKLLKKPLLKKLLKKL{ct:Amid} | CA-MA analogue P5 | Amidation | Free | Linear | L | None | 18 | Antibacterial and Antitumor | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14514057 | 2003 | KWKLKPLLKKLLKKL{ct:Amid} | P6 | Amidation | Free | Linear | L | None | 15 | Antibacterial and Antitumor | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14514057 | 2003 | KWKKLLKKPLKLKL{ct:Amid} | P7 | Amidation | Free | Linear | L | None | 14 | Antibacterial and Antitumor | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14514057 | 2003 | KPLLKKLLKKL{ct:Amid} | P8 | Amidation | Free | Linear | L | None | 11 | Antibacterial and Antitumor | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14514057 | 2003 | KLLKKPLKLKL{ct:Amid} | P9 | Amidation | Free | Linear | L | None | 11 | Antibacterial and Antitumor | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14531844 | 2003 | FLPIIAKVLSGLL{ct:Amid} | Temporin-1BYa | Amidation | Free | Linear | L | None | 13 | Antibacterial | Non-hemolytic | Human | Temporin-1B analog(Rana boylii) | NA | Non-hemolytic | ||
| 15019213 | 2003 | AKKVFKRLEKLFSKIQNDK | HP (2–20) | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal | <20% hemolysis at 2.15 to 215µM | Human | N-terminus of Helicobacter pylori ribosomal protein 1, HpRpL1 | NA | NA | ||
| 14637016 | 2003 | ILGKIWEGIKSLF | IsCT1 | Free | Free | Linear | L | None | 13 | Antimicrobial | ~20% hemolysis at 50μM | Sheep | IsCT analog (Opisthacanthus madagascariensis) | NA | NA | ||
| 14637016 | 2003 | ILGKIWEGIKSLF | IsCT1 | Free | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 50μM | Pig | IsCT analog (Opisthacanthus madagascariensis) | NA | NA | ||
| 14637016 | 2003 | ILGKIWEGIKSLF | IsCT1 | Free | Free | Linear | L | None | 13 | Antimicrobial | ~100% hemolysis at 50μM | Guinea-pig | IsCT analog (Opisthacanthus madagascariensis) | NA | NA | ||
| 14637016 | 2003 | IFGAIWNGIKSLF | IsCT2 | Free | Free | Linear | L | None | 13 | Antimicrobial | <20% hemolysis at 50μM | Sheep | IsCT analog (Opisthacanthus madagascariensis) | NA | NA | ||
| 14637016 | 2003 | IFGAIWNGIKSLF | IsCT2 | Free | Free | Linear | L | None | 13 | Antimicrobial | ~80% hemolysis at 50μM | Pig | IsCT analog (Opisthacanthus madagascariensis) | NA | NA | ||
| 14637016 | 2003 | IFGAIWNGIKSLF | IsCT2 | Free | Free | Linear | L | None | 13 | Antimicrobial | ~80% hemolysis at 50μM | Guinea-pig | IsCT analog (Opisthacanthus madagascariensis) | NA | NA | ||
| 14596922 | 2003 | GLPALISWIKRKRQQ{ct:Amid} | Mel(12-26) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 4500 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | LLPALISWIKRKRQQ{ct:Amid} | Mel(12-26,L1) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 192 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GSPALISWIKRKRQQ{ct:Amid} | Mel(12-26,S2) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 1588 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLLALISWIKRKRQQ{ct:Amid} | Mel(12-26,L3) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 35.2 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLSALISWIKRKRQQ{ct:Amid} | Mel(12-26,S3) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 44 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPLLISWIKRKRQQ{ct:Amid} | Mel(12-26,L4) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 203 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPASISWIKRKRQQ{ct:Amid} | Mel(12-26,S5) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 3840 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPALSSWIKRKRQQ{ct:Amid} | Mel(12-26,S6) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 650 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPALILWIKRKRQQ{ct:Amid} | Mel(12-26,L7) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 15.4 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPALISLIKRKRQQ{ct:Amid} | Mel(12-26,L8) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 9350 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPALISSIKRKRQQ{ct:Amid} | Mel(12-26,S8) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 13800 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPALISWSKRKRQQ{ct:Amid} | Mel(12-26,S9) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 6140 μg/ml | Human | Melittin analogs | NA | NA | ||
| 15752569 | 2005 | FLSLIPHAINAVSAIAKHN{ct:Amid} | PS-1 | Amidation | Free | Linear | L | None | 19 | Antibacterial and Antiprotozoa | 1.98% hemolysis at 64µM | Human | Phylloseptin analogs isolated from the skin secretion of the Brazilian tree-frogs, Phyllomedusa hypochondrialis and Phyllomedusa oreades | NA | NA | ||
| 15752569 | 2005 | FLSLIPHAINAVSTLVHHF{ct:Amid} | PS-2 | Amidation | Free | Linear | L | None | 19 | Antibacterial and Antiprotozoa | 2.05% hemolysis at 64µM | Human | Phylloseptin analogs isolated from the skin secretion of the Brazilian tree-frogs, Phyllomedusa hypochondrialis and Phyllomedusa oreades | NA | NA | ||
| 15328096 | 2004 | CVKVKVKVGSGVKVKVKVC{cyc:N-C}{nt:Acet}{ct:Amid} | V1 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 880000 nM | Human | Synthetic peptide | NA | NA | ||
| 15328096 | 2004 | CVKVSVKVGSGVKVSVKVC{cyc:N-C}{nt:Acet}{ct:Amid} | V2 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 5,89,000 nM | Human | Synthetic peptide | NA | NA | ||
| 15328096 | 2004 | CVKVRVKVGSGVKVRVKVC{cyc:N-C}{nt:Acet}{ct:Amid} | V3 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 590000 nM | Human | Synthetic peptide | NA | NA | ||
| 15328096 | 2004 | CVKVQVKVGSGVKVQVKVC{cyc:N-C}{nt:Acet}{ct:Amid} | V4 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 3226000 nM | Human | Synthetic peptide | NA | NA | ||
| 15328096 | 2004 | CAKAKAKAGSGAKAKAKAC{cyc:N-C}{nt:Acet}{ct:Amid} | V5 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 1055000 nM | Human | Synthetic peptide | NA | NA | ||
| 15328096 | 2004 | CFKFKFKFGSGFKFKFKFC{cyc:N-C}{nt:Acet}{ct:Amid} | V6 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 35000 nM | Human | Synthetic peptide | NA | NA | ||
| 15328096 | 2004 | CWKWKWKWGSGWKWKWKWC{cyc:N-C}{nt:Acet}{ct:Amid} | V7 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 45000 nM | Human | Synthetic peptide | NA | NA | ||
| 12147359 | 2002 | AKKVFKRLEKLFSKIQNDK | HP (2 – 20) | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100μM (non-hemolytic) | Human | HP (2 – 20) (Helicobacter pylori) | NA | Non-hemolytic | ||
| 12147359 | 2002 | AKKVFKRLEKLFSKIQNWK | Anal 1 | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal and Anticancer | 0% hemolysis at 100μM (non-hemolytic) | Human | HP (2 – 20) analogs (Helicobacter pylori) | NA | Non-hemolytic | ||
| 12147359 | 2002 | AKKVFKRLEKLFSKIWNDK | Anal 2 | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal and Anticancer | 0% hemolysis at 100μM (non-hemolytic) | Human | HP (2 – 20) analogs (Helicobacter pylori) | NA | Non-hemolytic | ||
| 12147359 | 2002 | AKKVFKRLEKLFSKIWNWK | Anal 3 | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal and Anticancer | 0% hemolysis at 100μM (non-hemolytic) | Human | HP (2 – 20) analogs (Helicobacter pylori) | NA | Non-hemolytic | ||
| 12147359 | 2002 | AKKVFKRLEKSFSKIQNDK | Anal 4 | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal and Anticancer | 0% hemolysis at 100μM (non-hemolytic) | Human | HP (2 – 20) analogs (Helicobacter pylori) | NA | Non-hemolytic | ||
| 12147359 | 2002 | AKKVSKRLEKLFSKIQNDK | Anal 5 | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal and Anticancer | 0% hemolysis at 100μM (non-hemolytic) | Human | HP (2 – 20) analogs (Helicobacter pylori) | NA | Non-hemolytic | ||
| 15572194 | 2004 | SADLVKKIWDNPAL{nt:Acet}{ct:Amid} | Polybine-I | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 0% hemolysis at 100μM (non-hemolytic) | Rat | Polybine-I (From venom of Polybia paulista) | NA | Non-hemolytic | ||
| 15572194 | 2004 | SVDMVMKGLKIWPL{nt:Acet}{ct:Amid} | Polybine-II | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 0% hemolysis at 100μM (non-hemolytic) | Rat | Polybine-II (From venom of Polybia paulista) | NA | Non-hemolytic | ||
| 15345319 | 2004 | KPTFRRLKWKYK{cyc:N-C} | LALF-14 | Free | Free | Cyclic | L | None | 12 | Antimicrobial | ~5% hemolysis at 100µg/ml | Human | Limulus analogs (Limulus polyphemus) | NA | NA | ||
| 15345319 | 2004 | HYRIKPTFRRLKWKYKGKFW{cyc:N-C} | LALf-22 | Free | Free | Cyclic | L | None | 20 | Antimicrobial | ~20% hemolysis at 100µg/ml | Human | Limulus analogs (Limulus polyphemus) | NA | NA | ||
| 15358153 | 2004 | AKKVFKRLEKLFSKIQNDK{ct:Amid} | HP (2–20) | Amidation | Free | Linear | L | None | 19 | Antibacterial | 0% hemolysis at 140µg/ml (non-hemolytic) | Human | HP (2–20) (Helicobacter pylori) | NA | Non-hemolytic | ||
| 15369808 | 2004 | ILGKIWEGIKSLF{ct:Amid} | IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | 80% hemolysis at 100µM | Human | IsCT | NA | NA | ||
| 15369808 | 2004 | ILGKIAEGIKSLF{ct:Amid} | [A6]-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | 0% hemolysis at 100µM (non-hemolytic) | Human | IsCT analogs (Opisthacanthus madagascariensis) | NA | Non-hemolytic | ||
| 15369808 | 2004 | ILGKILEGIKSLF{ct:Amid} | [L6]-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | ~20% hemolysis at 100µM | Human | IsCT analogs (Opisthacanthus madagascariensis) | NA | NA | ||
| 15369808 | 2004 | ILGKIWKGIKSLF{ct:Amid} | [K7]-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | ~50% hemolysis at 100µM | Human | IsCT analogs (Opisthacanthus madagascariensis) | NA | NA | ||
| 15369808 | 2004 | ILGKILKGIKKLF{ct:Amid} | [L6, K11]-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | ~20% hemolysis at 100µM | Human | IsCT analogs (Opisthacanthus madagascariensis) | NA | NA | ||
| 15369808 | 2004 | ILGKIWKIKKLF{ct:Amid} | [K7, P8, K11]-IsCT | Amidation | Free | Linear | L | None | 12 | Antibacterial and Antifungal | 0% hemolysis at 100µM (non-hemolytic) | Human | IsCT analogs (Opisthacanthus madagascariensis) | NA | Non-hemolytic | ||
| 12878508 | 2003 | WLNALLHHGLNCAKGVLA{ct:Amid} | 18Hc | Amidation | Free | Linear | L | None | 18 | Antibacterial | ~20% hemolysis at 100µg/ml | Human | Synthetic Analogs of Halocidin (Tunicate Halocynthia aurantium) | NA | NA | ||
| 12878508 | 2003 | WLNALLKKGLNCAKGVLA{ct:Amid} | 18HcKK | Amidation | Free | Linear | L | None | 18 | Antibacterial | <10% hemolysis at 100µg/ml | Human | Synthetic Analogs of Halocidin (Tunicate Halocynthia aurantium) | NA | NA | ||
| 12878508 | 2003 | KWLNALLHHGLNCAKGVLA{ct:Amid} | K19Hc | Amidation | Free | Linear | L | None | 19 | Antibacterial | ~10% hemolysis at 100µg/ml | Human | Synthetic Analogs of Halocidin (Tunicate Halocynthia aurantium) | NA | NA | ||
| 12878508 | 2003 | KWLNALLKKGLNCAKGVLA{ct:Amid} | K19HcKK | Amidation | Free | Linear | L | None | 19 | Antibacterial | <10% hemolysis at 100µg/ml | Human | Synthetic Analogs of Halocidin (Tunicate Halocynthia aurantium) | NA | NA | ||
| 12878508 | 2003 | KWKLFKKIPKFLHLAKKF{ct:Amid} | P18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | <0% hemolysis at 100µg/ml | Human | P18 (Halocynthia aurantium) | NA | Non-hemolytic | ||
| 11846794 | 2002 | RLYRRLYRRLYRRLYR | (RLYR)4 | Free | Free | Linear | L | None | 16 | Antibacterial and Antifungal | EC50 = 338µM | Human | Synthetic peptide | NA | NA | ||
| 11846794 | 2002 | RLYRRLYRK | (RLYR)2-[K] | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal | EC50 = 3700µM | Human | Synthetic peptide | NA | NA | ||
| 11846794 | 2002 | RLYRKVYG{cyc:N-C} | RLYRKVYG | Free | Free | Cyclic | L | None | 17 | Antibacterial and Antifungal | EC50 = 3950µM | Human | Synthetic peptide | NA | NA | ||
| 11846794 | 2002 | RLYRKVYGRLYRKVYGK{cyc:N-C} | (RLYRKVYG)2-[K] | Free | Free | Cyclic | L | None | 17 | Antibacterial and Antifungal | EC50 = 1420µM | Human | Synthetic peptide | NA | NA | ||
| 10819172 | 2000 | KLLLKLLLKLLK{cyc:N-C}{ct:Amid} | S1 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial | 100% hemolysis at 200µg/ml | Mouse | Synthetic peptide | NA | NA | ||
| 10819172 | 2000 | KLLLKLLLKLLK{cyc:N-C}{ct:Amid} | SC1 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial | 100% hemolysis at 200µg/ml | Mouse | Synthetic peptide | NA | NA | ||
| 10819172 | 2000 | KLLLKLLLKLLK{cyc:N-C}{ct:Amid} | SC2 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial | ~90% hemolysis at 200µg/ml | Mouse | Synthetic peptide | NA | NA | ||
| 11606214 | 2001 | V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antimicrobial | Strong hemolysis | Human | Gramicidin S | NA | NA | ||
| 11606214 | 2001 | VKLY{d}PVKLY{d}P{cyc:N-C} | GS10 | Free | Free | Cyclic | Mix | None | 10 | Antimicrobial | Strong hemolysis | Human | Gramicidin S analogs | NA | NA | ||
| 11606214 | 2001 | VKLKY{d}PKVKLY{d}P{cyc:N-C} | GS12 | Free | Free | Cyclic | Mix | None | 12 | Antimicrobial | Weak hemolysis | Human | Gramicidin S analogs | NA | NA | ||
| 11606214 | 2001 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | Very strong hemolysis | Human | Gramicidin S analogs | NA | NA | ||
| 11606214 | 2001 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | [D-Lys]4GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | Weak hemolysis | Human | Gramicidin S analogs | NA | NA | ||
| 11682479 | 2002 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 1.5µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | LKLK{d}LF{d}PLKLKLF{d}P{cyc:N-C} | Y2/F2, V3/L3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 12.5µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | LKLK{d}LY{d}PLKLKLY{d}P{cyc:N-C} | V3/L3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 25µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | VKLK{d}VF{d}PLKVKLF{d}P{cyc:N-C} | Y2/F2 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 40µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 200µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | AKLK{d}AY{d}PLKAKLY{d}P{cyc:N-C} | V3/A3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at >800µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | VKAK{d}VY{d}PAKVKAY{d}P{cyc:N-C} | L3/A3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at >800µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | AKAK{d}AY{d}PAKAKAY{d}P{cyc:N-C} | V3L3/A6 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at >800µg/ml | Human | Synthetic peptide | NA | NA | ||
| 10795591 | 2000 | KWCFRVCYRGICYRRCR{ct:Amid} | TP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 66.5% hemolysis at 80µg/ml | Human | Limulus hemocytes | NA | NA | ||
| 10795591 | 2000 | RGGRLCYCRRRFCVCVGR{ct:Amid} | PG-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 70.3% hemolysis at 80µg/ml | Human | Porcine neutrophils | NA | NA | ||
| 10795591 | 2000 | R{d}G{d}G{d}R{d}L{d}C{d}Y{d}C{d}R{d}R{d}R{d}F{d}C{d}V{d}C{d}V{d}G{d}R{d}{ct:Amid} | dPG-1 | Amidation | Free | Linear | D | None | 18 | Antimicrobial | 90% hemolysis at 80µg/ml | Human | PG-1 analog | NA | NA | ||
| 10795591 | 2000 | RGGRLCYARRRFAVCVGR{ct:Amid} | PG-1 “bullet” | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 14.7% hemolysis at 80µg/ml | Human | PG-1 analog | NA | NA | ||
| 10795591 | 2000 | RGGRLAYCRRRFCVAVGR{ct:Amid} | PG-1 “kite” | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolysis at 80µg/ml | Human | PG-1 analog | NA | NA | ||
| 10795591 | 2000 | RGGRLAYARRRFAVAVGR{ct:Amid} | PG-1 “snake” | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0.8% hemolysis at 80µg/ml | Human | PG-1 analog | NA | NA | ||
| 10795591 | 2000 | ILPWKWPWWPWRR | Indolicidin | Free | Free | Linear | L | None | 13 | Antimicrobial | 38.2% hemolysis at 80µg/ml | Human | Bovine neutrophils | NA | NA | ||
| 10799508 | 2000 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 10µg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 100µg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 1% hemolysis at 10µg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 8% hemolysis at 100µg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKKLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K3L4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 3% hemolysis at 10µg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKKLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K3L4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 37% hemolysis at 100µg/ml | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNW | Mast 18 | Free | Free | Linear | L | None | 18 | Antimicrobial | 2.7% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNW | Mast 19 | Free | Free | Linear | L | None | 18 | Antimicrobial | 5.1% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | NWKGIAAMAKKLL | Mastoparan X | Free | Free | Linear | L | None | 13 | Antimicrobial | 24% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 12429503 | 2002 | FLPIVGRLISGLL{ct:Amid} | Temporin-1AR | Amidation | Free | Linear | L | None | 13 | Antibacterial | HC50 = 210µM | Human | Temporin-1 analog (Rana areolata) | NA | NA | ||
| 10799508 | 2000 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 10μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 100μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 1% hemolytic at 10μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 8% hemolytic at 100μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKKLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K3L4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 3% hemolytic at 10μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10799508 | 2000 | VKKLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K3L4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 37% hemolytic at 100μg/ml | Human | Synthetic peptide | NA | NA | ||
| 15195974 | 2004 | KWKKLLKKLLKLL{ct:Amid} | K6L6W | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 75% hemolytic at 100μM | Human | Synthetic peptide | NA | NA | ||
| 15195974 | 2004 | KWKKLPKKLLKLL{ct:Amid} | K6L5WP | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12931994 | 2003 | RGGRLCYCRRRFCVCVGR{cyc:N-C}{ct:Amid} | Protegrin-I (2) | Amidation | Free | Cyclic | L | None | 18 | Antimicrobial | 37% hemolytic at 100μg/ml | Human | Protegrin | NA | NA | ||
| 12931994 | 2003 | LRLKKRRWKYRVP{d}{cyc:N-C} | 5 | Free | Free | Cyclic | Mix | None | 13 | Antimicrobial | 1.4% hemolytic at 100μg/ml | Human | Protegrin | NA | NA | ||
| 11738090 | 2001 | GFLGSLLKTGLKVGSNLL{ct:Amid} | XT-6 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HC50 > 150μM | Human | Isolated from norepinephrine-stimulated skin secretions of the diploid clawed frog, Xenopus tropicalis | NA | NA | ||
| 11738090 | 2001 | GLLGPLLKIAAKVGSNLL{ct:Amid} | XT-7 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HC50 = 70μM | Human | Isolated from norepinephrine-stimulated skin secretions of the diploid clawed frog, Xenopus tropicalis | NA | NA | ||
| 10973820 | 2000 | GEKLKKIGQKIKNFFQKL | CRAMP-18 | Free | Free | Linear | L | None | 18 | Antimicrobial and Anticancer | 0% hemolytic at 100μM (non-hemolytic) | Human | CRMAP | NA | Non-hemolytic | ||
| 10973820 | 2000 | GKKLKKIGQKIKNFFQKL | K2-CRAMP-18 | Free | Free | Linear | L | None | 18 | Antimicrobial and Anticancer | 0% hemolytic at 100μM (non-hemolytic) | Human | CRMAP-18 analogs | NA | Non-hemolytic | ||
| 10973820 | 2000 | GEKLKKIGKKIKNFFQKL | K9-CRAMP-18 | Free | Free | Linear | L | None | 18 | Antimicrobial and Anticancer | 0% hemolytic at 100μM (non-hemolytic) | Human | CRMAP-18 analogs | NA | Non-hemolytic | ||
| 10973820 | 2000 | GEKLKKIGQKIKKFFQKL | K13-CRAMP-18 | Free | Free | Linear | L | None | 18 | Antimicrobial and Anticancer | 0% hemolytic at 100μM (non-hemolytic) | Human | CRMAP-18 analogs | NA | Non-hemolytic | ||
| 10973820 | 2000 | GEKLKKIGQKIKNFFKKL | K16-CRAMP-18 | Free | Free | Linear | L | None | 18 | Antimicrobial and Anticancer | 0.2% hemolytic at 100μM | Human | CRMAP-18 analogs | NA | NA | ||
| 10879468 | 2000 | NWKGIAAMAKKLL | Mastroparan X | Free | Free | Linear | L | None | 13 | Antimicrobial and Hemolytic | 24% hemolytic at 10μM | Human | Wasp Venom | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWKLM | Mast 21 | Free | Free | Linear | L | None | 19 | Antimicrobial and Hemolytic | 5.4% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNW | Mast 18 | Free | Free | Linear | L | None | 18 | Antimicrobial and Hemolytic | 2.7% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNW | Mast 19 | Free | Free | Linear | L | None | 18 | Antimicrobial and Hemolytic | 5.1% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10821683 | 2000 | CKLLLKWLLKLLKC{cyc:N-C} | Cyclic-K4L7W | Free | Free | Cyclic | L | None | 14 | Cytolytic | 50% hemolytic at 50μM | Human | Synthetic peptide | NA | NA | ||
| 10821683 | 2000 | CH3-S-CKLLLKWLLKLLKC-S-CH3 | Linear-K4L7W | Free | Free | Linear | L | None | 14 | Cytolytic | 100% hemolytic at 5μM | Human | Synthetic peptide | NA | NA | ||
| 10821683 | 2000 | C{d}K{d}L{d}L{d}L{d}K{d}W{d}L{d}L{d}K{d}L{d}L{d}K{d}C{d}{cyc:N-C} | cyclic-[D]-L3,4,8,10-K4L7W | Free | Free | Cyclic | D | None | 14 | Cytolytic | 90% hemolytic at 50μM | Human | Synthetic peptide | NA | NA | ||
| 10821683 | 2000 | C{d}K{d}L{d}L{d}L{d}K{d}W{d}L{d}L{d}K{d}L{d}L{d}K{d}C{d}{nt:CH3-S-}{ct:-S-CH3} | linear-[D]-L3,4,8,10-K4L7W | Free | Free | Linear | D | None | 14 | Cytolytic | 5% hemolytic at 50μM | Human | Synthetic peptide | NA | NA | ||
| 10673369 | 1999 | KWCFRVCYRGICYRRCR-{nnr:X} | TP-1 | Free | Free | Linear | L | None | 17 | Antimicrobial | EC25 = 29μM | Human | Tachyplesin-1 | NA | NA | ||
| 10673369 | 1999 | KWCFCVCYRGICYCRCRG | cc TP | Free | Free | Linear | L | None | 18 | Antimicrobial | EC25 =590μM | Human | Tachyplesin-1 | NA | NA | ||
| 10673369 | 1999 | GFCRCLCRRGVCRCLCTK | RTD | Free | Free | Linear | L | None | 18 | Antimicrobial | EC25 =2350μM | Human | Tachyplesin-1 | NA | NA | ||
| 18068868 | 2007 | GFKDLLKGAAKALVKTVLF{ct:Amid} | Ascaphin-8 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 =55μM | Human | Frog skin | NA | NA | ||
| 18068868 | 2007 | GFKKLLKGAAKALVKTVLF{ct:Amid} | Lys4-Ascaphin-8 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 =24μM | Human | Frog skin | NA | NA | ||
| 18068868 | 2007 | GFKDLLKKAAKALVKTVLF{ct:Amid} | Lys8-Ascaphin-8 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 =11μM | Human | Frog skin | NA | NA | ||
| 10224074 | 1999 | V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antimicrobial and Hemolytic | 100% hemolytic at 12.5 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 1.5 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKV{d}KLY{d}P{cyc:N-C} | GS14V10 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 6.2 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKL{d}KVY{d}PLKVKLY{d}P{cyc:N-C} | GS14L3 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 12.5 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLY{d}P{d}{cyc:N-C} | GS14P14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 6.2 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}P{d}LKVKLY{d}P{cyc:N-C} | GS14P7 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 12.5 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14V1 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 40 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKL{d}Y{d}P{cyc:N-C} | GS14L12 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 25 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKV{d}Y{d}PLKVKLY{d}P{cyc:N-C} | GS14V5 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 150 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLYP{cyc:N-C} | GS14Y13 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 12.5 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PL{d}KVKLY{d}P{cyc:N-C} | GS14L8 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 50 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVYPLKVKLY{d}P{cyc:N-C} | GS14Y6 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 25 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VK{d}LKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K2 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 50 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLK{d}VKLY{d}P{cyc:N-C} | GS14K9 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 100 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 200 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVK{d}LY{d}P{cyc:N-C} | GS14K11 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at 150 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VK{d}LK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K2K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at >200 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 10224074 | 1999 | VK{d}LK{d}VY{d}PLK{d}VK{d}LY{d}P{cyc:N-C} | GS14K2K4K9K11 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial and Hemolytic | 100% hemolytic at >200 μg/ml | Human | Derivative of Gramicidin S | NA | NA | ||
| 23609760 | 2013 | FVDLKKIANIINSIFGK | Temporin-1CEa | Free | Free | Linear | L | None | 17 | Antimicrobial, Anticancer and moderate Hemolytic | LC50 =95.7μM | Human | Temporin-1CEa (Rana chensinensis) | NA | NA | ||
| 23609760 | 2013 | FVDLKKIANIINSIFKK | LK1 | Free | Free | Linear | L | None | 17 | Anticancer | LC50 =1,467μM | Human | Temporin-1CEa (Rana chensinensis) | NA | NA | ||
| 23609760 | 2013 | FKDLKKIANIINSIFKK | LK2(5) | Free | Free | Linear | L | None | 17 | Anticancer | LC50 =1,186μM | Human | Temporin-1CEa (Rana chensinensis) | NA | NA | ||
| 23609760 | 2013 | FVKLKKIANIINSIFKK | LK2(6) | Free | Free | Linear | L | None | 17 | Anticancer | LC50 =1,993μM | Human | Temporin-1CEa (Rana chensinensis) | NA | NA | ||
| 23609760 | 2013 | FKKLKKIANIINSIFKK | LK3 | Free | Free | Linear | L | None | 17 | Anticancer | LC50 =4,649μM | Human | Defencin | NA | NA | ||
| 23609760 | 2013 | FVKLKKILNIINSIFKK | LK2(6)A(L) | Free | Free | Linear | L | None | 17 | Anticancer | LC50 =86.99μM | Human | Temporin-1CEa (Rana chensinensis) | NA | NA | ||
| 23609760 | 2013 | FVKLKKILNIILSIFKK | LK2(6)AN(2L) | Free | Free | Linear | L | None | 17 | Anticancer | LC50 =28.34μM | Human | Temporin-1CEa (Rana chensinensis) | NA | NA | ||
| 23570790 | 2013 | WKSDVRRWRSRY | TSG-6 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.3 ±0.9% hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23570790 | 2013 | WKSYVRRWRSRY | TSG-7 | Free | Free | Linear | L | None | 12 | Antimicrobial | 1.5 ±1.4%hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23570790 | 2013 | WKSYVRRWRSR | TSG-8 | Free | Free | Linear | L | None | 11 | Antimicrobial | -1.2 ± 2.6%hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23570790 | 2013 | WWSYVRRWRSR | TSG-8-1 | Free | Free | Linear | L | None | 11 | Antimicrobial | 3.4 ±1.3% hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23570790 | 2013 | WKSYVRRWRS | TSG-9 | Free | Free | Linear | L | None | 10 | Antimicrobial | -0.4 ± 0.5%hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23570790 | 2013 | KKSYVRRWRS | TSG-9-1 | Free | Free | Linear | L | None | 10 | Antimicrobial | -0.6 ± 1.6% hemolytic at 100μM | Human | Derivative of Ixosin-B | NA | NA | ||
| 23519707 | 2013 | GLFDIIKKIAESF | AU | Free | Free | Linear | L | None | 13 | Antimicrobial | 50% hemolytic at 128μmol/L | Human | Aurein 1.2 | NA | NA | ||
| 23519707 | 2013 | GLFDIIKKIAESF | AU | Free | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 4 -16μmol/L | Human | Aurein 1.2 | NA | NA | ||
| 23344198 | 2013 | WLKKLLKKLLK{ct:Amid} | L5K5W 1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 32 μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | KWLKKLLKKLL{ct:Amid} | L5K5W 2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 16μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | LKWLKKLLKKL{ct:Amid} | L5K5W 3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 64μg/mL | Human | Defencin | NA | NA | ||
| 23344198 | 2013 | LLKWLKKLLKK{ct:Amid} | L5K5W 4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 128μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | KLLKWLKKLLK{ct:Amid} | L5K5W 5 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 64μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | KKLLKWLKKLL{ct:Amid} | L5K5W 6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 32μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | LKKLLKWLKKL{ct:Amid} | L5K5W 7 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 128μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | LLKKLLKWLKK{ct:Amid} | L5K5W 8 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 128μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | KLLKKLLKWLK{ct:Amid} | L5K5W 9 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 64μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | KKLLKKLLKWL{ct:Amid} | L5K5W 10 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 32μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 23344198 | 2013 | LKKLLKKLLKW{ct:Amid} | L5K5W 11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial and Hemolytic | MHC = 128μg/mL | Human | De novo designed L5K5W model peptide isomers | NA | NA | ||
| 22914980 | 2013 | KWKWKWKWKW{ct:Amid} | (KW)5 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 71% hemolytic at 200μM | Human | Synthetic KW peptides | NA | NA | ||
| 23226256 | 2013 | FDWDSVLKGVEGFVRGYF | TP1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolytic at 100 µg/ml (non-hemolytic) | Fish | Derivative of Piscidin (Nile tilapia, Oreochromis niloticus) | NA | Non-hemolytic | ||
| 23124812 | 2013 | FSGGNCRGFRRRCFCTK{ct:Amid} | SolyC | Amidation | Free | Linear | L | None | 17 | Antimicrobial | <5% hemolytic at 50mg/ml | Mouse | Tomato defensins (Tomato) | NA | NA | ||
| 23093034 | 2013 | SWKSMAKKLKEYMEKLKQRA | La5 | Free | Free | Linear | L | None | 20 | Antimicrobial | 2% hemolytic at 25mM | Human | Analogs of antimicrobial peptides La47 (From venom of Lachesana sp.) | NA | NA | ||
| 23019445 | 2013 | KWASLWNWFNITNWLWYIK{ct:Amid} | gp41w | Amidation | Free | Linear | L | None | 19 | Antimicrobial | EC50 =550μg/ml | Human | Gp41 derivative (HIV) | NA | NA | ||
| 23019445 | 2013 | KWARLWRWFRITRWLWYIK{ct:Amid} | gp41w-4R | Amidation | Free | Linear | L | None | 19 | Antimicrobial | EC50 = 7-14μg/ml | Human | Gp41 derivative (HIV) | NA | NA | ||
| 23019445 | 2013 | KWAKKWKWFAKAAWKWYKK{ct:Amid} | gp41w-KA | Amidation | Free | Linear | L | None | 19 | Antimicrobial | EC50 = 42μg/ml | Human | Gp41 derivative (HIV) | NA | NA | ||
| 23019445 | 2013 | KFAKKFKWFAKAAFKFFKK{ct:Amid} | gp41w-FKA | Amidation | Free | Linear | L | None | 19 | Antimicrobial | EC50 = 195μg/ml | Human | Gp41 derivative (HIV) | NA | NA | ||
| 22865764 | 2013 | RGRCYTVCRQLYCLRRCQ | Gomesin (Gm) | Free | Free | Linear | L | None | 18 | Antimicrobial | 40% hemolytic at 100mM | Human | Gomesin (Gm) (Acanthoscurria gomesiana) | NA | NA | ||
| 22865764 | 2013 | RGRCYTVCRQLYCLRRCQ | Cys(Acm)2,15]-Gm | Free | Free | Linear | L | None | 18 | Antimicrobial | 16% hemolytic at 100mM | Human | Gomesin (Gm) (Acanthoscurria gomesiana) | NA | NA | ||
| 22865764 | 2013 | RGRCYTVCRQLYCLRRCQ | [Thr2,6,11,15,D-Pro9]-Gm | Free | Free | Linear | L | None | 18 | Antimicrobial | 17% hemolytic at 100mM | Human | Gomesin (Gm) (Acanthoscurria gomesiana) | NA | NA | ||
| 22699557 | 2012 | IWRIFRRIFRIF{ct:Amid} | HFU4 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | MHC = 19.6 μM | Human | Synthetic peptide | NA | NA | ||
| 22699557 | 2012 | IWRIFRRIFRIFIRF{ct:Amid} | HFU5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | MHC = 15 μM | Human | Synthetic peptide | NA | NA | ||
| 22578463 | 2012 | KWLRRVWRWWR{ct:Amid} | MAP-04-03 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 100% hemolytic at 100μM | Human | Peptide amide analogs of Ixosin-B | NA | NA | ||
| 22578463 | 2012 | KRLRRVWRRWR{ct:Amid} | MAP-04-04 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 3% hemolytic at 100μM | Human | Peptide amide analogs of Ixosin-B | NA | NA | ||
| 22792229 | 2012 | FIKRIARLLRKIF | Kn2-7 | Free | Free | Linear | L | None | 13 | Antimicrobial | HC50= 90.27 µg/mL | Human | BmKn2 derivative (From venom of Mesobuthus martensii) | NA | NA | ||
| 22792229 | 2012 | FIGAIARLLSKIF | BmKn2 | Free | Free | Linear | L | None | 13 | Antimicrobial | HC50= 17.13 µg/mL | Human | BmKn2 derivative (From venom of Mesobuthus martensii) | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAKIKIGAKI{ct:Amid} | KIGAKI-wt | Amidation | Free | Linear | L | None | 18 | Antimicrobial | ~14% hemolytic at 7.5μM | Human | Membrane-active model peptide KIGAKI [(KIGAKI)3-NH2] | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAKIKIGAKI{ct:Amid} | KIGAKI-wt | Amidation | Free | Linear | L | None | 18 | Antimicrobial | ~54% hemolytic at 60μM | Human | Membrane-active model peptide KIGAKI [(KIGAKI)3-NH2] | NA | NA | ||
| 23652359 | 2013 | KIGAK{nnr:L-CF3-Bpg}KIGAKIKIGAKI{ct:Amid} | KIGAKI-6L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~23% hemolytic at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAK{nnr:L-CF3-Bpg}-KIGAKIKIGAKI{ct:Amid} | KIGAKI-6L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~50% hemolytic at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAK-{nnr:D-CF3-Bpg}-KIGAKIKIGAKI{ct:Amid} | KIGAKI-6D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~7% hemolysis at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAK-{nnr:D-CF3-Bpg}-KIGAKIKIGAKI{ct:Amid} | KIGAKI-6D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~10% hemolytic at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIK-{nnr:L-CF3-Bpg}-GAKIKIGAKI{ct:Amid} | KIGAKI-8L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~13% hemolytic at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIK-{nnr:L-CF3-Bpg}-GAKIKIGAKI{ct:Amid} | KIGAKI-8L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~38% hemolytic at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIK-{nnr:D-CF3-Bpg}-GAKIKIGAKI{ct:Amid} | KIGAKI-8D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~5% hemolytic at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIK-{nnr:D-CF3-Bpg}-GAKIKIGAKI{ct:Amid} | KIGAKI-8D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~8% hemolytic at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAK-{nnr:L-CF3-Bpg}-KIGAKI{ct:Amid} | KIGAKI-12L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~17% hemolytic at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAK-{nnr:L-CF3-Bpg}-KIGAKI{ct:Amid} | KIGAKI-12L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~38% hemolytic at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKI-12DKIGAKIKIGAK-{nnr:D-CF3-Bpg}-KIGAKI{ct:Amid} | KIGAKI-12D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~5% hemolysis at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKI-12DKIGAKIKIGAK-{nnr:D-CF3-Bpg}-KIGAKI{ct:Amid} | KIGAKI-12D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~7% hemolysis at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAKIK-{nnr:L-CF3-Bpg}-GAKI{ct:Amid} | KIGAKI-14L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~13% hemolysis at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAKIK-{nnr:L-CF3-Bpg}-GAKI{ct:Amid} | KIGAKI-14L | Amidation | Free | Linear | L | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~34% hemolytic at 60μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAKIK-{nnr:D-CF3-Bpg}-GAKI{ct:Amid} | KIGAKI-14D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~6% hemolysis at 7.5μM | Human | KIGAKI analog | NA | NA | ||
| 23652359 | 2013 | KIGAKIKIGAKIK-{nnr:D-CF3-Bpg}-GAKI{ct:Amid} | KIGAKI-14D | Amidation | Free | Linear | Mix | CF3-Bpg = 3-(trifluoromethyl)-bicyclopent-1.1.1-1-ylglycine | 17 | Antimicrobial | ~7% hemolysis at 60μM | Human | KIGAKI analog | NA | NA | ||
| 22029824 | 2012 | TSRCIFYRRKKCS | Andersonin-C1 | Free | Free | Linear | L | None | 13 | Antimicrobial | 15.2 ± 2.1% hemolytic at 50 μg/mL. | Human | Andersonin (Odorrana andersonii) | NA | NA | ||
| 22083756 | 2012 | CLRIGMRGRELMGGIGKTM | pCM19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0.109% hemolytic at 100 μg/mL | Human | Peptide of hGlyrichin,corresponding to amino acids 42 to 60 (Homo sapien) | NA | NA | ||
| 22083756 | 2012 | CLRIGMRGRELMGGIGKTM | pCM19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0.119% hemolytic at 3000 μg/mL | Human | Peptide of hGlyrichin,corresponding to amino acids 42 to 60 (Homo sapien) | NA | NA | ||
| 22249992 | 2012 | NWCKRGRKQCKTHPH | NWC15l | Free | Free | Linear | L | None | 15 | Antimicrobial | ~2% hemolytic at 60μM and 6μM | Human | ß-amyloid precursor protein derivative (Homo sapien) | NA | NA | ||
| 22249992 | 2012 | NWCKRGRKQCKTHPH{cyc:N-C} | NWC15c | Free | Free | Cyclic | L | None | 15 | Antimicrobial | ~2% hemolytic at 6μM | Human | ß-amyloid precursor protein derivative (Homo sapien) | NA | NA | ||
| 22249992 | 2012 | NWCKRGRKQCKTHPH{cyc:N-C} | NWC15c | Free | Free | Cyclic | L | None | 15 | Antimicrobial | ~3% hemolytic at 60μM | Human | ß-amyloid precursor protein derivative (Homo sapien) | NA | NA | ||
| 22249992 | 2012 | NWCKRGRKQCKTHPHFVIPY{cyc:N-C} | NWC20c | Free | Free | Cyclic | L | None | 20 | Antimicrobial | ~4% hemolytic at 6μM | Human | ß-amyloid precursor protein derivative (Homo sapien) | NA | NA | ||
| 22249992 | 2012 | NWCKRGRKQCKTHPHFVIPY{cyc:N-C} | NWC20c | Free | Free | Cyclic | L | None | 20 | Antimicrobial | ~3% hemolytic at 60μM | Human | ß-amyloid precursor protein derivative (Homo sapien) | NA | NA | ||
| 22328546 | 2012 | GIGAVLKVLTTGLPALISWI | MT20 | Free | Free | Linear | L | None | 20 | CPP | <80% hemolytic at 25μM at pH 8 | Human | Truncated peptides of melittin | NA | NA | ||
| 22328546 | 2012 | GIGAVLKVLTTGLPALISWI | MT20 | Free | Free | Linear | L | None | 20 | CPP | 40% hemolytic at 25μM at pH 5 | Human | Truncated peptides of melittin | NA | NA | ||
| 22328546 | 2012 | GIGAILKVLATGLPTLISWI | FL20 | Free | Free | Linear | L | None | 20 | CPP | <60% hemolytic at 25μM at pH 5 | Human | Truncated peptides of florae (Apis florae) | NA | NA | ||
| 22328546 | 2012 | GIGAILKVLATGLPTLISWI | FL20 | Free | Free | Linear | L | None | 20 | CPP | ~80% hemolytic at 25μM at pH 8 | Human | Truncated peptides of florae (Apis florae) | NA | NA | ||
| 22371493 | 2012 | GIIKVIKSLIEQFTGK | dPSMα1 | Free | Free | Linear | L | None | 16 | Immunosuppressive and antimicrobial | Non-hemolytic at 10 μg/mL | Human | Phenol-soluble modulins derivative (Staphylococcus aureus) | NA | Non-hemolytic | ||
| 22371493 | 2012 | MAIVGTIIKIIKAIIDIFAK | PSMα4 | Free | Free | Linear | L | None | 20 | Immunosuppressive and antimicrobial | 19% hemolytic at 10 μg/mL | Human | Phenol-soluble modulins derivative (Staphylococcus aureus) | NA | NA | ||
| 22371493 | 2012 | VGTIIKIIKAIIDIFAK | dPSMα4 | Free | Free | Linear | L | None | 17 | Immunosuppressive and antimicrobial | 52% hemolytic at 10 μg/mL | Human | Phenol-soluble modulins derivative (Staphylococcus aureus) | NA | NA | ||
| 22518150 | 2012 | KWKLFKKIPKFLHLAKKF{ct:Amid} | P18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC = 250 μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKFLHLAKKF{ct:Amid} | CP-P | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC = 250 μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKFLHSAKKF{ct:Amid} | S16 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KFKSFIKKLTSKFLHSAKKF{ct:Amid} | F2 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC = 250 μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFINKLTSKFLHSAKKF{ct:Amid} | N7 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKSTSKFLHSAKKF{ct:Amid} | S9 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKAKTSFLHSAKKF{ct:Amid} | A9 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLLSKFLHSAKKF{ct:Amid} | L10 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC <125 μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLASKFLHSAKKF{ct:Amid} | A10 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC= 250 μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTDKFLHSAKKF{ct:Amid} | D11 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTKKFLHSAKKF{ct:Amid} | K11 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKALHSAKKF{ct:Amid} | A13 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKFLHSKKKF{ct:Amid} | K17 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKFLHSADKF{ct:Amid} | D18 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKFLHSANKF{ct:Amid} | N18 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22518150 | 2012 | KWKSFIKKLTSKFLHSAKKN{ct:Amid} | N20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC >500μg/mL | Human | Designed antimicrobial peptide CP-P derivative | NA | NA | ||
| 22699557 | 2012 | IWRIFRRIFRIF{ct:Amid} | HFU4 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | MHC =19.6μM | Human | Synthetic peptides | NA | NA | ||
| 22699557 | 2012 | IWRIFRRIFRIFIRF{ct:Amid} | HFU5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | MHC =15.0μM | Human | Synthetic peptides | NA | NA | ||
| 22038181 | 2012 | AKKKGKCKGPLKLVAKC{cyc:N-C}{ct:Amid} | Las[des1-10, Ala25]-NH2 | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILAAIAKKK{ct:Amid} | Las[des15-27, Ala8]-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22526241 | 2012 | GFLSILKKVLPKVMAHMK{ct:Amid} | MEP | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 >100μM | Human | Melectin (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFLSILKKVLPKVXAHXK{ct:Amid} | MEP-N | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 50μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFLSILKKVLPKSXAHSK{ct:Amid} | MEP-Ns-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 18.1μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFLSSLKKSLPKVXAHXK{ct:Amid} | MEP-Ns-2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 14.7μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFLSSLKKSLPKSXAHSK{ct:Amid} | MEP-Ns-3 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 13.9μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFRSILKKVSPKVXAHXK{ct:Amid} | MEP-Ns-4 cis | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 11μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFRSILKKVSPKVXAHXK{ct:Amid} | MEP-Ns-4 trans | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 20μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFLSSLKKSLGKSXAHSK{ct:Amid} | MEP-Ns-5 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 29μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | GFLSSLKKSLAKSXAHSK{ct:Amid} | MEP-Ns-6 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 39.5μM | Human | Melectin analog (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNWKKILGKIIKVVK{ct:Amid} | LL-III | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 >200μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNWKKSLGKSIKVVK{ct:Amid} | LL-IIIs-1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 = 31.3μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNWKKILGKSIKVSK{ct:Amid} | LL-IIIs-2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 = 69μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VSWKKSLGKIIKVVK{ct:Amid} | LL-IIIs-3 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 = 30μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNSKKISGKSIKVSK{ct:Amid} | LL-IIIs-4 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 >100μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNRKKILGKSIKVVK{ct:Amid} | LL-IIIs-5 cis | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 = 100μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNRKKILGKSIKVVK{ct:Amid} | LL-IIIs-5 trans | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 >100μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNSKKISPKSIKVSK{ct:Amid} | LL-IIIs-6a | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 >100μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22526241 | 2012 | VNSKKISPKSIKVSK{ct:Amid} | LL-IIIs-6b | Amidation | Free | Linear | L | None | 15 | Antimicrobial | LC50 = 82μM | Human | Lasioglossin III (wild bee) | NA | NA | ||
| 22578463 | 2012 | KSLVRRWRSRW{ct:Amid} | MAP-04-01 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Amide analogs of Ixosin-B | NA | Non-hemolytic | ||
| 22578463 | 2012 | KSLRRVWRSWR{ct:Amid} | MAP-04-02 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Amide analogs of Ixosin-B | NA | Non-hemolytic | ||
| 22578463 | 2012 | KWLRRVWRWWR{ct:Amid} | MAP-04-03 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 100% hemolytic at 100μM | Human | Amide analogs of Ixosin-B | NA | NA | ||
| 22578463 | 2012 | KRLRRVWRRWR{ct:Amid} | MAP-04-04 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 3% hemolytic at 100μM | Human | Amide analogs of Ixosin-B | NA | NA | ||
| 22581068 | 2012 | SAVGRHGRRFGLRKHRKH | Chensinin-1 | Free | Free | Linear | L | None | 18 | Antimicrobial | LD50 >500 μM | Human | Skin of Rana chensinensis | NA | NA | ||
| 19635451 | 2010 | GIGAVLKVLALISWIKRKR{ct:Amid} | Mel-H | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 28% hemolytic at 0.4μM | Human | Melittin analog (Honey bee) | NA | NA | ||
| 19635451 | 2010 | GIGAVLKVLALISWIKRKR{ct:Amid} | Mel-H | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 42% hemolytic at 23μM | Human | Melittin analog (Honey bee) | NA | NA | ||
| 19635451 | 2010 | GIGA{d}VLK{d}VLA{d}LISWI{d}KRKR{ct:Amid} | Mel-dH | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | 5% hemolysis at 0.4μM | Human | Melittin diastereomeric analog (Honey bee) | NA | NA | ||
| 19635451 | 2010 | GIGA{d}VLK{d}VLA{d}LISWI{d}KRKR{ct:Amid} | Mel-dH | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial | 12% hemolytic at 23μM | Human | Melittin diastereomeric analog (Honey bee) | NA | NA | ||
| 19960443 | 2010 | P{d}S{d}L{d}V{d}S{d}L{d}V{d}VQ{d}LV{d}{nnr:Δ-But}-A{d}L{d}L{d}O{d}T{d}H{d}R{d}-I-{nnr:Hse}-{nnr:dab}-K{nt:β-hydroxyoctanoyl-Δ-But} | Tolaasin | Free | β-hydroxyoctanoyl-Δ-But | Linear | Mix | Δ-But = 2,3-dehydro-2-aminobutyric acid, Hse = L-homoserine, dab = D-2,4-diaminobutyric acid | 18 | Hemolytic | 100% hemolysis at 0.53 μg/mL | Rat | Tolaasin (Pseudomonas tolaasii) | NA | NA | ||
| 20015460 | 2010 | GVIKSVLKGVAKTVALGML{ct:Amid} | B2-RP | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 = 280μM | Human | Brevinin-2-related peptides (Hylarana erythraea) | NA | NA | ||
| 20058937 | 2010 | KKL{d}L{d}KLLL{d}KL{d}LK{ct:Amid} | K5L7 | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKL{d}L{d}KLLL{d}KL{d}LK{nt:Acetylation (CH3(CH2)4CO)}{ct:Amid} | C6-K5L7 | Amidation | Acetylation (CH3(CH2)4CO) | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKL{d}L{d}KLLL{d}KL{d}LK{nt:Acetylation (CH3(CH2)6CO)}{ct:Amid} | C8-K5L7 | Amidation | Acetylation (CH3(CH2)6CO) | Linear | Mix | None | 12 | Antimicrobial | 19% hemolytic at 100μM | Human | Synthetic peptides | NA | NA | ||
| 20058937 | 2010 | KKL{d}L{d}KKLK{d}KL{d}LK{ct:Amid} | K7L5 | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKL{d}L{d}KKLK{d}KL{d}LK{nt:Acetylation (CH3(CH2)4CO)}{ct:Amid} | C6-K7L5 | Amidation | Acetylation (CH3(CH2)4CO) | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKL{d}L{d}KKLK{d}KL{d}LK{nt:Acetylation (CH3(CH2)6CO)}{ct:Amid} | C8-K7L5 | Amidation | Acetylation (CH3(CH2)6CO) | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKK{d}L{d}KKLK{d}KK{d}LK{ct:Amid} | K9L3 | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKK{d}L{d}KKLK{d}KK{d}LK{nt:Acetylation (CH3(CH2)4CO)}{ct:Amid} | C6-K9L3 | Amidation | Acetylation (CH3(CH2)4CO) | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20058937 | 2010 | KKK{d}L{d}KKLK{d}KK{d}LK{nt:Acetylation (CH3(CH2)6CO)}{ct:Amid} | C8-K9L3 | Amidation | Acetylation (CH3(CH2)6CO) | Linear | Mix | None | 12 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 20798581 | 2010 | KKAAHVGKHVGKAALTHYL{ct:Amid} | Ple (7-25) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Pleurocidin (Pleuronectes americanus) | NA | Non-hemolytic | ||
| 20798581 | 2010 | GWGSFFKKAAHVGKHVGKA{ct:Amid} | Ple (1-19) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Pleurocidin (Pleuronectes americanus) | NA | Non-hemolytic | ||
| 20848624 | 2010 | F{d}PV{nnr:O}LF{d}PV{nnr:O}L{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antimicrobial | HC50=17.5±1.07μM | Human | Gramicidin S | NA | NA | ||
| 20848624 | 2010 | F{d}PV{nnr:O}LF{d}P-{nnr:Ada}-G{nnr:O}L{cyc:N-C} | GS2 | Free | Free | Cyclic | Mix | O = L-Ornithine, Ada = Adamantylglycine | 10 | Antimicrobial | HC50=10.1±1.11μM | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | F{d}PV{nnr:O}LF{d}PV{nnr:O}-{nnr:Ada}-A{cyc:N-C} | GS4 | Free | Free | Cyclic | Mix | O = L-Ornithine, Ada = Adamantylglycine | 10 | Antimicrobial | HC50 =5.20±1.13μM | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | F{d}PV{nnr:O}-{nnr:Ada}-AF{d}PV{nnr:O}-{nnr:Ada}-A{cyc:N-C} | GS5 | Free | Free | Cyclic | Mix | O = L-Ornithine, Ada = Adamantylglycine | 10 | Antimicrobial | HC50 =10.3±1.07μM | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | F{d}P-{nnr:Ada}-G{nnr:O}-{nnr:Ada}-AF{d}P-{nnr:Ada}-G{nnr:O}-{nnr:Ada}-A{cyc:N-C} | GS6 | Free | Free | Cyclic | Mix | O = L-Ornithine, Ada = Adamantylglycine | 10 | Antimicrobial | HC50 =7.55±1.10μM | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | FP-{nnr:tBuGly}-{nnr:O}-{nnr:tBuAla}-F{d}P-{nnr:tBuGly}-{nnr:O}-{nnr:tBuAla}{cyc:N-C} | GS7 | Free | Free | Cyclic | Mix | O = L-Ornithine, tBuGly = tert-butylglycine, tBuAla = tert-butylalanine | 10 | Antimicrobial | HC50 =9.30±1.07μM | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | F{d}P-{nnr:Chg}-{nnr:O}-{nnr:Cha}-F{d}P-{nnr:Chg}-{nnr:O}-{nnr:Cha}{cyc:N-C} | GS8 | Free | Free | Cyclic | Mix | O = L-Ornithine, Chg = Cyclohexylglycine, Cha = Cyclohexylalanine | 10 | Antimicrobial | HC50 =9.12±1.13μM | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | F{d}P{nnr:O}V{nnr:O}{cyc:N-C} | GS9 | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antimicrobial | Non-hemolytic | Human | Gramicidin S analogue | NA | NA | ||
| 20848624 | 2010 | F{d}P{nnr:O}-{nnr:Ada}Gly-{nnr:O}F{d}P{nnr:O}-{nnr:Ada}-Gly-{nnr:O}{cyc:N-C} | GS10 | Free | Free | Cyclic | Mix | O = L-Ornithine, Ada = Adamantylglycine | 10 | Antimicrobial | HC50=107±1.07μM | Human | Gramicidin S analogue | NA | NA | ||
| 21110126 | 2011 | FLGWLFKWASK{ct:Amid} | GA-W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =25μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FLGWLFKWAWK{ct:Amid} | GA-W3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =50 μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FLWWLFKWAWK{ct:Amid} | GA-W4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =25μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FLGWLFKWAKK{ct:Amid} | GA-K3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =50μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FLKWLFKWAKK{ct:Amid} | GA-K4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =6.3μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FLKWLFKWLKK{ct:Amid} | GA-K4L | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =12.5μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FAKWAFKWAKK{ct:Amid} | GA-K4A | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC >200μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21110126 | 2011 | FAKWAFKWLKK{ct:Amid} | GA-K4AL | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC >200μg/ml | Human | Brevinin-1EMa analog (Glandirana emeljanovi) | NA | NA | ||
| 21300831 | 2011 | GKKLLKKLKKLLKKG{nt:Acet}{ct:Amid} | Pep-1 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 0.3% hemolytic at 3.4mg/ml | Human | Synthetic peptides | NA | NA | ||
| 21300831 | 2011 | GKKL{d}L{d}KKL{d}KKL{d}L{d}KKG{nt:Acet}{ct:Amid} | MA-d | Amidation | Acetylation | Linear | Mix | None | 15 | Antimicrobial | 1% hemolytic at 3.4mg/ml | Human | Synthetic peptides | NA | NA | ||
| 21300831 | 2011 | GKKLLKKLKKLLKKW{nt:Acet}{ct:Amid} | MAw-1 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 17% hemolytic at 3.4mg/ml | Human | Synthetic peptides | NA | NA | ||
| 21300831 | 2011 | GKKLLKKLKKLWKKW{nt:Acet}{ct:Amid} | Maw-2 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 18% hemolytic at 3.4mg/ml | Human | Synthetic peptides | NA | NA | ||
| 21300831 | 2011 | GKKLLKKWKKLWKKW{nt:Acet}{ct:Amid} | Maw-3 | Amidation | Acetylation | Linear | L | None | 15 | Antimicrobial | 5% hemolytic at 3.4mg/ml | Human | Synthetic peptides | NA | NA | ||
| 21319749 | 2011 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 48% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | LLQWLSKLLGRLL{ct:Amid} | TL-1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 25% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | LLQWLSKLLGRWL{ct:Amid} | TL-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 78% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVQWFSKFLLRIL{ct:Amid} | [Leu10]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 80% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TLb | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FLPWFSKFLGRIL{ct:Amid} | [Leu2, Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 19% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVPWFSKFLPRIL{ct:Amid} | [Pro3, Pro10]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.5% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVPWFSKFLP{d}RIL{ct:Amid} | [Pro3, DPro10]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 0.6% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVQWFSKFLGKIL{ct:Amid} | [Lys11]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 14% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVQWFSKFLG{nnr:O}IL{ct:Amid} | [Orn11]TL | Amidation | Free | Linear | L | O = L-Ornithine | 13 | Antimicrobial | 22% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVQWFSRFLGRIL{ct:Amid} | [Arg7]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 29% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVRWFSKFLGRIL{ct:Amid} | [Arg3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 52% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVRWFSRFLGRIL{ct:Amid} | [Arg3, Arg7]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 43% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | FVPWFSKFLGOIL{ct:Amid} | [Pro3, Orn11]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 2% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | F{d}V{d}Q{d}W{d}F{d}S{d}K{d}F{d}L{d}GR{d}I{d}L{d}{ct:Amid} | D-TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 46% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21319749 | 2011 | L{d}I{d}R{d}GL{d}F{d}K{d}S{d}F{d}W{d}Q{d}V{d}F{d}{ct:Amid} | RI-TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 15% hemolytic at 6μM | Human | Temporin L Analogues | NA | NA | ||
| 21335383 | 2011 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 54 ±0.1% hemolytic at 250μM | Human | Synthetic peptide | NA | NA | ||
| 21335383 | 2011 | KKLFKKILKY{d}L{ct:Amid} | BP138 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 7 ±0.1% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKKILKYL{d}{ct:Amid} | BP139 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 23 ±0.9% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKKILK{d}YL{ct:Amid} | BP140 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 0± 0% hemolytic at 250μM (non-hemolytic) | Human | Synthetic peptide of BP100 | NA | Non-hemolytic | ||
| 21335383 | 2011 | KKLFKKIL{d}KYL{ct:Amid} | BP141 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 4 ±0.3% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFK{d}KILKYL{ct:Amid} | BP142 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 3± 0.6% hemolysis at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLF{d}KKILKYL{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 5± 0.8% hemolysis at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKL{d}FKKILKYL{ct:Amid} | BP144 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 7±0.4% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KK{d}LFKKILKYL{ct:Amid} | BP145 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 51±0.5% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKK{d}ILKYL{ct:Amid} | BP146 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 53 ±1.1% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}KLFKKILKYL{ct:Amid} | BP147 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 71±0.4% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKKI{d}LKYL{ct:Amid} | BP148 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 0±0% hemolytic at 250μM (non-hemolytic) | Human | Synthetic peptide of BP100 | NA | Non-hemolytic | ||
| 21335383 | 2011 | KKL{d}FKKILK{d}YL{ct:Amid} | BP149 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 0±0% hemolytic at 250μM (non-hemolytic) | Human | Synthetic peptide of BP100 | NA | Non-hemolytic | ||
| 21335383 | 2011 | KKLFKKIL{d}K{d}YL{ct:Amid} | BP150 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 1±0.1% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KK{d}L{d}FKK{d}ILK{d}YL{ct:Amid} | BP151 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 1±0.3% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKKI{d}L{d}K{d}YL{ct:Amid} | BP152 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 5±1.6% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}LF{d}KKILKYL{ct:Amid} | BP154 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 41±6.2% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKKIL{d}K{d}Y{d}L{d}{ct:Amid} | BP155 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 3±0.1% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKKL{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP156 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 49±1.2% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFKK{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP157 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 3±1.0% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLFK{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP158 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 28±2.1% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KKLF{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP159 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 58±5.7% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KK{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP160 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 65±1.9% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | KK{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP161 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 66±2.9% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}KKILKYL{ct:Amid} | BP162 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 17±0.7% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}KILKYL{ct:Amid} | BP163 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 8±5.0% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}K{d}ILKYL{ct:Amid} | BP164 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 0±0% hemolytic at 250μM (non-hemolytic) | Human | Synthetic peptide of BP100 | NA | Non-hemolytic | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}LKYL{ct:Amid} | BP165 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 6 ±0.2% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}KYL{ct:Amid} | BP166 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 1±0.2% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}YL{ct:Amid} | BP167 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 21±7.4% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{ct:Amid} | BP168 | Amidation | Free | Linear | Mix | None | 11 | Antimicrobial | 3±2.7% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP153 | Amidation | Free | Linear | D | None | 11 | Antimicrobial | 50±2.1% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSGIL{ct:Amid} | 1Ta | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 27.5% hemolytic at 40μM | Human | Temporin-1Ta (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSGIL{ct:Amid} | 1Ta | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.5% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | ALPLIGRVLSGIL{ct:Amid} | Ta A1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 62.5% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | ALPLIGRVLSGIL{ct:Amid} | Ta A1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 2% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FAPLIGRVLSGIL{ct:Amid} | Ta A2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 15% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FAPLIGRVLSGIL{ct:Amid} | Ta A2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLALIGRVLSGIL{ct:Amid} | Ta A3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLALIGRVLSGIL{ct:Amid} | Ta A3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPAIGRVLSGIL{ct:Amid} | Ta A4 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 11.5% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPAIGRVLSGIL{ct:Amid} | Ta A4 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 2% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLAGRVLSGIL{ct:Amid} | Ta A5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.5% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLAGRVLSGIL{ct:Amid} | Ta A5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIARVLSGIL{ct:Amid} | Ta A6 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 97% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIARVLSGIL{ct:Amid} | Ta A6 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGAVLSGIL{ct:Amid} | Ta A7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 39% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGAVLSGIL{ct:Amid} | Ta A7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 6% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRALSGIL{ct:Amid} | Ta A8 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10.5% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRALSGIL{ct:Amid} | Ta A8 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.5% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVASGIL{ct:Amid} | Ta A9 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.5% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVASGIL{ct:Amid} | Ta A9 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLAGIL{ct:Amid} | Ta A10 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 70% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLAGIL{ct:Amid} | Ta A10 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSAIL{ct:Amid} | Ta A11 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSAIL{ct:Amid} | Ta A11 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.5% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSGAL{ct:Amid} | Ta A12 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSGAL{ct:Amid} | Ta A12 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSGIA{ct:Amid} | Ta A13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.5% hemolytic at 40μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21337476 | 2011 | FLPLIGRVLSGIA{ct:Amid} | Ta A13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolytic at 1.25μM | Human | Temporin-1Ta analog (Skin of Rana temporaria) | NA | NA | ||
| 21343499 | 2011 | K{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid} | HDP D-P18 | Amidation | Free | Linear | D | None | 18 | Antimcrobial and Hemolytic | ~94% hemolytic at 500μM | Human | Host defense peptides analog (Rana temporaria) | NA | NA | ||
| 21343499 | 2011 | K{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid} | HDP D-P18 | Amidation | Free | Linear | D | None | 18 | Antimcrobial and Hemolytic | ~10% hemolytic at 50μM | Human | Host defense peptides analog (Rana temporaria) | NA | NA | ||
| 21607695 | 2011 | FKCRRWQWRMKKLGA | LfcinB15 | Free | Free | Linear | L | None | 15 | Antimicrobial | >7% hemolytic at 256mg/ml | Pig | Synthetic peptide derived from bovine lactoferricin | NA | NA | ||
| 21607695 | 2011 | RRWQWRMKKLG | LfcinB11 | Free | Free | Linear | L | None | 11 | Antimicrobial | ~6% hemolytic at 256mg/ml | Pig | Synthetic peptide derived from bovine lactoferricin | NA | NA | ||
| 21729875 | 2011 | WLRRIGKGVKIIGGAALDHL{ct:Amid} | NRC-02 | Amidation | Free | Linear | L | None | 20 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | FFRLLFHGVHHGGGYLNAA{ct:Amid} | NRC-09 | Amidation | Free | Linear | L | None | 19 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | FFRLLFHGVHHVGKIKPRA{ct:Amid} | NRC-10 | Amidation | Free | Linear | L | None | 19 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GWKKWLRKGAKHLGQAAIK{ct:Amid} | NRC-16 | Amidation | Free | Linear | L | None | 19 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GWKKWFTKGERLSQRHFA | NRC-18 | Free | Free | Linear | L | None | 18 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWICEVLSDFK | C5A | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC= 3.46μM | Human | C5A derived from the membrane anchor domain of the N-terminal region of NS5A protein | NA | NA | ||
| 21801309 | 2011 | SWLRDLWDWICEVLSDFK | I6L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 13.84μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWLCEVLSDFK | I10L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC =6.92μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWICELLSDFK | V13L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 3.44μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDLWDWLCEVLSDFK | I6L/I10L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 6.92μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDLWDWICELLSDFK | I6L/V13L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 53.75μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWLCELLSDFK | I10L/V13L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 3.44μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDLWDWLCELLSDFK | I6L/I10L/V13L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 107.50μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWLCEVLSDFK | I10L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 6.92μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWVCEVLSDFK | I10V | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC =13.93μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWACEVLSDFK | I10A | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 14.10μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWGCEVLSDFK | I10G | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 28.38μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWSCEVLSDFK | I10S | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC =28.00μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWECEVLSDFK | I10E | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC =217.91μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWKCEVLSDFK | I10K | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC =214.81μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21955251 | 2011 | GIIKKIIKKI{ct:Amid} | G(IIKK)2I | Amidation | Free | Linear | L | None | 10 | Antimicrobial and Antitumor | Non-hemolytic up to 250 μM | Human | Synthetic peptides | NA | Non-hemolytic | ||
| 21955251 | 2011 | GIIKKIIKKIIKKI{ct:Amid} | G(IIKK)3I | Amidation | Free | Linear | L | None | 14 | Antimicrobial and Antitumor | EC50 >250μM | Human | Synthetic peptides | NA | NA | ||
| 21955251 | 2011 | GIIKKIIKKIIKKIIKKI{ct:Amid} | G(IIKK)4I | Amidation | Free | Linear | L | None | 18 | Antimicrobial and Antitumor | EC50 = 41±2μM | Human | Synthetic peptides | NA | NA | ||
| 21956793 | 2011 | LLIILRRRIRKQAHAHSK{ct:Amid} | pVEC | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 200μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21956793 | 2011 | LLIILRRRWRKQARARSK{ct:Amid} | pVEC-a1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 200μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21956793 | 2011 | LLIILRRRWRKQAKAKSK{ct:Amid} | pVEC-a2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 200μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21956793 | 2011 | LLIILRRRWRRQARARSR{ct:Amid} | pVEC-a3 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 94μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21956793 | 2011 | LLIILKKKWKKQAKAKSK{ct:Amid} | pVEC-a4 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 200μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21968924 | 2011 | GRPNPVNNKPT{nnr:*}PHPRL | formaecin I | Free | Free | Linear | L | * = α-GalNAc | 16 | Antimicrobial | <5% hemolytic at 100 μM | Rat | Synthetic peptides | NA | NA | ||
| 21968924 | 2011 | GRPNPVNNKPTPHPRL | Non-glycosylated formaecin I | Free | Free | Linear | L | None | 16 | Antimicrobial | <5% hemolytic at 100 μM | Rat | non-glycosylated analogs of native formaecin I | NA | NA | ||
| 21968924 | 2011 | GKPRPYSPRPT{nnr:*}SHPRPIRV | M-drosocin | Free | Free | Linear | L | * = α-GalNAc | 19 | Antimicrobial | <5% hemolytic at 100 μM | Rat | Synthetic peptides | NA | NA | ||
| 21968924 | 2011 | GKPRPYSPRPTSHPRPIRV | Non-glycosylated M-drosocin | Free | Free | Linear | L | None | 19 | Antimicrobial | <5% hemolytic at 100 μM | Rat | non-glycosylated analogs of native M-drosocin | NA | NA | ||
| 22082130 | 2011 | KLAKKLAKLAKLAKAL | Modelin-5-COOH | Free | Free | Linear | L | None | 16 | Antimicrobial | ~1% hemolytic at 300μM | Pig | Synthetic peptide of Modelin-5 | NA | NA | ||
| 22082130 | 2011 | KLAKKLAKLAKLAKAL{ct:Amid} | Modelin-5-CONH2 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <2% hemolytic at 300μM | Pig | Synthetic peptide of Modelin-5 | NA | NA | ||
| 20927512 | 2011 | LGFGTFVLMLLGLVVELIK | TMDSP | Free | Free | Linear | L | None | 19 | Antimicrobial | Mild hemolytic at 50 μM | Sheep | Mutants of holin-like protein Tmp1 | NA | NA | ||
| 21762675 | 2011 | ELLKAVRLIK | Rev–NIS | Free | Free | Linear | L | None | 10 | Antimicrobial | 0% hemolytic upto 100μM (non-hemolytic) | Human | Rev–NIS (HIV) | NA | Non-hemolytic | ||
| 21762675 | 2011 | RLRKAVRLIK | Anal R | Free | Free | Linear | L | None | 10 | Antimicrobial | 0% hemolytic upto 100μM (non-hemolytic) | Human | Rev–NIS analog (HIV) | α helix | Non-hemolytic | ||
| 21762675 | 2011 | ELSKAVRLIK | Anal S | Free | Free | Linear | L | None | 10 | Antimicrobial | 0% hemolytic upto 100μM (non-hemolytic) | Human | Rev–NIS analog (HIV) | α helix | Non-hemolytic | ||
| 22029824 | 2012 | FIFPKKNIINSLFGR | Andersonin-D1 | Free | Free | Linear | L | None | 15 | Antimicrobial | Non-hemolytic upto 50 μg/mL | Human | Skin secretion of frog Odorrana andersonii | NA | Non-hemolytic | ||
| 22029824 | 2012 | ENMFNIKSSVESDSFWG | Andersonin-N1 | Free | Free | Linear | L | None | 17 | Antimicrobial | Non-hemolytic upto 50 μg/mL | Human | Skin secretion of frog Odorrana andersonii | NA | Non-hemolytic | ||
| 22029824 | 2012 | EMLKKKEVKMERKT | Andersonin-Q1 | Free | Free | Linear | L | None | 14 | Antimicrobial | Non-hemolytic upto 50 μg/mL | Human | Skin secretion of frog Odorrana andersonii | NA | Non-hemolytic | ||
| 19038369 | 2009 | ILPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID | Amidation | Free | Cyclic | L | None | 13 | Antimicrobial | 5-10% hemolysis at 25μg/mL | Human | Cytoplasmic granules of bovine neutrophils | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID-I | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 5-10% hemolysis at 25μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-W | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 5-10% hemolysis at 25μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-IW | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 5% hemolysis at 25μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID | Amidation | Free | Cyclic | L | None | 13 | Antimicrobial | 10% hemolysis at 50μg/mL | Human | Cytoplasmic granules of bovine neutrophils | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID-I | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 10% hemolysis at 50μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-W | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 10% hemolysis at 50μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-IW | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 5% hemolysis at 50μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID | Amidation | Free | Cyclic | L | None | 13 | Antimicrobial | 10% hemolysis at 100μg/mL | Human | Cytoplasmic granules of bovine neutrophils | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID-I | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 10-15% hemolysis at 100μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-W | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 10-15% hemolysis at 100μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-IW | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 10% hemolysis at 100μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID | Amidation | Free | Cyclic | L | None | 13 | Antimicrobial | 30% hemolysis at 200μg/mL | Human | Cytoplasmic granules of bovine neutrophils | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPWWPWRR{cyc:N-C}{ct:Amid} | ID-I | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 30% hemolysis at 200μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | ILPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-W | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | 30% hemolysis at 200μg/mL | Human | Indolicidin analog | NA | NA | ||
| 19038369 | 2009 | I{nnr:*}LPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid} | ID-IW | Amidation | Free | Cyclic | L | * = Reduced amide bond ψCH2NH | 13 | Antimicrobial | ~10% hemolysis at 200μg/mL | Human | Indolicidin analog | NA | NA | ||
| 20363271 | 2010 | KLKKLL{d}KKWLKL{d}LKKLLK{d}{ct:Amid} | K9L8W | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HC50 =14μM | Human | Synthetic peptide | α-helical | NA | ||
| 20363271 | 2010 | KLKKLL{d}KKWLKL{d}LKKLLK{d}{ct:Amid} | D3-K9L8W-1 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | HC50 =150μM | Human | Synthetic peptide | Random coil | NA | ||
| 20363271 | 2010 | KLKKL{d}LKKWL{d}KLLKK{d}LLK{ct:Amid} | D3-K9L8W-2 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | HC50 =116μM | Human | Synthetic peptide | Random coil | NA | ||
| 20363271 | 2010 | KLKK{d}LLKK{d}WLKL{d}LKKL{d}LK{ct:Amid} | D4-K9L8W | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | HC50 =800μM | Human | Synthetic peptide | Random coil | NA | ||
| 20363271 | 2010 | KL{d}K{d}KLL{d}KKW{d}LKL{d}LKK{d}LLK{d}{ct:Amid} | D6-K9L8W | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | HC50 =800μM | Human | Synthetic peptide | Random coil | NA | ||
| 20363271 | 2010 | KL{d}KK{d}LL{d}KK{d}WL{d}KL{d}LK{d}KL{d}LK{d}{ct:Amid} | D9-K9L8W-1 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | HC50 =800μM | Human | Synthetic peptide | Random coil | NA | ||
| 20363271 | 2010 | KLKKLLKKWL{d}K{d}L{d}L{d}K{d}K{d}L{d}L{d}K{d}{ct:Amid} | D9-K9L8W-2 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | HC50 =154μM | Human | Synthetic peptide | Random coil | NA | ||
| 20399752 | 2010 | KRFKKFFKKLK{ct:Amid} | ATRA-1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | EC50 =5.98μM | Human | Naja atra analog | α-helical | NA | ||
| 20399752 | 2010 | KRAKKFFKKPK{ct:Amid} | ATRA-2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | EC50 =107μM | Human | Naja atra analog | α-helical | NA | ||
| 20399752 | 2010 | KRAKKFFKKLK{ct:Amid} | ATRA-1A | Amidation | Free | Linear | L | None | 11 | Antimicrobial | EC50 =7.98μM | Human | Naja atra analog | α-helical | NA | ||
| 20399752 | 2010 | KRFKKFFKKPK{ct:Amid} | ATRA-1P | Amidation | Free | Linear | L | None | 11 | Antimicrobial | EC50 =95.92μM | Human | Naja atra analog | α-helical | NA | ||
| 20466006 | 2010 | YVPPVQKPHPNGPKFPTFP | PP30 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 125μM | Human | Pteromalus puparum cDNA clone (synthetic peptide) | Random coil | NA | ||
| 20466006 | 2010 | YVPPVQKPHPNGPKFPTFP | PP30 | Free | Free | Linear | L | None | 19 | Antimicrobial | 3.8% hemolysis at 250μM | Human | Pteromalus puparum cDNA clone (synthetic peptide) | Random coil | NA | ||
| 20637182 | 2010 | FSPQMLQDIIEAATAIL | A17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200μg/ml | Mouse | K-17 analog | α-helical | Non-hemolytic | ||
| 20637182 | 2010 | FSPQMLQDIIEKKTKIL | K17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0% hemolysis at 200μg/ml | Mouse | Beta-defensin gene | α-helical | Non-hemolytic | ||
| 20736034 | 2011 | LKKWLKKWLKK{ct:Amid} | L3K6W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | negligible hemolysis at 320μg/ml | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 20736034 | 2011 | LLKWLKKWLKK{ct:Amid} | L4K5W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0-5% hemolysis at 40μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLLKWLKK{ct:Amid} | L5K4W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 40-50% hemolysis at 40μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLLKWLLK{ct:Amid} | L6K3W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 55-60% hemolysis at 40μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLKKWLKK{ct:Amid} | L4K5W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5% hemolysis at 80μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLKKWLKK{ct:Amid} | L4K5W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 10% hemolysis at 160μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLLKWLKK{ct:Amid} | L5K4W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50-60% hemolysis at 80μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLLKWLKK{ct:Amid} | L5K4W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 60-65% hemolysis at 160μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLLKWLLK{ct:Amid} | L6K3W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 60-70% hemolysis at 80μg/ml | Human | Synthetic peptide | NA | NA | ||
| 20736034 | 2011 | LLKWLLKWLLK{ct:Amid} | L6K3W2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 70-75% hemolysis at 160μg/ml | Human | Synthetic peptide | NA | NA | ||
| 21073979 | 2011 | GKLNLFLSRLEILKLFVGAL | Pelteobagrin | Free | Free | Linear | L | None | 20 | Antimicrobial | no hemolysis upto <400μg/ml | Rabbit | Pelteobagrus fulvidraco derived from skin mucus of yellow catfish | α-helical | Non-hemolytic | ||
| 21241661 | 2011 | CVYAYVRVRGVLVRYRRCW | Arenicin-1(analog-1) | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 50μM | Human | Arenicin-1 analog | NA | NA | ||
| 21241661 | 2011 | CVYAYVRVRGVLVRYRRCW | Arenicin-1(analog-1) | Free | Free | Linear | L | None | 19 | Antimicrobial | 4% hemolysis at 100μM | Human | Arenicin-1 analog | NA | NA | ||
| 21497177 | 2011 | GRFKRFRKKFKKLFKKLS{ct:Amid} | BMAP -18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 10% hemolysis at >400μM | Human | BMAP-27 analog | α-helical | NA | ||
| 21497177 | 2011 | GRWKRWRKKWKKLWKKLS{ct:Amid} | BMAP- 18-W | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 10% hemolysis at 38μM | Human | BMAP-27 analog | α-helical | NA | ||
| 21497177 | 2011 | GRLKRLRKKLKKLLKKLS{ct:Amid} | BMAP -18-L | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 10% hemolysis at 300μM | Human | BMAP-27 analog | α-helical | NA | ||
| 21497177 | 2011 | GRIKRIRKKIKKLIKKLS{ct:Amid} | BMAP -18-I | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 10% hemolysis at 265μM | Human | BMAP-27 analog | α-helical | NA | ||
| 21497177 | 2011 | GR{d}F{d}KRF{d}RKKF{d}KKLF{d}KKLS{ct:Amid} | BMAP -18-f | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | 10% hemolysis at >400μM | Human | BMAP-27 analog | α-helical | NA | ||
| 21664395 | 2011 | WCPPMIPLCSRF{cyc:N-C}{ct:Amid} | Tigerinin-M1 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial | LC50 >500μM | Human | Derived from skin secretions of Xenopus muelleri | NA | NA | ||
| 21682682 | 2011 | LGRVDIHVWDGVYIRGR | KK42-63-3H | Free | Free | Linear | L | None | 17 | Cytotoxic | 5.9% hemolysis at 100μM | Human | synthetic peptide | NA | NA | ||
| 21682682 | 2011 | LGRVDIHVWDGVYI | PIP56-69 | Free | Free | Linear | L | None | 14 | Cytotoxic | 2.48% hemolysis at 100μM | Human | synthetic peptide | NA | NA | ||
| 21682682 | 2011 | VDIHVWDGVVDIHVWDGV | PIP-18 | Free | Free | Linear | L | None | 18 | Cytotoxic | 1.16% hemolysis at 100μM | Human | synthetic peptide | NA | NA | ||
| 21682682 | 2011 | LGRVDIHVWDGVYIRGR | P-NT.II | Free | Free | Linear | L | None | 17 | Cytotoxic | 9.5% hemolysis at 100μM | Human | synthetic peptide | NA | NA | ||
| 21682682 | 2011 | LGRVDIHVWDA{d}VYIRGR | [D-Ala66]-PNT.II | Free | Free | Linear | Mix | None | 17 | Cytotoxic | 3% hemolysis at 100μM | Human | synthetic peptide | NA | NA | ||
| 21682682 | 2011 | CVDIHVWDGVC{cyc:N-C} | Cyclic C-PIP[59-67]C | Free | Free | Cyclic | L | None | 11 | Cytotoxic | 7.2% hemolysis at 100μM | Human | synthetic peptide | NA | NA | ||
| 22800690 | 2012 | GFLGSLLKTGLKVGSNLL{ct:Amid} | CPF-SE3 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 =220μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | FLGALLGPLMNLLQ{ct:Amid} | PFQa | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LC50 =105μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22943778 | 2012 | FLPFLLSALPKVFCFFSKKC{cyc:N-C} | Brevinin-1ZHa | Free | Free | Cyclic | L | None | 20 | Antimicrobial | HC50 =3μM | Human | Derived from skin of Rana zhenhaiensis | NA | NA | ||
| 22943778 | 2012 | FLPLLLASLPSFLCLVFKKC{cyc:N-C} | Brevinin-1ZHb | Free | Free | Cyclic | L | None | 20 | Antimicrobial | HC50 =5μM | Human | Derived from skin of Rana zhenhaiensis | NA | NA | ||
| 22943778 | 2012 | LALKSGGWLRLFGLKDKKH | Chensinin-1ZHa | Free | Free | Linear | L | None | 19 | Antimicrobial | HC50 >92μM | Human | Derived from skin of Rana zhenhaiensis | NA | NA | ||
| 22960382 | 2012 | KIKIPWGKVKDFLVGGMKAV{ct:Amid} | Bicarinalin | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 50% hemolysis at 0.72mg/ml | Human | Derived from venom of Tetramorium bicarinatum | NA | NA | ||
| 22960382 | 2012 | LFKEILEKIKAKL{ct:Amid} | P-17 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | Inactive | Human | Derived from venom of Tetramorium bicarinatum | NA | Non-hemolytic | ||
| 22965637 | 2013 | ILGKLLSTAAGLLSNL{ct:Amid} | Alyteserin-2a | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =140μM | Human | Derived from skin secretions of Alytes obstetricans (alyteserin-2a) | α-helical | NA | ||
| 22965637 | 2013 | ILKKLLSTAAGLLSNL{ct:Amid} | G3K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =105μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLKTAAGLLSNL{ct:Amid} | S7K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =28μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLK{d}TAAGLLSNL{ct:Amid} | S7k | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =105μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAKLLSNL{ct:Amid} | G11K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =24μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAK{d}LLSNL{ct:Amid} | G11k | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =42μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAGLLKNL{ct:Amid} | S14K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =55μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAGLLSKL{ct:Amid} | N15K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =50μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAGLLSK{d}L{ct:Amid} | N15k | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =310μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLKTAAKLLSNL{ct:Amid} | S7K,G11K | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =38μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLK{d}TAAK{d}LLSNL{ct:Amid} | S7k,G11k | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =185μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAKLLSKL{ct:Amid} | G11K,N15K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =16μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAK{d}LLSKL{ct:Amid} | G11k,N15K | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =195μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSWAAGLLSNL{ct:Amid} | T8W | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =13μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTWAGLLSNL{ct:Amid} | A9W | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =39μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAWGLLSNL{ct:Amid} | A10W | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =11μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAWK{d}LLSNL{ct:Amid} | A10W,G11k | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =21μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAWGLLSKL{ct:Amid} | A10W,N15K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =6μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAWALLSK{d}L{ct:Amid} | A10W,N15k | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =27μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22974815 | 2013 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 48μM | Human | Derived from skin of Rana genus (Temporin L) | α-helical | NA | ||
| 22974815 | 2013 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 94% hemolysis at 24μM | Human | Derived from skin of Rana genus (Temporin L) | α-helical | NA | ||
| 22974815 | 2013 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 92% hemolysis at 12μM | Human | Derived from skin of Rana genus (Temporin L) | α-helical | NA | ||
| 22974815 | 2013 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 48% hemolysis at 6μM | Human | Derived from skin of Rana genus (Temporin L) | α-helical | NA | ||
| 22974815 | 2013 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 13% hemolysis at 3μM | Human | Derived from skin of Rana genus (Temporin L) | α-helical | NA | ||
| 22974815 | 2013 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3% hemolysis at 1.5μM | Human | Derived from skin of Rana genus (Temporin L) | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 92% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 42% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 6% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.5% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSK{d}FLGRIL{ct:Amid} | [Pro3, DLys7]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 18% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSK{d}FLGRIL{ct:Amid} | [Pro3, DLys7]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 8% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSK{d}FLGRIL{ct:Amid} | [Pro3, DLys7]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 5% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSK{d}FLGRIL{ct:Amid} | [Pro3, DLys7]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 7% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSK{d}FLGRIL{ct:Amid} | [Pro3, DLys7]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 4% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSK{d}FLGRIL{ct:Amid} | [Pro3, DLys7]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 2% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKF{d}LGRIL{ct:Amid} | [Pro3, DPhe8]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 94% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKF{d}LGRIL{ct:Amid} | [Pro3, DPhe8]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 19% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKF{d}LGRIL{ct:Amid} | [Pro3, DPhe8]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 19% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKF{d}LGRIL{ct:Amid} | [Pro3, DPhe8]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 17% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKF{d}LGRIL{ct:Amid} | [Pro3, DPhe8]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 5% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKF{d}LGRIL{ct:Amid} | [Pro3, DPhe8]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 4% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3, DLeu9]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 9% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3, DLeu9]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 8% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3, DLeu9]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 7% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3, DLeu9]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 3% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3, DLeu9]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 2% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3, DLeu9]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 2% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGR{d}IL{ct:Amid} | [Pro3, DArg11]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 22% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGR{d}IL{ct:Amid} | [Pro3, DArg11]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 16% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGR{d}IL{ct:Amid} | [Pro3, DArg11]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 8% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGR{d}IL{ct:Amid} | [Pro3, DArg11]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 6% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGR{d}IL{ct:Amid} | [Pro3, DArg11]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 4% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGR{d}IL{ct:Amid} | [Pro3, DArg11]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 2% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRI{d}L{ct:Amid} | [Pro3, DIle12]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 17% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRI{d}L{ct:Amid} | [Pro3, DIle12]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 14% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRI{d}L{ct:Amid} | [Pro3, DIle12]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 10% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRI{d}L{ct:Amid} | [Pro3, DIle12]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 5% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRI{d}L{ct:Amid} | [Pro3, DIle12]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 4% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFLGRI{d}L{ct:Amid} | [Pro3, DIle12]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 2% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{d}{ct:Amid} | [Pro3, DLeu13]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 15% hemolysis at 48μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{d}{ct:Amid} | [Pro3, DLeu13]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 17% hemolysis at 24μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{d}{ct:Amid} | [Pro3, DLeu13]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 17% hemolysis at 12μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{d}{ct:Amid} | [Pro3, DLeu13]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 8% hemolysis at 6μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{d}{ct:Amid} | [Pro3, DLeu13]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 6% hemolysis at 3μM | Human | Temporin L analog | α-helical | NA | ||
| 22974815 | 2013 | FVPWFSKFL{d}GRIL{d}{ct:Amid} | [Pro3, DLeu13]TL | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 3% hemolysis at 1.5μM | Human | Temporin L analog | α-helical | NA | ||
| 23262358 | 2013 | DLLGTLGNLPLPFI{ct:Amid} | frenatin 2D | Amidation | Free | Linear | L | None | 14 | Immunomodulatory | No hemolysis upto 500μM | Human | Derived from skin secretions of Discoglossus sardus (Alytidae) | NA | Non-hemolytic | ||
| 23270672 | 2013 | RRLMAAKAESRK | CL(14-25) | Free | Free | Linear | L | None | 12 | Antimicrobial | No or little hemolysis upto 800μM | Human | Oryza sativa L. japonica (cyanate lyase) | α-helical | Non-hemolytic | ||
| 23270672 | 2013 | RLMAAKAESRK | CL(15-25) | Free | Free | Linear | L | None | 11 | Antimicrobial | No or little hemolysis upto 800μM | Human | CL-analog | α-helical | Non-hemolytic | ||
| 23270672 | 2013 | LMAAKAESRK | CL(16-25) | Free | Free | Linear | L | None | 10 | Antimicrobial | No or little hemolysis upto 800μM | Human | CL-analog | α-helical | Non-hemolytic | ||
| 23270672 | 2013 | RRLMAAKAESR | CL(14-24) | Free | Free | Linear | L | None | 11 | Antimicrobial | No or little hemolysis upto 800μM | Human | CL-analog | α-helical | Non-hemolytic | ||
| 23270672 | 2013 | RRLMAAKAES | CL(14-23) | Free | Free | Linear | L | None | 10 | Antimicrobial | No or little hemolysis upto 800μM | Human | CL-analog | α-helical | Non-hemolytic | ||
| 23403131 | 2013 | GILKTIKSIASKLKRKAK | Δ(K12-Q18;Ν26−Α29) | Free | Free | Linear | L | None | 18 | Antimicrobial | EC50 =80μM | Human | Derived from venom of hadrurin and vejovine(Synthetic peptide) | α-helical | NA | ||
| 23403131 | 2013 | GILNTIKSIASKLKRKAK | K4N Δ(K12-Q18; Ν26−Α29) | Free | Free | Linear | L | None | 18 | Antimicrobial | EC50 =139μM | Human | Derived from venom of hadrurin and vejovine(Synthetic peptide) | α-helical | NA | ||
| 23403136 | 2013 | KKLLPIVANLLKSLL | TB_KKG6A | Free | Free | Linear | L | None | 15 | Antimicrobial | Inactive | Mouse | Temporin-1b analog | α-helical | Non-hemolytic | ||
| 23624072 | 2013 | GILGKLWEGFKSIV{ct:Amid} | Pantinin-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0% hemolysis up to 32μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | IFGAIWNGIKSLF{ct:Amid} | Pantinin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis up to 8μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | FLSTIWNGIKSLL{ct:Amid} | Pantinin-3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0% hemolysis upto 8μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | GILGKLWEGFKSIV{ct:Amid} | Pantinin-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 21% hemolysis at 64 μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | IFGAIWNGIKSLF{ct:Amid} | Pantinin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 8% hemolysis at 16μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | FLSTIWNGIKSLL{ct:Amid} | Pantinin-3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 70% hemolysis at 16μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | IFGAIWNGIKSLF{ct:Amid} | Pantinin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 81% hemolysis at 32μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | FLSTIWNGIKSLL{ct:Amid} | Pantinin-3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 32μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23624072 | 2013 | IFGAIWNGIKSLF{ct:Amid} | Pantinin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 64μM | Human | Derived from venom of Pandinus imperator | α-helical | NA | ||
| 23776609 | 2013 | RAGLQFPVGRLLR | BR1 | Free | Free | Linear | L | None | 13 | CPP | Inactive | Human | buforin IIb | NA | Non-hemolytic | ||
| 23776609 | 2013 | RAGLQFPVGRLLRRLLR | BR2 | Free | Free | Linear | L | None | 17 | CPP | Inactive | Human | buforin IIb | NA | Non-hemolytic | ||
| 9675125 | 1998 | MASRAAGLAARLARLALRAL | ESF1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.1% hemolysis at 50μg/ml | Human | magainin PGLa analog | α-helical | NA | ||
| 9675125 | 1998 | MASRAARLAARLARLALRAL | GR7 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.4% hemolysis at 50μg/ml | Human | ESF1 analog | β-sheet | NA | ||
| 9675125 | 1998 | MAARAARLAARLARLALRAL | SA3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.4% hemolysis at 50μg/ml | Human | ESF1 analog | β-sheet | NA | ||
| 9675125 | 1998 | MASRAAGLAARLARLALRAL | ESF1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.5% hemolysis at 200μg/ml | Human | magainin PGLa analog | α-helical | NA | ||
| 9675125 | 1998 | MASRAARLAARLARLALRAL | GR7 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.9% hemolysis at 200μg/ml | Human | ESF1 analog | β-sheet | NA | ||
| 9675125 | 1998 | MAARAARLAARLARLALRAL | SA3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.8% hemolysis at 200μg/ml | Human | ESF1 analog | β-sheet | NA | ||
| 9748603 | 1998 | GLAANFLPKIFCKITKRC{ct:Amid} | Brevinin 18 (oxi) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HD50=146μg/ml | Mouse | Brevinin 1E analogs | NA | NA | ||
| 9748603 | 1998 | GLAANFLPKIFCKITKRC{ct:Amid} | Brevinin 18 (red) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HD50=230μg/ml | Mouse | Brevinin 1E analogs | NA | NA | ||
| 6325405 | 1984 | PKDLKETLQEKKP | Synthetic peptide-2 | Free | Free | Linear | L | None | 13 | Not mentioned | 0% hemolysis upto 500μg/ml (non hemolytic) | Sheep | Synthetic peptide | NA | Non-hemolytic | ||
| 1362637 | 1992 | PKLLETFLSKWIG | SPF | Free | Free | Linear | L | None | 13 | Antibacterial | 10% hemolysis at 9μM | Rat | Seminalplasmin derivative | NA | NA | ||
| 1362637 | 1992 | PKLLKTFLSKWIG | SPFK | Free | Free | Linear | L | None | 13 | Antibacterial | 10% hemolysis at 9μM | Rat | SPF analog | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 0% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 12% hemolysis at 250μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 18% hemolysis at 500μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 0% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 20% hemolysis at 250μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 19% hemolysis at 500μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 0% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 23% hemolysis at 250μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 51% hemolysis at 500μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 0% hemolysis at 250μg | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 14% hemolysis at 500μg | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 0% hemolysis at 250μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 17% hemolysis at 500μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGD{nt:Formylation} | Peptide-E | Free | Formylation | Linear | L | None | 11 | Cytolytic | 0% hemolysis at 1000μg (non hemolytic) | Human | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MAQDIISTIGD{nt:Formylation} | Peptide-E | Free | Formylation | Linear | L | None | 11 | Cytolytic | 0% hemolysis at 1000μg (non hemolytic) | Horse | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MAQDIISTIGD{nt:Formylation} | Peptide-E | Free | Formylation | Linear | L | None | 11 | Cytolytic | 0% hemolysis at 1000μg (non hemolytic) | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MAQDIISTIGD{nt:Formylation} | Peptide-E | Free | Formylation | Linear | L | None | 11 | Cytolytic | 0% hemolysis at 1000μg (non hemolytic) | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MAQDIISTIGD{nt:Formylation} | Peptide-E | Free | Formylation | Linear | L | None | 11 | Cytolytic | 0% hemolysis at 1000μg (non hemolytic) | Sheep | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 9022710 | 1996 | FLPLIGRVLSGIL{ct:Amid} | Temporin A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | Lethal concentration >120μM | Human | Temporin analog (Rana esculenta) | NA | NA | ||
| 9022710 | 1996 | LLPIVGNLLKSLL{ct:Amid} | Temporin B | Amidation | Free | Linear | L | None | 13 | Antimicrobial | Lethal concentration >120μM | Human | Temporin analog (Rana esculenta) | NA | NA | ||
| 9273892 | 1997 | LALILRKIVTAL{nt:Fmoc}{ct:Amid} | FCR(3A) | Amidation | Fmoc | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 8μg | Rat | Crabrolin (Vespa crabro) | NA | NA | ||
| 9273892 | 1997 | LALILRKIVTAL{ct:Amid} | CR(3A) | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~90% hemolysis at 80μg | Rat | Crabrolin (Vespa crabro) | NA | NA | ||
| 9273892 | 1997 | LKLIPRKIVTAL{nt:Fmoc}{ct:Amid} | FCR(3K,6P) | Amidation | Fmoc | Linear | L | None | 13 | Antibacterial | ~60% hemolysis at 80μg | Rat | Crabrolin (Vespa crabro) | NA | NA | ||
| 9273892 | 1997 | LKLIPRKIVTAL{ct:Amid} | CR(3K,6P) | Amidation | Free | Linear | L | None | 13 | Antibacterial | Non-hemolytic | Rat | Crabrolin (Vespa crabro) | NA | Non-hemolytic | ||
| 9273892 | 1997 | LPLILRKIVTAL{nt:Fmoc}{ct:Amid} | FCR | Amidation | Fmoc | Linear | L | None | 13 | Antibacterial | ~80% hemolysis at 8μg | Rat | Crabrolin (Vespa crabro) | NA | NA | ||
| 9273892 | 1997 | LPLILRKIVTAL{ct:Amid} | CR | Amidation | Free | Linear | L | None | 13 | Antibacterial | Non-hemolytic | Rat | Crabrolin (Vespa crabro) | NA | Non-hemolytic | ||
| 10942757 | 2000 | ZCRRLCYKQRCVTYCRGR | Gomesin | Free | Free | Linear | L | None | 18 | Antimicrobial | 16% hemolysis at 1μM | Human | Gomesin (Acanthoscurria gomesiana) | NA | NA | ||
| 10942757 | 2000 | ZCRRLCYKQRCVTYCRGR | Gomesin | Free | Free | Linear | L | None | 18 | Antimicrobial | ~23% hemolysis at 100μM | Human | Gomesin (Acanthoscurria gomesiana) | NA | NA | ||
| 10942757 | 2000 | ZCRRLCYKQRCVTYCRGR{ct:Amid} | Gomesin | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 11% hemolysis at 1μM | Human | Gomesin (Acanthoscurria gomesiana) | NA | NA | ||
| 10942757 | 2000 | ZCRRLCYKQRCVTYCRGR{ct:Amid} | Gomesin | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 20% hemolysis at 100μM | Human | Gomesin (Acanthoscurria gomesiana) | NA | NA | ||
| 11835991 | 2002 | ILGPVISTIGGVLGGLLKNL{ct:Amid} | Maximin H1 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and Cytotoxic and Anti-HIV | 90-100% hemolysis at 50μg/ml | Rabbit | Maximin (skin secretions of Bombina maxima) | NA | NA | ||
| 11835991 | 2002 | ILGPVLSMVGSALGGLIKKI{ct:Amid} | Maximin H2 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and Cytotoxic and Anti-HIV | 90-100% hemolysis at 50μg/ml | Rabbit | Maximin (skin secretions of Bombina maxima) | NA | NA | ||
| 11835991 | 2002 | ILGPVLGLVGNALGGLIKKI{ct:Amid} | Maximin H3 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and Cytotoxic and Anti-HIV | 90-100% hemolysis at 50μg/ml | Rabbit | Maximin (skin secretions of Bombina maxima) | NA | NA | ||
| 11835991 | 2002 | ILGPVISKIGGVLGGLLKNL{ct:Amid} | Maximin H4 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and Cytotoxic and Anti-HIV | 90-100% hemolysis at 50μg/ml | Rabbit | Magainin (skin secretions of Bombina maxima) | NA | NA | ||
| 10604598 | 1999 | PKLLKTFLSKWIG | SPFK | Free | Free | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 65μg/ml | Rat | Synthetic peptide | NA | NA | ||
| 10604598 | 1999 | CKLLKTFLSKWIC{cyc:N-C} | SC | Free | Free | Cyclic | L | None | 13 | Antibacterial | 100% hemolysis at 40μg/ml | Rat | Synthetic peptide | NA | NA | ||
| 10604598 | 1999 | CKLLKTFLSKWIC{cyc:N-C}{ct:Amid} | SAC | Amidation | Free | Cyclic | L | None | 13 | Antibacterial | 100% hemolysis at 5μg/ml | Rat | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLALKALKAALKLA | KLAL | Free | Free | Linear | L | None | 18 | Antibacterial | EC50 = 10μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | K{d}L{d}ALKLALKALKAALKLA | k1/l2 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 7μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLA{d}L{d}KLALKALKAALKLA | a3/l4 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 33μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALK{d}L{d}ALKALKAALKLA | k5/l6 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 160μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLA{d}L{d}KALKAALKLA | a7/l8 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 180μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLALK{d}A{d}LKAALKLA | k9/a10 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 56μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLALKAL{d}K{d}AALKLA | l11/k12 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 540μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLALKALKA{d}A{d}LKLA | a13/a14 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 260μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLALKALKAAL{d}K{d}LA | l15/k16 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 210μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLALKALKAALKL{d}A{d} | l17/a18 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 70μM | Human | Synthetic peptide | NA | NA | ||
| 8855958 | 1996 | KKLKKLKKKWKKLKKKLK | Hel 5-13 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolysis at 100μM | Human | Synthetic peptide | α-helix | NA | ||
| 8855958 | 1996 | KKLKKLLKKWKKLLKKLK | Hel 7-11 | Free | Free | Linear | L | None | 18 | Antimicrobial | ~5% hemolysis upto 100μM (non hemolytic) | Human | Synthetic peptide | α-helix | Non-hemolytic | ||
| 8855958 | 1996 | KLLKKLLKLWKKLLKKLK | Hel 9-9 | Free | Free | Linear | L | None | 18 | Antimicrobial | ~45% hemolysis at 10μM | Human | Synthetic peptide | α-helix | NA | ||
| 8855958 | 1996 | KLLKKLLKLWKKLLKKLK | Hel 9-9 | Free | Free | Linear | L | None | 18 | Antimicrobial | ~60% hemolysis at 100μM | Human | Synthetic peptide | α-helix | NA | ||
| 8855958 | 1996 | KLLKLLLKLWKKLLKLLK | Hel 11-7 | Free | Free | Linear | L | None | 18 | Antimicrobial | ~45% hemolysis at 1μM | Human | Synthetic peptide | α-helix | NA | ||
| 8855958 | 1996 | KLLKLLLKLWKKLLKLLK | Hel 11-7 | Free | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 10μM | Human | Synthetic peptide | α-helix | NA | ||
| 8855958 | 1996 | KLLKLLLKLWLKLLKLLL | Hel 13-5 | Free | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 1μM | Human | Synthetic peptide | α-helix | NA | ||
| 11738089 | 2001 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial and Mast cell degranulating | Low hemolytic activity | Human | Anoplin (venom of the solitary wasp Anoplius samariensis) | α-helix | NA | ||
| 11738089 | 2001 | FLPLILRKIVTAL{ct:Amid} | Crabrolin | Amidation | Free | Linear | L | None | 13 | Antimicrobial and Mast cell degranulating | No hemolysis (non hemolytic) | Rat | Crabrolin (venom of the Vespa xanthoptera and Vespa crabro) | α-helix | Non-hemolytic | ||
| 11738090 | 2001 | GFLGSLLKTGLKVGSNLL{ct:Amid} | XT-6 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HC50 >150μM | Human | XT (skin secretions of the diploid frog Xenopus tropicalis) | NA | NA | ||
| 11738090 | 2001 | GLLGPLLKIAAKVGSNLL{ct:Amid} | XT-7 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | HC50 =70μM | Human | XT (skin secretions of the diploid frog Xenopus tropicalis) | NA | NA | ||
| 14636071 | 2003 | GALRGCWTKSYPPKPCK{ct:Amid} | Ranacyclin T | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 20% hemolysis at 100μM | Human | Ranacyclin (skin secretion of the frog Rana esculenta) | NA | NA | ||
| 14636071 | 2003 | SAPRGCWTKSYPPKPCK{ct:Amid} | Ranacyclin E | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 55% hemolysis at 100μM | Human | Ranacyclin (skin secretion of the frog Rana esculenta) | NA | NA | ||
| 14636071 | 2003 | LVRGCWTKSYPPKPCFVR{ct:Amid} | pLR | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 85% hemolysis at 100μM | Human | pLR (skin of the Northern Leopard frog Rana pipiens) | NA | NA | ||
| 19427345 | 2009 | FLGAIAAALPHVINAVTNAL{ct:Amid} | Kassinatuerin-2Ma | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | FFGAIAAALPHVISAIKNAL{ct:Amid} | Kassinatuerin-2Mb | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | FVGAIAAALPHVISAIKNAL{ct:Amid} | Kassinatuerin-2Mc | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | IIGAIAAALPHVINAIKNTF{ct:Amid} | Kassinatuerin-2Md | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | FIQYLAPLIPHAVKAISDLI{ct:Amid} | Kassinatuerin-2S | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19539775 | 2009 | FLSLALAALPKLFCLIFKKC | Brevinin-1CDYa | Free | Free | Linear | L | None | 20 | Antimicrobial | HC50 =125μM | Human | Brevinin-1 (skin secretions from the Chinese frog Rana dybowskii) | NA | NA | ||
| 19539775 | 2009 | FFPLALLCKVFKKC | Japonicin-1CDYa | Free | Free | Linear | L | None | 14 | Antimicrobial | HC50 >300μM | Human | Japonicin-1 (skin secretions from the Chinese frog Rana dybowskii) | NA | NA | ||
| 19539775 | 2009 | VLPLVGNLLNDLL{ct:Amid} | Temporin-CDYb | Amidation | Free | Linear | L | None | 13 | Antimicrobial | HC50 =180μM | Human | Temporin (skin secretions from the Chinese frog Rana dybowskii) | NA | NA | ||
| 19539775 | 2009 | IIPLPLGYFAKKT | Dybowskin-1CDYa | Free | Free | Linear | L | None | 13 | Antimicrobial | HC50 >300μM | Human | Dybowskin-1 (skin secretions from the Chinese frog Rana dybowskii) | NA | NA | ||
| 19539775 | 2009 | SAVGRHGRRFGLRKHRKH | Dybowskin-2CDYa | Free | Free | Linear | L | None | 18 | Antimicrobial | HC50 >300μM | Human | Dybowskin-2 (skin secretions from the Chinese frog Rana dybowskii) | NA | NA | ||
| 19109988 | 2010 | GFLSALKKYLPIVLKHV | Osmin | Free | Free | Linear | L | None | 17 | Antibacterial and Antifungal | Weak hemolytic activity i.e. 5.0HU/mg | Human | Osmin (venom from the solitary bee Osmia rufa) | NA | NA | ||
| 19109988 | 2010 | GFLSALKKYLPIVLKHV{ct:Amid} | Osmin | Amidation | Free | Linear | L | None | 17 | Antibacterial and Antifungal | Hemolytic activity i.e. 16.6HU/mg | Human | Osmin (venom from the solitary bee Osmia rufa) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >95% hemolysis at 30μM | Guinea-pig | Mastoparan B (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | 80% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LNLKSIVSWAKKVL{ct:Amid} | [Asn2]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~5% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LNLKSIVSWAKKVL{ct:Amid} | [Asn2]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~4% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLNSIVSWAKKVL{ct:Amid} | [Asn4]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >95% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLNSIVSWAKKVL{ct:Amid} | [Asn4]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >75% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLLSIVSWAKKVL{ct:Amid} | [Leu4]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~80% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLLSIVSWAKKVL{ct:Amid} | [Leu4]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >75% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LNLNSIVSWAKKVL{ct:Amid} | [Asn2,4]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~5% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LNLNSIVSWAKKVL{ct:Amid} | [Asn2,4]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~3% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSFAKKVL{ct:Amid} | [Phe9]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~5% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSFAKKVL{ct:Amid} | [Phe9]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~3% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSYAKKVL{ct:Amid} | [Tyr9]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~4% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSYAKKVL{ct:Amid} | [Tyr9]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~2% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWALKVL{ct:Amid} | [Leu11]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >80% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWALKVL{ct:Amid} | [Leu11]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >70% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWAKLVL{ct:Amid} | [Leu12]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~70% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWAKLVL{ct:Amid} | [Leu12]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >55% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWALLVL{ct:Amid} | [Leu11,12]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~80% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWALLVL{ct:Amid} | [Leu11,12]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~55% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 12067731 | 2002 | WLNALLHHGLNCAKGVLA | 18 monomer halocidin | Free | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolysis at 25μg/ml | Human | Halocidin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 12067731 | 2002 | WLNALLHHGLNCAKGVLA | 18 monomer halocidin | Free | Free | Linear | L | None | 18 | Antimicrobial | <10% hemolysis at 50μg/ml | Human | Halocidin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 12067731 | 2002 | WLNALLHHGLNCAKGVLA | 18 monomer halocidin | Free | Free | Linear | L | None | 18 | Antimicrobial | ~10% hemolysis at 100μg/ml | Human | Halocidin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 12067731 | 2002 | ALLHHGLNCAKGVLA | 15 monomer halocidin | Free | Free | Linear | L | None | 15 | Antimicrobial | 0% hemolysis at 100μg/ml (non hemolytic) | Human | Halocidin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | Non-hemolytic | ||
| 12581207 | 2003 | FIGLLISAGKAIHDLIRRRH{ct:Amid} | Chrysophsin-3 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 0% hemolysis at 1μM | Human | Chrysophsin (the gills of red sea bream Chrysophrys major) | NA | NA | ||
| 12581207 | 2003 | FIGLLISAGKAIHDLIRRRH{ct:Amid} | Chrysophsin-3 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 100% hemolysis at 100μM | Human | Chrysophsin (the gills of red sea bream Chrysophrys major) | NA | NA | ||
| 8223491 | 1993 | IIGPVLGLVGSALGGLLKKI{ct:Amid} | Peptide B | Amidation | Free | Linear | L | None | 20 | Antibacterial | Lethal concentration =17.0μM | Human | Synthetic peptide | NA | NA | ||
| 12969798 | 2004 | KAVAAKKSPKKAKKPAT | Oncorhyncin II | Free | Free | Linear | L | None | 17 | Antimicrobial | No hemolysis at 0.8μM(non hemolytic) | Trout | Oncorhyncin II (acid extract of rainbow trout skin secretion Oncorhynchus mykiss) | NA | Non-hemolytic | ||
| 7479693 | 1995 | IISTIGKLVKWIIDTV | Peptide-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 100% hemolysis at ~25μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGDLVKWIIKTV | Peptide-3 | Free | Free | Linear | L | None | 16 | Antimicrobial | 1-2% hemolysis at 20μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGDLVKWIIKTV | Peptide-3 | Free | Free | Linear | L | None | 16 | Antimicrobial | >50% hemolysis at 40μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGDLVKWIIKTV | Peptide-3 | Free | Free | Linear | L | None | 16 | Antimicrobial | 80% hemolysis at 60μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGDLVKWIIKTV | Peptide-3 | Free | Free | Linear | L | None | 16 | Antimicrobial | ~90% hemolysis at 80μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGDLVKWIIKTV | Peptide-3 | Free | Free | Linear | L | None | 16 | Antimicrobial | 100% hemolysis at ~90μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGKLVKWIIKTV | Peptide-4 | Free | Free | Linear | L | None | 16 | Antimicrobial | 50% hemolysis at ~15μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 7479693 | 1995 | IISTIGKLVKWIIKTV | Peptide-4 | Free | Free | Linear | L | None | 16 | Antimicrobial | 100% hemolysis at ~20μM | Guinea-pig | delta-toxin hemolysin analog | NA | NA | ||
| 21956830 | 2011 | FLKPLFNAALKLLP | Temporin-Ra | Free | Free | Linear | L | None | 14 | Antimicrobial | 1.3% hemolysis at 60µg/ml | Human | Derived from skin secretions of Rana ridibunda | NA | NA | ||
| 21956830 | 2011 | FLPVLAGVLSRA | Temporin-Rb | Free | Free | Linear | L | None | 12 | Antimicrobial | 1.1% hemolysis at 60µg/ml | Human | Derived from skin secretions of Rana ridibunda | NA | NA | ||
| 7744058 | 1995 | KIAEKFSGTRRG | CGB | Free | Free | Linear | L | None | 12 | Antimicrobial | No hemolysis (Non hemolytic) | Rabbit | Chromogranin-B derivative (Bovine) | NA | Non-hemolytic | ||
| 19088182 | 2009 | IFGAIAGLLKNIF{ct:Amid} | Meucin-13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 37.7% hemolysis at 6.25µM | Rabbit | Derived from venom of Mesobuthus eupeus | NA | NA | ||
| 19088182 | 2009 | IFGAIAGLLKNIF{ct:Amid} | Meucin-13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 59.2% hemolysis at 12.5µM | Rabbit | Derived from venom of Mesobuthus eupeus | NA | NA | ||
| 19088182 | 2009 | IFGAIAGLLKNIF{ct:Amid} | Meucin-13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | >90% hemolysis at 25µM | Rabbit | Derived from venom of Mesobuthus eupeus | NA | NA | ||
| 19088182 | 2009 | FFGHLFKLATKIIPSLFQ | Meucin-18 | Free | Free | Linear | L | None | 18 | Antimicrobial | 74% hemolysis at 6.25µM | Rabbit | Derived from venom of Mesobuthus eupeus | NA | NA | ||
| 19088182 | 2009 | FFGHLFKLATKIIPSLFQ | Meucin-18 | Free | Free | Linear | L | None | 18 | Antimicrobial | >90% hemolysis at 12.5µM | Rabbit | Derived from venom of Mesobuthus eupeus | NA | NA | ||
| 19088182 | 2009 | FFGHLFKLATKIIPSLFQ | Meucin-18 | Free | Free | Linear | L | None | 18 | Antimicrobial | >95% hemolysis at 25µM | Rabbit | Derived from venom of Mesobuthus eupeus | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLPKVMAHMK{ct:Amid} | MEP | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 >100µM | Rat | Derived from venom of Melecta albifrons | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLKKVMAHMK{ct:Amid} | MEP-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 27.3µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLKVMAHMK{ct:Amid} | MEP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | LC50 = 22.9µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLAKVMAHMK{ct:Amid} | MEP-3 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 29.7µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLGKVMAHMK{ct:Amid} | MEP-4 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 = 41.4µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | VLPKVMAHMK{ct:Amid} | MEP-8 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | LC50 >100µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVLP{ct:Amid} | MEP-9 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | LC50 >100µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 18942691 | 2008 | GFLSILKKVL{ct:Amid} | MEP-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | LC50 >100µM | Rat | Melectin analog (Melecta albifrons) | NA | NA | ||
| 17688900 | 2007 | FLSLALAALPKFLCLVFKKC | Brevinin-1DYa | Free | Free | Linear | L | None | 20 | Antimicrobial | LC50 <5µM | Human | Derived from skin of Rana dybowskii | NA | NA | ||
| 17688900 | 2007 | FLSLALAALPKLFCLIFKKC | Brevinin-1DYb | Free | Free | Linear | L | None | 20 | Antimicrobial | LC50 <5µM | Human | Derived from skin of Rana dybowskii | NA | NA | ||
| 17688900 | 2007 | FLPLLLAGLPKLLCLFFKKC | Brevinin-1DYc | Free | Free | Linear | L | None | 20 | Antimicrobial | LC50 <5µM | Human | Derived from skin of Rana dybowskii | NA | NA | ||
| 17272268 | 2007 | GLLSGTSVRGSI | Odorranain-V1 | Free | Free | Linear | L | None | 12 | Antimicrobial | 23.9±4.7% hemolysis at 50µg/ml | Human | Odorranain (Odorrana grahami) | NA | NA | ||
| 8849687 | 1996 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | ~20% hemolysis at 10µM | Rat | Derived from cytoplasmic granules of bovine neutrophils, | NA | NA | ||
| 8849687 | 1996 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~90% hemolysis at 20µM | Rat | Derived from cytoplasmic granules of bovine neutrophils, | NA | NA | ||
| 8849687 | 1996 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~100% hemolysis at 30µM | Rat | Derived from cytoplasmic granules of bovine neutrophils, | NA | NA | ||
| 8849687 | 1996 | ILAWKWAWWAWRR{ct:Amid} | ILA | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~20% hemolysis at 5µM | Rat | Indolicidin analog | NA | NA | ||
| 8849687 | 1996 | ILAWKWAWWAWRR{ct:Amid} | ILA | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 20µg/ml | Rat | Indolicidin analog | NA | NA | ||
| 8849687 | 1996 | ILPFKFPFFPFRR{ct:Amid} | ILF | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~20% hemolysis upto 80µg/ml | Rat | Indolicidin analog | NA | NA | ||
| 8810288 | 1996 | F{d}PV{nnr:O}LF{d}PV{nnr:O}L{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antibacterial | 100% hemolysis at 39µg/ml | Human | Gramicidin S (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | Y{d}PVKLY{d}PVKL{cyc:N-C} | GS10 | Free | Free | Cyclic | Mix | None | 10 | Antibacterial | 100% hemolysis at 67µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | Y{d}PVKLKY{d}PKVKL{cyc:N-C} | GS12 | Free | Free | Cyclic | Mix | None | 12 | Antibacterial | 100% hemolysis at 250µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | Y{d}PVKLKVY{d}PLKVKL{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial | 100% hemolysis at 6µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | Y{d}PLKVKY{d}PKLKV{cyc:N-C} | GS12LV | Free | Free | Cyclic | Mix | None | 12 | Antibacterial | 100% hemolysis at 92µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | F{d}PVKLKF{d}PKVKL{cyc:N-C} | GS12F | Free | Free | Cyclic | Mix | None | 12 | Antibacterial | 100% hemolysis at 400µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | F{d}PV{nnr:O}L{nnr:O}F{d}P{nnr:O}V{nnr:O}L{cyc:N-C} | GS12FO | Free | Free | Cyclic | Mix | O = L-Ornithine | 12 | Antibacterial | 100% hemolysis at 160µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | F{d}PL{nnr:O}L{nnr:O}F{d}P{nnr:O}L{nnr:O}L{cyc:N-C} | GS12FO/LL | Free | Free | Cyclic | Mix | O = L-Ornithine | 12 | Antibacterial | 100% hemolysis at 170µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8620888 | 1996 | GFFALIPKIIS | Des-(12-33)-pardaxin | Free | Free | Linear | L | None | 11 | Antibacterial | No hemolysis (Non hemolytic) | Human | Pardaxin analog (Pardachirus marmoratus) | NA | Non-hemolytic | ||
| 8620888 | 1996 | GFFALIPKIIS{ct:[NH(CH2)2NH2]2} | Des-(I 2-33)-pardaxin-[NH(CH2)2NH2]2 | [NH(CH2)2NH2]2 | Free | Linear | L | None | 11 | Antibacterial | No hemolysis (Non hemolytic) | Human | Pardaxin analog (Pardachirus marmoratus) | NA | Non-hemolytic | ||
| 8508915 | 1993 | FLPAIAGILSQLF{ct:Amid} | A1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LC50 ~20µM | Human | Derived from skin secretion of Rana esculenta | NA | NA | ||
| 8045297 | 1994 | KLLLKLLKLLLKLLLKLLK{ct:Dansylation} | L13K6 | Dansylation | Free | Linear | L | None | 19 | Cytotoxic | LD50 ~2.1µM | Human | Synthetic peptide | NA | NA | ||
| 8045297 | 1994 | LLLKLLKLLLKLLLKLLK{ct:Dansylation} | L13K5 | Dansylation | Free | Linear | L | None | 18 | Cytotoxic | LD50 =4.7µM | Human | Synthetic peptide | NA | NA | ||
| 8045297 | 1994 | KLLKLLLKLLLKLLK{ct:Dansylation} | L10K5 | Dansylation | Free | Linear | L | None | 15 | Cytotoxic | LD50 ~0.1µM | Human | Synthetic peptide | NA | NA | ||
| 19056441 | 2009 | IFGAILPLALGALKNLIK{ct:Amid} | Hy-a1 | Amidation | Free | Linear | L | None | 18 | Antibacterial | HC50 =18µM | Human | Derived from skin secretion of Hypsiboas albopunctatus | NA | NA | ||
| 23415652 | 2013 | LLGMIPLAISAISALSKL | Medusin-AC | Free | Free | Linear | L | None | 18 | Antimicrobial | 8.7% hemolysis at 32mg/ml | Horse | Medusin (Phyllomedusine frogs) | NA | NA | ||
| 23415652 | 2013 | LLGMIPVAISAISALSKL | Medusin-PH | Free | Free | Linear | L | None | 18 | Antimicrobial | 1.9% hemolysis at 128mg/ml | Horse | Medusin (Phyllomedusine frogs) | NA | NA | ||
| 23415652 | 2013 | LLGMIPLAISAISSLSKL | Medusin-PD | Free | Free | Linear | L | None | 18 | Antimicrobial | 6.9% hemolysis at 64mg/ml | Horse | Medusin (Phyllomedusine frogs) | NA | NA | ||
| 23483218 | 2013 | LNWGAILKHIIK{ct:Amid} | PNG-1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 =119µM | Human | Derived from venom of Panurgus calcaratus | NA | NA | ||
| 23483218 | 2013 | NLWAGILKHIIK{ct:Amid} | PNG-1/1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | KNWGAILKHIIK{ct:Amid} | PNG-1/2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LKWGAILKHIIK{ct:Amid} | PNG-1/3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNKGAILKHIIK{ct:Amid} | PNG-1/4 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWKAILKHIIK{ct:Amid} | PNG-1/5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 ~110µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGKILKHIIK{ct:Amid} | PNG-1/6 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >140µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAKLKHIIK{ct:Amid} | PNG-1/7 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAIKKHIIK{ct:Amid} | PNG-1/8 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAILKKIIK{ct:Amid} | PNG-1/9 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAILKHKIK{ct:Amid} | PNG-1/10 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAILKHIKK{ct:Amid} | PNG-1/11 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | KNWGKILKHIIK{ct:Amid} | PNG-1/12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | KNWKAILKHIIK{ct:Amid} | PNG-1/13 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAVLKHVVK{ct:Amid} | PNG-1/14 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGA-{nnr:Abu}-LKH-{nnr:Abu}-{nnr:Abu}-K{ct:Amid} | PNG-1/15 | Amidation | Free | Linear | L | Abu = 2-aminobutyric acid | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAALKHAAK{ct:Amid} | PNG-1/16 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAFLKHFFK{ct:Amid} | PNG-1/17 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 =81µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAGLKHGGK{ct:Amid} | PNG-1/18 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGALLKHLLK{ct:Amid} | PNG-1/19 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 =63µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGA-{nnr:Nle}-LKH-{nnr:Nle}-{nnr:Nle}-K{ct:Amid} | PNG-1/20 | Amidation | Free | Linear | L | Nle = Norleucine | 12 | Antimicrobial | LC50 =40µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGA-{nnr:Aca}-LKH-{nnr:Aca}-{nnr:Aca}-K{ct:Amid} | PNG-1/21 | Amidation | Free | Linear | L | Aca = 1-aminocyclohexane carboxylic acid | 12 | Antimicrobial | LC50 =43µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LNWGAWLKHWWK{ct:Amid} | PNG-1/22 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 =132µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23562719 | 2013 | KAYSMPRCKGGFRAVMCWL{ct:Amid} | Shuchin 3 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 1.3% hemolysis at 200µg/ml | Rabbit | Derived from skin of Rana shuchinae | NA | NA | ||
| 23562719 | 2013 | KAYSTPRCKGLFRALMCWL{ct:Amid} | Shuchin 4 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 1.2% hemolysis at 200µg/ml | Rabbit | Derived from skin of Rana shuchinae | NA | NA | ||
| 23562719 | 2013 | KAYSTPRCKYLFRAVLCWL{ct:Amid} | Shuchin 5 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 1.6% hemolysis at 200µg/ml | Rabbit | Derived from skin of Rana shuchinae | NA | NA | ||
| 23562719 | 2013 | KAYSMPRCKGGFRAVMCWL{ct:Amid} | Shuchin 3 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 1.7% hemolysis at 200µg/ml | Human | Derived from skin of Rana shuchinae | NA | NA | ||
| 23562719 | 2013 | KAYSTPRCKGLFRALMCWL{ct:Amid} | Shuchin 4 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 2.5% hemolysis at 200µg/ml | Human | Derived from skin of Rana shuchinae | NA | NA | ||
| 23562719 | 2013 | KAYSTPRCKYLFRAVLCWL{ct:Amid} | Shuchin 5 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 1.5% hemolysis at 200µg/ml | Human | Derived from skin of Rana shuchinae | NA | NA | ||
| 12354111 | 2002 | INLKALAALAKKIL | Mastoparan | Free | Free | Linear | L | None | 14 | Antibacterial and Antifungal | ~10% hemolysis at 100µM | Human | Mastoparan (wasp) | NA | NA | ||
| 15639237 | 2005 | GLGSVFGRLARILGRVIPKV{ct:Amid} | Peptide P1 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 20% hemolysis at 10µM | Human | Pilosulin 1 analog(Myrmecia pilosula) | NA | NA | ||
| 15639237 | 2005 | GLGSVFGRLARILGRVIPKV{ct:Amid} | Peptide P1 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 100% hemolysis at 100µM | Human | Pilosulin 1 analog(Myrmecia pilosula) | NA | NA | ||
| 15639237 | 2005 | GLLSKFGRLARKLARVIPKV{ct:Amid} | Peptide P2 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 15% hemolysis at 10µM | Human | Pilosulin 1 analog(Myrmecia pilosula) | NA | NA | ||
| 15639237 | 2005 | GLLSKFGRLARKLARVIPKV{ct:Amid} | Peptide P2 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 40% hemolysis at 100µM | Human | Pilosulin 1 analog(Myrmecia pilosula) | NA | NA | ||
| 10606532 | 1999 | KWL{d}L{d}LLKL{d}LL{d}LK{ct:Amid} | [D]L3,4,8,10-K3L8Wn | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 31% hemolysis at 50μM | Human | Synthetic peptide | NA | NA | ||
| 10606532 | 1999 | KLL{d}L{d}LWKL{d}LL{d}LK{ct:Amid} | [D]L3,4,8,10-K3L8Wm | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 39.4% hemolysis at 50μM | Human | Synthetic peptide | NA | NA | ||
| 10606532 | 1999 | KLL{d}L{d}LLKL{d}LL{d}WK{ct:Amid} | [D]L3,4,8,10-K3L8Wc | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 44.2% hemolysis at 50μM | Human | Synthetic peptide | NA | NA | ||
| 10606532 | 1999 | KWL{d}L{d}KLKL{d}KL{d}LK{ct:Amid} | [D]L3,4,8,10-K5L6Wn | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM (Non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KLL{d}L{d}KWKL{d}KL{d}LK{ct:Amid} | [D]L3,4,8,10-K5L6Wm | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM (Non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KLL{d}L{d}KLKL{d}KL{d}WK{ct:Amid} | [D]L3,4,8,10-K5L6Wc | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM (Non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KKWL{d}KLKL{d}KL{d}KK{ct:Amid} | [D]L4,8,10-K7L4Wn | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM (Non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KKL{d}L{d}KWKL{d}KL{d}KK{ct:Amid} | [D]L3,4,8,10-K7L4Wm | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM (Non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KKL{d}L{d}KLKL{d}KW{d}KK{ct:Amid} | [D]L3,4,8-K7L4Wc | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM (Non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 10632060 | 1999 | KKVVFKVKFKK{ct:Amid} | MP | Amidation | Free | Linear | L | None | 11 | Antifungal and Antibacterial | 0% hemolysis upto 500 μg/mL (Non hemolytic) | Mouse | Synthetic peptide | NA | Non-hemolytic | ||
| 10632060 | 1999 | K{d}{Ψ[CH2NH]}KVVFKVKFKK{d}{ct:Amid} | MP1 | Amidation | Free | Linear | Mix | None | 11 | Antifungal and Antibacterial | 0% hemolysis upto 500 μg/mL (Non hemolytic) | Mouse | Synthetic peptide | NA | Non-hemolytic | ||
| 10632060 | 1999 | K{Ψ[CH2OCONH]}KVVFKVKFKK{d}{ct:Amid} | MP6 | Amidation | Free | Linear | Mix | None | 11 | Antifungal and Antibacterial | 0% hemolysis upto 500 μg/mL (Non hemolytic) | Mouse | Synthetic peptide | NA | Non-hemolytic | ||
| 14636071 | 2003 | GALRGCWTKSYPPKPCK{cyc:N-C}{ct:Amid} | Ranacyclin T | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | 20% hemolysis at 100μM | Human | Derived from skin secretion of Rana temporaria | NA | NA | ||
| 14636071 | 2003 | SAPRGCWTKSYPPKPCK{cyc:N-C}{ct:Amid} | Ranacyclin E | Amidation | Free | Cyclic | L | None | 17 | Antimicrobial | 55% hemolysis at 100μM | Human | Derived from skin secretion of Rana esculenta | NA | NA | ||
| 14636071 | 2003 | LVRGCWTKSYPPKPCFVR{cyc:N-C} | pLR | Free | Free | Cyclic | L | None | 18 | Antimicrobial | 85% hemolysis at 100μM | Human | Derived from skin of Rana pipiens | NA | NA | ||
| 15996769 | 2005 | FLSSIGKILGNLL{ct:Amid} | Temporin-1Va | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =120μM | Human | Derived from skin secretion of Rana virgatipes | NA | NA | ||
| 15996769 | 2005 | FLSIIAKVLGSLF{ct:Amid} | Temporin-1Vb | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =30μM | Human | Derived from skin secretion of Rana virgatipes | NA | NA | ||
| 15996769 | 2005 | FLPLVTMLLGKLF{ct:Amid} | Temporin-1Vc | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =30μM | Human | Derived from skin secretion of Rana virgatipes | NA | NA | ||
| 19635516 | 2009 | IPPFIKKVLTTVF{ct:Amid} | Temporin-CPa | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =220μM | Human | Derived from skin secretions of Lithobates capito | NA | NA | ||
| 20656059 | 2010 | GMASKAGSIVGKIKIALGAL | PGLa-B2 | Free | Free | Linear | L | None | 20 | Antimicrobial | 27% hemolysis at 200μM | Human | Peptide glycine–leucine-amide (Xenopus borealis) | NA | NA | ||
| 21073979 | 2010 | GKLNLFLSRLEILKLFVGAL | Pelteobagrin | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis upto 400μM (Non hemolytic) | Rabbit | Derived from skin mucus of Pelteobagrus fulvidraco | NA | Non-hemolytic | ||
| 21396976 | 2011 | SFPFFPPGICKRLKRC | Limnonectin-1Fa | Free | Free | Linear | L | None | 16 | Antimicrobial | 0% hemolysis upto 160μM (Non hemolytic) | Horse | Limnonectin (Limnonectes fujianensis) | NA | Non-hemolytic | ||
| 21396976 | 2011 | SFHVFPPWMCKSLKKC | Limnonectin-1Fb | Free | Free | Linear | L | None | 16 | Antimicrobial | 0% hemolysis upto 160μM (Non hemolytic) | Horse | Limnonectin (Limnonectes fujianensis) | NA | Non-hemolytic | ||
| 9010936 | 1996 | GFFALIPKIISSPLFKTL{ct:Amid} | 18P | Amidation | Free | Linear | L | None | 18 | Antimicrobial | No hemolysis (Non hemolytic) | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 9010936 | 1996 | GFFALIAKIISSPLFKTL{ct:Amid} | 18A | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 33μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 9010936 | 1996 | GFFALIAQIISSPLFQTL{ct:Amid} | 18Q | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 56μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 9108731 | 1996 | GFFALIPKIISSPLFKTL{ct:Amid} | PX1–18 | Amidation | Free | Linear | L | None | 18 | Cytolytic | No hemolysis (Non hemolysis) | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 9108731 | 1996 | GFFALIAKIISSPLFKTL{ct:Amid} | PX1–18 (P7A) | Amidation | Free | Linear | L | None | 18 | Cytolytic | Conc. Required for hemolysis =7.1nmols | Human | Synthetic Peptide | NA | NA | ||
| 9518597 | 1998 | {nnr:Aib}-P-{nnr:Aib}-A-{nnr:Aib}-AQ-{nnr:Aib}-V-{nnr:Aib}-GL-{nnr:Aib}-PV-{nnr:Aib}-{nnr:Aib}-EQ{nt:Acet}{ct:Phenol} | Alam-P14 | Phenol | Acetylation | Linear | L | Aib = α- methylalanine | 19 | Cytolytic | EC50 =30μM | Human | Alamethicin | NA | NA | ||
| 9639668 | 1998 | GVVKVSRLKGESLRARL | bPaAP | Free | Free | Linear | L | None | 17 | Antimicrobial | 0.42% hemolysis at 200μg/ml | Human | Isolated from the stomach of the bullfrog, Rana catesbeiana | NA | NA | ||
| 9639668 | 1998 | AVVKVPLKKFKSIRE | mPcAP | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.40% hemolysis at 200μg/ml | Human | Isolated from the stomach of the bullfrog, Rana catesbeiana | NA | NA | ||
| 9756752 | 1998 | KKVVFKVKFK{ct:Amid} | KSL | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 0% hemolysis at 500μg/ml | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 9824303 | 1998 | KGRGKQGGKVRAKAKTRSS | Parasin I | Free | Free | Linear | L | None | 19 | Antimicrobial | 0.2% hemolysis at 200μg/ml | Human | Parasilurus asotus | NA | NA | ||
| 9889358 | 1998 | KLLKLLLKLLLKLLK | LK15 | Free | Free | Linear | L | None | 15 | Cytotoxin | LD50 =0.8 μM | Human | Synthetic Peptide | α-Helix | NA | ||
| 9889358 | 1998 | KLLKLLLKLLLKLLK{nt:Dansylation} | DnsLK15 | Free | Dansylation | Linear | L | None | 15 | Cytotoxin | LD50 =0.3 μM | Human | Synthetic Peptide | α-Helix | NA | ||
| 9889358 | 1998 | LKLLLLKLLKLKLWK | r-LK15 | Free | Free | Linear | L | None | 15 | Cytotoxin | LD50 =5 μM | Human | Synthetic Peptide | α-Helix | NA | ||
| 10195441 | 1999 | PKLLKTFLSKWIG | SPFK | Free | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 40μM | Rat | Synthetic Peptide | NA | NA | ||
| 10195441 | 2000 | PKLLKKFLKKWIG | K5 | Free | Free | Linear | L | None | 13 | Antimicrobial | 100% hemolysis at 175μM | Rat | Synthetic Peptide | NA | NA | ||
| 10195441 | 2001 | PKLLKTFLSKWKKIG | WKK | Free | Free | Linear | L | None | 15 | Antimicrobial | 100% hemolysis at 85μM | Rat | Synthetic Peptide | NA | NA | ||
| 10195441 | 2002 | PKLLKFLSKWIG | K3S | Free | Free | Linear | L | None | 12 | Antimicrobial | 100% hemolysis at 63μM | Rat | Synthetic Peptide | NA | NA | ||
| 10195441 | 2003 | PKLLKTFLKWIG | K3T | Free | Free | Linear | L | None | 12 | Antimicrobial | 100% hemolysis at >330μM | Rat | Synthetic Peptide | NA | NA | ||
| 10195441 | 2004 | PKLKTFLSKWIG | KTF | Free | Free | Linear | L | None | 12 | Antimicrobial | 0% hemolysis at 300μM | Rat | Synthetic Peptide | NA | Non-hemolytic | ||
| 10195441 | 2005 | PKLLKFLKWIG | K3 | Free | Free | Linear | L | None | 11 | Antimicrobial | 100% hemolysis at 365μM | Rat | Synthetic Peptide | NA | NA | ||
| 10217411 | 1999 | GLPALISWIKRKRQQG{ct:Amid} | MCF | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 100% hemolysis at 100μg/ml | Rat | Synthetic Peptide | NA | NA | ||
| 10217411 | 1999 | GLKKLISWIKRAAQQG{ct:Amid} | MCFA | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 100% hemolysis at 110μg/ml | Rat | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VOLF{d}PVOLF{d}P{cyc:N-C} | GS | Free | Free | Cyclic | Mix | None | 10 | Antimicrobial | 100% hemolysis at 12.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 1.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14V10 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 6.2μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKL{d}KVY{d}PLKVKLY{d}P{cyc:N-C} | GS14L3 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 12.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLY{d}P{d}{cyc:N-C} | GS14P14 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 6.2μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}P{d}LKVKLY{d}P{cyc:N-C} | GS14P7 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 12.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | V{d}KLKVYPLKVKLY{d}P{cyc:N-C} | GS14V1 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 40μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKL{d}Y{d}P{cyc:N-C} | GS14L12 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 25μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKV{d}Y{d}PLKVKLY{d}P{cyc:N-C} | GS14V5 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 150μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVKLYP{cyc:N-C} | GS14Y13 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 12.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PL{d}KVKLY{d}P{cyc:N-C} | GS14L8 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 50μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVYPLKVKLY{d}P{cyc:N-C} | GS14Y6 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 25μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VK{d}LKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K2 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 50μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLK{d}VKLY{d}P{cyc:N-C} | GS14K9 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VKLKVY{d}PLKVK{d}LY{d}P{cyc:N-C} | GS14K11 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at 150μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VK{d}LK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K2K4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10224074 | 1999 | VK{d}LK{d}VY{d}PLK{d}VK{d}LY{d}P{cyc:N-C} | GS14K2K4K9K11 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | 100% hemolysis at >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 10424354 | 1999 | KWKLFKKIGIGKFLHSAKKF{ct:Amid} | CA(1-8) – MA(1-12) | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 25μM | Human | Cecropia moth | NA | Non-hemolytic | ||
| 10424354 | 1999 | KWKLFKKIGIGKFLHSAKKF{ct:Amid} | CA(1-8) – MA(1-12) | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 100μM | Human | Cecropia moth | NA | Non-hemolytic | ||
| 10424354 | 1999 | KWKLFKKIGIGAVLKVLTTG{ct:Amid} | CA(1-8) - ME(1-12) | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 3.1% hemolysis at 25μM | Human | Cecropia moth | NA | NA | ||
| 10424354 | 1999 | KWKLFKKIGIGAVLKVLTTG{ct:Amid} | CA(1-8) - ME(1-12) | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 15.5% hemolysis at 100μM | Human | Cecropia moth | NA | NA | ||
| 15996769 | 2005 | FLSSIGKILGNLL{ct:Amid} | Temporin-1Va | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =120μM | Human | R. catesbeiana, R. clamitans, R. grylio and R. Septentrionalis | NA | NA | ||
| 15996769 | 2005 | FLSIIAKVLGSLF{ct:Amid} | Temporin-IVb | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =30μM | Human | R. catesbeiana, R. clamitans, R. grylio and R. Septentrionalis | NA | NA | ||
| 15996769 | 2005 | FLPLVTMLLGKLF{ct:Amid} | Temporin-1Vc | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LD50 =30μM | Human | R. catesbeiana, R. clamitans, R. grylio and R. Septentrionalis | NA | NA | ||
| 18375018 | 2000 | INWKKIFEKVKNLV{ct:Amid} | PDD-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIFQKVKNLV{ct:Amid} | PDD-A-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIFEKVKDLV{ct:Amid} | PDD-A-2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | IDWKKIFEKVKNLV{ct:Amid} | PDD-A-3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | IDWKKIFEKVKDLV{ct:Amid} | PDD-A-4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | IDWSKIFEKVKNLV{ct:Amid} | PDD-A-5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWSSIFEKVKNLV{ct:Amid} | PDD-A-6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWSSIFESVKNLV{ct:Amid} | PDD-A-7 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWSSIFESVSNLV{ct:Amid} | PDD-A-8 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIFEKVSNLV{ct:Amid} | PDD-A-9 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIFESVKNLV{ct:Amid} | PDD-A-10 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKSIFEKVKNLV{ct:Amid} | PDD-A-11 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | NIWKKIFEKVKNLV{ct:Amid} | PDD-A-12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKILGAL{ct:Amid} | PDD-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =45μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKILGAI{ct:Amid} | PDD-B-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =75μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLRLGRRILGAL{ct:Amid} | PDD-B-2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =25μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INFLKLGKKILGAL{ct:Amid} | PDD-B-3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >140μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKLGKKILGAL{ct:Amid} | PDD-B-4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >140μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INSLKLGKKILGAL{ct:Amid} | PDD-B-5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Polistes dorsalis dorsalis mastoparans (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKMMSAL{ct:Amid} | MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =100μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKK-{nnr:Nle}-{nnr:Nle}-SAL{ct:Amid} | MP-1 | Amidation | Free | Linear | L | Nle = Nle | 14 | Antimicrobial | IC50 =43μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKLLSAL{ct:Amid} | MP-2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 =44μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKLLSAL{nt:Fmoc}{ct:Amid} | MP-3 | Amidation | Fmoc | Linear | L | None | 14 | Antimicrobial | IC50 =6μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKLLSAL{nt:Acet}{ct:Amid} | MP-4 | Amidation | Acetylation | Linear | L | None | 14 | Antimicrobial | IC50 =44μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKMMSAI{ct:Amid} | MP-5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >100μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | SNWLKLGKKMMSAL{ct:Amid} | MP-6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >>100μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKMMSAL{nt:Fmoc}{ct:Amid} | MP-7 | Amidation | Fmoc | Linear | L | None | 14 | Antimicrobial | IC50 =13μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKMMSAL{nt:Acet}{ct:Amid} | MP-8 | Amidation | Acetylation | Linear | L | None | 14 | Antimicrobial | IC50 >>100μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWLKLGKKMMSAL{ct:OH} | MP-9 | OH | Free | Linear | L | None | 14 | Antimicrobial | IC50 >>100μM | Rat | Mischocytarus phthisicus mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIASIGKEVLKAL{ct:Amid} | PMM | Amidation | Free | Linear | L | None | 16 | Antimicrobial | IC50 =80μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIASIGKEVLKAI{ct:Amid} | PMM-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | IC50 >100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | NWKKIASIGKEVLKAL{ct:Amid} | PMM-2 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | IC50 >100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | WKKIASIGKEVLKAL{ct:Amid} | PMM-3 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | KKIASIGKEVLKAL{ct:Amid} | PMM-4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | KIASIGKEVLKAL{ct:Amid} | PMM-5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIASIGKEVLKA{ct:Amid} | PMM-6 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIASIGKEVLK{ct:Amid} | PMM-7 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKIASIGKEVL{ct:Amid} | PMM-8 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INQKKIASIGKEV{ct:Amid} | PMM-9 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | IWNKIAKSIGKVLEKAL{ct:Amid} | PMM-10 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | IC50 >100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | INWKKGKEVLKAL{ct:Amid} | PMM-11 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | NIWKKIASIAKEVLKAL{ct:Amid} | PMM-12 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | IC50 =32μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | KNWKKIASIGKEVLKAL{ct:Amid} | PMM-13 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18375018 | 2000 | SNWKKIASIGKEVLKAL{ct:Amid} | PMM-14 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | IC50 >>100μM | Rat | Polistes major major mastoparan (Polistinae wasps ) | NA | NA | ||
| 18568863 | 2008 | FKRLEKLFSKIWNWK{ct:Amid} | A3-NT | Amidation | Free | Linear | L | None | 15 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | GKPRPYSPRPTSHPRPIRV | Drosocin | Free | Free | Linear | L | None | 19 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | LNLKGIFKKVASLLT | Euminitin | Free | Free | Linear | L | None | 15 | Antimicrobial | MHC <1000μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | V{nnr:O}LF{d}PV{nnr:O}LF{d}P | GS | Free | Free | Linear | Mix | O = L-Ornithine | 10 | Antimicrobial | MHC =12.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VKLKVY{d}PLKVKLY{d}P | GS14 | Free | Free | Linear | Mix | None | 14 | Antimicrobial | MHC =1.5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VKLK{d}VY{d}PLKVKLY{d}P | GS14K4 | Free | Free | Linear | Mix | None | 14 | Antimicrobial | MHC =200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | AKLK{d}AY{d}PLKAKLY{d}P | GS14K4 V3/A3 | Free | Free | Linear | Mix | None | 14 | Antimicrobial | MHC >800μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC =25μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | IL-({nnr:Nlys})-WKW-({nnr:Nlys})-WW-({nnr:Nlys})-WRR{ct:Amid} | Indolicidin Ink | Amidation | Free | Linear | L | Nlys = Nlys | 13 | Antimicrobial | MHC >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KWKKLLKKPLLKKLLKKL{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KWKKLLKKPLLKK{ct:Amid} | P10 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KWKKPLLKKLLKKL{ct:Amid} | P11 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | GLGSVFGRLARIGRVIPKV{ct:Amid} | Pilosulin P1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | MHC <10μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | GLLSKFGRLARKLARVIPKV{ct:Amid} | Pilosulin P2 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | MHC <10μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VRRFPWWWPFLRR{ct:Amid} | TP | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VRRFPWWWPFLRR{ct:Amid} | TP | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC =50μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VRRF-({nnr:Nphe})-WWW-({nnr:Nphe})-FLRR{ct:Amid} | TPf | Amidation | Free | Linear | L | Nphe = Nphe | 13 | Antimicrobial | MHC >1μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VRRF-({nnr:Nlys})-WWW-({nnr:Nlys})-FLRR{ct:Amid} | TPk | Amidation | Free | Linear | L | Nlys = Nlys | 13 | Antimicrobial | MHC >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VRRFKWWWKFLRR{ct:Amid} | TPK | Amidation | Free | Linear | L | None | 13 | Antimicrobial | MHC >5μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | VRRF-({nnr:Nleu})-WWW-({nnr:Nleu})-FLRR{ct:Amid} | TPl | Amidation | Free | Linear | L | Nleu = Nleu | 13 | Antimicrobial | MHC >1μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KKFPWWWPFKK{ct:Amid} | Tritrpticin STP | Amidation | Free | Linear | L | None | 11 | Antimicrobial | MHC =100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KKF-({nnr:Nlys})-WWW-({nnr:Nlys})-FKK{ct:Amid} | Tritrpticin STPk | Amidation | Free | Linear | L | Nlys = Nlys | 11 | Antimicrobial | MHC >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18723059 | 2008 | FMPIIGRLMSGSL | VESP-VB1 | Free | Free | Linear | L | None | 13 | Antimicrobial | 10.2% hemolysis up to 200μg/ml | Rabbit | Synthetic Peptide | NA | NA | ||
| 18723059 | 2008 | FMPIIGRLMSGSL | VESP-VB1 | Free | Free | Linear | L | None | 13 | Antimicrobial | 3.2% hemolysis up to 200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18723059 | 2008 | INMKASAAVAKKLL | MP-VB1 | Free | Free | Linear | L | None | 14 | Antimicrobial | 1.7% hemolysis at 200μg/ml | Rabbit | Synthetic Peptide | NA | NA | ||
| 18723059 | 2008 | INMKASAAVAKKLL | MP-VB1 | Free | Free | Linear | L | None | 14 | Antimicrobial | 2.7% hemolysis at 200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18855761 | 2008 | KWKLFKKIPKFLHLAKKF{ct:Amid} | P18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC =50μM | Human | Synthetic Peptide | NA | NA | ||
| 18855761 | 2008 | KKKLFWKIPKFLHLAKKF{ct:Amid} | P18-W6 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC <200μM | Human | Synthetic Peptide | NA | NA | ||
| 18855761 | 2008 | KIKLFKKWPKFLHLAKKF{ct:Amid} | P18-W8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC =200μM | Human | Synthetic Peptide | NA | NA | ||
| 18855761 | 2008 | KAKLFKKIPKFLHLWKKF{ct:Amid} | P18-W15 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC =200μM | Human | Synthetic Peptide | NA | NA | ||
| 18855761 | 2008 | KWKLFKKI-{nnr:Nala}-KFLHLAKKF{ct:Amid} | P18-Nala9 | Amidation | Free | Linear | L | Nala = Nala | 18 | Antimicrobial | MHC =200μM | Human | Synthetic Peptide | NA | NA | ||
| 18855761 | 2008 | KWKLFKKIP{d}KFLHLAKKF{ct:Amid} | P18-D-Pro | Amidation | Free | Linear | L | None | 18 | Antimicrobial | MHC <200μM | Human | Synthetic Peptide | NA | NA | ||
| 16129513 | 2005 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MPI | Amidation | Free | Linear | L | None | 14 | Cytotoxic | EC50 =4.5 X10-5M | Rat | Venom of the tropical socialwasp P. paulista | NA | NA | ||
| 16129513 | 2005 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Cytotoxic | EC50 =4 X10-6M | Rat | Venom of the tropical socialwasp P. paulista | NA | NA | ||
| 17561225 | 2007 | LLGMIPLAISAISALSKL{ct:Amid} | Phylloseptin-L1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | LC50 =40μM | Human | Skin secretions of the lemur leaf frog Hylomantis lemur | NA | NA | ||
| 19778602 | 2010 | CVISAGWNHKIRCKLTGNC | Nigroain-B1 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | Non-hemolytic | ||
| 19778602 | 2010 | FKTWKRPPFQTSCSGIIKE | Nigroain-C1 | Free | Free | Linear | L | None | 19 | Antimicrobial | 0% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | Non-hemolytic | ||
| 19778602 | 2010 | CVHWQTNPARTSCIGP | Nigroain-D1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | Non-hemolytic | ||
| 19778602 | 2010 | DCTRWIIGINGRICRD | Nigroain-E | Free | Free | Linear | L | None | 16 | Antimicrobial | 7.62±1.60% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | NA | ||
| 19778602 | 2010 | FLPLVLGALSGILPKILGK | Temporin-TN1 | Free | Free | Linear | L | None | 19 | Antimicrobial | 95.7±4.12% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.7% hemolysis at 0.0625mg/ml | Human | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0.8% hemolysis at 0.125mg/ml | Human | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 5.9% hemolysis at 0.25mg/ml | Human | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 7.6% hemolysis at 0.5mg/ml | Human | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 7.8% hemolysis at 1mg/ml | Human | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 1.5% hemolysis at 0.0625mg/ml | Rabbit | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 7.2% hemolysis at 0.125mg/ml | Rabbit | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 7.8% hemolysis at 0.25mg/ml | Rabbit | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 9.5% hemolysis at 0.5mg/ml | Rabbit | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | KSLRPRCWIKIKFRCKSLKF | P1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 57.1% hemolysis at 1mg/ml | Rabbit | Piceain 1 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0.6% hemolysis at 0.0625mg/ml | Human | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0.8% hemolysis at 0.125mg/ml | Human | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 5.2% hemolysis at 0.25mg/ml | Human | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 5.3% hemolysis at 0.5mg/ml | Human | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 11.3% hemolysis at 1mg/ml | Human | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 2.2% hemolysis at 0.0625mg/ml | Rabbit | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 4.7% hemolysis at 0.125mg/ml | Rabbit | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 5.2% hemolysis at 0.25mg/ml | Rabbit | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 12.4% hemolysis at 0.5mg/ml | Rabbit | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 21644248 | 2011 | RPRCWIKIKFRCKSLKF | P2 | Free | Free | Linear | L | None | 17 | Antimicrobial | 66.3% hemolysis at 1mg/ml | Rabbit | Piceain 2 (Picea sitchensis) | NA | NA | ||
| 16675060 | 2006 | AVDLAKIANKVLSSLF{ct:Amid} | Temporin-1TGb | Amidation | Free | Linear | L | None | 16 | Antimicrobial | LD50 =250μM | Human | Extradermal tissues of Tago’s brown frog Rana tagoi | NA | NA | ||
| 16675060 | 2006 | FLPVILPVIGKLLSGIL{ct:Amid} | Temporin-1TGc | Amidation | Free | Linear | L | None | 17 | Antimicrobial | LD50 =50μM | Human | Extradermal tissues of Tago’s brown frog Rana tagoi | NA | NA | ||
| 16735513 | 2006 | SWKSMAKKLKEYMEKLKQRA{ct:Amid} | Ltc3a | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 20% hemolysis at >120μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 16735513 | 2006 | SWASMAKKLKEYMEKLKQRA{ct:Amid} | Ltc3b | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 20% hemolysis at >120μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 12804591 | 2003 | FLPILGKLLSGIL{ct:Amid} | MRP | Amidation | Free | Linear | L | None | 10 | Antimicrobial | LC50 = 8μM | Human | Rana tagoi | NA | NA | ||
| 15885852 | 2005 | IPHAVKAISDLI{ct:Amid} | Kassinatuerin-1 (10-21)fragment | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0% hemolysis at 400μM | Human | Kassina senegalensis | NA | NA | ||
| 11897590 | 2001 | ALWKTLLKKVLKA{ct:Amid} | P | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 11937508 | 2002 | ALWKTLLKKVLKA{ct:Amid} | K4-S4(1-13)NH2 | Amidation | Free | Linear | L | None | 13 | Antiparasitic | 3% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 11937508 | 2002 | ALWKTLLKKVLKA{nt:H2N-CH2-CO-P}{ct:Amid} | Glycyl-P | Amidation | H2N-CH2-CO-P | Linear | L | None | 13 | Antiparasitic | 2% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 11937508 | 2002 | ALWKTLLKKVLKA{nt:H2N-(CH2)3-CO-P}{ct:Amid} | Aminobutyryl-P | Amidation | H2N-(CH2)3-CO-P | Linear | L | None | 13 | Antiparasitic | 1% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 11937508 | 2002 | ALWKTLLKKVLKA{nt:H2N-(CH2)6-CO-P}{ct:Amid} | Aminoheptanoyl-P | Amidation | H2N-(CH2)6-CO-P | Linear | L | None | 13 | Antiparasitic | 1% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 11937508 | 2002 | ALWKTLLKKVLKA{nt:H2N-(CH2)11-CO-P}{ct:Amid} | Aminolauroyl-P | Amidation | H2N-(CH2)11-CO-P | Linear | L | None | 13 | Antiparasitic | 4% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 11937508 | 2002 | ALWKTLLKKVLKA{nt:H2N-C((CH2)4-NH2)H-CO-P}{ct:Amid} | Lysyl-P | Amidation | H2N-C((CH2)4-NH2)H-CO-P | Linear | L | None | 13 | Antiparasitic | 5% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 15513914 | 2004 | FLPLIGRVLSGIL{ct:Amid} | Temporin A | Amidation | Free | Linear | L | None | 13 | Antiparasitic | LC50 >120μM | Human | Rana temporaria | NA | NA | ||
| 15513914 | 2004 | LLPIVGNLLKSLL{ct:Amid} | Temporin B | Amidation | Free | Linear | L | None | 13 | Antiparasitic | LC50 >120μM | Human | Rana temporaria | NA | NA | ||
| 11279030 | 2001 | FIGTALGIASAIPAIVKLFK{ct:Amid} | W6 | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Insecticidal | Zone of inhibition 3mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | FIGTALGIASAIPAIVKLFK{ct:Amid} | W6 | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Insecticidal | Zone of inhibition 1mm at 0.4-0.5mM | Sheep | Ponericin | NA | NA | ||
| 10606532 | 1999 | KWL{d}L{d}LLKL{d}LL{d}LK{ct:Amid} | [D]L3,4,8,10-K3 L8W(n) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 31% hemolysis at 50μM | Human | Synthetic Peptide | NA | NA | ||
| 10606532 | 1999 | KLL{d}L{d}LWKL{d}LL{d}LK{ct:Amid} | [D]L3,4,8,10-K3 L8W(m) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 39.4% hemolysis at 50μM | Human | Synthetic Peptide | NA | NA | ||
| 10606532 | 1999 | KLL{d}L{d}LLKL{d}LL{d}WK{ct:Amid} | [D]L3,4,8,10-K3 L8W(c) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 44.2% hemolysis at 50μM | Human | Synthetic Peptide | NA | NA | ||
| 10606532 | 1999 | KWL{d}L{d}KLKL{d}KL{d}LK{ct:Amid} | [D]L3,4,8,10-K5L6W(n) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KLL{d}L{d}KWKL{d}KL{d}LK{ct:Amid} | [D]L3,4,8,10-K5L6W(m) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KLL{d}L{d}KLKL{d}KL{d}WK{ct:Amid} | [D]L3,4,8,10-K5L6W(c) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KKW{d}L{d}KLKL{d}KL{d}KK{ct:Amid} | [D]L4,8,10-K7L4W(n) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KKL{d}L{d}KWKL{d}KL{d}KK{ct:Amid} | [D]L3,4,8,10-K7L4W(m) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 10606532 | 1999 | KKL{d}L{d}KLKL{d}KW{d}KK{ct:Amid} | [D]L3,4,8-K7L4W(c) | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 19635516 | 2009 | IPPFIKKVLTTVF{ct:Amid} | Temporin-CPa | Amidation | Free | Linear | L | None | 12 | Antimicrobial | LC50 =220μM | Human | Lithobates capito | NA | NA | ||
| 19635516 | 2009 | HFLGTLVNLAKKIL{ct:Amid} | Temporin-DRa | Amidation | Free | Linear | L | None | 14 | Antimicrobial | LC50 =65μM | Human | Rana draytonii | NA | NA | ||
| 19635516 | 2009 | FVQWFSKFLGRIL{ct:Amid} | Temporin L | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LC50 =2μM | Human | Rana temporaria | NA | NA | ||
| 16137634 | 2005 | INLKALAALAKALL{ct:Amid} | Mastoparan 7 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % hemolysis at 25 µM | Bovine | Mastoparan analogs | NA | NA | ||
| 16142907 | 2005 | KWKKLLKKL{nnr:a}KLLKKLLK{ct:Amid} | KLW-L10-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | >20% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 16142907 | 2005 | KWKKLLKKLL{nnr:a}LLKKLLK{ct:Amid} | KLW-L11-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | >50% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 16142907 | 2005 | KWKKLLKK{nnr:a}LKLLKKLLK{ct:Amid} | KLW-L9,13-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | 0% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 16142907 | 2005 | KWKKLL{nnr:a}KLL{nnr:a}LLKKLLK{ct:Amid} | KLW-K7,11-a | Amidation | Free | Linear | L | a = Nala (Ala-peptoid) | 18 | Antimicrobial | ~30% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 15009528 | 2004 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14KL4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =2 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14LL4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =3 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14FL4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =3 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLYY{d}YPLKVKLY{d}P{cyc:N-C} | GS14YL4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =8 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLNVY{d}PLKVKLY{d}P{cyc:N-C} | GS14NL4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =2 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15009528 | 2004 | VKLNVY{d}PLKVKLY{d}P{cyc:N-C} | GS14GL4 | Free | Free | Cyclic | Mix | None | 14 | Antimicrobial | MHC =3 µg/ml | Human | Gramicidin S analog | NA | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLKVLTTG | HP(2-9)-ME(1-12) | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis upto 100µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | Non-hemolytic | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTTG | HM1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 13% hemolysis at 25µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTTG | HM1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 1% hemolysis at 12.5µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTTG | HM1 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 6.25µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLKVLTWG | HM2 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis upto 100µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | Non-hemolytic | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 44% hemolysis at 25µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 31% hemolysis at 12.5µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 12% hemolysis at 6.25µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 4% hemolysis at 3.12µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLWVLTWG | HM3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 1.5µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 44% hemolysis at 25µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 43% hemolysis at 12.5µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 30% hemolysis at 6.25µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 29% hemolysis at 3.1µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 13% hemolysis at 1.5µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AWKVFKRLGIGAVLWVLTWG | HM4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis at 0.78µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | NA | ||
| 15127790 | 2004 | AKKVFKRLGIGAVLKVLKKG | HM5 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0% hemolysis upto 100µM | Human | Analog of HP(2-9)-ME(1-12) (synthetic peptide) | α-helical | Non-hemolytic | ||
| 12110678 | 2002 | LKLLKKLLKKLLKLL{ct:Amid} | Amphipathic-1L | Amidation | Free | Linear | L | None | 15 | Antibacterial | 100% hemolytic at 100μM | Human | Synthetic peptide | NA | NA | ||
| 12110678 | 2002 | KLKLLKLLKLLKLLK{ct:Amid} | Scrambled-4L | Amidation | Free | Linear | L | None | 15 | Antibacterial | 82% hemolytic at 100μM | Human | Synthetic peptide | NA | NA | ||
| 12110678 | 2002 | KKKLLLLLLLLLKKK{ct:Amid} | Segregated-5L | Amidation | Free | Linear | L | None | 15 | Antibacterial | 66% hemolytic at 100μM | Human | Synthetic peptide | NA | NA | ||
| 12354111 | 2002 | INLKALAALAKKIL | Mastoparan | Free | Free | Linear | L | None | 14 | Antifungal | 10% hemolytic at 100μM | Human | Isolated from scorpion venom | NA | NA | ||
| 22699557 | 2012 | IWRIFR{ct:Amid} | HFU2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | MHC > 256 μM | Human | Synthetic peptide | NA | NA | ||
| 22699557 | 2012 | IWRIFRRIF{ct:Amid} | HFU3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | MHC = 101.4μM | Human | Synthetic peptide | NA | NA | ||
| 15298176 | 2004 | FGVLAKVAAHVVPAIAEHF{ct:Amid} | [∆1,2]Mac | Amidation | Free | Linear | L | None | 19 | Antibacterial | 0% hemolysis upto 100µM | Rabbit | Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata) | α-helical | Non-hemolytic | ||
| 16235231 | 2006 | {nnr:Z}CRRLCYKQRCVTYCRGR{cyc:N-C}{ct:Amid} | Gomesin | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | ~ 40% hemolysis at 100µM | Human | Gomesin (Acanthoscurria gomesiana) | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}SRRLSYKQRSVTYSRGR{ct:Amid} | [Ser2,6,11,15]-Gm | Amidation | Free | Linear | L | Z = pyroglutamic acid | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}SRRLCYKQRCVTYSRGR{cyc:N-C}{ct:Amid} | [Ser2,15]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}CRRLSYKQRSVTYCRGR{cyc:N-C}{ct:Amid} | [Ser6,11]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}DRRLSYKQRSVTYORGR{cyc:N-C}{ct:Amid} | Cyclo(2–15)[Asp2, Ser6, 11, Orn15]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}SRRLOYKQRDVTYSRGR{cyc:N-C}{ct:Amid} | Cyclo(6-11)[Ser2,15, Orn6, Asp11]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}CRRLEYKQRKVTYCRGR{cyc:N-C}{ct:Amid} | Bicyclo(2–15, 6–11)[Cys2, 15, Glu6, Lys11]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | <10% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 16235231 | 2006 | {nnr:Z}ERRLCYKQRCVTYKRGR{cyc:N-C}{ct:Amid} | Bicyclo(2–15, 6–11)[Glu2, Cys6, 11, Lys15]-Gm | Amidation | Free | Cyclic | L | Z = pyroglutamic acid | 18 | Antimicrobial | ~ 32% hemolysis at 100µM | Human | Gomesin analogs | NA | NA | ||
| 23483218 | 2013 | LNWGAILKHIIK{ct:Amid} | PNG-1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 119 µM | Human | Venom Of Bee Panurgus Calcaratus | α-Helix | NA | ||
| 23483218 | 2013 | NLWAGILKHIIK{ct:Amid} | PNG-1/1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | NLWAGILKHIIK{ct:Amid} | PNG-1/2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LKWGAILKHIIK{ct:Amid} | PNG-1/3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNKGAILKHIIK{ct:Amid} | PNG-1/4 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWKAILKHIIK{ct:Amid} | PNG-1/5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at ~110 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGKILKHIIK{ct:Amid} | PNG-1/6 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >140 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAKLKHIIK{ct:Amid} | PNG-1/7 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAIKKHIIK{ct:Amid} | PNG-1/8 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAILKKIIK{ct:Amid} | PNG-1/9 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAILKHKIK{ct:Amid} | PNG-1/10 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAILKHIKK{ct:Amid} | PNG-1/11 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | KNWGKILKHIIK{ct:Amid} | PNG-1/12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | KNWKAILKHIIK{ct:Amid} | PNG-1/13 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAVLKHVVK{ct:Amid} | PNG-1/14 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGA{nnr:Abu}LKH{nnr:Abu}{nnr:Abu}K{ct:Amid} | PNG-1/15 | Amidation | Free | Linear | L | Abu = 2-aminobutyric acid | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAALKHAAK{ct:Amid} | PNG-1/16 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAFLKHFFK{ct:Amid} | PNG-1/17 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 81 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAGLKHGGK{ct:Amid} | PNG-1/18 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGALLKHLLK{ct:Amid} | PNG-1/19 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 63 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGA{nnr:Nle}LKH{nnr:Nle}{nnr:Nle}K{ct:Amid} | PNG-1/20 | Amidation | Free | Linear | L | Nle = Norleucine | 12 | Antimicrobial | 50 % Hemolysis at 40 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGA{nnr:Aca}LKH{nnr:Aca}{nnr:Aca}K{ct:Amid} | PNG-1/21 | Amidation | Free | Linear | L | Aca = 1-aminocyclohexane carboxylic acid | 12 | Antimicrobial | 50 % Hemolysis at 43 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LNWGAWLKHWWK{ct:Amid} | PNG-1/22 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 132 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23719232 | 2013 | GLLKRIKTLL{nt:Amid}{ct:Amid} | Anoplin | Amidation | Amidation | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at >500 µg/ml | Human | Anoplius Samariensis | α-Helix | NA | ||
| 23719232 | 2013 | G{nnr:Laa}LIKRKTLL{nt:Amid}{ct:Amid} | Ano-Laa02 | Amidation | Amidation | Linear | L | Laa ((S)-2-aminoundecanoic acid) | 10 | Antimicrobial | 50 % Hemolysis at ~108 µg/ml | Human | Anoplin Analogs | α-Helix | NA | ||
| 23719232 | 2013 | GLLKRK{nnr:Laa}TLL{nt:Amid}{ct:Amid} | Ano-Laa06 | Amidation | Amidation | Linear | L | Laa ((S)-2-aminoundecanoic acid) | 10 | Antimicrobial | 50 % Hemolysis at ~39 µg/ml | Human | Anoplin Analogs | α-Helix | NA | ||
| 23719232 | 2013 | GLLIKRKTL{nnr:Laa}{nt:Amid}{ct:Amid} | Ano-Laa10 | Amidation | Amidation | Linear | L | Laa ((S)-2-aminoundecanoic acid) | 10 | Antimicrobial | 50 % Hemolysis at ~77 µg/ml | Human | Anoplin Analogs | α-Helix | NA | ||
| 23719232 | 2013 | GLLIKRKTLL{ct:Amid} | C9-Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at ~5 µg/ml | Human | Anoplin Analogs | α-Helix | NA | ||
| 23935838 | 2013 | AKKVFKRLEKLFSKIQNDK{ct:Amid} | HP (2–20) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | α-Helix | Non-hemolytic | ||
| 23935838 | 2013 | AKKVFKRLEKLFSKIQNWK{ct:Amid} | Anal 1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | α-Helix | Non-hemolytic | ||
| 23935838 | 2013 | AKKVFKRLEKLFSKIWNDK{ct:Amid} | Anal 2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | α-Helix | Non-hemolytic | ||
| 23935838 | 2013 | AKKVFKRLEKLFSKIWNWK{ct:Amid} | Anal 3 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | Random coil/Helical | Non-hemolytic | ||
| 23935838 | 2013 | AKKVFKRLEKSFSKIQNDK{ct:Amid} | Anal 4 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | α-Helix | Non-hemolytic | ||
| 23935838 | 2013 | AKKVSKRLEKLFSKIQNDK{ct:Amid} | Anal 5 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | α-Helix | Non-hemolytic | ||
| 23935838 | 2013 | AKKVFKRLPKLFSKIWNWK{ct:Amid} | Anal 3-Pro | Amidation | Free | Linear | L | None | 19 | Antibacterial/ Antifungal | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | Helix-hinge-Helix | Non-hemolytic | ||
| 23689723 | 2013 | RQIKIWFQNRRMKWKK{ct:Amid} | Penetratin | Amidation | Free | Linear | L | None | 16 | Antimicrobial | No Hemolysis at 100 µM | Human | Drosophila Transcription Factor Antennapedia | NA | Non-hemolytic | ||
| 23689723 | 2013 | LLIILRRRIRKQAHAHSL{ct:Amid} | pVEC | Amidation | Free | Linear | L | None | 18 | Antimicrobial | No Hemolysis at 100 µM | Human | Murine Vascular Endothelial Cadherin | NA | Non-hemolytic | ||
| 23689723 | 2013 | IAWVKAFIRKLRKGPLG{nt:Acet}{ct:Amid} | YTA-4 | Amidation | Acetylation | Linear | L | None | 17 | Antimicrobial | No Hemolysis at 100 µM | Human | Substrate Of Matrix Metalloprotease 2 | NA | Non-hemolytic | ||
| 23689723 | 2013 | KLALKALKALKAALKLA{ct:Amid} | MAP | Amidation | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 100 µM | Human | Designed Model Amphipathic Peptide | NA | Non-hemolytic | ||
| 24013774 | 2013 | VKRWKKWWRKWKKWV{ct:Amid} | LZ1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <4 % Hemolysis at 10 µg/ml | Human | Human Cathelicidin Family | NA | NA | ||
| 24013774 | 2013 | VKRWKKWWRKWKKWV{ct:Amid} | LZ1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <3 % Hemolysis at 20 µg/ml | Human | Human Cathelicidin Family | NA | NA | ||
| 24013774 | 2013 | VKRWKKWWRKWKKWV{ct:Amid} | LZ1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 40 µg/ml | Human | Human Cathelicidin Family | NA | Non-hemolytic | ||
| 24013774 | 2013 | VKRWKKWWRKWKKWV{ct:Amid} | LZ1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <2 % Hemolysis at 80 µg/ml | Human | Human Cathelicidin Family | NA | NA | ||
| 24013774 | 2013 | VKRWKKWWRKWKKWV{ct:Amid} | LZ1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 2 % Hemolysis at 160 µg/ml | Human | Human Cathelicidin Family | NA | NA | ||
| 24013774 | 2013 | VKRWKKWWRKWKKWV{ct:Amid} | LZ1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | | Human | Human Cathelicidin Family | NA | NA | | ||
| 23893489 | 2013 | KGCALVKVRGLTLKVCK | AMP72 | Free | Free | Linear | L | None | 17 | Antimicrobial | 12 % Hemolysis at 500 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KGCALVKVRGLTLKVCK | AMP73 | Free | Free | Linear | L | None | 17 | Antimicrobial | 4.2 % Hemolysis at 250 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KGCALVKVRGLTLKVCK | AMP74 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.5 % Hemolysis at 100 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KGCALVKVRGLTLKVCK | AMP75 | Free | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 12.5 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KGCALVKVRGLTLKVCK | AMP76 | Free | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 1 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KWCRKWQWRGVKFIKCV | AMP126 | Free | Free | Linear | L | None | 17 | Antimicrobial | 12.5 % Hemolysis at 500 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KWCRKWQWRGVKFIKCV | AMP127 | Free | Free | Linear | L | None | 17 | Antimicrobial | 6.9 % Hemolysis at 250 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KWCRKWQWRGVKFIKCV | AMP128 | Free | Free | Linear | L | None | 17 | Antimicrobial | 5.3 % Hemolysis at 100 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KWCRKWQWRGVKFIKCV | AMP129 | Free | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 12.5 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | KWCRKWQWRGVKFIKCV | AMP130 | Free | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 1 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | HKCAKIKWRGVHVKYCA | AMP2041 | Free | Free | Linear | L | None | 17 | Antimicrobial | 9.4 % Hemolysis at 500 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | HKCAKIKWRGVHVKYCA | AMP2042 | Free | Free | Linear | L | None | 17 | Antimicrobial | 6.4 % Hemolysis at 250 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | HKCAKIKWRGVHVKYCA | AMP2043 | Free | Free | Linear | L | None | 17 | Antimicrobial | 5.73 % Hemolysis at 100 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | HKCAKIKWRGVHVKYCA | AMP2044 | Free | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 12.5 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23893489 | 2013 | HKCAKIKWRGVHVKYCA | AMP2045 | Free | Free | Linear | L | None | 17 | Antimicrobial | <1 % Hemolysis at 1 µg/ml | Sheep | In Silico-Developed , Synthetic | Partial β-Sheet | NA | ||
| 23632907 | 2013 | ILPIRSLIKKLL{ct:Amid} | Temporin-1RNa | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 105.2 ± 10.2 µM | Human | Black-Spotted Frog,Rana Nigromaculata | α-Helix | NA | ||
| 23632907 | 2013 | FLPLKKLRFGLL{ct:Amid} | Temporin-1RNb | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 136.3 ± 5.6 µM | Human | Black-Spotted Frog,Rana Nigromaculata | α-Helix | NA | ||
| 23713064 | 2013 | QWGRRCCGWGPGRRYCRRWC | Ib-AMP4 | Free | Free | Linear | L | None | 20 | Antimicrobial | 15 % Hemolysis at 200 µg/ml | Sheep | Impatiens Balsamina | complex | NA | ||
| 23713064 | 2013 | QWGRRCCGWGPGRRYCRRWC | Ib-AMP5 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at <100 µg/ml | Sheep | Impatiens Balsamina | complex | Non-hemolytic | ||
| 23893605 | 2013 | KISKRILTGKK{ct:Amid} | NK11 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 10 µM | Human | Variant Of Nk-2 | α-Helix | Non-hemolytic | ||
| 23893605 | 2013 | KISKRILTGKK{ct:Amid} | NK11 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Variant Of Nk-2 | α-Helix | Non-hemolytic | ||
| 23876294 | 2013 | KW{nnr:ΔF}WK{nnr:ΔF}VK{nnr:ΔF}AK{nt:Acet}{ct:Amid} | IJ2 | Amidation | Acetylation | Linear | L | ΔF=α,β-didehydrophenylalanine | 11 | Antifungal | <40 % Hemolysis at 100 µM | Human | Candida Albicans | α-Helix | NA | ||
| 23876294 | 2013 | KA{nnr:ΔF}WK{nnr:ΔF}VK{nnr:ΔF}AK{nt:Acet}{ct:Amid} | IJ3 | Amidation | Acetylation | Linear | L | ΔF=α,β-didehydrophenylalanine | 11 | Antifungal | <40 % Hemolysis at 100 µM | Human | Candida Albicans | α-Helix | NA | ||
| 23876294 | 2013 | KW{nnr:ΔF}WK{nnr:ΔF}AK{nnr:ΔF}AK{nt:Acet}{ct:Amid} | IJ4 | Amidation | Acetylation | Linear | L | ΔF=α,β-didehydrophenylalanine | 11 | Antifungal | <10 % Hemolysis at 100 µM | Human | Candida Albicans | α-Helix | NA | ||
| 23609760 | 2013 | FVDLKKIANIINSIFGK{ct:Amid} | Temporin-1CEa | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 99.08 µM | Human | Chinese Brown Frog Rana Chensinensis | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}YGRKKRRQRRR{ct:Amid} | Tat | Amidation | Free | Linear | L | * = 5(6)-carboxyfluorescein amidated to the N-terminus | 11 | Antimicrobial | 44/88 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}RQIKIWFQNRRMKWKK{ct:Amid} | Antp | Amidation | Free | Linear | L | * = 5(6)-carboxyfluorescein amidated to the N-terminus | 16 | Antimicrobial | 45553 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}LLIILRRRIRKQAHAHSK{ct:Amid} | pVEC | Amidation | Free | Linear | L | * = 5(6)-carboxyfluorescein amidated to the N-terminus | 18 | Antimicrobial | 45292 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}VRLPPPVRLPPPVRLPPP{ct:Amid} | SAP | Amidation | Free | Linear | L | * = 5(6)-carboxyfluorescein amidated to the N-terminus | 18 | Antimicrobial | >742/>742c % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}PPPLRVPPPLRVPPPLRV{ct:Amid} | SAPr | Amidation | Free | Linear | L | * = 5(6)-carboxyfluorescein amidated to the N-terminus | 18 | Antimicrobial | >742/>742c % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 24012601 | 2013 | INLKAIAALAKKLL | Mastoparan-VT1 | Free | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Human | Venom Gland Of The Wasp Vespa Tropica | NA | Non-hemolytic | ||
| 24012601 | 2013 | NLKAIAALAKKLL | Mastoparan-VT2 | Free | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Human | Venom Gland Of The Wasp Vespa Tropica | NA | Non-hemolytic | ||
| 24012601 | 2013 | INLKAIATLAKKLL | Mastoparan-VT3 | Free | Free | Linear | L | None | 14 | Antimicrobial | 25.04±5.12 % Hemolysis at 100 µg/ml | Human | Venom Gland Of The Wasp Vespa Tropica | NA | Non-hemolytic | ||
| 24012601 | 2013 | FLPIIGKLLSGLL | VCP-VT1 | Free | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Human | Venom Gland Of The Wasp Vespa Tropica | NA | Non-hemolytic | ||
| 24012601 | 2013 | FLPIIGKLLSG | VCP-VT2 | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 100 µg/ml | Human | Venom Gland Of The Wasp Vespa Tropica | NA | Non-hemolytic | ||
| 24105706 | 2013 | KRIVQRIKDFLR{ct:Amid} | KR-12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Ll-37 | α-Helix | NA | ||
| 24105706 | 2013 | KRIVQRIKDWLR{ct:Amid} | KR-12-a1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | KRIVQRIKKWLR{ct:Amid} | KR-12-a2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | KRIVKRIKKWLR{ct:Amid} | KR-12-a3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | KRIVKLIKKWLR{ct:Amid} | KR-12-a4 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at 96 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | LRIVKLILKWLR{ct:Amid} | KR-12-a6 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at 22 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | KRIRKRIKKWLR{ct:Amid} | KR-12-a7 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24105706 | 2013 | KRIRKRIKKWKR{ct:Amid} | KR-12-a8 | Amidation | Free | Linear | L | None | 12 | Antimicrobial and Antiendotoxic | 50 % Hemolysis at >800 µM | Human | Analog Of Kr-12 | α-Helix | NA | ||
| 24307932 | 2013 | ARIVQRIKDFLR{ct:Amid} | KR-12A18 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-37 | Helical | Non-hemolytic | ||
| 24307932 | 2013 | KRIVQRIKDFLR{ct:Amid} | KR-12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 10.6 % Hemolysis at 100 µM | Human | Human Cathelicidin Ll-37 | Helical | NA | ||
| 24307932 | 2013 | KAIVQRIKDFLR{ct:Amid} | KR-12A19 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-38 | Helical | Non-hemolytic | ||
| 24307932 | 2013 | KRIVQAIKDFLR{ct:Amid} | KR-12A23 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 8.5 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-39 | Helical | NA | ||
| 24307932 | 2013 | KRIVQRIADFLR{ct:Amid} | KR-12A25 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 9.4 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-40 | Helical | NA | ||
| 24307932 | 2013 | KRIVQRIKDFLA{ct:Amid} | KR-12A29 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0.2 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-41 | Helical | Non-hemolytic | ||
| 24307932 | 2013 | AQIVQRIKDFLR{ct:Amid} | KR-12A18Q19 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-42 | Helical | Non-hemolytic | ||
| 24307932 | 2013 | KKIVQKIKDFLK{ct:Amid} | KR-12 K | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 5 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-43 | Helical | NA | ||
| 24307932 | 2013 | RRIVQRIRDFLR{ct:Amid} | KR-12R | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 58 % Hemolysis at 100 µM | Human | Mutant Of Kr-12, Human Cathelicidin Ll-44 | Helical | NA | ||
| 24243598 | 2013 | KWKKLLKKPLLKKLLKKL{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 23951222 | 2013 | RKKRLKLLKRLV | SP1 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | RKRAARLLKRLV | SP2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | RKRFARFAKRAV | SP3 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | KKKAARALKRAL | SP4 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | LLIAAFKKLVKK | SP5 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | ALAHFLKKAIKK | SP6 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | NA | NA | ||
| 23951222 | 2013 | LLIKFLKRFIKH | SP7 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | LLIRAAKKFIKK | SP8 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | LLKALKKLLKKLL | SP9 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at 50 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | LRFLKKILKHLF | SP10 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at 100 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | LRALAKALKHKL | SP11 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | LKALRKALKHLA | SP12 | Free | Free | Linear | L | None | 12 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | KRRLIARILRLAARALVKKR | SP13 | Free | Free | Linear | L | None | 20 | Antimicrobial | 25 % Hemolysis at 100 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | KRKLTLVFGVMAGVIGTKKR | SP14 | Free | Free | Linear | L | None | 20 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | Strand | NA | ||
| 23951222 | 2013 | KRKLIFLAAFLAALALFKKR | SP15 | Free | Free | Linear | L | None | 20 | Antimicrobial | 25 % Hemolysis at <20 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23951222 | 2013 | KRRLAAFRAFRGALKSVLKK | SP16 | Free | Free | Linear | L | None | 20 | Antimicrobial | 25 % Hemolysis at >200 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23710779 | 2013 | IKKILSKIKKLLK | L-K6 | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >5 µM | Human | Frog Skin Peptide Temporin-1Ceb | α-Helical | NA | ||
| 23710779 | 2013 | WKKILSKIKKLLK | I1W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >5 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKWLSKIKKLLK | I4W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >5 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKIWSKIKKLLK | L5W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >5 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKILSKIKKWLK | L11W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >5 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKILSKIKKLWK | L12W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >5 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKIWSKIKKWLK | L5WL11W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >500 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKIWSKIKKLWK | L5WL12W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >500 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKILSKIKKWWK | L11WL12W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >500 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23710779 | 2013 | IKKIWSKIKKWWK | L5WL11WL12W | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >500 µM | Human | L-K6 Analogues | α-Helical | NA | ||
| 23831136 | 2013 | NGVQPKYKWWKWWKKWW{ct:Amid} | KT2 | Amidation | Free | Linear | L | None | 17 | Antibacterial | <20 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | NGVQPKYRWWRWWRRWW{ct:Amid} | RT2 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 10 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | NGVQPKYKWWKWWKKWWW{ct:Amid} | KT3 | Amidation | Free | Linear | L | None | 18 | Antibacterial | <60 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | NGVQPKYRWWRWWRRWW | CRT2 | Free | Free | Linear | L | None | 17 | Antibacterial | 20 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | NGVQPKYRWWRWWRRWWW | CRT3 | Free | Free | Linear | L | None | 18 | Antibacterial | <30 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | NGVQPWYKWWKWWKKWW{ct:Amid} | KWKT2 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 60 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | NGVQPKYRWWRWWRRWWWW{ct:Amid} | RT4 | Amidation | Free | Linear | L | None | 19 | Antibacterial | <60 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | RWWRWWRRWW{ct:Amid} | RW2 | Amidation | Free | Linear | L | None | 10 | Antibacterial | <70 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | RWWRWWRRWWW{ct:Amid} | RW3 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <90 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 24105706 | 2013 | KRIVQRIKDFLR{ct:Amid} | KR-12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >800 µM | Human | Smallest Region Of Ll-37 | α-Helical | NA | ||
| 24055160 | 2013 | FFPFLLGALGSLLPKIF{ct:Amid} | Temporin-SN1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 82.5 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FITGLIGGLMKAL{ct:Amid} | Temporin-SN2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | FISGLIGGLMKAL{ct:Amid} | Temporin-SN3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | FITGLISGLLMKAL{ct:Amid} | Temporin-SN4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | FFPFLLGALGSLLPKIF{ct:Amid} | Temporin-SN1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FITGLIGGLMKAL{ct:Amid} | Temporin-SN2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | FISGLIGGLMKAL{ct:Amid} | Temporin-SN3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10.5 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FITGLISGLLMKAL{ct:Amid} | Temporin-SN4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 11.1 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FFPFLLGALGSLLPKIF{ct:Amid} | Temporin-SN1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FITGLIGGLMKAL{ct:Amid} | Temporin-SN2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 11.2 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FISGLIGGLMKAL{ct:Amid} | Temporin-SN3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 53.1 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FITGLISGLLMKAL{ct:Amid} | Temporin-SN4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 51.6 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 5 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 10 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 20 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 40 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | <10 % Hemolysis at 80 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | <10 % Hemolysis at 120 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 4 % Hemolysis at 160 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 2.5 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 5 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 10 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 15 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 18 % Hemolysis at 20 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ~90 % Hemolysis at 40 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 80 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 120 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 160 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 30 % Hemolysis at 5 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | <90 % Hemolysis at 10 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 20 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 40 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 80 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 120 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 160 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 30 % Hemolysis at 5 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 80 % Hemolysis at 10 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 20 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 40 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 80 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 120 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 160 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 24279498 | 2013 | RLARIVVIRVAR{ct:Amid} | WT | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ~40 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RRWRIVVIRVRR{ct:Amid} | sub3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ~55 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RLARIVRIRVRR{ct:Amid} | 7R11R | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ≤10 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RLRRIWVIRVAR{ct:Amid} | 3R6W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ≤10 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RLRRIWVIRVAR{ct:Amid} | 2R6W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ~20 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RWARRVVIRVAR{ct:Amid} | 2W5R | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ≤10 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RWWRIVVIRVAR{ct:Amid} | 2W3W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ~30 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24279498 | 2013 | RLWRWVVIRVAR{ct:Amid} | 3W5W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | ≤10 % Hemolysis at 50 µg/ml | Human | Synthetic | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYL | BP134 | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLAGPA | BP199 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLKDEL | BP214 | Free | Free | Linear | L | None | 15 | Antimicrobial | 2 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KDWEHLKDWEHLKDWEHL | tag54 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLKFLHSAK | BP180 | Free | Free | Linear | L | None | 18 | Antimicrobial | 12 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYL | BP134 | Free | Free | Linear | L | None | 11 | Antimicrobial | 8 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPA | BP199 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLKDEL | BP214 | Free | Free | Linear | L | None | 15 | Antimicrobial | 6 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KDWEHLKDWEHLKDWEHL | tag54 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLKFLHSAK | BP180 | Free | Free | Linear | L | None | 18 | Antimicrobial | 54 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYL | BP134 | Free | Free | Linear | L | None | 11 | Antimicrobial | 18 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPA | BP199 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLKDEL | BP214 | Free | Free | Linear | L | None | 15 | Antimicrobial | 9 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KDWEHLKDWEHLKDWEHL | tag54 | Free | Free | Linear | L | None | 18 | Antimicrobial | 1 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKFLHSAK | BP180 | Free | Free | Linear | L | None | 18 | Antimicrobial | 58 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 23860860 | 2014 | SGKLCCRRKK{ct:Amid} | D0 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 2.2 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 23860860 | 2014 | SGKLYYRRKK{ct:Amid} | D1 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 2 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 23860860 | 2014 | SGKLWWRRKK{ct:Amid} | D2 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 2.5 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 23860860 | 2014 | SGKRWWRRKK{ct:Amid} | D3 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 23860860 | 2014 | RGKRWWRRKK{ct:Amid} | D4 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 55 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 23860860 | 2014 | RWKRWWRRKK{ct:Amid} | D5 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 6.5 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 23860860 | 2014 | RKKRWWRRKK{ct:Amid} | D6 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 6.5 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 24021230 | 2014 | GRFRRLRKKTRKRLKKIGKV{ct:Amid} | PMAP-36 (1–20) | Amidation | Free | Linear | L | None | 20 | Antimicrobial | <5 % Hemolysis at >256 µM | Human | Porcine Cathelicidin | α-Helix | Low hemolytic | ||
| 24021230 | 2014 | RFRRLRKKTRKRLKKI{ct:Amid} | RI16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <5 % Hemolysis at >256 µM | Human | N-Terminal Of Pmap-36 | α-Helix | Low hemolytic | ||
| 24021230 | 2014 | RFRRLRWWTRKRLKKI{ct:Amid} | PRW3 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <5 % Hemolysis at >256 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 24021230 | 2014 | RFRRLRWKTRWRLKKI{ct:Amid} | PRW4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <5 % Hemolysis at >256 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 24021230 | 2014 | RFRRLRKWTRWRLKKI{ct:Amid} | PRW5 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <5 % Hemolysis at >256 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 24021230 | 2014 | RFRRLRWKTRKRLWKI{ct:Amid} | PRW6 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <5 % Hemolysis at >256 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 24102775 | 2014 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 22.0± 2.8 % Hemolysis at 150 µM | Human | Endoplasmic Reticulum (Er) | α-Helix | NA | ||
| 24176194 | 2014 | AKKVFKRLEKLFSKIWNWK{ct:Amid} | HPA3 | Amidation | Free | Linear | L | None | 19 | Antibacterial | 10 % Hemolysis at 49.2 µM | Human | Helicobacter Pylori | α-Helix | NA | ||
| 24176194 | 2014 | AKKVFKRLPKLFSKIWNWK{ct:Amid} | HPA3P | Amidation | Free | Linear | L | None | 19 | Antibacterial | 10 % Hemolysis at >800 µM | Human | Helicobacter Pylori | α-Helix | NA | ||
| 24176194 | 2014 | AKKVFKRLPKLPSKIWNWK{ct:Amid} | HPA3P2 | Amidation | Free | Linear | L | None | 19 | Antibacterial | 10 % Hemolysis at >800 µM | Human | Helicobacter Pylori | α-Helix | NA | ||
| 24176194 | 2014 | AKKVFKRLEKLFSKIWNWK{ct:Amid} | HPA3 | Amidation | Free | Linear | L | None | 19 | Antibacterial | 50 % Hemolysis at 397.7 µM | Human | Helicobacter Pylori | α-Helix | NA | ||
| 24176194 | 2014 | AKKVFKRLPKLFSKIWNWK{ct:Amid} | HPA3P | Amidation | Free | Linear | L | None | 19 | Antibacterial | 50 % Hemolysis at >800 µM | Human | Helicobacter Pylori | α-Helix | NA | ||
| 24176194 | 2014 | AKKVFKRLPKLPSKIWNWK{ct:Amid} | HPA3P2 | Amidation | Free | Linear | L | None | 19 | Antibacterial | 50 % Hemolysis at >800 µM | Human | Helicobacter Pylori | α-Helix | NA | ||
| 24211081 | 2014 | IRVKIRVKIRVK{ct:Amid} | IK12-all L | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >125 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | I{d}R{d}V{d}K{d}I{d}R{d}V{d}K{d}I{d}R{d}V{d}K{d}{ct:Amid} | IK12-all D | Amidation | Free | Linear | D | None | 12 | Antimicrobial | 10 % Hemolysis at >125 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24221355 | 2014 | RGLRRLGRKIAHGVKKYG{ct:Amid} | SMAP-18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at >400 µM | Human | Sheep Myeloid | α-Helix | NA | ||
| 24221355 | 2014 | RGWRRWGRKWAHGWKKYG{ct:Amid} | SMAP-18-W | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at >400 µM | Human | Sheep Myeloid | α-Helix | NA | ||
| 24277042 | 2014 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at 1052.3 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | G{nnr:Cha}LKK({nnr:2-Nal})KTLL{ct:Amid} | Cha2 Lys5 2Nal6 | Amidation | Free | Linear | L | Cha = β-cyclohexylalanine, 2-Nal = 3-(2-naphthyl)-L-alanine | 10 | Antimicrobial | 50 % Hemolysis at 15.3 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKR({nnr:2-Nal})KTLL{ct:Amid} | 2Nal6 Lys8 | Amidation | Free | Linear | L | 2-Nal = 3-(2-naphthyl)-L-alanine | 10 | Antimicrobial | 50 % Hemolysis at 50.1 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKR({nnr:2-Nal})KL{nnr:Cha}{ct:Amid} | Lys5 2Nal6 Cha10 | Amidation | Free | Linear | L | Cha = β-cyclohexylalanine, 2-Nal = 3-(2-naphthyl)-L-alanine | 10 | Antimicrobial | 50 % Hemolysis at 26.6 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKRIKKL{nnr:Cha}{ct:Amid} | Lys8 Cha10 | Amidation | Free | Linear | L | Cha = β-cyclohexylalanine | 10 | Antimicrobial | 50 % Hemolysis at 12.4 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | G{nnr:Cha}LKKIKKL{nnr:Cha}{ct:Amid} | Cha2 Lys5 Lys8 Cha10 | Amidation | Free | Linear | L | Cha = β-cyclohexylalanine | 10 | Antimicrobial | 50 % Hemolysis at 0.5 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKKI{d}KTLL{ct:Amid} | Lys5 D-Ile6 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 10 | Antimicrobial | 50 % Hemolysis at 7209 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKKI{d}KKLL{ct:Amid} | Lys5 D-Ile6 Lys8 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 10 | Antimicrobial | 50 % Hemolysis at 1962.4 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | G{nnr:Cha}LKR({nnr:D-2-Nal})KKLL{ct:Amid} | Cha2 D-2Nal6 Lys8 | Amidation | Free | Linear | Mix | Cha = β-cyclohexylalanine, D-2-Nal = D-3-(2-naphthyl)-L-alanine | 10 | Antimicrobial | 50 % Hemolysis at 27 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKRiKTL{nnr:Cha}{ct:Amid} | Cha2 D-Ile6 Cha10 | Amidation | Free | Linear | Mix | Cha = β-cyclohexylalanine | 10 | Antimicrobial | 50 % Hemolysis at 225.6 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKR({nnr:D-2-Nal})KTL{nnr:Cha}{ct:Amid} | D-2Nal6 Cha10 | Amidation | Free | Linear | Mix | Cha = β-cyclohexylalanine, D-2-Nal = D-3-(2-naphthyl)-L-alanine | 10 | Antimicrobial | 50 % Hemolysis at 74.3 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24277042 | 2014 | GLLKKI({nnr:D-2-Nal})KKL{nnr:Cha}{ct:Amid} | Lys5 D-2Nal6 Lys8 Cha10 | Amidation | Free | Linear | Mix | Cha = β-cyclohexylalanine, D-2-Nal = D-3-(2-naphthyl)-L-alanine | 10 | Antimicrobial | 50 % Hemolysis at 23.6 µM | Human | Venom Of Spider Wasp (Anoplius Samariensis) | α-Helix | NA | ||
| 24419338 | 2014 | KLLLKLKLKLLKGWKRKRFG | KG20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 2.4 % Hemolysis at 100 µM | mouse | Lipopolysaccharide Trap | α-Helix | NA | ||
| 25054164 | 2014 | LRPAILVRIK{ct:Amid} | balteatide | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <8 % Hemolysis at 512 mg/L | Horse | Purple-Sided Leaf Frog, Phyllomedusa Baltea | NA | Low hemolytic | ||
| 25054164 | 2014 | LRPAILVRTK{ct:Amid} | sauvatide | Amidation | Free | Linear | L | None | 10 | myotropic agent on rat | <8 % Hemolysis at 512 mg/L | Horse | Phyllomedusa Sauvagei Skin Secretion | NA | Low hemolytic | ||
| 24321546 | 2014 | LLCIALRKKLLCIALRKK{ct:Amid} | CopA3 (Dimer) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 20 % Hemolysis at 200 µg/ml | Human | Coprisin Analogs, Dung Beetle, Copris Tripartitus | α-Helix | NA | ||
| 24321546 | 2014 | LLCKALRKILLCKALRKI{ct:Amid} | CopIK (Dimer) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 2.6 % Hemolysis at 200 µg/ml | Human | Coprisin Analogs, Dung Beetle, Copris Tripartitus | α-Helix | NA | ||
| 24161537 | 2014 | LIAGLAANFLPKLFCKITK{ct:Amid} | B1CTcu1 | Amidation | Free | Linear | L | None | 19 | Antibacterial | 1 % Hemolysis at 10 µg/ml | Rabbit | Indian Ranid Frog Clinotarsus Curtipes | α-Helix | Non-hemolytic | ||
| 24389272 | 2014 | ILGEIWKGIKDIL{ct:Amid} | Spiniferin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at <48 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | Non-hemolytic | ||
| 24389272 | 2014 | ILGKIWKGIKNIL{ct:Amid} | Spiniferin-M | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at <3 µM | Human | Analog Of Spiniferin, Scorpion Heterometrus Spinifer | α-Helix | Non-hemolytic | ||
| 24389272 | 2014 | ILGKIWKGIKNIL{ct:Amid} | Spiniferin-M | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.7 % Hemolysis at 6 µM | Human | Analog Of Spiniferin, Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | ILGKIWKGIKNIL{ct:Amid} | Spiniferin-M | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 19.1 % Hemolysis at 12 µM | Human | Analog Of Spiniferin, Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | ILGKIWKGIKNIL{ct:Amid} | Spiniferin-M | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 31.9 % Hemolysis at 24 µM | Human | Analog Of Spiniferin, Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | ILGKIWKGIKNIL{ct:Amid} | Spiniferin-M | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 56.6 % Hemolysis at 48 µM | Human | Analog Of Spiniferin, Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24595375 | 2014 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 26 µM | Human | Brazilian Wasp Polybia Paulista | α-Helix | NA | ||
| 24796503 | 2014 | KLLKLLLKLWLKLLKLLL | Hel 13-5 | Free | Free | Linear | L | None | 18 | Pulmonary surfactant | ~100 % Hemolysis at 20 µM | Rat | Synthetic | α-Helix | NA | ||
| 24796503 | 2014 | KLLKLLL{d}K{d}L{d}LWLKL{d}LLKLLL | Hel 13-5D3 | Free | Free | Linear | Mix | Lowercase letters correspond to D-amino acids | 18 | Pulmonary surfactant | ~100 % Hemolysis at 20 µM | Rat | Synthetic | α-Helix | NA | ||
| 24796503 | 2014 | KLLKLLL{d}K{d}L{d}LWL{d}KL{d}LLKL{d}LL | Hel 13-5D5 | Free | Free | Linear | Mix | Lowercase letters correspond to D-amino acids | 18 | Pulmonary surfactant | 35 % Hemolysis at 30-50 µM | Rat | Synthetic | α-Helix | NA | ||
| 24411680 | 2014 | RKDVYRRRRRR{ct:Amid} | RR-11 | Amidation | Free | Linear | L | None | 11 | Anti-mycobacterial | 50 % Hemolysis at >2000 mg/L | Rat | Synthetic Modified Peptides Of Thymopentin | α-Helix | Non-hemolytic | ||
| 24411680 | 2014 | RRRRRRRKDVY{ct:Amid} | RY-11 | Amidation | Free | Linear | L | None | 11 | Anti-mycobacterial | 50 % Hemolysis at >2000 mg/L | Rat | Synthetic Modified Peptides Of Thymopentin | α-Helix | Non-hemolytic | ||
| 24378871 | 2014 | GVLSAFKNALPGIMKIIV{ct:Amid} | hylaranin-L1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 3 % Hemolysis at 8 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24378871 | 2014 | GVLSAFKNALPGIMKIIV{ct:Amid} | hylaranin-L1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 4.2 % Hemolysis at 16 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24378871 | 2014 | GVLSAFKNALPGIMKIIV{ct:Amid} | hylaranin-L1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 22.9 % Hemolysis at 64 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24378871 | 2014 | GVLSVIKNALPGIMRFIA{ct:Amid} | hylaranin-L2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 5.8 % Hemolysis at 8 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24378871 | 2014 | GVLSVIKNALPGIMRFIA{ct:Amid} | hylaranin-L2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 58.6 % Hemolysis at 16 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24756162 | 2014 | YVLWKRKRKFCFI{ct:Amid} | YI13C | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 21.5 % Hemolysis at 50 µM | mouse | Lipopolysaccharide (Lps)-Mediated Inflammations | β-boomerang | NA | ||
| 24756162 | 2014 | {nnr:C4}YVLWKRKRKFCFI{nt:Acet} | C4YI13C | Free | Acetylation | Linear | L | C4= C4 carbon chain | 12 | Antimicrobial | 14.1 % Hemolysis at 50 µM | mouse | Lipopolysaccharide (Lps)-Mediated Inflammations | β-boomerang | NA | ||
| 24756162 | 2014 | {nnr:C8}YVLWKRKRKFCFI{nt:Acet} | C8YI13C | Free | Acetylation | Linear | L | C8 = carbon chain | 12 | Antimicrobial | 21.5 % Hemolysis at 50 µM | mouse | Lipopolysaccharide (Lps)-Mediated Inflammations | β-boomerang | NA | ||
| 24756162 | 2014 | {nnr:C8}YVLAKRKRKACFI{nt:Acet} | C8YI13CAA | Free | Acetylation | Linear | L | C8 = carbon chain | 12 | Antimicrobial | 30.2 % Hemolysis at 50 µM | mouse | Lipopolysaccharide (Lps)-Mediated Inflammations | β-boomerang | NA | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 1 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | Non-hemolytic | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | Non-hemolytic | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 1.38 % Hemolysis at 10 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | NA | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 7.25 % Hemolysis at 20 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | NA | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 16.58 % Hemolysis at 40 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | NA | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 21.29 % Hemolysis at 60 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | NA | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 29.32 % Hemolysis at 80 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | NA | ||
| 24776889 | 2014 | FLFKLIPKAIKKLISKFK{nt:Amid} | AamAP1-Lysine | Free | Amidation | Linear | L | None | 18 | Antimicrobial | 38.25 % Hemolysis at 100 µM | Human | Analog Of Aamap1,Scorpion Venom | α-Helix | NA | ||
| 24496141 | 2014 | WKKIWSKIKKLLK{ct:Amid} | I1WL5W | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.6 % Hemolysis at 500 µM | Human | Tryptophan (Trp) Residues | α-Helix | Non-hemolytic | ||
| 24496141 | 2014 | IKKWWSKIKKLLK{ct:Amid} | I4WL5W | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 14.6 % Hemolysis at 500 µM | Human | Tryptophan (Trp) Residues | α-Helix | Non-hemolytic | ||
| 24688525 | 2014 | GATAIKQVKKLFKKKGG{nt:Amid} | Pln149(6-22) | Free | Amidation | Linear | L | None | 17 | Antimicrobial | <5 % Hemolysis at 1-500 µM | Human | Analog Of Plantaricin149, Lactobacillus Plantarum | α-Helix | Non-hemolytic | ||
| 24688525 | 2014 | GATAIKQVKKLFKKKGG{nt:Acet} | Ac-Pln149(6-22) | Free | Acetylation | Linear | L | None | 17 | Antimicrobial | <5 % Hemolysis at 1-500 µM | Human | Analog Of Plantaricin149, Lactobacillus Plantarum | α-Helix | Non-hemolytic | ||
| 24688525 | 2014 | NO{d}C{d}T{d}Y{d}L{d}GATAIKQVKKLFKKKGG{nt:Amid} | Noctyl-Pln149(6-22) | Free | Amidation | Linear | L | None | 17 | Antimicrobial | <5 % Hemolysis at 1-500 µM | Human | Analog Of Plantaricin149, Lactobacillus Plantarum | α-Helix | Non-hemolytic | ||
| 24688525 | 2014 | {nnr:Fmoc}GATAIKQVKKLFKKKGG{nt:Amid} | Fmoc-Pln149(6-22) | Free | Amidation | Linear | L | fmoc = 9-fluorenylmethoxycarbonyl | 17 | Antimicrobial | 12 % Hemolysis at 250 µM | Human | Analog Of Plantaricin149, Lactobacillus Plantarum | α-Helix | NA | ||
| 24688525 | 2014 | {nnr:Fmoc}GATAIKQVKKLFKKKGG{nt:Amid} | Fmoc-Pln149(6-22) | Free | Amidation | Linear | L | fmoc = 9-fluorenylmethoxycarbonyl | 17 | Antimicrobial | 24 % Hemolysis at 500 µM | Human | Analog Of Plantaricin149, Lactobacillus Plantarum | α-Helix | NA | ||
| 24412102 | 2014 | RVCSAIPLPICH{ct:Amid} | Tigerinin-1R | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 500 µg/ml | Human | Hoplobatrachus Rugulosus (Dicroglossidae) | α-Helix | Non-hemolytic | ||
| 24412102 | 2014 | RICYAMWIPYPC | tigerinin-1V | Free | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 500 µg/ml | Human | Lithobates Vaillanti (Ranidae) | α-Helix | Non-hemolytic | ||
| 24412102 | 2014 | WCPPMIPLCSRF{ct:Amid} | tigerinin-1M | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 500 µg/ml | Human | Xenopus Muelleri (Pipidae) | α-Helix | Non-hemolytic | ||
| 24616110 | 2014 | GFGMALKLLKKVL{ct:Amid} | MAC-1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 160 µM | Human | Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GF{d}GM{d}A{d}L{d}K{d}L{d}L{d}K{d}K{d}V{d}L{d}{ct:Amid} | MAC-1/1 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 152 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | LVKKLLKLAMGFG{ct:Amid} | MAC-1/7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | L{d}V{d}K{d}K{d}L{d}L{d}K{d}L{d}A{d}M{d}GF{d}G{ct:Amid} | MAC-1/8 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKL{nnr:Aca}KKVL{ct:Amid} | MAC-1/24 | Amidation | Free | Linear | Mix | Aca = 1-aminocyclohexane carboxylic acid | 15 | Antimicrobial | 50 % Hemolysis at 88 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALK{nnr:Aca}LKKVL{ct:Amid} | MAC-1/25 | Amidation | Free | Linear | Mix | Aca = 1-aminocyclohexane carboxylic acid | 15 | Antimicrobial | 50 % Hemolysis at 88 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMA{nnr:Aca}KLLKKVL{ct:Amid} | MAC-1/26 | Amidation | Free | Linear | Mix | Aca = 1-aminocyclohexane carboxylic acid | 15 | Antimicrobial | 50 % Hemolysis at 93 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | AFGMALKLLKKVL{ct:Amid} | MAC-1/2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 241 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | LFGMALKLLKKVL{ct:Amid} | MAC-1/3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 53 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFKMALKLLKKVL{ct:Amid} | MAC-1/9 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 199 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGKALKLLKKVL{ct:Amid} | MAC-1/31 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >800 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMAL{nnr:O}LL{nnr:O}{nnr:O}VL{ct:Amid} | MAC-1/20 | Amidation | Free | Linear | L | O = Ornithine | 13 | Antimicrobial | 50 % Hemolysis at 262 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKLLKKVL{d}{ct:Amid} | MAC-1/14 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKLLKKV{d}L{ct:Amid} | MAC-1/15 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKLLKK{d}VL{ct:Amid} | MAC-1/11 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKLLK{d}KVL{ct:Amid} | MAC-1/12 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKLL{d}KKVL{ct:Amid} | MAC-1/16 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALKL{d}LKKVL{ct:Amid} | MAC-1/17 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMALK{d}LLKKVL{ct:Amid} | MAC-1/13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMAL{d}KLLKKVL{ct:Amid} | MAC-1/18 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGMA{d}LKLLKKVL{ct:Amid} | MAC-1/4 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFGM{d}ALKLLKKVL{ct:Amid} | MAC-1/19 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GF{d}GMALKLLKKVL{ct:Amid} | MAC-1/6 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 177 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GFK{d}MALKLLKKVL{ct:Amid} | MAC-1/10 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 476 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | GF{d}K{d}MALKLLKKVL{ct:Amid} | MAC-1/27 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 391 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | A{d}FGMALKLLKKVL{ct:Amid} | MAC-1/28 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 120 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | A{d}FKMALKLLKKVL{ct:Amid} | MAC-1/29 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 131 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24616110 | 2014 | A{d}FK{d}MALKLLKKVL{ct:Amid} | MAC-1/30 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 13 | Antimicrobial | 50 % Hemolysis at 476 µM | Human | Analog Of Mac-1, Venom Of Solitary Bee Macropis Fulvipes | α-Helix | NA | ||
| 24704757 | 2014 | GLVGTLLGHIGKAILG{ct:Amid} | Frenatin 2.1S | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 167 ± 8 µM | Human | Litoria Infrafrenata | α-Helix | NA | ||
| 24704757 | 2014 | GLVGTLLGHIGKAILS{ct:Amid} | Frenatin 2.2S | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 169 ± 7 µM | Human | Litoria Infrafrenata | α-Helix | NA | ||
| 24704757 | 2014 | GLVGTLLGHIGKAILG | frenatin 2.3S | Free | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 404 ± 11 µM | Human | Discoglossus Sardus | coil | Non-hemolytic | ||
| 24945359 | 2014 | RFRRLRKKTRKRLKKI{ct:Amid} | RI16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 5 % Hemolysis at >256 µM | Human | Truncated From Pamp-36 | α-Helix | Low hemolytic | ||
| 24945359 | 2014 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 5 % Hemolysis at 128 µM | Human | Hybrid Peptide | α-Helix | Low hemolytic | ||
| 25019413 | 2014 | FWGLKGLKKFSKKL | Pin2 [14] | Free | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 25 µM | Human | Variant Of Pandinin 2,Scorpion Venom Pandinus Imperator | α-Helix | Non-hemolytic | ||
| 25019413 | 2014 | FWGLKGLKKFSKKL | Pin2 [14] | Free | Free | Linear | L | None | 14 | Antimicrobial | 25 % Hemolysis at 100 µM | Human | Variant Of Pandinin 2,Scorpion Venom Pandinus Imperator | α-Helix | NA | ||
| 25019413 | 2014 | FWGLKGLKGPGKFSKKL | Pin2 [17] | Free | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 25 µM | Human | Variant Of Pandinin 2,Scorpion Venom Pandinus Imperator | α-Helix | Non-hemolytic | ||
| 25019413 | 2014 | FWGLKGLKGPGKFSKKL | Pin2 [17] | Free | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Variant Of Pandinin 2,Scorpion Venom Pandinus Imperator | α-Helix | Non-hemolytic | ||
| 24200946 | 2014 | GFWGKLWEGVKNAI{ct:Amid} | UyCT1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 22.8 ± 1.6 µM | Human | Venom Of Australian Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 24200946 | 2014 | FWGKLWEGVKNAI{ct:Amid} | UyCT2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >100 µM | Human | Analog Of Uyct1, Venom Of Australian Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 24200946 | 2014 | ILSAIWSGIKSLF{ct:Amid} | UyCT3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 17.3 ± 0.8 µM | Human | Venom Of Australian Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 24200946 | 2014 | IWSAIWSGIKGLL{ct:Amid} | UyCT5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 14.1 ± 0.3 µM | Human | Venom Of Australian Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 24649883 | 2014 | GVVVRVGRVVVRWV{ct:Amid} | VR(+4) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 43 µM | Human | Analog Of Vr(+6) | α-Helix | NA | ||
| 24649883 | 2014 | GVVVRVGRVVVRWVRR{ct:Amid} | VR(+6) | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 94 µM | Human | Val/Arg-Rich Peptides | α-Helix | NA | ||
| 24649883 | 2014 | GVVVRVGRVVVRWVRRRR{ct:Amid} | VR(+8) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 90 µM | Human | Analog Of Vr(+6) | α-Helix | NA | ||
| 24649883 | 2014 | GVVVRVPRVVVRWVRR{ct:Amid} | VR(P) | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >128 µM | Human | Analog Of Vr(+6) | α-Helix | NA | ||
| 24649883 | 2014 | GVVVRVARVVVRWVRR{ct:Amid} | VR(A) | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 80 µM | Human | Analog Of Vr(+6) | α-Helix | NA | ||
| 24842084 | 2014 | FLSHIAGFLSNLF{ct:Amid} | Temporin-SHc(Temp-SHc) | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at >80 µM | Human | Skin Of Pelophylax Saharica | α-Helix | NA | ||
| 24842084 | 2014 | FLSHLAGFLSNLF{ct:Amid} | L5 temp-SHc | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at >80 µM | Human | Analogue Of Temp-Shc, Skin Of Pelophylax Saharica | α-Helix | NA | ||
| 24842084 | 2014 | HSLFLAGFLSNLF{ct:Amid} | (4-1)L5temp-SHc | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 2 µM | Human | Analogue Of Temp-Shc, Skin Of Pelophylax Saharica | α-Helix | NA | ||
| 24952979 | 2014 | IRCRRRFCRI{ct:Amid} | IR1 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | IRIRCRRRFCRIRI{ct:Amid} | IR2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 128 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | FRCRRRFCRF{ct:Amid} | FR1 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | FRFRCRRRFCRFRF{ct:Amid} | FR2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 64 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | WRCRRRFCRW{ct:Amid} | WR1 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | WRWRCRRRFCRWRW{ct:Amid} | WR2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 64 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | PRCRRRFCRP{ct:Amid} | PR1 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | PRPRCRRRFCRPRP{ct:Amid} | PR2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | RGGRLCYCRRRFCVCVGR{ct:Amid} | Protegrin-1(PG-1) | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 2 µM | Human | Porcine Leukocytes | β-Sheet | NA | ||
| 25332684 | 2014 | FLFSLIPHAISGLISAFK{ct:Amid} | AcrAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 64 µM | Horse | Venom Of The Arabian Scorpion, Androctonus Crassicauda | α-Helix/Random coil | NA | ||
| 25332684 | 2014 | FLFSLIPNAISGLLSAFK{ct:Amid} | AcrAP2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 64 µM | Horse | Venom Of The Arabian Scorpion, Androctonus Crassicauda | α-Helix/Random coil | NA | ||
| 25332684 | 2014 | FLFKLIPKAIKGLIKAFK{ct:Amid} | AcrAP1a | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 32 µM | Horse | Analogue Of Acrap1, Venom Of The Arabian Scorpion, Androctonus Crassicauda | α-Helix/Random coil | NA | ||
| 25332684 | 2014 | FLFKLIPKAIKGLLKAFK{ct:Amid} | AcrAP2a | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 32 µM | Horse | Analogue Of Acrap2, Venom Of The Arabian Scorpion, Androctonus Crassicauda | α-Helix/Random coil | NA | ||
| 24955933 | 2014 | FKVQNQHGQVVKIFHH | Astacidin 1 | Free | Free | Linear | L | None | 16 | Antifungal | 0 % Hemolysis at 100 µM | Human | Freshwater Crayfish Pacifastacus Leniusculus | NA | Non-hemolytic | ||
| 24955933 | 2014 | FKVQNQHGQVVKIFHH | Astacidin 1 | Free | Free | Linear | L | None | 16 | Antifungal | 0 % Hemolysis at 50 µM | Human | Freshwater Crayfish Pacifastacus Leniusculus | NA | Non-hemolytic | ||
| 24955933 | 2014 | FKVQNQHGQVVKIFHH | Astacidin 1 | Free | Free | Linear | L | None | 16 | Antifungal | 0 % Hemolysis at 25 µM | Human | Freshwater Crayfish Pacifastacus Leniusculus | NA | Non-hemolytic | ||
| 24955933 | 2014 | FKVQNQHGQVVKIFHH | Astacidin 1 | Free | Free | Linear | L | None | 16 | Antifungal | 0 % Hemolysis at 12.5 µM | Human | Freshwater Crayfish Pacifastacus Leniusculus | NA | Non-hemolytic | ||
| 24955933 | 2014 | FKVQNQHGQVVKIFHH | Astacidin 1 | Free | Free | Linear | L | None | 16 | Antifungal | 0 % Hemolysis at 6.3 µM | Human | Freshwater Crayfish Pacifastacus Leniusculus | NA | Non-hemolytic | ||
| 24955933 | 2014 | FKVQNQHGQVVKIFHH | Astacidin 1 | Free | Free | Linear | L | None | 16 | Antifungal | 0 % Hemolysis at 3.1 µM | Human | Freshwater Crayfish Pacifastacus Leniusculus | NA | Non-hemolytic | ||
| 24955933 | 2014 | FKVQNQHGQVVKIFHH | Astacidin 1 | Free | Free | Linear | L | None | 16 | Antifungal | 0 % Hemolysis at 1.6 µM | Human | Freshwater Crayfish Pacifastacus Leniusculus | NA | Non-hemolytic | ||
| 25086320 | 2014 | GIGSLLAKAAKLAAGLV{ct:Amid} | CPF-W6 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 190 µM | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25030320 | 2014 | KLAKKLAKLAKLAKAL{ct:Amid} | Modelin-5-CONH2 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 12 % Hemolysis at 300 µM | Sheep | Synthetic | α-Helical | NA | ||
| 25030320 | 2014 | KLAKKLAKLAKLAKAL{ct:Amid} | Modelin-5-CONH2 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2 % Hemolysis at 300 µM | Human | Synthetic | α-Helical | NA | ||
| 25030320 | 2014 | KLAKKLAKLAKLAKAL{ct:Amid} | Modelin-5-CONH2 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2 % Hemolysis at 300 µM | Pig | Synthetic | α-Helical | NA | ||
| 25445609 | 2014 | GRRRRSVQWCA{nt:NH3} | human lactoferrin (1-11) | Free | NH3 | Linear | L | None | 11 | Antibacterial and Antifungal | 0 % Hemolysis at 1 mM | Rabbit | Human Lactoferrins | NA | Non-hemolytic | ||
| 25445609 | 2014 | WNLLRQAQEKFGKDKSPK{nt:NH3} | human lactoferrampin | Free | NH3 | Linear | L | None | 18 | Antibacterial and Antifungal | 0 % Hemolysis at 1 mM | Rabbit | Human Lactoferrins | NA | Non-hemolytic | ||
| 25445609 | 2014 | APRKNVRWCTI{nt:NH3} | bovine lactoferrin (1-11) | Free | NH3 | Linear | L | None | 11 | Antibacterial and Antifungal | 0 % Hemolysis at 1 mM | Rabbit | Bovine Lactoferrins | NA | Non-hemolytic | ||
| 25445609 | 2014 | DLIWKLLSKAQEKFGKNKSR{nt:NH3} | bovine lactoferrampin | Free | NH3 | Linear | L | None | 20 | Antibacterial and Antifungal | 0 % Hemolysis at 1 mM | Rabbit | Bovine Lactoferrins | NA | Non-hemolytic | ||
| 25123582 | 2014 | GMASLLAKVLPHVVKLIK | codesane(COD) | Free | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 105 µM | Human | Venom Of Wild Bee Colletes Daviesanus | α-Helix | NA | ||
| 25123582 | 2014 | GMAKLLAKVLPHVVKLIK | COD-1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 150 µM | Human | Analog Of Cod, Venom Of Wild Bee Colletes Daviesanus | α-Helix | NA | ||
| 25123582 | 2014 | GMASKLAKVLPHVVKLIK | COD-2 | Free | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Cod, Venom Of Wild Bee Colletes Daviesanus | α-Helix | NA | ||
| 25123582 | 2014 | GMASLLAKVLPKVVKLIK | COD-3 | Free | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Analog Of Cod, Venom Of Wild Bee Colletes Daviesanus | α-Helix | NA | ||
| 25123582 | 2014 | GMASLWAKVLPHVVKLIK | COD-4 | Free | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 162.5 µM | Human | Analog Of Cod, Venom Of Wild Bee Colletes Daviesanus | α-Helix | NA | ||
| 25123582 | 2014 | GMASLW{d}AKVLPHVVKLIK | COD-5 | Free | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 18 | Antimicrobial | 50 % Hemolysis at >>200 µM | Human | Analog Of Cod, Venom Of Wild Bee Colletes Daviesanus | α-Helix | NA | ||
| 25494332 | 2014 | RFRRLRKKTRKRLKKI{ct:Amid} | RI16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 25494332 | 2014 | RFRRLRKKWRKRLKKI{ct:Amid} | T9W | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 50 % Hemolysis at >256 µM | Human | Mutant Peptide | α-Helix | NA | ||
| 25494332 | 2014 | RFRRLRKKIRKRLKKI{ct:Amid} | T9I | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >256 µM | Human | Mutant Peptide | α-Helix | NA | ||
| 25494332 | 2014 | RFRRLRKKKRKRLKKI{ct:Amid} | T9K | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >256 µM | Human | Mutant Peptide | α-Helix | NA | ||
| 25494332 | 2014 | RFRRLRKKFRKRLKKI{ct:Amid} | T9F | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >256 µM | Human | Mutant Peptide | α-Helix | NA | ||
| 24952727 | 2014 | APKAMKLLKKLLKLQKKGI | SHAP1 | Free | Free | Linear | L | None | 19 | Wound healing, Antibacterial, Antifungal | 0 % Hemolysis at 1 µM | Human | Synthetic Peptide | α-Helical | Non-hemolytic | ||
| 24952727 | 2014 | APKAMKLLKKLLKLQKKGI | SHAP1 | Free | Free | Linear | L | None | 19 | Wound healing, Antibacterial, Antifungal | 0 % Hemolysis at 10 µM | Human | Synthetic Peptide | α-Helical | Non-hemolytic | ||
| 24952727 | 2014 | APKAMKLLKKLLKLQKKGI | SHAP1 | Free | Free | Linear | L | None | 19 | Wound healing, Antibacterial, Antifungal | 0 % Hemolysis at 100 µM | Human | Synthetic Peptide | α-Helical | Non-hemolytic | ||
| 24952727 | 2014 | APKAMKLLKKLLKLQKKGI | SHAP1 | Free | Free | Linear | L | None | 19 | Wound healing, Antibacterial, Antifungal | <5 % Hemolysis at 200 µM | Human | Synthetic Peptide | α-Helical | Non-hemolytic | ||
| 24706599 | 2014 | {nnr:pGlu}CRRLCYKQRCVTYCRGR | Gomesin (Gm) | Amidation | Free | Linear | L | pGlu = pyroglutamic | 18 | Antimicrobial | 10 % Hemolysis at 0.4 µM | Human | Hemolymph Of The Spider Acanthoscurria Gomesiana | β-Hairpin | NA | ||
| 24706599 | 2014 | {nnr:pGlu}CRRLCYKQRCVTYCRGR | Gomesin (Gm) | Amidation | Free | Linear | L | pGlu = pyroglutamic | 18 | Antimicrobial | 40 % Hemolysis at 100 µM | Human | Hemolymph Of The Spider Acanthoscurria Gomesiana | β-Hairpin | NA | ||
| 24706599 | 2014 | WCRRLCYKQRCVTYCRGR{ct:Amid} | [Trp1 ]-Gm | Amidation | Free | Linear | L | None | 18 | Antimicrobial | <35 % Hemolysis at 100 µM | Human | Gomesin Analogs | β-Hairpin | NA | ||
| 24706599 | 2014 | {nnr:pGlu}CRRLCWKQRCVTYCRGR | [Trp7 ]-Gm | Amidation | Free | Linear | L | pGlu = pyroglutamic | 18 | Antimicrobial | 35 % Hemolysis at 100 µM | Human | Gomesin Analogs | β-Hairpin | NA | ||
| 24706599 | 2014 | {nnr:pGlu}CRRLCYKWRCVTYCRGR | [Trp9 ]- Gm | Amidation | Free | Linear | L | pGlu = pyroglutamic | 18 | Antimicrobial | 40 % Hemolysis at 100 µM | Human | Gomesin Analogs | β-Hairpin | NA | ||
| 24466055 | 2014 | GRFRRLRKKTRK{ct:Amid} | GK12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Truncated Derivative Of Cathelicidin Pmap-36 | α-Helix | Non-hemolytic | ||
| 24466055 | 2014 | RLKKIGKVLKWI{ct:Amid} | RI12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Truncated Derivative Of Cathelicidin Pmap-36 | α-Helix | Non-hemolytic | ||
| 24466055 | 2014 | PPIVGSIPLGCG{ct:Amid} | PG12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Truncated Derivative Of Cathelicidin Pmap-36 | α-Helix | Non-hemolytic | ||
| 24101243 | 2014 | VDNANDLLSKVKKDKSD | A1 | Free | Free | Linear | L | None | 17 | Antibacterial | 0 % Hemolysis at 500 μg/ml | Human | Human C8Α Complement System Peptide | α-Helix | Non-hemolytic | ||
| 24101243 | 2014 | TSFLNELNKYNEKKFI | A2 | Free | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 500 μg/ml | Human | Human C8Α Complement System Peptide | α-Helix | Non-hemolytic | ||
| 24101243 | 2014 | VIDKAKMESLGITSRDTT | A3 | Free | Free | Linear | L | None | 18 | Antibacterial | 0 % Hemolysis at 500 μg/ml | Human | Human C8Α Complement System Peptide | α-Helix | Non-hemolytic | ||
| 24101243 | 2014 | KKFGGGKTERARKAMAVE | A4 | Free | Free | Linear | L | None | 18 | Antibacterial | 0 % Hemolysis at 500 μg/ml | Human | Human C8Α Complement System Peptide | α-Helix | Non-hemolytic | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 9.6 ± 0.9 % Hemolysis at 5 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 14.3 ± 1.2 % Hemolysis at 10 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 20.2 ± 1.8 % Hemolysis at 25 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 27.3 ± 2.8 % Hemolysis at 50 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 35.6 ± 1.4 % Hemolysis at 100 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 43.6 ± 2.8 % Hemolysis at 150 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 46.6 ± 3.1 % Hemolysis at 200 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | VVYALKRQGRTLYGF | MrH4 C-terminal peptide(VVY15) | Free | Free | Linear | L | None | 15 | Antimicrobial | 51.4 ± 2.3 % Hemolysis at 250 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25421112 | 2015 | LLSNVAGLLKQFAK | XPF2 | Free | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 256 μg/ml | Human | Silurana Tropicalis | α-Helix | NA | ||
| 25421112 | 2015 | LLRRVAGLLKQFAK | XPF4 | Free | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 256 μg/ml | Human | Silurana Tropicalis | α-Helix | Low hemolytic | ||
| 25421112 | 2015 | LLRRVARLLKRFAK | XPF6 | Free | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 128 μg/ml | Human | Silurana Tropicalis | α-Helix | Low hemolytic | ||
| 26688811 | 2015 | KWKYPKLLKKLLK | KW-13 | Free | Free | Linear | L | None | 13 | Antibacterial | <1 % Hemolysis at 10 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 26688811 | 2015 | KWKYPKLLKKLLK | KW-13 | Free | Free | Linear | L | None | 13 | Antibacterial | <1 % Hemolysis at 40 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 26688811 | 2015 | KWKYPKLLKKLLK | KW-13 | Free | Free | Linear | L | None | 13 | Antibacterial | <1 % Hemolysis at 160 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 26688811 | 2015 | KWKYPKLLKKLLK | KW-13 | Free | Free | Linear | L | None | 13 | Antibacterial | <1 % Hemolysis at 640 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 4.1 ± 1.2 % Hemolysis at 64 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.1 ± 0.1 % Hemolysis at 32 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.0 ± 1.6 % Hemolysis at 16 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.0 ± 1.4 % Hemolysis at 8 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.0 ± 1.1 % Hemolysis at 4 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 0.0 ± 0.0 % Hemolysis at 2 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Hemolysis at 1 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Hemolysis at 0.5 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | WKKIRVRLSA{ct:Amid} | SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Hemolysis at 0.25 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 11.1 ± 0.9 % Hemolysis at 64 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 10.9 ± 1.9 % Hemolysis at 32 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 6.4 ± 1.6 % Hemolysis at 16 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 5.9 ± 0.2 % Hemolysis at 8 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.4 ± 1.1 % Hemolysis at 4 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.1 ± 0.5 % Hemolysis at 2 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 2.0 ± 1.2 % Hemolysis at 1 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Hemolysis at 0.5 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25617899 | 2015 | KWKIRVRLSA{ct:Amid} | β-SB056-lin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | Hemolysis at 0.25 μg/ml | Human | Sb056 Analogues, Mofification Of Sb056-Lin | β-Sheets | NA | ||
| 25172690 | 2015 | GLSRLFTALK | ACWWP1 | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibacterial | 0 % Hemolysis at 512 μg/ml | Mouse | Boiled–Dried Anchovies Cooking Wastewater | α-Helix | Non-hemolytic | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.8 % Hemolysis at 1.6 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.3 % Hemolysis at 3.1 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.4 % Hemolysis at 6.3 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.4 % Hemolysis at 12.5 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.5 % Hemolysis at 25 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.3 % Hemolysis at 50 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25462167 | 2015 | AGLQFPVGRIGRLLRK | Scolopendin 2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 ± 0.2 % Hemolysis at 100 µM | Human | Centipede Scolopendra Subspinipes | α-Helix | Non-hemolytic | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 5.3 ± 0.8 % Hemolysis at 5 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 8.9 ± 1.2 % Hemolysis at 10 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 14.5 ± 2.1 % Hemolysis at 25 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 19.7 ± 2.5 % Hemolysis at 50 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 24.7 ± 1.9 % Hemolysis at 100 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 28.5 ± 1.5 % Hemolysis at 150 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 33.6 ± 2.4 % Hemolysis at 200 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 37.4 ± 2.0 % Hemolysis at 250 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 7.9 ± 1.4 % Hemolysis at 5 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 11.5 ± 1.3 % Hemolysis at 10 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 18.7 ± 2.5 % Hemolysis at 25 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 25.4 ± 2.2 % Hemolysis at 50 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 31.4 ± 3.5 % Hemolysis at 100 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 36.8 ± 1.7 % Hemolysis at 150 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 41.5 ± 2.5 % Hemolysis at 200 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 46.5 ± 2.2 % Hemolysis at 250 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25869360 | 2015 | LRLKSIVSYAKKVL | Mastoparan-S | Free | Free | Linear | L | None | 14 | Antibaterial, Antifungal | 0.2 % Hemolysis at 10 μg/ml | Human | Insect Sphodromantis Viridis | NA | NA | ||
| 25869360 | 2015 | LRLKSIVSYAKKVL | Mastoparan-S | Free | Free | Linear | L | None | 14 | Antibaterial, Antifungal | 0.25 % Hemolysis at 20 μg/ml | Human | Insect Sphodromantis Viridis | NA | NA | ||
| 25869360 | 2015 | LRLKSIVSYAKKVL | Mastoparan-S | Free | Free | Linear | L | None | 14 | Antibaterial, Antifungal | 0.46 % Hemolysis at 40 μg/ml | Human | Insect Sphodromantis Viridis | NA | NA | ||
| 25869360 | 2015 | LRLKSIVSYAKKVL | Mastoparan-S | Free | Free | Linear | L | None | 14 | Antibaterial, Antifungal | 1.2 % Hemolysis at 60 μg/ml | Human | Insect Sphodromantis Viridis | NA | NA | ||
| 25869360 | 2015 | LRLKSIVSYAKKVL | Mastoparan-S | Free | Free | Linear | L | None | 14 | Antibaterial, Antifungal | 2.3 % Hemolysis at 80 μg/ml | Human | Insect Sphodromantis Viridis | NA | NA | ||
| 25869360 | 2015 | LRLKSIVSYAKKVL | Mastoparan-S | Free | Free | Linear | L | None | 14 | Antibaterial, Antifungal | 2.9 % Hemolysis at 100 μg/ml | Human | Insect Sphodromantis Viridis | NA | NA | ||
| 25869360 | 2015 | LRLKSIVSYAKKVL | Mastoparan-S | Free | Free | Linear | L | None | 14 | Antibaterial, Antifungal | 3 % Hemolysis at 20 µM | Human | Insect Sphodromantis Viridis | NA | NA | ||
| 25869360 | 2015 | LKLKSIVSWAKKVL | Mastoparan-В | Free | Free | Linear | L | None | 14 | Antibaterial, Antifungal | 71 % Hemolysis at 20 µM | Human | Insect Sphodromantis Viridis | NA | NA | ||
| 25311453 | 2015 | YSKSLPLSVLNP | Synthesized AN5-1 | Free | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 256 μg/ml | Human | Fermentation Broth Of Paenibacillus Alvei | NA | Low hemolytic | ||
| 25311453 | 2015 | YSKSLPLSVLNP | Biosynthesized AN5-1 | Free | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 256 μg/ml | Human | Fermentation Broth Of Paenibacillus Alvei | NA | Low hemolytic | ||
| 25680229 | 2015 | GIGKFLKKAKKF{ct:Amid} | CEM1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibacterial | 0 % Hemolysis at 0-512 μg/ml | Human | Pexiganan, Synthetic Peptide | α-Helix | Non-hemolytic | ||
| 25680229 | 2015 | IGKFLKKAKKFG{ct:Amid} | CEM2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibacterial | 0 % Hemolysis at 0-512 μg/ml | Human | Pexiganan, Synthetic Peptide | α-Helix | Non-hemolytic | ||
| 25735802 | 2015 | RFRRLRWKTRWRLKKI{ct:Amid} | PRW4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRCKTRCRLKKI{ct:Amid} | K4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRDKTRDRLKKI{ct:Amid} | K4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRIKTRIRLKKI{ct:Amid} | K4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRPKTRPRLKKI{ct:Amid} | K4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRW{d}KTRW{d}RLKKI{ct:Amid} | PRW4-d | Amidation | Free | Linear | Mix | w = Wd (D-Trp-substituted) | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRWRTRWRLRRI{ct:Amid} | PRW4-R | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at 0.25 µM | Human | Control,Bee Venom | α-Helix | NA | ||
| 25965506 | 2015 | GIWKKWIKKVVNVLKNLF{ct:Amid} | KU1 | Amidation | Free | Linear | L | None | 18 | Antifungal | 10 % Hemolysis at 8.07 ± 1.60 mg/L | Human | Synthetic, Mixed Backbone Of Kabt-Amp And Uperin 3.6 | α-Helix | NA | ||
| 25965506 | 2015 | GIWKKWIKKWLNVLKNLF{ct:Amid} | KU2 | Amidation | Free | Linear | L | None | 18 | Antifungal | 10 % Hemolysis at 7.33 ± 0.73 mg/L | Human | Synthetic, Mixed Backbone Of Kabt-Amp And Uperin 3.7 | α-Helix | NA | ||
| 25965506 | 2015 | GIWKKWIKKWLKVLKNLF{ct:Amid} | KU3 | Amidation | Free | Linear | L | None | 18 | Antifungal | 10 % Hemolysis at 5.65 ± 0.85 mg/L | Human | Synthetic, Mixed Backbone Of Kabt-Amp And Uperin 3.8 | α-Helix | NA | ||
| 25965506 | 2015 | GIWKKWIKKWLKKLKNLF{ct:Amid} | KU4 | Amidation | Free | Linear | L | None | 18 | Antifungal | 10 % Hemolysis at 49.38 ± 5.14 mg/L | Human | Synthetic, Mixed Backbone Of Kabt-Amp And Uperin 3.9 | α-Helix | NA | ||
| 25965506 | 2015 | GVIKAAKKVVNVLKNLF{ct:Amid} | Upn-lys4 | Amidation | Free | Linear | L | None | 17 | Antifungal | 10 % Hemolysis at >256 mg/L | Human | Uperin 3.6 Analogs, Mixed Backbone Of Kabt-Amp And Uperin 3.6 | α-Helix | NA | ||
| 25965506 | 2015 | GVIKAAKKVVKVLKNLF{ct:Amid} | Upn-lys5 | Amidation | Free | Linear | L | None | 17 | Antifungal | 10 % Hemolysis at >256 mg/L | Human | Uperin 3.6 Analogs, Mixed Backbone Of Kabt-Amp And Uperin 3.7 | α-Helix | NA | ||
| 25965506 | 2015 | GVIKAAKKVVKVLKKLF{ct:Amid} | Upn-lys6 | Amidation | Free | Linear | L | None | 17 | Antifungal | 10 % Hemolysis at >256 mg/L | Human | Uperin 3.6 Analogs, Mixed Backbone Of Kabt-Amp And Uperin 3.8 | α-Helix | NA | ||
| 25965506 | 2015 | GVIDAAKKVVNVLKNLF{ct:Amid} | Uperin 3.6 | Amidation | Free | Linear | L | None | 17 | Antifungal | 10 % Hemolysis at >256 mg/L | Human | Australian Toadlet, Uperoleia Mjobergii | α-Helix | NA | ||
| 25965506 | 2015 | GIWKKWIKKVVNVLKNLF{ct:Amid} | KU1 | Amidation | Free | Linear | L | None | 18 | Antifungal | 50 % Hemolysis at 58.19 ± 2.04 mg/L | Human | Mixed Backbone Of Kabt-Amp And Uperin 3.6 | α-Helix | NA | ||
| 25965506 | 2015 | GIWKKWIKKWLNVLKNLF{ct:Amid} | KU2 | Amidation | Free | Linear | L | None | 18 | Antifungal | 50 % Hemolysis at 57.71 ± 9.80 mg/L | Human | Mixed Backbone Of Kabt-Amp And Uperin 3.6 | α-Helix | NA | ||
| 25965506 | 2015 | GIWKKWIKKWLKVLKNLF{ct:Amid} | KU3 | Amidation | Free | Linear | L | None | 18 | Antifungal | 50 % Hemolysis at 55.20 ± 11.90 mg/L | Human | Mixed Backbone Of Kabt-Amp And Uperin 3.6 | α-Helix | NA | ||
| 25965506 | 2015 | GIWKKWIKKWLKKLKNLF{ct:Amid} | KU4 | Amidation | Free | Linear | L | None | 18 | Antifungal | 50 % Hemolysis at >256 mg/L | Human | Mixed Backbone Of Kabt-Amp And Uperin 3.6 | α-Helix | NA | ||
| 25965506 | 2015 | GVIKAAKKVVNVLKNLF{ct:Amid} | Upn-lys4 | Amidation | Free | Linear | L | None | 17 | Antifungal | 50 % Hemolysis at >256 mg/L | Human | Uperin 3.6 Analogs, Mixed Backbone Of Kabt-Amp And Uperin 3.6 | α-Helix | NA | ||
| 25965506 | 2015 | GVIKAAKKVVKVLKNLF{ct:Amid} | Upn-lys5 | Amidation | Free | Linear | L | None | 17 | Antifungal | 50 % Hemolysis at >256 mg/L | Human | Uperin 3.6 Analogs, Mixed Backbone Of Kabt-Amp And Uperin 3.7 | α-Helix | NA | ||
| 25965506 | 2015 | GVIKAAKKVVKVLKKLF{ct:Amid} | Upn-lys6 | Amidation | Free | Linear | L | None | 17 | Antifungal | 50 % Hemolysis at >256 mg/L | Human | Uperin 3.6 Analogs, Mixed Backbone Of Kabt-Amp And Uperin 3.8 | α-Helix | NA | ||
| 25965506 | 2015 | GVIDAAKKVVNVLKNLF{ct:Amid} | Uperin 3.6 | Amidation | Free | Linear | L | None | 17 | Antifungal | 50 % Hemolysis at >256 mg/L | Human | Australian Toadlet,Uperoleia Mjobergii | α-Helix | NA | ||
| 25997127 | 2015 | IAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5-L | Amidation | Free | Linear | L | None | 20 | Antibacterial | 30.5 % Hemolysis at 50 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | AGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5-LI | Amidation | Free | Linear | L | None | 19 | Antibacterial | 26 % Hemolysis at 50 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | GLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5-LIA | Amidation | Free | Linear | L | None | 18 | Antibacterial | 26.5 % Hemolysis at 100 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LAANFLPQILCKIARKC{ct:Amid} | B1CTcu5-LIAG | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 30 % Hemolysis at 12.5 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LIAGLAANFLPQILCKIARK{ct:Amid} | B1CTcu5-C | Amidation | Free | Linear | L | None | 20 | Antibacterial | 13 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LIAGLAANFLPQILC{ct:Amid} | B1CTcu5-Rana | Amidation | Free | Linear | L | None | 15 | Antibacterial | NA | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | Non-hemolytic | ||
| 25997127 | 2015 | LIAGLAANFL{ct:Amid} | B1CTcu5L1-L10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | NA | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | Non-hemolytic | ||
| 25997127 | 2015 | PQILCKIARKC{ct:Amid} | B1CTcu5P11-C21 | Amidation | Free | Linear | L | None | 11 | Antibacterial | NA | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | Non-hemolytic | ||
| 26046345 | 2015 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial | 56.98 % Hemolysis at 250 μg/ml | Human | Neutrophil Blood Cells Of Cows | α-Helix | NA | ||
| 26046345 | 2015 | LLPWKWPWWKWRR{ct:Amid} | IN1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 3.6 % Hemolysis at 250 μg/ml | Human | Indolicidin Analog | α-Helix | Low hemolytic | ||
| 26046345 | 2015 | RRPWRWPWWPWRR{ct:Amid} | IN2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 15.39 % Hemolysis at 250 μg/ml | Human | Indolicidin Analog | α-Helix | NA | ||
| 26046345 | 2015 | RRPWRWPRWPWRR{ct:Amid} | IN3 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 2.39 % Hemolysis at 250 μg/ml | Human | Indolicidin Analog | α-Helix | Low hemolytic | ||
| 26046345 | 2015 | FLGGLIKIVPAMICAVTKKC{ct:OH} | Ranalexin | OH | Free | Linear | L | None | 20 | Antibacterial | <15 % Hemolysis at 250 μg/ml | Human | Bullfrog (Rana Catesbeiana) Skin | α-Helix | NA | ||
| 26046345 | 2015 | FLGGLIKWWPWRR{ct:Amid} | RN7-IN6 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antipneumococcal | 0 % Hemolysis at 15.62 μg/ml | Human | Indolicidin Ranalexin Hybrid Peptide | α-Helix | Non-hemolytic | ||
| 26046345 | 2015 | FLGGLIKPWWPWRR{ct:Amid} | RN7-IN7 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <10 % Hemolysis at 250 μg/ml | Human | Indolicidin Ranalexin Hybrid Peptide | α-Helix | Non-hemolytic | ||
| 26046345 | 2015 | FLGGLIKWPWWPWRR{ct:Amid} | RN7-IN8 | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antipneumococcal | 0 % Hemolysis at 15.62 μg/ml | Human | Indolicidin Ranalexin Hybrid Peptide | α-Helix | Non-hemolytic | ||
| 26046345 | 2015 | FLGGLIKKWPWWPWRR{ct:Amid} | RN7-IN9 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antipneumococcal | 0 % Hemolysis at 15.62 μg/ml | Human | Indolicidin Ranalexin Hybrid Peptide | α-Helix | Non-hemolytic | ||
| 26046345 | 2015 | FLGGLIKWKWPWWPWRR{ct:Amid} | RN7-IN10 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antipneumococcal | 5.9 % Hemolysis at 15.62 μg/ml | Human | Indolicidin Ranalexin Hybrid Peptide | α-Helix | NA | ||
| 25826179 | 2015 | FKKLKKLFSKLWNWK{nt:Acet}{ct:Amid} | HPRP-A1 | Amidation | Acetylation | Linear | L | None | 15 | Antibacterial | MHC % Hemolysis at 32 µM | Human | N-Terminus Of Ribosomal Protein L1 Of Helicobacter Pylori | α-Helix | NA | ||
| 25826179 | 2015 | FKKLKKLFSKLKNWW{nt:Acet}{ct:Amid} | HPRP-A2 | Amidation | Acetylation | Linear | L | None | 15 | Antibacterial | MHC % Hemolysis at 16 µM | Human | Analog Of Hprp-A1 | α-Helix | NA | ||
| 25826179 | 2015 | KFLKLKWLKSWKNFK{nt:Acet}{ct:Amid} | HPRP-A3 | Amidation | Acetylation | Linear | L | None | 15 | Antibacterial | MHC % Hemolysis at 250 µM | Human | Analog Of Hprp-A1 | α-Helix | NA | ||
| 25826179 | 2015 | FKLKLKFSNKLKWKW{nt:Acet}{ct:Amid} | HPRP-B | Amidation | Acetylation | Linear | L | None | 15 | Antibacterial | MHC % Hemolysis at 64 µM | Human | Analog Of Hprp-A1 | β-Sheets | NA | ||
| 25826179 | 2015 | LFKKNKLWFKSKKWL{nt:Acet}{ct:Amid} | HPRP-C | Amidation | Acetylation | Linear | L | None | 15 | Antibacterial | MHC % Hemolysis at 500 µM | Human | Analog Of Hprp-A1 | Random coil | NA | ||
| 25941221 | 2015 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 64 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 26126210 | 2015 | LKGCWTKSIPPKPCF | ORB-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >500 μg/ml | Human | Synthetic Peptide | β-Hairpin | Low hemolytic | ||
| 26126210 | 2015 | LKGCWTKSIPPKPCF{ct:Amid} | ORB-N | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >500 μg/ml | Human | Orb-1 Analog | β-Hairpin | NA | ||
| 26156126 | 2015 | AVAVVGQAATVVK{ct:Amid} | PapC | Amidation | Free | Linear | L | None | 13 | Antimicrobial and Antiinflammatory Activities | 49 % Hemolysis at 6.25 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | NA | ||
| 26096124 | 2015 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at 512 μg/ml | Human | Venom Of The Solitary Wasp | α-Helix | NA | ||
| 26028561 | 2015 | FKRLKKLFKKIWNWK{ct:Amid} | HPA3NT3 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 68.2 % Hemolysis at 250 µM | Rat | Helicobacter Pylori | α-Helix | NA | ||
| 26028561 | 2015 | FKRLKKLISWIKRKRQQ{ct:Amid} | Hn-Mc | Amidation | Free | Linear | L | None | 17 | Antibacterial | 1.1 % Hemolysis at 250 µM | Rat | Hybrid Peptide | α-Helix | Low hemolytic | ||
| 26204061 | 2015 | GIIKKIIKKIIKKI{ct:Amid} | FITC | Amidation | Free | Linear | L | None | 14 | Antibacterial and Anticancer | 50 % Hemolysis at 256 µM | Human | Synthetic Amphiphiles | α-Helix | Low hemolytic | ||
| 26204061 | 2015 | IIKKIIKKIIKKI{ct:Amid} | 1 | Amidation | Free | Linear | L | None | 13 | Antibacterial and Anticancer | 50 % Hemolysis at 256 µM | Human | Synthetic Amphiphiles | α-Helix | Low hemolytic | ||
| 26204061 | 2015 | GIIKKIIKKIIKK{ct:Amid} | 2 | Amidation | Free | Linear | L | None | 13 | Antibacterial and Anticancer | 50 % Hemolysis at 500 µM | Human | Synthetic Amphiphiles | α-Helix | Low hemolytic | ||
| 26204061 | 2015 | IIKKIIKKIIKK{ct:Amid} | Rhodamine | Amidation | Free | Linear | L | None | 12 | Antibacterial and Anticancer | 50 % Hemolysis at >1000 µM | Human | Synthetic Amphiphiles | α-Helix | Low hemolytic | ||
| 26160494 | 2015 | KKYRYHLKPFSKK{nt:NH3+}{ct:Carboxyl (COO-)} | p-(Ser11)-BthTX-I(COO-) | Carboxyl (COO-) | NH3+ | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >128 µmol/L | Human | Analogues Bothropstoxin-I (Bthtx-I) | α-Helix | NA | ||
| 26160494 | 2015 | KKYRYHLKPFSKK{nt:NH3+}{ct:Amid} | [p-(Ser11)-BthTX-I(CONH2)] | Amidation | NH3+ | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >128 µmol/L | Human | Analogues Bothropstoxin-I (Bthtx-I) | α-Helix | NA | ||
| 26160494 | 2015 | KKYRYHLKPFCKK{nt:NH3+}{ct:Carboxyl (COO-)} | p-BthTX-I | Carboxyl (COO-) | NH3+ | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >128 µmol/L | Human | Bothropstoxin-I (Bthtx-I) | α-Helix | NA | ||
| 26235946 | 2015 | KAAKAAKKAAKAAWK{nt:Acet}{ct:Amid} | Ac-UM-14W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | <1 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKA{nnr:X}KKAAKAAWK{nt:Acet}{ct:Amid} | Ac-SS-14W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | <1 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKA{nnr:X}KK{nnr:X}AKA{nnr:X}WK{nt:Acet}{ct:Amid} | Ac-DS-14W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 38.8 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKA{nnr:X}KK{nnr:X}AKW{nnr:X}AK{nt:Acet}{ct:Amid} | Ac-DS-12W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 42.5 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Acet}{ct:Amid} | Ac-DS-3W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 42.5 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}WKA{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Acet}{ct:Amid} | Ac-DS-5W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 38.5 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Succinylated}{ct:Amid} | Su-DS-5W | Amidation | Succinylated | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 32.6 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:H}{ct:Amid} | H-DS-5W | Amidation | H | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 25.5 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | KAAKAAKKAAKAAWK{nt:Acet}{ct:Amid} | Ac-UM-14W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | <1 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKA{nnr:X}KKAAKAAWK{nt:Acet}{ct:Amid} | Ac-SS-14W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | <1 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKA{nnr:X}KK{nnr:X}AKA{nnr:X}WK{nt:Acet}{ct:Amid} | Ac-DS-14W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 22.1 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKA{nnr:X}KK{nnr:X}AKW{nnr:X}AK{nt:Acet}{ct:Amid} | Ac-DS-12W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 25.3 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Acet}{ct:Amid} | Ac-DS-3W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 28.9 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}WKA{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Acet}{ct:Amid} | Ac-DS-5W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 22 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Succinylated}{ct:Amid} | Su-DS-5W | Amidation | Succinylated | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 19.5 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:H}{ct:Amid} | H-DS-5W | Amidation | H | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 13.5 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26311041 | 2015 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 15.4 µM | Human | Amphibian Skin Temporins | α-Helix | NA | ||
| 26311041 | 2015 | FVQWWSKWLGRIL{ct:Amid} | TL-1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 21.4 µM | Human | Analog Of Tl | α-Helix | NA | ||
| 26311041 | 2015 | FVRWWSKWLRRIL{ct:Amid} | TL-2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 8.5 µM | Human | Analog Of Tl | α-Helix | NA | ||
| 26311041 | 2015 | FVRWWSRWLRRIL{ct:Amid} | TL-3 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 8 µM | Human | Analog Of Tl | α-Helix | NA | ||
| 26311041 | 2015 | FVKWWSKWLKKIL{ct:Amid} | TL-4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 15.9 µM | Human | Analog Of Tl | α-Helix | NA | ||
| 26291880 | 2015 | ILPWKWPWWPWRR{ct:Amid} | IL | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100 % Hemolysis | Human | Cpp | α-Helix | NA | ||
| 26291880 | 2015 | ILPWKWKWWPWRR{ct:Amid} | IL-K7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 42 % Hemolysis | Human | Indolicidin Modification | α-Helix | NA | ||
| 26291880 | 2015 | ILPWKWPFFPWRR{ct:Amid} | IL-F89 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 22 % Hemolysis | Human | Indolicidin Modification | α-Helix | NA | ||
| 26291880 | 2015 | ILPWRWRFFPWRR{ct:Amid} | IL-R57F89 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 13 % Hemolysis | Human | Indolicidin Modification | α-Helix | NA | ||
| 26291880 | 2015 | ILPWKWKFFPWRR{ct:Amid} | IL-K7F89 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis | Human | Indolicidin Modification | α-Helix | NA | ||
| 26291880 | 2015 | RRWKFFPWRR{ct:Amid} | SAP10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 1 % Hemolysis | Human | Synthetic | α-Helix | NA | ||
| 26408816 | 2015 | {nnr:O}F{nnr:O}RPVYIPRPRPPHPRL{nt:gu}{ct:OH} | Api723 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.66 ± 0.84 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}{nnr:O}FRPVYIPRPRPPHPRL{nt:gu}{ct:OH} | Api724 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.08 ± 0.60 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}{nnr:O}WRPVYIPRPRPPHPRL{nt:gu}{ct:OH} | Api732 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.99 ± 0.60 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}W{nnr:O}RPVYIPRPRPPHPRL{nt:gu}{ct:OH} | Api733 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.51 ± 0.36 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}F{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api753 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.28 ± 0.19 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}{nnr:O}FRPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api754 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.32 ± 0.38 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api755 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | -0.35 ± 0.89 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}{nnr:O}IRPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api756 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | -0.12 ± 0.30 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}Y{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api757 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.31 ± 0.50 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}{nnr:O}YRPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api758 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.08 ± 0.17 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}{nnr:O}WRPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api759 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.55 ± 0.16 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26408816 | 2015 | {nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu}{ct:OH} | Api760 | OH | gu | Linear | L | gu = N,N,N0,N-tetramethylguanidino, O = L-Ornithine | 18 | Antimicrobial | 0.54 ± 0.46 % Hemolysis at 0.6 g/L | Human | Api137 Analogs | α-Helix | Non-hemolytic | ||
| 26088720 | 2015 | (WKWK)PG(KWKW){ct:Amid} | WK2 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 5 % Hemolysis at 512 µM | Human | Tryptophan Zipper | β-Hairpin | NA | ||
| 26088720 | 2015 | (WKWKWK)PG(KWKWKW){ct:Amid} | WK3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 5 % Hemolysis at 512 µM | Human | Tryptophan Zipper | β-Hairpin | NA | ||
| 26088720 | 2015 | (WKWKWKWK)PG(KWKWKWKW){ct:Amid} | WK4 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 5 % Hemolysis at 8 µM | Human | Tryptophan Zipper | β-Hairpin | NA | ||
| 26352292 | 2015 | LPFFLLSLIPSAISAIKKI{ct:Amid} | VpAmp1.0 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 50 % Hemolysis at 9.2 ± 0.3 µM | Human | Scorpion Vaejovispunctatus | α-Helix | NA | ||
| 26352292 | 2015 | FFLLSLIPSAISAIKKI{ct:Amid} | VpAmp1.1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 33.7 ± 2.4 µM | Human | Scorpion Vaejovispunctatus | α-Helix | NA | ||
| 26530005 | 2015 | GKLWLKGGKLWLKG{ct:Amid} | GG2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | AKLWLKAAKLWLKA{ct:Amid} | AA2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 5 % Hemolysis at 128 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26489599 | 2015 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | 23 ± 1 % Hemolysis at 100 µM | Human | Derivative Of Indolicidin From Bovine Neutrophils | NA | NA | ||
| 26608073 | 2015 | KRFWQLVPLAIKIYRAWKRR | dCATH | Free | Free | Linear | L | None | 20 | Antimicrobial | 50 % Hemolysis at 20 µM | Human | Cathelicidin Ortholog From Ducks | α-Helix | NA | ||
| 26608073 | 2015 | KRFWQLVPLAIKIYRAWKRR | dCATH | Free | Free | Linear | L | None | 20 | Antimicrobial | 50 % Hemolysis at 32 µM | Human | Cathelicidin Ortholog From Ducks | α-Helix | NA | ||
| 26380930 | 2015 | PLLKKLLKKP{ct:Amid} | PP | Amidation | Free | Linear | L | None | 10 | Anti-mycobacterial | 50 % Hemolysis at >500 μg/ml | Rat | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 26380930 | 2015 | CLLKKLLKKC{ct:Amid} | CC | Amidation | Free | Linear | L | None | 10 | Anti-mycobacterial | 50 % Hemolysis at >500 μg/ml | Rat | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 26380930 | 2015 | ILLKKLLKKI{ct:Amid} | II | Amidation | Free | Linear | L | None | 10 | Anti-mycobacterial | 50 % Hemolysis at >500 μg/ml | Rat | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 26380930 | 2015 | MLLKKLLKKM{ct:Amid} | MM | Amidation | Free | Linear | L | None | 10 | Anti-mycobacterial | 50 % Hemolysis at >500 μg/ml | Rat | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 26380930 | 2015 | WLLKKLLKKW{ct:Amid} | WW | Amidation | Free | Linear | L | None | 10 | Anti-mycobacterial | 50 % Hemolysis at 363 μg/ml | Rat | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 26496638 | 2015 | YLEALEAESITTGV | PT14-4a | Free | Free | Linear | L | None | 14 | Antifungal | 0 % Hemolysis at 0-450 mg/L | Human | Bacteria Bacillus Amyloliquefaciens | α-Helix | Non-hemolytic | ||
| 26656394 | 2015 | KLRKLFRKLLKLIRKLLR | Cap11-1-18m2 | Free | Free | Linear | L | None | 18 | Antibacterial | 52 ± 6 % Hemolysis at 64 μg/ml | Horse | Truncated Derivative Of Cap11 | α-Helical | NA | ||
| 26656394 | 2015 | ILPWKWPWWPWR | Indolicidin | Free | Free | Linear | L | None | 12 | Antibacterial | 12 ± 0 % Hemolysis at 128 μg/ml | Horse | Mammalian, Bovine Neutrophils | Extended | NA | ||
| 26656394 | 2015 | RLARIVVIRVAR | Bac2A | Free | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Non-Amidated Version Of Bac2A-Nh2 | α-Helical/β-Sheet | Non-hemolytic | ||
| 26656394 | 2015 | RLARIVVIRVAR{ct:Amid} | Bac2A-NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Linear Variant Of Bactenecin From Bovine Neutrophils | NA | Non-hemolytic | ||
| 26656394 | 2015 | RRWKIVVIRWRR{ct:Amid} | Sub5-NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Synthetic Variant Of Bac2A-Nh2 | NA | Non-hemolytic | ||
| 26656394 | 2015 | GIHDILKYGKPS | Myxinidin | Free | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Fish, Epidermal Mucus Of Hagfish | NA | Non-hemolytic | ||
| 26656394 | 2015 | GIHDILKYGKPS{ct:Amid} | Myxinidin-NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Amidated Form Of Myxinidin | NA | Non-hemolytic | ||
| 26656394 | 2015 | VDKGSYLPRPTPPRPIYNRN | Pyrrhocoricin | Free | Free | Linear | L | None | 20 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Insects, Pyrrhocoris Apterus | NA | Non-hemolytic | ||
| 26656394 | 2015 | GNNRPVYIPQPRPPHPRI | Apidaecin IA | Free | Free | Linear | L | None | 18 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Insects, Honey Bee | Extended, proline rich | Non-hemolytic | ||
| 26656394 | 2015 | VDKPDYRPRPRPPNM | Metalnikowin I | Free | Free | Linear | L | None | 15 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Insects, Palomena Prasina | NA | Non-hemolytic | ||
| 26295533 | 2015 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 21 % Hemolysis at 0.25 mg/ml | Human | Bovine Cathelicidin | α-Helical | NA | ||
| 26295533 | 2015 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | ~10 % Hemolysis at 0.1 mg/ml | Human | Bovine Cathelicidin | α-Helical | NA | ||
| 26295533 | 2015 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 5 % Hemolysis at 0.05 mg/ml | Human | Bovine Cathelicidin | α-Helical | NA | ||
| 26295533 | 2015 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 6 % Hemolysis at 0.025 mg/ml | Human | Bovine Cathelicidin | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVVIRVAR{cyc:N-C}{ct:Amid} | Bac2A | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.25 mg/ml | Human | Bovine Host Defense Peptide Variant | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVVIRVAR{cyc:N-C}{ct:Amid} | Bac2A | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.1 mg/ml | Human | Bovine Host Defense Peptide Variant | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVVIRVAR{cyc:N-C}{ct:Amid} | Bac2A | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.05 mg/ml | Human | Bovine Host Defense Peptide Variant | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVVIRVAR{cyc:N-C}{ct:Amid} | Bac2A | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.025 mg/ml | Human | Bovine Host Defense Peptide Variant | α-Helical | NA | ||
| 26295533 | 2015 | RLRRIVVIRVAR{cyc:N-C}{ct:Amid} | R3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.25 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLRRIVVIRVAR{cyc:N-C}{ct:Amid} | R3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.1 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLRRIVVIRVAR{cyc:N-C}{ct:Amid} | R3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.05 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLRRIVVIRVAR{cyc:N-C}{ct:Amid} | R3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.025 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVPIRVAR{cyc:N-C}{ct:Amid} | P7 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.25 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVPIRVAR{cyc:N-C}{ct:Amid} | P7 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.1 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVPIRVAR{cyc:N-C}{ct:Amid} | P7 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.05 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVPIRVAR{cyc:N-C}{ct:Amid} | P7 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.025 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | VRWRIRVAVIRA{cyc:N-C}{ct:Amid} | W3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 10 % Hemolysis at 0.25 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | VRWRIRVAVIRA{cyc:N-C}{ct:Amid} | W3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 5 % Hemolysis at 0.1 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | VRWRIRVAVIRA{cyc:N-C}{ct:Amid} | W3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | >5 % Hemolysis at 0.05 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | VRWRIRVAVIRA{cyc:N-C}{ct:Amid} | W3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.025 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RRWRIVVIRVRR{cyc:N-C}{ct:Amid} | Sub3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <10 % Hemolysis at 0.25 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RRWRIVVIRVRR{cyc:N-C}{ct:Amid} | Sub3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 10 % Hemolysis at 0.1 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RRWRIVVIRVRR{cyc:N-C}{ct:Amid} | Sub3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 5 % Hemolysis at 0.05 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RRWRIVVIRVRR{cyc:N-C}{ct:Amid} | Sub3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.025 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA | PA | Free | Free | Linear | L | None | 15 | Hemolytic | 50 % Hemolysis at 0.77 mM | Human | Peptide Inhibitors Of Complement C1 (Pic1) | NA | NA | ||
| 26196285 | 2015 | RALILEPICCQERAA | PA-I1R | Free | Free | Linear | L | None | 15 | Hemolytic | 91.93 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IRLILEPICCQERAA | PA-A2R | Free | Free | Linear | L | None | 15 | Hemolytic | 87.28 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IARILEPICCQERAA | PA-L3R | Free | Free | Linear | L | None | 15 | Hemolytic | 80.45 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALRLEPICCQERAA | PA-I4R | Free | Free | Linear | L | None | 15 | Hemolytic | 43.71 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALIREPICCQERAA | PA-L5R | Free | Free | Linear | L | None | 15 | Hemolytic | 93.4 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILRPICCQERAA | PA-E6R | Free | Free | Linear | L | None | 15 | Hemolytic | 87.59 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILERICCQERAA | PA-P7R | Free | Free | Linear | L | None | 15 | Hemolytic | 89.85 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPRCCQERAA | PA-I8R | Free | Free | Linear | L | None | 15 | Hemolytic | 62.32 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPIRCQERAA | PA-C9R | Free | Free | Linear | L | None | 15 | Hemolytic | 89.54 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICRQERAA | PA-C10R | Free | Free | Linear | L | None | 15 | Hemolytic | 89.8 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCRERAA | PA-Q11R | Free | Free | Linear | L | None | 15 | Hemolytic | 90.87 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQRRAA | PA-E12R | Free | Free | Linear | L | None | 15 | Hemolytic | 95.83 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERRA | PA-A14R | Free | Free | Linear | L | None | 15 | Hemolytic | 88.65 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAR | PA-A15R | Free | Free | Linear | L | None | 15 | Hemolytic | 44.24 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | EALILEPICCQERAA | PA-I1E | Free | Free | Linear | L | None | 15 | Hemolytic | 89.27 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IELILEPICCQERAA | PA-A2E | Free | Free | Linear | L | None | 15 | Hemolytic | 92.24 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IAEILEPICCQERAA | PA-L3E | Free | Free | Linear | L | None | 15 | Hemolytic | 100.27 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALELEPICCQERAA | PA-I4E | Free | Free | Linear | L | None | 15 | Hemolytic | 92.07 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALIEEPICCQERAA | PA-L5E | Free | Free | Linear | L | None | 15 | Hemolytic | 94.33 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEEICCQERAA | PA-P7E | Free | Free | Linear | L | None | 15 | Hemolytic | 96.1 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPECCQERAA | PA-I8E | Free | Free | Linear | L | None | 15 | Hemolytic | 95.74 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPIECQERAA | PA-C9E | Free | Free | Linear | L | None | 15 | Hemolytic | 91.62 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICEQERAA | PA-C10E | Free | Free | Linear | L | None | 15 | Hemolytic | 95.21 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCEERAA | PA-Q11E | Free | Free | Linear | L | None | 15 | Hemolytic | 65.6 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQEEAA | PA-R13E | Free | Free | Linear | L | None | 15 | Hemolytic | 101.99 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQEREA | PA-A14E | Free | Free | Linear | L | None | 15 | Hemolytic | 98.09 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAE | PA-A15E | Free | Free | Linear | L | None | 15 | Hemolytic | 93.13 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG24} | PA-dPEG24 | dPEG24 | Free | Linear | L | None | 15 | Inhibits complement activation in vivo | 2.99 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG20} | PA-dPEG20 | dPEG20 | Free | Linear | L | None | 15 | Hemolytic | 11.41 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG16} | PA-dPEG16 | dPEG16 | Free | Linear | L | None | 15 | Hemolytic | 12.04 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG12} | PA-dPEG12 | dPEG12 | Free | Linear | L | None | 15 | Hemolytic | 11.41 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG08} | PA-dPEG08 | dPEG08 | Free | Linear | L | None | 15 | Hemolytic | 34.66 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG06} | PA-dPEG06 | dPEG06 | Free | Linear | L | None | 15 | Hemolytic | 44.82 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG04} | PA-dPEG04 | dPEG04 | Free | Linear | L | None | 15 | Hemolytic | 12.36 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG03} | PA-dPEG03 | dPEG03 | Free | Linear | L | None | 15 | Hemolytic | 12.57 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG02} | PA-dPEG02 | dPEG02 | Free | Linear | L | None | 15 | Hemolytic | 11.62 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 25982541 | 2015 | FIGAAARLASKIF{ct:Amid} | BmKn2A1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 0-100 μg/mL | Human | Analogs Of The Scorpion Venom Bmkn Peptides | α-Helical | Non-hemolytic | ||
| 25982541 | 2015 | FIGAVARLVSKIF{ct:Amid} | BmKn2V1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <100 % Hemolysis at 100 μg/mL | Human | Analogs Of The Scorpion Venom Bmkn Peptides | α-Helical | NA | ||
| 25982541 | 2015 | FIGALARLLSKIF{ct:Amid} | BmKn2L1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <100 % Hemolysis at 100 μg/mL | Human | Analogs Of The Scorpion Venom Bmkn Peptides | α-Helical | NA | ||
| 25982541 | 2015 | FIGAIAKLLKKIF{ct:Amid} | BmKn2K7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <100 % Hemolysis at 100 μg/mL | Human | Analogs Of The Scorpion Venom Bmkn Peptides | α-Helical | NA | ||
| 25982541 | 2015 | FIGAVKGLLSKIF{ct:Amid} | BmKn1-6Lys | Amidation | Free | Linear | L | None | 13 | Antibacterial | <60 % Hemolysis at 100 μg/mL | Human | Analogs Of The Scorpion Venom Bmkn Peptides | α-Helical | NA | ||
| 25982541 | 2015 | FKGALAGLLSKKF{ct:Amid} | BmKn1L2K2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 0-100 μg/mL | Human | Analogs Of The Scorpion Venom Bmkn Peptides | α-Helical | Non-hemolytic | ||
| 25934283 | 2015 | KLDLKLDLKLDL | KLD | Free | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 50 μg/mL | Human | Self-Assembling | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | KLDLKLDLKLDL | KLD | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.5 % Hemolysis at 100 μg/mL | Human | Self-Assembling | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | KLDLKLDLKLDL | KLD | Free | Free | Linear | L | None | 12 | Antimicrobial | <1 % Hemolysis at 200 μg/mL | Human | Self-Assembling | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | RKLDLKLDLKLDL | KLD-R | Free | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 50 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | RKLDLKLDLKLDL | KLD-R | Free | Free | Linear | L | None | 13 | Antimicrobial | 0.5 % Hemolysis at 100 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | RKLDLKLDLKLDL | KLD-R | Free | Free | Linear | L | None | 13 | Antimicrobial | 1.5 % Hemolysis at 200 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRKLDLKLDLKLDL | KLD-2R | Free | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 50 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | RRKLDLKLDLKLDL | KLD-2R | Free | Free | Linear | L | None | 14 | Antimicrobial | 1 % Hemolysis at 100 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRKLDLKLDLKLDL | KLD-2R | Free | Free | Linear | L | None | 14 | Antimicrobial | <2.5 % Hemolysis at 200 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRRKLDLKLDLKLDL | KLD-3R | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.5 % Hemolysis at 50 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | Non-hemolytic | ||
| 25934283 | 2015 | RRRKLDLKLDLKLDL | KLD-3R | Free | Free | Linear | L | None | 15 | Antimicrobial | <1.5 % Hemolysis at 100 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRRKLDLKLDLKLDL | KLD-3R | Free | Free | Linear | L | None | 15 | Antimicrobial | 2.5 % Hemolysis at 200 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRRRKLDLKLDLKLDL | KLD-4R | Free | Free | Linear | L | None | 16 | Antimicrobial | 1.5 % Hemolysis at 50 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRRRKLDLKLDLKLDL | KLD-4R | Free | Free | Linear | L | None | 16 | Antimicrobial | <3 % Hemolysis at 100 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25934283 | 2015 | RRRRKLDLKLDLKLDL | KLD-4R | Free | Free | Linear | L | None | 16 | Antimicrobial | 5 % Hemolysis at 200 μg/mL | Human | Kld-12 Designed Variant | β-Sheet | NA | ||
| 25451872 | 2015 | FIGAVAGLLSKIF{ct:Amid} | BmKn1OR | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAVAGLLSKIF{ct:Amid} | BmKn1OR | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAIARLLSKIF{ct:Amid} | BmKn2OR | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAIARLLSKIF{ct:Amid} | BmKn2OR | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAAAGLASKIF{ct:Amid} | BmKn1A1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAAAGLASKIF{ct:Amid} | BmKn1A1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAVAGLVSKIF{ct:Amid} | BmKn1V1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAVAGLVSKIF{ct:Amid} | BmKn1V1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGALAGLLSKIF{ct:Amid} | BmKn1L1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGALAGLLSKIF{ct:Amid} | BmKn1L1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAVAKLLKKIF{ct:Amid} | BmKn1K7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <100 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAVAKLLKKIF{ct:Amid} | BmKn1K7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <100 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAVAELLEKIF{ct:Amid} | BmKn1E7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | Non-hemolytic | ||
| 25451872 | 2015 | FIGAVAELLEKIF{ct:Amid} | BmKn1E7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | Non-hemolytic | ||
| 25640709 | 2015 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5N | Amidation | Free | Linear | L | None | 20 | Antibacterial | 20 % Hemolysis at 90 µM | Human | Synthetic Homologue Of Maximin H5 | α-Helical | NA | ||
| 25640709 | 2015 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5N | Amidation | Free | Linear | L | None | 20 | Antibacterial | <12 % Hemolysis at <25 µM | Human | Synthetic Homologue Of Maximin H6 | α-Helical | NA | ||
| 25640709 | 2015 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5N | Amidation | Free | Linear | L | None | 20 | Antibacterial | 15 % Hemolysis at >450 µM | Human | Synthetic Homologue Of Maximin H7 | α-Helical | NA | ||
| 25640709 | 2015 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5C | Amidation | Free | Linear | L | None | 20 | Antibacterial | 12 % Hemolysis at 180 µM | Human | Isoform Of Mh5N | α-Helical | NA | ||
| 25640709 | 2015 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5C | Amidation | Free | Linear | L | None | 20 | Antibacterial | <12 % Hemolysis at <25 µM | Human | Isoform Of Mh5N | α-Helical | NA | ||
| 25640709 | 2015 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5C | Amidation | Free | Linear | L | None | 20 | Antibacterial | 25 % Hemolysis at >450 µM | Human | Isoform Of Mh5N | α-Helical | NA | ||
| 26144972 | 2015 | VARGWKRKCPLFGKGG | VG16KRKP | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 0.12 % Hemolysis at 25 µM | Human | Analogue Of Vg16 | Loop-type | Non-hemolytic | ||
| 26144972 | 2015 | VARGWKRKCPLFGKGG | VG16KRKP | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | <0.12 % Hemolysis at 50 µM | Human | Analogue Of Vg16 | Loop-type | Non-hemolytic | ||
| 26144972 | 2015 | VARGWKRKCPLFGKGG | VG16KRKP | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 0.1 % Hemolysis at 100 µM | Human | Analogue Of Vg16 | Loop-type | Non-hemolytic | ||
| 26144972 | 2015 | VARGWKRKCPLFGKGG | VG16KRKP | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 0.09 % Hemolysis at 150 µM | Human | Analogue Of Vg16 | Loop-type | Non-hemolytic | ||
| 26144972 | 2015 | VARGWKRKCPLFGKGG | VG16KRKP | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | <0.12 % Hemolysis at 200 µM | Human | Analogue Of Vg16 | Loop-type | Non-hemolytic | ||
| 26144972 | 2015 | VARGWKRKCPLFGKGG | VG16KRKP | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 0.1 % Hemolysis at 250 µM | Human | Analogue Of Vg16 | Loop-type | Non-hemolytic | ||
| 25530580 | 2015 | GLLTRIKTLL{ct:Amid} | 4T | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLL{nnr:Hser}RIKTLL{ct:Amid} | 4Hser | Amidation | Free | Linear | L | HSer = homoserine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLSRIKTLL{ct:Amid} | 4S | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Solitary Spider Wasp, Anoplius Samariensis | α-Helical | NA | ||
| 25530580 | 2015 | GLL{nnr:O}RIKTLL{ct:Amid} | 4Orn | Amidation | Free | Linear | L | O = L-Ornithine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKRIKSLL{ct:Amid} | 8S | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLL{nnr:Dab}RIKTLL{ct:Amid} | 4Dab | Amidation | Free | Linear | L | Dab = 2,4-diaminobutanoic acid | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLL{nnr:Dap}RIKTLL{ct:Amid} | 4Dap | Amidation | Free | Linear | L | Dap = 2,3-diaminopropanoic acid | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKKIKKLL{ct:Amid} | 5K8K | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKRIKKLL{ct:Amid} | 8K | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLL{nnr:Dab}RIK{nnr:Dab}LL{ct:Amid} | 4,8Dab | Amidation | Free | Linear | L | Dab = 2,4-diaminobutanoic acid | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G({nnr:O-Me-Ser})({nnr:O-Me-Ser})KRIKT({nnr:O-Me-Ser})({nnr:O-Me-Ser}){ct:Amid} | 2,3,9,10(O-Me-Ser) | Amidation | Free | Linear | L | O-Me-Ser = O-methyl-serine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G({nnr:O-Me-Ser})LKRIKTL({nnr:O-Me-Ser}){ct:Amid} | 2,10(O-Me-Ser) | Amidation | Free | Linear | L | O-Me-Ser = O-methyl-serine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GVVKRIKTVV{ct:Amid} | 2,3,9,10V | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GMMKRIKTMM{ct:Amid} | 2,3,9,10M | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G({nnr:O-Me-Ser})LKRIKTLL{ct:Amid} | 2(O-Me-Ser) | Amidation | Free | Linear | L | O-Me-Ser = O-methyl-serine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GNV{d}A{d}NV{d}A{d}KRIKTNV{d}A{d}NV{d}A{d}{ct:Amid} | 2,3,9,10Nva | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GVLKRIKTLV{ct:Amid} | 2,10V | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLMKRIKTML{ct:Amid} | 3,9M | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GMLKRIKTLM{ct:Amid} | 2,10M | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Nva}LKRIKTL{nnr:Nva}{ct:Amid} | 2,10Nva | Amidation | Free | Linear | L | Nva = Norvaline | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GMLKRIKTLL{ct:Amid} | 2M | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 400 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Nle}LKRIKTL{nnr:Nle}{ct:Amid} | 2,10Nle | Amidation | Free | Linear | L | Nle = Norleucine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Nle}{nnr:Nle}KRIKT{nnr:Nle}{nnr:Nle}{ct:Amid} | 2,3,9,10Nle | Amidation | Free | Linear | L | Nle = Norleucine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Epa}LKRIKTL{nnr:Epa}{ct:Amid} | 2,10Epa | Amidation | Free | Linear | L | Epa = 2-amino,3-ethylpentanoic acid | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Hle}LKRIKTL{nnr:Hle}{ct:Amid} | 2,10Hle | Amidation | Free | Linear | L | Hle = homoleucine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Cha}LKRIKTLL{ct:Amid} | 2Cha | Amidation | Free | Linear | L | Cha = 3- cyclohexylalanine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKRIKTL{nnr:Cha}{ct:Amid} | 10Cha | Amidation | Free | Linear | L | Cha = 3- cyclohexylalanine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:βNal}KRIKTLL{ct:Amid} | 2(βNal) | Amidation | Free | Linear | L | βNal = 3(2-naphtyl)alanine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Hle}{nnr:Hle}KRIKT{nnr:Hle}{nnr:Hle}{ct:Amid} | 2,3,9,10Hle | Amidation | Free | Linear | L | Hle = homoleucine | 10 | Antibacterial | 50 % Hemolysis at 380 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Aoc}LKRIKTL{nnr:Aoc}{ct:Amid} | 2,10Aoc | Amidation | Free | Linear | L | Aoc = 2-aminooctanoic acid | 10 | Antibacterial | 50 % Hemolysis at 500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Cha}LKRIKT{nnr:Cha}L{ct:Amid} | 2,9Cha | Amidation | Free | Linear | L | Cha = 3- cyclohexylalanine | 10 | Antibacterial | 50 % Hemolysis at 350 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Cha}LKRIKTL{nnr:Cha}{ct:Amid} | 2,10Cha | Amidation | Free | Linear | L | Cha = 3- cyclohexylalanine | 10 | Antibacterial | 50 % Hemolysis at 300 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Aoc}{nnr:Aoc}KRIKT{nnr:Aoc}{nnr:Aoc}{ct:Amid} | 2,3,9,10Aoc | Amidation | Free | Linear | L | Aoc = 2-aminooctanoic acid | 10 | Antibacterial | 50 % Hemolysis at 125 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GALKR{nnr:βNal}KTLA{ct:Amid} | 2,10A6(βNal) | Amidation | Free | Linear | L | βNal = 3(2-naphtyl)alanine | 10 | Antibacterial | 50 % Hemolysis at 71 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Nva}{nnr:Nva}KR{nnr:βNal}KT{nnr:Nva}{nnr:Nva}{ct:Amid} | 2,3,9,10Nva6(βNal) | Amidation | Free | Linear | L | Nva = Norvaline, βNal = 3(2-naphtyl)alanine | 10 | Antibacterial | 50 % Hemolysis at 120 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Nva}LKR{nnr:βNal}KTL{nnr:Nva}{ct:Amid} | 2,10Nva6(βNal) | Amidation | Free | Linear | L | Nva = Norvaline, βNal = 3(2-naphtyl)alanine | 10 | Antibacterial | 50 % Hemolysis at 100 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GL{nnr:Nva}KR{nnr:βNal}KT{nnr:Nva}L{ct:Amid} | 3,9Nva6(βNal) | Amidation | Free | Linear | L | Nva = Norvaline, βNal = 3(2-naphtyl)alanine | 10 | Antibacterial | 50 % Hemolysis at 20 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKKIKWLL{ct:Amid} | 5K8W | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 130 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKKIKWLL{ct:Amid} | 5W | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 20 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKFIKWLL{ct:Amid} | 5F8W | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 2 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25664972 | 2015 | GLFDIVKKVVGALC{ct:Amid} | Aurein 2.2∆3-cys | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 15.6 μg/mL | Sheep | Aurein 2.2 Conjugates | α-Helical | NA | ||
| 25664972 | 2015 | GLFDIVKKVVGALC{ct:Amid} | Aurein 2.2∆3-cys | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 31.2 μg/mL | Sheep | Aurein 2.2 Conjugates | α-Helical | NA | ||
| 25664972 | 2015 | GLFDIVKKVVGALC{ct:Amid} | Aurein 2.2∆3-cys | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <10 % Hemolysis at 62.5 μg/mL | Sheep | Aurein 2.2 Conjugates | α-Helical | NA | ||
| 25664972 | 2015 | GLFDIVKKVVGALC{ct:Amid} | Aurein 2.2∆3-cys | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at 125 μg/mL | Sheep | Aurein 2.2 Conjugates | α-Helical | NA | ||
| 25664972 | 2015 | GLFDIVKKVVGALC{ct:Amid} | Aurein 2.2∆3-cys | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 15 % Hemolysis at 250 μg/mL | Sheep | Aurein 2.2 Conjugates | α-Helical | NA | ||
| 25728268 | 2015 | MLIFVHIIAPVISGC{ct:Amid} | Pep N-ter | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 300-900 µM | Human | Derived From Pepa1 | NA | NA | ||
| 25728268 | 2015 | AIAFFSYWLSRRNTK{ct:Amid} | Pep C-ter | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 420 µM | Human | Derived From Pepa2 | NA | NA | ||
| 25728268 | 2015 | FFSYWLSRRNTK{ct:Amid} | Pep1 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 50 % Hemolysis at 300-900 µM | Human | Derived From Pepa3 | NA | NA | ||
| 25728268 | 2015 | FFSYWLSRRTK{ct:Amid} | Pep2 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 50 % Hemolysis at 300-900 µM | Human | Derived From Pepa4 | NA | NA | ||
| 25728268 | 2015 | FFSWLSRRTK{ct:Amid} | Pep3 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 300-900 µM | Human | Derived From Pepa5 | NA | NA | ||
| 25683050 | 2015 | RWTWRGSGRWTWR{nt:Acet}{ct:Amid} | l-RW | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 8-500 μg/mL | Rabbit | Synthetic | NA | Non-hemolytic | ||
| 25581614 | 2015 | HLNKRVQRELIGWLDWLK | AmyI-1-18 | Free | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 20 % Hemolysis at 1000 µM | Sheep | Α-Amylase (Amyi-1) Of Rice (Oryza Sativa L. Japonica) | α-Helical | Non-hemolytic | ||
| 25773522 | 2015 | ILGKIWEGIKSLF{ct:Amid} | IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~86 % Hemolysis at 90 µM | Human | Scorpion, Opisthacanthus Madagascariensis | α-Helical | NA | ||
| 25773522 | 2015 | ILGKIWKGIKSLF{ct:Amid} | E7K-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 48 % Hemolysis at 90 µM | Human | Isct Designed Analogs | α-Helical | NA | ||
| 25773522 | 2015 | ILGKIWEGKKSLF{ct:Amid} | I9K-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0.4 % Hemolysis at 90 µM | Human | Isct Designed Analogs | α-Helical | Non-hemolytic | ||
| 25773522 | 2015 | ILGKIWKGKKSLF{ct:Amid} | E7K,I9K-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0.14 % Hemolysis at 90 µM | Human | Isct Designed Analogs | α-Helical | Non-hemolytic | ||
| 25773522 | 2015 | ILGKIWEGIKSLF{ct:Amid} | IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 43.59 µM | Human | Scorpion, Opisthacanthus Madagascariensis | α-Helical | NA | ||
| 25773522 | 2015 | ILGKIWKGIKSLF{ct:Amid} | E7K-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 92.17 µM | Human | Isct Designed Analogs | α-Helical | NA | ||
| 25773522 | 2015 | ILGKIWEGKKSLF{ct:Amid} | I9K-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 500 µM | Human | Isct Designed Analogs | α-Helical | Non-hemolytic | ||
| 25773522 | 2015 | ILGKIWKGKKSLF{ct:Amid} | E7K,I9K-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 500 µM | Human | Isct Designed Analogs | α-Helical | Non-hemolytic | ||
| 25583073 | 2015 | VDIHVWDGVVDIHVWDGV | PIP-18[59–76] | Free | Free | Linear | L | None | 18 | Antibacterial, Wound healing activity | <20 % Hemolysis at 100 μg/mL | Human | Python Reticulatus Serum Protein | α-Helical | Low hemolytic | ||
| 25583073 | 2015 | LGRVDIHVWDGVYIRGR | [D-Ala66]-PNT.II | Free | Free | Linear | L | None | 17 | Antibacterial | <30 % Hemolysis at 100 μg/mL | Human | Python Reticulatus Serum Protein | α-Helical | NA | ||
| 25583073 | 2015 | CVDIHVWDGVC{cyc:N-C} | Cyclic C-PIP[57-67]C | Free | Free | Cyclic | L | None | 11 | Antibacterial | 30 % Hemolysis at 100 μg/mL | Human | Python Reticulatus Serum Protein | β or Helical | NA | ||
| 25462264 | 2015 | VKRFKKFFRKLKKSV{ct:Amid} | B1 | Amidation | Free | Linear | L | None | 15 | Anticancer, Anti-migratory | 5 % Hemolysis at 160 µM | Rabbit | Derivative Of Cathelicidin-Bf15 (Bf-15) | α-Helical | Low hemolytic | ||
| 25462264 | 2015 | VKRFKKFFRKLKKAV{ct:Amid} | B1-Ala | Amidation | Free | Linear | L | None | 15 | Anticancer, Anti-migratory | 5 % Hemolysis at 160 µM | Rabbit | B1 Analog | α-Helical | Low hemolytic | ||
| 25462264 | 2015 | VKRFKKFFRKLKKVV{ct:Amid} | B1-Val | Amidation | Free | Linear | L | None | 15 | Anticancer, Anti-migratory | 5 % Hemolysis at 160 µM | Rabbit | B1 Analog | α-Helical | Low hemolytic | ||
| 25462264 | 2015 | VKRFKKFFRKLKKLV{ct:Amid} | B1-Leu | Amidation | Free | Linear | L | None | 15 | Anticancer, Anti-migratory | 5 % Hemolysis at 160 µM | Rabbit | B1 Analog | α-Helical | Low hemolytic | ||
| 25462264 | 2015 | VKRFKKFFRKLKKFV{ct:Amid} | B1-Phe | Amidation | Free | Linear | L | None | 15 | Anticancer, Anti-migratory | 5 % Hemolysis at 160 µM | Rabbit | B1 Analog | α-Helical | Low hemolytic | ||
| 25462264 | 2015 | VKRFKKFFRKLKKGV{ct:Amid} | B1-Gly | Amidation | Free | Linear | L | None | 15 | Anticancer, Anti-migratory | 5 % Hemolysis at 160 µM | Rabbit | B1 Analog | α-Helical | Low hemolytic | ||
| 25462264 | 2015 | VKRFKKFFRKLKKQV{ct:Amid} | B1-Gln | Amidation | Free | Linear | L | None | 15 | Anticancer, Anti-migratory | 5 % Hemolysis at 160 µM | Rabbit | B1 Analog | α-Helical | Low hemolytic | ||
| 25462264 | 2015 | VKRFKKFFRKLKKTV{ct:Amid} | B1-Thr | Amidation | Free | Linear | L | None | 15 | Anticancer, Anti-migratory | 5 % Hemolysis at 160 µM | Rabbit | B1 Analog | α-Helical | Low hemolytic | ||
| 25462264 | 2015 | VKRFKKFFRKLKKKV{ct:Amid} | B1-Lys | Amidation | Free | Linear | L | None | 15 | Anticancer, Anti-migratory | 5 % Hemolysis at 160 µM | Rabbit | B1 Analog | α-Helical | Low hemolytic | ||
| 25462264 | 2015 | VKRFKKFFRKLKKRV{ct:Amid} | B1-Arg | Amidation | Free | Linear | L | None | 15 | Anticancer, Anti-migratory | 5 % Hemolysis at 160 µM | Rabbit | B1 Analog | α-Helical | Low hemolytic | ||
| 25462264 | 2015 | VKRFKKFFRKLKKHV{ct:Amid} | B1-His | Amidation | Free | Linear | L | None | 15 | Anticancer, Anti-migratory | <10 % Hemolysis at 160 µM | Rabbit | B1 Analog | α-Helical | Low hemolytic | ||
| 25462264 | 2015 | VKRFKKFFRKLKKDV{ct:Amid} | B1-Asp | Amidation | Free | Linear | L | None | 15 | Anticancer, Anti-migratory | 5 % Hemolysis at 160 µM | Rabbit | B1 Analog | α-Helical | Low hemolytic | ||
| 25462264 | 2015 | VKRFKKFFRKLKKEV{ct:Amid} | B1-Glu | Amidation | Free | Linear | L | None | 15 | Anticancer, Anti-migratory | 5 % Hemolysis at 160 µM | Rabbit | B1 Analog | α-Helical | Low hemolytic | ||
| 25425644 | 2015 | {nnr:T1}-VGLALIVAGVV-{nnr:T2} | TM4(89–99) | Free | Free | Linear | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH4 | 11 | Antimicrobial | 10 % Hemolysis at >200 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVGLALIVAGVVV-{nnr:T2} | TM4(88–100) | Free | Free | Linear | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH5 | 13 | Antimicrobial | 10 % Hemolysis at >200 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVGLALINAGVVV-{nnr:T2} | TM4(88–100)-N95 | Free | Free | Linear | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH6 | 13 | Antimicrobial | 10 % Hemolysis at >200 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVLVGIAGVALVV- {nnr:T2} | TM4(88–100)scr | Free | Free | Stapled | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH7 | 13 | Antimicrobial | Not specified | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVGL{nnr:X}LIV{nnr:X}GVVV-{nnr:T2} | S-TM4(88–100) | Free | Free | Stapled | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH8 | 13 | Antimicrobial | 10 % Hemolysis at 12.5 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVGL{nnr:X}LIG{nnr:X}GVVV-{nnr:T2} | S-TM4(88–100)-G95 | Free | Free | Stapled | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH9 | 13 | Antimicrobial | 10 % Hemolysis at 25 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVGL{nnr:X}LIN{nnr:X}GVVV-{nnr:T2} | S-TM4(88–100)-N95 | Free | Free | Stapled | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH10 | 13 | Antimicrobial | 10 % Hemolysis at >200 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-V{nnr:X'}GLALIN{nnr:X}GVVV-{nnr:T2} | S1-TM4(88–100)-N95 | Free | Free | Stapled | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH11 | 13 | Antimicrobial | 10 % Hemolysis at 100 µM | Human | Synthetic | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VVGL{nnr:X'}LINAGV{nnr:X}V-{nnr:T2} | S2-TM4(88–100)-N95 | Free | Free | Stapled | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH12 | 13 | Antimicrobial | 10 % Hemolysis at 100 µM | Human | Synthetic | α-Helical | NA | ||
| 26407061 | 2016 | {nnr:C4}-VARGWKRKCPLFGKGG | C4VG16KRKP | Free | Free | Linear | L | C4 = 4-carbon long acylated analog | 18 | Antimicrobial | <0.25 % Hemolysis at 1 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | {nnr:C4}-VARGWKRKCPLFGKGG | C4VG16KRKP | Free | Free | Linear | L | C4 = 4-carbon long acylated analog | 18 | Antimicrobial | <0.35 % Hemolysis at 5 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | {nnr:C4}-VARGWKRKCPLFGKGG | C4VG16KRKP | Free | Free | Linear | L | C4 = 4-carbon long acylated analog | 18 | Antimicrobial | <0.35 % Hemolysis at 10 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | {nnr:C4}-VARGWKRKCPLFGKGG | C4VG16KRKP | Free | Free | Linear | L | C4 = 4-carbon long acylated analog | 18 | Antimicrobial | <0.35 % Hemolysis at 25 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | {nnr:C4}-VARGWKRKCPLFGKGG | C4VG16KRKP | Free | Free | Linear | L | C4 = 4-carbon long acylated analog | 18 | Antimicrobial | <0.35 % Hemolysis at 50 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26407061 | 2016 | {nnr:C4}-VARGWKRKCPLFGKGG | C4VG16KRKP | Free | Free | Linear | L | C4 = 4-carbon long acylated analog | 18 | Antimicrobial | <0.45 % Hemolysis at 100 µM | Human | N-Terminal Lipidated Analogue | Turn/Loop | Non-hemolytic | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.69 % Hemolysis at 0.11 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.78 % Hemolysis at 0.22 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.8 % Hemolysis at 0.44 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.94 % Hemolysis at 0.88 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 2.06 % Hemolysis at 1.75 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 2.1 % Hemolysis at 3.5 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 2.15 % Hemolysis at 7 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 2.37 % Hemolysis at 14.01 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 2.77 % Hemolysis at 28.01 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26549174 | 2016 | FLGMLLHGVGHAIHGLI | Of-Pis1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 3.22 % Hemolysis at 56.02 µM | Human | Rock Bream (Oplegnathus Fasciatus) | α-Helical | NA | ||
| 26574005 | 2016 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 33 % Hemolysis at 150 µM | Human | Cecropin-Α-Melittin 29 Hybrid | NA | NA | ||
| 26574005 | 2016 | RRLFRRILRWL{ct:Amid} | RW-BP100 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLF{d}KKILKYL{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLFKK{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP157 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | 8 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | RKLFKRILKYL{ct:Amid} | BP201 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 45 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KRLFRKILKYL{ct:Amid} | BP202 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 44 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLFKKILRYL{ct:Amid} | BP203 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 31 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KRLFRKILRYL{ct:Amid} | BP204 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 69 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLFRRILKYL{ct:Amid} | BP205 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 63 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | RRLFKKILKYL{ct:Amid} | BP206 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 68 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLFKKI{d}LKYL{ct:Amid} | BP207 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | Not determined | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP208 | Amidation | Free | Linear | L | X = F (NPhe) | 18 | Antimicrobial | Not determined | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLFK{nnr:B}{nnr:Z}{nnr:Z}{nnr:B}{nnr:X}{nnr:Z}{ct:Amid} | BP209 | Amidation | Free | Linear | L | X = F (NPhe), Z = L (NLeu), B= K(NLys) | 18 | Antimicrobial | Not determined | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | RRL({nnr:2Nal})RRILRYL{ct:Amid} | BP210 | Amidation | Free | Linear | L | 2Nal = 2-Nal | 18 | Antimicrobial | 100 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLF{d}KKILRYL{ct:Amid} | BP211 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | 43 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKL({nnr:D2-nal})KKILKYL{ct:Amid} | BP212 | Amidation | Free | Linear | Mix | D2-nal = D-2-nal | 18 | Antimicrobial | 85 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | KKLFKK{d}I{d}L{d}R{d}Y{d}L{d}{ct:Amid} | BP213 | Amidation | Free | Linear | Mix | None | 18 | Antimicrobial | <8 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26574005 | 2016 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{ct:Amid} | BP214 | Amidation | Free | Linear | D | None | 18 | Antimicrobial | 42 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26680221 | 2016 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Antifungal | <20% % Hemolysis at 30 µM | Human | Polybia Paulista | α-Helix | NA | ||
| 26680221 | 2016 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Antifungal | <10 % Hemolysis at <20 µM | Human | Polybia Paulista | α-Helix | NA | ||
| 26680221 | 2016 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Antifungal | 30 % Hemolysis at <30 µM | Human | Polybia Paulista | α-Helix | NA | ||
| 26680221 | 2016 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Antifungal | 60 % Hemolysis at 70 µM | Human | Polybia Paulista | α-Helix | NA | ||
| 26680221 | 2016 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Antifungal | 60 % Hemolysis at 130 µM | Human | Polybia Paulista | α-Helix | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | W362 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 5 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | 3W62 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 5 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-W362 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 5 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-3W62 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 5 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | W362 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 10 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | 3W62 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 10 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-W362 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 10 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-3W62 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 10 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | W362 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 20 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | 3W62 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | <10 % Hemolysis at 20 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-W362 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 20 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-3W62 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 20 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | W362 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | 20 % Hemolysis at 40 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:acetic acid}{ct:Amid} | 3W62 | Amidation | acetic acid | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 40 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | WKKKQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-W362 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 40 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 27774141 | 2016 | KKKWQLQLQLQLQLQLKK{nt:PEG750}{ct:Amid} | P-3W62 | Amidation | PEG750 | Linear | L | None | 18 | Antimicrobial | <5 % Hemolysis at 40 µM | Human | Self-Assembling Antimicrobial Nanofiber (Saan) | β-Sheets | NA | ||
| 26385363 | 2016 | AAKAAAKAAAKAA{ct:Amid} | KL0A10 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at >256 µM | Human | Mirror-Like Peptides | α-Helix | NA | ||
| 26385363 | 2016 | LLKAAAKAAAKLL{ct:Amid} | KL4A6 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at >256 µM | Human | Mirror-Like Peptides | α-Helix | NA | ||
| 26385363 | 2016 | AAKLLLKLLLKAA{ct:Amid} | KL6A4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at 8 µM | Human | Mirror-Like Peptides | α-Helix | NA | ||
| 26385363 | 2016 | LLKLLLKLLLKLL{ct:Amid} | KL10A0 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at 2 µM | Human | Mirror-Like Peptides | α-Helix | NA | ||
| 26814379 | 2016 | RWCVYARVRGVRYRRCW | ALP1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 68 µM | Human | Arenicin-Like Peptides | β-Hairpin | NA | ||
| 26814379 | 2016 | RWCVYACVRGVCYRRCW | ALP2 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 10 µM | Human | Arenicin-Like Peptides | β-Hairpin | NA | ||
| 26814379 | 2016 | RWCVRARVRGVRYRRCW | ALP3 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 88 µM | Human | Arenicin-Like Peptides | β-Hairpin | NA | ||
| 26814379 | 2016 | RWCVYARRRGVRYRRCW | ALP4 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 73 µM | Human | Arenicin-Like Peptides | β-Hairpin | NA | ||
| 26814379 | 2016 | RWCVYARVRGRRYRRCW | ALP5 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 50 µM | Human | Arenicin-Like Peptides | β-Hairpin | NA | ||
| 26814379 | 2016 | RWCVYARVRGVRYRRCR | ALP6 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 110 µM | Human | Arenicin-Like Peptides | β-Hairpin | NA | ||
| 26918792 | 2016 | AKRHHGYKRKFH{ct:Amid} | P113 | Amidation | Free | Linear | L | None | 12 | Antifungal | 0 % Hemolysis at 128 μg/ml | Rabbit | Hybrid Peptide | α-Helix | Non-hemolytic | ||
| 26918792 | 2016 | WLNALLHHGLNCAKGVLA{ct:Amid} | halocidin (di-18Hc) | Amidation | Free | Linear | L | None | 18 | Antifungal | 75 % Hemolysis at 128 μg/ml | Rabbit | Halocynthia Aurantium | α-Helix | NA | ||
| 26918792 | 2016 | WLNALLHHGYKRKFH{ct:Amid} | HHP1 | Amidation | Free | Linear | L | None | 15 | Antifungal | 0 % Hemolysis at 128 μg/ml | Rabbit | Hybrid Peptide | α-Helix | Non-hemolytic | ||
| 26918792 | 2016 | AKRHHGLNCAKFH{ct:Amid} | di-pH2 | Amidation | Free | Linear | L | None | 13 | Antifungal | 0 % Hemolysis at 128 μg/ml | Rabbit | Hybrid Peptide | α-Helix | Non-hemolytic | ||
| 26918792 | 2016 | WLNAKRHHGYKCKFH{ct:Amid} | di-WP2 | Amidation | Free | Linear | L | None | 15 | Antifungal | 0 % Hemolysis at 128 μg/ml | Rabbit | Hybrid Peptide | α-Helix | Non-hemolytic | ||
| 26850838 | 2016 | HLNKRVQRELIGWLDWLK | AmyI-1-18 | Free | Free | Linear | L | None | 18 | Antifungal | 0.1 % Hemolysis at 100 µM | Sheep | Α-Amylase Of Rice (Oryza Sativa L. Japonica) | α-Helix | Low hemolytic | ||
| 26850838 | 2016 | HLNARVQRELIGWLDWLK | Amyl-1-18 (K4A) | Free | Free | Linear | L | None | 18 | Antifungal | Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 26850838 | 2016 | HLNKAVQRELIGWLDWLK | Amyl-1-18 (R5A) | Free | Free | Linear | L | None | 18 | Antifungal | Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 26850838 | 2016 | HLNKRVQAELIGWLDWLK | AmyI-1-18 (R8A) | Free | Free | Linear | L | None | 18 | Antifungal | Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 26850838 | 2016 | HLNKRVQRELIGWLDWLA | AmyI-1-18 (K18A) | Free | Free | Linear | L | None | 18 | Antifungal | Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 26850838 | 2016 | HLLKRVQRELIGWLDWLK | AmyI-1-18 (N3L) | Free | Free | Linear | L | None | 18 | Antifungal | 10 % Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 26850838 | 2016 | HLNKRVQRLLIGWLDWLK | AmyI-1-18 (E9L) | Free | Free | Linear | L | None | 18 | Antifungal | 7 % Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 26850838 | 2016 | HLNKRVQRELRGWLDWLK | AmyI-1-18 (I11R) | Free | Free | Linear | L | None | 18 | Antifungal | 2 % Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | Low hemolytic | ||
| 26850838 | 2016 | HLNKRVQRELIRWLDWLK | AmyI-1-18 (G12R) | Free | Free | Linear | L | None | 18 | Antifungal | 5 % Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 26850838 | 2016 | HLNKRVQRELIGWLRWLK | AmyI-1-18 (D15R) | Free | Free | Linear | L | None | 18 | Antifungal | 4 % Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 26850838 | 2016 | HLLKRVQRELIGWLRWLK | AmyI-1-18 (N3L, D15R) | Free | Free | Linear | L | None | 18 | Antifungal | 23 % Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 26850838 | 2016 | HLNKRVQRLLIRWLRWLK | AmyI-1-18 (G12R, D15R) | Free | Free | Linear | L | None | 18 | Antifungal | 14 % Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27014065 | 2016 | SKKPVPIIYCNRRSGKCQRM | TS | Free | Free | Linear | L | None | 20 | Antimicrobial | <15 % Hemolysis at 1 mmol/L | Human | Tumor-Specific Cell-Surface | β-Sheet | NA | ||
| 27014065 | 2016 | CIRTPKISKPIKFELSG | P1c | Free | Free | Linear | L | None | 17 | Antimicrobial | <15 % Hemolysis at 1 mmol/L | Human | Human Connective Tissue | Random coil | NA | ||
| 26881456 | 2016 | VKRFKKFFRKLKKSV{ct:Amid} | cathelicidin-BF15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at >320 μg/ml | Human | Bungarus Fasciatus | α-Helix | NA | ||
| 26881456 | 2016 | VKRFKKFFRKFKKSV{ct:Amid} | FS-15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKRWKKWWRKLKKSV{ct:Amid} | WS-15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKRWKKFWRKWKKWW{ct:Amid} | ZY8 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 51.7 ± 5.3 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKRWKKWRWKWKKWV{ct:Amid} | ZY13 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKWRWKKWRWKWKWKV{ct:Amid} | ZY15 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 178.3 ± 11.5 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKWRWKWKWRWKWKWKV{ct:Amid} | ZY16 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 62.8 ± 5.8 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKRFKKFFRKLKKSV{ct:Amid} | cathelicidin-BF15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Bungarus Fasciatus | α-Helix | NA | ||
| 26881456 | 2016 | VKRFKKFFRKFKKSV{ct:Amid} | FS-15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKRWKKWWRKLKKSV{ct:Amid} | WS-15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKRWKKFWRKWKKWW{ct:Amid} | ZY8 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKRWKKWRWKWKKWV{ct:Amid} | ZY13 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKWRWKKWRWKWKWKV{ct:Amid} | ZY15 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26881456 | 2016 | VKWRWKWKWRWKWKWKV{ct:Amid} | ZY16 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Designed Peptides | α-Helix | NA | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:iPr})({nnr:Boc}){ct:OH} | gA3K(iPr) | OH | Free | Linear | Mix | K{d} = D-lysine, fmoc = 9-fluorenylmethoxycarbonyl, iPr = Isopropyl group, Boc = ε-amino group of the lysine side chain | 15 | Antibacterial | 0 % Hemolysis at 10 µM | Human | Bacillus Brevis | β-Helix | Non-hemolytic | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:Cy})({nnr:Boc}){ct:OH} | gA3K(Cy) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, Cy = Cyclohexyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | 55 % Hemolysis at 20 µM | Human | Bacillus Brevis | β-Helix | NA | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:CyMe})({nnr:Boc}){ct:OH} | gA3K(CyMe) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, CyMe = Cyclohexylmethyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | <90 % Hemolysis at 10 µM | Human | Bacillus Brevis | β-Helix | NA | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:Bn})({nnr:Boc}){ct:OH} | gA3K(Bn) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, Bn = Benzyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | <90 % Hemolysis at 10 µM | Human | Bacillus Brevis | β-Helix | NA | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:2pyr})({nnr:Boc}){ct:OH} | gA3K(2pyr) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, 2pyr = 2-Pyridyl group, Boc = ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | 0 % Hemolysis at 10 µM | Human | Bacillus Brevis | β-Helix | Non-hemolytic | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:3pyr})({nnr:Boc}){ct:OH} | gA3K(3pyr) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, 3pyr = 3-Pyridyl group, Boc = ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | 0 % Hemolysis at 10 µM | Human | Bacillus Brevis | β-Helix | Non-hemolytic | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:4pyr})({nnr:Boc}){ct:OH} | gA3K(4pyr) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, 4pyr = 4-Pyridyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | 0 % Hemolysis at 10 µM | Human | Bacillus Brevis | β-Helix | Non-hemolytic | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:4AMBn})({nnr:Boc}){ct:OH} | gA3K(4AMBn) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, 4AMBn = 4-Aminomethylbenzyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | <25 % Hemolysis at 75 µM | Human | Bacillus Brevis | β-Helix | NA | ||
| 26876358 | 2016 | GEGFLGMLLHGVGHAIHGLIHGK | Rbpisc | Free | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at <63 µM | Fish | Oplegnathus Fasciatus | Helix-Loop-Helix | NA | ||
| 26876358 | 2016 | GEGFLGMLLHGVGHAIHGLIHGK | Rbpisc | Free | Free | Linear | L | None | 15 | Antibacterial | 13 % Hemolysis at 125 µM | Fish | Oplegnathus Fasciatus | Helix-Loop-Helix | NA | ||
| 26876358 | 2016 | GEGFLGMLLHGVGHAIHGLIHGK | Rbpisc | Free | Free | Linear | L | None | 15 | Antibacterial | 28.9 % Hemolysis at 250 µM | Fish | Oplegnathus Fasciatus | Helix-Loop-Helix | NA | ||
| 26876358 | 2016 | GEGFLGMLLHGVGHAIHGLIHGK | Rbpisc | Free | Free | Linear | L | None | 15 | Antibacterial | 70.13 % Hemolysis at 500 µM | Fish | Oplegnathus Fasciatus | Helix-Loop-Helix | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 2.3 % Hemolysis at 25 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 5.6 % Hemolysis at 50 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 18.7 % Hemolysis at 100 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 29.5 % Hemolysis at 200 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 3.1 % Hemolysis at 25 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 7.3 % Hemolysis at 50 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 20.5 % Hemolysis at 100 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 32.9 % Hemolysis at 200 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 26998557 | 2016 | GIMSSLMKKLAAHIAK{ct:Amid} | HYL | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Hylaeus Signatus | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLKAHIAK{ct:Amid} | HYL-1 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLAKHIAK{ct:Amid} | HYL-2 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLAAHIKK{ct:Amid} | HYL-3 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLKKHIAK{ct:Amid} | HYL-4 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMISLMKKLAAHIAK{ct:Amid} | HYL-5 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 320 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLAAIIAK{ct:Amid} | HYL-6 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 93 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLAKIIAK{ct:Amid} | HYL-7 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLKKIIAK{ct:Amid} | HYL-8 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | G{d}I{d}M{d}S{d}S{d}L{d}M{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid} | HYL-9 | Amidation | Free | Linear | D | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLAKIIKK{ct:Amid} | HYL-10 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLKKIIKK{ct:Amid} | HYL-11 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 284 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSLLKKLKKIIAK{ct:Amid} | HYL-12 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 333 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | G{d}I{d}L{d}S{d}S{d}L{d}L{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid} | HYL-13 | Amidation | Free | Linear | D | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 373 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GI{nnr:X}SSL{nnr:X}KKLKKIIAK{ct:Amid} | HYL-14 | Amidation | Free | Linear | L | X = norleucine | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILKSLLKKLKKIIAK{ct:Amid} | HYL-15 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSKLLKKLKKIIAK{ct:Amid} | HYL-16 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 364 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | KILSSLLKKLKKIIAK{ct:Amid} | HYL-17 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 165 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIWSSLLKKLKKIIAK{ct:Amid} | HYL-18 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSWLKKLKKIIAK{ct:Amid} | HYL-19 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 197 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSLWKKLKKIIAK{ct:Amid} | HYL-20 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 191 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | G{d}I{d}L{d}S{d}S{d}L{d}W{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid} | HYL-21 | Amidation | Free | Linear | D | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GKLSSLWKKLKKIIAK{ct:Amid} | HYL-22 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSLLKKWKKIIAK{ct:Amid} | HYL-23 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 115 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSLLKKLKKWIAK{ct:Amid} | HYL-24 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 57 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSLWKKLKKWIAK{ct:Amid} | HYL-25 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSLWKKPKKIIAK{ct:Amid} | HYL-26 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 7 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 15 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 29 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 59 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 118 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 235 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 470 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <30 % Hemolysis at 940 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <50 % Hemolysis at 1880 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 26795535 | 2016 | RGLRRLGRKIAHGVKKYG{ct:Amid} | SMAP-18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at <512 µM | Human | Derived From Smap-29 | α-Helix | NA | ||
| 26795535 | 2016 | R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}I{d}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}{ct:Amid} | SMAP-18-E1 | Amidation | Free | Linear | D | i = D-Isoleucine | 18 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at <512 µM | Human | Smap-18 D-Enantiomeric Peptides | α-Helix | NA | ||
| 26795535 | 2016 | R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}{nnr:i}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}{ct:Amid} | SMAP-18-E2 | Amidation | Free | Linear | D | i = d-allo-isoleucine | 18 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at <512 µM | Human | Smap-18 D-Enantiomeric Peptides | α-Helix | NA | ||
| 26837216 | 2016 | RRRQKRIVVRRRLIR | P3 | Free | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Cell-Penetrating Peptides | α-Helix | Non-hemolytic | ||
| 26837216 | 2016 | RRWRRWNRFNRRRCR | P8 | Free | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Cell-Penetrating Peptides | α-Helix | Non-hemolytic | ||
| 26849911 | 2016 | RRLIWLILRLLR{ct:Amid} | RR12Wpolar | Amidation | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 5 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIWLILRLLR{ct:Amid} | RR12Wpolar | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 10 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIRLILRLLR{ct:Amid} | RR12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 25 µM | mouse | Synthetic | α-Helix | NA | ||
| 26849911 | 2016 | RRLIWLILRLLR{ct:Amid} | RR12Wpolar | Amidation | Free | Linear | L | None | 12 | Antibacterial | <40 % Hemolysis at 25 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIRLWLRLLR{ct:Amid} | RR12Whydro | Amidation | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 25 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIRLILRLLR{ct:Amid} | RR12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 50 µM | mouse | Synthetic | α-Helix | NA | ||
| 26849911 | 2016 | RRLIWLILRLLR{ct:Amid} | RR12Wpolar | Amidation | Free | Linear | L | None | 12 | Antibacterial | <60 % Hemolysis at 50 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIRLWLRLLR{ct:Amid} | RR12Whydro | Amidation | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 50 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIRLILRLLR{ct:Amid} | RR12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | <40 % Hemolysis at 100 µM | mouse | Synthetic | α-Helix | NA | ||
| 26849911 | 2016 | RRLIWLILRLLR{ct:Amid} | RR12Wpolar | Amidation | Free | Linear | L | None | 12 | Antibacterial | <80 % Hemolysis at 100 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIRLWLRLLR{ct:Amid} | RR12Whydro | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 100 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26896660 | 2016 | RIVQRIKKWLLKWKKLGY{ct:Amid} | peptide 5 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 8 ± 2 % Hemolysis at 55 µM | Human | Cationic Amps | α-Helix | NA | ||
| 26896660 | 2016 | RIVQRILKWLKKWYKLGK{ct:Amid} | peptide 8 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 85 ± 12 % Hemolysis at 55 µM | Human | Cationic Amps | α-Helix | NA | ||
| 26896660 | 2016 | RIVQRIAKWAKKWYKAGK{ct:Amid} | peptide 8.1 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 5 ± 1 % Hemolysis at 55 µM | Human | Cationic Amps | α-Helix | NA | ||
| 26902768 | 2016 | KRFWPLVPVAINTVA{ct:Amid} | Fow-3(1-15) | Amidation | Free | Linear | L | None | 15 | Antibacterial | <5 % Hemolysis at 256 µM | Human | Truncated Peptides Of Fowlicidin-3 | α-Helix | NA | ||
| 26902768 | 2016 | KRFWPLVPVAINTVAA{ct:Amid} | Fow-3(1-19) | Amidation | Free | Linear | L | None | 19 | Antibacterial | 38.9 % Hemolysis at 256 µM | Human | Truncated Peptides Of Fowlicidin-3 | α-Helix | NA | ||
| 27243004 | 2016 | {nnr:O}W{nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api793 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 20 | Antibacterial Gram- | 1.3 ± 0.4 % Hemolysis at 0.1 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}I{nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api795 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 20 | Antibacterial Gram- | −0.8 ± 0.4 % Hemolysis at 0.1 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}W{nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api793 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 20 | Antibacterial Gram- | 1.6 ± 0.5 % Hemolysis at 0.6 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}I{nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api795 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 20 | Antibacterial Gram- | 0.0 ± 0.7 % Hemolysis at 0.6 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 26802742 | 2016 | FIGALLRPALKLLA{ct:Amid} | Pxt-2 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 2 % Hemolysis at 50 µM | Rat | X. Tropicalis Skin | α-Helix | NA | ||
| 26802742 | 2016 | FIGALLGPLLNLLK{ct:Amid} | Pxt-5 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 69.8 % Hemolysis at 50 µM | Rat | X. Tropicalis Skin | α-Helix | NA | ||
| 26802742 | 2016 | NLLGSLLKTGLKVGSNLL{ct:Amid} | Pxt-12 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 0 % Hemolysis at 50 µM | Rat | X. Tropicalis Skin | α-Helix | Non-hemolytic | ||
| 26802742 | 2016 | ALLKLAPRLLAGIF{ct:Amid} | Reverse Pxt-2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 1.5 % Hemolysis at 50 µM | Rat | X. Tropicalis Skin | α-Helix | NA | ||
| 26802742 | 2016 | KLLNLLPGLLAGIF{ct:Amid} | Reverse Pxt-5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 5.2 % Hemolysis at 50 µM | Rat | X. Tropicalis Skin | α-Helix | NA | ||
| 26802742 | 2016 | LLNSGVKLGTKLLSGLLN{ct:Amid} | Reverse Pxt-12 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 50 µM | Rat | X. Tropicalis Skin | α-Helix | Non-hemolytic | ||
| 26802742 | 2016 | INLKALAALAKKIL{ct:Amid} | Mastoparan | Amidation | Free | Linear | L | None | 14 | Antibacterial | 13.5 % Hemolysis at 50 µM | Rat | Wasp Venom | α-Helix | NA | ||
| 26905802 | 2016 | WILEYLWKVPFDFWRGVI | E1P47 | Free | Free | Linear | L | None | 18 | Antiviral, Anti-HIV | 100 % Hemolysis at 0 µM | Rabbit | Gb Virus C | α-Helix | NA | ||
| 26905802 | 2016 | WILEYLWKVPFDFWRGVI | E1P47 | Free | Free | Linear | L | None | 18 | Antiviral, Anti-HIV | 50 % Hemolysis at 1 µM | Rabbit | Gb Virus C | α-Helix | NA | ||
| 26905802 | 2016 | WILEYLWKVPFDFWRGVI | E1P47 | Free | Free | Linear | L | None | 18 | Antiviral, Anti-HIV | 25 % Hemolysis at 2 µM | Rabbit | Gb Virus C | α-Helix | NA | ||
| 26905802 | 2016 | WILEYLWKVPFDFWRGVI | E1P47 | Free | Free | Linear | L | None | 18 | Antiviral, Anti-HIV | <25 % Hemolysis at 3 µM | Rabbit | Gb Virus C | α-Helix | NA | ||
| 26905802 | 2016 | WILEYLWKVPFDFWRGVI | E1P47 | Free | Free | Linear | L | None | 18 | Antiviral, Anti-HIV | <25 % Hemolysis at 4 µM | Rabbit | Gb Virus C | α-Helix | NA | ||
| 26905802 | 2016 | WILEYLWKVPFDFWRGVI | E1P47 | Free | Free | Linear | L | None | 18 | Antiviral, Anti-HIV | <25 % Hemolysis at 5 µM | Rabbit | Gb Virus C | α-Helix | NA | ||
| 26920749 | 2016 | IDGLKAIWKKVADLLKNT{ct:Amid} | L1A | Amidation | Free | Linear | L | None | 18 | Antibacterial | 4 % Hemolysis at 148 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26920749 | 2016 | IDGLKAIWKKVADLLKNT{nt:Acet}{ct:Amid} | Ac-L1A | Amidation | acetylation | Linear | L | None | 18 | Antibacterial | 5 % Hemolysis at 145 µM | Human | Synthetic Peptide | α-Helix | Non-hemolytic | ||
| 26920749 | 2016 | IDGLKAIVKKVADLLKNT{nt:Abz = ortho-aminobenzoic acid}{ct:Amid} | Abz-L1A-W8V | Amidation | Abz = ortho-aminobenzoic acid | Linear | L | None | 18 | Antibacterial | 46 % Hemolysis at 140 µM | Human | Synthetic Peptide | α-Helix | Non-hemolytic | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 7 % Hemolysis at 1.25 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 9 % Hemolysis at 2.5 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 13 % Hemolysis at 5 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 18 % Hemolysis at 10 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 36 % Hemolysis at 20 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 59 % Hemolysis at 40 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 80 % Hemolysis at 80 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 92 % Hemolysis at 160 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 9 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 13 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 26 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 43 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 65 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 87 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 11 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 9 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 15 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 20 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 31 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 48 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 12 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 3 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 10 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 10 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 5 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 18 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 40 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 69 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 93 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 5 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 14 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 36 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 64 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 91 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 1 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 3 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 3 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 5 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 3 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 9 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 11 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 11 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 10 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 11 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 16 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 12 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 11 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 13 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 22 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 38 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 57 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 5 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 12 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 13 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 23 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 37 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 1 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 5 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 5 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLKSLLGWKRKRFG{ct:Amid} | LG21 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 8.5 % Hemolysis at 100 µM | Mouse | Hybrid Amp Consisted Of Temporin B (Tb) And Lps Binding Motif. | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGALLKSLLGWKRKRFG{ct:Amid} | LG21N7A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLASLLGWKRKRFG{ct:Amid} | LG21K10A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 12 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLKALLGWKRKRFG{ct:Amid} | LG21S11A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLKSLLGWARKRFG{ct:Amid} | LG21K16A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 25 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLKSLLGWKAKRFG{ct:Amid} | LG21R17A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 38 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLKSLLGWKRARFG{ct:Amid} | LG21K18A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 28 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLKSLLGWKRKAFG{ct:Amid} | LG21R19A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 25 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27046192 | 2016 | RWWRWWRRWWR | WR12 | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 20 µM | Human | Cationic Antibiotic Peptides (Ecaps) | α-Helix | NA | ||
| 27046192 | 2016 | KWWKWWKKWWK | WK12 | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 20 µM | Human | Cationic Antibiotic Peptides (Ecaps) | α-Helix | NA | ||
| 27197902 | 2016 | GLRRALLRLLRSLRRLLLRA | P7 | Free | Free | Linear | L | None | 20 | Antibacterial, Antitumor, Antifungal | 0 % Hemolysis at 4-32 µM | Mouse | Cell-Penetrating Peptide Pptg20 | α-Helix | Non-hemolytic | ||
| 27251456 | 2016 | RKKTRKRLKKIGKVLKWI{ct:Amid} | RI18 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 5 % Hemolysis at 128 µM | Human | Pmap-36 Analogues | α-Helix(50% TFE and 30 mM SDS) | NA | ||
| 27251456 | 2016 | TRKRLKKIGKVLKWI{ct:Amid} | TI15 | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 5 % Hemolysis at >128 µM | Human | Pmap-36 Analogues | α-Helix(50% TFE and 30 mM SDS) | NA | ||
| 27251456 | 2016 | RLKKIGKVLKWI{ct:Amid} | RI12 | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antifungal | 5 % Hemolysis at >128 µM | Human | Pmap-36 Analogues | α-Helix(50% TFE and 30 mM SDS) | NA | ||
| 27331141 | 2016 | KWCFRVCYRGICYRRCR{ct:Amid} | tachyplesin-1 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antifungal | 27.8 ± 3.9 % Hemolysis at 300 μg/ml | Human | Hemocyte Debris Of Tachypleus Tridentatus | β-Hairpin | NA | ||
| 27331141 | 2016 | RRWCFRVCYRGFCYRKCR{ct:Amid} | polyphemusin-1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 29.6 ± 2.4 % Hemolysis at 300 μg/ml | Human | Hemocyte Debris Of Limulus Polyphemus | β-Hairpin | NA | ||
| 27331141 | 2016 | ZCRRLCYKQRCVTYCRGR{nt:Z= N- terminal pyroglutamic acid}{ct:Amid} | gomesin | Amidation | Z= N- terminal pyroglutamic acid | Linear | L | None | 18 | Antibacterial, Antifungal | 4.4 ± 0.1 % Hemolysis at 300 μg/ml | Human | Hemocytes Of The Spider Acanthoscurria Gomesiana | β-Hairpin | NA | ||
| 27331141 | 2016 | RGGRLCYCRRRFCVCVGR{ct:Amid} | protegrin-1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 64.8 ± 3.5 % Hemolysis at 300 μg/ml | Human | Porcine Neutrophils | β-Hairpin | NA | ||
| 26952034 | 2016 | ASKAGAIAGKIAKVALKAL | XLAsp-P1 | Free | Free | Linear | L | None | 19 | Antibacterial, Anticancer | 0 % Hemolysis at 8 µg/mL | Rabbit | Skin Of Xenopus Laevis | α-Helix | Low hemolytic | ||
| 26952034 | 2016 | ASKAGAIAGKIAKVALKAL | XLAsp-P2 | Free | Free | Linear | L | None | 19 | Antibacterial, Anticancer | 0 % Hemolysis at 16 µg/mL | Rabbit | Skin Of Xenopus Laevis | α-Helix | Low hemolytic | ||
| 26952034 | 2016 | ASKAGAIAGKIAKVALKAL | XLAsp-P3 | Free | Free | Linear | L | None | 19 | Antibacterial, Anticancer | 0 % Hemolysis at 32 µg/mL | Rabbit | Skin Of Xenopus Laevis | α-Helix | Low hemolytic | ||
| 26952034 | 2016 | ASKAGAIAGKIAKVALKAL | XLAsp-P4 | Free | Free | Linear | L | None | 19 | Antibacterial, Anticancer | 6.4 % Hemolysis at 64 µg/mL | Rabbit | Skin Of Xenopus Laevis | α-Helix | Low hemolytic | ||
| 26952034 | 2016 | ASKAGAIAGKIAKVALKAL | XLAsp-P5 | Free | Free | Linear | L | None | 19 | Antibacterial, Anticancer | <20 % Hemolysis at 128 µg/mL | Rabbit | Skin Of Xenopus Laevis | α-Helix | Low hemolytic | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGG | Smp24T | Free | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 16 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGG | Smp24T | Free | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 32 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGG | Smp24T | Free | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 64 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGG | Smp24T | Free | Free | Linear | L | None | 19 | Antimicrobial | <20 % Hemolysis at 128 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGG | Smp24T | Free | Free | Linear | L | None | 19 | Antimicrobial | <50 % Hemolysis at 256 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGG | Smp24T | Free | Free | Linear | L | None | 19 | Antimicrobial | 50 % Hemolysis at 512 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27351824 | 2016 | LLPIVGNLLKSLL{ct:Amid} | TB | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 20-160 µg/mL | Human | Frog Rana Temporaria Skin | α-Helix | NA | ||
| 27351824 | 2016 | LLPIVGNLLKSLL{ct:Amid} | TB | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 45 % Hemolysis at 320 µg/mL | Human | Frog Rana Temporaria Skin | α-Helix | NA | ||
| 27311856 | 2016 | #ERROR! | Kunitzin-RE | Free | Free | Linear | L | None | 17 | Antibacterial | little hemolysis % at 120 µM | Horse | European Frog, Rana Esculenta | Loop | Low hemolytic | ||
| 27311856 | 2016 | AVNIPFKVHLRCKAAFC | Kunitzin-OS | Free | Free | Linear | L | None | 12 | Antibacterial | little hemolysis % at 120 µM | Horse | Chinese Frog, Odorrana Schmackeri | Loop | Low hemolytic | ||
| 27165480 | 2016 | ERILSILRHQNLLKE{nt:Amid}{ct:carboxylic acid} | CGA-N15 | carboxylic acid | Amidation | Linear | L | None | 15 | Antifungal | 5 % Hemolysis at 0.031 mmol/L | Human | Derivative Of Cga-N46 | α-Helix | NA | ||
| 27165480 | 2016 | LQDLALQGAKERAHQQ{nt:Amid}{ct:carboxylic acid} | CGA-N16 | carboxylic acid | Amidation | Linear | L | None | 16 | Antifungal | 5 % Hemolysis at 0.056 mmol/L | Human | Derivative Of Cga-N46 | α-Helix | NA | ||
| 27165480 | 2016 | ALQGAKERAHQQ{nt:Amid}{ct:carboxylic acid} | CGA-N12 | carboxylic acid | Amidation | Linear | L | None | 12 | Antifungal | 5 % Hemolysis at 0.39 mmol/L | Human | Derivative Of Cga-N46 | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLLKKLLKLAG | LK | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 5 µM | Human | Cell Penetrating Peptides (Cpps) | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLGKKLLKLAG | L8G | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 40 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLSKKLLKLAG | L8S | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 80 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLPKKLLKLAG | L8P | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 1280 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLNKKLLKLAG | L8N | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 640 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLQKKLLKLAG | L7Q | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 640 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLDKKLLKLAG | L8D | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at >1280 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLEKKLLKLAG | L8E | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at >1280 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLKKKLLKLAG | L8K | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 640 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLRKKLLKLAG | L8R | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 640 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27442521 | 2016 | LKKLLKLHKKLLKLAG | L8H | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 160 µM | Human | Lk Mutant Peptide | α-Helix | NA | ||
| 27560386 | 2016 | RICTPIPFPMCY{cyc:N-C}{ct:Amid} | tigerinin-1O | Amidation | Free | Cyclic | L | None | 12 | Cytotoxic | 0 % Hemolysis at 500 µM | Mouse | African Crowned Bullfrog Hoplobatrachus Occipitalis | NA | Non-hemolytic | ||
| 27560386 | 2016 | RTCIPIPLVMC{cyc:N-C}{ct:Amid} | tigerinin-2O | Amidation | Free | Cyclic | L | None | 11 | Cytotoxic | 0 % Hemolysis at 500 µM | Mouse | African Crowned Bullfrog Hoplobatrachus Occipitalis | NA | Non-hemolytic | ||
| 27560386 | 2016 | RICTAIPLPMCL{cyc:N-C}{ct:Amid} | tigerinin-3O | Amidation | Free | Cyclic | L | None | 12 | Cytotoxic | 0 % Hemolysis at 500 µM | Mouse | African Crowned Bullfrog Hoplobatrachus Occipitalis | NA | Non-hemolytic | ||
| 27560386 | 2016 | RTCIPIPPVCF{cyc:N-C}{ct:Amid} | tigerinin-4O | Amidation | Free | Cyclic | L | None | 11 | Cytotoxic | 0 % Hemolysis at 500 µM | Mouse | African Crowned Bullfrog Hoplobatrachus Occipitalis | NA | Non-hemolytic | ||
| 27336672 | 2016 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 1.6 % Hemolysis at 90 µM pHat6 | Sheep | Belly Toad, Bombina Maxima | α-Helical | NA | ||
| 27336672 | 2016 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 1.2 % Hemolysis at 90 µM pHat8 | Sheep | Belly Toad, Bombina Maxima | α-Helical | NA | ||
| 27723187 | 2016 | {nnr:CH3}-(KWFETWFTEWPKKKRK)-{nnr:H3C}{nt:Acet-CH3}{ct:CH3-Amid} | CH3–Pep3–H3C | CH3-Amidation | Acetylation-CH3 | Linear | L | CH3 = CH3, H3C = H3C | 16 | Cytotoxic | 13.38 % Hemolysis at 100 µg/mL | Rat | Cpp | α-Helix | NA | ||
| 27723187 | 2016 | KLPVMACHKKKKKKHC{nt:Acet}{ct:Amid} | BipM–ACHK6HC | Amidation | Acetylation | Linear | L | None | 16 | Cytotoxic | 0.19 % Hemolysis at 100 µg/mL | Rat | Cpp | α-Helix | NA | ||
| 27723187 | 2016 | KLPVMARRRRRRRR{nt:Acet}{ct:Amid} | BipM–AR8 | Amidation | Acetylation | Linear | L | R8 = Octa-arginine | 14 | Cytotoxic | 1.78 % Hemolysis at 100 µg/mL | Rat | Cpp | α-Helix | NA | ||
| 27423268 | 2016 | INLKALAALAKKIL{ct:Amid} | [I5 , R8 ] mastoparan | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Mp Derived | α-Helix | NA | ||
| 27423268 | 2016 | INLKILARLAKKIL{ct:Amid} | mastoparan L | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 40 % Hemolysis at 10 µM | Human | Wasp Venom | α-Helix | NA | ||
| 27862650 | 2016 | GLLKRIKTLL{ct:Amid} | 1 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Anoplin(Wasp, Anoplius Samariensis) | α-Helix | NA | ||
| 27862650 | 2016 | GLLKRIKTLL{nt:C8-octanoic}{ct:Amid} | 2 | Amidation | C8-octanoic | Linear | L | C8 = Octanoic Acid | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | GLLKRIKTLL{nt:C10- decanoic}{ct:Amid} | 3 | Amidation | C10- decanoic | Linear | L | C10 = decanoic | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | GLLKFIKKLL{ct:Amid} | 4 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | KLLKFIKKLL{ct:Amid} | 5 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | RLLKFIKKLL{ct:Amid} | 6 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | GLLKFIKKLL{nt:C8-octanoic}{ct:Amid} | 7 | Amidation | C8-octanoic | Linear | L | C8 = Octanoic Acid | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | GLLKFIKKLL{nt:C10- decanoic}{ct:Amid} | 8 | Amidation | C10- decanoic | Linear | L | C10 = decanoic | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27862650 | 2016 | GLLKFIKKLL{nt:C12-dodecanoic}{ct:Amid} | 9 | Amidation | C12-dodecanoic | Linear | L | C12 = dodecanoic | 10 | Antimicrobial | <50 % Hemolysis at 500 µg/mL | Human | Analogs Of Anoplin | α-Helix | NA | ||
| 27439393 | 2016 | WMQKVIDRFGG | T-1 | Free | Free | Linear | L | None | 11 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27439393 | 2016 | KKWMQKVIDRFGG | T-2 | Free | Free | Linear | L | None | 13 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27439393 | 2016 | RLKKWMQKVIDRFGG | T-3 | Free | Free | Linear | L | None | 15 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27439393 | 2016 | VFRLKKWMQKVIDRFGG | T-4 | Free | Free | Linear | L | None | 17 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27439393 | 2016 | THVFRLKKWMQKVIDRFGG | T-5 | Free | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRELIGWLDWLK | AmyI-1-18 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0.1 % Hemolysis at 100 µM | Sheep | Α-Amylase In Rice (Oryza Sativa L. Japonica) | α-Helix | NA | ||
| 27478151 | 2016 | HLNARVQRELIGWLDWLK | AmyI-1-18(K4A) | Free | Free | Linear | L | None | 18 | Antimicrobial | Hemolysis not determined at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | Non-hemolytic | ||
| 27478151 | 2016 | HLNKAVQRELIGWLDWLK | AmyI-1-18(R5A) | Free | Free | Linear | L | None | 18 | Antimicrobial | Hemolysis not determined at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | Non-hemolytic | ||
| 27478151 | 2016 | HLNKRVQAELIGWLDWLK | AmyI-1-18(R8A) | Free | Free | Linear | L | None | 18 | Antimicrobial | Hemolysis not determined at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | Non-hemolytic | ||
| 27478151 | 2016 | HLNKRVQRELIGWLDWLA | AmyI-1-18(K18A) | Free | Free | Linear | L | None | 18 | Antimicrobial | Hemolysis not determined at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRELRGWLDWLK | AmyI-1-18(I11R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 1 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRELIRWLDWLK | AmyI-1-18(G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 2 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRELIGWLRWLK | AmyI-1-18(D15R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 2 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIGWLDWLK{ct:Amid} | AmyI-1-18(N3L) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 3 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIGWLDWLK{ct:Amid} | AmyI-1-18(E9L) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 5 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIRWLDWLK | AmyI-1-18(E9L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 9 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIRWLDWLK | AmyI-1-18(E9L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | <20 % Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIRWLDWLK | AmyI-1-18(E9L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | <20 % Hemolysis at 200 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIRWLDWLK | AmyI-1-18(E9L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | <20 % Hemolysis at 300 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIRWLDWLK | AmyI-1-18(E9L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | <20 % Hemolysis at 400 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLNKRVQRLLIRWLDWLK | AmyI-1-18(E9L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | <20 % Hemolysis at 500 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRLLIGWLDWLK | AmyI-1-18(N3L, E9L) | Free | Free | Linear | L | None | 18 | Antimicrobial | 14 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRLLIGWLDWLK | AmyI-1-18(N3L, E9L) | Free | Free | Linear | L | None | 18 | Antimicrobial | <20 % Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRLLIGWLDWLK | AmyI-1-18(N3L, E9L) | Free | Free | Linear | L | None | 18 | Antimicrobial | 20 % Hemolysis at 200 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRLLIGWLDWLK | AmyI-1-18(N3L, E9L) | Free | Free | Linear | L | None | 18 | Antimicrobial | <40 % Hemolysis at 300 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRLLIGWLDWLK | AmyI-1-18(N3L, E9L) | Free | Free | Linear | L | None | 18 | Antimicrobial | <40 % Hemolysis at 400 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRLLIGWLDWLK | AmyI-1-18(N3L, E9L) | Free | Free | Linear | L | None | 18 | Antimicrobial | <40 % Hemolysis at 500 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIRWLDWLK | AmyI-1-18(N3L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 14 % Hemolysis at 50 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIRWLDWLK | AmyI-1-18(N3L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 31 % Hemolysis at 100 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIRWLDWLK | AmyI-1-18(N3L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 40 % Hemolysis at 200 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIRWLDWLK | AmyI-1-18(N3L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | <50 % Hemolysis at 300 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIRWLDWLK | AmyI-1-18(N3L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 60 % Hemolysis at 400 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27478151 | 2016 | HLLKRVQRELIRWLDWLK | AmyI-1-18(N3L, G12R) | Free | Free | Linear | L | None | 18 | Antimicrobial | 87 % Hemolysis at 500 µM | Sheep | Amyi-1-18 Analogs | α-Helix | NA | ||
| 27907988 | 2016 | KRIVQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antitumor | 30 % Hemolysis at 0.78 µg/mL | Rabbit | Cathelicidin Ll-37 | α-Helix | NA | ||
| 27907988 | 2016 | KRIVQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antitumor | <45 % Hemolysis at 7.8 µg/mL | Rabbit | Cathelicidin Ll-37 | α-Helix | NA | ||
| 27907988 | 2016 | KRIVQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antitumor | <45 % Hemolysis at 15.6 µg/mL | Rabbit | Cathelicidin Ll-37 | α-Helix | NA | ||
| 27907988 | 2016 | KRIVQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antitumor | 70 % Hemolysis at 31.2 µg/mL | Rabbit | Cathelicidin Ll-37 | α-Helix | NA | ||
| 27907988 | 2016 | KRIVQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antitumor | 70 % Hemolysis at 62.5 µg/mL | Rabbit | Cathelicidin Ll-37 | α-Helix | NA | ||
| 27907988 | 2016 | KRIVQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antitumor | 73 % Hemolysis at 125 µg/mL | Rabbit | Cathelicidin Ll-37 | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 1 mg/L | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 128 mg/L | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 256 mg/L | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 512 mg/L | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 1 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 2 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 4 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 8 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 16 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 32 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 64 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 128 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 256 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 512 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 1 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 2 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 4 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 8 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 16 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 32 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 64 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 128 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 256 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 512 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 1 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 2 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 4 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 8 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 16 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 32 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 64 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 128 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 256 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <10 % Hemolysis at 512 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 2 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 4 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 8 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 16 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 32 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 64 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 128 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 256 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 512 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 1 µM in 1hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 1 µM in 2hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 5 µM in 1hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 5 µM in 2hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 10 µM in 1hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 10 µM in 2hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 20 µM in 1hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 20 µM in 2hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 40 µM in 1hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 40 µM in 2hr | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 4.96 % Hemolysis at 60 µM | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 6.58 % Hemolysis at 60 µM | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 22.31 % Hemolysis at 80 µM | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 22.88 % Hemolysis at 80 µM | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 37.77 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | NA | ||
| 28096686 | 2016 | FLFSLIPSAIGGLISAFK | Pepcon | Free | Free | Linear | L | None | 18 | Antimicrobial | 39.27 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | NA | ||
| 26949161 | 2016 | AEAEARARAEAEARAR{nt:Acet}{ct:Amid} | EAR16-II | Amidation | Acetylation | Linear | L | None | 16 | Anticancer | <5 % Hemolysis at 1.25-125 µg/mL | Rabbit | Complementary Peptide Eak16-Ii | α-Helix; β-Strand | Non-hemolytic | ||
| 27917162 | 2016 | ILSAIWSGIKSLF{ct:Amid} | NDBP-5.7 | Amidation | Free | Linear | L | None | 13 | Antifungal | >50 % Hemolysis at 50 µM | Human | Scorpion Tityus Obscurus | α-Helix | NA | ||
| 26952110 | 2016 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 100 μg/mL | Human | Scorpion Heterometrus Petersii | α-Helical | NA | ||
| 26952110 | 2016 | GILGKLWKGVKSIF{ct:Amid} | K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 100 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | LILGKLWKGVKSIF{ct:Amid} | L1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 100 μg/mL | Human | Hp1404 Derivative | α-Helical | Non-hemolytic | ||
| 26952110 | 2016 | SILGKLWKGVKSIF{ct:Amid} | S1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 100 μg/mL | Human | Hp1404 Derivative | α-Helical | Non-hemolytic | ||
| 26952110 | 2016 | FILGKLWKGVKSIF{ct:Amid} | F1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <5 % Hemolysis at 100 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | KILGKLWKGVKSIF{ct:Amid} | K1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 100 μg/mL | Human | Hp1404 Derivative | α-Helical | Non-hemolytic | ||
| 26952110 | 2016 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <50 % Hemolysis at 200 μg/mL | Human | Scorpion Heterometrus Petersii | α-Helical | NA | ||
| 26952110 | 2016 | GILGKLWKGVKSIF{ct:Amid} | K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <50 % Hemolysis at 200 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | LILGKLWKGVKSIF{ct:Amid} | L1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 200 μg/mL | Human | Hp1404 Derivative | α-Helical | Non-hemolytic | ||
| 26952110 | 2016 | SILGKLWKGVKSIF{ct:Amid} | S1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 200 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | #ERROR! | F1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <40 % Hemolysis at 200 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | KILGKLWKGVKSIF{ct:Amid} | K1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 200 μg/mL | Human | Hp1404 Derivative | α-Helical | Non-hemolytic | ||
| 26952110 | 2016 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <100 % Hemolysis at 400 μg/mL | Human | Scorpion Heterometrus Petersii | α-Helical | NA | ||
| 26952110 | 2016 | GILGKLWKGVKSIF{ct:Amid} | K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <80 % Hemolysis at 400 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | LILGKLWKGVKSIF{ct:Amid} | L1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 400 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | SILGKLWKGVKSIF{ct:Amid} | S1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 50 % Hemolysis at 400 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | FILGKLWKGVKSIF{ct:Amid} | F1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <80 % Hemolysis at 400 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | KILGKLWKGVKSIF{ct:Amid} | K1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 11.5 % Hemolysis at 400 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 27104500 | 2016 | INWKKIKSIIKAAMN{ct:Amid} | mastoparan V1 (MP-V1) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Venom Of Social Wasp Vespula Vulgaris | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | INWKKIKSIIKAAMN{ct:Amid} | mastoparan V1 (MP-V1) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 6.6 % Hemolysis at 50 µM | Human | Venom Of Social Wasp Vespula Vulgaris | α-Helical | NA | ||
| 27104500 | 2016 | INWKKIKSIIKAAMN{ct:Amid} | mastoparan V1 (MP-V1) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | ~20 % Hemolysis at 100 µM | Human | Venom Of Social Wasp Vespula Vulgaris | α-Helical | NA | ||
| 27104500 | 2016 | INLKALAALAKKIL{ct:Amid} | mastoparan L (MP-L) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Vespula Lewisii | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | INLKALAALAKKIL{ct:Amid} | mastoparan L (MP-L) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Vespula Lewisii | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | INWKGIAAMAKKLL{ct:Amid} | mastoparan X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Vespa Simillina Xanthoptera | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | INWKGIAAMAKKLL{ct:Amid} | mastoparan X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Vespa Simillina Xanthoptera | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | INWKGIAAMAKKLL{ct:Amid} | mastoparan X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 100 µM | Human | Vespa Simillina Xanthoptera | α-Helical | NA | ||
| 27104500 | 2016 | LKLKSIVSWAKKVL{ct:Amid} | mastoparan B (MP-B) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Vespa Basalis | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | LKLKSIVSWAKKVL{ct:Amid} | mastoparan B (MP-B) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Vespa Basalis | α-Helical | Non-hemolytic | ||
| 27104500 | 2016 | LKLKSIVSWAKKVL{ct:Amid} | mastoparan B (MP-B) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Vespa Basalis | α-Helical | Non-hemolytic | ||
| 27008420 | 2016 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Anti-plant-pathogenic bacteria and fungi | 4 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C7H15})FKKLQ{cyc:N-C} | BPC498 | Free | Free | Cyclic | L | CO-C7H15 = octanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 78 ± 4 % Hemolysis at 150 µM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C3H7})FKKLQ{cyc:N-C} | BPC500 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 28 ± 5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C4H9})FKKLQ{cyc:N-C} | BPC526 | Free | Free | Cyclic | L | CO-C4H9 = pentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 62 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-isoC5H11})FKKLQ{cyc:N-C} | BPC504 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 89 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-nC5H11})FKKLQ{cyc:N-C} | BPC528 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 98 ± 7 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-nC5H11})FKKLQ{cyc:N-C} | BPC596 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 93 ± 5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C6H13})FKKLQ{cyc:N-C} | BPC592 | Free | Free | Cyclic | L | CO-C6H13 = 2-methylhexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 4 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C8H17})FKKLQ{cyc:N-C} | BPC594 | Free | Free | Cyclic | L | CO-C8H17 = 4-methyloctanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 93 ± 11 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C11H23})FKKLQ{cyc:N-C} | BPC530 | Free | Free | Cyclic | L | CO-C11H23 = lauroyl | 10 | Anti-plant-pathogenic bacteria and fungi | 89 ± 7 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C11H22OH})FKKLQ{cyc:N-C} | BPC524 | Free | Free | Cyclic | L | CO-C11H22OH = 12-hydroxylauroyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 8 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C15H31})FKKLQ{cyc:N-C} | BPC502 | Free | Free | Cyclic | L | CO-C15H31 = palmitoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 78 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C17H33})FKKLQ{cyc:N-C} | BPC622 | Free | Free | Cyclic | L | CO-C17H33 = oleoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 91 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFKK({nnr:CO-nC5H11})LQ{cyc:N-C} | BPC582 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 92 ± 3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFK({nnr:CO-nC5H11})KLQ{cyc:N-C} | BPC584 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 72 ± 5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLK({nnr:CO-nC5H11})KFKKLQ{cyc:N-C} | BPC586 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 92 ± 9 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-nC5H11})LKKFKKLQ{cyc:N-C} | BPC588 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 95 ± 4 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-C3H7})LKKFKKLQ{cyc:N-C} | BPC708 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 2 ± 0.5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-nC5H11})KLKKFKKLQ{cyc:N-C} | BPC590 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 9 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-C3H7})KLKKFKKLQ{cyc:N-C} | BPC710 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 7 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C} | BPC712 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 30 ± 4 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKLK-{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C} | BPC726 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 12 | Anti-plant-pathogenic bacteria and fungi | 0 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC624 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 53 ± 5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-isoC5H11}F{d}KKLQ{cyc:N-C} | BPC626 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 51 ± 7 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKLK-{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC674 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 12 | Anti-plant-pathogenic bacteria and fungi | 51 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-C7H15}F{d}KKLQ{cyc:N-C} | BPC668 | Free | Free | Cyclic | Mix | CO-C7H15 = octanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 79 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{nnr:CO-C3H7}LKKF{d}KKLQ{cyc:N-C} | BPC714 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{nnr:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C} | BPC680 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 77 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{nnr:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C} | BPC716 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 2 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{nnr:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C} | BPC686 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 10 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-C3H7}FKKLQ{cyc:N-C} | BPC702 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 1 ± 0.1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}LK-{nnr:CO-C3H7}FKKLQ{cyc:N-C} | BPC724 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 12 | Anti-plant-pathogenic bacteria and fungi | 3 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-nC5H11}FKKLQ{cyc:N-C} | BPC628 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 19 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-isoC5H11}FKKLQ{cyc:N-C} | BPC630 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 22 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}LK-{nnr:CO-nC5H11}FKKLQ{cyc:N-C} | BPC672 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 12 | Anti-plant-pathogenic bacteria and fungi | 33 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-C7H15}FKKLQ{cyc:N-C} | BPC666 | Free | Free | Cyclic | Mix | CO-C7H15 = octanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 61 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{d}{nnr:CO-nC5H11}LKKFKKLQ{cyc:N-C} | BPC678 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 68 ± 3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{d}{nnr:CO-C3H7}LKKFKKLQ{cyc:N-C} | BPC704 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 9 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{d}{nnr:CO-nC5H11}KLKKFKKLQ{cyc:N-C} | BPC684 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 8 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{d}{nnr:CO-C3H7}KLKKFKKLQ{cyc:N-C} | BPC706 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 35 ± 3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC632 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 21 ± 13 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-isoC5H11}F{d}KKLQ{cyc:N-C} | BPC634 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 7 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C3H7})HKKLQ{cyc:N-C} | BPC718 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-C3H7})HKKLQ{cyc:N-C} | BPC728 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 0 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Non-hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-nC5H11})HKKLQ{cyc:N-C} | BPC636 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 5 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-isoC5H11})HKKLQ{cyc:N-C} | BPC638 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 6 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-nC5H11})HKKLQ{cyc:N-C} | BPC676 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C7H15})HKKLQ{cyc:N-C} | BPC670 | Free | Free | Cyclic | L | CO-C7H15 = octanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 34 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-nC5H11})LKKHKKLQ{cyc:N-C} | BPC682 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 20 ± 3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-C3H7})LKKHKKLQ{cyc:N-C} | BPC720 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-nC5H11})KLKKHKKLQ{cyc:N-C} | BPC688 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 1 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-C3H7})KLKKHKKLQ{cyc:N-C} | BPC722 | Free | Free | Cyclic | L | CO-C3H7= butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Anti-plant-pathogenic bacteria and fungi | 6 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C7H15})FKKLQ{cyc:N-C} | BPC498 | Free | Free | Cyclic | L | CO-C7H15 = octanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 12 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C3H7})FKKLQ{cyc:N-C} | BPC500 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 38 ± 4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C4H9})FKKLQ{cyc:N-C} | BPC526 | Free | Free | Cyclic | L | CO-C4H9 = pentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 78 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-isoC5H11})FKKLQ{cyc:N-C} | BPC504 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 93 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-nC5H11})FKKLQ{cyc:N-C} | BPC528 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-nC5H11})FKKLQ{cyc:N-C} | BPC596 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 100 ± 11 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C6H13})FKKLQ{cyc:N-C} | BPC592 | Free | Free | Cyclic | L | CO-C6H13 = 2-methylhexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 98 ± 6 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C8H17})FKKLQ{cyc:N-C} | BPC594 | Free | Free | Cyclic | L | CO-C8H17 = 4-methyloctanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 96 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C11H23})FKKLQ{cyc:N-C} | BPC530 | Free | Free | Cyclic | L | CO-C11H23 = lauroyl | 10 | Anti-plant-pathogenic bacteria and fungi | 91 ± 9 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C11H22OH})FKKLQ{cyc:N-C} | BPC524 | Free | Free | Cyclic | L | CO-C11H22OH = 12-hydroxylauroyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 6 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C15H31})FKKLQ{cyc:N-C} | BPC502 | Free | Free | Cyclic | L | CO-C15H31 = palmitoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 99 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C17H33})FKKLQ{cyc:N-C} | BPC622 | Free | Free | Cyclic | L | CO-C17H33 = oleoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 97 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFKK({nnr:CO-nC5H11})LQ{cyc:N-C} | BPC582 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 96 ± 10 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFK({nnr:CO-nC5H11})KLQ{cyc:N-C} | BPC584 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 97 ± 12 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLK({nnr:CO-nC5H11})KFKKLQ{cyc:N-C} | BPC586 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 95 ± 20 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-nC5H11})LKKFKKLQ{cyc:N-C} | BPC588 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 92 ± 12 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-C3H7})LKKFKKLQ{cyc:N-C} | BPC708 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-nC5H11})KLKKFKKLQ{cyc:N-C} | BPC590 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 9 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-C3H7})KLKKFKKLQ{cyc:N-C} | BPC710 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 13 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C} | BPC712 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 38 ± 7 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKLK-{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C} | BPC726 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 12 | Anti-plant-pathogenic bacteria and fungi | 4 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC624 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 64 ± 9 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-isoC5H11}F{d}KKLQ{cyc:N-C} | BPC626 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 54 ± 4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKLK-{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC674 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 12 | Anti-plant-pathogenic bacteria and fungi | 56 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-C7H15}F{d}KKLQ{cyc:N-C} | BPC668 | Free | Free | Cyclic | Mix | CO-C7H15 = octanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 79 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{nnr:CO-C3H7}LKKF{d}KKLQ{cyc:N-C} | BPC714 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{nnr:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C} | BPC680 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 81 ± 4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{nnr:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C} | BPC716 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 4 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{nnr:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C} | BPC686 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 14 ± 0.4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-C3H7}FKKLQ{cyc:N-C} | BPC702 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 2 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}LK-{nnr:CO-C3H7}FKKLQ{cyc:N-C} | BPC724 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 12 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-nC5H11}FKKLQ{cyc:N-C} | BPC628 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 34 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-isoC5H11}FKKLQ{cyc:N-C} | BPC630 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 28 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}LK-{nnr:CO-nC5H11}FKKLQ{cyc:N-C} | BPC672 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 12 | Anti-plant-pathogenic bacteria and fungi | 33 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-C7H15}FKKLQ{cyc:N-C} | BPC666 | Free | Free | Cyclic | Mix | CO-C7H15 = octanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 73 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{d}{nnr:CO-nC5H11}LKKFKKLQ{cyc:N-C} | BPC678 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 73 ± 4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{d}{nnr:CO-C3H7}LKKFKKLQ{cyc:N-C} | BPC704 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 16 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{d}{nnr:CO-nC5H11}KLKKFKKLQ{cyc:N-C} | BPC684 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 13 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{d}{nnr:CO-C3H7}KLKKFKKLQ{cyc:N-C} | BPC706 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 46 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC632 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 22 ± 10 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}({nnr:CO-isoC5H11})F{d}KKLQ{cyc:N-C} | BPC634 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 17 ± 8 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C3H7})HKKLQ{cyc:N-C} | BPC718 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 4 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-C3H7})HKKLQ{cyc:N-C} | BPC728 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 7 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-nC5H11})HKKLQ{cyc:N-C} | BPC636 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 16 ± 5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-isoC5H11})HKKLQ{cyc:N-C} | BPC638 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 8 ± 5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-nC5H11})HKKLQ{cyc:N-C} | BPC676 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C7H15})HKKLQ{cyc:N-C} | BPC670 | Free | Free | Cyclic | L | CO-C7H15 = octanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 40 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-nC5H11})LKKHKKLQ{cyc:N-C} | BPC682 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 27 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-C3H7})LKKHKKLQ{cyc:N-C} | BPC720 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 4 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-nC5H11})KLKKHKKLQ{cyc:N-C} | BPC688 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 1 ± 0.2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Non-hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-C3H7})KLKKHKKLQ{cyc:N-C} | BPC722 | Free | Free | Cyclic | L | CO-C3H7= butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 26450121 | 2016 | GIHDILKYGKPS | Myxinidin | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 0 % Hemolysis at 50-400 µM | Human | Epidermal Mucus Of The Hagfish | α-Helical | Non-hemolytic | ||
| 26450121 | 2016 | GIHHILKYGKPS | Myxinidin 1 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 0 % Hemolysis at 50-400 µM | Human | Epidermal Mucus Of The Hagfish | α-Helical | Non-hemolytic | ||
| 26450121 | 2016 | KIKWILKYWKWS | Myxinidin 2 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 10 % Hemolysis at 50 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | KIKWILKYWKWS | Myxinidin 2 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | <20 % Hemolysis at 100 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | KIKWILKYWKWS | Myxinidin 2 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 30 % Hemolysis at 200 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | KIKWILKYWKWS | Myxinidin 2 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 50 % Hemolysis at 400 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | RIRWILRYWRWS | Myxinidin 3 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 12 % Hemolysis at 25 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | RIRWILRYWRWS | Myxinidin 4 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 30 % Hemolysis at 50 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | RIRWILRYWRWS | Myxinidin 5 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | <50 % Hemolysis at 100 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | RIRWILRYWRWS | Myxinidin 6 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 60 % Hemolysis at 200 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | RIRWILRYWRWS | Myxinidin 7 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | ~60 % Hemolysis at 400 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 25546564 | 2016 | VRPPPASKSL | 1 | Free | Free | Linear | L | None | 10 | Antioxidant | <25 % Hemolysis at 1 mg/mL | Rat | Synthetic | NA | NA | ||
| 25546564 | 2016 | LPGGGHGDL | 2 | Free | Free | Linear | L | None | 10 | Antioxidant | <35 % Hemolysis at 1 mg/mL | Rat | Synthetic | NA | NA | ||
| 27936728 | 2016 | CKRWWKWIRW{ct:Amid} | CysHHC10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at >1000 μg/ml | Human | Synthetic | NA | NA | ||
| 27900727 | 2016 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MPI | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <0.7 % Hemolysis at 256 µM | Human | Social Wasp Polybia Paulista | α-Helical | Non-hemolytic | ||
| 27900727 | 2016 | IDWKKL{d}L{d}DAAKQIL{d}{ct:Amid} | D-lys-MPI | Amidation | Free | Linear | Mix | l = D-Lys lowercase letters correspond to D-amino acids | 15 | Antimicrobial | 0 % Hemolysis at 256 µM | Human | Polybia-Mpi Analogues | α-Helical | Non-hemolytic | ||
| 27900727 | 2016 | I{d}D{d}W{d}K{d}K{d}L{d}L{d}D{d}A{d}A{d}K{d}Q{d}I{d}L{d}{ct:Amid} | D-MPI | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 15 | Antimicrobial | 0.4 % Hemolysis at 256 µM | Human | Polybia-Mpi Analogues | α-Helical | Non-hemolytic | ||
| 26549611 | 2017 | KWCFRVCYRGICYRRCR | THI | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 12 µM | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | NA | ||
| 26549611 | 2017 | KWCFRSCYRGICYRRCR | V6S | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 280 µM | Human | Thi Analog | β-Hairpin | NA | ||
| 26549611 | 2017 | KWCFRRCYRGICYRRCR | V6R | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 200 µM | Human | Thi Analog | β-Hairpin | NA | ||
| 26549611 | 2017 | KWCFRVCSRGICYRRCR | Y8S | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 310 µM | Human | Thi Analog | β-Hairpin | NA | ||
| 26549611 | 2017 | KWCFRVCRRGICYRRCR | Y8R | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 195 µM | Human | Thi Analog | β-Hairpin | NA | ||
| 26549611 | 2017 | KWCFRVCYRGSCYRRCR | I11S | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 190 µM | Human | Thi Analog | β-Hairpin | NA | ||
| 26549611 | 2017 | KWCFRVCYRGRCYRRCR | I11R | Free | Free | Linear | L | None | 17 | Antimicrobial | 2 % Hemolysis at 180 µM | Human | Thi Analog | β-Hairpin | NA | ||
| 27487034 | 2017 | RRGRRGP{nnr:O}GP{nnr:O}GP{nnr:O}GPCCY{ct:Amid} | RR4SS | Amidation | Free | Linear | L | O = 4-hydroxy-L-proline | 19 | Antimicrobial | 0 % Hemolysis at 0.3-30 µM | Human | R3 Derivatives | Triple-Helical | Non-hemolytic | ||
| 28025839 | 2017 | IKQVKKLFKK{ct:Amid} | A2 | Amidation | Free | Linear | L | None | 10 | Antifungal | 3.8 % Hemolysis at 6.25 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{ct:Amid} | A2 | Amidation | Free | Linear | L | None | 10 | Antifungal | 4.4 % Hemolysis at 12.5 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{ct:Amid} | A2 | Amidation | Free | Linear | L | None | 10 | Antifungal | 5 % Hemolysis at 25 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{ct:Amid} | A2 | Amidation | Free | Linear | L | None | 10 | Antifungal | 6.9 % Hemolysis at 50 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{ct:Amid} | A2 | Amidation | Free | Linear | L | None | 10 | Antifungal | 8.7 % Hemolysis at 100 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{ct:Amid} | A2 | Amidation | Free | Linear | L | None | 10 | Antifungal | 12.2 % Hemolysis at 200 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{ct:Amid} | A2 | Amidation | Free | Linear | L | None | 10 | Antifungal | 20.9 % Hemolysis at 400 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Octanoicacid}{ct:Amid} | C8:0-A2 | Amidation | Octanoicacid | Linear | L | None | 10 | Antifungal | 6.3 % Hemolysis at 6.25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Octanoicacid}{ct:Amid} | C8:0-A2 | Amidation | Octanoicacid | Linear | L | None | 10 | Antifungal | 9.2 % Hemolysis at 12.5 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Octanoicacid}{ct:Amid} | C8:0-A2 | Amidation | Octanoicacid | Linear | L | None | 10 | Antifungal | 10.8 % Hemolysis at 25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Octanoicacid}{ct:Amid} | C8:0-A2 | Amidation | Octanoicacid | Linear | L | None | 10 | Antifungal | 11.5 % Hemolysis at 50 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Octanoicacid}{ct:Amid} | C8:0-A2 | Amidation | Octanoicacid | Linear | L | None | 10 | Antifungal | 23.6 % Hemolysis at 100 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Octanoicacid}{ct:Amid} | C8:0-A2 | Amidation | Octanoicacid | Linear | L | None | 10 | Antifungal | 61.8 % Hemolysis at 200 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Octanoicacid}{ct:Amid} | C8:0-A2 | Amidation | Octanoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 400 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:nDecanoicacid}{ct:Amid} | C10:0-A2 | Amidation | nDecanoicacid | Linear | L | None | 10 | Antifungal | 9.2 % Hemolysis at 6.25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:nDecanoicacid}{ct:Amid} | C10:0-A2 | Amidation | nDecanoicacid | Linear | L | None | 10 | Antifungal | 9 % Hemolysis at 12.5 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:nDecanoicacid}{ct:Amid} | C10:0-A2 | Amidation | nDecanoicacid | Linear | L | None | 10 | Antifungal | 12.25 % Hemolysis at 25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:nDecanoicacid}{ct:Amid} | C10:0-A2 | Amidation | nDecanoicacid | Linear | L | None | 10 | Antifungal | 19.7 % Hemolysis at 50 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:nDecanoicacid}{ct:Amid} | C10:0-A2 | Amidation | nDecanoicacid | Linear | L | None | 10 | Antifungal | 28.2 % Hemolysis at 100 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:nDecanoicacid}{ct:Amid} | C10:0-A2 | Amidation | nDecanoicacid | Linear | L | None | 10 | Antifungal | 52.8 % Hemolysis at 200 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:nDecanoicacid}{ct:Amid} | C10:0-A2 | Amidation | nDecanoicacid | Linear | L | None | 10 | Antifungal | 66.6 % Hemolysis at 400 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:4Methoxydecanoicacid}{ct:Amid} | 4-OMe-C10:0-A2 | Amidation | 4Methoxydecanoicacid | Linear | L | None | 10 | Antifungal | 14.1 % Hemolysis at 6.25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:4Methoxydecanoicacid}{ct:Amid} | 4-OMe-C10:0-A2 | Amidation | 4Methoxydecanoicacid | Linear | L | None | 10 | Antifungal | 28.4 % Hemolysis at 12.5 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:4Methoxydecanoicacid}{ct:Amid} | 4-OMe-C10:0-A2 | Amidation | 4Methoxydecanoicacid | Linear | L | None | 10 | Antifungal | 47.5 % Hemolysis at 25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:4Methoxydecanoicacid}{ct:Amid} | 4-OMe-C10:0-A2 | Amidation | 4Methoxydecanoicacid | Linear | L | None | 10 | Antifungal | 68.9 % Hemolysis at 50 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:4Methoxydecanoicacid}{ct:Amid} | 4-OMe-C10:0-A2 | Amidation | 4Methoxydecanoicacid | Linear | L | None | 10 | Antifungal | 84.7 % Hemolysis at 100 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:4Methoxydecanoicacid}{ct:Amid} | 4-OMe-C10:0-A2 | Amidation | 4Methoxydecanoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 200 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:4Methoxydecanoicacid}{ct:Amid} | 4-OMe-C10:0-A2 | Amidation | 4Methoxydecanoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 400 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Undec10enoicacid}{ct:Amid} | C11:1-A2 | Amidation | Undec10enoicacid | Linear | L | None | 10 | Antifungal | 28.1 % Hemolysis at 6.25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Undec10enoicacid}{ct:Amid} | C11:1-A2 | Amidation | Undec10enoicacid | Linear | L | None | 10 | Antifungal | 40.7 % Hemolysis at 12.5 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Undec10enoicacid}{ct:Amid} | C11:1-A2 | Amidation | Undec10enoicacid | Linear | L | None | 10 | Antifungal | 61.1 % Hemolysis at 25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Undec10enoicacid}{ct:Amid} | C11:1-A2 | Amidation | Undec10enoicacid | Linear | L | None | 10 | Antifungal | 82.7 % Hemolysis at 50 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Undec10enoicacid}{ct:Amid} | C11:1-A2 | Amidation | Undec10enoicacid | Linear | L | None | 10 | Antifungal | 96.3 % Hemolysis at 100 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Undec10enoicacid}{ct:Amid} | C11:1-A2 | Amidation | Undec10enoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 200 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Undec10enoicacid}{ct:Amid} | C11:1-A2 | Amidation | Undec10enoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 400 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Dodecanoicacid}{ct:Amid} | C12:0-A2 | Amidation | Dodecanoicacid | Linear | L | None | 10 | Antifungal | 42.1 % Hemolysis at 6.25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Dodecanoicacid}{ct:Amid} | C12:0-A2 | Amidation | Dodecanoicacid | Linear | L | None | 10 | Antifungal | 74.4 % Hemolysis at 12.5 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Dodecanoicacid}{ct:Amid} | C12:0-A2 | Amidation | Dodecanoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Dodecanoicacid}{ct:Amid} | C12:0-A2 | Amidation | Dodecanoicacid | Linear | L | None | 10 | Antifungal | 96.7 % Hemolysis at 50 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Dodecanoicacid}{ct:Amid} | C12:0-A2 | Amidation | Dodecanoicacid | Linear | L | None | 10 | Antifungal | 97.9 % Hemolysis at 100 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Dodecanoicacid}{ct:Amid} | C12:0-A2 | Amidation | Dodecanoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 200 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Dodecanoicacid}{ct:Amid} | C12:0-A2 | Amidation | Dodecanoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 400 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Tetradecanoicacid}{ct:Amid} | C14:0-A2 | Amidation | Tetradecanoicacid | Linear | L | None | 10 | Antifungal | 6.2 % Hemolysis at 6.25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Tetradecanoicacid}{ct:Amid} | C14:0-A2 | Amidation | Tetradecanoicacid | Linear | L | None | 10 | Antifungal | 7 % Hemolysis at 12.5 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Tetradecanoicacid}{ct:Amid} | C14:0-A2 | Amidation | Tetradecanoicacid | Linear | L | None | 10 | Antifungal | 8.2 % Hemolysis at 25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Tetradecanoicacid}{ct:Amid} | C14:0-A2 | Amidation | Tetradecanoicacid | Linear | L | None | 10 | Antifungal | 12.3 % Hemolysis at 50 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Tetradecanoicacid}{ct:Amid} | C14:0-A2 | Amidation | Tetradecanoicacid | Linear | L | None | 10 | Antifungal | 16.4 % Hemolysis at 100 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Tetradecanoicacid}{ct:Amid} | C14:0-A2 | Amidation | Tetradecanoicacid | Linear | L | None | 10 | Antifungal | 24.7 % Hemolysis at 200 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Tetradecanoicacid}{ct:Amid} | C14:0-A2 | Amidation | Tetradecanoicacid | Linear | L | None | 10 | Antifungal | 40.9 % Hemolysis at 400 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Hexadecanoicacid}{ct:Amid} | C16:0-A2 | Amidation | Hexadecanoicacid | Linear | L | None | 10 | Antifungal | 9.1 % Hemolysis at 6.25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Hexadecanoicacid}{ct:Amid} | C16:0-A2 | Amidation | Hexadecanoicacid | Linear | L | None | 10 | Antifungal | 9.8 % Hemolysis at 12.5 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Hexadecanoicacid}{ct:Amid} | C16:0-A2 | Amidation | Hexadecanoicacid | Linear | L | None | 10 | Antifungal | 8.4 % Hemolysis at 25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Hexadecanoicacid}{ct:Amid} | C16:0-A2 | Amidation | Hexadecanoicacid | Linear | L | None | 10 | Antifungal | 10.5 % Hemolysis at 50 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Hexadecanoicacid}{ct:Amid} | C16:0-A2 | Amidation | Hexadecanoicacid | Linear | L | None | 10 | Antifungal | 17.5 % Hemolysis at 100 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Hexadecanoicacid}{ct:Amid} | C16:0-A2 | Amidation | Hexadecanoicacid | Linear | L | None | 10 | Antifungal | 35.7 % Hemolysis at 200 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Hexadecanoicacid}{ct:Amid} | C16:0-A2 | Amidation | Hexadecanoicacid | Linear | L | None | 10 | Antifungal | 63.2 % Hemolysis at 400 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:17Methyloctadec13(Z)Enoicacid}{ct:Amid} | 17-Me-C18:1- A2 | Amidation | 17Methyloctadec13(Z)Enoicacid | Linear | L | None | 10 | Antifungal | 82.7 % Hemolysis at 6.25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:17Methyloctadec13(Z)Enoicacid}{ct:Amid} | 17-Me-C18:1- A2 | Amidation | 17Methyloctadec13(Z)Enoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 12.5 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:17Methyloctadec13(Z)Enoicacid}{ct:Amid} | 17-Me-C18:1- A2 | Amidation | 17Methyloctadec13(Z)Enoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:17Methyloctadec13(Z)Enoicacid}{ct:Amid} | 17-Me-C18:1- A2 | Amidation | 17Methyloctadec13(Z)Enoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 50 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:17Methyloctadec13(Z)Enoicacid}{ct:Amid} | 17-Me-C18:1- A2 | Amidation | 17Methyloctadec13(Z)Enoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 100 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:17Methyloctadec13(Z)Enoicacid}{ct:Amid} | 17-Me-C18:1- A2 | Amidation | 17Methyloctadec13(Z)Enoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 200 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:17Methyloctadec13(Z)Enoicacid}{ct:Amid} | 17-Me-C18:1- A2 | Amidation | 17Methyloctadec13(Z)Enoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 400 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Heptadec6ynoicacid}{ct:Amid} | C17:1- A2 | Amidation | Heptadec6ynoicacid | Linear | L | None | 10 | Antifungal | 81 % Hemolysis at 6.25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Heptadec6ynoicacid}{ct:Amid} | C17:1- A2 | Amidation | Heptadec6ynoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 12.5 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Heptadec6ynoicacid}{ct:Amid} | C17:1- A2 | Amidation | Heptadec6ynoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Heptadec6ynoicacid}{ct:Amid} | C17:1- A2 | Amidation | Heptadec6ynoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 50 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Heptadec6ynoicacid}{ct:Amid} | C17:1- A2 | Amidation | Heptadec6ynoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 100 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Heptadec6ynoicacid}{ct:Amid} | C17:1- A2 | Amidation | Heptadec6ynoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 200 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Heptadec6ynoicacid}{ct:Amid} | C17:1- A2 | Amidation | Heptadec6ynoicacid | Linear | L | None | 10 | Antifungal | 96 % Hemolysis at 400 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Icos6ynoicacid}{ct:Amid} | C20:1- A2 | Amidation | Icos6ynoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 6.25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Icos6ynoicacid}{ct:Amid} | C20:1- A2 | Amidation | Icos6ynoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 12.5 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Icos6ynoicacid}{ct:Amid} | C20:1- A2 | Amidation | Icos6ynoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 25 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Icos6ynoicacid}{ct:Amid} | C20:1- A2 | Amidation | Icos6ynoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 50 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Icos6ynoicacid}{ct:Amid} | C20:1- A2 | Amidation | Icos6ynoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 100 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Icos6ynoicacid}{ct:Amid} | C20:1- A2 | Amidation | Icos6ynoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 200 µM | Human | A2 Analogs | α-Helix | NA | ||
| 28025839 | 2017 | IKQVKKLFKK{nt:Icos6ynoicacid}{ct:Amid} | C20:1- A2 | Amidation | Icos6ynoicacid | Linear | L | None | 10 | Antifungal | 100 % Hemolysis at 400 µM | Human | A2 Analogs | α-Helix | NA | ||
| 27450123 | 2017 | GFLSILKKVLPKVMAHMK{ct:Amid} | MEP(melectin) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 100 µM | Rat | Cleptoparasitic Bee Melecta Albifrons | α-Helix | NA | ||
| 27450123 | 2017 | GLLSALRKMIPHILSHIKK{ct:Amid} | ANTP(antapin) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 50 % Hemolysis at 97.8 µM | Human | Wild Bee Anthophora Plumipes | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKNAI{ct:Amid} | UyCT1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at 31.5 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ILSAIWSGIKSLF{ct:Amid} | UyCT3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 15.78 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IWSAIWSGIKGLL{ct:Amid} | UyCT5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 2.39 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ILSAIWSGIKGLL{ct:Amid} | Uy17 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 26.65 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FLSTIWNGIKGLL{ct:Amid} | Uy192 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 35.85 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FPFLLSLIPSAISAIKRL{ct:Amid} | Uy234 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 55.14 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ISQSDAILSAIWSGIKSLF{ct:Amid} | Um2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 10 % Hemolysis at 2.36 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKSAI{ct:Amid} | Um3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at 70.48 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FFSALLSGIKSLF{ct:Amid} | Um4 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at not convergent at 100 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IFKAIWSGIKSLF{ct:Amid} | Um5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 11.944 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IFGAIWSGIKSLF{ct:Amid} | D1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 15.5 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FLSTIWNGIKSLF{ct:Amid} | D2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 2.94 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWKPVKKAI{ct:Amid} | D4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at not convergent at 100 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLLEGVKKAI{ct:Amid} | D5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at 110.86 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKNAIKKK{ct:Amid} | D11 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 39.76 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKNAI{ct:Amid} | UyCT1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 142.5 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ILSAIWSGIKSLF{ct:Amid} | UyCT3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 58.15 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IWSAIWSGIKGLL{ct:Amid} | UyCT5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 20.59 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ILSAIWSGIKGLL{ct:Amid} | Uy17 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 138.4 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FLSTIWNGIKGLL{ct:Amid} | Uy192 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 155.6 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FPFLLSLIPSAISAIKRL{ct:Amid} | Uy234 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 104.5 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ISQSDAILSAIWSGIKSLF{ct:Amid} | Um2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 50 % Hemolysis at 129 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKSAI{ct:Amid} | Um3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 126.2 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FFSALLSGIKSLF{ct:Amid} | Um4 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at not convergent at 100 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IFKAIWSGIKSLF{ct:Amid} | Um5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 59.25 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IFGAIWSGIKSLF{ct:Amid} | D1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 48 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FLSTIWNGIKSLF{ct:Amid} | D2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 24.48 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWKPVKKAI{ct:Amid} | D4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at not convergent at 100 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLLEGVKKAI{ct:Amid} | D5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 1636 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKNAIKKK{ct:Amid} | D11 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 1110 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKNAI{ct:Amid} | UyCT1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 90 % Hemolysis at 644.46 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ILSAIWSGIKSLF{ct:Amid} | UyCT3 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 214.22 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IWSAIWSGIKGLL{ct:Amid} | UyCT5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 177.49 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ILSAIWSGIKGLL{ct:Amid} | Uy17 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 718.55 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FLSTIWNGIKGLL{ct:Amid} | Uy192 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 675.22 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FPFLLSLIPSAISAIKRL{ct:Amid} | Uy234 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 90 % Hemolysis at 198.04 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | ISQSDAILSAIWSGIKSLF{ct:Amid} | Um2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 90 % Hemolysis at 7033.22 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKSAI{ct:Amid} | Um3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 90 % Hemolysis at 246.84 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FFSALLSGIKSLF{ct:Amid} | Um4 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at not convergent at 100 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IFKAIWSGIKSLF{ct:Amid} | Um5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 293.9 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | IFGAIWSGIKSLF{ct:Amid} | D1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 148.51 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FLSTIWNGIKSLF{ct:Amid} | D2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 90 % Hemolysis at 200.83 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWKPVKKAI{ct:Amid} | D4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 90 % Hemolysis at not convergent at 100 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLLEGVKKAI{ct:Amid} | D5 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 90 % Hemolysis at 24141.72 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | GFWGKLWEGVKNAIKKK{ct:Amid} | D11 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 90 % Hemolysis at 30984.53 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 27912176 | 2017 | FLGALWNVAKSVF{ct:Amid} | VmCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 6.25 µmol/L | Human | Vaejovis Mexicanus Smithi | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLKALWNVAKSVF{ct:Amid} | [K]3 -VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 1.6 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLGALWKVAKSVF{ct:Amid} | [K]7 -VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 1.6 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLGALWNVAKKVF{ct:Amid} | [K]11-VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 1.6 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLGELWNVAKSVF{ct:Amid} | [E]4 -VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 25 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLGALWEVAKSVF{ct:Amid} | [E]7 -VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 1.6 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLGALWNVWKSVF{ct:Amid} | [W]9 -VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 1.6 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 27912176 | 2017 | FLGELWNVWKSVF{ct:Amid} | [E]4 [W]9 -VmCT1-NH2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <12 % Hemolysis at 1.6 µmol/L | Human | Vmct1 Analogs | α-Helix | Non-hemolytic | ||
| 28012857 | 2017 | ILGPVLGLVSDTLDDVLGIL | Maximin H5 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 0-25 µM | Human | Bombina Maxima Smap2 9 Rglrrlgrkiahgvkkygptvlriiri Ag 29 3256.0 0 12.3 1 +9 Derivative Of Ovispi | α-Helix | Non-hemolytic | ||
| 28012857 | 2017 | ILGPVLGLVSDTLDDVLGIL | Maximin H5 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 0-25 µM | Horse | Bombina Maxima Smap2 9 Rglrrlgrkiahgvkkygptvlriiri Ag 29 3256.0 0 12.3 1 +9 Derivative Of Ovispi | α-Helix | Non-hemolytic | ||
| 28108242 | 2017 | INWLKLGKMVIDAL{ct:Amid} | Polybia-MPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 48.47 µM | Human | Pseudopolybia Vespiceps Testacea | α-Helix | NA | ||
| 28108242 | 2017 | INWLKLGKMVIDAL{ct:Amid} | Polybia-MPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 24.18 µM | Mouse | Pseudopolybia Vespiceps Testacea | α-Helix | NA | ||
| 28165293 | 2017 | GRRRRSVQWCA | hLF11 | Free | Free | Linear | L | None | 11 | Anticancer | <2 % Hemolysis at 10 µM | Human | Human-Derived | β-Hairpin | NA | ||
| 28165293 | 2017 | GRRRRSVQWSA | hLF11C10S | Free | Free | Linear | L | None | 11 | Anticancer | <2 % Hemolysis at 10 µM | Human | Human-Derived | β-Hairpin | NA | ||
| 28165293 | 2017 | GRRRRSVQWCA{cyc:N-C} | Cyclo-hLF11 | Free | Free | Cyclic | L | None | 11 | Anticancer | <2 % Hemolysis at 10 µM | Human | Human-Derived | β-Hairpin | NA | ||
| 28165293 | 2017 | GRRRRSVQWCA{cyc:N-C} | Cyclo-hLF11C10S | Free | Free | Cyclic | L | None | 11 | Anticancer | <2 % Hemolysis at 10 µM | Human | Human-Derived | β-Hairpin | NA | ||
| 28165293 | 2017 | APRKNVRWCT | bLF10 | Free | Free | Linear | L | None | 10 | Anticancer | <2 % Hemolysis at 10 µM | Human | Bovine Derived | β-Hairpin | NA | ||
| 28165293 | 2017 | APRKNVRWST | bLF10C9S | Free | Free | Linear | L | None | 10 | Anticancer | <2 % Hemolysis at 10 µM | Human | Bovine Derived | β-Hairpin | NA | ||
| 28165293 | 2017 | APRKNVRWCT{cyc:N-C} | Cyclo-bLF10 | Free | Free | Cyclic | L | None | 10 | Anticancer | <2 % Hemolysis at 10 µM | Human | Bovine Derived | β-Hairpin | NA | ||
| 28165293 | 2017 | APRKNVRWCTAPRKNVRWCT | Dimer bLF10 | Free | Free | Linear | L | None | 20 | Anticancer | <2 % Hemolysis at 10 µM | Human | Bovine Derived | β-Hairpin | NA | ||
| 28165293 | 2017 | APRKNVRWCTISQPEW | bLF16 | Free | Free | Linear | L | None | 16 | Anticancer | <2 % Hemolysis at 10 µM | Human | Bovine Derived | β-Hairpin | NA | ||
| 28165293 | 2017 | GRRRRSVQWCAPRRWQWR{ct:Amid} | hLF11-P-LFcinB1 | Amidation | Free | Linear | L | None | 18 | Anticancer | <2 % Hemolysis at 10 µM | Human | Human-Derived | β-Hairpin | NA | ||
| 28165293 | 2017 | GRRRRSVQWCAGGRRWQWR{ct:Amid} | hLF11-GG-LFcinB1 | Amidation | Free | Linear | L | None | 19 | Anticancer | <2 % Hemolysis at 10 µM | Human | Human-Derived | β-Hairpin | NA | ||
| 28178190 | 2017 | FRIRVRVFKRIVQRIKDFLR{ct:Amid} | FV-LL | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Hybrid | α-Helix | Non-hemolytic | ||
| 28178190 | 2017 | FRRIRVRVFKRIVQRIKDF{ct:Amid} | FV-MA | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 50 % Hemolysis at 128 µM | Human | Hybrid | α-Helix | NA | ||
| 28178190 | 2017 | FRIRVRVAKKFGKAFVG{ct:Amid} | FV-CE | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Hybrid | α-Helix | Non-hemolytic | ||
| 28275372 | 2017 | IFSAIAGLLSNLL{ct:Amid} | NDBP-5.5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 6.25-400 µM | Human | Hadrurus Gertschi | α-Helix | Non-hemolytic | ||
| 28275372 | 2017 | IFSAIAGLLSNLL{ct:Amid} | NDBP-5.5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 611.8 µM | Human | Hadrurus Gertschi | α-Helix | NA | ||
| 28275372 | 2017 | IFSAIAGLLSNLL{ct:Amid} | NDBP-5.5 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 39 % Hemolysis at 1600 µM | Human | Hadrurus Gertschi | α-Helix | NA | ||
| 27591703 | 2017 | KKWRWWLKALAKK{ct:Amid} | pEM-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <5 % Hemolysis at 64 μg/ml | Human | Snake Bothrops Asper | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 64 μg/ml | Human | Hornet Vespa Basalis | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | INLKAIAALAKKLL{ct:Amid} | MP-VT1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 64 μg/ml | Human | Venom Of Vespa Tropica | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRWWLKALAKKLL{ct:Amid} | PV | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 8 μg/ml | Human | Hybrid | α-Helix | NA | ||
| 27591703 | 2017 | KKWRWWLKALAKKLL{ct:Amid} | PV | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 16 μg/ml | Human | Hybrid | α-Helix | NA | ||
| 27591703 | 2017 | KKWRWWLKALAKKLL{ct:Amid} | PV | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 85 % Hemolysis at 32 μg/ml | Human | Hybrid | α-Helix | NA | ||
| 27591703 | 2017 | KKWRWWLKALAKKLL{ct:Amid} | PV | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 90 % Hemolysis at 64 μg/ml | Human | Hybrid | α-Helix | NA | ||
| 27591703 | 2017 | LKLKAIAALAKKKW{ct:Amid} | BVP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 64 μg/ml | Human | Hybrid | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRKLLKWLAKK{ct:Amid} | PVP | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <5 % Hemolysis at 64 μg/ml | Human | Hybrid | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRKLLKKLKKLL{ct:Amid} | PV3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <5 % Hemolysis at 64 μg/ml | Human | Hybrid | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRWWLKALAKK{ct:Amid} | pEM-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <17 % Hemolysis at 64 μg/ml | Sheep | Snake Bothrops Asper | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <17 % Hemolysis at 64 μg/ml | Sheep | Hornet Vespa Basalis | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | INLKAIAALAKKLL{ct:Amid} | MP-VT1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <17 % Hemolysis at 64 μg/ml | Sheep | Venom Of Vespa Tropica | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRWWLKALAKKLL{ct:Amid} | PV | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <17 % Hemolysis at 64 μg/ml | Sheep | Hybrid | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | LKLKAIAALAKKKW{ct:Amid} | BVP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 64 μg/ml | Sheep | Hybrid | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRKLLKWLAKK{ct:Amid} | PVP | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <17 % Hemolysis at 64 μg/ml | Sheep | Hybrid | α-Helix | Non-hemolytic | ||
| 27591703 | 2017 | KKWRKLLKKLKKLL{ct:Amid} | PV3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <17 % Hemolysis at 64 μg/ml | Sheep | Hybrid | α-Helix | Non-hemolytic | ||
| 27876749 | 2017 | KRFKKFFKKVKKSV{ct:Amid} | Ctn[1–14] | Amidation | Free | Linear | L | None | 14 | Antifungal | 20 % Hemolysis at 50 µM | Human | Fragment Of Ctn | α-Helix | NA | ||
| 27876749 | 2017 | KRFKKFFKKVKKSV{ct:Amid} | Ctn[1–14] | Amidation | Free | Linear | L | None | 14 | Antifungal | 40 % Hemolysis at 100 µM | Human | Fragment Of Ctn | α-Helix | NA | ||
| 27876749 | 2017 | KKRLKKIFKKPMVIGVTIPF{ct:Amid} | Ctn[15–34] | Amidation | Free | Linear | L | None | 20 | Antifungal | <5 % Hemolysis at 100 µM | Human | Fragment Of Ctn | Unstrcutured | NA | ||
| 28287172 | 2017 | FKAWRWAWRMKKLAAPS | Lfcin4 | Free | Free | Linear | L | None | 17 | Antimicrobial, Anti-endotoxin | 4.87 % Hemolysis at 512 µM | Mouse | Lfcinb17-31 Derivatives | α-Helix | Non-hemolytic | ||
| 28287172 | 2017 | FKCRRWQWRMKKLGA | Lfcin1 | Free | Free | Linear | L | None | 16 | Antimicrobial, Anti-endotoxin | 7.5 % Hemolysis at 256 µM | Mouse | Lfcinb17-31 Derivatives | α-Helix | Non-hemolytic | ||
| 28287172 | 2017 | FKAFRRWKKLAAPS | Lfcin5 | Free | Free | Linear | L | None | 15 | Antimicrobial, Anti-endotoxin | 2.2 % Hemolysis at 512 µM | Mouse | Lfcinb17-31 Derivatives | α-Helix | Non-hemolytic | ||
| 28248495 | 2017 | RQIKIWFQNRRW | MAAPC01 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 516.5 µM | Human | Homeobox Domain Of The Antp Protein | α-Helix | NA | ||
| 28248495 | 2017 | GWIRNQFRKIWQR | MAAPC02 | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >1000 µM | Human | Homeobox Domain Of The Antp Protein | α-Helix | NA | ||
| 28248495 | 2017 | GWRRNQFWIKIQR | MAAPC03 | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >1000 µM | Human | Homeobox Domain Of The Antp Protein | α-Helix | NA | ||
| 28248495 | 2017 | GWRNQIRKGWQR | MAAPC04 | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >2000 µM | Human | Homeobox Domain Of The Antp Protein | α-Helix | NA | ||
| 28248495 | 2017 | RQIKIWFQNRRW | MAAPC05 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 676.7 µM | Human | Homeobox Domain Of The Antp Protein | α-Helix | NA | ||
| 28453851 | 2017 | F{d}A{d}K{d}L{d}L{d}A{d}K{d}L{d}A{d}K{d}K{d}L{d}L{d} | D-HB43 | Free | Free | Linear | D | None | 13 | Antimicrobial | 50 % Hemolysis at 77 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | F{d}L{d}G{d}G{d}L{d}I{d}K{d}I{d}V{d}P{d}A{d}M{d}I{d}C{d}A{d}V{d}T{d}K{d}K{d}C{d} | D-Ranalexin | Free | Free | Linear | D | None | 20 | Antimicrobial | 50 % Hemolysis at 195 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | RRWCFRVCYRGFCYRKCR | L-Polyphemusin | Free | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 1885 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | W{d}G{d}L{d}R{d}R{d}L{d}L{d}K{d}Y{d}G{d}K{d}R{d}S{d} | D-WMR3,6Leu | Free | Free | Linear | D | None | 13 | Antimicrobial | 50 % Hemolysis at >4000 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | K{d}W{d}K{d}L{d}F{d}K{d}K{d}L{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d} | DP188Leu | Free | Free | Linear | D | None | 13 | Antimicrobial | 50 % Hemolysis at 873 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | I{d}L{d}R{d}W{d}P{d}W{d}W{d}P{d}W{d}R{d}R{d}K{d} | D-Omiganan | Free | Free | Linear | D | None | 12 | Antimicrobial | 50 % Hemolysis at 1775.5 μg/ml | Human | Synthetic | NA | NA | ||
| 28282123 | 2017 | KKAGKIAKKAGKIA{ct:Amid} | KIA(7)14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 3 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAK{ct:Amid} | KIA(7)15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAKIA{ct:Amid} | KIA(7)17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 5 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGK{ct:Amid} | KIA19 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 12 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAKKIAKIAKKIA{ct:Amid} | KIKA14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 2 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAK{ct:Amid} | KIKA15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 8 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAKIA{ct:Amid} | KIKA17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 9 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KKAGKIAKKAGKIA{ct:Amid} | KIA(7)14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 3 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAK{ct:Amid} | KIA(7)15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 6 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAKIA{ct:Amid} | KIA(7)17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 5 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGK{ct:Amid} | KIA19 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAKKIAKIAKKIA{ct:Amid} | KIKA14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 3 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAK{ct:Amid} | KIKA15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 4 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAKIA{ct:Amid} | KIKA17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 6 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KKAGKIAKKAGKIA{ct:Amid} | KIA(7)14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 4 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAK{ct:Amid} | KIA(7)15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAKIA{ct:Amid} | KIA(7)17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 4 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGK{ct:Amid} | KIA19 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 7 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAKKIAKIAKKIA{ct:Amid} | KIKA14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 4 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAK{ct:Amid} | KIKA15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 4 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAKIA{ct:Amid} | KIKA17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 9 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KKAGKIAKKAGKIA{ct:Amid} | KIA(7)14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 6 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAK{ct:Amid} | KIA(7)15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKKAGKIAKIA{ct:Amid} | KIA(7)17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 5 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGK{ct:Amid} | KIA19 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 10 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAKKIAKIAKKIA{ct:Amid} | KIKA14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 5 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAK{ct:Amid} | KIKA15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 6 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAKKIAKIA{ct:Amid} | KIKA17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 14 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28322271 | 2017 | GGLRSLGRKILRAWKKYG{ct:Amid} | BMAP-28(1-18) | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antiprotozoal | 3.4 % Hemolysis at 10 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GGLRSLGRKILRAWKKYG{ct:Amid} | BMAP-28(1-18) | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antiprotozoal | 9.6 % Hemolysis at 30 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GGFRSFGRKIFRAWKKYG{ct:Amid} | Syn1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antiprotozoal | 1.9 % Hemolysis at 10 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GGFRSFGRKIFRAWKKYG{ct:Amid} | Syn1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antiprotozoal | 7.2 % Hemolysis at 30 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GGLRSLGRKAARAWKKYG{ct:Amid} | Syn2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antiprotozoal | 0.8 % Hemolysis at 10 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GGLRSLGRKAARAWKKYG{ct:Amid} | Syn2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antiprotozoal | 1.9 % Hemolysis at 30 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GRKILRAWKKYG{ct:Amid} | Syn3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antiprotozoal | 0.5 % Hemolysis at 10 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28322271 | 2017 | GRKILRAWKKYG{ct:Amid} | Syn3 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antiprotozoal | 1.2 % Hemolysis at 30 µM | Human | Bmap-28 Derivatives | α-Helix | NA | ||
| 28559266 | 2017 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antifungal, Antibiofilm | 2.3 - 3.3 % Hemolysis at 32-128 μg/ml | Murine | Variant Of Bovine Hdp Bac2A | NA | NA | ||
| 28230992 | 2017 | LRRLRRRWRRRLRRL{ct:Amid} | 1 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | ARRARRRWRRRARRA{ct:Amid} | 2 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | FRRFRRRWRRRFRRF{ct:Amid} | 3 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | WRRWRRRWRRRWRRW{ct:Amid} | 4 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | LRRLRRRWLRRLRRR{ct:Amid} | 5 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | LRRLRRRWWRRRLRRL{ct:Amid} | 8 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at 256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | LRRLRRRWWWRRRLRR{ct:Amid} | 9 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at >256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28408902 | 2017 | KEFKRIVQRIKDFLRNLV | KE-18 | Free | Free | Linear | L | None | 18 | Antimicrobial | 1.17 (±0.18) % Hemolysis at 175 μg/ml | Human | Truncated Mimetics | α-Helix | NA | ||
| 28408902 | 2017 | KRIVQRIKDFLR | KR-12 | Free | Free | Linear | L | None | 12 | Antimicrobial | 0.45 (±0.10) % Hemolysis at 175 μg/ml | Human | Truncated Mimetics | α-Helix | NA | ||
| 28254375 | 2017 | ASVVNKLTGGVAGLLK | TP | Free | Free | Linear | L | None | 16 | Antibacterial | <10 % Hemolysis at 1.25-160 µM | Mouse | Tibetan Swine | α-Helix | NA | ||
| 28254375 | 2017 | ASVVNKLTGGVAGLLK | TP | Free | Free | Linear | L | None | 16 | Antibacterial | 9.4 ± 1.01 % Hemolysis at 320 µM | Mouse | Tibetan Swine | α-Helix | NA | ||
| 28346717 | 2017 | RERSKGSKYLYVG{ct:Amid} | Crinicepsin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <5 % Hemolysis at 100 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | RERSKGSKYLYVG{ct:Amid} | Crinicepsin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <5 % Hemolysis at 150 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | RERSKGSKYLYVG{ct:Amid} | Crinicepsin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <5 % Hemolysis at 200 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | RERSKGSKYLYVG{ct:Amid} | Crinicepsin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 10 % Hemolysis at 250 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | RERSKGSKYLYVG{ct:Amid} | Crinicepsin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <15 % Hemolysis at 300 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28346717 | 2017 | RERSKGSKYLYVG{ct:Amid} | Crinicepsin-2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 14.5 % Hemolysis at 500 μg/ml | Human | Ant Trichomyrmex Criniceps(Mayr) | α-Helix | NA | ||
| 28429216 | 2017 | KWCFRVCYGICYRRCR{nt:Acet}{ct:Amid} | tachyplesin I | Amidation | Acetylation | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 90 µM | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | NA | ||
| 28429216 | 2017 | KWCFRVCYGICYRRCR{nt:Acet}{ct:Amid} | tachyplesin I | Amidation | Acetylation | Linear | L | None | 16 | Antimicrobial | 25 % Hemolysis at 50 µM | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | NA | ||
| 28443279 | 2017 | LLPIVGNLLKSLL{ct:Amid} | TB | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 96 µM | Human | Frog Skin-Derived | α-Helix | Non-hemolytic | ||
| 28443279 | 2017 | FLPIVGLLKSLLK{ct:Amid} | TB_L1FK | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <10 % Hemolysis at 48 µM | Human | Tb Analogs | α-Helix | Non-hemolytic | ||
| 28443279 | 2017 | FLPIVGLLKSLLK{ct:Amid} | TB_L1FK | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 40 % Hemolysis at 96 µM | Human | Tb Analogs | α-Helix | NA | ||
| 28443279 | 2017 | KKLLPIVANLLKSLL{ct:Amid} | TB_KKG6A | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <10 % Hemolysis at 24 µM | Human | Tb Analogs | α-Helix | Non-hemolytic | ||
| 28443279 | 2017 | KKLLPIVANLLKSLL{ct:Amid} | TB_KKG6A | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 48 µM | Human | Tb Analogs | α-Helix | NA | ||
| 28443279 | 2017 | KKLLPIVANLLKSLL{ct:Amid} | TB_KKG6A | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 55 % Hemolysis at 96 µM | Human | Tb Analogs | α-Helix | NA | ||
| 28073163 | 2017 | {nnr:Val}WWVAARAARR{ct:Amid} | LP1 | Amidation | Free | Linear | L | Val = valerylamide, X = (S)-2-(4-pentenyl)-alanine | 10 | Antimicrobial | 50 % Hemolysis at 1810 µM | Human | Synthetic | β-Strand | NA | ||
| 28073163 | 2017 | {nnr:Val}WWV{nnr:X}ARA{nnr:X}RR{ct:Amid} | Val-HSLP | Amidation | Free | Linear | L | Val = valerylamide, X = (S)-2-(4-pentenyl)-alanine, * = Hydrocarbon-stapled using Grubbs 1st Generation Catalyst | 10 | Antimicrobial | 50 % Hemolysis at 14.5 µM | Human | Hslp Analogs | β-Strand | NA | ||
| 28073163 | 2017 | {nnr:Val}WWV{nnr:X}ARA{nnr:X}RR{ct:Amid} | Val-nHSLP | Amidation | Free | Linear | L | Val = valerylamide, X = (S)-2-(4-pentenyl)-alanine | 10 | Antimicrobial | 50 % Hemolysis at 13.4 µM | Human | Hslp Analogs | β-Strand | NA | ||
| 28073163 | 2017 | {nnr:Cap}WWV{nnr:X}AFA{nnr:X}RRR{ct:Amid} | Cap-HSLP | Amidation | Free | Linear | L | Cap = caproylamide, X = (S)-2-(4-pentenyl)-alanine, *= Hydrocarbon-stapled | 11 | Antimicrobial | 50 % Hemolysis at 4.49 µM | Human | Hslp Analogs | β-Strand | NA | ||
| 28073163 | 2017 | {nnr:Cap}WWV{nnr:X}AFA{nnr:X}RRR{ct:Amid} | Cap-nHSLP | Amidation | Free | Linear | L | Cap = caproylamide, X = (S)-2-(4-pentenyl)-alanine | 11 | Antimicrobial | 50 % Hemolysis at 3.59 µM | Human | Hslp Analogs | β-Strand | NA | ||
| 28236791 | 2017 | GLLWKWGWKWKEFLRIVGY{ct:Amid} | Peptido 6 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 51.36 % Hemolysis at 128 μg/ml | Human | Synthetic | α-Helix | NA | ||
| 28236791 | 2017 | GLLRKWGKKWKEFLRRVWK{ct:Amid} | Peptido 6.2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 34.46 % Hemolysis at 128 μg/ml | Human | Synthetic | α-Helix | NA | ||
| 28546807 | 2017 | GFVALLKKLPLILKHLH{ct:Amid} | Xac-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 37.5 ± 1.9 % Hemolysis at 100 µM | Rat | Venom Of X. Appendiculata | α-Helix | NA | ||
| 28546807 | 2017 | GFVALLKKLPLILKHLP{ct:Amid} | Xac-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 23.5 ± 1.3 % Hemolysis at 100 µM | Rat | Venom Of X. Appendiculata | α-Helix | NA | ||
| 28546807 | 2017 | INLKALAALAKKIL{ct:Amid} | Mastoparan | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 40.6 ± 2.7 % Hemolysis at 100 µM | Rat | Wasp Venom | α-Helix | NA | ||
| 28126555 | 2017 | RCGNQQFKVFVNGQ | G4 | Free | Free | Linear | L | None | 14 | Batericidal | 0 % Hemolysis at 100 µM | Fish | Channa Striatus | α-Helix | Non-hemolytic | ||
| 28126555 | 2017 | RCGNQQFKVFVNGQWWWWW | G4W | Free | Free | Linear | L | None | 19 | Batericidal | 0 % Hemolysis at 100 µM | Fish | Fish Galectin 4 Derived Membrane | α-Helix | Non-hemolytic | ||
| 28314993 | 2017 | YGRKKRRQRRR{ct:Amid} | Tat(47–57) | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Sequence Of Hiv Transactivator Protein | α-Helix | NA | ||
| 28314993 | 2017 | RQIKIWFQNRRMKWKK{ct:Amid} | Penetratin | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Third Helix Of The Homeodomain Of Drosophila Antennapedia Protein | α-Helix | NA | ||
| 28314993 | 2017 | RAGLQFPVGRVHRLLRK{ct:Amid} | Buforin II (5-21) | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Amphibians | α-Helix | NA | ||
| 28314993 | 2017 | KRLFKKLLFSLRKY{ct:Amid} | Dhvar4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Synthetic Derivatives | α-Helix | NA | ||
| 28314993 | 2017 | YKQCHKKGGKKGSG{ct:Amid} | Crot(1–9,38–42) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Venom Of Rattlesnake | α-Helix | NA | ||
| 28314993 | 2017 | KWKLFKKIGAVLKVL{ct:Amid} | CM15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 18.9 ± 1.71 µM | Human | Hybrid | α-Helix | NA | ||
| 28314993 | 2017 | TKPKGTKPKGTKPKGTKPKG{ct:Amid} | OT20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Synthetic | α-Helix | NA | ||
| 28657596 | 2017 | ILGKIWEGIKSLF{ct:Amid} | IsCT1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~100 % Hemolysis at 50 μg/ml | Human | Scorpion Opithancatus Madagascariensis | α-Helix | NA | ||
| 28657596 | 2017 | ILGKIWEGIKSLF{ct:Amid} | IsCT1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~100 % Hemolysis at 100 μg/ml | Human | Scorpion Opithancatus Madagascariensis | α-Helix | NA | ||
| 28657596 | 2017 | IFGAIWNGIKSLF{ct:Amid} | IsCT2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~100 % Hemolysis at 50 μg/ml | Human | Scorpion Opithancatus Madagascariensis | α-Helix | NA | ||
| 28657596 | 2017 | IFGAIWNGIKSLF{ct:Amid} | IsCT2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~100 % Hemolysis at 100 μg/ml | Human | Scorpion Opithancatus Madagascariensis | α-Helix | NA | ||
| 28657596 | 2017 | ILGKAWEGAKSLF{ct:Amid} | IsCT1A1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28657596 | 2017 | ILGKVWEGVKSLF{ct:Amid} | IsCT1V1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28657596 | 2017 | ILGKLWEGLKSLF{ct:Amid} | IsCT1L1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 80 % Hemolysis at 50 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28657596 | 2017 | ILGKLWEGLKSLF{ct:Amid} | IsCT1L1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <100 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28657596 | 2017 | ILGKIWKGIKSLF{ct:Amid} | IsCT1K7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 50 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28657596 | 2017 | ILGKIWKGIKSLF{ct:Amid} | IsCT1K7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <70 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28657596 | 2017 | ILGKIWEGIESLF{ct:Amid} | IsCT1E7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | Non-hemolytic | ||
| 28657596 | 2017 | ILGAAWNGAKSLF{ct:Amid} | IsCT2A1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | Non-hemolytic | ||
| 28657596 | 2017 | ILGAVWNGVKSLF{ct:Amid} | IsCT2V1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 20 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28661457 | 2017 | DLRDSWKVIGSDKK | AI-Hemocidin 2 | Free | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at >500 μg/ml | Human | Arca Inflata | α-Helix | NA | ||
| 28661457 | 2017 | DLRDSWKVIGSDKK | AI-Hemocidin 2 | Free | Free | Linear | L | None | 14 | Antibacterial | 10.27 ± 0.42 % Hemolysis at 500 μg/ml | Human | Arca Inflata | α-Helix | NA | ||
| 28004513 | 2017 | GVSRCLSRRGVSRCLSRR | 2Ser_L | Free | Free | Linear | L | None | 12 | Antitumour | 0.0 ± 0.4 % Hemolysis at 5 μg/ml | Human | Synthesized Θ-Defensin Analogues | NA | Non-hemolytic | ||
| 28004513 | 2017 | GVSRCLSRRGVSRCLSRR | 2Ser_L | Free | Free | Linear | L | None | 12 | Antitumour | 0.0 ± 0.5 % Hemolysis at 10 μg/ml | Human | Synthesized Θ-Defensin Analogues | NA | Non-hemolytic | ||
| 28004513 | 2017 | GVSRCLSRRGVSRCLSRR | 2Ser_L | Free | Free | Linear | L | None | 12 | Antitumour | 0.0 ± 0.1 % Hemolysis at 25 μg/ml | Human | Synthesized Θ-Defensin Analogues | NA | Non-hemolytic | ||
| 28459130 | 2017 | RKSREWRSKKTQPRRPR | Glycinin-17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0.3 % Hemolysis at 0-500 µM | Sheep | Soybean Proteins | NA | Non-hemolytic | ||
| 28459130 | 2017 | KNQYGRIRVLQRFNQR | BCAS-16 | Free | Free | Linear | L | None | 16 | Antimicrobial | 40 % Hemolysis at 50 µM | Sheep | Soybean Proteins | NA | NA | ||
| 28459130 | 2017 | KNQYGRIRVLQRFNQR | BCAS-16 | Free | Free | Linear | L | None | 16 | Antimicrobial | >40 % Hemolysis at 200 µM | Sheep | Soybean Proteins | NA | NA | ||
| 28459130 | 2017 | KNQYGRIRVLQRFNQR | BCAS-16 | Free | Free | Linear | L | None | 16 | Antimicrobial | >40 % Hemolysis at 300 µM | Sheep | Soybean Proteins | NA | NA | ||
| 28459130 | 2017 | KNQYGRIRVLQRFNQR | BCAS-16 | Free | Free | Linear | L | None | 16 | Antimicrobial | >40 % Hemolysis at 400 µM | Sheep | Soybean Proteins | NA | NA | ||
| 28459130 | 2017 | KNQYGRIRVLQRFNQR | BCAS-16 | Free | Free | Linear | L | None | 16 | Antimicrobial | >40 % Hemolysis at 500 µM | Sheep | Soybean Proteins | NA | NA | ||
| 28459130 | 2017 | RIRLLQRFNKR | BCBS-11 | Free | Free | Linear | L | None | 11 | Antimicrobial | 1.4 % Hemolysis at 0-500 µM | Sheep | Soybean Proteins | NA | Non-hemolytic | ||
| 28461043 | 2017 | AIGHCLGATL | Andricin 01 | Free | Free | Linear | L | None | 10 | Antimicrobial | 0 % Hemolysis at 25 μg/ml | Human | Andrias Davidianus, The Chinese Giant Salamander | NA | NA | ||
| 28461043 | 2017 | AIGHCLGATL | Andricin 01 | Free | Free | Linear | L | None | 10 | Antimicrobial | 0 % Hemolysis at 50 μg/ml | Human | Andrias Davidianus, The Chinese Giant Salamander | NA | NA | ||
| 28461043 | 2017 | AIGHCLGATL | Andricin 01 | Free | Free | Linear | L | None | 10 | Antimicrobial | 4.3 ± 0.16 % Hemolysis at 100 μg/ml | Human | Andrias Davidianus, The Chinese Giant Salamander | NA | NA | ||
| 28461043 | 2017 | AIGHCLGATL | Andricin 01 | Free | Free | Linear | L | None | 10 | Antimicrobial | 16.3 ± 2.16 % Hemolysis at 200 μg/ml | Human | Andrias Davidianus, The Chinese Giant Salamander | NA | NA | ||
| 28522372 | 2017 | RLLRKFFRKLKKSV | Cbf-14 | Free | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Sheep | Cathelicidin-Bf | α-Helix | Non-hemolytic | ||
| 28522372 | 2017 | R{nnr:Nle}LRKFFRKLKKSV | Cbf-14-N | Free | Free | Linear | L | Nle = Norleucine | 14 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Sheep | Mutant Of Cbf-14 | α-Helix | Non-hemolytic | ||
| 28522372 | 2017 | RLLR{nnr:O}FFRKLKKSV{ct:Amid} | Cbf-14-1 | Amidation | Free | Linear | L | O = L-Ornithine | 14 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Sheep | Mutant Of Cbf-14 | α-Helix | Non-hemolytic | ||
| 28522372 | 2017 | RLLR{nnr:O}FFR{nnr:O}LKKSV{ct:Amid} | Cbf-14-2 | Amidation | Free | Linear | L | O = L-Ornithine | 14 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Sheep | Mutant Of Cbf-14 | α-Helix | Non-hemolytic | ||
| 28522372 | 2017 | RLLR{nnr:O}FFR{nnr:O}LK{nnr:O}SV{ct:Amid} | Cbf-14-3 | Amidation | Free | Linear | L | O = L-Ornithine | 14 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Sheep | Mutant Of Cbf-14 | α-Helix | Non-hemolytic | ||
| 28522372 | 2017 | RDLDLDRDKDFDFDRDKDLDKDKDSDVD | D-Cbf-14 | Free | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Sheep | Mutant Of Cbf-14 | α-Helix | Non-hemolytic | ||
| 28675109 | 2017 | FKRIVQRIKDFLRNLV{ct:Amid} | FK-16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at ~35 µM | Human | Ll-37 Peptide | α-Helix | NA | ||
| 28733329 | 2017 | YPCKLNLKLGKVPFH{ct:Amid} | Periplanetasin-2 | Amidation | Free | Linear | L | None | 15 | Antifungal | 0 % Hemolysis at 80 µM | Human | American Cockroach Periplaneta Americana | NA | Non-hemolytic | ||
| 28733329 | 2017 | YPCKLNLKLGKVPFH{ct:Amid} | Periplanetasin-2 | Amidation | Free | Linear | L | None | 15 | Antifungal | 0 % Hemolysis at 40 µM | Human | American Cockroach Periplaneta Americana | NA | Non-hemolytic | ||
| 28733329 | 2017 | YPCKLNLKLGKVPFH{ct:Amid} | Periplanetasin-2 | Amidation | Free | Linear | L | None | 15 | Antifungal | 0 % Hemolysis at 20 µM | Human | American Cockroach Periplaneta Americana | NA | Non-hemolytic | ||
| 28733329 | 2017 | YPCKLNLKLGKVPFH{ct:Amid} | Periplanetasin-2 | Amidation | Free | Linear | L | None | 15 | Antifungal | 0 % Hemolysis at 10 µM | Human | American Cockroach Periplaneta Americana | NA | Non-hemolytic | ||
| 28733329 | 2017 | YPCKLNLKLGKVPFH{ct:Amid} | Periplanetasin-2 | Amidation | Free | Linear | L | None | 15 | Antifungal | 0 % Hemolysis at 5 µM | Human | American Cockroach Periplaneta Americana | NA | Non-hemolytic | ||
| 28733329 | 2017 | YPCKLNLKLGKVPFH{ct:Amid} | Periplanetasin-2 | Amidation | Free | Linear | L | None | 15 | Antifungal | 0 % Hemolysis at 2.5 µM | Human | American Cockroach Periplaneta Americana | NA | Non-hemolytic | ||
| 28733329 | 2017 | YPCKLNLKLGKVPFH{ct:Amid} | Periplanetasin-2 | Amidation | Free | Linear | L | None | 15 | Antifungal | 0 % Hemolysis at 1.3 µM | Human | American Cockroach Periplaneta Americana | NA | Non-hemolytic | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 99 % Hemolysis at 80 µM | Human | Bee Venom | NA | NA | ||
| 28855917 | 2017 | GFVALLKKLPLILKHLH{ct:Amid} | xylopin | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 30 % Hemolysis at 1 mM | Mouse | Xylocopa Appendiculata Circumvolans | α-Helix | Non-hemolytic | ||
| 28608418 | 2017 | LVGKLLKGAVGDVCGLLPIC | OA-A1 | Free | Free | Linear | L | None | 20 | Anti-diabetic | 1.82% ± 0.14 % Hemolysis at 1 nM | Human | Skin Secretions Of Odorrana Andersonii | NA | NA | ||
| 28608418 | 2017 | LVGKLLKGAVGDVCGLLPIC | OA-A1 | Free | Free | Linear | L | None | 20 | Anti-diabetic | 2.82% ± 0.17 % Hemolysis at 10 nM | Human | Skin Secretions Of Odorrana Andersonii | NA | NA | ||
| 28608418 | 2017 | LVGKLLKGAVGDVCGLLPIC | OA-A1 | Free | Free | Linear | L | None | 20 | Anti-diabetic | 1.03% ± 0.86 % Hemolysis at 100 nM | Human | Skin Secretions Of Odorrana Andersonii | NA | NA | ||
| 28608418 | 2017 | LVGKLLKGAVGDVCGLLPIC | OA-A1 | Free | Free | Linear | L | None | 20 | Anti-diabetic | 2.72% ± 0.54 % Hemolysis at 1 µM | Human | Skin Secretions Of Odorrana Andersonii | NA | NA | ||
| 28608418 | 2017 | LVGKLLKGAVGDVCGLLPIC | OA-A1 | Free | Free | Linear | L | None | 20 | Anti-diabetic | 2.58% ± 0.11 % Hemolysis at 10 µM | Human | Skin Secretions Of Odorrana Andersonii | NA | NA | ||
| 28608418 | 2017 | LVGKLLKGAVGDVCGLLPIC | OA-A1 | Free | Free | Linear | L | None | 20 | Anti-diabetic | 1.26% ± 0.39 % Hemolysis at 100 µM | Human | Skin Secretions Of Odorrana Andersonii | NA | NA | ||
| 28754346 | 2017 | INWKAILGKIGK | Communis | Free | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 142.6 µM | Swiss mouse | Chartergellus Communis | α-Helix | Non-hemolytic | ||
| 28754346 | 2017 | INWKAILGKIGKAAAAVL{ct:Amid} | Communis-AAAA | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 142.6 µM | Swiss mouse | Chartergellus Communis | α-Helix | NA | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0.32 % Hemolysis at 50 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 50 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0.16 % Hemolysis at 100 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 100 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 250 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 250 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 500 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 500 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 50 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 50 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 100 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 100 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0.21 % Hemolysis at 250 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 250 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0.16 % Hemolysis at 500 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 500 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0 % Hemolysis at 50 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0.59 % Hemolysis at 50 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0 % Hemolysis at 100 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0 % Hemolysis at 100 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0.11 % Hemolysis at 250 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0.51 % Hemolysis at 250 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0.53 % Hemolysis at 500 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0.98 % Hemolysis at 500 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 0 % Hemolysis at 50 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 4.4 % Hemolysis at 50 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 0 % Hemolysis at 100 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 5.8 % Hemolysis at 100 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 0 % Hemolysis at 250 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 7.54 % Hemolysis at 250 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 0.2 % Hemolysis at 500 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 9.66 % Hemolysis at 500 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28894233 | 2017 | IFGAILPLALGALKNLIK | RGD-Hylin a1 | Free | Free | Linear | L | None | 18 | Antibacterial | 30 % Hemolysis at 12.5 μg/ml | Human | Skin Of South American Tree Frogs | NA | NA | ||
| 28894233 | 2017 | IFGAILPLALGALKNLIK | RGD-Hylin a1 | Free | Free | Linear | L | None | 18 | Antibacterial | 76 % Hemolysis at 25 μg/ml | Human | Skin Of South American Tree Frogs | NA | NA | ||
| 28894233 | 2017 | IFGAILPLALGALKNLIK | RGD-Hylin a1 | Free | Free | Linear | L | None | 18 | Antibacterial | 82 % Hemolysis at 37 μg/ml | Human | Skin Of South American Tree Frogs | NA | NA | ||
| 28894233 | 2017 | IFGAILPLALGALKNLIK | RGD-Hylin a1 | Free | Free | Linear | L | None | 18 | Antibacterial | 99 % Hemolysis at 50 μg/ml | Human | Skin Of South American Tree Frogs | NA | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 1 µM | Sheep | Synthetic | NA | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 2 µM | Sheep | Synthetic | NA | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 4 µM | Sheep | Synthetic | NA | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 8 µM | Sheep | Synthetic | NA | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 16 µM | Sheep | Synthetic | NA | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 32 µM | Sheep | Synthetic | NA | NA | ||
| 28571698 | 2017 | FKIGGFIKKLWRSLLA | ZXR-2 | Free | Free | Linear | L | None | 16 | Antimicrobial | ~15 % Hemolysis at 64 µM | Sheep | Synthetic | NA | NA | ||
| 28656506 | 2017 | GKPRPYSPRPTSHPRPIRV | n-drosocin | Free | Free | Linear | L | None | 19 | Antibacterial | <10 % Hemolysis at 200 µM | Rat | Drosophila Melanogaster | Random coil | NA | ||
| 28656506 | 2017 | GKPRPYSPRPTSHPRPIRV | M-drosocin | Free | Free | Linear | L | None | 19 | Antibacterial | <10 % Hemolysis at 200 µM | Rat | Drosophila Melanogaster | Random coil | NA | ||
| 28656506 | 2017 | GKPRPYSPRPTSHPRPIRV | Di-drosocin | Free | Free | Linear | L | None | 19 | Antibacterial | <10 % Hemolysis at 200 µM | Rat | Drosophila Melanogaster | Random coil | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}GRIL{ct:Amid} | 1 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 21(±4) % Hemolysis at 50 µM | Human | Amphibian Temporins | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}GRIL{ct:Amid} | 1 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 7(±3) % Hemolysis at 25 µM | Human | Amphibian Temporins | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}GRIL{ct:Amid} | 1 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 6(±3) % Hemolysis at 12.5 µM | Human | Amphibian Temporins | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}GRIL{ct:Amid} | 1 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 3(±2) % Hemolysis at 6.25 µM | Human | Amphibian Temporins | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}GRIL{ct:Amid} | 1 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 1(±1) % Hemolysis at 3.125 µM | Human | Amphibian Temporins | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}K{d}RIL{ct:Amid} | 9 | Amidation | Free | Linear | Mix | l = D-Leucine, k = D-Lys | 13 | Antibacterial | 7(±4) % Hemolysis at 50 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}K{d}RIL{ct:Amid} | 9 | Amidation | Free | Linear | Mix | l = D-Leucine, k = D-Lys | 13 | Antibacterial | 5(±3) % Hemolysis at 25 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}K{d}RIL{ct:Amid} | 9 | Amidation | Free | Linear | Mix | l = D-Leucine, k = D-Lys | 13 | Antibacterial | 5(±2) % Hemolysis at 12.5 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}K{d}RIL{ct:Amid} | 9 | Amidation | Free | Linear | Mix | l = D-Leucine, k = D-Lys | 13 | Antibacterial | 1(±2) % Hemolysis at 6.25 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}K{d}RIL{ct:Amid} | 9 | Amidation | Free | Linear | Mix | l = D-Leucine, k = D-Lys | 13 | Antibacterial | 0(±1) % Hemolysis at 3.125 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}WRIL{ct:Amid} | 10 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 37(±1) % Hemolysis at 50 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}WRIL{ct:Amid} | 10 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 20(±3) % Hemolysis at 25 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}WRIL{ct:Amid} | 10 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 7(±1) % Hemolysis at 12.5 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}WRIL{ct:Amid} | 10 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 4(±2) % Hemolysis at 6.25 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}WRIL{ct:Amid} | 10 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 2(±1) % Hemolysis at 3.125 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28894024 | 2017 | LLGPVLGLVSNVLGGLL{ct:Amid} | Bombinin HL | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >512 mg/l | Horse | Bombina Orientalis | α-Helix | NA | ||
| 28894024 | 2017 | LLGPVLGLVSNVLGGLL{ct:Amid} | Bombinin HD | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >512 mg/l | Horse | Bombina Orientalis | α-Helix | NA | ||
| 29185466 | 2017 | GFGMALKLLKKVL{ct:Amid} | Macropin | Amidation | Free | Linear | L | None | 13 | Anti-bioflm, Antibacterial | 5 % Hemolysis at 25 µM | Human | Macropis Fulvipes Venom | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 23 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 64 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 128 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 256 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 512 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29163899 | 2017 | CW{d}WW{d}KK{d}KK{d}KC{cyc:N-C}{ct:Amid} | RH5 | Amidation | Free | Cyclic | Mix | None | 10 | Antimicrobial | MHC at 1000 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CW{d}WW{d}WK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid} | RH6 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 31 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | C{d}WW{d}WW{d}KK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid} | RH7 | Amidation | Free | Cyclic | Mix | None | 12 | Antimicrobial | MHC at 31 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CwWwWkKkKkC{cyc:N-C}{ct:Amid} | RH6m | Amidation | Free | Cyclic | Mix | Cyclized with α,α′-dichloro-meta-xylene | 11 | Antimicrobial | MHC at 31 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CwWwWkKkKkC{cyc:N-C}{ct:Amid} | RH6o | Amidation | Free | Cyclic | Mix | Cyclized with α,α′-dichloro-ortho-xylene. | 11 | Antimicrobial | MHC at 31 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CwWwWkKkKkC{cyc:N-C}{ct:Amid} | RH6ss | Amidation | Free | Cyclic | Mix | Cyclized with disulfide bridge | 11 | Antimicrobial | Minimum Hemolytic Concentration | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CF{d}FF{d}FK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid} | RH8 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 500 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CL{d}LL{d}LK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid} | RH9 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at >2000 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CK{d}KK{d}WW{d}WW{d}KK{d}C{cyc:N-C}{ct:Amid} | RH10 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 250 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CW{d}WK{d}KK{d}KK{d}WW{d}C{cyc:N-C}{ct:Amid} | RH11 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 125 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | C{d}WW{d}KK{d}KK{d}KW{d}WC{d}{cyc:N-C}{ct:Amid} | dRH11 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | Minimum Hemolytic Concentration | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CwWkKkKkWwC{cyc:N-C}{ct:Amid} | RH11m | Amidation | Free | Cyclic | Mix | Cyclized with α,α′-dichloro-meta-xylene | 11 | Antimicrobial | Minimum Hemolytic Concentration | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CwWkKkKkWwC{cyc:N-C}{ct:Amid} | RH11o | Amidation | Free | Cyclic | Mix | Cyclized with α,α′-dichloro-ortho-xylene. | 11 | Antimicrobial | Minimum Hemolytic Concentration | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CK{d}WK{d}WK{d}WK{d}WK{d}C{cyc:N-C}{ct:Amid} | RH12 | Amidation | Free | Cyclic | Mix | None | 10 | Antimicrobial | MHC at 1000 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CWW{d}KK{d}KK{d}KW{d}WW{d}C{cyc:N-C}{ct:Amid} | RH13 | Amidation | Free | Cyclic | Mix | None | 12 | Antimicrobial | MHC at 125 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | C{d}W{d}WK{d}KK{d}KK{d}WW{d}WC{d}{cyc:N-C}{ct:Amid} | dRH13 | Amidation | Free | Cyclic | Mix | None | 12 | Antimicrobial | Minimum Hemolytic Concentration | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CW{d}WK{d}KK{d}KW{d}WW{d}C{cyc:N-C}{ct:Amid} | RH14 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 8 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CW{d}KK{d}KK{d}KK{d}WW{d}C{cyc:N-C}{ct:Amid} | RH15 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 250 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CL{d}LK{d}KK{d}KK{d}LL{d}C{cyc:N-C}{ct:Amid} | RH16 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at >2000 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CWWKKKKKWWC{cyc:N-C}{ct:Amid} | RH17 | Amidation | Free | Cyclic | Mix | None | 11 | Antimicrobial | MHC at 250 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | C({nnr:Me})wWkKkKkW({nnr:Me})wC{cyc:N-C}{ct:Amid} | RH18 | Amidation | Free | Cyclic | Mix | Me = N-methylation of the peptide bond. | 11 | Antimicrobial | MHC at 8 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | Cw({nnr:Me})WkKkKkW({nnr:Me})wC{cyc:N-C}{ct:Amid} | RH19 | Amidation | Free | Cyclic | Mix | Me = N-methylation of the peptide bond. | 11 | Antimicrobial | MHC at 1000 µg/mL | Human | Camp | β-Sheet | NA | ||
| 29163899 | 2017 | CwW({nnr:Me})kKkK({nnr:Me})kWwC{cyc:N-C}{ct:Amid} | RH20 | Amidation | Free | Cyclic | Mix | Me = N-methylation of the peptide bond. | 11 | Antimicrobial | MHC at 1000 µg/mL | Human | Camp | β-Sheet | NA | ||
| 28987278 | 2017 | ERFQPMFRRPG | REP-ERF | Free | Free | Linear | L | None | 12 | LPS-neutralizing, angiogenic activities | 3.2 % Hemolysis at 500 µM | Sheep | Peptic Hydrolysates Of Rice Endosperm Protein | NA | Non-hemolytic | ||
| 28987278 | 2017 | RVRQNIDNPNRADTYNPRAG | REP-RVR | Free | Free | Linear | L | None | 20 | LPS-neutralizing, angiogenic activities | 9.5 % Hemolysis at 500 µM | Sheep | Peptic Hydrolysates Of Rice Endosperm Protein | NA | Non-hemolytic | ||
| 28987278 | 2017 | VVRRVIEPRGLL | REP-VVR | Free | Free | Linear | L | None | 12 | LPS-neutralizing, angiogenic activities,Antimicrobial | 3.3 % Hemolysis at 500 µM | Sheep | Peptic Hydrolysates Of Rice Endosperm Protein | NA | Non-hemolytic | ||
| 28699258 | 2017 | IVPFLLGMVPKLVCLITKKC | Brevinin-1ITa | Free | Free | Linear | L | None | 20 | Cytotoxic | 50 % Hemolysis at 7 µM | mouse | Italian Stream Frog Rana Italica | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | Hc1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 1.09 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | Hc1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 2.9 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | Hc1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 3.26 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | Hc1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 4.35 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | Hc1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 8.33 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFR{ct:Amid} | Hc2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 1.45 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFR{ct:Amid} | Hc2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0.36 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFR{ct:Amid} | Hc2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 1.09 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFR{ct:Amid} | Hc2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 2.9 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFR{ct:Amid} | Hc2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 3.98 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKF{ct:Amid} | Hc3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2.17 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKF{ct:Amid} | Hc3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 4.35 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKF{ct:Amid} | Hc3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 5.43 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKF{ct:Amid} | Hc3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 5.8 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKF{ct:Amid} | Hc3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 6.88 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKK{ct:Amid} | Hc4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2.9 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKK{ct:Amid} | Hc4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 1.81 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKK{ct:Amid} | Hc4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 1.09 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKK{ct:Amid} | Hc4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2.54 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKK{ct:Amid} | Hc4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 4.71 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVK{ct:Amid} | Hc5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 3.62 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVK{ct:Amid} | Hc5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 1.09 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVK{ct:Amid} | Hc5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 2.9 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVK{ct:Amid} | Hc5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5.43 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVK{ct:Amid} | Hc5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5.07 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAV{ct:Amid} | Hc6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 1.45 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAV{ct:Amid} | Hc6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 2.9 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAV{ct:Amid} | Hc6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 1.81 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAV{ct:Amid} | Hc6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0.72 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAV{ct:Amid} | Hc6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 3.62 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRA{ct:Amid} | Hc7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 2.17 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRA{ct:Amid} | Hc7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.45 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRA{ct:Amid} | Hc7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.72 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRA{ct:Amid} | Hc7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.26 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRA{ct:Amid} | Hc7 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5.07 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKFRK{ct:Amid} | Hc8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 2.17 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKFRK{ct:Amid} | Hc8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 3.62 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKFRK{ct:Amid} | Hc8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 0.36 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKFRK{ct:Amid} | Hc8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 2.17 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKFRK{ct:Amid} | Hc8 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 1.45 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKFRK{ct:Amid} | Hc9 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 3.99 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKFRK{ct:Amid} | Hc9 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2.9 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKFRK{ct:Amid} | Hc9 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2.54 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKFRK{ct:Amid} | Hc9 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2.54 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKFRK{ct:Amid} | Hc9 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 4.17 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KRLLKSVRRAVKKFRK{ct:Amid} | Hc10 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2.17 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KRLLKSVRRAVKKFRK{ct:Amid} | Hc10 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2.9 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KRLLKSVRRAVKKFRK{ct:Amid} | Hc10 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 3.99 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KRLLKSVRRAVKKFRK{ct:Amid} | Hc10 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 1.81 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | KRLLKSVRRAVKKFRK{ct:Amid} | Hc10 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2.17 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | RLLKSVRRAVKKFRK{ct:Amid} | Hc11 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 4.71 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | RLLKSVRRAVKKFRK{ct:Amid} | Hc11 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 3.26 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | RLLKSVRRAVKKFRK{ct:Amid} | Hc11 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 2.9 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | RLLKSVRRAVKKFRK{ct:Amid} | Hc11 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 4.71 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | RLLKSVRRAVKKFRK{ct:Amid} | Hc11 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5.8 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LLKSVRRAVKKFRK{ct:Amid} | Hc12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 2.17 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LLKSVRRAVKKFRK{ct:Amid} | Hc12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 1.45 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LLKSVRRAVKKFRK{ct:Amid} | Hc12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0.11 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LLKSVRRAVKKFRK{ct:Amid} | Hc12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 4.35 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LLKSVRRAVKKFRK{ct:Amid} | Hc12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 3.99 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LKSVRRAVKKFRK{ct:Amid} | Hc13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.45 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LKSVRRAVKKFRK{ct:Amid} | Hc13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.81 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LKSVRRAVKKFRK{ct:Amid} | Hc13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.36 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LKSVRRAVKKFRK{ct:Amid} | Hc13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.45 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | LKSVRRAVKKFRK{ct:Amid} | Hc13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.16 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKF{ct:Amid} | Hc14 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 3.98 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKF{ct:Amid} | Hc14 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 2.54 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKF{ct:Amid} | Hc14 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 1.98 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKF{ct:Amid} | Hc14 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 1.36 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FFKRLLKSVRRAVKKF{ct:Amid} | Hc14 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 3.26 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKF{ct:Amid} | Hc15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 3.62 % Hemolysis at 12.5 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKF{ct:Amid} | Hc15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 4.35 % Hemolysis at 25 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKF{ct:Amid} | Hc15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 5.07 % Hemolysis at 50 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKF{ct:Amid} | Hc15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 8.7 % Hemolysis at 100 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28572668 | 2017 | FKRLLKSVRRAVKKF{ct:Amid} | Hc15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 9.06 % Hemolysis at 200 µg/mL | Human | Hc-Cath Truncated Derivatives | α-Helix | NA | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 14.5 % Hemolysis at 200 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 11.2 % Hemolysis at 100 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 7.8 % Hemolysis at 50 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPMLADLVSKIFGK{ct:Amid} | Temporin-DY1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CGYKYGCMVKVDR{ct:Amid} | Daiyunin-1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | IVRPPIRCKAAFC{ct:Amid} | Daiyunin-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 78.1 % Hemolysis at 200 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 48.8 % Hemolysis at 100 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 20.2 % Hemolysis at 50 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 7.3 % Hemolysis at 25 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPLLAGLAAKWFGK{ct:Amid} | Temporin-HB1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 78 % Hemolysis at 200 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 77.8 % Hemolysis at 100 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 77.4 % Hemolysis at 50 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 64.8 % Hemolysis at 25 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 33.3 % Hemolysis at 12.5 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 7.9 % Hemolysis at 6.3 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPFLAGLFGKIFGK{ct:Amid} | Temporin-HB2 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 8.5 % Hemolysis at 200 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 6.8 % Hemolysis at 100 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GAPKGCWTKSYPPQPCFGKK{ct:Amid} | Ranacyclin-HB1 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 99.8 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 95.3 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 59 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 13 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLTGLIGGLMKALGK{ct:Amid} | Temporin-MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 92.4 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 84.8 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 39.9 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 15.9 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFPLVLGALGSILPKVFGK{ct:Amid} | Temporin-MS4 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | QYRPGSFGPLNQK{ct:Amid} | Maosonensis-1MS1 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DYSIRTRLHQESSRNDF{ct:Amid} | Odorranaopin-MS1 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | DNVYSRPPQRFGQNVIS{ct:Amid} | Odorranaopin-MS2 | Amidation | Free | Linear | L | None | 17 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 5 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FKTWKNRPILSSCSGIIKG{ct:Amid} | Nigroain-C-MS1 | Amidation | Free | Linear | L | None | 19 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 16.6 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 16.1 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CQWQFISPSRAGCIGP{ct:Amid} | Nigroain-D-SN1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLPIPGVRCKILRTC{ct:Amid} | Pleskein-1 | Amidation | Free | Linear | L | None | 16 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFLLPIPNDVKCKLGICKS{ct:Amid} | Pleskein-2 | Amidation | Free | Linear | L | None | 20 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28402481 | 2017 | ILPSKLCRLLGNC{ct:Amid} | Pleskein-3 | Amidation | Free | Linear | L | None | 13 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Nanorana Pleskei | NA | Non-hemolytic | ||
| 28026016 | 2017 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Antimicrobial | 3 ± 0.6 % Hemolysis at 150 µM | Horse | Synthetic Peptidotriazoles | NA | NA | ||
| 28026016 | 2017 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Antimicrobial | 3 ± 0.6 % Hemolysis at 250 µM | Horse | Synthetic Peptidotriazoles | NA | NA | ||
| 28026016 | 2017 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Antimicrobial | 4 ± 0.7 % Hemolysis at 375 µM | Horse | Synthetic Peptidotriazoles | NA | NA | ||
| 28833783 | 2017 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <10 % Hemolysis at 50 µM | Human | Venom Of The Social Wasp Polybia Paulista | NA | NA | ||
| 28833783 | 2017 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 30 % Hemolysis at 150 µM | Human | Venom Of The Social Wasp Polybia Paulista | NA | NA | ||
| 28833783 | 2017 | IDWKKLLKAAK{nnr:Pra}IL{cyc:N-C}{nt:Acet}{ct:Amid} | C-MPI-1 | Amidation | Acetylation | Cyclic | Mix | Pra = L-propargylglycine | 16 | Antimicrobial | 30 % Hemolysis at 50 µM | Human | Mpi Analogs | α-Helical | NA | ||
| 28833783 | 2017 | IDWKKLLKAAK{nnr:Pra}IL{cyc:N-C}{nt:Acet}{ct:Amid} | C-MPI-1 | Amidation | Acetylation | Cyclic | Mix | Pra = L-propargylglycine | 16 | Antimicrobial | 35 % Hemolysis at 150 µM | Human | Mpi Analogs | α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0.1 % Hemolysis at <20 µM | Human | Social Wasp Polybia Paulista | α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLK{d}SL{ct:Amid} | D-lys-CP | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | 0 % Hemolysis at <20 µM | Human | D-Lysine Substituted Derivative | α-Helical | Non-hemolytic | ||
| 28981608 | 2017 | I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid} | D-CP | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | <0.2 % Hemolysis at <20 µM | Human | D-Counterpart Of Polybia-Cp | Left-hand α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <0.4 % Hemolysis at >30 µM | Human | Social Wasp Polybia Paulista | α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLK{d}SL{ct:Amid} | D-lys-CP | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | 0 % Hemolysis at >30 µM | Human | D-Lysine Substituted Derivative | α-Helical | Non-hemolytic | ||
| 28981608 | 2017 | I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid} | D-CP | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | <0.4 % Hemolysis at >30 µM | Human | D-Counterpart Of Polybia-Cp | Left-hand α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0.6 % Hemolysis at <70 µM | Human | Social Wasp Polybia Paulista | α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLK{d}SL{ct:Amid} | D-lys-CP | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | 0 % Hemolysis at <70 µM | Human | D-Lysine Substituted Derivative | α-Helical | Non-hemolytic | ||
| 28981608 | 2017 | I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid} | D-CP | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | <0.5 % Hemolysis at <70 µM | Human | D-Counterpart Of Polybia-Cp | Left-hand α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLKSL{ct:Amid} | Polybia-CP | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0.6 % Hemolysis at 130 µM | Human | Social Wasp Polybia Paulista | α-Helical | NA | ||
| 28981608 | 2017 | ILGTILGLLK{d}SL{ct:Amid} | D-lys-CP | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | 0.2 % Hemolysis at 130 µM | Human | D-Lysine Substituted Derivative | α-Helical | NA | ||
| 28981608 | 2017 | I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid} | D-CP | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | 0.5 % Hemolysis at 130 µM | Human | D-Counterpart Of Polybia-Cp | Left-hand α-Helical | NA | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 1 μg/ml in 1hr | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 5 μg/ml in 1hr | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 50 μg/ml in 1hr | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | <5 % Hemolysis at 100 μg/ml in 1hr | Human | Synthetic Peptide | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | <5 % Hemolysis at 1 μg/ml in 1hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | <5 % Hemolysis at 5 μg/ml in 1hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | <5 % Hemolysis at 50 μg/ml in 1hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | <5 % Hemolysis at 100 μg/ml in 1hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | <5 % Hemolysis at 1 μg/ml in 24hr | Human | Synthetic Peptide | NA | NA | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | <10 % Hemolysis at 5 μg/ml in 24hr | Human | Synthetic Peptide | NA | NA | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | <15 % Hemolysis at 50 μg/ml in 24hr | Human | Synthetic Peptide | NA | NA | ||
| 28856417 | 2017 | KIQGTCYRGKAKCCK | HBD-1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 21.62 % Hemolysis at 100 μg/ml in 24hr | Human | Synthetic Peptide | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | 5 % Hemolysis at 1 μg/ml in 24hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | <10 % Hemolysis at 5 μg/ml in 24hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | <10 % Hemolysis at 50 μg/ml in 24hr | Human | Hbd-1 Motif | NA | NA | ||
| 28856417 | 2017 | ACPIFTKIQGTCYRG | Pep-B | Free | Free | Linear | L | None | 15 | Antimicrobial | 9 % Hemolysis at 100 μg/ml in 24hr | Human | Hbd-1 Motif | NA | NA | ||
| 28756544 | 2017 | GLFDIIKKIAESF{ct:Amid} | aurein 1.2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 1-512 μg/ml | Human | Australian Bell Frogs, Ranoidea Aurea | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | FSEAIKKIIDFLG{ct:Amid} | r-aurein 1.2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | Analog Of Aurein 1.2 | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | FSEAIKKIIDFLG{ct:Amid} | r-aurein 1.2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <10 % Hemolysis at 512 μg/ml | Human | Analog Of Aurein 1.2 | α-Helical | NA | ||
| 28756544 | 2017 | KWKLFKKIGAVLKVL{ct:Amid} | CAMEL | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 45299 μg/ml | Human | Hybrid Peptide | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | KWKLFKKIGAVLKVL{ct:Amid} | CAMEL | Amidation | Free | Linear | L | None | 15 | Antimicrobial | <10 % Hemolysis at 64 μg/ml | Human | Hybrid Peptide | α-Helical | NA | ||
| 28756544 | 2017 | KWKLFKKIGAVLKVL{ct:Amid} | CAMEL | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 512 μg/ml | Human | Hybrid Peptide | α-Helical | NA | ||
| 28756544 | 2017 | LVKLVAGIKKFLKWK{ct:Amid} | r-CAMEL | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | Analog Of Camel | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | LVKLVAGIKKFLKWK{ct:Amid} | r-CAMEL | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 512 μg/ml | Human | Analog Of Camel | α-Helical | NA | ||
| 28756544 | 2017 | GLFDVIKKVASVIGGL{ct:Amid} | citropin 1.1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | Green Tree Frog, Ranoidea Citropa | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | GLFDVIKKVASVIGGL{ct:Amid} | citropin 1.1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | <20 % Hemolysis at 512 μg/ml | Human | Green Tree Frog, Ranoidea Citropa | α-Helical | NA | ||
| 28756544 | 2017 | LGGIVSAVKKIVDFLG{ct:Amid} | r-citropin 1.1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 1-512 μg/ml | Human | Analog Of Citropin 1.1 | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | ILRWPWWPWRRK{ct:Amid} | omiganan | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | Analog Of Indolicidin, Cytoplasmic Granules Of Bovine Neutrophils | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | ILRWPWWPWRRK{ct:Amid} | omiganan | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <10 % Hemolysis at 512 μg/ml | Human | Analog Of Indolicidin, Cytoplasmic Granules Of Bovine Neutrophils | α-Helical | NA | ||
| 28756544 | 2017 | KRRWPWWPWRLI{ct:Amid} | r-omiganan | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | Analog Of Omiganan | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | KRRWPWWPWRLI{ct:Amid} | r-omiganan | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <20 % Hemolysis at 512 μg/ml | Human | Analog Of Omiganan | α-Helical | NA | ||
| 28756544 | 2017 | FLPLIGRVLSGIL{ct:Amid} | temporin A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | European Red Frog, Rana Temporaria | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | FLPLIGRVLSGIL{ct:Amid} | temporin A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 70 % Hemolysis at 512 μg/ml | Human | European Red Frog, Rana Temporaria | α-Helical | NA | ||
| 28756544 | 2017 | LIGSLVRGILPLF{ct:Amid} | r-temporin A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 1-64 μg/ml | Human | Analog Of Temporin A | α-Helical | Non-hemolytic | ||
| 28756544 | 2017 | LIGSLVRGILPLF{ct:Amid} | r-temporin A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | <10 % Hemolysis at 512 μg/ml | Human | Analog Of Temporin A | α-Helical | NA | ||
| 28921993 | 2017 | PLILLRLLRGQF{ct:Amid} | WWSP(2) | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 5-40 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | AAVLLPVLLAAP{ct:Amid} | KFGF(3) | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 5-40 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | KLALKALKALKAALKLA{ct:Amid} | MAP-1(4) | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 5-40 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | PLIKLRLDRGQF{ct:Amid} | sWWSP(6) | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 5-40 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | AAKLLPDLLAAP{ct:Amid} | sKFGF(7) | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 5-40 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | KLALKALKKLKADLKLA{ct:Amid} | sMAP-1(8) | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 5-40 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 31554187 | 2019 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 50 µM | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | FDVMGIIKKIASAL{ct:Amid} | EMP-EF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 181 µM | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | FDIMGLIKKVAGAL{ct:Amid} | EMP-ER | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 200 µM | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LKLMGIVKKVLGAL{ct:Amid} | EMP-EM1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LKLLGIVKKVLGAI{ct:Amid} | EMP-EM2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LNLKGIFKKVKSLLT | Eumenitin | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LNLKGLFKKVASLLT | Eumenitin-F | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 353 µM | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LNLKGLIKKVASLLN | Eumenitin-R | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 530 µM | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | SLLSLIRKLIT{ct:Amid} | Decoralin | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis | Human | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 50 µM | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | FDVMGIIKKIASAL{ct:Amid} | EMP-EF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 181 µM | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | FDIMGLIKKVAGAL{ct:Amid} | EMP-ER | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 200 µM | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LKLMGIVKKVLGAL{ct:Amid} | EMP-EM1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LKLLGIVKKVLGAI{ct:Amid} | EMP-EM2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LNLKGIFKKVKSLLT | Eumenitin | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LNLKGLFKKVASLLT | Eumenitin-F | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 353 µM | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | LNLKGLIKKVASLLN | Eumenitin-R | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 530 µM | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | SLLSLIRKLIT{ct:Amid} | Decoralin | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31554187 | 2019 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis | Mouse | Solitary Wasp Venoms | α-Helical | NA | ||
| 31311351 | 2019 | KRWWKWIRW{ct:Amid} | HHC-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 5 % Hemolysis at 130 µM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | AILFLSLGAIKKG | BRGP-001 | Free | Free | Linear | L | None | 13 | Antimicrobial | 17.48 % Hemolysis at 1.127 mM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | FLIKSLAGAKGIL | BRGP-002 | Free | Free | Linear | L | None | 13 | Antimicrobial | 2.87 % Hemolysis at 1.879 mM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | KGGAIKSLFLILA | BRGP-003 | Free | Free | Linear | L | None | 13 | Antimicrobial | 8.8 % Hemolysis at 1.127 mM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | KGIKGALSILFAL | BRGP-004 | Free | Free | Linear | L | None | 13 | Antimicrobial | 27.9 % Hemolysis at 1.503 mM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | GIKGALKSILFAL | BRGP-005 | Free | Free | Linear | L | None | 13 | Antimicrobial | 13.81 % Hemolysis at 0.188 mM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | FALSILGALGIKK | BRGP-006 | Free | Free | Linear | L | None | 13 | Antimicrobial | 16.34 % Hemolysis at 1.503 mM | Human | Synthetic | α-Helical | NA | ||
| 37809653 | 2023 | PQQYPEMNTRRNW | BRGP-007 | Free | Free | Linear | L | None | 13 | Antimicrobial | 7.58 % Hemolysis at 1.454 mM | Human | Synthetic | not Helix | NA | ||
| 37760701 | 2023 | IFGMIPGLIGGLISAFK{ct:α-Amidation} | TtAP-2 | α-Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 31 ± 4 μg/mL | Mouse | Trinidad Thick-Tailed Scorpion Tityus Trinitatis | α-Helical | NA | ||
| 37760701 | 2023 | FFSLIPSLIGGLVSAIK{ct:α-Amidation} | TtAP-3 | α-Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 95 ± 3 μg/mL | Mouse | Trinidad Thick-Tailed Scorpion Tityus Trinitatis | α-Helical | NA | ||
| 37746048 | 2023 | DASTKKLSECLRRIGDELDS | BHP | Free | Free | Linear | L | None | 20 | Antitumor | 0 % Hemolysis at 3-200 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 37888622 | 2023 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Anterhynchium Flavormarginatum Micado | α-Helical | NA | ||
| 37888622 | 2023 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 110.6 ± 9.8 µM | Human | Anterhynchium Flavormarginatum Micado | α-Helical | NA | ||
| 37888622 | 2023 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Anterhynchium Flavormarginatum Micado | α-Helical | NA | ||
| 37888622 | 2023 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 122.1 ± 13.1 µM | Rat | Anterhynchium Flavormarginatum Micado | α-Helical | NA | ||
| 37888622 | 2023 | FDVMGIIKKIASAL{ct:Amid} | EMP-EF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Eumenes Fraterculus | α-Helical | NA | ||
| 37888622 | 2023 | FDVMGIIKKIASAL{ct:Amid} | EMP-EF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 125.2 ± 20.6 µM | Human | Eumenes Fraterculus | α-Helical | NA | ||
| 37888622 | 2023 | FDVMGIIKKIASAL{ct:Amid} | EMP-EF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 48 % Hemolysis at 320 μg/mL | Rat | Eumenes Fraterculus | α-Helical | NA | ||
| 37888622 | 2023 | FDVMGIIKKIASAL{ct:Amid} | EMP-EF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 216.8 ± 1.6 µM | Rat | Eumenes Fraterculus | α-Helical | NA | ||
| 37888622 | 2023 | FDIMGLIKKVAGAL{ct:Amid} | EMP-ER | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 25 % Hemolysis at 320 μg/mL | Human | Eumenes Rubrofemoratus | α-Helical | NA | ||
| 37888622 | 2023 | FDIMGLIKKVAGAL{ct:Amid} | EMP-ER | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 46 % Hemolysis at 30 μg/mL | Rat | Eumenes Rubrofemoratus | α-Helical | NA | ||
| 37888622 | 2023 | FDIMGLIKKVAGAL{ct:Amid} | EMP-ER | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 230.6 ± 3.7 µM | Rat | Eumenes Rubrofemoratus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGLIKKVASLLN | Eumenitin-R | Free | Free | Linear | L | None | 15 | Antimicrobial | 5 % Hemolysis at 320 μg/mL | Human | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGLFKKVASLLT | Eumenitin-F | Free | Free | Linear | L | None | 15 | Antimicrobial | 67 % Hemolysis at 320 μg/mL | Human | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGIFKKVASLLT | Eumenitin | Free | Free | Linear | L | None | 15 | Antimicrobial | 6 % Hemolysis at 320 μg/mL | Human | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGLFKKVASLLT | Eumenitin-F | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 157.1 ± 2.6 µM | Human | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGLIKKVASLLN | Eumenitin-R | Free | Free | Linear | L | None | 15 | Antimicrobial | 7 % Hemolysis at 320 μg/mL | Rat | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGLFKKVASLLT | Eumenitin-F | Free | Free | Linear | L | None | 15 | Antimicrobial | 44 % Hemolysis at 320 μg/mL | Rat | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGIFKKVASLLT | Eumenitin | Free | Free | Linear | L | None | 15 | Antimicrobial | 4 % Hemolysis at 320 μg/mL | Rat | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | LNLKGLFKKVASLLT | Eumenitin-F | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 207.1 ± 2.0 µM | Rat | Eumenes Rubronotatus | α-Helical | NA | ||
| 37888622 | 2023 | INLKGLIKKVASLLT | EpVP1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 9 % Hemolysis at 320 μg/mL | Human | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKKVASAL{ct:Amid} | EpVP2a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 79 % Hemolysis at 320 μg/mL | Human | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKSVVSAL{ct:Amid} | EpVP2b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKKVASAL{ct:Amid} | EpVP2a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 151.9 ± 6.3 µM | Human | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKSVVSAL{ct:Amid} | EpVP2b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 34.1 ± 3.5 µM | Human | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | INLKGLIKKVASLLT | EpVP1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Rat | Eumenes Pomiformis | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | FDLLGLVKKVASAL{ct:Amid} | EpVP2a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 41 % Hemolysis at 320 μg/mL | Rat | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKSVVSAL{ct:Amid} | EpVP2b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKKVASAL{ct:Amid} | EpVP2a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 238.8 ± 7.6 µM | Rat | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | FDLLGLVKSVVSAL{ct:Amid} | EpVP2b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 50.6 ± 2.6 µM | Rat | Eumenes Pomiformis | α-Helical | NA | ||
| 37888622 | 2023 | LKLMGIVKKVLGAL{ct:Amid} | EMP-EM1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 21 % Hemolysis at 320 μg/mL | Human | Eumenes Micado | α-Helical | NA | ||
| 37888622 | 2023 | LKLLGIVKKVLGAI{ct:Amid} | EMP-EM2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 8 % Hemolysis at 320 μg/mL | Human | Eumenes Micado | α-Helical | NA | ||
| 37888622 | 2023 | LKLMGIVKKVLGAL{ct:Amid} | EMP-EM1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 7 % Hemolysis at 320 μg/mL | Rat | Eumenes Micado | α-Helical | NA | ||
| 37888622 | 2023 | LKLLGIVKKVLGAI{ct:Amid} | EMP-EM2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 2 % Hemolysis at 320 μg/mL | Rat | Eumenes Micado | α-Helical | NA | ||
| 37888622 | 2023 | GRILSFIKGLAEHL{ct:Amid} | EMP-OD | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 2 % Hemolysis at 320 μg/mL | Human | Orancistrocerus Drewseni | α-Helical | NA | ||
| 37888622 | 2023 | KDLHTVVSAILQAL{ct:Amid} | OdVP3a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 24 % Hemolysis at 320 μg/mL | Human | Orancistrocerus Drewseni | α-Helical | NA | ||
| 37888622 | 2023 | GRILSFIKGLAEHL{ct:Amid} | EMP-OD | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 49 % Hemolysis at 320 μg/mL | Rat | Orancistrocerus Drewseni | α-Helical | NA | ||
| 37888622 | 2023 | KDLHTVVSAILQAL{ct:Amid} | OdVP3a | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 27 % Hemolysis at 320 μg/mL | Rat | Orancistrocerus Drewseni | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALAKKIL{ct:Amid} | Mastoparan (L) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Vespula Lewisii | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALAKKIL{ct:Amid} | Mastoparan (L) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 82.9 ± 3.8 µM | Human | Vespula Lewisii | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALAKKIL{ct:Amid} | Mastoparan (L) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 41 % Hemolysis at 320 μg/mL | Rat | Vespula Lewisii | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALAKKIL{ct:Amid} | Mastoparan (L) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 242.5 ± 2.6 µM | Rat | Vespula Lewisii | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIKSIIKAAMN{ct:Amid} | Mastoparan-V1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 9 % Hemolysis at 320 μg/mL | Human | Vespula Vulgaris | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIKSLIKAAMS{ct:Amid} | Mastoparan-V2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 15 % Hemolysis at 320 μg/mL | Human | Vespula Vulgaris | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIKSIIKAAMN{ct:Amid} | Mastoparan-V1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 16 % Hemolysis at 320 μg/mL | Rat | Vespula Vulgaris | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIKSLIKAAMS{ct:Amid} | Mastoparan-V2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 52 % Hemolysis at 320 μg/mL | Rat | Vespula Vulgaris | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIKSLIKAAMS{ct:Amid} | Mastoparan-V2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 182.4 ± 3.6 µM | Rat | Vespula Vulgaris | α-Helical | NA | ||
| 37888622 | 2023 | INMKASAAVAKKLL{ct:Amid} | MP-VB1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Human | Vespa Bicolor | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INMKAVAAVAKKPL{ct:Amid} | MP-VB2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Human | Vespa Bicolor | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INMKASAAVAKKLL{ct:Amid} | MP-VB1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 7 % Hemolysis at 320 μg/mL | Rat | Vespa Bicolor | α-Helical | NA | ||
| 37888622 | 2023 | INMKAVAAVAKKPL{ct:Amid} | MP-VB2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Rat | Vespa Bicolor | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INWKGIAAMAKKLL{ct:Amid} | Mastoparan-X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 29 % Hemolysis at 320 μg/mL | Human | Vespa. Xanthoptera | α-Helical | NA | ||
| 37888622 | 2023 | INWKGIAAMAKKLL{ct:Amid} | Mastoparan-X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 349.4 ± 4.9 µM | Human | Vespa. Xanthoptera | α-Helical | NA | ||
| 37888622 | 2023 | INWKGIAAMAKKLL{ct:Amid} | Mastoparan-X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 70 % Hemolysis at 320 μg/mL | Rat | Vespa. Xanthoptera | α-Helical | NA | ||
| 37888622 | 2023 | INWKGIAAMAKKLL{ct:Amid} | Mastoparan-X(V) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 156.5 ± 2.4 µM | Rat | Vespa. Xanthoptera | α-Helical | NA | ||
| 37888622 | 2023 | IKWKAILDAVKKVL{ct:Amid} | Mastoparan-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 7 % Hemolysis at 320 μg/mL | Human | Vespa Analis | α-Helical | NA | ||
| 37888622 | 2023 | IKWKAILDAVKKVL{ct:Amid} | Mastoparan-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 56 % Hemolysis at 320 μg/mL | Rat | Vespa Analis | α-Helical | NA | ||
| 37888622 | 2023 | IKWKAILDAVKKVL{ct:Amid} | Mastoparan-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 183.0 ± 3.4 µM | Rat | Vespa Analis | α-Helical | NA | ||
| 37888622 | 2023 | LKLKSIVSWAKKVL{ct:Amid} | Mastoparan-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 22 % Hemolysis at 320 μg/mL | Human | Vespa Basalis | α-Helical | NA | ||
| 37888622 | 2023 | LKLKSIVSWAKKVL{ct:Amid} | Mastoparan-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 19 % Hemolysis at 320 μg/mL | Rat | Vespa Basalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKALLAVAKKIL{ct:Amid} | Mastoparan-C | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Vespa Crabro | α-Helical | NA | ||
| 37888622 | 2023 | INLKALLAVAKKIL{ct:Amid} | Mastoparan-C | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 30.2 ± 1.3 µM | Human | Vespa Crabro | α-Helical | NA | ||
| 37888622 | 2023 | INLKALLAVAKKIL{ct:Amid} | Mastoparan-C | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Vespa Crabro | α-Helical | NA | ||
| 37888622 | 2023 | INLKALLAVAKKIL{ct:Amid} | Mastoparan-C | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 64.4 ± 10.7 µM | Rat | Vespa Crabro | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALVKKVL{ct:Amid} | Mastoparan-II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 78 % Hemolysis at 320 μg/mL | Human | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALVKKVL{ct:Amid} | HR1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 56 % Hemolysis at 320 μg/mL | Human | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALVKKVL{ct:Amid} | Mastoparan-II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 134.6 ± 1.2 µM | Human | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALVKKVL{ct:Amid} | HR1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 197.7 ± 8.9 µM | Human | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALVKKVL{ct:Amid} | Mastoparan-II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 90 % Hemolysis at 320 μg/mL | Rat | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALVKKVL{ct:Amid} | HR1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 39 % Hemolysis at 320 μg/mL | Rat | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKALAALVKKVL{ct:Amid} | Mastoparan-II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 146.8 ± 3.4 µM | Rat | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALVKKVL{ct:Amid} | HR1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 253.4 ± 13.0 µM | Rat | Vespa Orientalis | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIFQKVKNLV{ct:Amid} | PDD-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 30 % Hemolysis at 320 μg/mL | Human | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAL{ct:Amid} | PDD-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIFQKVKNLV{ct:Amid} | PDD-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 353.5 ± 44.8 µM | Human | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAL{ct:Amid} | PDD-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 48.5 ± 3.4 µM | Human | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIFQKVKNLV{ct:Amid} | PDD-A | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 27 % Hemolysis at 320 μg/mL | Rat | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAL{ct:Amid} | PDD-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAL{ct:Amid} | PDD-B | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 55.6 ± 4.1 µM | Rat | Polistes Dorsalis | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIAEIGKQVLSAL{ct:Amid} | Dominulin A | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 4 % Hemolysis at 320 μg/mL | Human | Polistes Dominulus | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIAEIGKQVLSAL{ct:Amid} | Dominulin B | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 8 % Hemolysis at 320 μg/mL | Rat | Polistes Dominulus | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIAEIGKQVLSAL{ct:Amid} | Dominulin A | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Human | Polistes Dominulus | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INWKKIAEIGKQVLSAL{ct:Amid} | Dominulin B | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Rat | Polistes Dominulus | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INWLKLGKKILGAI{ct:Amid} | Pm-R1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | LNFKALAALAKKIL{ct:Amid} | Pm-R2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 66 % Hemolysis at 320 μg/mL | Human | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKQILGAL{ct:Amid} | Pm-R3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAI{ct:Amid} | Pm-R1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 72.0 ± 8.5 µM | Human | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | LNFKALAALAKKIL{ct:Amid} | Pm-R2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 165.9 ± 8.0 µM | Human | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKQILGAL{ct:Amid} | Pm-R3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 32.3 ± 1.7 µM | Human | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAI{ct:Amid} | Pm-R1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 92 % Hemolysis at 320 μg/mL | Rat | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | LNFKALAALAKKIL{ct:Amid} | Pm-R2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 34 % Hemolysis at 320 μg/mL | Rat | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKQILGAL{ct:Amid} | Pm-R3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKILGAI{ct:Amid} | Pm-R1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 105.1 ± 2.2 µM | Rat | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | LNFKALAALAKKIL{ct:Amid} | Pm-R2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 249.5 ± 9.9 µM | Rat | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKQILGAL{ct:Amid} | Pm-R3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 73.5 ± 5.1 µM | Rat | Polistes Rothneyi Iwatai | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAAFAKKLL{ct:Amid} | Mastoparan-T(D) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 15 % Hemolysis at 320 μg/mL | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAAFAKKLL{ct:Amid} | Mastoparan-T(D) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 19 % Hemolysis at 320 μg/mL | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKFL{ct:Amid} | Mastoparan-T1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKLL{ct:Amid} | Mastoparan-T2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLRGFAALVKKFL{ct:Amid} | Mastoparan-T3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLFGFAALVKKFL{ct:Amid} | Mastoparan-T4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKFL{ct:Amid} | Mastoparan-T1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 30.8 ± 1.6 µM | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKLL{ct:Amid} | Mastoparan-T2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 11.8 ± 3.1 µM | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLRGFAALVKKFL{ct:Amid} | Mastoparan-T3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 112.1 ± 8.0 µM | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLFGFAALVKKFL{ct:Amid} | Mastoparan-T4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 28.5 ± 2.3 µM | Human | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKFL{ct:Amid} | Mastoparan-T1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 87 % Hemolysis at 320 μg/mL | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKLL{ct:Amid} | Mastoparan-T2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLRGFAALVKKFL{ct:Amid} | Mastoparan-T3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLFGFAALVKKFL{ct:Amid} | Mastoparan-T4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKFL{ct:Amid} | Mastoparan-T1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 22.7 ± 7.1 µM | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLKVFAALVKKLL{ct:Amid} | Mastoparan-T2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 21.1 ± 2.4 µM | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLRGFAALVKKFL{ct:Amid} | Mastoparan-T3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 51.6 ± 2.1 µM | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INLFGFAALVKKFL{ct:Amid} | Mastoparan-T4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 17.6 ± 2.4 µM | Rat | Vespa Tropica | α-Helical | NA | ||
| 37888622 | 2023 | INWKGIAAMKKLL{ct:Amid} | Mastoparan-like peptide 12b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Human | Vespa Magnifica | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INWKGIAAMKKLL{ct:Amid} | Mastoparan-like peptide 12b | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Rat | Vespa Magnifica | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INLKAIAALAKKLL{ct:Amid} | Mastoparan-M | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 18 % Hemolysis at 320 μg/mL | Human | Vespa Mandarinia | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALAKKLL{ct:Amid} | Mastoparan-M | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 28 % Hemolysis at 320 μg/mL | Rat | Vespa Mandarinia | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALAKKLF{ct:Amid} | Mastoparan AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 47 % Hemolysis at 320 μg/mL | Human | Vespa Affinis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALAKKLF{ct:Amid} | Mastoparan AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 227.0 ± 3.1 µM | Human | Vespa Affinis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALAKKLF{ct:Amid} | Mastoparan AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 92 % Hemolysis at 320 μg/mL | Rat | Vespa Affinis | α-Helical | NA | ||
| 37888622 | 2023 | INLKAIAALAKKLF{ct:Amid} | Mastoparan AF | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 107.3 ± 15.7 µM | Rat | Vespa Affinis | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAIIDAL{ct:Amid} | Agelaia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWKAILQRIKKML{ct:Amid} | Agelaia-MPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAIIDAL{ct:Amid} | Agelaia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 3.7 ± 0.14 µM | Human | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWKAILQRIKKML{ct:Amid} | Agelaia-MPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 44.8 ± 10.4 µM | Human | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAIIDAL{ct:Amid} | Agelaia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 98 % Hemolysis at 320 μg/mL | Rat | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWKAILQRIKKML{ct:Amid} | Agelaia-MPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 97 % Hemolysis at 320 μg/mL | Rat | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAIIDAL{ct:Amid} | Agelaia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 7.0 ± 0.7 µM | Rat | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWKAILQRIKKML{ct:Amid} | Agelaia-MPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 62.1 ± 3.8 µM | Rat | Agelaia Pallipes Pallipes | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKMMSAL{ct:Amid} | MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 87 % Hemolysis at 320 μg/mL | Human | Mischocyttarus Phthisicus | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKMMSAL{ct:Amid} | MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 123.6 ± 15.3 µM | Human | Mischocyttarus Phthisicus | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKMMSAL{ct:Amid} | MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at 320 μg/mL | Rat | Mischocyttarus Phthisicus | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVSAIL{ct:Amid} | Protopolybia-MP I | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 5 % Hemolysis at 320 μg/mL | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVSAIL{ct:Amid} | Protopolybia-MP I | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 5 % Hemolysis at 320 μg/mL | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWKAIIEAAKQAL{ct:Amid} | ProtopolybiaMPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 13 % Hemolysis at 320 μg/mL | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWKAIIEAAKQAL{ct:Amid} | ProtopolybiaMPII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 24 % Hemolysis at 320 μg/mL | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIDAL{ct:Amid} | ProtopolybiaMPIII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 96 % Hemolysis at 320 μg/mL | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIDAL{ct:Amid} | ProtopolybiaMPIII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 93 % Hemolysis at 320 μg/mL | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIDAL{ct:Amid} | ProtopolybiaMPIII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 61.9 ± 8.3 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIDAL{ct:Amid} | ProtopolybiaMPIII | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 34.6 ± 2.8 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWKALLDAAKKVL{ct:Amid} | ProtonectarinaMP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Protonectarina Sylveirae | α-Helical | NA | ||
| 37888622 | 2023 | INWKALLDAAKKVL{ct:Amid} | ProtonectarinaMP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 85.2 ± 5.9 µM | Human | Protonectarina Sylveirae | α-Helical | NA | ||
| 37888622 | 2023 | INWKALLDAAKKVL{ct:Amid} | ProtonectarinaMP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 35 % Hemolysis at 320 μg/mL | Rat | Protonectarina Sylveirae | α-Helical | NA | ||
| 37888622 | 2023 | INWKALLDAAKKVL{ct:Amid} | ProtonectarinaMP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 326.5 ± 26.4 µM | Rat | Protonectarina Sylveirae | α-Helical | NA | ||
| 37888622 | 2023 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP I | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 56 % Hemolysis at 320 μg/mL | Human | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKMVIDAL{ct:Amid} | Polybia-MP II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 91 % Hemolysis at 320 μg/mL | Human | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWLKLGKMVMDVL{ct:Amid} | Polybia-MP III | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 79 % Hemolysis at 320 μg/mL | Human | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWLKLRVISVIDL{ct:Amid} | Polybia-MP IV | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Human | Polybia Paulista | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INWHDIAIKNIDAL{ct:Amid} | Polybia-MP V | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Human | Polybia Paulista | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP I | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 176.6 ± 7.0 µM | Human | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKMVIDAL{ct:Amid} | Polybia-MP II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 23.3 ± 1.4 µM | Human | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWLKLGKMVMDVL{ct:Amid} | Polybia-MP III | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 38.5 ± 5.9 µM | Human | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP I | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKMVIDAL{ct:Amid} | Polybia-MP II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWLKLGKMVMDVL{ct:Amid} | Polybia-MP III | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWLKLRVISVIDL{ct:Amid} | Polybia-MP IV | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Rat | Polybia Paulista | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | INWHDIAIKNIDAL{ct:Amid} | Polybia-MP V | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 320 μg/mL | Rat | Polybia Paulista | α-Helical | Non-hemolytic | ||
| 37888622 | 2023 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP I | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 51.4 ± 2.2 µM | Rat | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKMVIDAL{ct:Amid} | Polybia-MP II | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 29.1 ± 1.5 µM | Rat | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | IDWLKLGKMVMDVL{ct:Amid} | Polybia-MP III | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 74.8 ± 10.4 µM | Rat | Polybia Paulista | α-Helical | NA | ||
| 37888622 | 2023 | INWKKMAATALKMI{ct:Amid} | Parapolybia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 32 % Hemolysis at 320 μg/mL | Human | Parapolybia Indica | α-Helical | NA | ||
| 37888622 | 2023 | INWKKMAATALKMI{ct:Amid} | Parapolybia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 306.4 ± 162.6 µM | Human | Parapolybia Indica | α-Helical | NA | ||
| 37888622 | 2023 | INWKKMAATALKMI{ct:Amid} | Parapolybia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 22 % Hemolysis at 320 μg/mL | Rat | Parapolybia Indica | α-Helical | NA | ||
| 37888622 | 2023 | INWAKLGKLALQAL{ct:Amid} | Ropalidia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Ropalidia | α-Helical | NA | ||
| 37888622 | 2023 | INWAKLGKLALQAL{ct:Amid} | Ropalidia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 42.5 ± 1.7 µM | Human | Ropalidia | α-Helical | NA | ||
| 37888622 | 2023 | INWAKLGKLALQAL{ct:Amid} | Ropalidia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 94 % Hemolysis at 320 μg/mL | Rat | Ropalidia | α-Helical | NA | ||
| 37888622 | 2023 | INWAKLGKLALQAL{ct:Amid} | Ropalidia-MP | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 122.2 ± 4.3 µM | Rat | Ropalidia | α-Helical | NA | ||
| 37888622 | 2023 | VDWKKIGQHILSVL{ct:Amid} | Mastoparan-J | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Polistes Jadwigae | α-Helical | NA | ||
| 37888622 | 2023 | VDWKKIGQHILSVL{ct:Amid} | Mastoparan-J | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 69.5 ± 3.2 µM | Human | Polistes Jadwigae | α-Helical | NA | ||
| 37888622 | 2023 | VDWKKIGQHILSVL{ct:Amid} | Mastoparan-J | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polistes Jadwigae | α-Helical | NA | ||
| 37888622 | 2023 | VDWKKIGQHILSVL{ct:Amid} | Mastoparan-J | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 60.1 ± 1.3 µM | Rat | Polistes Jadwigae | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIASIGKEVLKAL{ct:Amid} | PMM2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Human | Polistes Major Major | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIASIGKEVLKAL{ct:Amid} | PMM2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 42.6 ± 2.5 µM | Human | Polistes Major Major | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIASIGKEVLKAL{ct:Amid} | PMM2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 320 μg/mL | Rat | Polistes Major Major | α-Helical | NA | ||
| 37888622 | 2023 | INWKKIASIGKEVLKAL{ct:Amid} | PMM2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 80.9 ± 6.4 µM | Rat | Polistes Major Major | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIDAL{ct:Amid} | Protopolybia-MPIII-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 176.4 ± 1.0 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIDAL{ct:Amid} | Protopolybia-MPIII-1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 158.4 ± 2.3 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSDAL{ct:Amid} | Protopolybia-MPIII-2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 673.3 ± 189.0 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSDAL{ct:Amid} | Protopolybia-MPIII-2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 639.5 ± 1.6 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIAAL{ct:Amid} | Protopolybia-MPIII-3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 16.8 ± 1.0 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIAAL{ct:Amid} | Protopolybia-MPIII-3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 21.5 ± 1.2 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIDIL{ct:Amid} | Protopolybia-MPIII-4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 11.3 ± 6.2 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIDIL{ct:Amid} | Protopolybia-MPIII-4 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 19.8 ± 1.2 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIAAL{ct:Amid} | Protopolybia-MPIII-6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 110.0 ± 2.5 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIAAL{ct:Amid} | Protopolybia-MPIII-6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 107.6 ± 3.2 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIDIL{ct:Amid} | Protopolybia-MPIII-7 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 37.8 ± 3.7 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIDIL{ct:Amid} | Protopolybia-MPIII-7 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 57.5 ± 2.7 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSAAL{ct:Amid} | Protopolybia-MPIII-8 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 307.8 ± 6.2 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSAAL{ct:Amid} | Protopolybia-MPIII-8 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 444.0 ± 2.1 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSDIL{ct:Amid} | Protopolybia-MPIII-9 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 167.3 ± 2.7 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSDIL{ct:Amid} | Protopolybia-MPIII-9 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 161.7 ± 1.3 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIAIL{ct:Amid} | Protopolybia-MPIII-10 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 11.3 ± 1.2 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVIAIL{ct:Amid} | Protopolybia-MPIII-10 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 11.7 ± 1.0 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSAIL{ct:Amid} | Protopolybia-MPIII-11 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 140.6 ± 2.4 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKAVSAIL{ct:Amid} | Protopolybia-MPIII-11 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 133.6 ± 2.2 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIAIL{ct:Amid} | Protopolybia-MPIII-12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 43.9 ± 3.6 µM | Human | Protopolybia Exigua | α-Helical | NA | ||
| 37888622 | 2023 | INWLKLGKKVIAIL{ct:Amid} | Protopolybia-MPIII-12 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 55.2 ± 2.2 µM | Rat | Protopolybia Exigua | α-Helical | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P2 | Free | Free | Linear | L | None | 12 | Antibiofilm | 0.84 ± 1.42 % Hemolysis at 1 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P3 | Free | Free | Linear | L | None | 12 | Antibiofilm | 0 % Hemolysis at 2 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P4 | Free | Free | Linear | L | None | 12 | Antibiofilm | 0 % Hemolysis at 4 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P5 | Free | Free | Linear | L | None | 12 | Antibiofilm | 0 % Hemolysis at 8 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P6 | Free | Free | Linear | L | None | 12 | Antibiofilm | <10 % Hemolysis at 16 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P7 | Free | Free | Linear | L | None | 12 | Antibiofilm | 10 % Hemolysis at 32 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P8 | Free | Free | Linear | L | None | 12 | Antibiofilm | 9.92 ± 1.04 % Hemolysis at 64 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P9 | Free | Free | Linear | L | None | 12 | Antibiofilm | 16.62 ± 0.85 % Hemolysis at 128 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P10 | Free | Free | Linear | L | None | 12 | Antibiofilm | <40 % Hemolysis at 256 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P11 | Free | Free | Linear | L | None | 12 | Antibiofilm | 72.03 ± 5.61 % Hemolysis at 512 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 38062792 | 2023 | VDKPPYLPRPRPPRRIYNR | Onc | Free | Free | Linear | L | None | 19 | Antimicrobial | MHC at >1000 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38062792 | 2023 | KKLLKLLKLLL | ln65 | Free | Free | Linear | L | None | 11 | Antimicrobial | MHC at 125 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | K{d}K{d}LLK{d}LLK{d}LLL | ln69 | Free | Free | Linear | Mix | k = D-lysine | 11 | Antimicrobial | MHC at 1000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | {nnr:NLys}KLLKLLKLL{nnr:NLeu} | EB1 | Free | Free | Linear | L | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at 1000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | {nnr:Nlys}KLLKLLK{d}LL{nnr:Nleu} | EB2 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | KKLLKLLK{nnr:Nleu}{nnr:Nleu}{nnr:Nleu} | EB3 | Free | Free | Linear | L | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | KKLLK{nnr:Nleu}{nnr:Nleu}{nnr:Nlys}{nnr:Nleu}{nnr:Nleu}{nnr:Nleu} | EB4 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | {nnr:Nlys}{nnr:Nlys}{nnr:Nleu}{nnr:Nleu}{nnr:Nlys}LLKLLL | EB5 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at 1000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | {nnr:Nlys}{nnr:Nlys}LL{nnr:Nlys}LLKLLL | EB6 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at 250 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | {nnr:Nlys}{nnr:Nlys}LL{nnr:Nlys}LL{nnr:Nlys}LLL | EB7 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | KK{nnr:Nleu}{nnr:Nleu}K{nnr:Nleu}{nnr:Nleu}K{nnr:Nleu}{nnr:Nleu}{nnr:Nleu} | EB8 | Free | Free | Linear | L | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | K{nnr:Nlys}L{nnr:Nleu}K{nnr:Nleu}L{nnr:Nlys}L{nnr:Nleu}L | EB9 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | {nnr:Nlys}K{nnr:Nleu}L{nnr:Nlys}L{nnr:Nleu}K{nnr:Nleu}L{nnr:Nleu} | EB10 | Free | Free | Linear | Mix | NLys = (lysine-like residue), NLeu = (leucine-like residue) | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 38062792 | 2023 | K{d}K{d}L{d}L{d}K{d}L{d}L{d}K{d}L{d}L{d}L{d} | EB11 | Free | Free | Linear | D | None | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 37797458 | 2023 | VDKPPYLPRPRPPRRIYNR{ct:Amid} | oncocin(1a) | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 6.5 % Hemolysis at 800 μg/mL | Human | Resin Bound | NA | NA | ||
| 37797458 | 2023 | ({nnr:gVal})DKPPYLPRPRPPRRIYNR{ct:Amid} | 1b | Amidation | Free | Linear | L | gVal = N-terminal-guanidine valine | 18 | Antimicrobial | 0.7 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | (Me4{nnr:gVal})DKPPYLPRPRPPRRIYNR{ct:Amid} | 1c | Amidation | Free | Linear | L | gVal = N-terminal-guanidine valine | 18 | Antimicrobial | 0.2 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYLP({nnr:Har})PRPPRRIYNR{ct:Amid} | 2a | Amidation | Free | Linear | L | Har = homoarginine | 20 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPRP({nnr:Har})PPRRIYNR{ct:Amid} | 2b | Amidation | Free | Linear | L | Har = homoarginine | 20 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPRPRPP({nnr:Har})RIYNR{ct:Amid} | 2c | Amidation | Free | Linear | L | Har = homoarginine | 20 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPRPRPPR({nnr:Har})IYNR{ct:Amid} | 2d | Amidation | Free | Linear | L | Har = homoarginine | 20 | Antimicrobial | 0.2 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYLPRPRPPRRIYN({nnr:Har}){ct:Amid} | 2e | Amidation | Free | Linear | L | Har = homoarginine | 20 | Antimicrobial | 1.4 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYLPRPRPPR({nnr:Har})IYN({nnr:Har}){ct:Amid} | 3 | Amidation | Free | Linear | L | Har = homoarginine | 18 | Antimicrobial | 1.4 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYLP({nnr:Har})P({nnr:Har})PP({nnr:Har})({nnr:Har})IYN({nnr:Har}){ct:Amid} | 4 | Amidation | Free | Linear | L | Har = homoarginine | 15 | Antimicrobial | 1.3 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | ({nnr:gVal})DKPPYLP({nnr:Har})P({nnr:Har})PP({nnr:Har})({nnr:Har})IYN({nnr:Har}){ct:Amid} | 5 | Amidation | Free | Linear | L | Har = homoarginine, gVal = N-terminal-guanidine valine | 14 | Antimicrobial | 0.5 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDK({nnr:Hyp})PYLPRPRPPRRIYNR{ct:Amid} | 6a | Amidation | Free | Linear | L | Hyp = trans-4-Hydroxy-l-proline | 19 | Antimicrobial | 1.4 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKP({nnr:Hyp})YLPRPRPPRRIYNR{ct:Amid} | 6b | Amidation | Free | Linear | L | Hyp = trans-4-Hydroxy-l-proline | 19 | Antimicrobial | 1.5 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYL({nnr:Hyp})RPRPPRRIYNR{ct:Amid} | 6c | Amidation | Free | Linear | L | Hyp = trans-4-Hydroxy-l-proline | 19 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPR({nnr:Hyp})RPPRRIYNR{ct:Amid} | 6d | Amidation | Free | Linear | L | Hyp = trans-4-Hydroxy-l-proline | 19 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPRPR({nnr:Hyp})PRRIYNR{ct:Amid} | 6e | Amidation | Free | Linear | L | Hyp = trans-4-Hydroxy-l-proline | 19 | Antimicrobial | 1.4 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYLPRPRP({nnr:Hyp})RRIYNR{ct:Amid} | 6f | Amidation | Free | Linear | L | Hyp = trans-4-Hydroxy-l-proline | 19 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDK({nnr:Dfp})PYLPRPRPPRRIYNR{ct:Amid} | 7a | Amidation | Free | Linear | L | Dfp = 4,4-Difluoro-l-proline | 19 | Antimicrobial | 1 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKP({nnr:Dfp})YLPRPRPPRRIYNR{ct:Amid} | 7b | Amidation | Free | Linear | L | Dfp = 4,4-Difluoro-l-proline | 19 | Antimicrobial | 1.5 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYL({nnr:Dfp})PRPRPPRRIYNR{ct:Amid} | 7c | Amidation | Free | Linear | L | Dfp = 4,4-Difluoro-l-proline | 19 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPR({nnr:Dfp})PRPPRRIYNR{ct:Amid} | 7d | Amidation | Free | Linear | L | Dfp = 4,4-Difluoro-l-proline | 19 | Antimicrobial | No Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPRPR({nnr:Dfp})PRRIYNR{ct:Amid} | 7e | Amidation | Free | Linear | L | Dfp = 4,4-Difluoro-l-proline | 19 | Antimicrobial | 1 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDKPPYLPRPRP({nnr:Dfp})RRIYNR{ct:Amid} | 7f | Amidation | Free | Linear | L | Dfp = 4,4-Difluoro-l-proline | 19 | Antimicrobial | Hemolysis determined at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDK({nnr:Hyp})({nnr:Hyp})YLPRPR({nnr:Hyp})PRR{d}IYNR{d}{ct:Amid} | 9 | Amidation | Free | Linear | Mix | Hyp = trans-4-Hydroxy-l-proline | 17 | Antimicrobial | 1.2 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 37797458 | 2023 | VDK({nnr:Dfp})({nnr:Dfp})YLPRPR({nnr:Dfp})PRR{d}IYNR{d}{ct:Amid} | 10 | Amidation | Free | Linear | Mix | Dfp = 4,4-Difluoro-l-proline | 17 | Antimicrobial | 0.2 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 38435443 | 2023 | RFGRFLRKILRFLKK | mCHTL131-140 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.355731 ± 0.0395 % Hemolysis at 1 mg/ml | Human | Chicken Cathelicidin-2 | α-Helical | Non-hemolytic | ||
| 38435443 | 2023 | RFGRFLRKILRFLKK | mCHTL131-141 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.250329 ± 0.0456 % Hemolysis at 0.5 mg/ml | Human | Chicken Cathelicidin-3 | α-Helical | Non-hemolytic | ||
| 38435443 | 2023 | RFGRFLRKILRFLKK | mCHTL131-142 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.27668 ± 0.0395 % Hemolysis at 0.25 mg/ml | Human | Chicken Cathelicidin-4 | α-Helical | Non-hemolytic | ||
| 38435443 | 2023 | RFGRFLRKILRFLKK | mCHTL131-143 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.184453 ± 0.114 % Hemolysis at 0.125 mg/ml | Human | Chicken Cathelicidin-5 | α-Helical | Non-hemolytic | ||
| 38435443 | 2023 | RFGRFLRKILRFLKK | mCHTL131-144 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.184453 ± 0.0604 % Hemolysis at 0.0625 mg/ml | Human | Chicken Cathelicidin-6 | α-Helical | Non-hemolytic | ||
| 38435443 | 2023 | RFGRFLRKILRFLKK | mCHTL131-145 | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.184453 ± 0.0913 % Hemolysis at 0.03125 mg/ml | Human | Chicken Cathelicidin-7 | α-Helical | Non-hemolytic | ||
| 37972089 | 2023 | KKLFKKILRYL{ct:Amid} | BP203 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 31 % Hemolysis at ~300 μg/mL | Sheep | Bp100 Analog | NA | NA | ||
| 37972089 | 2023 | KKLFKKILRYL{ct:Amid} | BP203 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 200 μg/mL | Sheep | Bp100 Analog | NA | Non-hemolytic | ||
| 37972089 | 2023 | KWLRRPWRRWR{ct:Amid} | MAP-0403 J-2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 3.4 % Hemolysis at ~678 μg/mL | Sheep | Analog Of Map-0403 | NA | NA | ||
| 37972089 | 2023 | KWLRRPWRRWR{ct:Amid} | MAP-0403 J-2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 200 μg/mL | Sheep | Analog Of Map-0403 | NA | Non-hemolytic | ||
| 38097636 | 2023 | KWKLFKKIGAVLKVL{ct:Amid} | C(1–7)M(2–9) | Amidation | Free | Linear | L | None | 15 | Antibioflm | 50 % Hemolysis at 88.89±4.62 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38097636 | 2023 | KWKLFKKIGKVLKVL{ct:Amid} | CM-10K | Amidation | Free | Linear | L | None | 15 | Antibioflm | 50 % Hemolysis at 85.78±9.01 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38097636 | 2023 | KWKLFKKIGKVLKKL{ct:Amid} | CM-10K14K | Amidation | Free | Linear | L | None | 15 | Antibioflm | 50 % Hemolysis at 561.90±88.19 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38097636 | 2023 | VWKLFKKIGKVLKKL{ct:Amid} | CM-1V10K14K | Amidation | Free | Linear | L | None | 15 | Antibioflm | 50 % Hemolysis at 118.90±8.19 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38097636 | 2023 | VWKLFKKIGAVLKKL{ct:Amid} | CM-1V14K | Amidation | Free | Linear | L | None | 15 | Antibioflm | 50 % Hemolysis at 131.70±9.23 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38097636 | 2023 | KWKLFKKIGAVLKVLA{ct:Amid} | CM-A | Amidation | Free | Linear | L | None | 16 | Antibioflm | 50 % Hemolysis at 42.58±1.98 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38247578 | 2023 | KGGDLGLFEPTL | EYHp6 | Free | Free | Linear | L | None | 12 | Anti-Salmonella | 0 % Hemolysis at 4 mM | Human | Egg Yolk Hydrolysate | NA | Non-hemolytic | ||
| 38247578 | 2023 | KGGDLGLFEPTL | EYHp6 | Free | Free | Linear | L | None | 12 | Anti-Salmonella | <20 % Hemolysis at 8 mM | Human | Egg Yolk Hydrolysate | NA | NA | ||
| 38802469 | 2024 | AFCGGRCRGFRRRLFCTKAC | AMP | Free | Free | Linear | L | None | 20 | Antibacterial and Antibioflm | <1 % Hemolysis at 1.5625-100 μg/mL | Human | Synthetic | expanded conformation | Non-hemolytic | ||
| 38467553 | 2024 | {nnr:GA}-KKIRARLKYAC{ct:Amid} | AB-12 | Amidation | Free | Linear | L | GA = gallic acid | 13 | Antioxidant (Antiradical) | 0 % Hemolysis at 1000 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | {nnr:GA}-KKIRARLKYAC{ct:Amid} | AB-12 | Amidation | Free | Linear | L | GA = gallic acid | 13 | Antioxidant (Antiradical) | 0 % Hemolysis at 500 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | {nnr:GA}-KKIRARLKYAC{ct:Amid} | AB-12 | Amidation | Free | Linear | L | GA = gallic acid | 13 | Antioxidant (Antiradical) | 0 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | RRRRRRRRKKKKKKKACAC{ct:Amid} | AB-13 | Amidation | Free | Linear | L | None | 19 | Antioxidant (Antiradical) | 0 % Hemolysis at 1000 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | RRRRRRRRKKKKKKKACAC{ct:Amid} | AB-13 | Amidation | Free | Linear | L | None | 19 | Antioxidant (Antiradical) | 0 % Hemolysis at 500 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | RRRRRRRRKKKKKKKACAC{ct:Amid} | AB-13 | Amidation | Free | Linear | L | None | 19 | Antioxidant (Antiradical) | 0 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38535822 | 2024 | FLWGLIPGAISAVTSLIKK{ct:Amid} | Ctriporin | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 90.6 ± 11.8 % Hemolysis at 256 μg/mL | Human | Scorpion Chaerilus Tricostatus | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIPGAISAVTSLIKK{ct:Amid} | CM1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 75.6 ± 10.1 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIPKAISAVTSLIKK{ct:Amid} | CM2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 74.3 ± 9.2 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIPKAIKAVTSLIKK{ct:Amid} | CM3 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 89.1 ± 12.1 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIPKAIKKVTSLIKK{ct:Amid} | CM4 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 14.0 ± 4.7 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIPKAIKKVKSLIKK{ct:Amid} | CM5 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 9.8 ± 0.6 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIPKAIKKVKKLIKK{ct:Amid} | CM6 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 8.1 ± 1.9 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38535822 | 2024 | FLWKLIKKAIKKVKKLIKK{ct:Amid} | CM7 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 57.5 ± 9.8 % Hemolysis at 256 μg/mL | Human | Ctriporin Analogs | α-Helical | NA | ||
| 38794259 | 2024 | AVNIPFKVHFRCKAAFC | OSTI−1949 | Free | Free | Linear | L | None | 17 | Antimicrobial | 20 % Hemolysis at 287.8 µM | Horse | Kunitz-Type Inhibitor From Odorrana Schmackeri | α-Helical | NA | ||
| 38794259 | 2024 | VIFKVFWRCKAAFC | OSTI−1716 | Free | Free | Linear | L | None | 14 | Antimicrobial | 20 % Hemolysis at 270.4 µM | Horse | Osti−1949 Analogues | α-Helical | NA | ||
| 38794259 | 2024 | IKFKVHFRCKAAFC | OSTI−1696 | Free | Free | Linear | L | None | 14 | Antimicrobial | 20 % Hemolysis at 297.7 µM | Horse | Osti−1949 Analogues | β-Strand | NA | ||
| 38794259 | 2024 | AVKRAVKRFKVHFRCKAAFC | OSTI−2363 | Free | Free | Linear | L | None | 20 | Antimicrobial | 20 % Hemolysis at 555.4 µM | Horse | Osti−1949 Analogues | β-Strand | NA | ||
| 38794259 | 2024 | AVNIPFKVHFKVHFRCKAAFC | OSTI−2461 | Free | Free | Linear | L | None | 20 | Antimicrobial | 20 % Hemolysis at 304.2 µM | Horse | Osti−1949 Analogues | α-Helical | NA | ||
| 38791374 | 2024 | KRCRFRIYRWGFPRRRF | blap-6 | Free | Free | Linear | L | None | 17 | Antifungal | 0 % Hemolysis at 1.3 µM | Human | Chinese Medicinal Beetle Blaps Rhynchopetera | β-Sheet and Random coli | Non-hemolytic | ||
| 38791374 | 2024 | KRCRFRIYRWGFPRRRF | blap-6 | Free | Free | Linear | L | None | 17 | Antifungal | 0 % Hemolysis at 2.6 µM | Human | Chinese Medicinal Beetle Blaps Rhynchopetera | β-Sheet and Random coli | Non-hemolytic | ||
| 38791374 | 2024 | KRCRFRIYRWGFPRRRF | blap-6 | Free | Free | Linear | L | None | 17 | Antifungal | 0 % Hemolysis at 5.2 µM | Human | Chinese Medicinal Beetle Blaps Rhynchopetera | β-Sheet and Random coli | Non-hemolytic | ||
| 38791374 | 2024 | KRCRFRIYRWGFPRRRF | blap-6 | Free | Free | Linear | L | None | 17 | Antifungal | <5 % Hemolysis at 10.4 µM | Human | Chinese Medicinal Beetle Blaps Rhynchopetera | β-Sheet and Random coli | NA | ||
| 38791374 | 2024 | KRCRFRIYRWGFPRRRF | blap-6 | Free | Free | Linear | L | None | 17 | Antifungal | <5 % Hemolysis at 20.8 µM | Human | Chinese Medicinal Beetle Blaps Rhynchopetera | β-Sheet and Random coli | NA | ||
| 38791374 | 2024 | KRCRFRIYRWGFPRRRF | blap-6 | Free | Free | Linear | L | None | 17 | Antifungal | <10 % Hemolysis at 41.7 µM | Human | Chinese Medicinal Beetle Blaps Rhynchopetera | β-Sheet and Random coli | NA | ||
| 38791374 | 2024 | KRCRFRIYRWGFPRRRF | blap-6 | Free | Free | Linear | L | None | 17 | Antifungal | <20 % Hemolysis at 83.3 µM | Human | Chinese Medicinal Beetle Blaps Rhynchopetera | β-Sheet and Random coli | NA | ||
| 38791374 | 2024 | KRCRFRIYRWGFPRRRF | blap-6 | Free | Free | Linear | L | None | 17 | Antifungal | 90 % Hemolysis at 166.6 µM | Human | Chinese Medicinal Beetle Blaps Rhynchopetera | β-Sheet and Random coli | NA | ||
| 38755634 | 2024 | FLVKLILKILRR{ct:Amid} | BiF2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 1.95 μg/mL | Human | Derivative Of Bif | α-Helical | NA | ||
| 38755634 | 2024 | FLVKLIKKILRR{ct:Amid} | BiF2_7K | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 15.63 μg/mL | Human | Derivative Of Bif | α-Helical | NA | ||
| 38755634 | 2024 | FLVKKIKKILRR{ct:Amid} | BiF2_5K7K | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 10 % Hemolysis at >250 μg/mL | Human | Lysine-Substituted Hybrid Peptide | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 0.19 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 0.39 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 0.78 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 1.56 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 3.12 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 6.25 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 12.5 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 25 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 50 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 100 µM | Human | Synthetic | α-Helical | NA | ||
| 38578302 | 2024 | KYWKKYWKKYWK{ct:Amid} | KK12YW | Amidation | Free | Linear | L | None | 11 | Antibacterial | 0 % Hemolysis at 0.44-229.27 μg/mL | Fish | Synthetic | α-Helical | Non-hemolytic | ||
| 38578302 | 2024 | KYWKKYWKKYWK{ct:Amid} | KK12YW | Amidation | Free | Linear | L | None | 11 | Antibacterial | 25 % Hemolysis at 458.55 μg/mL | Fish | Synthetic | α-Helical | NA | ||
| 38578302 | 2024 | KYWKKYWKKYWK{ct:Amid} | KK12YW | Amidation | Free | Linear | L | None | 11 | Antibacterial | <50 % Hemolysis at 917.1 μg/mL | Fish | Synthetic | α-Helical | NA | ||
| 38578302 | 2024 | KYWKKYWKKYWK{ct:Amid} | KK12YW | Amidation | Free | Linear | L | None | 11 | Antibacterial | <50 % Hemolysis at 1834.21 μg/mL | Fish | Synthetic | α-Helical | NA | ||
| 38578302 | 2024 | KYWKKYWKKYWK{ct:Amid} | KK12YW | Amidation | Free | Linear | L | None | 11 | Antibacterial | <50 % Hemolysis at 3668.42 μg/mL | Fish | Synthetic | α-Helical | NA | ||
| 38578302 | 2024 | KYWKKYWKKYWK{ct:Amid} | KK12YW | Amidation | Free | Linear | L | None | 11 | Antibacterial | 51.2 % Hemolysis at 7336.84 μg/mL | Fish | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 2 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 4 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 8 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 16 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 32 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 64 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 128 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 4 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 8 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 16 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 32 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 64 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <40 % Hemolysis at 128 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 4 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 8 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 16 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <30 % Hemolysis at 32 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <50 % Hemolysis at 64 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <80 % Hemolysis at 128 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 4 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <40 % Hemolysis at 8 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <70 % Hemolysis at 16 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <120 % Hemolysis at 32 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <120 % Hemolysis at 64 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <120 % Hemolysis at 128 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 4 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 8 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 16 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <40 % Hemolysis at 32 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <40 % Hemolysis at 64 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <40 % Hemolysis at 128 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38587584 | 2024 | GLFKKLRRKIKKGF{ct:Amid} | AS-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | IKKWFKKIFKRL{ct:Amid} | AS-12W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLWRKIKKWF{ct:Amid} | AS-14WW | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLRRKIKKGF{ct:Amid} | AS-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 32 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | IKKWFKKIFKRL{ct:Amid} | AS-12W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 32 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLWRKIKKWF{ct:Amid} | AS-14WW | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <20 % Hemolysis at 32 μg/mL | Sheep | As-21 Mutants | α-Helical | NA | ||
| 38587584 | 2024 | GLFKKLRRKIKKGF{ct:Amid} | AS-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 64 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | IKKWFKKIFKRL{ct:Amid} | AS-12W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 64 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLWRKIKKWF{ct:Amid} | AS-14WW | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <20 % Hemolysis at 64 μg/mL | Sheep | As-21 Mutants | α-Helical | NA | ||
| 38587584 | 2024 | GLFKKLRRKIKKGF{ct:Amid} | AS-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 128 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | IKKWFKKIFKRL{ct:Amid} | AS-12W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 128 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLWRKIKKWF{ct:Amid} | AS-14WW | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <40 % Hemolysis at 128 μg/mL | Sheep | As-21 Mutants | α-Helical | NA | ||
| 38587584 | 2024 | GLFKKLRRKIKKGF{ct:Amid} | AS-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 256 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | IKKWFKKIFKRL{ct:Amid} | AS-12W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 256 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLWRKIKKWF{ct:Amid} | AS-14WW | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <80 % Hemolysis at 256 μg/mL | Sheep | As-21 Mutants | α-Helical | NA | ||
| 38587584 | 2024 | GLFKKLRRKIKKGF{ct:Amid} | AS-14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at 512 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | IKKWFKKIFKRL{ct:Amid} | AS-12W | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 0 % Hemolysis at 512 μg/mL | Sheep | As-21 Mutants | α-Helical | Non-hemolytic | ||
| 38587584 | 2024 | GLFKKLWRKIKKWF{ct:Amid} | AS-14WW | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <80 % Hemolysis at 512 μg/mL | Sheep | As-21 Mutants | α-Helical | NA | ||
| 38561076 | 2024 | YVPGVIESLL{ct:Amid} | Peptide YL | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at >500 µM | Mouse | Skin Secretions Of The Banana Tree Dwelling Frog Boana Platanera | α-Helical | NA | ||
| 38561076 | 2024 | GLLSTVGGLVGGLLNNLGL{ct:Amid} | Plasticin PL | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 50 % Hemolysis at 272 ± 13 µM | Mouse | Skin Secretions Of The Banana Tree Dwelling Frog Boana Platanera | α-Helical | NA | ||
| 38561076 | 2024 | FLGLIPALAGAIGNLIK{ct:Amid} | Hylin PL | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at 65 ± 5 µM | Mouse | Skin Secretions Of The Banana Tree Dwelling Frog Boana Platanera | α-Helical | NA | ||
| 36988897 | 2024 | GLPLLISWIKRKRQQ{ct:Amid} | M1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 40 % Hemolysis at 16 μg/mL | Human | Analog Of Mlt | α-Helical | NA | ||
| 36988897 | 2024 | GLPLLRSWIKRKRQQ{ct:Amid} | M2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 14.25 % Hemolysis at 16 μg/mL | Human | Analog Of Mlt | α-Helical | NA | ||
| 38043914 | 2024 | FVKWFKKFLTRIL | TRIL | Free | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µM | Human | Analogue Of Temporin-L | NA | Non-hemolytic | ||
| 38043914 | 2024 | FVKWFKKFLTRIL | TRIL | Free | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µM | Human | Analogue Of Temporin-L | NA | Non-hemolytic | ||
| 38043914 | 2024 | FVKWFKKFLTRIL | TRIL | Free | Free | Linear | L | None | 13 | Antimicrobial | <50 % Hemolysis at 64 µM | Human | Analogue Of Temporin-L | NA | NA | ||
| 38043914 | 2024 | FVKWFKKFLTRIL | TRIL | Free | Free | Linear | L | None | 13 | Antimicrobial | <100 % Hemolysis at 128 µM | Human | Analogue Of Temporin-L | NA | NA | ||
| 38043914 | 2024 | FVKWFKKFLTRIL | TRIL | Free | Free | Linear | L | None | 13 | Antimicrobial | <100 % Hemolysis at 256 µM | Human | Analogue Of Temporin-L | NA | NA | ||
| 38043914 | 2024 | FVKWFKKFLTRIL | TRIL | Free | Free | Linear | L | None | 13 | Antimicrobial | 100 % Hemolysis at 512 µM | Human | Analogue Of Temporin-L | NA | NA | ||
| 37992185 | 2024 | YGKAAAAK‐{nnr:Aic}‐AAAKAAAAK | peptideA | Free | Free | Linear | L | Aic = 2−aminoindane‐2‐carboxylicacid | 18 | Antibacterial | 0 % Hemolysis at | Human | Synthetic | NA | Non-hemolytic | | ||
| 37760693 | 2024 | FLWRISKFLGKKL{ct:Amid} | HRZN-13 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 0.7 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | Non-hemolytic | ||
| 37760693 | 2024 | FLWRISKFLGRKL{ct:Amid} | HRZN-14 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 5.6 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | Non-hemolytic | ||
| 37760693 | 2024 | FLPWISKFLGKIL{ct:Amid} | HRZN-15 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 100 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | FLPWISKFLGKIL{ct:Amid} | HRZN-15 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 8.6 % Hemolysis at 10 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | FLKKIWKLLGKLL{ct:Amid} | HRZN-16 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 100 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | FLKKIWKLLGKLL{ct:Amid} | HRZN-16 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 67 % Hemolysis at 10 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | KLWKLLKKLGRLL{ct:Amid} | HRZN-17 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 18 % Hemolysis at 10 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | KLWKLLKKLGRLL{ct:Amid} | HRZN-17 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 74 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 28941793 | 2017 | FIG{nnr:M(ox)}IPGLIGGLISAIK{ct:Amid} | Im-4 | Amidation | Free | Linear | L | M(ox) = oxidized Methionine | 17 | Antimicrobial, Insecticidal,neurotoxic | 50 % Hemolysis at >30 µM | Sheep | Modified Isometrus Maculatus Scorpion Venom | α-Helix | NA | ||
| 28941793 | 2017 | FFFLPSLIGGLVSAIK{ct:Amid} | Im-6 | Amidation | Free | Linear | L | None | 16 | Antimicrobial and Insecticidal | 50 % Hemolysis at >25 µM | Sheep | Isometrus Maculatus Scorpion Venom | α-Helix | NA | ||
| 29075946 | 2017 | IDWKKLLDAAKQIL{ct:Amid} | MP1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | <1 % Hemolysis at 12.5 µM | Human | Venom Of The Social Wasp Polybia Paulista | α-Helix | NA | ||
| 29075946 | 2017 | IDWKK{nnr:*}LDA{nnr:*}KQIL{ct:Amid} | MP1S | Amidation | Free | Linear | L | * = indicate cross-linked residues connected by oct-4-enyl hydrocarbon staple | 12 | Antimicrobial | 6.7 % Hemolysis at 12.5 µM | Human | Stapled Helices Of Polybia-Mp1 | Helical | NA | ||
| 29075946 | 2017 | IDWKK{nnr:*}LNA{nnr:*}KQIL{ct:Amid} | MP1S-D8N | Amidation | Free | Linear | L | * = indicate cross-linked residues connected by oct-4-enyl hydrocarbon staple | 12 | Antimicrobial | 16.3 % Hemolysis at 12.5 µM | Human | Stapled Helices Of Polybia-Mp1 | Helical | NA | ||
| 29075946 | 2017 | IDWKK{nnr:*}LDA{nnr:*}KKIL{ct:Amid} | MP1S-Q12K | Amidation | Free | Linear | L | * = indicate cross-linked residues connected by oct-4-enyl hydrocarbon staple | 12 | Antimicrobial | 9.6 % Hemolysis at 12.5 µM | Human | Stapled Helices Of Polybia-Mp1 | Helical | NA | ||
| 29075946 | 2017 | IDWKKLLDAAKQIL{ct:Amid} | MP1 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 3.2 % Hemolysis at 25 µM | Human | Venom Of The Social Wasp Polybia Paulista | α-Helix | NA | ||
| 29075946 | 2017 | IDWKK{nnr:*}LDA{nnr:*}KQIL{ct:Amid} | MP1S | Amidation | Free | Linear | L | * = indicate cross-linked residues connected by oct-4-enyl hydrocarbon staple | 12 | Antimicrobial | 12.3 % Hemolysis at 25 µM | Human | Stapled Helices Of Polybia-Mp1 | Helical | NA | ||
| 29075946 | 2017 | IDWKK{nnr:*}LNA{nnr:*}KQIL{ct:Amid} | MP1S-D8N | Amidation | Free | Linear | L | * = indicate cross-linked residues connected by oct-4-enyl hydrocarbon staple | 12 | Antimicrobial | 37.8 % Hemolysis at 25 µM | Human | Stapled Helices Of Polybia-Mp1 | Helical | NA | ||
| 29075946 | 2017 | IDWKK{nnr:*}LDA{nnr:*}KKIL{ct:Amid} | MP1S-Q12K | Amidation | Free | Linear | L | * = indicate cross-linked residues connected by oct-4-enyl hydrocarbon staple | 12 | Antimicrobial | 13.9 % Hemolysis at 25 µM | Human | Stapled Helices Of Polybia-Mp1 | Helical | NA | ||
| 29077406 | 2017 | F{d}PV{nnr:O}L-F{d}PV{nnr:O}L{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = Ornithine, f = D-Phenylalanine | 10 | Antimicrobial | 90 % Hemolysis at 12 μg/mL | Human | Aneurinibacillus Migulanus | C2-symmetric antiparallel β-Sheet | NA | ||
| 29077406 | 2017 | F{d}({nnr:Dyp})V{nnr:O}LF{d}PV{nnr:O}L{cyc:N-C} | GS mimetic 15 | Free | Free | Cyclic | Mix | O = Ornithine, Dyp = cis-dihydroxyproline, f = D-Phenylalanine | 10 | Antimicrobial | 90 % Hemolysis at 85 μg/mL | Human | Gs Derivative Synthesized | β-Turn | NA | ||
| 29077406 | 2017 | {nnr:D-Hot[(7S,8S)-{nnr:O}-(2(S)-decyliden)]═Tap}-V-{nnr:O}-L-F{d}-P-V-{nnr:O}-L{cyc:N-C} | GS mimetic 17 | Free | Free | Cyclic | Mix | O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine | 10 | Antimicrobial | 90 % Hemolysis at 38 μg/mL | Human | Gs Analogue Modified With A C8- Alkyl Chain | twisted β-Sheet structure | NA | ||
| 29077406 | 2017 | {nnr:D-Hot[(7S,8S)-{nnr:O}-(2(S)-pentadecyliden)]═Tap}-V-{nnr:O}-L- F{d}-P-V-{nnr:O}-L{cyc:N-C} | GS mimetic 18 | Free | Free | Cyclic | Mix | O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine | 10 | Antimicrobial | 90 % Hemolysis at 6 μg/mL | Human | Gs Analogue 18 Modified With A C13-Alkyl Chain | twisted β-Sheet structure | NA | ||
| 29077406 | 2017 | {nnr:D-Hot[(7S,8S)-{nnr:O}-(2(S)-8-pentadecyliden)]═Tap}-V-{nnr:O}L-F{d}-P-V-{nnr:O}-L{cyc:N-C} | GS mimetic 19 | Free | Free | Cyclic | Mix | O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine | 10 | Antimicrobial | 90 % Hemolysis at 5 μg/mL | Human | Gs Analogue Modified With Two C7-Alkyl Chains | twisted β-Sheet structure | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Anticancer, Antimicrobial | 10 % Hemolysis at 14 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-P-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1-Pro6 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antimicrobial | 10 % Hemolysis at 83 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-P-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1-Pro9 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antimicrobial | 10 % Hemolysis at 165 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1 11mer | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 11 | Antimicrobial | 10 % Hemolysis at 103 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1 17mer | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 17 | Antimicrobial | 10 % Hemolysis at 3 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}-{nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}-{nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}-{nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}{nt:H}{ct:Amid} | peptoid 2 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nssb = N-(S)-(sec-butyl)glycine | 12 | Antimicrobial | 10 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Npm}-{nnr:Npm}-{nnr:NLys}-{nnr:Npm}-{nnr:Npm}-{nnr:NLys}-{nnr:Npm}-{nnr:Npm}-{nnr:NLys}-{nnr:Npm}-{nnr:Npm}{nt:H}{ct:Amid} | peptoid 1 achiral | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Npm = N-(phenylmethyl)glycine | 12 | Antimicrobial | 10 % Hemolysis at 180 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:NLys}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:NLys}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1-NLys5,11 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antimicrobial | 10 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nsna}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nsna}{nt:H}{ct:Amid} | peptoid 1-Nsna6,12 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine, Nsna = (S)-N-(1-naphthylethyl) glycine | 12 | Antimicrobial | 10 % Hemolysis at 7 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Anticancer, Antimicrobial | 50 % Hemolysis at 62 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-P-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1-Pro6 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antimicrobial | 50 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-P-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1-Pro9 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antimicrobial | 50 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1 11mer | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 11 | Antimicrobial | 50 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1 17mer | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 17 | Antimicrobial | 50 % Hemolysis at 15 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}-{nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}-{nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}-{nnr:NLys}-{nnr:Nssb}-{nnr:Nssb}{nt:H}{ct:Amid} | peptoid 2 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nssb = N-(S)-(sec-butyl)glycine | 12 | Antimicrobial | 50 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Npm}-{nnr:Npm}-{nnr:NLys}-{nnr:Npm}-{nnr:Npm}-{nnr:NLys}-{nnr:Npm}-{nnr:Npm}-{nnr:NLys}-{nnr:Npm}-{nnr:Npm}{nt:H}{ct:Amid} | peptoid 1 achiral | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Npm = N-(phenylmethyl)glycine | 12 | Antimicrobial | 50 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:NLys}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:NLys}-{nnr:Nspe}{nt:H}{ct:Amid} | peptoid 1-NLys5,11 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antimicrobial | 50 % Hemolysis at >200 μM | Human | Synthetic | NA | NA | ||
| 29196622 | 2017 | {nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nsna}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:NLys}-{nnr:Nspe}-{nnr:Nsna}{nt:H}{ct:Amid} | peptoid 1-Nsna6,12 | Amidation | H | Linear | L | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine, Nsna = (S)-N-(1-naphthylethyl) glycine | 12 | Antimicrobial | 50 % Hemolysis at 27 μM | Human | Synthetic | NA | NA | ||
| 29219046 | 2017 | LALRTAGWLRLLGFRDKKKN | Ulmin-1ULa | Free | Free | Linear | L | None | 20 | Antimicrobial Peptides | 4 % Hemolysis at 32 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | LALRTAGWLRLLGFRDKKKN | Ulmin-1ULa | Free | Free | Linear | L | None | 20 | Antimicrobial Peptides | 5 % Hemolysis at 64 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | LALRTAGWLRLLGFRDKKKN | Ulmin-1ULa | Free | Free | Linear | L | None | 20 | Antimicrobial Peptides | 8 % Hemolysis at 128 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29568446 | 2017 | ACLLQSLLCPYSTHRCG{cyc:N-C} | P8-d-C10 | Free | Free | Bicyclic | L | None | 17 | Antibacterial | 6 % Hemolysis at 32 μg/mL | Sheep | Peptide Phage | NA | Low hemolytic | ||
| 29568446 | 2017 | ACLLQSLLCPYSTHACG{cyc:N-C} | P8-d-(R15A)-C10 | Free | Free | Bicyclic | L | None | 17 | Antibacterial | 0 % Hemolysis at 32 μg/mL | Sheep | Peptide Phage | NA | Non-hemolytic | ||
| 29568446 | 2017 | ACLLQSLLCPYSTARCG{cyc:N-C} | P8-d-(H14R, R15A)-C10 | Free | Free | Bicyclic | L | None | 17 | Antibacterial | 2 % Hemolysis at 32 μg/mL | Sheep | Peptide Phage | NA | Low hemolytic | ||
| 29568446 | 2017 | ACLLQSLLCAYSTHRCG{cyc:N-C} | P8-d-(P10R, R15A)-C10 | Free | Free | Bicyclic | L | None | 17 | Antibacterial | 0 % Hemolysis at 32 μg/mL | Sheep | Peptide Phage | NA | Non-hemolytic | ||
| 29568446 | 2017 | ACLLQALLCPYSTHRCG{cyc:N-C} | P8-d-(S6R, R15A)-C10 | Free | Free | Bicyclic | L | None | 17 | Antibacterial | 0 % Hemolysis at 32 μg/mL | Sheep | Peptide Phage | NA | Non-hemolytic | ||
| 29568446 | 2017 | ACLLQALLCPYSTHRCG{cyc:N-C} | P8-L-(S6R, R15A)-C10 | Free | Free | Bicyclic | L | None | 17 | Antibacterial | 0 % Hemolysis at 32 μg/mL | Sheep | Peptide Phage | NA | Non-hemolytic | ||
| 28960954 | 2017 | KWCFRVCYRGICYRRCR | TP1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.25 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | Low hemolytic | ||
| 28960954 | 2017 | AWCFRVCYRGICYRRCR | TP1[K1A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 2.1 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KACFRVCYRGICYRRCR | TP1[W2A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 8 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWAFRVCYRGICYRRSR | TP1[C3A,C16S] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 8 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCARVCYRGICYRRCR | TP1[F4A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 40 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | NA | ||
| 28960954 | 2017 | KWCFAVCYRGICYRRCR | TP1[R5A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 2 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRACYRGICYRRCR | TP1[V6A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 1.2 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVAYRGISYRRCR | TP1[C7A,C12S] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 1 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCARGICYRRCR | TP1[Y8A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 8 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYAGICYRRCR | TP1[R9A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 2 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRAICYRRCR | TP1[G10A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.5 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRGACYRRCR | TP1[I11A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 32 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | NA | ||
| 28960954 | 2017 | KWCFRVSYRGIAYRRCR | TP1[C7S,C12A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.6 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRGICARRCR | TP1[Y13A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 1 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRGICYARCR | TP1[R14A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.5 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRGICYRACR | TP1[R15A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.45 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWSFRVCYRGICYRRAR | TP1[C3S,C16A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 3 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRGICYRRCA | TP1[R17A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.45 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWAFRVCYRGICYRRAR | TP1[C3A,C16A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 40 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | β-Sheet | NA | ||
| 28960954 | 2017 | KWCFRVAYRGIAYRRCR | TP1[C7A,C12A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 8 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWAFRVAYRGIAYRRAR | TP1[C3A,C7A,C12A,C16A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.24 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | Low hemolytic | ||
| 28960954 | 2017 | KWCFRRCYAGICYRRCR | TP1[V6R,R9A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 11 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | RWCFRVCYRGICYRRCR | TP1[K1R] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 1 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCGRVCYRGICYRRCR | TP1[F4G] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.47 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCSRVCYRGICYRRCR | TP1[F4S] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.23 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | Low hemolytic | ||
| 28960954 | 2017 | KWCFRVCGRGICYRRCR | TP1[Y8G] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.4 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWCFRVCYRGGCYRRCR | TP1[I11G] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.2 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | Low hemolytic | ||
| 28960954 | 2017 | KWCARVCARGACYRRCR | TP1[F4A,Y8A,I11A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.9 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | KWC-FVCYRGICYRRCG | TP1[-R5,R17G] | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 0.3 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | AWCARVCYRGICYRRCR | TP1[K1A,F4A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 32 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | AWCFRVCARGICYRRCR | TP1[K1A,Y8A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.4 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | NA | ||
| 28960954 | 2017 | AWCFRVCYRGACYRRCR | TP1[K1A,I11A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.2 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | Low hemolytic | ||
| 28960954 | 2017 | KWCFRVCYAGICYRRCA | TP1[R9A,R17A] | Free | Free | Linear | L | None | 17 | Antimicrobial | 10 % Hemolysis at 0.2 μg/ml | Human | Horseshoe Crab Tachypleus Tridentatus | Random Coil (RC) | Low hemolytic | ||
| 29140694 | 2017 | F{d}PFF{d}NQYV{nnr:O}L{cyc:N-C} | Tyrocidine A | Free | Free | Cyclic | Mix | BE2 = 2-AMINOBENZOIC ACID, f = D-Phenylalanine, O = L-Ornithine | 10 | Antimicrobial | 100 % Hemolysis at 5 μg/ml | Mouse | Bacillus Brevis | β-Hairpin | NA | ||
| 29140694 | 2017 | F{d}{nnr:BE2}FF{d}NQYV{nnr:O}L{cyc:N-C} | Tyrocidine A analogue AC3.27 | Free | Free | Cyclic | Mix | BE2 = 2-AMINOBENZOIC ACID, f = D-Phenylalanine, O = L-Ornithine | 10 | Antifungal | ~60 % Hemolysis at 38 μg/ml | Mouse | Synthetic Analogue Of Tyrocidine A | β-Hairpin | NA | ||
| 29140694 | 2017 | F{d}{nnr:BE2}FF{d}NKYV{nnr:O}L{cyc:N-C} | Tyrocidine A analogue AC3.28 | Free | Free | Cyclic | Mix | BE2 = 2-AMINOBENZOIC ACID, f = D-Phenylalanine, O = L-Ornithine | 10 | Antifungal | ~60 % Hemolysis at 38 μg/ml | Mouse | Synthetic Analogue Of Tyrocidine A | β-Hairpin | NA | ||
| 29188836 | 2017 | F{d}PVRLF{d}PVRL{cyc:N-C} | GS-2 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 10.03±0.49 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | A{d}PVRLF{d}PVRL{cyc:N-C} | MGR-1 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 67.18±2.94 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}AVRLF{d}PVRL{cyc:N-C} | MGR-2 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 55.03±1.77 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}PARLF{d}PVRL{cyc:N-C} | MGR-3 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 30.56±1.80 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}PVALF{d}PVRL{cyc:N-C} | MGR-4 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 14.41±0.51 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}PVRAF{d}PVRL{cyc:N-C} | MGR-5 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 36.33±1.98 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | A{d}PVRLA{d}PVRL{cyc:N-C} | DGR-1 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 137.40±6.20 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}AVRLF{d}AVRL{cyc:N-C} | DGR-2 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 199.90±9.80 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}PARLF{d}PARL{cyc:N-C} | DGR-3 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 88.95±7.51 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}PVALF{d}PVAL{cyc:N-C} | DGR-4 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at >200 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}PVRAF{d}PVRA{cyc:N-C} | DGR-5 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at >200 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29091404 | 2017 | GLFDIIKKIAESF{ct:Amid} | 1 | Amidation | Free | Linear | L | None | 13 | Antifungal | 10 % Hemolysis at 7.6 ± 0.9 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | GLFKIIKKIAKSF{ct:Amid} | 2 | Amidation | Free | Linear | L | None | 13 | Antifungal | 10 % Hemolysis at 2.9 ± 0.1 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}F{nnr:βK}I{nnr:βI}K{nnr:βK}I{nnr:βA}K{nnr:βS}F{ct:Amid} | 3a | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 2.5 ± 0.1 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}F{nnr:βK}I{nnr:βI}K{nnr:βK}I{nnr:βL}K{nnr:βS}F{ct:Amid} | 3b | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 3.2 ± 0.3 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}F{nnr:βK}I{nnr:βI}K{nnr:βK}I{nnr:βL}K{nnr:βL}F{ct:Amid} | 3c | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 19.2 ± 2.6 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}F{nnr:βK}I{nnr:X}K{nnr:βK}I{nnr:βA}K{nnr:X}F{ct:Amid} | 3Ca | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 4.3 ± 0.2 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}F{nnr:βK}I{nnr:X}K{nnr:βK}I{nnr:βL}K{nnr:X}F{ct:Amid} | 3Cb | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 21.6 ± 6.8 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | GL{nnr:βF}KI{nnr:βI}KK{nnr:βI}AK{nnr:βS}F{ct:Amid} | 4a | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 7.1 ± 1.0 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | GL{nnr:βF}KI{nnr:βI}KK{nnr:βI}LK{nnr:βS}F{ct:Amid} | 4b | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 6.8 ± 0.8 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | GL{nnr:βF}KI{nnr:βI}KK{nnr:βI}LK{nnr:βL}F{ct:Amid} | 4c | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 32.6 ± 2.3 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | GL{nnr:X}KI{nnr:βI}KK{nnr:X}AK{nnr:βS}F{ct:Amid} | 4Ca | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 2.6 ± 0.1 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | GL{nnr:X}KI{nnr:βI}KK{nnr:X}LK{nnr:βS}F{ct:Amid} | 4Cb | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 2.3 ± 0.1 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | GL{nnr:X}KI{nnr:βI}KK{nnr:X}LK{nnr:βL}F{ct:Amid} | 4Cc | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 24.5 ± 2.0 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}FKI{nnr:βI}KKI{nnr:βA}KSF{ct:Amid} | 5a | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 2.6 ± 0.3 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}FKI{nnr:βI}KKI{nnr:βL}KSF{ct:Amid} | 5b | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 5.5 ± 1.6 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}FKI{nnr:βI}KKI{nnr:βL}KLF{ct:Amid} | 5c | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 41.9 ± 5.2 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:X}FKI{nnr:βI}KKI{nnr:X}KSF{ct:Amid} | 5Ca | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 2.6 ± 0.2 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:X}FKI{nnr:βI}KKI{nnr:X}KLF{ct:Amid} | 5Cb | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 19.8 ± 2.5 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}F{nnr:βK}II{nnr:βK}K{nnr:βI}A{nnr:βK}SF{ct:Amid} | 6a | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 4.3 ± 0.4 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}F{nnr:βK}II{nnr:βK}K{nnr:βI}L{nnr:βK}SF{ct:Amid} | 6b | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 3.4 ± 0.1 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}F{nnr:βK}II{nnr:βK}K{nnr:βI}L{nnr:βK}LF{ct:Amid} | 6c | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 3.4 ± 0.2 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:X}F{nnr:βK}II{nnr:βK}K{nnr:X}A{nnr:βK}SF{ct:Amid} | 6Ca | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 4.9 ± 0.4 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:X}F{nnr:βK}II{nnr:βK}K{nnr:X}L{nnr:βK}SF{ct:Amid} | 6Cb | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 2.7 ± 0.2 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:X}F{nnr:βK}II{nnr:βK}K{nnr:X}L{nnr:βK}LF{ct:Amid} | 6Cc | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 2.3 ± 0.1 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}FKI{nnr:βI}KK{nnr:βI}AKS{nnr:βF}{ct:Amid} | 7a | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 2.6 ± 0.3 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}FKI{nnr:βI}KK{nnr:βI}LKS{nnr:βF}{ct:Amid} | 7b | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 8.7 ± 0.3 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}FKI{nnr:βI}KK{nnr:βI}LKL{nnr:βF}{ct:Amid} | 7c | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 40.1 ± 3.0 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:X}FKI{nnr:βI}KK{nnr:X}AKS{nnr:βF}{ct:Amid} | 7Ca | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 2.4 ± 0.3 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:X}FKI{nnr:βI}KK{nnr:X}LKS{nnr:βF}{ct:Amid} | 7Cb | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 5.2 ± 0.7 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:X}FKI{nnr:βI}KK{nnr:X}LKL{nnr:βF}{ct:Amid} | 7Cc | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 28.4 ± 5.0 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:X}FKI{nnr:βI}KK{nnr:X}AES{nnr:βF}{ct:Amid} | 8 | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 3.1 ± 0.4 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:X}FDI{nnr:βI}KK{nnr:X}AKS{nnr:βF}{ct:Amid} | 9 | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 2.3 ± 0.1 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:X}FKI{nnr:βI}KK{nnr:βI}AKS{nnr:βF}{ct:Amid} | 10 | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 4.8 ± 0.2 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 29091404 | 2017 | G{nnr:βL}FKI{nnr:βI}KK{nnr:X}AKS{nnr:βF}{ct:Amid} | 11 | Amidation | Free | Linear | L | replacing key α-amino acids with β-amino acids | 13 | Antifungal | 10 % Hemolysis at 2.9 ± 0.2 μg/ml | Human | Α/Β-Peptide Aurein Analogues (Australian Bell Frogs) | H-bonded helices | NA | ||
| 28636781 | 2018 | IIGPV LGLIG KALGG LL{ct:Amid} | Bombinin H-BO | Amidation | Free | Linear | L | None | 17 | Antimicrobial and Haemolytic | 38 % Hemolysis at 128 mg/ml | Human | African Clawed Frog (Xenopus Laevis) | α-Helical | NA | ||
| 28636781 | 2018 | IIGPV LGLIG KALGG LL{ct:Amid} | Bombinin H-BO | Amidation | Free | Linear | L | None | 17 | Antimicrobial and Haemolytic | 85 % Hemolysis at 256 mg/ml | Human | African Clawed Frog (Xenopus Laevis) | α-Helical | NA | ||
| 28650592 | 2018 | LVGKLLKGAVGDVCGLLPIC{ct:disulfide bridge} | OM-LV20 | disulfide bridge | Free | Linear | L | None | 20 | Wound healing activity | 0 % Hemolysis at 1 mM | Human | Frog(Odorrana Margaretae) | NA | Non-hemolytic | ||
| 28815904 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | Tachyplesin I | Amidation | Free | Linear | L | None | 17 | Antimicrobial peptides | ~20 % Hemolysis at 50 μM | Human | Horseshoe Crab Tachypleus Tridentatus | β-Hairpin | NA | ||
| 28815904 | 2018 | {nnr:Z}CRRLCYKQRCVTYCRGR{nt:Z- pyroglutamic acid}{ct:Amid} | Gomesin | Amidation | Z- pyroglutamic acid | Linear | L | Z = pyroglutamic acid | 18 | Antimicrobial peptides | 8 % Hemolysis at 100 μM | Human | Spider Acanthoscurria Gomesiana | β-Hairpin | NA | ||
| 28837852 | 2018 | VKLKKRNVNLKTILGVG | MrChit3 - MrVG | Free | Free | Linear | L | None | 17 | Antimicrobial | ≤5 % Hemolysis at 20 μM | Human | Prawn (Macrobrachium Rosenbergii) Chitinase-3 | NA | Low hemolytic | ||
| 28837852 | 2018 | VKLKKRNVNLKTILGVG | MrChit3 - MrVG | Free | Free | Linear | L | None | 17 | Antimicrobial | ≤5 % Hemolysis at 40 μM | Human | Prawn (Macrobrachium Rosenbergii) Chitinase-3 | NA | Low hemolytic | ||
| 28837852 | 2018 | VKLKKRNVNLKTILGVG | MrChit3 - MrVG | Free | Free | Linear | L | None | 17 | Antimicrobial | ≤5 % Hemolysis at 80 μM | Human | Prawn (Macrobrachium Rosenbergii) Chitinase-3 | NA | Low hemolytic | ||
| 28837852 | 2018 | VKLKKRNVNLKTILGVG | MrChit3 - MrVG | Free | Free | Linear | L | None | 17 | Antimicrobial | ≤5 % Hemolysis at 160 μM | Human | Prawn (Macrobrachium Rosenbergii) Chitinase-3 | NA | Low hemolytic | ||
| 29038271 | 2018 | NPYNQTS{nnr:X}NPYNQTS{nnr:X}{cyc:N-C}{ct:Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant} | AF3, AF4 | Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant | Free | Cyclic | L | X = Xaa is a β-amino fatty acid variant for AF3-anteiso-C17, X = Xaa is a β-amino fatty acid variant for AF4-iso-C17 | 16 | Antifungal, Antifungal | 3.87±3.7 % Hemolysis at 4,4 μg/ml | Human | Bacillus Subtilis Rlid 12.1 | NA | NA | ||
| 29038271 | 2018 | NPYNQTS{nnr:X}NPYNQTS{nnr:X}{cyc:N-C}{ct:Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant} | AF3, AF5 | Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant | Free | Cyclic | L | X = Xaa is a β-amino fatty acid variant for AF3-anteiso-C17, X = Xaa is a β-amino fatty acid variant for AF5-iso-C18 | 16 | Antifungal, Antifungal | 3.43±3.1 % Hemolysis at 4,4 μg/ml | Human | Bacillus Subtilis Rlid 12.1 | NA | NA | ||
| 29038271 | 2018 | NPYNQTS{nnr:X}NPYNQTS{nnr:X}{cyc:N-C}{ct:Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant} | AF3, AF5 | Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant | Free | Cyclic | L | X = Xaa is a β-amino fatty acid variant for AF3-anteiso-C17, X = Xaa is a β-amino fatty acid variant for AF5-iso-C18 | 16 | Antifungal, Antifungal | 4.11±5.9 % Hemolysis at 2,4 μg/ml | Human | Bacillus Subtilis Rlid 12.1 | NA | NA | ||
| 29038271 | 2018 | NPYNQTS{nnr:X}NPYNQTS{nnr:X}{cyc:N-C}{ct:Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant} | AF4, AF5 | Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant | Free | Cyclic | L | X = Xaa is a β-amino fatty acid variant for AF4-iso-C17, X = Xaa is a β-amino fatty acid variant for AF5-iso-C18 | 16 | Antifungal, Antifungal | 3.12±3.4 % Hemolysis at 4,4 μg/ml | Human | Bacillus Subtilis Rlid 12.1 | NA | NA | ||
| 29038271 | 2018 | NPYNQTS{nnr:X}NPYNQTS{nnr:X}{cyc:N-C}{ct:Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant} | AF4, AF5 | Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant | Free | Cyclic | L | X = Xaa is a β-amino fatty acid variant for AF4-iso-C17, X = Xaa is a β-amino fatty acid variant for AF5-iso-C18 | 16 | Antifungal, Antifungal | 2.96±4.1 % Hemolysis at 2,4 μg/ml | Human | Bacillus Subtilis Rlid 12.1 | NA | NA | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | 1 % Hemolysis at 8 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | Low hemolytic | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | 1 % Hemolysis at 16 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | Low hemolytic | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | 1 % Hemolysis at 32 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | Low hemolytic | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | 1 % Hemolysis at 64 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | Low hemolytic | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | 1 % Hemolysis at 128 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | Low hemolytic | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | 2.4 % Hemolysis at 256 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | Low hemolytic | ||
| 29130500 | 2018 | GLTRLFSVIK | andricin B | Free | Free | Linear | L | None | 10 | Antimicrobial peptides | <20 % Hemolysis at 512 μg/ml | Human | Andrias Davidianus (Chinese Giant Salamander) | Random coil | NA | ||
| 29183811 | 2018 | KCRRRKVHGPMIRIRKK | TO17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 300 μM | Fish | Red Drum (Sciaenops Ocellatus) Tissue Factor Pathway Inhibitor (Tfpi)-1 | NA | Non-hemolytic | ||
| 28918200 | 2018 | VYWLPAVLGSLLGFTP{ct:Carboxyl (COO-)} | Pep-14 | Carboxyl (COO-) | Free | Linear | L | None | 16 | ND | 0 % Hemolysis at 125 μM | Rat | Scorpion Tityus Obscurus | NA | Non-hemolytic | ||
| 28918200 | 2018 | PHWLFFGVSVLC{ct:Carboxyl (COO-)} | Pep-16 | Carboxyl (COO-) | Free | Linear | L | None | 12 | ND | 0 % Hemolysis at 125 μM | Rat | Scorpion Tityus Obscurus | NA | Non-hemolytic | ||
| 28918200 | 2018 | VTLTLPPAES{ct:Amid} | Pep-17 | Amidation | Free | Linear | L | None | 10 | ND | 0 % Hemolysis at 125 μM | Rat | Scorpion Tityus Obscurus | NA | Non-hemolytic | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | Peptoid - 1 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 100 % Hemolysis at 200 mM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl){nt:H}{ct:Amid} | Peptoid - 3 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 100 % Hemolysis at 200 mM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3){nt:H}{ct:Amid} | Peptoid - 4 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 100 % Hemolysis at 200 mM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF){nt:H}{ct:Amid} | Peptoid - 5 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 100 % Hemolysis at 200 mM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid} | Peptoid - 6 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 13 | Antibacterial | 48.1 ± 3 % Hemolysis at 200 mM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid} | Peptoid - 7 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 10 | Antibacterial | 9.8 ± 0.8 % Hemolysis at 200 mM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | Peptoid - 1 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 10 % Hemolysis at 9.1 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl){nt:H}{ct:Amid} | Peptoid - 3 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 10 % Hemolysis at <6.25 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3){nt:H}{ct:Amid} | Peptoid - 4 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 10 % Hemolysis at <6.25 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF){nt:H}{ct:Amid} | Peptoid - 5 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 10 % Hemolysis at <6.25 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid} | Peptoid - 6 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 13 | Antibacterial | 10 % Hemolysis at 19.5 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid} | Peptoid - 7 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 10 | Antibacterial | 10 % Hemolysis at >200 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | Peptoid - 1 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 50 % Hemolysis at 63.4 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl){nt:H}{ct:Amid} | Peptoid - 3 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 50 % Hemolysis at 10.4 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3){nt:H}{ct:Amid} | Peptoid - 4 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 50 % Hemolysis at 8.3 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF){nt:H}{ct:Amid} | Peptoid - 5 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 50 % Hemolysis at <6.25 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid} | Peptoid - 6 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 13 | Antibacterial | 50 % Hemolysis at >200 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid} | Peptoid - 7 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 10 | Antibacterial | 50 % Hemolysis at >200 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29191658 | 2018 | FLPIVAKLLSGLL{ct:Amid} | Temporin-PE | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 39.64 μM | Horse | Frog(Pelophylax Kl. Esculentus) | α-Helical | NA | ||
| 29191658 | 2018 | FLYIVAKLLSGLL{ct:Amid} | Temporin-PEa | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 531.7 μM | Horse | Frog(Pelophylax Kl. Esculentus) | α-Helical | NA | ||
| 29359791 | 2018 | VLDKVLEELGKVSRKIAVGI{ct:Amid} | StII16-35 | Amidation | Free | Linear | L | None | 20 | Candidacidal | 50 % Hemolysis at 128 μM | Human | Derived From Sticholysin Ii (Sea Anemone Stichodactyla Helianthus) | amphiphilic α-Helix | NA | ||
| 29360748 | 2018 | RVCSAIPLPICH{cyc:3-11}{ct:Amid} | tigerinin-1R | Amidation | Free | Cyclic | L | C–C in parentheses means that the two Cys residues in the sequences form intermolecular disulfide bond | 12 | Non-toxic insulin-releasing peptide | <2 % Hemolysis at 250 μM | Human | Frog (Hoplobatrachus Ugulosus) | Random coils (48), and type I reverse βTurns (12) in 50 aqueous TFE | Non-hemolytic | ||
| 29360748 | 2018 | RVCSLLPLPLCH{cyc:3-11}{ct:Amid} | tigerinin-1R-L4 | Amidation | Free | Cyclic | L | C–C in parentheses means that the two Cys residues in the sequences form intermolecular disulfide bond | 12 | Non-toxic insulin-releasing peptide | <3 % Hemolysis at 250 μM | Human | Tigerinin-1R Analogs | Random coil | Low hemolytic | ||
| 29360748 | 2018 | RVASAIPLPIAH{nt:Acet}{ct:Amid} | tigerinin-linear | Amidation | Acetylation | Linear | L | Ac = N-acetyl; C-Terminal = amide | 12 | Non-toxic insulin-releasing peptide | <2 % Hemolysis at 250 μM | Human | Tigerinin-1R Analogs | Random coil | Low hemolytic | ||
| 29360748 | 2018 | RVKSAIPLPICH{nt:Acet}{ct:Amid} | [C3K]tigerinin-1R | Amidation | Acetylation | Linear | L | Ac = N-acetyl; C-Terminal = amide | 12 | Non-toxic insulin-releasing peptide | <2 % Hemolysis at 250 μM | Human | Tigerinin-1R Analogs | Random coil | Low hemolytic | ||
| 29360748 | 2018 | RVCSAIPLPIKH{nt:Acet}{ct:Amid} | [C11K]tigerinin-1R | Amidation | Acetylation | Linear | L | Ac = N-acetyl; C-Terminal = amide | 12 | Non-toxic insulin-releasing peptide | <2 % Hemolysis at 250 μM | Human | Tigerinin-1R Analogs | Random coil | Low hemolytic | ||
| 29364903 | 2018 | KLIPILSKTIPAGKNLFYKI | NCP-2 | Free | Free | Linear | L | None | 20 | Antimicrobial | 8 % Hemolysis at 100 μg/ml | Sheep | Subsequence Of Naja Cardiotoxin Peptide-0(Naja Atra Subsp. Atra Cardiotoxin 1 (Ctx-1)) Chinese Cobra Snake | α-Helix | NA | ||
| 29364903 | 2018 | KLIWILSKTIPAGKNLFYKI | NCP-3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 9 % Hemolysis at 100 μg/ml | Sheep | Subsequence Of Naja Cardiotoxin Peptide-0(Naja Atra Subsp. Atra Cardiotoxin 1 (Ctx-1)) Chinese Cobra Snake | Beta Sheet | NA | ||
| 29364903 | 2018 | KLIPILSKTIPAGKNLFYKI | NCP-2 | Free | Free | Linear | L | None | 20 | Antimicrobial | 2 % Hemolysis at 12.5 μg/ml | Sheep | Subsequence Of Naja Cardiotoxin Peptide-0(Naja Atra Subsp. Atra Cardiotoxin 1 (Ctx-1)) Chinese Cobra Snake | α-Helix | NA | ||
| 29364903 | 2018 | KLIWILSKTIPAGKNLFYKI | NCP-3 | Free | Free | Linear | L | None | 20 | Antimicrobial | 3 % Hemolysis at 12.5 μg/ml | Sheep | Subsequence Of Naja Cardiotoxin Peptide-0(Naja Atra Subsp. Atra Cardiotoxin 1 (Ctx-1)) Chinese Cobra Snake | Beta Sheet | NA | ||
| 29379033 | 2018 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 2 % Hemolysis at 12.5 μM | Mouse | Scorpion Heterometrus Petersii | amphipathic α-Helical | NA | ||
| 29379033 | 2018 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 11 % Hemolysis at 25 μM | Mouse | Scorpion Heterometrus Petersii | amphipathic α-Helical | NA | ||
| 29379033 | 2018 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 55 % Hemolysis at 50 μM | Mouse | Scorpion Heterometrus Petersii | amphipathic α-Helical | NA | ||
| 29379033 | 2018 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 92 % Hemolysis at 100 μM | Mouse | Scorpion Heterometrus Petersii | amphipathic α-Helical | NA | ||
| 29379033 | 2018 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % Hemolysis at 200 μM | Mouse | Scorpion Heterometrus Petersii | amphipathic α-Helical | NA | ||
| 29379033 | 2018 | ILKKLLKGVKSI{ct:Amid} | Hp1404-T1c | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <2 % Hemolysis at 200 μM | Mouse | Synthetic Peptides From Hp1404 | amphipathic α-Helical | Non-hemolytic | ||
| 29379033 | 2018 | ILKKLLKKVKSI{ct:Amid} | Hp1404-T1d | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <2 % Hemolysis at 200 μM | Mouse | Synthetic Peptides From Hp1404 | amphipathic α-Helical | Non-hemolytic | ||
| 29379033 | 2018 | ILKKLLKKVKKI{ct:Amid} | Hp1404-T1e | Amidation | Free | Linear | L | None | 12 | Antimicrobial | <2 % Hemolysis at 200 μM | Mouse | Synthetic Peptides From Hp1404 | amphipathic α-Helical | Non-hemolytic | ||
| 29098406 | 2018 | IIGPVLGLVGKALGGLL{ct:Amid} | Bombinin H-BO1 | Amidation | Free | Linear | L | None | 17 | broad-spectrum Antimicrobial | 42.03 % Hemolysis at 40.4 μM | Human | Oriental Fre-Bellied Toad, Bombina Orientalis, | Alphα-Helical amphipathic | NA | ||
| 29098406 | 2018 | IIGPVLGLVGKALGGLL{ct:Amid} | Bombinin H-BO1 | Amidation | Free | Linear | L | None | 17 | broad-spectrum Antimicrobial | 100 % Hemolysis at 161.1 μM | Human | Oriental Fre-Bellied Toad, Bombina Orientalis, | Alphα-Helical amphipathic | NA | ||
| 29310083 | 2018 | KWLKKWLKWLKK{ct:Amid} | A-12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 56 % Hemolysis at 250 μg/ml | Human | Analogues Of Α/Β Diastereomeric Peptide | α-Helical | NA | ||
| 29310083 | 2018 | KW{nnr:L}KKW{nnr:L}KW{nnr:L}KK{ct:Amid} | βA-12 | Amidation | Free | Linear | L | L = β-amino acid | 12 | Antibacterial | 0 % Hemolysis at 250 μg/ml | Human | Analogues Of Α/Β Diastereomeric Peptide | α-Helical | Non-hemolytic | ||
| 29310083 | 2018 | K{d}W{d}LK{d}K{d}W{d}LK{d}W{d}LK{d}K{d}{ct:Amid} | DA-12 | Amidation | Free | Linear | Mix | None | 12 | Antibacterial | 0 % Hemolysis at 250 μg/ml | Human | Analogues Of Α/Β Diastereomeric Peptide | α-Helical | Non-hemolytic | ||
| 29310083 | 2018 | K{d}W{d}{nnr:L}K{d}K{d}W{d}{nnr:L}K{d}W{d}{nnr:L}K{d}K{d}{ct:Amid} | UNA-12 | Amidation | Free | Linear | Mix | L = β-amino acid | 12 | Antibacterial | 0 % Hemolysis at 250 μg/ml | Human | Analogues Of Α/Β Diastereomeric Peptide | α-Helical | Non-hemolytic | ||
| 29310083 | 2018 | ILPWKWPWWPWRR{ct:Amid} | IL | Amidation | Free | Linear | L | None | 13 | Antibacterial | 70 % Hemolysis at 250 μg/ml | Human | Control Host Defense Peptide | NA | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFK{ct:Amid} | MeuFSPL-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 25 μM | Mouse | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLINAFK{ct:Amid} | MeuFSPL-2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 25 μM | Mouse | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | IFGAIAGLLKNIF{ct:Amid} | Meucin-13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 100 % Hemolysis at 12.5 μM | Mouse | Mesobuthus Eupeus Scorpion Species | NA | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSLFQ | Meucin-18 | Free | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 25 μM | Mouse | Mesobuthus Eupeus Scorpion Species | NA | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFK{ct:Amid} | MeuFSPL-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 99 % Hemolysis at 25 μM | Lizard | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFK{ct:Amid} | MeuFSPL-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 40 % Hemolysis at 25 μM | Pigeons | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29249197 | 2018 | RADARADARADARADA{nt:Acet}{ct:NHCOCH3} | RADA 16-I hydrogels | NHCOCH3 | Acetylation | Linear | L | Ac = N-acetyl (NHCOCH3) | 16 | Hemostatic agent | 0.78 ± 0.1 % Hemolysis at 0.1 w/v | Rabbit | Synthesised Monomer Peptide | β-Sheet at higher conc | Low hemolytic | ||
| 29249197 | 2018 | RADARADARADARADA{nt:Acet}{ct:NHCOCH3} | RADA 16-I hydrogels | NHCOCH3 | Acetylation | Linear | L | Ac = N-acetyl (NHCOCH3) | 16 | Hemostatic agent | 1±0.1 % Hemolysis at 0.2 w/v | Rabbit | Synthesised Monomer Peptide | Betα-Sheet at higher conc | Low hemolytic | ||
| 29249197 | 2018 | RADARADARADARADA{nt:Acet}{ct:NHCOCH3} | RADA 16-I hydrogels | NHCOCH3 | Acetylation | Linear | L | Ac = N-acetyl (NHCOCH3) | 16 | Hemostatic agent | 1.07±0.1 % Hemolysis at 0.3 w/v | Rabbit | Synthesised Monomer Peptide | Betα-Sheet at higher conc | Low hemolytic | ||
| 29249197 | 2018 | RADARADARADARADA{nt:Acet}{ct:NHCOCH3} | RADA 16-I hydrogels | NHCOCH3 | Acetylation | Linear | L | Ac = N-acetyl (NHCOCH3) | 16 | Hemostatic agent | 1.1±0.1 % Hemolysis at 0.5 w/v | Rabbit | Synthesised Monomer Peptide | Betα-Sheet at higher conc | Low hemolytic | ||
| 29277569 | 2018 | VYPFMWGGAYCFCKAKLV{ct:Amid} | VT18-KKLV | Amidation | Free | Linear | L | None | 18 | Antibacterial | 3 % Hemolysis at 100 µg/ml | Human | Chikungunya Virus Fusion Domain Vt18-Derived Peptides | Double Strand β-Sheet | Low hemolytic | ||
| 29277569 | 2018 | VYPFCWGGAYAFCKAKLV{ct:Amid} | VT18-CAKKLV | Amidation | Free | Linear | L | None | 18 | Antibacterial | 3.8 % Hemolysis at 100 µg/ml | Human | Chikungunya Virus Fusion Domain Vt18-Derived Peptides | Double Strand β-Sheet | Low hemolytic | ||
| 29277569 | 2018 | VYPFCWGGAYAFCKAKLV{cyc:N-C}{ct:Amid} | cVT18-CAKKLV | Amidation | Free | Cyclic | L | None | 18 | Antibacterial | 1.8 % Hemolysis at 100 µg/ml | Human | Vt18-Cakklv Cyclized Between Cys88 And Cys96 | Double Strand β-Sheet | Low hemolytic | ||
| 29551999 | 2018 | FKCRRWQWRMKKLGA | Reference Peptide (LfcinB (17–31)) | Free | Free | Linear | L | None | 15 | Antibacterial | 6.6 % Hemolysis at 25 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29551999 | 2018 | RRWQWRRRWQWRK{nnr:Ahx} | Dimeric (LfcinB (20–25)2) | Free | Free | Branched | L | Ahx = hydrophobic spacer that prevents steric hindrance | 15 | Antibacterial | 5.6 % Hemolysis at 100 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29551999 | 2018 | FKCRRWQWRMKKLGA | Reference Peptide (LfcinB (17–31)) | Free | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29551999 | 2018 | RRWQWRRRWQWRK{nnr:Ahx} | Dimeric (LfcinB (20–25)2) | Free | Free | Branched | L | Ahx = hydrophobic spacer that prevents steric hindrance | 15 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29275987 | 2018 | KKKKKK-AAFAAWAAFAA{nt:6 Lys}{ct:Amid} | 6K-F17 | Amidation | 6 Lys | Linear | L | None | 17 | Antimicrobial Peptide | 10 % Hemolysis at 320 µM | Human | Cationic Antimicrobial Peptide | Random coil | NA | ||
| 29275987 | 2018 | KKKKKK-AAF{nnr:X}AWA{nnr:X}FAA{nt:6 Lys}{ct:Amid} | S-6K-F17 | Amidation | 6 Lys | Stapled | L | X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined | 17 | Antibacterial | 2 % Hemolysis at 4 µM | Human | 6K-F17 Hydrocarbon Staple | Random coil | NA | ||
| 29275987 | 2018 | KKKKKK-AGF{nnr:X}AWA{nnr:X}FGA{nt:6 Lys}{ct:Amid} | S-6K-F17-2G | Amidation | 6 Lys | Stapled | L | X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined | 17 | Antibacterial | MHC at 15[5.8] µM | Human | 6K-F17 Hydrocarbon Staple | NA | NA | ||
| 29275987 | 2018 | KKKKKK-AGF{nnr:X}AWG{nnr:X}FGA{nt:6 Lys}{ct:Amid} | S-6K-F17-3G | Amidation | 6 Lys | Stapled | L | X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined | 17 | Antibacterial | MHC at 128[43.8] µM | Human | 6K-F17 Hydrocarbon Staple | Random coil | NA | ||
| 29275987 | 2018 | KKKKKK-NGF{nnr:X}AWG{nnr:X}FGA{nt:6 Lys}{ct:Amid} | S-6K-F17-3GN | Amidation | 6 Lys | Stapled | L | X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined | 17 | Antibacterial | MHC at 587[130.6] µM | Human | 6K-F17 Hydrocarbon Staple | Helical | NA | ||
| 29282543 | 2018 | GKEFKRIVWLSKTAKKL{ct:Amid} | LC | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0.14 % Hemolysis at 128 μM | Human | Lc From Ll37 And Cp-1 | at aq :unordered conformation, at membrane : α-Helix | Low hemolytic | ||
| 29282543 | 2018 | GKEFKRIVKWPWWPWRR{ct:Amid} | LI | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2.42 % Hemolysis at 128 μM | Human | Ll37 Hybrids With Indolicidin And Np-1, | at aq :unordered conformation, at membrane :β-Turn and β-Hairpin structures | Low hemolytic | ||
| 29282543 | 2018 | GKEFKRIVGRIYRLCCR{ct:Amid} | LN | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 2.08 % Hemolysis at 128 μM | Human | Ll37 Hybrids With Indolicidin And Np-1, | at aq :unordered conformation, at membrane : α-Helix | Low hemolytic | ||
| 29282543 | 2018 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 46.22 % Hemolysis at 128 μM | Human | Bos Taurus | NA | Low hemolytic | ||
| 29282543 | 2018 | GKEFKRIVWLSKTAKKL{ct:Amid} | LC | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ≥5 % Hemolysis at >128 μM | Human | Lc From Ll37 And Cp-1 | at aq :unordered conformation, at membrane : α-Helix | Low hemolytic | ||
| 29282543 | 2018 | GKEFKRIVKWPWWPWRR{ct:Amid} | LI | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ≥5 % Hemolysis at >128 μM | Human | Ll37 Hybrids With Indolicidin And Np-1, | at aq :unordered conformation, at membrane :β-Turn and β-Hairpin structures | Low hemolytic | ||
| 29282543 | 2018 | GKEFKRIVGRIYRLCCR{ct:Amid} | LN | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ≥5 % Hemolysis at >128 μM | Human | Ll37 Hybrids With Indolicidin And Np-1, | at aq :unordered conformation, at membrane : α-Helix | Low hemolytic | ||
| 29282543 | 2018 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial | ≥5 % Hemolysis at 32 μM | Human | Bos Taurus | NA | Low hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:NHCH2CH2OH} | 1 | NHCH2CH2OH | Cbz | Linear | L | Cbz = carboxybenzyl, AzPro = azaproline | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Hexadecameric Analogous Peptides | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Acet}{ct:NHCH2CH2OH} | 2 | NHCH2CH2OH | Acetylation | Linear | L | AzPro = azaproline, Ac = N-acetyl | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Hexadecameric Analogous Peptides | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Formyl}{ct:NHCH2CH2OH} | 3 | NHCH2CH2OH | Formyl | Linear | L | AzPro = azaproline, Formyl = Formyl | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Hexadecameric Analogous Peptides | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Formyl}{ct:NHCH2CH2OH} | 5 | NHCH2CH2OH | Formyl | Linear | L | AzPro = azaproline, Formyl = Formyl | 14 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Formyl}{ct:NHCH2CH2OH} | 6 | NHCH2CH2OH | Formyl | Linear | L | AzPro = azaproline, Formyl = Formyl | 12 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Formyl}{ct:NHCH2CH2OH} | 7 | NHCH2CH2OH | Formyl | Linear | L | AzPro = azaproline, Formyl = Formyl | 10 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:OtBu} | 8 | OtBu | Cbz | Linear | L | AzPro = azaproline, OtBu = ortho-tert-butyl, Cbz = carboxybenzyl | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Hexadecameric Analogous Peptides | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}{nt:Boc}{ct:Cbz} | 10 | Cbz | Boc | Linear | L | AzPro = azaproline, Boc = tert-butyloxycarbonyl, Cbz = carboxybenzyl | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Hexadecameric Analogous Peptides | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:OH} | 14 | OH | Cbz | Linear | L | AzPro = azaproline, Cbz = carboxybenzyl, OH = Hydroxyl | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:HCl.H}{ct:OtBu} | 15 | OtBu | HCl.H | Linear | L | AzPro = azaproline, HCl = hydrochloric acid, OtBu = ortho-tert-butyl | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | VGAL{d}AV{d}VV{d}WL{d}WL{d}WL{d}W{nt:Formyl}{ct:NHCH2CH2OH}{nt:Formyl}{ct:NHCH2CH2OH} | 24(Gramicidin A) | NHCH2CH2OH | Formyl | Linear | Mix | N-Terminal = Formyl | 15 | Antibacterial | 50 % Hemolysis at 5 µM | Human | Gramicidin A Amp | β 6.3-Helical | NA | ||
| 29643444 | 2018 | TVLRGCWTFSFPPKPCI{ct:Amid} | HECI | Amidation | Free | Linear | L | None | 17 | Anticancer | <15 % Hemolysis at 128 µM | Horse | Frogs (Hylarana Erythraea Chymotrypsin Inhibitor) | NA | NA | ||
| 29643444 | 2018 | TVLRGCWTKSFPPKPCI{ct:Amid} | K9-HECI | Amidation | Free | Linear | L | None | 17 | Anti-proliferation of cancer cells | ~5 % Hemolysis at 128 µM | Horse | Analogue Of Heci | NA | Low hemolytic | ||
| 29553266 | 2018 | KIAKGALKALKIAKVALKAL{ct:Amid} | kiadin-2 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 50 % Hemolysis at 30 ± 3 µM | Human | Modification Of Kiadin-1 Natural Amp (Pgla-H) | α-Helical | NA | ||
| 29553266 | 2018 | KIAKGALKALKIAKGALKAL{ct:Amid} | kiadin-3 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 100± 5 µM | Human | Modification Of Kiadin-1 Natural Amp (Pgla-H) | α-Helical | NA | ||
| 29553266 | 2018 | KIGKALGKALKALGKALGKA{ct:Amid} | kiadin-4 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and cytotoxic activity | 50 % Hemolysis at 15± 2 µM | Human | Ab Initio Designed | α-Helical | NA | ||
| 29553266 | 2018 | KIAGKAGKIAKIAGKAGKIA{ct:Amid} | kiadin-5 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 0 µM | Human | Ab Initio Designed | α-Helical | Non-hemolytic | ||
| 29553266 | 2018 | KIALKALKALKALGKALKAL{ct:Amid} | kiadin-6 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 50 % Hemolysis at 10 ± 1 µM | Human | Ab Initio Designed | α-Helical | NA | ||
| 29670004 | 2018 | FFSLIPSLVGGLISAFK{ct:Amid} | Stigmurin | Amidation | Free | Linear | L | None | 17 | Antimicrobial,Antiproliferative, Antiparasitic | 3 % Hemolysis at 75 µM | Human | Scorpion Tityus Stigmurus Venom Gland | Random | Low hemolytic | ||
| 29670004 | 2018 | FFSLIPKLVKGLISAFK{ct:Amid} | StigA6 | Amidation | Free | Linear | L | None | 17 | Antiparasitic, Antimicrobial, Anticancer | 30 % Hemolysis at 75 µM | Human | Analogs To Stigmurin | Random coil | NA | ||
| 29670004 | 2018 | FFKLIPKLVKGLISAFK{ct:Amid} | StigA16 | Amidation | Free | Linear | L | None | 17 | Antiparasitic, Antimicrobial, Anticancer | 30 % Hemolysis at 75 µM | Human | Analogs To Stigmurin | Random coil | NA | ||
| 29670183 | 2018 | IITHPNFNGNTLDNDIMLIK | Lunathrombase | Free | Free | Linear | L | None | 20 | Anticoagulant, in-vitro thrombolytic activity, Antiplatelet | 7.65 ± 0.53(m/mm3) % Hemolysis at 10 mg/kg | Goat | Serine Protease From Leaves Of Leucas Indica Plant | e CD spectrum of lunathrombase demonstrated that it consists of 23.4% α-Helix, 17% Beta Sheets, with a Turn of 28.2% and 31% Random coils | Non-hemolytic | ||
| 29549839 | 2018 | SKVWRHWRRFWHRAHRKL | Chensinin-1b | Free | Free | Linear | L | None | 14 | Antimicrobial | 0 % Hemolysis at >500 µM | Human | Chinese Brown Frog Rana Cheninensis | NA | Non-hemolytic | ||
| 29549839 | 2018 | {conj:CH3(CH2)6CO}SKVWRHWRRFWHRAHRKL | OA-C1b | Free | CH3(CH2)6CO | Linear | L | octanoic acid (OA),conjugation of aliphatic acid was designed lipo-chensinin-1b | 14 | Antimicrobial | 0 % Hemolysis at >500 µM | Human | Designed Lipo-Chensinin-1B | Random coil at aq, α-Helical at TFE solution | Non-hemolytic | ||
| 29549839 | 2018 | {conj:CH3(CH2)10CO}SKVWRHWRRFWHRAHRKL | LA-C1b | Free | CH3(CH2)10CO | Linear | L | lauric acid (LA) conjugation of aliphatic acid was designed lipo-chensinin-1b | 14 | Antimicrobial | 0 % Hemolysis at >500 µM | Human | Designed Lipo-Chensinin-1B | Random coil at aq | Non-hemolytic | ||
| 29549839 | 2018 | {conj:CH3(CH2)14CO}SKVWRHWRRFWHRAHRKL | PA-C1b | Free | CH3(CH2)14CO | Linear | L | palmitic acid (PA) conjugation of aliphatic acid was designed lipo-chensinin-1b | 14 | Anticancer and Anti-inflammation | 0 % Hemolysis at >500 µM | Human | Designed Lipo-Chensinin-1B | Random coil at aq, β-Strand at TFE solution | Non-hemolytic | ||
| 29904274 | 2018 | LNLKALLAVAKKIL{ct:Amid} | MP-C | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 40.11 µM | Horse | European Hornet (Vespa Crabro) | Random-coil at aq, α-Helical at membrane mimic solution | NA | ||
| 29904274 | 2018 | CLNLKALLAVAKKILC{cyc:N-C}{ct:Amid} | cMP-C | Amidation | Free | Cyclic | L | None | 16 | Antimicrobial | 50 % Hemolysis at 9.19 µM | Horse | Modifcation In Mp-C A Skeleton-Based Cyclization By Two Cysteine Residues | α-Helical at aq, α-Helical at membrane mimic solution | NA | ||
| 29307075 | 2018 | KWKLFKKIGAVLKVL ({nnr:AcO−}){ct:Amid} | CAMEL acetate | Amidation | Free | Linear | L | AcO− = Counter-ion acetate | 15 | Antimicrobial | 80 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | GLFDVIKKVASVIGGL ({nnr:AcO−}){ct:Amid} | Citropin 1.1 acetate | Amidation | Free | Linear | L | AcO− = Counter-ion acetate | 16 | Antimicrobial | 10 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | FLPLIGRVLSGIL ({nnr:AcO−}){ct:Amid} | Temporin A acetate | Amidation | Free | Linear | L | AcO− = Counter-ion acetate | 13 | Antimicrobial | ~4 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 29307075 | 2018 | KWKLFKKIGAVLKVL ({nnr:TFA−}){ct:Amid} | CAMEL trifluoroacetate | Amidation | Free | Linear | L | TFA− = Counter-ion trifluoroacetate | 15 | Antimicrobial | 50 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | GLFDVIKKVASVIGGL ({nnr:TFA−}){ct:Amid} | Citropin 1.1 trifluoroacetate | Amidation | Free | Linear | L | TFA− = Counter-ion trifluoroacetate | 16 | Antimicrobial | 12 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | FLPLIGRVLSGIL ({nnr:TFA−}){ct:Amid} | Temporin A trifluoroacetate | Amidation | Free | Linear | L | TFA− = Counter-ion trifluoroacetate | 13 | Antimicrobial | 2.5 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 29307075 | 2018 | KWKLFKKIGAVLKVL ({nnr:Cl−}){ct:Amid} | CAMEL chloride | Amidation | Free | Linear | L | Cl− = Counter-ion chloride | 15 | Antistaphylococcal | 65 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | GLFDVIKKVASVIGGL ({nnr:Cl−}){ct:Amid} | Citropin 1.1 chloride | Amidation | Free | Linear | L | Cl− = Counter-ion chloride | 16 | Antimicrobial | 6 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | FLPLIGRVLSGIL({nnr:Cl−}){ct:Amid} | Temporin A chloride | Amidation | Free | Linear | L | Cl− = Counter-ion chloride | 13 | Antimicrobial | 1 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 29765362 | 2018 | KWCFRVCYRGICYRKCR{cyc:3-7}{cyc:12-16} | Tachyplesin III | Free | Free | Linear | L | cysteines with the same type font formed on disulfide | 17 | Antimicrobial | 1 % Hemolysis at 50 mg/L | Mouse | Horseshoe Crab | NA | Non-hemolytic | ||
| 29765362 | 2018 | KWCFRVCYRGICYRKCR{cyc:3-7}{cyc:12-16} | Tachyplesin III | Free | Free | Linear | L | cysteines with the same type font formed on disulfide | 17 | Antimicrobial | 2 % Hemolysis at 100 mg/L | Mouse | Horseshoe Crab | NA | Non-hemolytic | ||
| 29765362 | 2018 | KWCFRVCYRGICYRKCR{cyc:3-7}{cyc:12-16} | Tachyplesin III | Free | Free | Linear | L | cysteines with the same type font formed on disulfide | 17 | Antimicrobial | 4 % Hemolysis at 200 mg/L | Mouse | Horseshoe Crab | NA | NA | ||
| 29765362 | 2018 | KWCFRVCYRGICYRKCR{cyc:3-7}{cyc:12-16} | Tachyplesin III | Free | Free | Linear | L | cysteines with the same type font formed on disulfide | 17 | Antimicrobial | 6 % Hemolysis at 400 mg/L | Mouse | Horseshoe Crab | NA | NA | ||
| 29648811 | 2018 | RRLRLLLRLRR{ct:Amid} | 9 - L6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RLLRRLRRLLR{ct:Amid} | 10 - L6pf | Amidation | Free | Linear | L | pf = perfect amphipathicity peptides | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RRFRFFFRFRR{ct:Amid} | 11 - F6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RFFRRFRRFFR{ct:Amid} | 12 - F6pf | Amidation | Free | Linear | L | pf = perfect amphipathicity peptides | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RRIRIIIRIRR{ct:Amid} | 13 - I6 | Amidation | Free | Linear | L | None | 11 | Antifungal, Antibacterial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RIIRRIRRIIR{ct:Amid} | 14 - I6pf | Amidation | Free | Linear | L | pf = perfect amphipathicity peptides | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RRWRWWWRWRR{ct:Amid} | 15 - W6 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RWWRRWRRWWR{ct:Amid} | 16 - W6pf | Amidation | Free | Linear | L | pf = perfect amphipathicity peptides | 11 | Antimicrobial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29648811 | 2018 | RRIRIIIRIRR{nt:Fluorescein isothiocyanate (FITC)-labeled peptide}{ct:Amid} | 17 - FITC-I6 | Amidation | Fluorescein isothiocyanate (FITC)-labeled peptide | Linear | L | FITC = Fluorescein isothiocyanate-labeled peptide | 11 | Antimicrobial | 9.26 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29783753 | 2018 | LRLKKYKVPQL{ct:Amid} | Cp1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 16 µM | Human | Synthesized From Bovine Αs1-Casein | unordered conformation at different environment | Non-hemolytic | ||
| 29783753 | 2018 | LRLKKYKVPQL{ct:Amid} | Cp1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5 % Hemolysis at 32 µM | Human | Synthesized From Bovine Αs1-Casein | unordered conformation at different environment | Low hemolytic | ||
| 29783753 | 2018 | LRLKKYKVPQL{ct:Amid} | Cp1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 23.54 % Hemolysis at 512 µM | Human | Synthesized From Bovine Αs1-Casein | unordered conformation at different environment | NA | ||
| 29738954 | 2018 | FGRKKRRQRRR{nt:Acet}{ct:Amid} | ctrlTat peptide | Amidation | Acetylation | Linear | L | None | 11 | Antibacterial | 12 % Hemolysis at 1 µM | Human | Human Immunodeficiency Virus 1 (Hiv-1) Tat Protein | at water Random coil structure, at TFE α-Helical | NA | ||
| 29738954 | 2018 | FG{nnr:r}KKR{nnr:r}Q{nnr:r}R{nnr:r}-{nnr:βA}{nt:Acet}{ct:Amid} | γTatM4 | Amidation | Acetylation | Linear | Mix | r = (2S,4S)-4-amino-N-(3-guanidinopropyl)-proline, βA = βAla(β-Alanine){nnr:Bala} – β-Alanine | 11 | Antibacterial and Anti-TB | 10 % Hemolysis at 1 µM | Human | Tat Peptide Analogues | NA | NA | ||
| 29738954 | 2018 | FGRKKRRQRRR{nt:Acet}{ct:Amid} | ctrlTat peptide | Amidation | Acetylation | Linear | L | None | 11 | Antibacterial | 14 % Hemolysis at 40 µM | Human | Human Immunodeficiency Virus 1 (Hiv-1) Tat Protein | at water Random coil structure, at TFE α-Helical | NA | ||
| 29738954 | 2018 | FG{nnr:r}KKR{nnr:r}Q{nnr:r}R{nnr:r}-{nnr:βA}{nt:Acet}{ct:Amid} | γTatM4 | Amidation | Acetylation | Linear | Mix | r = (2S,4S)-4-amino-N-(3-guanidinopropyl)-proline, βA = βAla(β-Alanine){nnr:Bala} – β-Alanine | 11 | Antibacterial and Anti-TB | 12 % Hemolysis at 40 µM | Human | Tat Peptide Analogues | NA | NA | ||
| 28659061 | 2018 | NLLNDALGTVNGLLGRS | Dc1 | Free | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >256 µM | Human | Frog Skin Secretion Of D. Columbianus | water = unordered structures , TFE = α-Helix | Non-hemolytic | ||
| 28659061 | 2018 | NLLNKALGTVNGLLGRS | Dc1.1 | Free | Free | Linear | L | None | 17 | Antibacterial | 50 % Hemolysis at >256 µM | Human | Dc1 Analogue | water = unordered structures , TFE = α-Helix | Non-hemolytic | ||
| 28659061 | 2018 | NLLKSALKTVNKLLAAS{ct:Amid} | Dc1.2 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 50 % Hemolysis at >256 µM | Human | Dc1 Analogue | water = unordered structures , TFE = α-Helix | Non-hemolytic | ||
| 29614317 | 2018 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 0 % Hemolysis | Human | Solitary Wasp | water = Random coil, TFE/H2O(30%) = α-Helix | Non-hemolytic | ||
| 29614317 | 2018 | GLLKRIKTLL{nt:palmitoyl group (C16)}{ct:Amid} | Pal-anoplin | Amidation | palmitoyl group (C16) | Linear | L | C16 = palmitoyl group | 10 | Antifungal | 0 % Hemolysis | Human | Truncated Analogues Of Pal-Anoplin | water = Helical, TFE/H2O(30%) = Helical | NA | ||
| 29621496 | 2018 | {nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{cyc:N-C} | C1dec | Free | Free | Cyclic | Mix | Nap = N-(3-aminopropyl)glycine, Npm = N-(1-phenylmethyl)glycine | 10 | Antibacterial | 10 % Hemolysis at 250 μg/mL | Human | Synthetic Peptoids Mimic Antimicrobial Peptides | NA | NA | ||
| 29621496 | 2018 | V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C} | CGS (gramicidin S) | Free | Free | Cyclic | Mix | O = L-Ornithine, f = D-phenylalanine | 10 | Antibacterial | 10 % Hemolysis at >15.6 μg/mL | Human | Gram-Positive Bacterium Brevibacillus Brevis | NA | NA | ||
| 29626660 | 2018 | INLKAIAALAKKLL{ct:Amid} | Mastoparan-1 (MP-I) | Amidation | Free | Linear | L | None | 14 | Antimicrobial against MRSA | 18.7 % Hemolysis at 128 mg/L | Human | Hornet Venom | Helical | NA | ||
| 29626660 | 2018 | INLKAIAALAKKLL{ct:Amid} | Mastoparan-1 (MP-I) | Amidation | Free | Linear | L | None | 14 | Antimicrobial against MRSA | 0 % Hemolysis at 0.5 mg/L | Human | Hornet Venom | Helical | Non-hemolytic | ||
| 29626660 | 2018 | INLKAIAALAKKLL{ct:Amid} | Mastoparan-1 (MP-I) | Amidation | Free | Linear | L | None | 14 | Antimicrobial against MRSA | 0 % Hemolysis at 64 mg/L | Human | Hornet Venom | Helical | Non-hemolytic | ||
| 29870123 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | Tachyplesin I | Amidation | Free | Linear | L | First Disulfide Bond = CysII─CysIII, Second Disulfide Bond = CysI─CysIV | 17 | Antimicrobial | 9.6 % Hemolysis at 8 μg/mL | Human | Horseshoe Crabs(Limulus Lymphocyte Granulosa Cells) | antiparallel β‐Strand connected by a β‐Turn and stabilized by 2 disulfide bonds | NA | ||
| 29870123 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | 3C7C | Amidation | Free | Linear | L | First Disulfide Bond = CysI─CysIII, Second Disulfide Bond = CysII─CysIV | 17 | Antimicrobial | 14.3 % Hemolysis at 8 μg/mL | Human | Tachyplesin I Isomers | Random coil | NA | ||
| 29870123 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | 3C12C | Amidation | Free | Linear | L | First Disulfide Bond = CysI─CysII, Second Disulfide Bond = CysIII─CysIV | 17 | Antimicrobial | 4.8 % Hemolysis at 8 μg/mL | Human | Tachyplesin I Isomers | Random coil | NA | ||
| 29870123 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | Tachyplesin I | Amidation | Free | Linear | L | First Disulfide Bond = CysII─CysIII, Second Disulfide Bond = CysI─CysIV | 17 | Antimicrobial | 72.8 % Hemolysis at 512 μg/mL | Human | Horseshoe Crabs(Limulus Lymphocyte Granulosa Cells) | antiparallel β‐Strand connected by a β‐Turn and stabilized by 2 disulfide bonds | NA | ||
| 29870123 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | 3C7C | Amidation | Free | Linear | L | First Disulfide Bond = CysI─CysIII, Second Disulfide Bond = CysII─CysIV | 17 | Antimicrobial | 20.5 % Hemolysis at 64 μg/mL | Human | Tachyplesin I Isomers | Random coil | NA | ||
| 29870123 | 2018 | KWCFRVCYRGICYRRCR{ct:Amid} | 3C12C | Amidation | Free | Linear | L | First Disulfide Bond = CysI─CysII, Second Disulfide Bond = CysIII─CysIV | 17 | Antimicrobial | 14.9 % Hemolysis at 64 μg/mL | Human | Tachyplesin I Isomers | Random coil | NA | ||
| 30108987 | 2018 | {nnr:KP}FF{nnr:KP}FF{nnr:KP}FFK{nt:H}{ct:Amid} | CAP11 | Amidation | H | Linear | L | KP = phosphonium isostere of (trimethyl)lysine | 10 | Antimicrobial | 1.5 ± 0.1 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Non-hemolytic | ||
| 30108987 | 2018 | {nnr:RP}FF{nnr:RP}FF{nnr:RP}FF{nnr:RP}{nt:H}{ct:Amid} | CAP12 | Amidation | H | Linear | L | RP = phosphonium side chain length comparable o that of arginine | 10 | Antimicrobial | 3.1 ± 0.1 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Low hemolytic | ||
| 30108987 | 2018 | {nnr:KP}WW{nnr:KP}WW{nnr:KP}WW{nnr:KP}{nt:H}{ct:Amid} | CAP13 | Amidation | H | Linear | L | KP = phosphonium isostere of (trimethyl)lysine | 10 | NA | 11.0 ± 1.6 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | NA | ||
| 30108987 | 2018 | {nnr:RP}WW{nnr:RP}WW{nnr:RP}WW{nnr:RP}{nt:H}{ct:Amid} | CAP14 | Amidation | H | Linear | L | RP = phosphonium side chain length comparable o that of arginine | 10 | NA | 5.8 ± 1.0 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | NA | ||
| 30108987 | 2018 | {nnr:KP}LL{nnr:KP}LL{nnr:KP}LL{nnr:KP}{nt:H}{ct:Amid} | CAP15 | Amidation | H | Linear | L | KP = phosphonium isostere of (trimethyl)lysine | 10 | NA | 2.1 ± 0.5 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Low hemolytic | ||
| 30108987 | 2018 | {nnr:RP}LL{nnr:RP}LL{nnr:RP}LL{nnr:RP}{nt:H}{ct:Amid} | CAP16 | Amidation | H | Linear | L | RP = phosphonium side chain length comparable o that of arginine | 10 | NA | 0.6 ± 0.2 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Non-hemolytic | ||
| 30108987 | 2018 | {nnr:KP}II{nnr:KP}II{nnr:KP}II{nnr:KP}{nt:H}{ct:Amid} | CAP17 | Amidation | H | Linear | L | KP = phosphonium isostere of (trimethyl)lysine | 10 | NA | 2.3 ± 1.5 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Low hemolytic | ||
| 30108987 | 2018 | {nnr:RP}II{nnr:RP}II{nnr:RP}II{nnr:RP}{nt:H}{ct:Amid} | CAP18 | Amidation | H | Linear | L | RP = phosphonium side chain length comparable o that of arginine | 10 | NA | 3.9 ± 0.7 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Low hemolytic | ||
| 29984236 | 2018 | FKC R RWQWRM KKLGA | LfcinB reference | Free | Free | Linear | L | None | 15 | Antibacterial | 7.9 % Hemolysis at 12.5 μM | Human | Bovine Lactoferricin B | NA | NA | ||
| 29984236 | 2018 | RRWQWRRRWQWR-K-{nnr:Ahx} | Dimeric | Free | Free | Linear | L | Ahx = Aminohexanoic acid | 13 | Antibacterial | <5 % Hemolysis at 100 μM | Human | Synthesised And Modified From Motif | NA | Low hemolytic | ||
| 29925795 | 2018 | KWKLFKKIFKRIVQRIKDFLRN | Synthesized C–L | Free | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 219 ± 2.98 µg/mL | Sheep | Combination Of Cecropin A (C) And Ll-37 (L) Sequences | NA | NA | ||
| 29966346 | 2018 | GLFDVIKKVASVIGGL | citropin 1.1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 9 % Hemolysis at 128 µg/mL | Human | Frog Litoria Citropa | water = Random coil, TFE or SDS = Alphα-Helical structure | NA | ||
| 29966346 | 2018 | GLFDVIKKVASVIGGL | citropin 1.1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 74 % Hemolysis at 512 µg/mL | Human | Frog Litoria Citropa | water = Random coil, TFE or SDS = Alphα-Helical structure | NA | ||
| 29799150 | 2018 | AAGK{d}W{d}K{d}L{d}F{d}K{d}K{d}L{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid} | AAG‐P18 | Amidation | Free | Linear | Mix | None | 18 | Antibacterial | 75 % Hemolysis at 250 μM | Human | Cecropin/Magainin Hybrid | NA | NA | ||
| 29799150 | 2018 | AAGW{d}G{d}L{d}R{d}R{d}L{d}L{d}K{d}Y{d}G{d}K{d}R{d}S{d}{ct:Amid} | AAG‐WMR | Amidation | Free | Linear | Mix | None | 13 | Antibacterial | 5 % Hemolysis at 10 μM | Human | Myxinidin Analogue From Hagfish | NA | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 0 % Hemolysis at 1 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | Non-hemolytic | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 0 % Hemolysis at 5 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | Non-hemolytic | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 5.1 % Hemolysis at 10 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 16.8 % Hemolysis at 20 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 36.1 % Hemolysis at 40 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 47.9 % Hemolysis at 60 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 49.4 % Hemolysis at 80 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 29197569 | 2018 | KWKLFKKYGRKKRRQRRR | CA-TAT | Free | Free | Linear | L | None | 18 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Attaching Cecropin A (1-7)+ Tat(47-57) | NA | Low hemolytic | ||
| 29197569 | 2018 | YGRKKRRQRRR | TAT(47-57) | Free | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Human Immunodeficiency Virus Type 1 (Hiv–1) Transactivation Of Transcription (Tat) Protein | NA | Low hemolytic | ||
| 30052685 | 2018 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 43 ± 1.4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | C5H11CO-KKLFKKILKYL{nt:hexanoyl}{ct:Amid} | BP367 | Amidation | hexanoyl | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 83 ± 6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC5H11})KLFKKILKYL{nt:Acet}{ct:Amid} | BP368 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 96 ± 0.9 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC5H11})LFKKILKYL{nt:Acet}{ct:Amid} | BP369 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 84 ± 8 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC5H11})FKKILKYL{nt:Acet}{ct:Amid} | BP370 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antimicrobial | 11 ± 2 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC5H11})KKILKYL{nt:Acet}{ct:Amid} | BP371 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 75 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC5H11})KILKYL{nt:Acet}{ct:Amid} | BP372 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 97 ± 2 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC5H11})ILKYL{nt:Acet}{ct:Amid} | BP373 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 92 ± 1 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC5H11})LKYL{nt:Acet}{ct:Amid} | BP374 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 19 ± 3 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC5H11})KYL{nt:Acet}{ct:Amid} | BP375 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 70 ± 6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC5H11})YL{nt:Acet}{ct:Amid} | BP376 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 90 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC5H11})L{nt:Acet}{ct:Amid} | BP377 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 92 ± 5 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC5H11}){nt:Acet}{ct:Amid} | BP378 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antimicrobial | 26 ± 0.4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | C3H7CO-KKLFKKILKYL{nt:butanoyl}{ct:Amid} | BP379 | Amidation | butanoyl | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 93 ± 0.8 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC3H7})KLFKKILKYL{nt:Acet}{ct:Amid} | BP380 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 93 ± 6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC3H7})LFKKILKYL{nt:Acet}{ct:Amid} | BP381 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 54 ± 6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC3H7})FKKILKYL{nt:Acet}{ct:Amid} | BP382 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 0.9 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC3H7})KKILKYL{nt:Acet}{ct:Amid} | BP383 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 22 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC3H7})KILKYL{nt:Acet}{ct:Amid} | BP384 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC3H7})ILKYL{nt:Acet}{ct:Amid} | BP385 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 3 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC3H7})LKYL{nt:Acet}{ct:Amid} | BP386 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | NA | 1 ± 0.1 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | Non-hemolytic | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC3H7})KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 14 ± 0.5 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC3H7})YL{nt:Acet}{ct:Amid} | BP388 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 38 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC3H7})L{nt:Acet}{ct:Amid} | BP389 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 22 ± 2 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC3H7}){nt:Acet}{ct:Amid} | BP390 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 5 ± 0.3 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | Low hemolytic | ||
| 30052685 | 2018 | C11H23CO-KKLFKKILKYL{nt:lauroyl}{ct:Amid} | BP391 | Amidation | lauroyl | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 0.9 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC11H23})KLFKKILKYL{nt:Acet}{ct:Amid} | BP392 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 0.9 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC11H23})LFKKILKYL{nt:Acet}{ct:Amid} | BP393 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 97 ± 0.6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC11H23})FKKILKYL{nt:Acet}{ct:Amid} | BP394 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 1 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC11H23})KKILKYL{nt:Acet}{ct:Amid} | BP395 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC11H23})KILKYL{nt:Acet}{ct:Amid} | BP396 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC11H23})ILKYL{nt:Acet}{ct:Amid} | BP397 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC11H23})LKYL{nt:Acet}{ct:Amid} | BP398 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 3 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC11H23})KYL{nt:Acet}{ct:Amid} | BP399 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 5 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC11H23})YL{nt:Acet}{ct:Amid} | BP400 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 99 ± 0.4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC11H23})L{nt:Acet}{ct:Amid} | BP401 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 1 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC11H23}){nt:Acet}{ct:Amid} | BP402 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 57 ± 4.6 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | C5H11CO-KKLFKKILKYL{nt:hexanoyl}{ct:Amid} | BP367 | Amidation | hexanoyl | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 95 ± 13 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC5H11})KLFKKILKYL{nt:Acet}{ct:Amid} | BP368 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 97 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC5H11})LFKKILKYL{nt:Acet}{ct:Amid} | BP369 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 86 ± 8 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC5H11})FKKILKYL{nt:Acet}{ct:Amid} | BP370 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antimicrobial | 14 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC5H11})KKILKYL{nt:Acet}{ct:Amid} | BP371 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 95 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC5H11})KILKYL{nt:Acet}{ct:Amid} | BP372 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 100 ± 0.9 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC5H11})ILKYL{nt:Acet}{ct:Amid} | BP373 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 95 ± 6 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC5H11})LKYL{nt:Acet}{ct:Amid} | BP374 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 28 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC5H11})KYL{nt:Acet}{ct:Amid} | BP375 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 86 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC5H11})YL{nt:Acet}{ct:Amid} | BP376 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 89 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC5H11})L{nt:Acet}{ct:Amid} | BP377 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 89 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC5H11}){nt:Acet}{ct:Amid} | BP378 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antimicrobial | 52 ± 6 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | C3H7CO-KKLFKKILKYL{nt:butanoyl}{ct:Amid} | BP379 | Amidation | butanoyl | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 96 ± 1 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC3H7})KLFKKILKYL{nt:Acet}{ct:Amid} | BP380 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 97 ± 5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC3H7})LFKKILKYL{nt:Acet}{ct:Amid} | BP381 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 76 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC3H7})FKKILKYL{nt:Acet}{ct:Amid} | BP382 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC3H7})KKILKYL{nt:Acet}{ct:Amid} | BP383 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 40 ± 4 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC3H7})KILKYL{nt:Acet}{ct:Amid} | BP384 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC3H7})ILKYL{nt:Acet}{ct:Amid} | BP385 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC3H7})LKYL{nt:Acet}{ct:Amid} | BP386 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | NA | 3 ± 0 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | Non-hemolytic | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC3H7})KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 18 ± 1 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC3H7})YL{nt:Acet}{ct:Amid} | BP388 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 89 ± 10 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC3H7})L{nt:Acet}{ct:Amid} | BP389 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 39 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC3H7}){nt:Acet}{ct:Amid} | BP390 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 7 ± 0.9 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | Low hemolytic | ||
| 30052685 | 2018 | C11H23CO-KKLFKKILKYL{nt:lauroyl}{ct:Amid} | BP391 | Amidation | lauroyl | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 0.5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC11H23})KLFKKILKYL{nt:Acet}{ct:Amid} | BP392 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC11H23})LFKKILKYL{nt:Acet}{ct:Amid} | BP393 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 99 ± 0.5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC11H23})FKKILKYL{nt:Acet}{ct:Amid} | BP394 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC11H23})KKILKYL{nt:Acet}{ct:Amid} | BP395 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC11H23})KILKYL{nt:Acet}{ct:Amid} | BP396 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 7 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC11H23})ILKYL{nt:Acet}{ct:Amid} | BP397 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC11H23})LKYL{nt:Acet}{ct:Amid} | BP398 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC11H23})KYL{nt:Acet}{ct:Amid} | BP399 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 6 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC11H23})YL{nt:Acet}{ct:Amid} | BP400 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 14 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC11H23})L{nt:Acet}{ct:Amid} | BP401 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC11H23}){nt:Acet}{ct:Amid} | BP402 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 0.5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 29682907 | 2018 | ACPIFTKIQGTYRGKAKCK{ct:myristoylated} | MPhd1 | myristoylated | Free | Linear | L | Myr = Myristic acid | 19 | Antibacterial | >70 % Hemolysis at 10 μM | Rat | Human-Β-Defensins | buffer = β-conformation | NA | ||
| 29682907 | 2018 | FCPRRYKQIGTGLPGTKCK{ct:myristoylated} | MPhd2 | myristoylated | Free | Linear | L | Myr = Myristic acid | 19 | Antibacterial | >20 % Hemolysis at 10 μM | Rat | Human-Β-Defensins | buffer = unordered conformation | NA | ||
| 29750913 | 2018 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis at >64 μM | Human | Combination Of Melittin And Cecropin A | membrane = α-Helical | NA | ||
| 29750913 | 2018 | KKLFKKILKYLA-hexadecyl-1-amine{ct:n-hexadecyl acyl chain} | BP100-Ala-NH-C16H33 | n-hexadecyl acyl chain | Free | Linear | L + chain | additional alanine and an n-hexadecyl acyl chain at the C-terminus | 12 | Antimicrobial | 50 % Hemolysis at 6.3 μM | Human | Synthesized Analog Of Bp100 | membrane = α-Helical | NA | ||
| 29750913 | 2018 | C{d}ILC-KKLFKKILKYL{cyc:1‑4} | Cyclo (1‑4)‑cILC-BP100 | Free | Free | Cyclic | Mix | disulfide bond between D-Cys1 and Cys4 at N-Terminal | 11 | Antimicrobial | 50 % Hemolysis at 8.7 μM | Human | Synthesized Analog Of Bp100 | membrane =Partly α-Helical and partly β-Turn | NA | ||
| 29842923 | 2018 | FLPIVGRLISGIL | Temporin-CPb | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >100 μM | Human | Gopher Frog Lithobates Capito | NA | NA | ||
| 29842923 | 2018 | SILPTIVSFLSKVF | Temporin-1Ga | Free | Free | Linear | L | None | 14 | Antibacterial, Antifungal, Anticancer | 50 % Hemolysis at 12.5 μM | Human | Frog Rana Grylio | NA | NA | ||
| 29842923 | 2018 | FLPFLKSILGKIL | Temporin-1OLa | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Anticancer | 50 % Hemolysis at 50 μM | Human | Frog Rana Okaloosae | α-Helical | NA | ||
| 29842923 | 2018 | FLSAITSILGKFF | Temporin-1SPa | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 37.5 μM | Human | Frog Rana Septentrionalis | NA | NA | ||
| 29842923 | 2018 | FLPLLASLFSRLF | Temporin-1Oc | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at <12.5 μM | Human | Frog Rana Ornativentris | NA | NA | ||
| 29842923 | 2018 | IPPFIKKVLTTVF | Temporin-CPa | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >100 μM | Human | Gopher Frog Lithobates Capito | NA | NA | ||
| 29900628 | 2018 | RVRWRlF{d}-{nnr:2-Abz}-A{d}RWRVR | Peptide 2 | Free | Free | Linear | Mix | 2-Abz = 2-aminobenzoic acid, f = D-Phenylalanine | 13 | Antibacterial, Antifungal | <3 % Hemolysis at 200 μM | Mouse | Synthetic Amphipathic Antimicrobial Peptide | aqueous = β‐Hairpin | Low hemolytic | ||
| 29900628 | 2018 | RIKWRlF{d}-{nnr:2-Abz}-A{d}RWKIR | Peptide 3 | Free | Free | Linear | Mix | 2-Abz = 2-aminobenzoic acid, f = D-Phenylalanine | 13 | Antibacterial | <3 % Hemolysis at 600 μM | Mouse | Synthetic Amphipathic Antimicrobial Peptide | aqueous = β‐Hairpin | Non-hemolytic | ||
| 30011202 | 2018 | VVKCSFRPGSPAPRCK | odorranain-A-OT | Free | Free | Linear | L | None | 16 | Antioxidant | 5 % Hemolysis at 150 μM | Human | Frog Odorranain | NA | NA | ||
| 30011202 | 2018 | FVPAILCSILKTC | odorranain-G-OT | Free | Free | Linear | L | None | 13 | Antioxidant | 4 % Hemolysis at 150 μM | Human | Frog Odorranain | NA | NA | ||
| 30011202 | 2018 | FFRTSCRSVC | MFL | Free | Free | Linear | L | None | 10 | Antioxidant | 7 % Hemolysis at 150 μM | Human | Derived From Margaratain-B1, Andersnin-C1, And Pleurain-R1 | NA | NA | ||
| 30011202 | 2018 | TSRCIFYRRCVCS | AFL | Free | Free | Linear | L | None | 10 | Antioxidant | 21 % Hemolysis at 150 μM | Human | Derived From Margaratain-B1, Andersnin-C1, And Pleurain-R1 | NA | NA | ||
| 30011202 | 2018 | CVRFRTNTARTVCIAP | PFL | Free | Free | Linear | L | None | 16 | Antioxidant | 5 % Hemolysis at 150 μM | Human | Derived From Margaratain-B1, Andersnin-C1, And Pleurain-R1 | NA | NA | ||
| 30110916 | 2018 | KLLKHKLLVTLA | HJH-1 | Free | Free | Linear | L | None | 12 | Antibacterial | 20 % Hemolysis at 400 µg/mL | Rabbit | Hemoglobin Α-Subunit Of Bovine Erythrocytes P3 | NA | Low hemolytic | ||
| 30021422 | 2018 | VKEWIKYLKSLF | LPcin-YK3 | Free | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 1 μg/ml | Mouse | Bovine Lactophoricin-Derived Peptide | aqueous = Random coils, DPC solution = α-Helical | Non-hemolytic | ||
| 30021422 | 2018 | VKEWIKYLKSLF | LPcin-YK3 | Free | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 10 μg/ml | Mouse | Bovine Lactophoricin-Derived Peptide | aqueous = Random coils, DPC solution = α-Helical | Non-hemolytic | ||
| 30021422 | 2018 | VKEWIKYLKSLF | LPcin-YK3 | Free | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 40 μg/ml | Mouse | Bovine Lactophoricin-Derived Peptide | aqueous = Random coils, DPC solution = α-Helical | Non-hemolytic | ||
| 30161192 | 2018 | SLTFEVLDKVLGELGKVSRK | StI12-31 | Free | Free | Linear | L | None | 20 | NA | 0 % Hemolysis at 64 μM | Human | Derived From Sea Anemone Actinoporins Sticholysin I | α-Helical | Non-hemolytic | ||
| 30161192 | 2018 | SLTFQVLDKVLEELGKVSRK | StII11-30 | Free | Free | Linear | L | None | 20 | NA | 0 % Hemolysis at 64 μM | Human | Derived From Sea Anemone Actinoporins Sticholysin Ii | α-Helical | Non-hemolytic | ||
| 30161192 | 2018 | {nnr:TOAC}-SLTFQVLDKVLEELGKVSRK{nt:TOAC} | N-TOAC-StII11-30 | Free | TOAC | Linear | L | TOAC = 2,2,6,6-tetramethyl-N-oxyl-4-amino-4-carboxylic acid | 20 | NA | 0 % Hemolysis at 64 μM | Human | Derived From Sea Anemone Actinoporins Sticholysin Ii | α-Helical | Non-hemolytic | ||
| 29760411 | 2018 | FVPAILCSILKTC | Paenialvin-D | Free | Free | Linear | Mix | None | 16 | Antibacterial | 0.64 % Hemolysis at 50 μg/ml | Rabbit | Bacteria Paenibacillus Alvei Dsm 29 | NA | Non-hemolytic | ||
| 30192822 | 2018 | IFGAILPLALGALKNLIK | Hylin-a1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 1 % Hemolysis at 25 mM | Human | Hypsiboas Albopunctatus | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | KIFGAIWPLALGALKNLIK | K0-W6-Hy-a1 | Free | Free | Linear | L | None | 19 | Antibacterial | 1 % Hemolysis at 25 mM | Human | Analogue Of Hylin-A1 | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | VRRFPWWWPFLRR | Tritrpticin | Free | Free | Linear | L | None | 13 | Antimicrobial | 14 % Hemolysis at 25 mM | Human | Porcine Cathelicidin | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | IETFLKQLRSAANKIVGL | Citrus-amp1 | Free | Free | Linear | L | None | 18 | Antibacterial | 1 % Hemolysis at 25 mM | Human | Citrus Sinensis | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | LESLASSAVRTANKARAKL | Citrus-amp2 | Free | Free | Linear | L | None | 19 | NA | 0 % Hemolysis at 25 mM | Human | Citrus Aurantium | amphipathic α-Helix | Non-hemolytic | ||
| 30192822 | 2018 | IFGAILPLALGALKNLIK | Hylin-a1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 50 mM | Human | Hypsiboas Albopunctatus | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | KIFGAIWPLALGALKNLIK | K0-W6-Hy-a1 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 50 mM | Human | Analogue Of Hylin-A1 | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | VRRFPWWWPFLRR | Tritrpticin | Free | Free | Linear | L | None | 13 | Antimicrobial | 53 % Hemolysis at 50 mM | Human | Porcine Cathelicidin | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | IETFLKQLRSAANKIVGL | Citrus-amp1 | Free | Free | Linear | L | None | 18 | Antibacterial | 3 % Hemolysis at 50 mM | Human | Citrus Sinensis | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | LESLASSAVRTANKARAKL | Citrus-amp2 | Free | Free | Linear | L | None | 19 | NA | 0 % Hemolysis at 50 mM | Human | Citrus Aurantium | amphipathic α-Helix | Non-hemolytic | ||
| 30192822 | 2018 | IFGAILPLALGALKNLIK | Hylin-a1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0 % Hemolysis at 75 mM | Human | Hypsiboas Albopunctatus | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | KIFGAIWPLALGALKNLIK | K0-W6-Hy-a1 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 75 mM | Human | Analogue Of Hylin-A1 | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | VRRFPWWWPFLRR | Tritrpticin | Free | Free | Linear | L | None | 13 | Antimicrobial | 83 % Hemolysis at 75 mM | Human | Porcine Cathelicidin | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | IETFLKQLRSAANKIVGL | Citrus-amp1 | Free | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 75 mM | Human | Citrus Sinensis | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | LESLASSAVRTANKARAKL | Citrus-amp2 | Free | Free | Linear | L | None | 19 | NA | 0 % Hemolysis at 75 mM | Human | Citrus Aurantium | amphipathic α-Helix | Non-hemolytic | ||
| 30192822 | 2018 | IFGAILPLALGALKNLIK | Hylin-a1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 1 % Hemolysis at 100 mM | Human | Hypsiboas Albopunctatus | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | KIFGAIWPLALGALKNLIK | K0-W6-Hy-a1 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 100 mM | Human | Analogue Of Hylin-A1 | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | VRRFPWWWPFLRR | Tritrpticin | Free | Free | Linear | L | None | 13 | Antimicrobial | 99 % Hemolysis at 100 mM | Human | Porcine Cathelicidin | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | IETFLKQLRSAANKIVGL | Citrus-amp1 | Free | Free | Linear | L | None | 18 | Antibacterial | 28 % Hemolysis at 100 mM | Human | Citrus Sinensis | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | LESLASSAVRTANKARAKL | Citrus-amp2 | Free | Free | Linear | L | None | 19 | NA | 1 % Hemolysis at 100 mM | Human | Citrus Aurantium | amphipathic α-Helix | Non-hemolytic | ||
| 30258724 | 2018 | ALWKSLLKNVGKA{ct:Amid} | DP-1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >512 μM | Horse | Truncated Analogue | α-Helical | NA | ||
| 30262770 | 2018 | KWRRWQWRRWK{ct:Amid} | KW-WK | Amidation | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derived From Lfcinb18–28 | 10 mM PBS = unordered conformations, 50% TFE = α-Helix (negative bands at 208 nm, 222 nm), 30 mM SDS = α-Helix | Non-hemolytic | ||
| 30262770 | 2018 | FPRRWQWRRPF{ct:Amid} | FP-PF | Amidation | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derived From Lfcinb18–28 | 10 mM PBS = unordered conformations, 50% TFE = Disordered structure, 30 mM SDS = Disordered structure | Non-hemolytic | ||
| 30262770 | 2018 | FWRRWQWRRRWF{ct:Amid} | FW-WF | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 8 μM | Human | Derived From Lfcinb18–28 | 10 mM PBS = unordered conformations, 50% TFE = α-Helix (negative bands at 208 nm, 222 nm), 30 mM SDS = α-Helix | NA | ||
| 30262770 | 2018 | FWRRWQWRRRWF{ct:Amid} | FW-WF | Amidation | Free | Linear | L | None | 12 | Antibacterial | 52.91 % Hemolysis at 128 μM | Human | Derived From Lfcinb18–28 | 10 mM PBS = unordered conformations, 50% TFE = α-Helix (negative bands at 208 nm, 222 nm), 30 mM SDS = α-Helix | NA | ||
| 30262770 | 2018 | KKRRWQWRRKK{ct:Amid} | KK-KK | Amidation | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derived From Lfcinb18–28 | 10 mM PBS = unordered conformations, 50% TFE = α-Helix (negative bands at 208 nm, 222 nm), 30 mM SDS = Disordered structure | Non-hemolytic | ||
| 30262770 | 2018 | KCRRWQWRMKK{ct:Amid} | LFcinB18–28 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Truncated Peptide Of Lfcinb | 10 mM PBS = unordered conformations, 50% TFE = β-Sheet (positive peak 195-198 nm, negative peak 217-218 nm), 30 mM SDS = Disordered structure | Non-hemolytic | ||
| 29626331 | 2018 | AILRKATRRLVKLIV{ct:Amid} | P3-B | Amidation | Free | Linear | L | None | 15 | Antibacterial | 4.4 % Hemolysis at 50 μM | Human | Synthetic Amps | α-Helix | Low hemolytic | ||
| 29626331 | 2018 | AIWRKATRRLVKLIV{ct:Amid} | P3-C | Amidation | Free | Linear | L | None | 15 | Antibacterial | 68.7 % Hemolysis at 50 μM | Human | Synthetic Amps | α-Helix Loop | NA | ||
| 30215282 | 2018 | SWKSMAKKLKEYMEKLKQRA{ct:Amid} | Ltc 3a | Amidation | Free | Linear | L | None | 20 | Antibacterial | 20 % Hemolysis at >120 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | SWASMAKKLKEYMEKLKQRA{ct:Amid} | Ltc 3b | Amidation | Free | Linear | L | None | 20 | Antibacterial | 20 % Hemolysis at >120 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | KAFKQRVLKRKKAMKRQKAF | P1 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Mutation Oxki4A(11-30)4K | aqueous = Random coil, SDS= α-Helical | Non-hemolytic | ||
| 30215282 | 2018 | GIRAPKSWKAKAFKQRVLKR | P2 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Mutation Oxt 4A(1-20)(C→A) | aqueous = Random coil, SDS= α-Helical | Non-hemolytic | ||
| 30215282 | 2018 | KSWKAKAFKQRVLKRLLAML | P3 | Free | Free | Linear | L | None | 20 | Antibacterial | 40 % Hemolysis at 100 μM | Human | Mutation Oxt 4A(6-25) (C→A) | aqueous = Random coil, SDS= α-Helical | NA | ||
| 30215282 | 2018 | FAHQRLMALLRKLVRQKFAK | P4 | Free | Free | Linear | L | None | 20 | Antibacterial | 40 % Hemolysis at 100 μM | Human | Mutation Oxt 4A(10-30)Inversion | aqueous = Random coil, SDS= α-Helical | NA | ||
| 30215282 | 2018 | SMWSGMWRKRLKAMLRQHAF | P5 | Free | Free | Linear | L | None | 20 | Antibacterial | >5 % Hemolysis at 100 μM | Human | Mutation Ltc1(1-8)Oxt 4A(19-30)(L22→K) | aqueous = Random coil, SDS= α-Helical | Low hemolytic | ||
| 30283025 | 2018 | KKKKKKAAFAAWAAFAA{ct:Amid} | 6K-F17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm | 0 % Hemolysis at >500 μg/ml | Human | Synthetic Amps | NA | Non-hemolytic | ||
| 30364142 | 2018 | FKLFKKILKVL{nt:Acet}{ct:Amid} | BP21 | Amidation | Acetylation | Linear | L | None | 11 | Antifungal | 4.3 % Hemolysis at 8 µmol L−1 | Human | Giant Silk Moth Hyalophora Cecropia Cecropins | NA | Low hemolytic | ||
| 30322120 | 2018 | FLGAVLKVAGKLVPAAI | Brevinin-1GHb | Free | Free | Linear | L | None | 17 | Antibacterial | 20 % Hemolysis at 512 µM | Horse | Analogue Of Brevinin-1Gha | α-Helix | Low hemolytic | ||
| 30240951 | 2018 | GLFAVIKKVASVIKGL{ct:Amid} | A4K14-citropin 1.1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | >20 % Hemolysis at 10 µM | Human | Australian Freetail Lizards | α-Helix | NA | ||
| 30240951 | 2018 | GKWLSLLKHILK{ct:Amid} | Halictine-2/11 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | >35 % Hemolysis at 10 µM | Human | Derived From Bee Venom | α-Helix | NA | ||
| 30240951 | 2018 | VNWKKILGKIIKVVK{ct:Amid} | Lasioglossin-III | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Anticancer | >35 % Hemolysis at 10 µM | Human | Derived From Bee Venom | α-Helix | NA | ||
| 30240951 | 2018 | GLFAVIKKVASVIKGL{ct:Amid} | A4K14-citropin 1.1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 100 % Hemolysis at 100 µM | Human | Australian Freetail Lizards | α-Helix | NA | ||
| 30240951 | 2018 | GKWLSLLKHILK{ct:Amid} | Halictine-2/11 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 100 % Hemolysis at 100 µM | Human | Derived From Bee Venom | α-Helix | NA | ||
| 30240951 | 2018 | VNWKKILGKIIKVVK{ct:Amid} | Lasioglossin-III | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Anticancer | 100 % Hemolysis at 100 µM | Human | Derived From Bee Venom | α-Helix | NA | ||
| 30360541 | 2018 | GFWSSVWDGAKNVGTAI | Nico(1-17) | Free | Free | Linear | L | None | 17 | Antibacterial | 1 % Hemolysis at 128 µM | Human | Fragment Of Nicomicin-1 | aqueous = α-Helix, Membrane-Mimicking Environment = α-Helix | Non-hemolytic | ||
| 30360541 | 2018 | IKNAKVCVYAVCVSHK | Nico(18-33) | Free | Free | Linear | L | None | 16 | Antibacterial | 50 % Hemolysis at 128 µM | Human | Fragment Of Nicomicin-1 | aqueous = Random coil, Membrane-Mimicking Environment = Disordered | NA | ||
| 30121851 | 2018 | FIFHIIRFFNFRVFRI | FI16 | Free | Free | Linear | L | None | 16 | Antimicrobial | 2 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | KIFDAEILLNGKRKGLG | KG17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | FIKIFHHIFKGNPKFSIIK | FK19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | Non-hemolytic | ||
| 30121851 | 2018 | KIRFTRTVSRLLKAALAST | KT19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | Non-hemolytic | ||
| 30121851 | 2018 | AKAFKKAFEKLAAVVPFGGT | AT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | Non-hemolytic | ||
| 30121851 | 2018 | GKSNKPALTLIQARILKHKT | GT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 1 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | VILTRFRFLNRIVEPLLKKA | VA20 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | Non-hemolytic | ||
| 30121851 | 2018 | FFHHIFDPQIKSGLLVSMYD | FD20 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | FIFHIIRFFNFRVFRI | FI16 | Free | Free | Linear | L | None | 16 | Antimicrobial | 5.39 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | NA | NA | ||
| 30121851 | 2018 | KIFDAEILLNGKRKGLG | KG17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | FIKIFHHIFKGNPKFSIIK | FK19 | Free | Free | Linear | L | None | 19 | Antibacterial | 44.03 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | KIRFTRTVSRLLKAALAST | KT19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | Non-hemolytic | ||
| 30121851 | 2018 | AKAFKKAFEKLAAVVPFGGT | AT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | Non-hemolytic | ||
| 30121851 | 2018 | GKSNKPALTLIQARILKHKT | GT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | VILTRFRFLNRIVEPLLKKA | VA20 | Free | Free | Linear | L | None | 20 | Antibacterial | 10.79 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | NA | ||
| 30121851 | 2018 | FFHHIFDPQIKSGLLVSMYD | FD20 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | FIFHIIRFFNFRVFRI | FI16 | Free | Free | Linear | L | None | 16 | Antimicrobial | 9.53 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | NA | NA | ||
| 30121851 | 2018 | KIFDAEILLNGKRKGLG | KG17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.25 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | FIKIFHHIFKGNPKFSIIK | FK19 | Free | Free | Linear | L | None | 19 | Antibacterial | 63.35 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | KIRFTRTVSRLLKAALAST | KT19 | Free | Free | Linear | L | None | 19 | Antibacterial | 7.78 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | AKAFKKAFEKLAAVVPFGGT | AT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | Non-hemolytic | ||
| 30121851 | 2018 | GKSNKPALTLIQARILKHKT | GT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | VILTRFRFLNRIVEPLLKKA | VA20 | Free | Free | Linear | L | None | 20 | Antibacterial | 25.34 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | NA | ||
| 30121851 | 2018 | FFHHIFDPQIKSGLLVSMYD | FD20 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | FIFHIIRFFNFRVFRI | FI16 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10.79 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | NA | NA | ||
| 30121851 | 2018 | KIFDAEILLNGKRKGLG | KG17 | Free | Free | Linear | L | None | 17 | Antimicrobial | 1.13 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | FIKIFHHIFKGNPKFSIIK | FK19 | Free | Free | Linear | L | None | 19 | Antibacterial | 66.49 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | KIRFTRTVSRLLKAALAST | KT19 | Free | Free | Linear | L | None | 19 | Antibacterial | 21.58 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | AKAFKKAFEKLAAVVPFGGT | AT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | Non-hemolytic | ||
| 30121851 | 2018 | GKSNKPALTLIQARILKHKT | GT20 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | VILTRFRFLNRIVEPLLKKA | VA20 | Free | Free | Linear | L | None | 20 | Antibacterial | 42 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | NA | ||
| 30121851 | 2018 | FFHHIFDPQIKSGLLVSMYD | FD20 | Free | Free | Linear | L | None | 20 | Antibacterial | 9.2 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | NA | NA | ||
| 30325566 | 2018 | DDDELLVDLL{nt:CH3-(CH2)16-(CO)-NH = fatty acid chain}{ct:Amid} | LP5 | Amidation | CH3-(CH2)16-(CO)-NH = fatty acid chain | Linear | L | CH3-(CH2)16-(CO)-NH = N-Terminal fatty acid chain | 10 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Lipopeptide | NA | Non-hemolytic | ||
| 30325566 | 2018 | HHHELLVDLL{nt:CH3-(CH2)16-(CO)-NH = fatty acid chain}{ct:Amid} | LP6 | Amidation | CH3-(CH2)16-(CO)-NH = fatty acid chain | Linear | L | CH3-(CH2)16-(CO)-NH = N-Terminal fatty acid chain | 10 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Lipopeptide | NA | Non-hemolytic | ||
| 30325566 | 2018 | RRRELLVDLL{nt:CH3-(CH2)16-(CO)-NH = fatty acid chain}{ct:Amid} | LP7 | Amidation | CH3-(CH2)16-(CO)-NH = fatty acid chain | Linear | L | CH3-(CH2)16-(CO)-NH = N-Terminal fatty acid chain | 10 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Lipopeptide | NA | Non-hemolytic | ||
| 30325566 | 2018 | YYYELLVDLL{nt:CH3-(CH2)16-(CO)-NH = fatty acid chain}{ct:Amid} | LP8 | Amidation | CH3-(CH2)16-(CO)-NH = fatty acid chain | Linear | L | CH3-(CH2)16-(CO)-NH = N-Terminal fatty acid chain | 10 | Antibacterial | high % Hemolysis at 100 µM | Human | Synthetic Lipopeptide | NA | NA | ||
| 30423858 | 2018 | DEMKLDGFNMHLE{ct:Amid} | P1-Ll-1577 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 12 % Hemolysis at 320 µM | Human | Frog Leptodactylus Latrans | Random coil | NA | ||
| 30423858 | 2018 | AAGKGLVSNLLEK{ct:Amid} | P2-Ll-1298 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 320 µM | Human | Frog Leptodactylus Latrans | TFE = ɑ-Helix | NA | ||
| 30423858 | 2018 | GLLDFLKAAGKGLVSNLLEK{ct:Amid} | P3-Ll-2085 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 100 % Hemolysis at 40 µM | Human | Frog Leptodactylus Latrans | TFE = ɑ-Helix | NA | ||
| 30538681 | 2018 | IHKFWRCRRRFCRWFKHI{ct:Amid} | PQ | Amidation | Free | Linear | L | None | 18 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Designs Amps | 10 mM PBS = unordered, 30 mM SDS and 50% TFE = α-Helix | Low hemolytic | ||
| 30538681 | 2018 | IHKFWRPGRWFKHI{ct:Amid} | PP | Amidation | Free | Linear | L | None | 14 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Designs Amps | 10 mM PBS = unordered, 30 mM SDS and 50% TFE = α-Helix | Low hemolytic | ||
| 30538681 | 2018 | IHKFWRGGRWFKHI{ct:Amid} | GG | Amidation | Free | Linear | L | None | 14 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Designs Amps | 10 mM PBS = unordered, 30 mM SDS and 50% TFE = α-Helix | Low hemolytic | ||
| 30538681 | 2018 | IHKFWRRWFKHI{ct:Amid} | Qa | Amidation | Free | Linear | L | None | 12 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Designs Amps | α-Helix | Low hemolytic | ||
| 30538681 | 2018 | IHFKWRRWKFHI{ct:Amid} | Qna | Amidation | Free | Linear | L | None | 12 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Designs Amps | unordered | Low hemolytic | ||
| 30538681 | 2018 | RGGRLCYCRRRFCVCVGR{ct:Amid} | PG-1 | Amidation | Free | Linear | L | None | 18 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Designs Amps | β-Hairpin | Low hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 2 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 4 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 16 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 32 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 1 % Hemolysis at 64 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 4 % Hemolysis at 128 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 11 % Hemolysis at 256 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 35 % Hemolysis at 512 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555984 | 2018 | YYHFWHRGVTKR | YR12 | Free | Free | Linear | L | None | 12 | Antibacterial | ~5 % Hemolysis at 100 µM | Human | Human Prodomain Of Human Furin | NA | Low hemolytic | ||
| 30555984 | 2018 | YYHFWHRGVTKRSLSPHRPR | YR20 | Free | Free | Linear | L | None | 20 | Antibacterial | ~5 % Hemolysis at 100 µM | Human | Human Prodomain Of Human Furin | NA | Low hemolytic | ||
| 30570384 | 2018 | RKYVRFLHRWVKYFRAYL | Adevonin | Free | Free | Linear | L | None | 18 | Antibacterial | 0 % Hemolysis at 87.5 µM | Human | Plant Adenanthera Pavonina Designed From Apti | SDS = α-Helix | Non-hemolytic | ||
| 30570384 | 2018 | RKYVRFLHRWVKYFRAYL | Adevonin | Free | Free | Linear | L | None | 18 | Antibacterial | >70 % Hemolysis at 175 µM | Human | Plant Adenanthera Pavonina Designed From Apti | SDS = α-Helix | NA | ||
| 30563217 | 2018 | VGTDFSGNDDISDVQK | Lg-AMP1 | Free | Free | Linear | L | None | 16 | Antibacterial | 0.1 % Hemolysis at 68.5 µM | Human | Spider Venom (Loxosceles Gaucho) | α-Helix | Non-hemolytic | ||
| 30563217 | 2018 | VGTDFSGNDDISDVQK | Lg-AMP1 | Free | Free | Linear | L | None | 16 | Antibacterial | 0.15 % Hemolysis at 137 µM | Human | Spider Venom (Loxosceles Gaucho) | α-Helix | Non-hemolytic | ||
| 29523276 | 2018 | QVKGAKLWLSLMKWGGI | GIBIM-P1 | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | GFLGKGLFSVVKGVLKG | GIBIM-P2 | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | GFLGKGLFSVVKGVLKI | GIBIM-P2G17I | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | GFLGKGLFSVVKGVLKL | GIBIM-P2G17L | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | GFLGKGLFSVVKNVLKG | GIBIM-P2G13N | Free | Free | Linear | L | None | 17 | Antibacterial | 10 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | NVAATARGWLKKLGKRI | GIBIM-P3 | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | NVGATARGWLKKLGKRI | GIBIM-P3A3G | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | NVAASARGWLKKLGKRI | GIBIM-P3T5S | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | NVAATKRGWLKKLGKRI | GIBIM-P3A6K | Free | Free | Linear | L | None | 17 | Antibacterial | ~15 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | ANVAATARGWLKKIGKK | GIBIM-P4 | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | INVAATARGWLKKIGKK | GIBIM-P4A1I | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | VNVAATARGWLKKIGKK | GIBIM-P4A1V | Free | Free | Linear | L | None | 17 | Antibacterial | 11 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | AFVAATARGWLKKIGKK | GIBIM-P4N2F | Free | Free | Linear | L | None | 17 | Antibacterial | 31 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | ATKKCGLFSILKGVGKI | GIBIM-P5 | Free | Free | Linear | L | None | 17 | Antibacterial | 25 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | AKKKCGLFSILKGVGKI | GIBIM-P5T2K | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | ATKKCGLFKILKGVGKI | GIBIM-P5S9K | Free | Free | Linear | L | None | 17 | Antibacterial | 30 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29959905 | 2019 | KRFIKWYNAWNEKRRVY{ct:Amid} | CXCL14-C17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <10 % Hemolysis at 1024 µM | Human | Human Chemokine Cxcl14 | α-Helix | NA | ||
| 29959905 | 2019 | KRFIKWYKAWNKKRRVY{ct:Amid} | CXCL14-C17-a1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <10 % Hemolysis at 1024 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | NA | ||
| 29959905 | 2019 | KRFIKWYKAWNKKWRKY{ct:Amid} | CXCL14-C17-a2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | 10 % Hemolysis at 480 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | NA | ||
| 29959905 | 2019 | KRFKKWYKAWRKKWRKY{ct:Amid} | CXCL14-C17-a3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | 10 % Hemolysis at 700 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | NA | ||
| 29959905 | 2019 | KRFIKWYNAWNEKRRVY{ct:Amid} | CXCL14-C17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <5 % Hemolysis at 256 µM | Human | Human Chemokine Cxcl14 | α-Helix | Non-hemolytic | ||
| 29959905 | 2019 | KRFIKWYKAWNKKRRVY{ct:Amid} | CXCL14-C17-a1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <5 % Hemolysis at 256 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | Non-hemolytic | ||
| 29959905 | 2019 | KRFIKWYKAWNKKWRKY{ct:Amid} | CXCL14-C17-a2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <5 % Hemolysis at 256 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | Non-hemolytic | ||
| 29959905 | 2019 | KRFKKWYKAWRKKWRKY{ct:Amid} | CXCL14-C17-a3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <5 % Hemolysis at 256 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | Non-hemolytic | ||
| 30120878 | 2019 | TSVRQRWRWRQRVRTS{ct:Amid} | P38 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 50 μg/ml | Human | Derived From Human Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 30120878 | 2019 | KRSKRKRRIHQRVRIS{ct:Amid} | P22 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 50 μg/ml | Human | Derived From Human Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 30120878 | 2019 | TLSKEKERIVQRVRTS{ct:Amid} | P7 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 50 μg/ml | Human | Derived From Human Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 30176540 | 2019 | AKRHHGYKRKFH{nt:Acet}{ct:Amid} | P-113 | Amidation | Acetylation | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μg/ml | Human | Human Fragment Of The Saliva Protein Histatin 5 | NA | Non-hemolytic | ||
| 30176540 | 2019 | AKRFFGYKRKFF{nt:Acet}{ct:Amid} | Phe-P-113 | Amidation | Acetylation | Linear | L | None | 12 | Antimicrobial, Anti-inflammatory | 0 % Hemolysis at 25 μg/ml | Human | Analoge Of P-113 | NA | Non-hemolytic | ||
| 30176540 | 2019 | AKR{nnr:nal}{nnr:nal}GYKRKF{nnr:nal}{nt:Acet}{ct:Amid} | Nal-P-113 | Amidation | Acetylation | Linear | L | Nal = β-naphthylalanine | 12 | Antimicrobial, Anti-inflammatory | 0 % Hemolysis at 25 μg/ml | Human | Analoge Of P-113 | NA | Non-hemolytic | ||
| 30176540 | 2019 | AKR{nnr:bip}{nnr:bip}GYKRKF{nnr:bip}{nt:Acet}{ct:Amid} | Bip-P-113 | Amidation | Acetylation | Linear | L | Bip = β-(4,4’-biphenyl)alanine | 12 | Antimicrobial, Anti-inflammatory | 4 % Hemolysis at 25 μg/ml | Human | Analoge Of P-113 | NA | NA | ||
| 30176540 | 2019 | AKR{nnr:dip}{nnr:dip}GYKRKF{nnr:dip}{nt:Acet}{ct:Amid} | Dip-P-113 | Amidation | Acetylation | Linear | L | Dip = β-diphenylalanine | 12 | Antimicrobial, Anti-inflammatory,salt resistance, serum proteolytic stability, peptide-induced permeabilization | 0 % Hemolysis at 25 μg/ml | Human | Analoge Of P-113 | NA | Non-hemolytic | ||
| 30488526 | 2019 | KKFFRAWWAPRFLK{ct:Amid} | KK14 | Amidation | Free | Linear | L | None | 14 | Antifungal | ~10 % Hemolysis at 200 μg/ml | Sheep | Synthetic Peptide | aqueous = Antiparallel, SDS = Random coil | Low hemolytic | ||
| 30488526 | 2019 | KKFFRAW{nnr:dip}APRFLK{ct:Amid} | KK14(Dip) | Amidation | Free | Linear | L | Dip = β,β-diphenylalanine | 14 | Antifungal | ~10 % Hemolysis at 200 μg/ml | Sheep | Synthetic Analogues Of Kk14 | aqueous = Antiparallel, SDS = Random coil | Low hemolytic | ||
| 30488526 | 2019 | K{d}K{d}F{d}F{d}R{d}A{d}W{d}W{d}A{d}P{d}R{d}F{d}L{d}K{d}{ct:Amid} | kk14 | Amidation | Free | Linear | D | None | 14 | Antifungal | ~10 % Hemolysis at 200 μg/ml | Sheep | Synthetic Analogues Of Kk14 | aqueous = Random coil, SDS = Random coil | Low hemolytic | ||
| 30488526 | 2019 | KKFFRAWWARRFLK{ct:Amid} | KK14(R) | Amidation | Free | Linear | L | None | 14 | Antifungal | ~10 % Hemolysis at 200 μg/ml | Sheep | Synthetic Analogues Of Kk14 | aqueous = Antiparallel, SDS = Random coil | Low hemolytic | ||
| 30658410 | 2019 | GILDWGKKVMDWIKDKM{ct:Amid} | PLP1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, histamine-releasing activity | 0 % Hemolysis at 50 µM | Human | Ant Odontomachus Monticola | α-Helix | Non-hemolytic | ||
| 30658410 | 2019 | IWGALLGTLIPAITSAIQ{ct:Amid} | PLP5 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 94.8 % Hemolysis at 50 µM | Human | Ant Odontomachus Monticola | α-Helix | NA | ||
| 30658410 | 2019 | GILDWGKKVMDWIKDKM{ct:Amid} | PLP1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, histamine-releasing activity | 0 % Hemolysis at 10 µM | Human | Ant Odontomachus Monticola | α-Helix | Non-hemolytic | ||
| 30658410 | 2019 | IWGALLGTLIPAITSAIQ{ct:Amid} | PLP5 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 6.9 % Hemolysis at 10 µM | Human | Ant Odontomachus Monticola | α-Helix | NA | ||
| 30709056 | 2019 | FFSLIPSLVGGLISAFK | Stigmurin | Free | Free | Linear | L | None | 17 | Antimicrobial | 5.8 % Hemolysis at 150 µM | Human | Scorpion Tityus Stigmurus Venom | Water and PBS = Random coil, SDS 20mM = α-Helix, 40% TFE = α-Helix | Low hemolytic | ||
| 30709056 | 2019 | FFSLIPSLVKKLIKAFK | StigA25 | Free | Free | Linear | L | None | 17 | Antimicrobial, Antiparasitic | 18.5 % Hemolysis at 9.4 µM | Human | Analogs Of Stigmurin | Water and PBS = Random coil, SDS 20mM = α-Helix, 60% TFE = α-Helix | NA | ||
| 30709056 | 2019 | FFKLIPKLVKKLIKAFK | StigA31 | Free | Free | Linear | L | None | 17 | Antimicrobial, Antiparasitic | 11.2 % Hemolysis at 9.4 µM | Human | Analogs Of Stigmurin | Water and PBS = Random coil, SDS 20mM = α-Helix, 30% TFE = α-Helix | NA | ||
| 30717183 | 2019 | GMWSKILGHLIR | HAL-1 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 82 µM | Rat | Eusocial Bee Venom Halictus Sexcinctus | 30% TFE = α-Helix | NA | ||
| 30717183 | 2019 | GMWSKILGPLIR | HAL-1/2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Rat | Analogs Of Hal-1 | 30% TFE = α-Helix | NA | ||
| 30717183 | 2019 | GMWSKILGHLIK | HAL-1/6 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 132 µM | Rat | Analogs Of Hal-1 | 30% TFE = α-Helix | NA | ||
| 30717183 | 2019 | GMWKKILGKLIR | HAL-1/10 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Rat | Analogs Of Hal-1 | 30% TFE = α-Helix | NA | ||
| 30717183 | 2019 | GKWSKILGKLIR | HAL-1/20 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >200 µM | Rat | Analogs Of Hal-1 | 30% TFE = α-Helix | NA | ||
| 30612735 | 2019 | FLSLIPHIASGIASLVKNF{ct:Amid} | Phylloseptin-PBa1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anticancer | 50 % Hemolysis at 18.6 µM | Horse | Leaf Forg (Phyllomedusa Burmeisteri) | α-Helix | NA | ||
| 30612735 | 2019 | FLSLLPHIASGIASLVSKF{ct:Amid} | Phylloseptin-PBa2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anticancer | 50 % Hemolysis at 15.82 µM | Horse | Leaf Forg (Phyllomedusa Burmeisteri) | α-Helix | NA | ||
| 30612735 | 2019 | FLSLIPHIVSGVAALANHL{ct:Amid} | Phylloseptin-PBa3 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anticancer | 50 % Hemolysis at 52.98 µM | Horse | Leaf Forg (Phyllomedusa Burmeisteri) | α-Helix | NA | ||
| 30384016 | 2019 | YGRKKRRQRRR | TAT(47–57) | Free | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at >62.5 μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 30384016 | 2019 | YGRKKRRQRRRSISLL | TAT–SISLL | Free | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >250 μg/ml | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30384016 | 2019 | SISLLYGRKKRRQRRR | SISLL–TAT | Free | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >250 μg/ml | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30414293 | 2019 | RNCTWLFSTKLKLPA | RN15 | Free | Free | Linear | L | None | 15 | Antibacterial | <10 % Hemolysis at 200 μg/mL | Human | Siamese Crocodile Crocodylus Siamensis | α-Helix | Low hemolytic | ||
| 30872680 | 2019 | FLPKLFAKITKKNMAHIR | Andersonin-Y1 (AY1) | Free | Free | Linear | L | None | 18 | Antibacterial | 5 % Hemolysis at 100 µM | Human | Frog Odorrana Andersonii | membrane bound structure = Helical Hairpin (Helix-Loop-Helix) structure, Aqueous = unstructured | Low hemolytic | ||
| 30521892 | 2019 | RYAKMKRRRRRVARRHRRR | PEP-NKSM | Free | Free | Linear | L | None | 19 | biofilm Anti-adherent activity, Antibiofilm | 12 % Hemolysis at 256 µM | Human | Derived From Human Virus Proteomes | α-Helix | Low hemolytic | ||
| 30842341 | 2019 | GLLSGINAEWPC | OA-GL12 | Free | Free | Linear | L | None | 12 | Wound-healing peptide, Antioxidant | 8.9 ± 0.43 % Hemolysis at 0.1 nM | Human | Frog Odorrana Andersonii | NA | NA | ||
| 30842341 | 2019 | GLLSGINAEWPC | OA-GL12 | Free | Free | Linear | L | None | 12 | Wound-healing peptide, Antioxidant | 9.8 ± 0.45 % Hemolysis at 1 nM | Human | Frog Odorrana Andersonii | NA | NA | ||
| 30842341 | 2019 | GLLSGINAEWPC | OA-GL12 | Free | Free | Linear | L | None | 12 | Wound-healing peptide, Antioxidant | 9.9 ± 0.75 % Hemolysis at 10 nM | Human | Frog Odorrana Andersonii | NA | NA | ||
| 30337232 | 2019 | FPFPRPPHQK | FSB-FPF | Free | Free | Linear | L | None | 10 | LPS-neutralizing and angiogenic activities | <0.10 % Hemolysis at 500 µM | Sheep | Beta-Conglycinin Alpha Subunit | NA | Non-hemolytic | ||
| 30337232 | 2019 | GQSSRPQDRHQK | FSB-GQS | Free | Free | Linear | L | None | 12 | LPS-neutralizing and angiogenic activities | <0.10 % Hemolysis at 500 µM | Sheep | Glycinin G1 | NA | Non-hemolytic | ||
| 30337232 | 2019 | ERQFPFPRPPHQK | FSB-ERQ | Free | Free | Linear | L | None | 13 | LPS-neutralizing and angiogenic activities | <0.10 % Hemolysis at 500 µM | Sheep | Beta-Conglycinin Alpha Subunit | NA | Non-hemolytic | ||
| 30337232 | 2019 | GEIPRPRPRPQHPE | FSB-GEI | Free | Free | Linear | L | None | 14 | LPS-neutralizing and angiogenic activities | <0.10 % Hemolysis at 500 µM | Sheep | Beta-Conglycinin Alpha Subunit | NA | Non-hemolytic | ||
| 30337232 | 2019 | EQPRPIPFPRPQPR | FSB-EQP | Free | Free | Linear | L | None | 14 | LPS-neutralizing and angiogenic activities | 0.24 % Hemolysis at 500 µM | Sheep | Beta-Conglycinin Alpha Subunit | NA | Non-hemolytic | ||
| 30753486 | 2019 | VNWKKILGKIIKVVK{ct:Amid} | LL-III | Amidation | Free | Linear | L | None | 15 | Antibiofilm, Antifungal | 50 % Hemolysis at 157 µM | Human | Lasioglossum Laticeps Bee Venoms | 30% TFE = α-Helix | NA | ||
| 30753486 | 2019 | VNWKKILGK{d}IIKVVK{ct:Amid} | LL-III/43 | Amidation | Free | Linear | Mix | None | 15 | Antibiofilm, Antifungal | 50 % Hemolysis at 400 µM | Human | Derived From Ll-Iii But With D-Leu | 30% TFE = α-Helix | NA | ||
| 30753486 | 2019 | GKWMSLLKHILK{ct:Amid} | HAL-2 | Amidation | Free | Linear | L | None | 12 | Antibiofilm, Antifungal | 50 % Hemolysis at 78 µM | Human | Halictus Sexcinctus Bee Venom | 30% TFE = α-Helix | NA | ||
| 30753486 | 2019 | GKWMKLLKKILK{ct:Amid} | peptide I | Amidation | Free | Linear | L | None | 12 | Antibiofilm, Antifungal | 50 % Hemolysis at 339 µM | Human | Analogs Of Hal-2 | 30% TFE = α-Helix | NA | ||
| 30753486 | 2019 | GKWMKLL{d}KKILK{ct:Amid} | peptide VIII | Amidation | Free | Linear | Mix | None | 12 | Antibiofilm, Antifungal | 50 % Hemolysis at 400 µM | Human | Modified Hal-2 | 30% TFE = α-Helix | NA | ||
| 31016971 | 2019 | LLGDFFRKSKEKIGKEFKRI | Fragment LL-20 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 10 µM | Human | Fragment Of Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 30127331 | 2019 | FLPFFAACAITRKC{ct:Amid} | Amurin-9KY | Amidation | Free | Linear | L | C8-C14 = heptapeptide ring | 14 | Antibacterial | 2 % Hemolysis at 100 μg/mL | Human | Frog Rana Kunyuensis China | water = Random coil, 50% TFE-water = α-Helix | Non-hemolytic | ||
| 30127331 | 2019 | FLPFFAACAITRKC{ct:Amid} | Amurin-9KY1 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 15.4 % Hemolysis at 100 μg/mL | Human | Derived From Amurin-9Ky | NA | NA | ||
| 30127331 | 2019 | FLPFFAACAITRKC{ct:heptapeptide ring C8-C14} | Amurin-9KY2 | heptapeptide ring C8-C14 | Free | Linear | L | None | 14 | NA | 17.9 % Hemolysis at 100 μg/mL | Human | Derived From Amurin-9Ky | NA | NA | ||
| 30127331 | 2019 | FLPFFAACAITRKC | Amurin-9KY3 | Free | Free | Linear | L | None | 14 | NA | 20.8 % Hemolysis at 100 μg/mL | Human | Derived From Amurin-9Ky | NA | NA | ||
| 30919848 | 2019 | GKKLGLWLGLKKG{ct:Amid} | F1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | KKLLGWGLLKK{ct:Amid} | F2 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = unordered conformations | Non-hemolytic | ||
| 30919848 | 2019 | KKLGLWLGLKK{ct:Amid} | F4 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | GKKLLWLLKKG{ct:Amid} | F5 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | LKGKLWLKGKL{ct:Amid} | F6 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | KLLGKWKGLLK{ct:Amid} | F7 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30919848 | 2019 | KKLLKGLLKGW{ct:Amid} | F8 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30919848 | 2019 | KKIGIWIGIKK{ct:Amid} | F9 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | RRLGLWLGLRR{ct:Amid} | F10 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | KKLTLWLTLKK{ct:Amid} | F11 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | KKLGLCLGLKK{ct:Amid} | F12 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 31159194 | 2019 | CYGRKKRRQRR | Tat | Free | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 5.5) | Human | Cell Penetrating Cargo Delivery Peptides | NA | NA | ||
| 31159194 | 2019 | CRQIKIWFQNRRMKWKK | Penetratin | Free | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 5.5) | Human | Cell Penetrating Cargo Delivery Peptides | NA | NA | ||
| 31159194 | 2019 | CYGRKKRRQRR | Tat | Free | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 7.4) | Human | Cell Penetrating Cargo Delivery Peptides | NA | NA | ||
| 31159194 | 2019 | CRQIKIWFQNRRMKWKK | Penetratin | Free | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 7.4) | Human | Cell Penetrating Cargo Delivery Peptides | NA | NA | ||
| 31001677 | 2019 | GKPRPYSPRPTSHPRPIRV | Drosocin | Free | Free | Linear | L | None | 19 | Antiparasitic | <20 % Hemolysis at 100 μM | Mouse | Drosophila Melanogaster | NA | NA | ||
| 31001677 | 2019 | GKPRPYSPRPTSHPRPIRV | Drosocin | Free | Free | Linear | L | None | 19 | Antiparasitic | <20 % Hemolysis at 100 μM | Pig | Drosophila Melanogaster | low hemolytic | NA | ||
| 31199859 | 2019 | FIGAIARLLSKIF | BmKn-2 | Free | Free | Linear | L | None | 13 | Antimicrobial, Anticancer, Antibiofilm | 100 % Hemolysis at 800 μM | Sheep | Scorpion Mesobuthus Martensii Karsch | α-Helix | NA | ||
| 31199859 | 2019 | FIGAIARLLSKI | BmKn-21 | Free | Free | Linear | L | None | 12 | Antibiofilm, Antibacterial | 100 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | NA | ||
| 31199859 | 2019 | FIGAIARLLSK | BmKn-22 | Free | Free | Linear | L | None | 11 | Antibiofilm, Antibacterial | 10 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | Low hemolytic | ||
| 31199859 | 2019 | FIGAIARLLS | BmKn-23 | Free | Free | Linear | L | None | 10 | Antibiofilm, Antibacterial | 5 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | Non-hemolytic | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAAL{ct:Amid} | RPb | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 178 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAAL{ct:Amid} | RPb | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 20 % Hemolysis at 64 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 30927490 | 2019 | ACYCRIPACIAGERR | HNP‐F | Free | Free | Linear | L | None | 15 | Hemostatic drug | 8.2 % Hemolysis at 5 μM | Mouse | Anterior‐Half Fragment Of Hnp | NA | NA | ||
| 30927490 | 2019 | YGTCIYQGRLWAFCC | HNP‐R | Free | Free | Linear | L | None | 15 | Antimicrobial | 9.9 % Hemolysis at 5 μM | Mouse | D Posterior‐Half Fragment Of Hnp | NA | NA | ||
| 30927490 | 2019 | ACYCRIPACIAGERR | HNP‐F | Free | Free | Linear | L | None | 15 | Hemostatic drug | 8.8 % Hemolysis at 500 μM | Mouse | Anterior‐Half Fragment Of Hnp | NA | Low hemolytic | ||
| 30927490 | 2019 | YGTCIYQGRLWAFCC | HNP‐R | Free | Free | Linear | L | None | 15 | Antimicrobial | 8.4 % Hemolysis at 500 μM | Mouse | D Posterior‐Half Fragment Of Hnp | NA | Low hemolytic | ||
| 30927490 | 2019 | ACYCRIPACIAGERR | HNP‐F | Free | Free | Linear | L | None | 15 | Hemostatic drug | 9.5 % Hemolysis at 5000 μM | Mouse | Anterior‐Half Fragment Of Hnp | NA | Low hemolytic | ||
| 30927490 | 2019 | YGTCIYQGRLWAFCC | HNP‐R | Free | Free | Linear | L | None | 15 | Antimicrobial | 9.2 % Hemolysis at 5000 μM | Mouse | D Posterior‐Half Fragment Of Hnp | NA | Low hemolytic | ||
| 32641937 | 2019 | CGAGHVPC-YY{d}({nnr:GABA})F{d}YG{cyc:1-8} | MccJ25-derived peptide | Free | Free | Cyclic | Mix | GABA = gamma amino butyric acid | 14 | Antibacterial | 0.26 ± 0.01 % Hemolysis at 200 μM | Human | Bacteria Enterobacteriacea Mccj25- Derived Peptide | β-Sheet | Non-hemolytic | ||
| 31087626 | 2019 | FVPWFSKFLGRIL{ct:Amid} | [Pro3]TL, 2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | >40 % Hemolysis at 3.12 μM | Sheep | Analogue Temporin L | PB =Random coil, DPC = α-Helix, SDS = α-Helix, DPC/SDS = α-Helix | NA | ||
| 31087626 | 2019 | FV{nnr:cis4-MeS-Pro}WFSKFLGRIL{ct:Amid} | peptide 6 | Amidation | Free | Linear | L | cis-4MeS-Pro = cis-4-Methylthio-L-Proline | 13 | Antimicrobial | >20 % Hemolysis at 3.12 μM | Sheep | Modification Of Proline In [Pro3]Tl | PB =β-Sheet, DPC = α-Helix, SDS = α-Helix, DPC/SDS = α-Helix | NA | ||
| 31087626 | 2019 | FV{nnr:cis4-NH2-Pro}WFSKFLGRIL{ct:Amid} | peptide 7 | Amidation | Free | Linear | L | cis-4NH2-Pro = cis-4-amino-L-Proline | 13 | Antimicrobial | >30 % Hemolysis at 50 μM | Sheep | Modification Of Proline In [Pro3]Tl | PB =Random coil, DPC = α-Helix, SDS = α-Helix, DPC/SDS = α-Helix | NA | ||
| 31087626 | 2019 | FV({nnr:cis-4PhO-Pro})WFSKFLGRIL{ct:Amid} | peptide 11 | Amidation | Free | Linear | L | cis-4PhO-Pro = cis-4-Phenoxy-L-Proline | 13 | Antimicrobial | >40 % Hemolysis at 3.12 μM | Sheep | Modification Of Proline In [Pro3]Tl | PB =Random coil, DPC = α-Helix, SDS = α-Helix, DPC/SDS = α-Helix | NA | ||
| 31016969 | 2019 | KKLRLKIAFK | PaDBS1R6F10 | Free | Free | Linear | L | None | 10 | Antibiofilm, Antibacterial, Anti-infective | 50 % Hemolysis at >100 μM | Human | Derived From A Pyrobaculum Aerophilum Ribosomal Protein | NA | Low hemolytic | ||
| 31145591 | 2019 | RWKRHISEQLRRRDRLQR | K17 | Free | Free | Linear | L | None | 18 | Antibacterial | >1 % Hemolysis at 500 μM | Mouse | Synthetic Amp | NA | Non-hemolytic | ||
| 31409990 | 2019 | ILPWKWPWWPWRR{ct:Amid} | indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antifungal | 20 % Hemolysis at 50 µg/mL | Human | Host Defense Peptides (Hdps) | NA | NA | ||
| 31409990 | 2019 | ILPWKWPWWPWRR{ct:Amid} | indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antifungal | 1 % Hemolysis at 0.78 µg/mL | Human | Host Defense Peptides (Hdps) | NA | NA | ||
| 31363941 | 2019 | KWKKLLKKPLLKKLLKKL{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilms | 14 % Hemolysis at 100 μM | mouse | Cecropin A-Magainin 2 Hybrid Analog Peptide | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | NA | ||
| 31363941 | 2019 | KWKKLLKKPLLKKLLK{ct:Amid} | P5-CT1 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | Non-hemolytic | ||
| 31363941 | 2019 | KWKKLLKKPLLKKL{ct:Amid} | P5-CT2 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = Random coil, LTA and LPS = Random coil | Non-hemolytic | ||
| 31363941 | 2019 | KWKKLLKKPLLK{ct:Amid} | P5-CT3 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = Random coil, LTA and LPS = Random coil | Non-hemolytic | ||
| 31363941 | 2019 | KKLLKKPLLKKLLKKL{ct:Amid} | P5-NT1 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | Non-hemolytic | ||
| 31363941 | 2019 | LLKKPLLKKLLKKL{ct:Amid} | P5-NT2 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | Non-hemolytic | ||
| 31363941 | 2019 | KKPLLKKLLKKL{ct:Amid} | P5-NT3 | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | Non-hemolytic | ||
| 31059203 | 2019 | KWLRRVWRWWR{ct:Amid} | MAP-0403 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 70.7 % Hemolysis at 100 μM | Human | Synthetic Amp | α-Helix | NA | ||
| 31059203 | 2019 | KWLRWVRRRWW{ct:Amid} | J-1 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 46.2 % Hemolysis at 100 μM | Human | Map-0403 Peptide Analogs | SDS = β-Sheet | NA | ||
| 31059203 | 2019 | KWLRRPWRRWR{ct:Amid} | J-2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 3.4 % Hemolysis at 100 μM | Human | Map-0403 Peptide Analogs | SDS = Random coil | Low hemolytic | ||
| 31059203 | 2019 | KWLRRPWRWWR{ct:Amid} | J-3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 55.6 % Hemolysis at 100 μM | Human | Map-0403 Peptide Analogs | SDS = Random coil | NA | ||
| 31375699 | 2019 | KIFKKFKTIIKKVWRIFGRF | AmphiArc2 | Free | Free | Linear | L | None | 20 | Anticancer | 50 % Hemolysis at >15 μM | Human | Synthetic Peptide | water = unstructured, hydrophobic environment (in 50% v/v water:2,2-trifuoroethanol, TFE) = α-Helix | NA | ||
| 31359624 | 2019 | GIIAGIIIKIKK{ct:Amid} | zp3 | Amidation | Free | Linear | L | None | 12 | Antibacterial | <5 % Hemolysis at 256 μM | Rat | Derived From Phenol-Soluble Modulins (Psms) Virulent Staphylococcus Aureus Strains | water = Random coil, SDS = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.2 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 61 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.1 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.6 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 89.6 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 40.2 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 23.5 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 256 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 58.8 % Hemolysis at 256 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 23.2 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 49.3 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 11.9 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 15.4 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 128 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 19.2 % Hemolysis at 128 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 6.6 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.7 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 16.1 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 2.9 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 12 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 64 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 4.5 % Hemolysis at 64 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.5 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 3.4 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 5.5 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.4 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 6.5 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 32 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.5 % Hemolysis at 32 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 1.2 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 16 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.4 % Hemolysis at 16 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.2 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.4 % Hemolysis at 8 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.4 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.2 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.5 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.2 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.5 % Hemolysis at 4 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 4 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.6 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.6 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.6 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 17.4 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | NA | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.6 % Hemolysis at 2 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 2 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | ALFDIIKKIAESF{ct:Amid} | G1A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GAFDIIKKIAESF{ct:Amid} | L2A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLADIIKKIAESF{ct:Amid} | F3A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFAIIKKIAESF{ct:Amid} | D4A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.2 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDAIKKIAESF{ct:Amid} | I5A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.2 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIAKKIAESF{ct:Amid} | I6A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.4 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIAKIAESF{ct:Amid} | K7A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.2 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKAIAESF{ct:Amid} | K8A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKAAESF{ct:Amid} | I9A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.6 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAASF{ct:Amid} | E11A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.1 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAEAF{ct:Amid} | S12A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | SDS or DPC = α-Helix | Non-hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESA{ct:Amid} | F13A | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0.3 % Hemolysis at 1 µg/ml | Human | Synthetic Analogs Of Aurein 1.2 | phosphate buffer = Random coil, SDS or DPC = α-Helix | Low hemolytic | ||
| 30569430 | 2019 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 1 µg/ml | Human | Australian Bell Frogs Ranoidea Aurea And Ranoidea Raniformis | phosphate buffer = Random coil, SDS or DPC = α-Helix | Non-hemolytic | ||
| 31062442 | 2019 | LKKLLKLLKKLLKL{ct:Amid} | LK | Amidation | Free | Linear | L | None | 14 | Antitumor | 60 % Hemolysis at 200 μM | Mouse | Synthetic Cell‐Penetrating Peptides (Cpps) | TFE/water(pH = 7.4, pH = 6) = α-Helix | NA | ||
| 31062442 | 2019 | LHHLLHHLHHLLHH{ct:Amid} | LH | Amidation | Free | Linear | L | None | 14 | Antitumor | 0 % Hemolysis at 200 μM | Mouse | Synthetic Cell‐Penetrating Peptides (Cpps) | TFE/water(pH = 7.4, pH = 6) = α-Helix | Non-hemolytic | ||
| 31291603 | 2019 | RIVELTLPRVSVRL{ct:Amid} | CF-14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <5 % Hemolysis at 500 µg/ml | Sheep | Catfish Skin Mucus Of Pelteobagrus Fulvidraco | PBS buffer = Random coil, membrane-mimetic 2.5% SDS micelle = α-Helix | Non-hemolytic | ||
| 31319057 | 2019 | GFKRIVQRIKDFLRNLV{ct:Amid} | GF-17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 180 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17tF-W | Amidation | Free | Linear | Mix | X1 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 12.1 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17mF-W | Amidation | Free | Linear | Mix | X1 = 4-methylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 7.1 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | Low hemolytic | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17W2 | Amidation | Free | Linear | Mix | X1 = 4-methylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 8 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | Low hemolytic | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17tF2 | Amidation | Free | Linear | Mix | X1 = 4-t-butylphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 32.5 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17B-tF | Amidation | Free | Linear | Mix | X1 = biphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 30.2 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KD {nnr:X2}L{d}RKLV{ct:Amid} | 17BIPHE2 | Amidation | Free | Linear | Mix | X1 = biphenylalanine, X2 = biphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 61.5 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17tF-W | Amidation | Free | Linear | Mix | X1 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17mF-W | Amidation | Free | Linear | Mix | X1 = 4-methylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17W2 | Amidation | Free | Linear | Mix | X1 = 4-methylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17tF2 | Amidation | Free | Linear | Mix | X1 = 4-t-butylphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17B-tF | Amidation | Free | Linear | Mix | X1 = biphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KD {nnr:X2}L{d}RKLV{ct:Amid} | 17BIPHE2 | Amidation | Free | Linear | Mix | X1 = biphenylalanine, X2 = biphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 180 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31448597 | 2019 | KWKLFKKIGAVLKVL{ct:Amid} | CM15 | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 40 ± 5 % Hemolysis at 2 μM | mouse | Derived From Citropin1.1 | α-Helix | NA | ||
| 31448597 | 2019 | GGHKWKLFKKIGAVLKVL{ct:Amid} | GGH-CM15 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 29 ± 2 % Hemolysis at 2 μM | mouse | Variant Of Cm15 | α-Helix | NA | ||
| 31448597 | 2019 | VIHKWKLFKKIGAVLKVL{ct:Amid} | VIH-CM15 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 29 ± 3 % Hemolysis at 1 μM | mouse | Variant Of Cm15 | α-Helix | NA | ||
| 31448597 | 2019 | GLFDVIKKVASVIGGL{ct:Amid} | citropin1.1 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antibiofilm | 16.5 ± 3 % Hemolysis at 10 μM | mouse | Tree Frog Of The Litora Genus | α-Helix | NA | ||
| 31448597 | 2019 | GGHGLFDVIKKVASVIGGL{ct:Amid} | GGH-citropin1.1 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm | 0.2 ± 0.05 % Hemolysis at 34 μM | mouse | Modified Citropin1.1 | α-Helix | Non-hemolytic | ||
| 31448597 | 2019 | VIHGLFDVIKKVASVIGGL{ct:Amid} | VIH-citropin1.1 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm | 0.9 ± 0.1 % Hemolysis at >33 μM | mouse | Modified Citropin1.1 | α-Helix | Non-hemolytic | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 29.12 % Hemolysis at 1 M | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | NA | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 25.14 % Hemolysis at 500 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | NA | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 250 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | Non-hemolytic | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 125 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | Non-hemolytic | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 32 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | Non-hemolytic | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 16 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | Non-hemolytic | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 8 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | Non-hemolytic | ||
| 31541146 | 2019 | VAEARQGSFSY | Pinipesin | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 4 μM | Human | Centipede Scolopendra Subspinipes Subspinipes | water = Helix, 50% TFE/water = type II β-Turn | Non-hemolytic | ||
| 31448889 | 2019 | KIKKIIKKIIKI{ct:Amid} | A1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 5 % Hemolysis at 4000 μM | Human | Synthetic Surfactant-Like Cationic Amps | α-Helical | Low hemolytic | ||
| 31448889 | 2019 | GIVKOIVKOIVKOI{ct:Amid} | A2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 4000 μM | Human | Synthetic Surfactant-Like Cationic Amps | α-Helical | Low hemolytic | ||
| 31448889 | 2019 | GIVKKIVKKIVKKI{ct:Amid} | A3 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 1500 μM | Human | Synthetic Surfactant-Like Cationic Amps | α-Helical | Low hemolytic | ||
| 31448889 | 2019 | GIIKKIIKKIIKKI | A4 | Free | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 2000 μM | Human | Synthetic Surfactant-Like Cationic Amps | α-Helical | Low hemolytic | ||
| 31448889 | 2019 | GIIKKIIKKIIKKI{ct:Amid} | A5 (G3) | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 900 μM | Human | Synthetic Surfactant-Like Cationic Amps | α-Helical | Low hemolytic | ||
| 31448889 | 2019 | GILKKILKKILKKL{ct:Amid} | A6 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 80 μM | Human | Synthetic Surfactant-Like Cationic Amps | α-Helical | NA | ||
| 31207076 | 2019 | LRWWLWKLLRRMR{ct:Amid} | LR-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm, | 0 % Hemolysis at 3.3 μM(PBS) | Rabbit | Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,) | NA | Non-hemolytic | ||
| 31207076 | 2019 | LRWWLWKLLRRMR{ct:Amid} | LR-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm, | 0 % Hemolysis at 3.3 μM(IGF) | Rabbit | Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,) | NA | Non-hemolytic | ||
| 31207076 | 2019 | LRWWLWKLLRRMR{ct:Amid} | LR-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm, | >80 % Hemolysis at 52.3 μM(PBS) | Rabbit | Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,) | NA | NA | ||
| 31207076 | 2019 | LRWWLWKLLRRMR{ct:Amid} | LR-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm, | 100 % Hemolysis at 52.3 μM(IGF) | Rabbit | Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,) | NA | NA | ||
| 31513374 | 2019 | CFQWKRAMRKVR{ct:Amid} | HLopt2-NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 µg/ml | Human | Antimicrobial Analogue | NA | Non-hemolytic | ||
| 31513374 | 2019 | {conj:CIP-CH2CO}CFQWKRAMRKVR{ct:Amid} | CIP-CH2CO-HLopt2-NH2 | Amidation | CIP-CH2CO | Linear | L | Cip = ciprofloxacin | 12 | Antibacterial | 0 % Hemolysis at 200 µg/ml | Human | Hlopt2 With Conjugate | NA | Non-hemolytic | ||
| 31513374 | 2019 | {conj:CIP-Cys-S-S}CFQWKRAMRKVR{ct:Amid} | CIP-Cys-S-S-HLopt2-NH2 | Amidation | CIP-Cys-S-S | Linear | L | Cip = ciprofloxacin | 13 | Antibacterial | 0 % Hemolysis at 200 µg/ml | Human | Hlopt2 With Conjugate | NA | Non-hemolytic | ||
| 31513374 | 2019 | {conj:LVX}CFQWKRAMRKVR{ct:Amid} | LVX-HLopt2-NH2 | Amidation | LVX | Linear | L | Lvx = levofloxacin | 12 | Antibacterial | 0 % Hemolysis at 200 µg/ml | Human | Hlopt2 With Conjugate | NA | Non-hemolytic | ||
| 31653005 | 2019 | ALWKSILKNVGKAAGKAVL{ct:Amid} | DMPC-19 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 256 μM | Horse | Dm-Pc Designed Truncated Derivatives | aqueous = Random coil, 50% TFE buffer = Helical | Low hemolytic | ||
| 31653005 | 2019 | ALWKKLLKKA{ct:Amid} | DMPC-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <5 % Hemolysis at 256 μM | Horse | Dm-Pc Designed Truncated Derivatives | aqueous = Random coil, 50% TFE buffer = Helical | Low hemolytic | ||
| 31653005 | 2019 | ALWKKLLKK-{nnr:Cha}{ct:Amid} | DMPC-10A | Amidation | Free | Linear | L | Cha = cyclohexylalanine | 10 | Antimicrobial | >35 % Hemolysis at 256 μM | Horse | Dm-Pc Designed Truncated Derivatives | aqueous = Random coil, 50% TFE buffer = Helical | NA | ||
| 31749789 | 2019 | RLCRIVVIRVCR{ct:Amid} | L2C3V10C11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 64 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Low hemolytic | ||
| 31749789 | 2019 | RRFRIVVIRWLR{ct:Amid} | R2F3W10L11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 128 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Low hemolytic | ||
| 31749789 | 2019 | RRWRIVVIRWRR{ct:Amid} | R2W3W10R11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 128 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Low hemolytic | ||
| 31749789 | 2019 | RKWRIVVIRVRR{ct:Amid} | K2W3V10R11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Non-hemolytic | ||
| 31749789 | 2019 | RWRRIVVIRVRR{ct:Amid} | W2R3V10R11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Non-hemolytic | ||
| 31749789 | 2019 | RWKRIVVIRKRR{ct:Amid} | W2K3K10R11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Non-hemolytic | ||
| 31749789 | 2019 | RKRRIVVIRRKR{ct:Amid} | K2R3R10K11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Non-hemolytic | ||
| 31710627 | 2019 | FPFLLSLIPSAISAIKRL{ct:Amid} | Uy234 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 26.18 % Hemolysis at 380 μM | Human | Scorpion Urodacus Yaschenkoi | α-Helix | Low hemolytic | ||
| 31710627 | 2019 | ILSAIWSGIKGLL{ct:Amid} | Uy17 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 25 % Hemolysis at >380 μM | Human | Scorpion Urodacus Yaschenkoi | α-Helix | Low hemolytic | ||
| 31710627 | 2019 | FLSTIWNGIKGLL{ct:Amid} | Uy192 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 25 % Hemolysis at >380 μM | Human | Scorpion Urodacus Yaschenkoi | α-Helix | Low hemolytic | ||
| 31710627 | 2019 | FFSLIPSLISGLI{ct:Amid} | QnCs-BUAP | Amidation | Free | Linear | L | None | 13 | Antibacterial | 25 % Hemolysis at >380 μM | Human | Synthetic Peptide From Conserved Region | α-Helix | Low hemolytic | ||
| 31674183 | 2019 | {nnr:Dhb}-L{nnr:O}I{nnr:V}{nnr:V}K{nnr:V}{nnr:V}KYL{nt:FA = Fatty acid}{ct:Valinol} | brevibacillin V | Valinol | FA = Fatty acid | Linear | L | O = Ornithine, V = Valinol, FA = Fatty acid, Dhb = dehydrobutyrine | 13 | Antimicrobial | <8 % Hemolysis at 512 µg/ml | Sheep | Brevibacillus Laterosporus Fmb70 | NA | Low hemolytic | ||
| 31674183 | 2019 | {nnr:Dhb}-L{nnr:O}II{nnr:V}K{nnr:V}{nnr:V}KYL{nt:FA = Fatty acid}{ct:Valinol} | brevibacillin | Valinol | FA = Fatty acid | Linear | L | O = Ornithine, V = Valinol, FA = Fatty acid, Dhb = dehydrobutyrine | 13 | Antimicrobial | <8 % Hemolysis at 512 µg/ml | Sheep | Brevibacillus Laterosporus Osy-I1 Lipotridecapeptide | NA | Low hemolytic | ||
| 31752079 | 2019 | FLQHIIGALGHLF | GHa | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 20 µM | Human | Frog Hylarana Guentheri | α-Helix | NA | ||
| 31752079 | 2019 | FLQKIIGALGKLF | GHaK | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 16 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQKIIGALGHLF | GHa4K | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 26 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQHIIGALGKLF | GHa11K | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 15 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQHIIGALGHLF | GHa | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 115 µM | Human | Frog Hylarana Guentheri | α-Helix | NA | ||
| 31752079 | 2019 | FLQKIIGALGKLF | GHaK | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 66 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQKIIGALGHLF | GHa4K | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 69 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQHIIGALGKLF | GHa11K | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 40 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31667994 | 2019 | GIGKFLHSAKKFGKAFV{nt:H}{ct:Amid} | peptide-7 | Amidation | H | Linear | L | None | 17 | Antibacterial | Hemolysis at >100 µM | Human | Truncated Peptide | 1%SDS = Random coil | NA | ||
| 31667994 | 2019 | GIKKFLKSAKKFVKAFK{nt:H}{ct:Amid} | peptide-8 | Amidation | H | Linear | L | None | 17 | Antibacterial | Hemolysis at 50 µM | Human | Truncated Peptide | 1%SDS = α-Helix | NA | ||
| 31667994 | 2019 | GIGKFLHS{nnr:U}KKFGK{nnr:U}FV{nt:H}{ct:Amid} | peptide-9 | Amidation | H | Linear | L | U = Aib(2-aminoisobutyric acid) | 17 | Antibacterial | Hemolysis at >100 µM | Human | Truncated Peptide | 1%SDS = α-Helix | NA | ||
| 31667994 | 2019 | GIGKFLHS{nnr:Z}KKFGK{nnr:Z}FV{nt:H}{ct:Amid} | peptide-10 | Amidation | H | Linear | L | Z = Ac6c(1-aminocyclohexylcarboxylic acid) | 17 | Antibacterial | Hemolysis at 3 µM | Human | Truncated Peptide | NA | NA | ||
| 31667994 | 2019 | GIKKFLKS{nnr:U}KKFVK{nnr:U}FK{nt:H}{ct:Amid} | peptide-11 | Amidation | H | Linear | L | U = Aib(2-aminoisobutyric acid) | 17 | Antibacterial | Hemolysis at 50 µM | Human | Truncated Peptide | 1%SDS = Helical | NA | ||
| 31667994 | 2019 | GIKKFLKS{nnr:Z}KKFVK{nnr:Z}FK{nt:H}{ct:Amid} | peptide-12 | Amidation | H | Linear | L | Z = Ac6c(1-aminocyclohexylcarboxylic acid) | 17 | Antibacterial | Hemolysis at 3 µM | Human | Truncated Peptide | 1%SDS = Helical | NA | ||
| 31775224 | 2019 | IRIRPIRIRP{cyc:N-C} | OIR2 | Free | Free | Cyclic | L | None | 10 | Antibacterial | ≥5 % Hemolysis at >128 µM | Human | Synthetic Cyclic Amps | aqueous = unordered, β-Hairpin | Low hemolytic | ||
| 31775224 | 2019 | IRIRIRPIRIRIRP{cyc:N-C} | OIR3 | Free | Free | Cyclic | L | None | 14 | Antibacterial, Anti-Inflammatory | ≥5 % Hemolysis at >128 µM | Human | Synthetic Cyclic Amps | aqueous = unordered, β-Hairpin | Low hemolytic | ||
| 31775224 | 2019 | IRIRPIRIRP | IR2 | Free | Free | Linear | L | None | 10 | Antibacterial | ≥5 % Hemolysis at >128 µM | Human | Synthetic Linear Amps | aqueous = unordered, 30 mM anionic = unordered | Low hemolytic | ||
| 31775224 | 2019 | IRIRIRPIRIRIRP | IR3 | Free | Free | Linear | L | None | 14 | Antibacterial, Anti-Inflammatory | ≥5 % Hemolysis at >128 µM | Human | Synthetic Linear Amps | aqueous = unordered, 30 mM anionic = unordered | Low hemolytic | ||
| 31775224 | 2019 | IRIRP{d}IRIRP{d} | DIR2 | Free | Free | Linear | Mix | p = D-Proline | 10 | Antibacterial | ≥5 % Hemolysis at >128 µM | Human | Synthetic D-Proline Amps | aqueous = unordered, 50% TFE = β-Sheet | Low hemolytic | ||
| 31775224 | 2019 | IRIRIRP{d}IRIRIRP{d} | DIR3 | Free | Free | Linear | Mix | p = D-Proline | 14 | Antibacterial, Anti-Inflammatory | ≥5 % Hemolysis at >128 µM | Human | Synthetic D-Proline Amps | aqueous = unordered, 50% TFE = β-Hairpin | Low hemolytic | ||
| 31442359 | 2019 | WLKAAAKAAAKLW{ct:Amid} | WL | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at 256 µM | Human | Synthetic Peptide | 30 mM SDS or 50% TFE = α‐Helix | Low hemolytic | ||
| 31442359 | 2019 | LWKAAAKAAAKWL{ct:Amid} | LW | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | 30 mM SDS or 50% TFE = α‐Helix | Low hemolytic | ||
| 31442359 | 2019 | LWKAAAKAAAKLL{ct:Amid} | LW-1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at 256 µM | Human | Synthetic Peptide | 30 mM SDS or 50% TFE = α‐Helix | Low hemolytic | ||
| 31442359 | 2019 | LWKAAAKAAAKLW{ct:Amid} | LW-2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at 256 µM | Human | Synthetic Peptide | 30 mM SDS or 50% TFE = α‐Helix | Low hemolytic | ||
| 31442359 | 2019 | AAKAWLKLWAKAA{ct:Amid} | LW-3 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | 30 mM SDS or 50% TFE = α‐Helix | Low hemolytic | ||
| 31520928 | 2019 | YEIKINRHFKTLKKNLKK{ct:Amid} | H5 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | Bighead Carp Aristicluthys Nobilia Ifn-I | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKINRHFKTLKKNLKK{ct:Amid} | P1 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKTLNKNLKK{ct:Amid} | P2 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKLNKNLKK{ct:Amid} | P3 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YFRTIRRFFKKLFKTLKK{ct:Amid} | P4 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 640 µg/ml | Murine | H5-Derived Peptides | MME = α‐Helical | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKLKKILKK{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 10 % Hemolysis at 640 µg/ml | Murine | H5-Derived Peptides | Helical | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKRFKFRKK{ct:Amid} | P6 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | WVRKVRRWWKKVKKVVKK{ct:Amid} | P7 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 80.04 ± 7.2 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | NA | ||
| 31520928 | 2019 | SYEIKINRHFKTLKKNLKKK{ct:Amid} | P8 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | SYERKINRHFKTLKKNLKKK{ct:Amid} | P9 | Amidation | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | WYERLINRKFKWLKGRLSKK{ct:Amid} | P10 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 178.82 ± 12.6 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | NA | ||
| 31520928 | 2019 | LYKRYILRKFKFLKKKLKKK{ct:Amid} | P11 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | VWKRWVVRKWKWVKKKVKKK{ct:Amid} | P12 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 57.24 ± 5.2 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | NA | ||
| 31520928 | 2019 | YEIKINRHFKTLKKNLKK{ct:Amid} | H5 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | Bighead Carp Aristicluthys Nobilia Ifn-I | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKINRHFKTLKKNLKK{ct:Amid} | P1 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKTLNKNLKK{ct:Amid} | P2 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKLNKNLKK{ct:Amid} | P3 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YFRTIRRFFKKLFKTLKK{ct:Amid} | P4 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | MME = α‐Helical | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKLKKILKK{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | Helical | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKRFKFRKK{ct:Amid} | P6 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | WVRKVRRWWKKVKKVVKK{ct:Amid} | P7 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | Low hemolytic | ||
| 31520928 | 2019 | SYEIKINRHFKTLKKNLKKK{ct:Amid} | P8 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | SYERKINRHFKTLKKNLKKK{ct:Amid} | P9 | Amidation | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | WYERLINRKFKWLKGRLSKK{ct:Amid} | P10 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | Low hemolytic | ||
| 31520928 | 2019 | LYKRYILRKFKFLKKKLKKK{ct:Amid} | P11 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | VWKRWVVRKWKWVKKKVKKK{ct:Amid} | P12 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | Low hemolytic | ||
| 31642159 | 2019 | ILGKIWEGIKSLF{ct:Amid} | IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 6.25 mmol/L | Human | Scorpion Venom Opisthacanthus Madagascariensis | α-Helical | NA | ||
| 31642159 | 2019 | ILLKIWEGIKSLF{ct:Amid} | [L]3-IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 3.3 mmol/L | Human | Isct1 Analogs | α-Helical | NA | ||
| 31642159 | 2019 | ALGKFWEKIKSLF{ct:Amid} | [A]1[F]5[K]8-IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 25 μmol/L | Human | Isct1 Analogs | α-Helical | NA | ||
| 31642159 | 2019 | ILKKIWEGIKSLF{ct:Amid} | [K]3-IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 6.25 μmol/L | Human | Isct1 Analogs | α-Helical | NA | ||
| 31642159 | 2019 | ILGKFWEGIKSLF{ct:Amid} | [F]5-IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 6.25 mmol/L | Human | Isct1 Analogs | α-Helical | NA | ||
| 31642159 | 2019 | ILGKIWEPIKSLF{ct:Amid} | [P]8-IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 100 μmol/L | Human | Isct1 Analogs | α-Helical | Non-hemolytic | ||
| 31642159 | 2019 | WLGKIWEGIKSLF{ct:Amid} | [W]1-IsCT1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 0 % Hemolysis at 1.56 mmol/L | Human | Isct1 Analogs | α-Helical | NA | ||
| 31713951 | 2019 | IRGYKGGYCK{ct:Amid} | Os(3‐12)NH2 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 0 % Hemolysis at 25 µM | Human | Synthetic Peptide Analogues Of Os | water = unstructured, SDS = unstructured | Non-hemolytic | ||
| 31713951 | 2019 | CKGAFKQTCKCY{ct:Amid} | Os(11‐22)NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 µM | Human | Synthetic Peptide Analogues Of Os | water = Random coil, SDS = Random coil | Non-hemolytic | ||
| 31713951 | 2019 | IRGYKGGYCK{ct:Amid} | Os(3‐12)NH2 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Peptide Analogues Of Os | water = unstructured, SDS = unstructured | Non-hemolytic | ||
| 31713951 | 2019 | CKGAFKQTCKCY{ct:Amid} | Os(11‐22)NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Peptide Analogues Of Os | water = Random coil, SDS = Random coil | Non-hemolytic | ||
| 31827113 | 2019 | G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-IEI-{nnr:aIle}-S | M1 (or M) | Free | Free | Linear | Mix | dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid | 13 | Antibacterial | 10 % Hemolysis at 128 µg/ml | Rabbit | Tridecaptin M A Mud Bacterium, Paenibacillus Sp. M-152 | NA | Low hemolytic | ||
| 31827113 | 2019 | G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-IEVV{d}S | M2 | Free | Free | Linear | Mix | dab = D-2,4-diaminobutyric acid (D-Dab), Dab = 2,4-diaminobutyric acid | 13 | Antibacterial | 2 % Hemolysis at 128 µg/ml | Rabbit | Variants Of Tridecaptin M | NA | Non-hemolytic | ||
| 31827113 | 2019 | G-{nnr:dab}-GS{d}DFS-{nnr:Dab}-{nnr:dab}-IEIV{d}S | M5 | Free | Free | Linear | Mix | dab = D-2,4-diaminobutyric acid (D-Dab), Dab = 2,4-diaminobutyric acid | 13 | Antibacterial | 0 % Hemolysis at 128 µg/ml | Rabbit | Variants Of Tridecaptin M | NA | Non-hemolytic | ||
| 31827113 | 2019 | G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-IEIV{d}S | M6 | Free | Free | Linear | Mix | dab = D-2,4-diaminobutyric acid (D-Dab), Dab = 2,4-diaminobutyric acid | 13 | Antibacterial | >15 % Hemolysis at 128 µg/ml | Rabbit | Variants Of Tridecaptin M | NA | NA | ||
| 31827113 | 2019 | G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-VEI-{nnr:aIle}-S | M7 | Free | Free | Linear | Mix | dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid | 13 | Antibacterial | 1 % Hemolysis at 128 µg/ml | Rabbit | Variants Of Tridecaptin M | NA | Non-hemolytic | ||
| 31827113 | 2019 | G-{nnr:dab}-GS{d}DFS-{nnr:Dab}-{nnr:dab}-IEI-{nnr:aIle}-S | M8 | Free | Free | Linear | Mix | dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid | 13 | Antibacterial | >9 % Hemolysis at 128 µg/ml | Rabbit | Variants Of Tridecaptin M | NA | Low hemolytic | ||
| 31324383 | 2019 | IPHVYNSPSPIK{d}PNRL | SBH-IPH | Free | Free | Linear | L | None | 16 | ND = not detected | 1.3 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | AK{d}GITVIGAR | SBH-AKG | Free | Free | Linear | L | None | 10 | ND = not detected | 0 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | PSVIK{d}K{d}GISK{d} | SBH-PSV | Free | Free | Linear | L | None | 10 | ND = not detected | 2.46 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | NRVF{d}GALK{d}GAL | SBH-NRV | Free | Free | Linear | L | None | 11 | ND = not detected | 0.055 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | RTRGGF{d}MVSR | SBH-RTR | Free | Free | Linear | L | None | 10 | ND = not detected | 0.85 % Hemolysis at 1000 µM | Sheep | Soybean Alpha-Galactosidase | NA | Non-hemolytic | ||
| 31324383 | 2019 | LLILMK{d}VGNK{d}L | SBH-LLI | Free | Free | Linear | L | None | 11 | Antimicrobial | 1.8 % Hemolysis at 1000 µM | Sheep | Soybean Auxin Efflux Carrier Component | NA | Non-hemolytic | ||
| 31324383 | 2019 | LPRSF{d}SK{d}SK{d}K{d}K{d} | SBH-LPR | Free | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | F{d}RAPYIASLLR | SBH-FRA | Free | Free | Linear | L | None | 11 | Antimicrobial | 1.3 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | LPLRTRLLK{d}VL | SBH-LPL | Free | Free | Linear | L | None | 11 | Antimicrobial | 0.056 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | DRRPPPRRDVV | SBH-DRR | Free | Free | Linear | L | None | 11 | ND = not detected | 2.1 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | K{d}K{d}IQVIGK{d}ARVPI | SBH-KKI | Free | Free | Linear | L | None | 13 | ND = not detected | 1.9 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | K{d}AVK{d}K{d}RK{d}K{d}K{d}LAK{d}AK{d}K{d} | SBH-KAV | Free | Free | Linear | L | None | 15 | Antimicrobial | 0.44 % Hemolysis at 1000 µM | Sheep | Soybean Serine/Threonineprotein Kinase Rio1 | NA | Non-hemolytic | ||
| 31676352 | 2019 | GLLK{d}{conj:C4}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C4 | Amidation | Free | Linear | Mix | C4 = C4 | 10 | Antibacterial, | 10 % Hemolysis at >256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}{conj:C6}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C6 | Amidation | Free | Linear | Mix | C6 = C6 | 10 | Antibacterial | 10 % Hemolysis at >256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}{conj:C8}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C8 | Amidation | Free | Linear | Mix | C8 = C8 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}{conj:C10}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C10 | Amidation | Free | Linear | Mix | C10 = C10 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}{conj:C12}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C12 | Amidation | Free | Linear | Mix | C12 = C12 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 32 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLK{d}{conj:C14}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C14 | Amidation | Free | Linear | Mix | C14 = C14 | 10 | Antibacterial | 10 % Hemolysis at 32 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLK{d}{conj:C16}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C16 | Amidation | Free | Linear | Mix | C16 = C16 | 10 | Antibacterial | 10 % Hemolysis at 16 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C4}TLL{ct:Amid} | Ano-D4,7-7C4 | Amidation | Free | Linear | Mix | C4 = C4 | 10 | Antibacterial | 10 % Hemolysis at >256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C6}TLL{ct:Amid} | Ano-D4,7-7C6 | Amidation | Free | Linear | Mix | C6 = C6 | 10 | Antibacterial | 10 % Hemolysis at >256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C8}TLL{ct:Amid} | Ano-D4,7-7C8 | Amidation | Free | Linear | Mix | C8 = C8 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C10}TLL{ct:Amid} | Ano-D4,7-7C10 | Amidation | Free | Linear | Mix | C10 = C10 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 128 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C12}TLL{ct:Amid} | Ano-D4,7-7C12 | Amidation | Free | Linear | Mix | C12 = C12 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 32 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C14}TLL{ct:Amid} | Ano-D4,7-7C14 | Amidation | Free | Linear | Mix | C14 = C14 | 10 | Antibacterial | 10 % Hemolysis at 16 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C16}TLL{ct:Amid} | Ano-D4,7-7C16 | Amidation | Free | Linear | Mix | C16 = C16 | 10 | Antibacterial | 10 % Hemolysis at 16 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 µM | mouse | Venom Sac Of Solitary Spider Wasps | α-Helical | Low hemolytic | ||
| 30678611 | 2019 | FFTTSCRSGC | OA-FF10 | Free | Free | Linear | L | None | 10 | Promoted Wound healing and proliferation of human keratinocytes (HaCaT) | 0 % Hemolysis at 100 µM | Human | Frog Species, Odorrana Andersonii | NA | Non-hemolytic | ||
| 31938070 | 2020 | GIGKFLKKAKKFGK | MSI-78 | Free | Free | Linear | L | None | 14 | Antibacterial | 50 % Hemolysis at >400 µM | Sheep | Derived From The Magainin 2 Peptide | α-Helix | Low hemolytic | ||
| 31938070 | 2020 | GIWKFLKKAKKFWK | MSI-1 | Free | Free | Linear | L | None | 14 | Antibacterial | 50 % Hemolysis at >400 µM | Sheep | Msi-78 Analogs | SDS = α-Helix | Low hemolytic | ||
| 31938070 | 2020 | GIWKFLKKAKKFW | MSI-3 | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >400 µM | Sheep | Msi-78 Analogs | Helical | Low hemolytic | ||
| 31938070 | 2020 | WIRKFLKRVKKFG | MSI-4 | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >400 µM | Sheep | Msi-78 Analogs | Helical | Low hemolytic | ||
| 31887002 | 2020 | LKKLCARLKKLCAR{ct:Amid} | CAR2 | Amidation | Free | Linear | L | None | 14 | Antifungal, Antibacterial | 10 % Hemolysis at >128 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical | Low hemolytic | ||
| 31887002 | 2020 | LKKLACRLKKLACR{ct:Amid} | ACR2 | Amidation | Free | Linear | L | None | 14 | Antifungal, Antibacterial | 10 % Hemolysis at >128 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical | Low hemolytic | ||
| 31483516 | 2020 | VGGTICGPACAVAGAHYLPI | 1 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | low helicity, Random coil | Low hemolytic | ||
| 31483516 | 2020 | GWFKTYKDWPVIISNVPGVI | 2 | Free | Free | Linear | L | None | 20 | Antibacterial | increased % Hemolysis at 128 μM | Sheep | Synthetic Peptide | low helicity, Random coil | NA | ||
| 31483516 | 2020 | IKKIGKKAAKKVIVKAIQAI | 3 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 31483516 | 2020 | KKIGKKAAKKVIVKAIQAIV | 4 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 31483516 | 2020 | FLGEWLFVTRKAKRKHKHAA | 5 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | VKFAIKKIGKKAAKKVIVKA | 6 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | SFLGEWLFVTRKAKRKHKHA | 7 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | QAAKKMSNKEKAAKRWIAMR | 8 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | AKAIVRTIEQAPKTAKAKKS | 9 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | EVVPKVKKHFKDKENKKKLF | 10 | Free | Free | Linear | L | None | 20 | Antibacterial | increased % Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | NA | ||
| 31483516 | 2020 | KKIAIITKNLKNFFIMLNII | 11 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | β-Sheet | Low hemolytic | ||
| 31483516 | 2020 | KKSINSLHLAMLKKQRLNRD | 12 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | LLLGIKYKKIGANNFREVKK | 13 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | FMKKIVKIGKIARYSHKAKK | 14 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | LFRKKRHHWFVRTKNSLSKN | 15 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | VNHGYRKVTLTKTVRIKKFM | 16 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | low helicity, Random coil | Low hemolytic | ||
| 31778756 | 2020 | RIVQRIKKWLLKWKKLGY | peptide 5 | Free | Free | Linear | L | None | 18 | Antibiofilm, Antibacterial | <10 % Hemolysis at 1024 μg/ml | mouse | Synthetic Peptide | SDS = α-Helix | Low hemolytic | ||
| 31778756 | 2020 | GLLRKWGKKWKEFLRRVWK | peptide 6.2 | Free | Free | Linear | L | None | 19 | Antibiofilm, Antibacterial | <5 % Hemolysis at 128 μg/ml | mouse | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 31778756 | 2020 | GLLRKWGKKWKEFLRRVWK | peptide 6.2 | Free | Free | Linear | L | None | 19 | Antibiofilm, Antibacterial | 30 % Hemolysis at 1024 μg/ml | mouse | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 31802582 | 2020 | GWWRRTVDKVRNAGRK{ct:-OH} | P2-HC(1‐16) | -OH | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVRNAGRK{ct:Amid} | P3-HC(1‐16)A8 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Low hemolytic | ||
| 31802582 | 2020 | AWWRRTVAKVRK{ct:Amid} | P8-G1A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 1.6 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Low hemolytic | ||
| 31802582 | 2020 | GAWRRTVAKVRK{ct:Amid} | P9-W2A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWARRTVAKVRK{ct:Amid} | P10-W3A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWARTVAKVRK{ct:Amid} | P11-R4A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 3.6 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Low hemolytic | ||
| 31802582 | 2020 | GWWRATVAKVRK{ct:Amid} | P12-R5A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRAVAKVRK{ct:Amid} | P13-T6A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 4.1 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Low hemolytic | ||
| 31802582 | 2020 | GWWRRTAAKVRK{ct:Amid} | P14-V7A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVRK{ct:Amid} | P6-HC(1‐12)A8K12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 25.1 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | α‐‐Helical | NA | ||
| 31802582 | 2020 | GWWRRTVAAVRK{ct:Amid} | P15-K9A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5.1 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Low hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKARK{ct:Amid} | P16-V10A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 1 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVAK{ct:Amid} | P17-R11A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVRA{ct:Amid} | P18-K12A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVDKVRNAGRK{ct:-OH} | P2-HC(1‐16) | -OH | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVRNAGRK{ct:Amid} | P3-HC(1‐16)A8 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | AWWRRTVAKVRK{ct:Amid} | P8-G1A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GAWRRTVAKVRK{ct:Amid} | P9-W2A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWARRTVAKVRK{ct:Amid} | P10-W3A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWARTVAKVRK{ct:Amid} | P11-R4A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRATVAKVRK{ct:Amid} | P12-R5A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRAVAKVRK{ct:Amid} | P13-T6A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0.9 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Low hemolytic | ||
| 31802582 | 2020 | GWWRRTAAKVRK{ct:Amid} | P14-V7A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVRK{ct:Amid} | P6-HC(1‐12)A8K12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 2.4 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | α‐‐Helical | NA | ||
| 31802582 | 2020 | GWWRRTVAAVRK{ct:Amid} | P15-K9A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKARK{ct:Amid} | P16-V10A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVAK{ct:Amid} | P17-R11A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVRA{ct:Amid} | P18-K12A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31927997 | 2020 | KLLKLLKKLLKLLK | KL1 | Free | Free | Linear | L | None | 14 | Anticancer | 10 % Hemolysis at 0.52 μM | Human | Synthetic Peptide | PBS buffer = α-Helical, deionized water and 0.9% NaCl = Random coil | NA | ||
| 31927997 | 2020 | KELKLLKKLLKLLK | L2E | Free | Free | Linear | L | None | 14 | Anticancer | 10 % Hemolysis at 61.7 μM | Human | Kl1 Analogues. | Random coil, 10%TFE = single Helix | NA | ||
| 31927997 | 2020 | KQLKLLKKLLKLLK | L2Q | Free | Free | Linear | L | None | 14 | Anticancer | 10 % Hemolysis at 35.5 μM | Human | Kl1 Analogues. | NA | NA | ||
| 31927997 | 2020 | KKLKLLKKLLKLLK | L2K | Free | Free | Linear | L | None | 14 | Anticancer | 10 % Hemolysis at 19.5 μM | Human | Kl1 Analogues. | NA | NA | ||
| 32153522 | 2020 | KRIVQRIKDFLR | KR-12 | Free | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at >80 μM | Human | Fragment Of Ll-37 | SDS = α-Helical, Tris-buffer = Random coil | NA | ||
| 32153547 | 2020 | QQCRRPLYCRRR | NCR247C | Free | Free | Linear | L | None | 12 | Antibacterial | 0.88 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | QQCRRPLYCRRRWSHPQFEK | NCR247C-StrepII | Free | Free | Linear | L | None | 20 | Antibacterial | 1.75 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | KALAALAKKIL | X2 | Free | Free | Linear | L | None | 11 | Antibacterial | 1.75 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | QQCRRPLYCRRR | NCR247C | Free | Free | Linear | L | None | 12 | Antibacterial | 0.88 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | QQCRRPLYCRRRWSHPQFEK | NCR247C-StrepII | Free | Free | Linear | L | None | 20 | Antibacterial | 1.75 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | KALAALAKKIL | X2 | Free | Free | Linear | L | None | 11 | Antibacterial | 0.88 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 31585860 | 2020 | KVPVILAGCK | LPR-KVP | Free | Free | Linear | L | None | 10 | Antimicrobial, LPS-neutralizing, angiogenic | 1.87 % Hemolysis at 500 μM | Sheep | Rice Protein Uncharacterized Protein | NA | Low hemolytic | ||
| 31585860 | 2020 | RPPKPDAPRIY | LPR-RPP | Free | Free | Linear | L | None | 11 | Antimicrobial, LPS-neutralizing, angiogenic | 2.53 % Hemolysis at 500 μM | Sheep | Rice Protein 1,4-A-Glucan-Branching Enzyme,Chloroplastic/Amyloplastic,(Ec 2.4.1.1) | NA | Low hemolytic | ||
| 31585860 | 2020 | KRKARKKGRFSKK | LPR-KRK | Free | Free | Linear | L | None | 13 | Antimicrobial, LPS-neutralizing, angiogenic | 4.26 % Hemolysis at 500 μM | Sheep | Rice Protein Uncharacterized Protein | NA | Low hemolytic | ||
| 30962256 | 2019 | LRHKVYGYCVLGP{ct:Amid} | Periplanetasin-4 | Amidation | Free | Linear | L | None | 13 | Antifungal | 0 % Hemolysis at 1.3 μM | Human | American Cockroach (Periplaneta Americana) | NA | Low hemolytic | ||
| 30962256 | 2019 | LRHKVYGYCVLGP{ct:Amid} | Periplanetasin-4 | Amidation | Free | Linear | L | None | 13 | Antifungal | 0 % Hemolysis at 2.5 μM | Human | American Cockroach (Periplaneta Americana) | NA | Low hemolytic | ||
| 30962256 | 2019 | LRHKVYGYCVLGP{ct:Amid} | Periplanetasin-4 | Amidation | Free | Linear | L | None | 13 | Antifungal | 0 % Hemolysis at 5 μM | Human | American Cockroach (Periplaneta Americana) | NA | Low hemolytic | ||
| 30962256 | 2019 | LRHKVYGYCVLGP{ct:Amid} | Periplanetasin-4 | Amidation | Free | Linear | L | None | 13 | Antifungal | 0 % Hemolysis at 10 μM | Human | American Cockroach (Periplaneta Americana) | NA | Low hemolytic | ||
| 30962256 | 2019 | LRHKVYGYCVLGP{ct:Amid} | Periplanetasin-4 | Amidation | Free | Linear | L | None | 13 | Antifungal | 0 % Hemolysis at 20 μM | Human | American Cockroach (Periplaneta Americana) | NA | Low hemolytic | ||
| 30962256 | 2019 | LRHKVYGYCVLGP{ct:Amid} | Periplanetasin-4 | Amidation | Free | Linear | L | None | 13 | Antifungal | 0 % Hemolysis at 40 μM | Human | American Cockroach (Periplaneta Americana) | NA | Low hemolytic | ||
| 30962256 | 2019 | LRHKVYGYCVLGP{ct:Amid} | Periplanetasin-4 | Amidation | Free | Linear | L | None | 13 | Antifungal | 0 % Hemolysis at 80 μM | Human | American Cockroach (Periplaneta Americana) | NA | Low hemolytic | ||
| 32258871 | 2020 | ACPIFTKIQGTYRGKAKCK | Phd1 | Free | Free | Linear | L | None | 19 | Antibacterial | >12.5 % Hemolysis at 5 μM | Rat | Human-Β-Defensins Hbd1 Analogues | NA | NA | ||
| 32258871 | 2020 | ACPIFTKIQGTYRGKAKCK{nt:Myr = myristoylated} | MPhd1 | Free | Myr = myristoylated | Linear | L | None | 19 | Antibacterial | >80 % Hemolysis at 5 μM | Rat | Myristoylated Mphd1 | NA | NA | ||
| 31954105 | 2020 | LRKVRRLLRRL{nt:Amid}{ct:Amid} | AMP 21 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 25 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical, SDS = α-Helical | Non-hemolytic | ||
| 31954105 | 2020 | LRKVWRWLRRL{nt:Amid}{ct:Amid} | AMP 22 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 25 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Non-hemolytic | ||
| 31954105 | 2020 | LRKFRRLLRRL{nt:Amid}{ct:Amid} | AMP 23 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 25 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Non-hemolytic | ||
| 31954105 | 2020 | LRRLRRLLRRL{nt:Amid}{ct:Amid} | AMP 24 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 25 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Non-hemolytic | ||
| 31954105 | 2020 | LRKVRRLLRRL{nt:Amid}{ct:Amid} | AMP 21 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 50 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical, SDS = α-Helical | Non-hemolytic | ||
| 31954105 | 2020 | LRKVWRWLRRL{nt:Amid}{ct:Amid} | AMP 22 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | >10 % Hemolysis at 50 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | NA | ||
| 31954105 | 2020 | LRKFRRLLRRL{nt:Amid}{ct:Amid} | AMP 23 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | >5 % Hemolysis at 50 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Low hemolytic | ||
| 31954105 | 2020 | LRRLRRLLRRL{nt:Amid}{ct:Amid} | AMP 24 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | >5 % Hemolysis at 50 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Low hemolytic | ||
| 31954105 | 2020 | LRKVRRLLRRL{nt:Amid}{ct:Amid} | AMP 21 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 100 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical, SDS = α-Helical | Non-hemolytic | ||
| 31954105 | 2020 | LRKVWRWLRRL{nt:Amid}{ct:Amid} | AMP 22 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | >10 % Hemolysis at 100 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | NA | ||
| 31954105 | 2020 | LRKFRRLLRRL{nt:Amid}{ct:Amid} | AMP 23 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | >5 % Hemolysis at 100 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Low hemolytic | ||
| 31954105 | 2020 | LRRLRRLLRRL{nt:Amid}{ct:Amid} | AMP 24 | Amidation | Amidation | Linear | L | None | 11 | Antimicrobial | >5 % Hemolysis at 100 μM | Human | Synthetic Salt Tolerant Undecapeptides | water = Random coil, TFE = Helical, DPC = Random coil, D8PG = α-Helical | Low hemolytic | ||
| 32206496 | 2020 | RKGSRMGKKCECP | Tn CRT2 | Free | Free | Linear | L | None | 13 | Antimicrobial | 50.38 % Hemolysis at 40 μM | Human | Toadfish Thalassophryne Nattereri | α-Helix, aqueous bufer = Random coil | NA | ||
| 32206496 | 2020 | RKGSQMGKKCECP | Tn CRT3 | Free | Free | Linear | L | None | 13 | Antimicrobial | 34.49 % Hemolysis at 40 μM | Human | Toadfish Thalassophryne Nattereri | β-Sheet, aqueous bufer = Random coil | NA | ||
| 32003561 | 2020 | KWCFRVCYRGICYRRCRX | TPI (Tachyplesin I) | Free | Free | Linear | L | None | 18 | Antimicrobial | ≤10 % Hemolysis at 0.25 μg/mL | Human | Asian Horseshoe Crabs Tachypleus Tridentatus | β-Hairpin | NA | ||
| 32003561 | 2020 | K{d}W{d}C{d}F{d}R{d}V{d}C{d}Y{d}R{d}G{d}L{d}C{d}Y{d}R{d}R{d}C{d}R{d}X{d} | TPAD | Free | Free | Linear | D | None | 18 | Antibacterial | 10 % Hemolysis at 16 μg/mL | Human | D-Amino Acid Analogue Of Tpi | β-Hairpin | NA | ||
| 32242658 | 2020 | RRRRRRRRRRRR | R12 | Free | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >4000 μg/mL | Rat | Arginine-Based Four-Armed Copolypeptides | NA | Non-hemolytic | ||
| 32242658 | 2020 | RRRRRRRRRRRRKKK{ct:Amid} | 4R3 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at >4000 μg/mL | Rat | Arginine-Based Four-Armed Copolypeptides | NA | Non-hemolytic | ||
| 32134261 | 2020 | FIIWPLRYRK{ct:Amid} | somuncurin-1 | Amidation | Free | Linear | L | None | 10 | Antibacterial | <5 % Hemolysis at 180 μM | Human | Frog Pleurodema Somuncurence | water = Random coil, TFE = α-Helical | Low hemolytic | ||
| 32134261 | 2020 | FILKRSYPQYY{ct:Amid} | somuncurin-2 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 180 μM | Human | Frog Pleurodema Somuncurence | water = Random coil, TFE = Random coil | Low hemolytic | ||
| 32134261 | 2020 | NLVGSLLGGILKK{ct:Amid} | thaulin-3 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 180 μM | Human | Frog Pleurodema Somuncurence | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 32342079 | 2020 | RLKKIGKVLKWI{ct:Amid} | RI12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36) | 10 mM PBS = Random coil + <30% α-Helical, TFE = α-Helical | Low hemolytic | ||
| 32342079 | 2020 | RWKKIGKVWKWI{ct:Amid} | RI12[L2W,L9W] | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36) | 10 mM PBS & TFE = TrpZip Hairpin | Low hemolytic | ||
| 32342079 | 2020 | RWKKIGWVWKWI{ct:Amid} | RI12[L2W,K7W,L9W] | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 128 μM | Human | Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36) | 10 mM PBS & TFE = TrpZip Hairpin | Low hemolytic | ||
| 32342079 | 2020 | RLKKIGWVLKWI{ct:Amid} | RI12[K7W] | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 128 μM | Human | Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36) | 10 mM PBS = Random coil + <30% α-Helical, TFE = α-Helical | Low hemolytic | ||
| 32342079 | 2020 | RLWKIGKVLKWI{ct:Amid} | RI12[K3W] | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36) | 10 mM PBS = Random coil + <30% α-Helical, TFE = α-Helical | Low hemolytic | ||
| 32342079 | 2020 | RLWKIGWVLKWI{ct:Amid} | RI12[K3W,K7W] | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 32 μM | Human | Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36) | 10 mM PBS = Random coil + <30% α-Helical, TFE = α-Helical | NA | ||
| 32619153 | 2020 | ITRYLDKILRILRKYLKA | Pep-IA18 | Free | Free | Linear | L | None | 18 | Antifungal, Antibiofilm | 1 % Hemolysis at 450 μM | Human | Designed From Profilin, A Protein From Insect (Fall Armyworm)Spodoptera Frugiperda | water = Random coil, 50% TFE/water (v/v) and SDS micelle = α-Helix | Non-hemolytic | ||
| 32619153 | 2020 | ITRYLDKILRILRKYLKA | Pep-IA18 | Free | Free | Linear | L | None | 18 | Antifungal, Antibiofilm | | Human | Designed From Profilin, A Protein From Insect (Fall Armyworm)Spodoptera Frugiperda | water = Random coil, 50% TFE/water (v/v) and SDS micelle = α-Helix | Non-hemolytic | | ||
| 32670215 | 2020 | KRFWQLVPLAIKIYRAWKRR{ct:Amid} | dCATH | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 4 μM | Human | Cath Amp From Duck | α-Helix | NA | ||
| 32670215 | 2020 | KRFAQLVPLAIKIYRAAKRR{ct:Amid} | dCATH-AA | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 256 μM | Human | Modified Verison Of Dcath | α-Helix | Low hemolytic | ||
| 32670215 | 2020 | KRFWQLVPLAIKIYRA{ct:Amid} | dCATH(1–16) | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at 256 μM | Human | Modified Verison Of Dcath | α-Helix | Low hemolytic | ||
| 32670215 | 2020 | KRFWQLVPLAIKIYRAW{ct:Amid} | dCATH(1–17) | Amidation | Free | Linear | L | None | 17 | Antibacterial | 10 % Hemolysis at 8 μM | Human | Modified Verison Of Dcath | α-Helix | NA | ||
| 32670215 | 2020 | KRFWQLVPLAIKIYRAWK{ct:Amid} | dCATH(1–18) | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 8 μM | Human | Modified Verison Of Dcath | α-Helix | NA | ||
| 32670215 | 2020 | QLVPLAIKIYRAWKRR{ct:Amid} | dCATH(5–20) | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at 128 μM | Human | Modified Verison Of Dcath | α-Helix | Low hemolytic | ||
| 32670215 | 2020 | WQLVPLAIKIYRAWKRR{ct:Amid} | dCATH(4–20) | Amidation | Free | Linear | L | None | 17 | Antibacterial | 10 % Hemolysis at 16 μM | Human | Modified Verison Of Dcath | α-Helix | NA | ||
| 32670215 | 2020 | FWQLVPLAIKIYRAWKRR{ct:Amid} | dCATH(3–20) | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 4 μM | Human | Modified Verison Of Dcath | α-Helix | NA | ||
| 32670215 | 2020 | QLVPLAIKIYRA{ct:Amid} | dCATH(5–16) | Amidation | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 256 μM | Human | Modified Verison Of Dcath | unordered conformation | Low hemolytic | ||
| 32670215 | 2020 | KRFAQLVPLAIKIYRA{ct:Amid} | dCATH(1–16)-4A | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at 256 μM | Human | Modified Verison Of Dcath | α-Helix | Low hemolytic | ||
| 32670215 | 2020 | QLVPLAIKIYRAAKRR{ct:Amid} | dCATH(5–20)-17A | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at 256 μM | Human | Modified Verison Of Dcath | α-Helix | Low hemolytic | ||
| 32499514 | 2020 | RKEKIKKRIGKIDRL{ct:Amid} | P0 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >250 µg/ml | Human | Designed From The Conserved Sequences Of Cathelicidin | α-Helical | Low hemolytic | ||
| 32499514 | 2020 | KIAKRIWKILRR{ct:Amid} | P7 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 250 µg/ml | Human | Modification By Truncation Of P0 | NA | Low hemolytic | ||
| 32499514 | 2020 | GLFDIVKKVAG{ct:Amid} | A0 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 10 % Hemolysis at >250 µg/ml | Human | Designed From The Conserved Sequences Of Aurein | α-Helical | Low hemolytic | ||
| 32499514 | 2020 | RLFRRVKKVAG{ct:Amid} | A3 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 10 % Hemolysis at >250 µg/ml | Human | Modification By Truncation Of A0 | NA | Low hemolytic | ||
| 32499514 | 2020 | KIAKRIWKILRRRLFRRV{ct:Amid} | PA-18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 3.91 µg/ml | Human | Truncated Derivatives Of The Hybrid Analogue (P7A3) | α-Helical | NA | ||
| 32499514 | 2020 | KIAKRIWKILRRRLFRR{ct:Amid} | PA-17 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 10 % Hemolysis at 3.91 µg/ml | Human | Truncated Derivatives Of The Hybrid Analogue (P7A3) | NA | NA | ||
| 32499514 | 2020 | KIAKRIWKILRRRLFR{ct:Amid} | PA-16 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at 3.91 µg/ml | Human | Truncated Derivatives Of The Hybrid Analogue (P7A3) | NA | NA | ||
| 32499514 | 2020 | KIAKRIWKILRRRLF{ct:Amid} | PA-15 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at 3.91 µg/ml | Human | Truncated Derivatives Of The Hybrid Analogue (P7A3) | NA | NA | ||
| 32499514 | 2020 | KIAKRIWKILRRRL{ct:Amid} | PA-14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 15.63 µg/ml | Human | Truncated Derivatives Of The Hybrid Analogue (P7A3) | NA | NA | ||
| 32499514 | 2020 | KIAKRIWKILRRR{ct:Amid} | PA-13 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at 125 µg/ml | Human | Truncated Derivatives Of The Hybrid Analogue (P7A3) | aqueous = Random coil, 30mM SDS, 50% TFE, and 0.05% LPS (MME) = α-Helical | NA | ||
| 32521823 | 2020 | RYRRKKKMKKALQYIKLLKE{ct:Amid} | 35409 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 1.56 μM | Human | Parasite Plasmodium Falciparum Rifin Protein-Derived Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | NA | ||
| 32521823 | 2020 | RKKKMKKALQYIKLLKE{ct:Amid} | 35409-1 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiotic Synergy | 10 % Hemolysis at >200 μM | Human | 35409 Seven Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = α-Helix (200 to 260nm) | Non-hemolytic | ||
| 32521823 | 2020 | KKKMKKALQYIKLLKE{ct:Amid} | 35409-2 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antibiotic Synergy | 10 % Hemolysis at >200 μM | Human | 35409 Seven Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = α-Helix (200 to 260nm) | Non-hemolytic | ||
| 32521823 | 2020 | KKMKKALQYIKLLKE{ct:Amid} | 35409-3 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Seven Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = Helical | Non-hemolytic | ||
| 32521823 | 2020 | KMKKALQYIKLLKE{ct:Amid} | 35409-4 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiotic Synergy | 10 % Hemolysis at >200 μM | Human | 35409 Seven Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = α-Helix (200 to 260nm) | Non-hemolytic | ||
| 32521823 | 2020 | MKKALQYIKLLKE{ct:Amid} | 35409-5 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Seven Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = Helical | Non-hemolytic | ||
| 32521823 | 2020 | ALQYIKLLKE{ct:Amid} | 35409-6 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Seven Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32521823 | 2020 | RYRRKKKMKKALQYIKL{ct:Amid} | 35409-8 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Five Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32521823 | 2020 | RYRRKKKMKKALQY{ct:Amid} | 35409-9 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Five Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32521823 | 2020 | RYRRKKKMKKA{ct:Amid} | 35409-10 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Five Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32521823 | 2020 | RYRRKKKMKK{ct:Amid} | 35409-11 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Five Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32521823 | 2020 | KKMKKALQYIKLLK{ct:Amid} | 35409-13 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiotic Synergy | 10 % Hemolysis at >200 μM | Human | 35409 Four Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = α-Helix (200 to 260nm) | Non-hemolytic | ||
| 32521823 | 2020 | KKMKKALQYIKL{ct:Amid} | 35409-14 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 100 μM | Human | 35409 Four Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | NA | ||
| 32521823 | 2020 | RKKKMKKALQY{ct:Amid} | 35409-15 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 10 % Hemolysis at 200 μM | Human | 35409 Four Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32576874 | 2020 | GFLSILKKVLPKVMAHMK{ct:Amid} | Melectin | Amidation | Free | Linear | L | None | 18 | Antibacterial, Anti-inflammatory | 0 % Hemolysis at 32 μM | Sheep | Bee Venom Melecta Albifrons | LTA and LPS (208 and 222nm) = α-Helical | Non-hemolytic | ||
| 32636607 | 2020 | RNFFKRIRRAGKRIRKAI{nt:Amid} | CAMP-CecD | Free | Amidation | Linear | L | None | 18 | Antibacterial | 0 % Hemolysis at 256 µg/mL | Human | Derived Δm2 Greater Wax Moth Galleria Mellonella | Helical | Non-hemolytic | ||
| 32439180 | 2020 | ARLDVASEFRKKWNKWALSR{ct:Amid} | PAMP | Amidation | Free | Linear | L | None | 20 | Antibacterial | >10 % Hemolysis at >256 μM | Sheep | Proadrenomedullin | NA | Non-hemolytic | ||
| 32439180 | 2020 | FRKKWNKWALSR{ct:Amid} | PAMP(9-20) | Amidation | Free | Linear | L | None | 12 | Antibacterial | >10 % Hemolysis at >256 μM | Sheep | Derived From Pamp | NA | Non-hemolytic | ||
| 32151610 | 2020 | LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | analogs of 1 (12res) | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 12 | Antibacterial | −1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | {nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | analogs of 1 (13res) | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 13 | Antibacterial | −1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | L-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | analogs of 1 (14res) | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 0 ± 3 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | Non-hemolytic | ||
| 32151610 | 2020 | LL-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | analogs of 1 (15res) | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 15 | Antibacterial | 0 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | LLL-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | analogs of 1 (16res) | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 16 | Antibacterial | −1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | Non-hemolytic | ||
| 32151610 | 2020 | LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH} | 12-residue R4R11 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 12 | Antibacterial | −1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | β-Sheet, TFE = α-Helical | Non-hemolytic | ||
| 32151610 | 2020 | {nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH} | 13-residue R4R11 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 12 | Antibacterial | −1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | β-Sheet, TFE = α-Helical | Non-hemolytic | ||
| 32151610 | 2020 | LL-{nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH} | 15-residue R4R11 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 15 | Antibacterial | 0 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | β-Sheet, TFE = α-Helical | Non-hemolytic | ||
| 32151610 | 2020 | LLL-{nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH} | 16-residue R4R11 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 16 | Antibacterial | −1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | β-Sheet, TFE = α-Helical | NA | ||
| 32151610 | 2020 | LLR-{nnr:CE}-LL-{nnr:CE}-R-LL-{nnr:CE}-L{nt:H}{ct:OH} | 12-residue R5R10 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 12 | Antibacterial | 96 ± 6 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | {nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH} | 13-residue R5R10 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 13 | Antibacterial | 28 ± 7 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | LL-{nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH} | 15-residue R5R10 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 15 | Antibacterial | 102 ± 10 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | LLL-{nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH} | 16-residue R5R10 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 16 | Antibacterial | 104 ± 5 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | L-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | 15C5 1 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 0 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | NA | Non-hemolytic | ||
| 32151610 | 2020 | L-{nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH} | 15C5 R4R11 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | NA | Non-hemolytic | ||
| 32151610 | 2020 | L-{nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH} | 15C5 R5R10 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 13 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | NA | NA | ||
| 32151610 | 2020 | L-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | 18C6 1 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 2 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | NA | NA | ||
| 32151610 | 2020 | L-{nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH} | 18C6 R4R11 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 0 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | NA | Non-hemolytic | ||
| 32151610 | 2020 | L-{nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH} | 18C6 R5R10 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 22 ± 2 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | NA | NA | ||
| 32333997 | 2020 | MSLLERKLLMHFLRV | La-AMP1 | Free | Free | Linear | L | None | 15 | Antibacterial | 52 % Hemolysis at 128 µg/mL | Human | Plant Lippia Alba | α-Helix | NA | ||
| 32333997 | 2020 | GLMKLLRELLHMFSRVG | La-AMP1a | Free | Free | Linear | L | None | 17 | Antibacterial | 0.5 % Hemolysis at 128 µg/mL | Human | Derived From La-Amp1 Plant Lippia Alba | α-Helix | Non-hemolytic | ||
| 32333997 | 2020 | MRIGLRFVLM | Lr-AMP1 | Free | Free | Linear | L | None | 10 | Antibacterial | 71.5 % Hemolysis at 128 µg/mL | Human | Plant Lippia Rotundifolia | Random coil | NA | ||
| 32333997 | 2020 | SVAGRAMRIGLRFVLM | Lr-AMP1d | Free | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 128 µg/mL | Human | Derived From Lr-Amp1 Plant Lippia Rotundifolia | α-Helix | Non-hemolytic | ||
| 32333997 | 2020 | GIAGLLRSFVRMLAKIMGG | Lr-AMP1e | Free | Free | Linear | L | None | 19 | Antibacterial | 50 % Hemolysis at 128 µg/mL | Human | Derived From Lr-Amp1 Plant Lippia Rotundifolia | α-Helix | NA | ||
| 32333997 | 2020 | GSVLRAIMRMFAKLMG | Lr-AMP1f | Free | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 128 µg/mL | Human | Derived From Lr-Amp1 Plant Lippia Rotundifolia | α-Helix | Non-hemolytic | ||
| 32333997 | 2020 | GIHGVVRSFMRMLGHLG | Lr-AMP1g | Free | Free | Linear | L | None | 17 | Antibacterial | 0 % Hemolysis at 128 µg/mL | Human | Derived From Lr-Amp1 Plant Lippia Rotundifolia | α-Helix | Non-hemolytic | ||
| 32333997 | 2020 | GSVIRALMRMFARLVG | Lr-AMP1h | Free | Free | Linear | L | None | 16 | Antibacterial | 2.3 % Hemolysis at 128 µg/mL | Human | Derived From Lr-Amp1 Plant Lippia Rotundifolia | α-Helix | NA | ||
| 32567085 | 2020 | FKRIVQRIKDFLR{nt:NA}{ct:Amid} | 1 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | LKRIVQRIKDFLR{nt:NA}{ct:Amid} | 2 | Amidation | NA | Linear | L | None | 13 | Antibacterial, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | AKRIVQRIKDFLR{nt:NA}{ct:Amid} | 3 | Amidation | NA | Linear | L | None | 13 | Antibacterial, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | F{nnr:κ}RIVQRILDFLR{nt:Acet}{ct:Amid} | 4 | Amidation | Acetylation | Linear | L | κ = κ | 13 | Antibacterial, Anticancer | 50 % Hemolysis at 450 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FK({nnr:SA})RIVQRILDFLR{nt:Acet}{ct:Amid} | 5 | Amidation | Acetylation | Linear | L | SA = SA | 14 | Antibacterial, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRIVQRIRDFLR{nt:NA}{ct:Amid} | 6 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRIVQRIRDFLR{nt:Acet}{ct:Amid} | 7 | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRIVQ{nnr:κ}IKDFLR{nt:NA}{ct:Amid} | 8 | Amidation | NA | Linear | L | κ = κ | 13 | Antibacterial, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRIVQLIKDFLR{nt:NA}{ct:Amid} | 9 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 114 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FKRIVQLIKDFLR{nt:Acet}{ct:Amid} | 10 | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 227 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FKRIVQRIKDLLR{nt:NA}{ct:Amid} | 11 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRIVQRIKDLLR{nt:Acet}{ct:Amid} | 12 | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRIVQIIKKFLR{nt:NA}{ct:Amid} | 13 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 361 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FKRIVQIIKKFLR{nt:Acet}{ct:Amid} | 14 | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 292 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FKRIVQLLKKLLR{nt:NA}{ct:Amid} | 15 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 411 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FKRIVQLLKKLLR{nt:Acet}{ct:Amid} | 16 | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 185 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FKRILQRIKDFLR{nt:NA}{ct:Amid} | 17 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRILQRIKDFLR{nt:Acet}{ct:Amid} | 18 | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32654770 | 2020 | {nnr:Aβ}LLKRIKTLL{ct:Amid} | Ano-1β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | G{nnr:Aβ}LKRIKTLL{ct:Amid} | Ano-2β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GL{nnr:Aβ}KRIKTLL{ct:Amid} | Ano-3β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLL{nnr:Aβ}RIKTLL{ct:Amid} | Ano-4β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLK{nnr:Aβ}IKTLL{ct:Amid} | Ano-5β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKR{nnr:Aβ}KTLL{ct:Amid} | Ano-6β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRI{nnr:Aβ}TLL{ct:Amid} | Ano-7β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRIK{nnr:Aβ}LL{ct:Amid} | Ano-8β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRIKT{nnr:Aβ}L{ct:Amid} | Ano-9β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRIKTL{nnr:Aβ}{ct:Amid} | Ano-10β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | {nnr:Aβ}LLKRIK{nnr:Aβ}LL{ct:Amid} | Ano-1β8β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Venom Sac Of Solitary Spider Wasps | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32630734 | 2020 | FIQHLIPLIPHAIQGIKDIF{ct:Amid} | Kassiniatuerin-3 | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Antibiofilm, Antiproliferation | ~2 % Hemolysis at 160 μM | Horse | Frog Kassina Senegalensis | aqueous = Random coil, 50% TFE = Helical | Low hemolytic | ||
| 32569466 | 2020 | WFQVKTRVRTKVQFW | WF-1 | Free | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at 64 μM | Human | Mutagenesis Modification Peptide Of Wi-6 | SDS = β-Sheet | NA | ||
| 32569466 | 2020 | FWRRYKKVKKYRRWF | FW-2 | Free | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Mutagenesis Modification Peptide Of Wi-6 | PBS (aqueous)= Disordered, TFE = α-Helical | Low hemolytic | ||
| 32569466 | 2020 | FWQVIKKVKKIVQWF | FW-3 | Free | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at 64 μM | Human | Mutagenesis Modification Peptide Of Wi-6 | PBS (aqueous)= Disordered, TFE = α-Helical | NA | ||
| 32569466 | 2020 | FKQFYRRVRRYFQKF | FK-4 | Free | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at 128 μM | Human | Mutagenesis Modification Peptide Of Wi-6 | PBS (aqueous)= Disordered, TFE = α-Helical | NA | ||
| 32569466 | 2020 | FRQWYRRVRRYWQRF | FR-5 | Free | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at 64 μM | Human | Mutagenesis Modification Peptide Of Wi-6 | PBS (aqueous)= Disordered, TFE = α-Helical | NA | ||
| 32569466 | 2020 | WIQPKTKVIPYVRYL | WI-6 | Free | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at 256 μM | Human | Bovine Αs2-Casein F21 (193-207) | PBS (aqueous)= Disordered | Low hemolytic | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 11 % Hemolysis at 1 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 12 % Hemolysis at 2 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 16 % Hemolysis at 4 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 20 % Hemolysis at 8 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 28 % Hemolysis at 16 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 40 % Hemolysis at 32 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 59 % Hemolysis at 64 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 81 % Hemolysis at 128 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 94 % Hemolysis at 256 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 47 % Hemolysis at 1 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 86 % Hemolysis at 2 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 96 % Hemolysis at 4 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 96 % Hemolysis at 8 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 95 % Hemolysis at 16 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 94 % Hemolysis at 32 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 94 % Hemolysis at 64 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 91 % Hemolysis at 128 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 89 % Hemolysis at 256 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 33 % Hemolysis at 1 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 80 % Hemolysis at 2 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 95 % Hemolysis at 4 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 95 % Hemolysis at 8 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 90 % Hemolysis at 16 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 82 % Hemolysis at 32 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 79 % Hemolysis at 64 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 78 % Hemolysis at 128 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 78 % Hemolysis at 256 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32722535 | 2020 | GIFSKLAGKKLKNLLISG{ct:Amid} | Esc(1-18) | Amidation | Free | Linear | L | None | 18 | Antibacterial | ~10 % Hemolysis at 64 μM | Sheep | Frog Derived Esculentin Peptide | NA | NA | ||
| 32229648 | 2020 | AHFLPPIIRA{ct:Amid} | Dq-1133 | Amidation | Free | Linear | L | None | 10 | NA | 0 % Hemolysis at 10 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | Non-hemolytic | ||
| 32229648 | 2020 | GVIPDDFRIR | Dq-1187 | Free | Free | Linear | L | None | 10 | NA | 0 % Hemolysis at 10 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | Non-hemolytic | ||
| 32229648 | 2020 | LVGALVSTLLSLVPSLMK{ct:Amid} | Dq-1840 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 7.8 % Hemolysis at 10 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | NA | ||
| 32229648 | 2020 | AHFLPPIIRA{ct:Amid} | Dq-1133 | Amidation | Free | Linear | L | None | 10 | NA | 1.5 % Hemolysis at 50 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | Non-hemolytic | ||
| 32229648 | 2020 | GVIPDDFRIR | Dq-1187 | Free | Free | Linear | L | None | 10 | NA | 0.3 % Hemolysis at 50 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | Non-hemolytic | ||
| 32229648 | 2020 | LVGALVSTLLSLVPSLMK{ct:Amid} | Dq-1840 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 35.3 % Hemolysis at 50 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | NA | ||
| 32126228 | 2020 | VRRFPWWWPFLRR | Tritrpticin | Free | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Trp-Rich Porcine Cathelicidin Peptide | NA | NA | ||
| 32126228 | 2020 | VRRFPWWWPFLRR{ct:Amid} | Tritrp-Arg | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at 62.2 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | V({nnr:Agb})({nnr:Agb})FPWWWPFL({nnr:Agb})({nnr:Agb}){ct:Amid} | Tritrp-Agb | Amidation | Free | Linear | L | Agb = (S)-2-amino-4 guanidinobutyric acid | 13 | Anticancer | 50 % Hemolysis at 34.6 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | V({nnr:hArg})({nnr:hArg})FPWWWPFL({nnr:hArg})({nnr:hArg}){ct:Amid} | Tritrp-hArg | Amidation | Free | Linear | L | hArg = homo-arginine Arg Derivative | 13 | Anticancer | 50 % Hemolysis at 41.3 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VKKFPWWWPFLKK{ct:Amid} | Tritrp-Lys | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | V({nnr:Dap})({nnr:Dap})FPWWWPFL({nnr:Dap})({nnr:Dap}){ct:Amid} | Tritrp-Dap | Amidation | Free | Linear | L | Dap = 2,3-diaminopropionic acid Lys Derivative | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | V({nnr:Dab})({nnr:Dab})FPWWWPFL({nnr:Dab})({nnr:Dab}){ct:Amid} | Tritrp-Dab | Amidation | Free | Linear | L | Dab = 2,4-diaminobutyric acid Lys Derivative | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | V{nnr:O}{nnr:O}FPWWWPFL{nnr:O}{nnr:O}{ct:Amid} | Tritrp-Orn | Amidation | Free | Linear | L | O = L-Ornithine | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFAWWWAFLRR{ct:Amid} | Tritrp-P59A | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at 52.5 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VKKFAWWWAFLKK{ct:Amid} | Tritrp-P59A-Lys | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFAWWWPFLRR{ct:Amid} | Tritrp-P5A | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VKKFAWWWPFLKK{ct:Amid} | Tritrp-P5A-Lys | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPWWWAFLRR{ct:Amid} | Tritrp-P9A | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at 29.3 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VKKFPWWWAFLKK{ct:Amid} | Tritrp-P9A-Lys | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPFFFPFLRR{ct:Amid} | Tritrp-W678F | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFP({nnr:bTA})({nnr:bTA})({nnr:bTA})PFLRR{ct:Amid} | Tritrp-W678bTA | Amidation | Free | Linear | L | bTA = β-3-benzothienyl-1-AlaTrpDerivative | 13 | Anticancer | 50 % Hemolysis at 12.2 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFP({nnr:hW})WWPFLRR{ct:Amid} | Tritrp-W6hW | Amidation | Free | Linear | L | hW = 5-hydroxytryptophan Trp Derivative | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPW({nnr:hW})WPFLRR{ct:Amid} | Tritrp-W7hW | Amidation | Free | Linear | L | hW = 5-hydroxytryptophan Trp Derivative | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPWW({nnr:hW})PFLRR{ct:Amid} | Tritrp-W8hW | Amidation | Free | Linear | L | hW = 5-hydroxytryptophan Trp Derivative | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFP({nnr:hW})({nnr:hW})({nnr:hW})PFLRR{ct:Amid} | Tritrp-W678hW | Amidation | Free | Linear | L | hW = 5-hydroxytryptophan Trp Derivative | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPAWWPFLRR{ct:Amid} | Tritrp-W6A | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPWAWPFLRR{ct:Amid} | Tritrp-W7A | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPWWAPFLRR{ct:Amid} | Tritrp-W8A | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPAAWPFLRR{ct:Amid} | Tritrp-W67A | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPAWAPFLRR{ct:Amid} | Tritrp-W68A | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPWAAPFLRR{ct:Amid} | Tritrp-W78A | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPAAAPFLRR{ct:Amid} | Tritrp-W678A | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPYWWPFLRR{ct:Amid} | Tritrp-W6Y | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPWYWPFLRR{ct:Amid} | Tritrp-W7Y | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPWWYPFLRR{ct:Amid} | Tritrp-W8Y | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPYYWPFLRR{ct:Amid} | Tritrp-W67Y | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPYWYPFLRR{ct:Amid} | Tritrp-W68Y | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPWYYPFLRR{ct:Amid} | Tritrp-W78Y | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | VRRFPYYYPFLRR{ct:Amid} | Tritrp-W678Y | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | CVRRFPWWYPFLRRC{cyc:N-C}{ct:Amid} | Tritrp-DiSu* | Amidation | Free | Cyclic | L | None | 15 | Anticancer | 50 % Hemolysis at 20.9 μM | Human | Modification Tritrpticin | NA | NA | ||
| 32126228 | 2020 | FPVTWRWWRWWRG{ct:Amid} | PuroA-Arg | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Antimicrobial Peptides | NA | NA | ||
| 32126228 | 2020 | FPVTWKWWKWWKG{ct:Amid} | PuroA-Lys | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Antimicrobial Peptides | NA | NA | ||
| 32126228 | 2020 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin-Arg | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Antimicrobial Peptides | NA | NA | ||
| 32126228 | 2020 | ILPWKWPWWPWKK{ct:Amid} | Indolicidin-Lys | Amidation | Free | Linear | L | None | 13 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Antimicrobial Peptides | NA | NA | ||
| 32126228 | 2020 | FRVTWRTKWWKG{ct:Amid} | PuroB3 | Amidation | Free | Linear | L | None | 12 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Antimicrobial Peptides | NA | NA | ||
| 32126228 | 2020 | FRVT({nnr:hW})RTK({nnr:hW})({nnr:hW})KG{ct:Amid} | PuroB3-hW | Amidation | Free | Linear | L | hW = 5-hydroxytryptophan Trp Derivative | 12 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Antimicrobial Peptides | NA | NA | ||
| 32406577 | 2020 | ALWKTLLKKVLKAAAK{ct:Amid} | K4S4(1–16)a | Amidation | Free | Linear | L | None | 16 | Antibacterial | 50 % Hemolysis at 88.21 ± 5.1 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32406577 | 2020 | ALWKTLLKKVLKAAA{ct:Amid} | K4S4(1–15)a | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 83.25 ± 7.0 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32406577 | 2020 | ALWKTLLKKVLKAAAK | K4S4(1–15) | Free | Free | Linear | L | None | 16 | Antibacterial | 50 % Hemolysis at >100 ± 0.0 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32534825 | 2020 | GATIRAVNSR | PepGAT | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 50 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | KAANRIKYFQ | PepKAA | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 50 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | GATIRAVNSR | PepGAT | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 100 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | KAANRIKYFQ | PepKAA | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 100 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | GATIRAVNSR | PepGAT | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 250 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | KAANRIKYFQ | PepKAA | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 250 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | GATIRAVNSR | PepGAT | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 500 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | KAANRIKYFQ | PepKAA | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 500 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32752241 | 2020 | HHWRRYARIGFRAVRTVIGK{ct:Amid} | Trichoplaxin-2 [T2] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 10 % Hemolysis at 1.4 μM | Human | Phylum Placozo Trichoplax Adhaerens | Helical | NA | ||
| 32752241 | 2020 | KIAKVALKALKIAKVALKAL{ct:Amid} | DiPGLa-H [PG2] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 10 % Hemolysis at 3 μM | Human | Template From Pgla-H Xenopus Laevis | Helical | NA | ||
| 32752241 | 2020 | KIAKVALKALKIAKGALKAL{ct:Amid} | Kiadin-1 [KIA1] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 10 % Hemolysis at 3 μM | Human | Template From Pgla-H Xenopus Laevis | Helical | NA | ||
| 32752241 | 2020 | KIGKKILKALKGALKELA{ct:Amid} | Mapegin [MAPA] | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Anticancer | 10 % Hemolysis at 1.7 μM | Human | Syntheitc Cell-Penetrating Peptide | Helical | NA | ||
| 32752241 | 2020 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP1 [MP1] | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Anticancer | 10 % Hemolysis at 20 μM | Human | Synthetic Amps | Helical | NA | ||
| 32752241 | 2020 | HHWRRYARIGFRAVRTVIGK{ct:Amid} | Trichoplaxin-2 [T2] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 20 % Hemolysis at 3 μM | Human | Phylum Placozo Trichoplax Adhaerens | Helical | NA | ||
| 32752241 | 2020 | KIAKVALKALKIAKVALKAL{ct:Amid} | DiPGLa-H [PG2] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 20 % Hemolysis at 14 μM | Human | Template From Pgla-H Xenopus Laevis | Helical | NA | ||
| 32752241 | 2020 | KIAKVALKALKIAKGALKAL{ct:Amid} | Kiadin-1 [KIA1] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 20 % Hemolysis at 6 μM | Human | Template From Pgla-H Xenopus Laevis | Helical | NA | ||
| 32752241 | 2020 | KIGKKILKALKGALKELA{ct:Amid} | Mapegin [MAPA] | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Anticancer | 20 % Hemolysis at 3 μM | Human | Syntheitc Cell-Penetrating Peptide | Helical | NA | ||
| 32752241 | 2020 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP1 [MP1] | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Anticancer | 20 % Hemolysis at 37 μM | Human | Synthetic Amps | Helical | NA | ||
| 32752241 | 2020 | HHWRRYARIGFRAVRTVIGK{ct:Amid} | Trichoplaxin-2 [T2] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 50 % Hemolysis at 28 μM | Human | Phylum Placozo Trichoplax Adhaerens | Helical | NA | ||
| 32752241 | 2020 | KIAKVALKALKIAKVALKAL{ct:Amid} | DiPGLa-H [PG2] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 50 % Hemolysis at 18 μM | Human | Template From Pgla-H Xenopus Laevis | Helical | NA | ||
| 32752241 | 2020 | KIAKVALKALKIAKGALKAL{ct:Amid} | Kiadin-1 [KIA1] | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Anticancer | 50 % Hemolysis at 20 μM | Human | Template From Pgla-H Xenopus Laevis | Helical | NA | ||
| 32752241 | 2020 | KIGKKILKALKGALKELA{ct:Amid} | Mapegin [MAPA] | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Anticancer | 50 % Hemolysis at 20 μM | Human | Syntheitc Cell-Penetrating Peptide | Helical | NA | ||
| 32752241 | 2020 | IDWKKLLDAAKQIL{ct:Amid} | Polybia-MP1 [MP1] | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Anticancer | 50 % Hemolysis at 170 μM | Human | Synthetic Amps | Helical | NA | ||
| 32781587 | 2020 | FLPLIAGLAAKCAITKKC | B1A1 | Free | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >512 µM | Horse | Truncated Analogue Of B1A | aqueous = Random coil, 1% SDS micelle solution = α-Helix | Low hemolytic | ||
| 32781587 | 2020 | FLPKIFCAITKKC | B1A2 | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 10 % Hemolysis at >512 µM | Horse | Truncated Analogue Of B1A | aqueous = Random coil, 1% SDS micelle solution = α-Helix | Low hemolytic | ||
| 32781587 | 2020 | KFLPKIFCAITKKC | KB2 | Free | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 10 % Hemolysis at 154 µM | Horse | Derived From B1A2 | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KKFLPKIFCAITKKC | KKB2 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 10 % Hemolysis at 207 µM | Horse | Modification Of Kb2 | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KFLPWKIFCAITKKC | KWB2 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 10 % Hemolysis at 99.81 µM | Horse | Modified From Kb2 | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KKFLPWKIFCAITKKC | KKWB2 | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 10 % Hemolysis at 140.04 µM | Horse | Modification Of Kwb | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KFWPWKIFCAITKKC | KW3,5B2 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 10 % Hemolysis at 32.07 µM | Horse | B1A Analogues | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KFLPWKWFCAITKKC | KW5,7B2 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 10 % Hemolysis at 58.42 µM | Horse | B1A Analogues | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32847054 | 2020 | ASSFLTPRLSSLGKRSWAV | AV19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 5 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32847054 | 2020 | NYWLLVLRRLLITKKVMWF | NF19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 5 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32847054 | 2020 | IYFHLFRKINFNLRIYYFI | II19 | Free | Free | Linear | L | None | 19 | NA | 0 % Hemolysis at 5 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32847054 | 2020 | ASSFLTPRLSSLGKRSWAV | AV19 | Free | Free | Linear | L | None | 19 | Antibacterial | 33 % Hemolysis at 100 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | NA | ||
| 32847054 | 2020 | NYWLLVLRRLLITKKVMWF | NF19 | Free | Free | Linear | L | None | 19 | Antibacterial | 50 % Hemolysis at 100 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32847054 | 2020 | IYFHLFRKINFNLRIYYFI | II19 | Free | Free | Linear | L | None | 19 | NA | 19 % Hemolysis at 100 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32847054 | 2020 | IYFHLFRKINFNLRIYYFI | II19 | Free | Free | Linear | L | None | 19 | NA | 11 % Hemolysis at 20 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32847054 | 2020 | NYWLLVLRRLLITKKVMWF | NF19 | Free | Free | Linear | L | None | 19 | Antibacterial | 35 % Hemolysis at 50 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32847054 | 2020 | IYFHLFRKINFNLRIYYFI | II19 | Free | Free | Linear | L | None | 19 | NA | 17 % Hemolysis at 50 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32872343 | 2020 | SALRGCWTKSYPPKPCL{ct:Amid} | SL-BBI | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ≥5 % Hemolysis at 512 μM | Horse | Broad-Folded Frog (Sylvirana Latouchii) | NH4AC = β-Sheet and Random coil, 50%TFE/NH4AC = β-Sheet and Random coil | Non-hemolytic | ||
| 32872343 | 2020 | AALRGCWTKSIPPKPCK{ct:Amid} | K-SL | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ≥5 % Hemolysis at 512 μM | Horse | Sl-Bbi Analogues | NH4AC = β-Sheet and Random coil, 50%TFE/NH4AC = β-Sheet, Random coil and Helix | Non-hemolytic | ||
| 32872343 | 2020 | SALRGCWTFSIPPKPCL{ct:Amid} | F-SL | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Anticancer | ≥10 % Hemolysis at 512 μM | Horse | Sl-Bbi Analogues | NH4AC = β-Sheet and Random coil, 50%TFE/NH4AC = β-Sheet and Random coil | Low hemolytic | ||
| 32590058 | 2020 | G{d}F{d}G{d}S{d}L{d}L{d}G{d}K{d}A{d}L{d}R{d}L{d}G{d}A{d}N{d}V{d}L{d}{ct:Amid} | DCPF-C1 | Amidation | Free | Linear | D | None | 17 | Antibacterial | ≥10 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = α-Helical (reverse Helical) | NA | ||
| 32590058 | 2020 | K{d}FW{d}SLLK{d}KALRLW{d}ANVL{ct:Amid} | CPF-2 | Amidation | Free | Linear | Mix | None | 17 | Antibiofilm, Antibacterial | 100 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = Random coil | NA | ||
| 32590058 | 2020 | K{d}F{d}W{d}S{d}L{d}L{d}K{d}K{d}A{d}L{d}R{d}L{d}W{d}A{d}N{d}V{d}L{d}{ct:Amid} | DCPF-2 | Amidation | Free | Linear | Mix | None | 17 | Antibacterial | 100 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = α-Helical (reverse Helical) | NA | ||
| 32590058 | 2020 | K{d}FW{d}SLLK{d}KAL{d}R{d}LW{d}KK{d}VL{ct:Amid} | CPF-2-1 | Amidation | Free | Linear | Mix | None | 17 | Antibacterial | 0 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = Random coil | Non-hemolytic | ||
| 32590058 | 2020 | K{d}FW{d}SLLK{d}KAL{d}R{d}LW{d}AK{d}VL{ct:Amid} | CPF-2-2 | Amidation | Free | Linear | Mix | None | 17 | Antibacterial | 0 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = Random coil | Non-hemolytic | ||
| 32590058 | 2020 | GFGSLLGKALRLWKKVL{ct:Amid} | CPF-13 | Amidation | Free | Linear | D | None | 17 | Antibacterial | ≥75 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = α-Helical | NA | ||
| 32590058 | 2020 | GFGSLLGKALRLW{d}KK{d}VL{ct:Amid} | CPF-14 | Amidation | Free | Linear | Mix | None | 17 | Antibacterial | ≥10 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = α-Helical | NA | ||
| 32590058 | 2020 | GFGSLLGKAL{d}R{d}LW{d}KK{d}VL{ct:Amid} | CPF-15 | Amidation | Free | Linear | Mix | None | 17 | Antibacterial | ≥75 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = Random coil | NA | ||
| 32786271 | 2020 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | HC1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 33 % Hemolysis at 50 μM | Mouse | Snake Hydrophis Cyanocinctus | water = Random coil, 60 mM SDS solution = α-helica | NA | ||
| 32786271 | 2020 | K{d}FFK{d}R{d}LLK{d}SVR{d}R{d}AVK{d}K{d}FR{d}K{d}{ct:Amid} | HC1-D1 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 28 % Hemolysis at 50 μM | Mouse | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = Random coil | NA | ||
| 32786271 | 2020 | K{d}ffK{d}R{d}L{d}L{d}K{d}S{d}V{d}R{d}R{d}A{d}V{d}K{d}K{d}F{d}R{d}K{d}{ct:Amid} | HC1-D2 | Amidation | Free | Linear | D | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 31 % Hemolysis at 50 μM | Mouse | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = α-Helix | NA | ||
| 32786271 | 2020 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | HC1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 13 % Hemolysis at 50 μM | Human | Snake Hydrophis Cyanocinctus | water = Random coil, 60 mM SDS solution = α-helica | NA | ||
| 32786271 | 2020 | K{d}FFK{d}R{d}LLK{d}SVR{d}R{d}AVK{d}K{d}FR{d}K{d}{ct:Amid} | HC1-D1 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 9 % Hemolysis at 50 μM | Human | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = Random coil | NA | ||
| 32786271 | 2020 | K{d}ffK{d}R{d}L{d}L{d}K{d}S{d}V{d}R{d}R{d}A{d}V{d}K{d}K{d}F{d}R{d}K{d}{ct:Amid} | HC1-D2 | Amidation | Free | Linear | D | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 12 % Hemolysis at 50 μM | Human | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = α-Helix | NA | ||
| 32841003 | 2020 | GITDLRGMLKRLKKMK | Sm-A1 | Free | Free | Linear | L | None | 16 | Antibacterial, Antibiofilm | 10 % Hemolysis at 80 μM | Human | Derived From Turbot Viscera Hydrolysate | α-Helix | Low hemolytic | ||
| 32841003 | 2020 | HTMWRCVRLSACLFSVRRR | Sm-A3 | Free | Free | Linear | L | None | 19 | Antibacterial | 10 % Hemolysis at 10 μM | Human | Derived From Turbot Viscera Hydrolysate | α-Helix | NA | ||
| 32967114 | 2020 | FIGTLIPLALGALTKLFK{ct:Amid} | Figainin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Anticancer, Anti-infective, Antitrypanosomal | 50 % Hemolysis at 10 μM | Human | Frog Boana Raniceps | water and 10% (v/v) TFE = Disordered, 30% (v/v) and 50% (v/v) TFE = α-Helical | NA | ||
| 32967333 | 2020 | ALWKKLLKK-{nnr:Cha}{ct:Amid} | DMPC-10A | Amidation | Free | Linear | L | Cha = Cyclohexanylalanine | 10 | Antibacterial, Antibiofilm | ≥20 % Hemolysis at 128 μM | Horse | Derived From A Dermaseptin (Phyllomedusa Frogs) | amphipathic environment = α-Helix | NA | ||
| 32967333 | 2020 | AL{d}WK{d}K{d}L{d}L{d}K{d}K{d}-{nnr:Cha}{ct:Amid} | DMPC-10B | Amidation | Free | Linear | Mix | Cha = Cyclohexanylalanine | 10 | Antibacterial, Antibiofilm | 0 % Hemolysis at 128 μM | Horse | Modificaiton Of Dmpc-10A | TFE = α-Helix | Non-hemolytic | ||
| 32959824 | 2020 | LKLLKKLLKLLKKL | LK Free | Free | Free | Linear | L | None | 14 | Antibacterial | ~100 % Hemolysis at 50 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 32710881 | 2020 | FQRYFHRYARFLAKIWKG | Adepamycin | Free | Free | Linear | L | None | 18 | Antibacterial, Antifungal | < 10 % Hemolysis at 1.3 μM | Human | Synthetic Peptide | aqueous = Disordered, TFE = α-Helix | NA | ||
| 32710881 | 2020 | FQRYFHRYARFLAKIWKG | Adepamycin | Free | Free | Linear | L | None | 18 | Antibacterial, Antifungal | < 10 % Hemolysis at 10.4 μM | Human | Synthetic Peptide | aqueous = Disordered, TFE = α-Helix | NA | ||
| 32710881 | 2020 | FQRYFHRYARFLAKIWKG | Adepamycin | Free | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 60 % Hemolysis at 335 μM | Human | Synthetic Peptide | aqueous = Disordered, TFE = α-Helix | NA | ||
| 33101226 | 2020 | KIGKVLLVKGIKKIGKVL{ct:Amid} | KV3 | Amidation | Free | Linear | L | None | 18 | Antifungal | 10 % Hemolysis at >64 μM | Human | Derivatives Of The Template Peptide Kv(Porcine Myeloid Amp) | aqueous solution (10-mM PBS) = unordered, 30-mM SDS(MME) = α-Helical | Low hemolytic | ||
| 33101226 | 2020 | RIGRVLLVRGIRRIGRVL{ct:Amid} | RV3 | Amidation | Free | Linear | L | None | 18 | Antifungal | 10 % Hemolysis at >64 μM | Human | Derivatives Of The Template Peptide Kv(Porcine Myeloid Amp) | aqueous solution (10-mM PBS) = unordered, 30-mM SDS(MME) = α-Helical | Low hemolytic | ||
| 33101226 | 2020 | KIGKFLLFKGIKKIGKFL{ct:Amid} | KF3 | Amidation | Free | Linear | L | None | 18 | Antifungal | 10 % Hemolysis at >64 μM | Human | Derivatives Of The Template Peptide Kv(Porcine Myeloid Amp) | aqueous solution (10-mM PBS) = unordered, 30-mM SDS(MME) = α-Helical | Low hemolytic | ||
| 33101226 | 2020 | KIGKWLLWKGIKKIGKWL{ct:Amid} | KW3 | Amidation | Free | Linear | L | None | 18 | Antifungal | 10 % Hemolysis at 2.69 μM | Human | Derivatives Of The Template Peptide Kv(Porcine Myeloid Amp) | aqueous solution (10-mM PBS) = unordered, 30-mM SDS(MME) = α-Helical | NA | ||
| 33101226 | 2020 | RIGRFLLFRGIRRIGRFL{ct:Amid} | RF3 | Amidation | Free | Linear | L | None | 18 | Antifungal | 10 % Hemolysis at >64 μM | Human | Derivatives Of The Template Peptide Kv(Porcine Myeloid Amp) | aqueous solution (10-mM PBS) = unordered, 30-mM SDS(MME) = α-Helical | Low hemolytic | ||
| 33101226 | 2020 | RIGRWLLWRGIRRIGRWL{ct:Amid} | RW3 | Amidation | Free | Linear | L | None | 18 | Antifungal | 10 % Hemolysis at 3.81 μM | Human | Derivatives Of The Template Peptide Kv(Porcine Myeloid Amp) | aqueous solution (10-mM PBS) = unordered, 30-mM SDS(MME) = α-Helical | NA | ||
| 32591801 | 2020 | AFRPIPTHSC | P1 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 32591801 | 2020 | YNYSYIITRS | P2 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 32591801 | 2020 | PTTVHIIYRI | P3 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | NA | ||
| 32591801 | 2020 | ASVTWLLYAM | P4 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 32591801 | 2020 | LRCLMLKFPI | P5 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | NA | ||
| 32591801 | 2020 | CLRPSIISRA | P6 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 32591801 | 2020 | WRYQWTILFI | P7 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 32591801 | 2020 | FCIRLATYVI | P8 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 32591801 | 2020 | PGHRVSCWLS | P9 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | NA | ||
| 32715598 | 2020 | RKIKVYLPRMK | TK9.1 | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 0 % Hemolysis at 42 μg/ml | Mouse | Ovalbumin Peptide Fragment | α-Helix | Non-hemolytic | ||
| 32715598 | 2020 | RKIKRYLRRMI | TK9.1.3 | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 0 % Hemolysis at 42 μg/ml | Mouse | Ovalbumin Peptide Fragment | α-Helix | Non-hemolytic | ||
| 32715598 | 2020 | RKIKVYLPRMK | TK9.1 | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 10 % Hemolysis at 1660 μg/ml | Mouse | Ovalbumin Peptide Fragment | α-Helix | Non-hemolytic | ||
| 32715598 | 2020 | RKIKRYLRRMI | TK9.1.3 | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 10 % Hemolysis at 1660 μg/ml | Mouse | Ovalbumin Peptide Fragment | α-Helix | Non-hemolytic | ||
| 32726461 | 2020 | VLESFKVSFLSALEEYTKKL{nt:H}{ct:OH} | apoA‐I221–240 | OH | H | Linear | L | None | 20 | Anti‐inflammatory | 1.34 ± 0.66 % Hemolysis at 200 μM | mouse | Apolipoprotein A-I (Apoa-I) Mimetic Peptides | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | VVEKAKEAAEHAKEAATKAL{nt:H}{ct:OH} | P1 | OH | H | Linear | L | None | 20 | NA | −1.84 ± 0.26 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | ΑΑΕΚΑΚEAAEHAKEVVTKVL{nt:H}{ct:OH} | P2 | OH | H | Linear | L | None | 20 | NA | 1.25 ± 0.65 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | ΑΑΕΚΑKEAAEHVKEVVTKVL{nt:H}{ct:OH} | P3 | OH | H | Linear | L | None | 20 | NA | −0.28 ± 0.49 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | AAEKAKEAVEHVKEVVTKVL{nt:H}{ct:OH} | P4 | OH | H | Linear | L | None | 20 | NA | 0.99 ± 0.66 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | AAEKAKEAVEHVKEFLTKVL{nt:H}{ct:OH} | P5 | OH | H | Linear | L | None | 20 | NA | 1.20 ± 0.78 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | ΑΑΕΚΑKEAVEHFKEFFTKFL{nt:H}{ct:OH} | P6 | OH | H | Linear | L | None | 20 | NA | −1.78 ± 0.17 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | AAEKLKEVAEHFKEFFTKVL{nt:H}{ct:OH} | P7 | OH | H | Linear | L | None | 20 | NA | −0.74 ± 0.41 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | VLEKVKEVVEHVKEVVTKVL{nt:H}{ct:OH} | P8 | OH | H | Linear | L | None | 20 | NA | −0.52 ± 0.49 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | VLEKLKELVEHVKEVVTKVL{nt:H}{ct:OH} | P9 | OH | H | Linear | L | None | 20 | NA | −0.37 ± 0.87 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | VLEKLKELVEHLKELVTKVL{nt:H}{ct:OH} | P10 | OH | H | Linear | L | None | 20 | NA | −0.41 ± 0.60 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | VLEKLKELLEHLKELLTKVL{nt:H}{ct:OH} | P11 | OH | H | Linear | L | None | 20 | NA | 1.64 ± 0.78 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | FLEKLKELLEHLKELLTKLL{nt:H}{ct:OH} | P12 | OH | H | Linear | L | None | 20 | Anti‐atherosclerotic, Anti‐inflammatory and Antioxidant | 1.71 ± 0.73 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | FFEKFKEFFEHFKEFFTKFF{nt:H}{ct:OH} | P13 | OH | H | Linear | L | None | 20 | NA | 1.99 ± 0.67 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | FFEKFKEFFEHFKEWWTKWL{nt:H}{ct:OH} | P14 | OH | H | Linear | L | None | 20 | NA | 2.63 ± 0.70 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | FFEKFKEFWEHWKEWWTKWL{nt:H}{ct:OH} | P15 | OH | H | Linear | L | None | 20 | NA | 7.06 ± 0.86 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = α‐Helical, 50% TFE = α‐Helical and β‐Sheet | Low hemolytic | ||
| 32726461 | 2020 | FFEKWKEWWEHWKEWWTKWF{nt:H}{ct:OH} | P16 | OH | H | Linear | L | None | 20 | NA | 5.94 ± 0.58 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = α‐Helical, 50% TFE = α‐Helical and β‐Sheet | Low hemolytic | ||
| 32726461 | 2020 | WWEKWKEWWEHWKEWWTKWW{nt:H}{ct:OH} | P17 | OH | H | Linear | L | None | 20 | NA | 7.86 ± 0.64 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = α‐Helical, 50% TFE = α‐Helical and β‐Sheet | Low hemolytic | ||
| 32726461 | 2020 | DWFKAFYDKVAEKFKEAF{nt:Acet}{ct:Amid} | L‐4F | Amidation | Acetylation | Linear | L | None | 18 | Anti‐atherosclerotic, Anti‐inflammatory and Antioxidant | 2.10 ± 0.48 % Hemolysis at 200 μM | mouse | Synthetic Peptide | aqueous = α‐Helical, 50% TFE = α‐Helical | Non-hemolytic | ||
| 33063186 | 2020 | FTILKKLKSFIK | Coco1 | Free | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 100 μM | Human | Derived From The Green Algae Coccomyxa Subellipsoidea | NA | NA | ||
| 33063186 | 2020 | KLVKKLLKKYITF | Coco2 | Free | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at 100 μM | Human | Derived From The Green Algae Coccomyxa Subellipsoidea | NA | NA | ||
| 33063186 | 2020 | LARFVLRILKYGFK | Coco3 | Free | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 9.38 μM | Human | Derived From The Green Algae Coccomyxa Subellipsoidea. | α‐Helix | NA | ||
| 33063186 | 2020 | IPLLRKGKKIIWW | Opero1 | Free | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at 100 μM | Human | Derived From The Invertebrate Operophtera Brumata | NA | NA | ||
| 33063186 | 2020 | GLKKVIKLLRPLL | Opero2 | Free | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at 100 μM | Human | Derived From The Invertebrate Operophtera Brumata | NA | NA | ||
| 33063186 | 2020 | IVIKSLGKFLKNVGGFAG | Pyro1 | Free | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 100 μM | Human | Derived From The Thermophilic Bacteria Pyrococcus | NA | NA | ||
| 33063186 | 2020 | FKLVWKLLKKLALKL | Aper1 | Free | Free | Linear | L | None | 15 | Anticancer, Antimicrobial | 10 % Hemolysis at 5.96 μM | Human | Derived From The Thermophilic Bacteria Aeropyrum Pernix. | NA | NA | ||
| 33063186 | 2020 | ITKWLLNAIKKGFKL | Thermo1 | Free | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at 21.9 μM | Human | Derived From The Thermophilic Bacteria Thermococcus Onnurineus. | NA | NA | ||
| 33063186 | 2020 | IHKLVKLWLNLGKKF | Thermo2 | Free | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at 39.3 μM | Human | Derived From The Thermophilic Bacteria Thermococcus Onnurineus. | NA | NA | ||
| 33063186 | 2020 | LFSIIWKLNRKLIKA | Thermo3 | Free | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at 37.3 μM | Human | Derived From The Thermophilic Bacteria Thermococcus Onnurineus. | NA | NA | ||
| 33074344 | 2020 | EKKRLLKWWR{nt:H}{ct:Amid} | AMP-2 | Amidation | H | Linear | L | None | 10 | Antibacterial | <1 % Hemolysis at 0.2 mg/ml | Sheep | Synthetic Peptide | Helix | Non-hemolytic | ||
| 33074344 | 2020 | KWWKLLRKKR{nt:H}{ct:Amid} | AMP-3 | Amidation | H | Linear | L | None | 10 | Antibacterial | <1 % Hemolysis at 0.2 mg/ml | Sheep | Synthetic Peptide | Helix | Non-hemolytic | ||
| 32909733 | 2020 | KIKKIIKKIIKI{ct:Amid} | KI | Amidation | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 4000 μM | Human | Synthetic Peptide | Random coil | Non-hemolytic | ||
| 32909733 | 2020 | GIIKKIIKKIIKKI{ct:Amid} | G3 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 50 % Hemolysis at 800 μM | Human | Synthetic Peptide | Random coil | Low hemolytic | ||
| 32909733 | 2020 | GILKKILKKILKKL{ct:Amid} | G7 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 50 % Hemolysis at 80 μM | Human | Synthetic Peptide | aqueous = α-Helical | NA | ||
| 33194795 | 2020 | RIHPPPFYPPFRRFL{ct:Amid} | ChBac3.4 (12-26) | Amidation | Free | Linear | L | None | 15 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Truncated Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRLPFRRPPIRIHPPPFY{ct:Amid} | ChBac3.4(1-19)-NH2 | Amidation | Free | Linear | L | None | 19 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Truncated Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRLPFRRPPIRIH{ct:Amid} | ChBac3.4(1-14)-NH2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Truncated Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRRFRLPFRRPPIRIH{ct:Amid} | RFR-ChBac3.4(1-14)-NH2 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Truncated Variants | NA | Low hemolytic | ||
| 33092132 | 2020 | GIFDVLKNLAKGVITSLAS{ct:Amid} | Ocellatin-3N | Amidation | Free | Linear | L | None | 19 | Antibacterial | 50 % Hemolysis at 210 μg/ml | Mouse | Ocellatins Frog Leptodactylus Nesiotus | α-Helical at 4–11, 13–18 | NA | ||
| 33193152 | 2020 | FLSLIPKIAGGIAALVKNL{ct:Amid} | Phylloseptin-PV1 (PPV1) | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Antiproliferative, Antibiofilm | ≥50 % Hemolysis at 32 μM | Horse | White-Lined Leaf Frog Phyllomedusa Vaillantii | aqueous = Random coil, 50% TFE = α-Helix | NA | ||
| 33193152 | 2020 | FLSLIPKIAGGIAALVKNL{ct:Amid} | Phylloseptin-PV1 (PPV1) | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Antiproliferative, Antibiofilm | ≥95 % Hemolysis at 64 μM | Horse | White-Lined Leaf Frog Phyllomedusa Vaillantii | aqueous = Random coil, 50% TFE = α-Helix | NA | ||
| 32891601 | 2020 | GKWMTLLKHILK{ct:Amid} | P5T | Amidation | Free | Linear | L | None | 12 | Anti-leishmanial | 6.5 ± 0.9 % Hemolysis at 64 μM | Human | Analogues Of The Halictine-2 (Honeybee, Halictus Sexcinctus) | 10 mM PB = Disordered, 10 mM SDS or 50% TFE = α-Helix | Non-hemolytic | ||
| 33084564 | 2020 | RRWRRFFQKAKRLLRRFG | DRGN-6 | Free | Free | Linear | L | None | 18 | Antibacterial | ~10 % Hemolysis at 10 μg/ml | Sheep | Synthetic Peptides Komodo Dragon Cathelicidin-Inspired Antimicrobial Peptides | Helical | NA | ||
| 33084564 | 2020 | RRWRRFFQKAKRLLRRFG | DRGN-7 | Free | Free | Linear | L | None | 18 | Antibacterial | ~10 % Hemolysis at 10 μg/ml | Sheep | Synthetic Peptides Komodo Dragon Cathelicidin-Inspired Antimicrobial Peptides | Helical | NA | ||
| 33084564 | 2020 | RRWRRFFRKAKRLLRRFG{ct:Amid} | DRGN-8 | Amidation | Free | Linear | L | None | 18 | Antibacterial | ~10 % Hemolysis at 10 μg/ml | Sheep | Synthetic Peptides Komodo Dragon Cathelicidin-Inspired Antimicrobial Peptides | Helical | NA | ||
| 33175275 | 2020 | AFALIAGALYRIFHRR | LHH1 | Free | Free | Linear | L | None | 16 | Antibacterial | 50 % Hemolysis at 187.2 μM | Goat | Lactobacillus Casei Hz1 | water = Random coil, 50% TFE and 30 mM SDS = α-Helical | Low hemolytic | ||
| 32445120 | 2020 | RKRLRKFRNKKKIGQKIQ | Rabbit CAP18 | Free | Free | Linear | L | None | 18 | Antibacterial | ≥50 % Hemolysis at 1000 μg/mL | Human | Rabbit Cap18 Peptides | NA | Low hemolytic | ||
| 32445120 | 2020 | WKFFRKLLKKIRKKFKR | hCap18 | Free | Free | Linear | L | None | 17 | Antibacterial | 95 % Hemolysis at 1000 μg/mL | Human | Truncated Human Cap18 Peptides | Random coil | Low hemolytic | ||
| 32445120 | 2020 | WRKRLRKFRLKKKILQ | rCap18 | Free | Free | Linear | L | None | 16 | Antibacterial | ≥5 % Hemolysis at 1000 μg/mL | Human | Truncated Rabbit Cap18 Peptides | Random coil | Non-hemolytic | ||
| 32569448 | 2020 | GGLRRLGRKILRAVKKYG | CP | Free | Free | Linear | L | None | 18 | Antibacterial | 0.2 ± 0.2 % Hemolysis at 100 μM | Human | Modified Bmap28(1-18) Synthetic Peptide | NA | Non-hemolytic | ||
| 32569448 | 2020 | GGLRSLGLKILLAWKKYG | DP | Free | Free | Linear | L | None | 18 | Antibacterial | 14.9 ± 2.5 % Hemolysis at 100 μM | Human | Modified Bmap28(1-18) Synthetic Peptide | NA | NA | ||
| 32569448 | 2020 | RGLRRLGRKIKKGLKKYG | Mapcon | Free | Free | Linear | L | None | 18 | Antibacterial | 0 ± 0.02 % Hemolysis at 100 μM | Human | Map Family Consensus Peptide | NA | Non-hemolytic | ||
| 32569448 | 2020 | GGLRSLGRKILRAWKKYG | BMAP28(1-18) | Free | Free | Linear | L | None | 18 | Antibacterial | 4.6 ± 1.2 % Hemolysis at 100 μM | Human | Map Family Peptide | NA | NA | ||
| 32569448 | 2020 | GGLRSLGLKILLAWKKYG | DP | Free | Free | Linear | L | None | 18 | Antibacterial | 0.27 ± 0.44 % Hemolysis at 6.25 μM | Human | Modified Bmap28(1-18) Synthetic Peptide | NA | NA | ||
| 32569448 | 2020 | GGLRSLGRKILRAWKKYG | BMAP28(1-18) | Free | Free | Linear | L | None | 18 | Antibacterial | 1.11 ± 1.24 % Hemolysis at 25 μM | Human | Map Family Peptide | NA | NA | ||
| 33316868 | 2020 | RRWYRRWYRRWY{ct:Amid} | RY12WY | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 1437.1 μM | Fish | Synthetic Short Amps | right-handed α-Helical | Non-hemolytic | ||
| 33316868 | 2020 | RRWYRRWYRRWY{ct:Amid} | RY12WY | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antifungal | 0 % Hemolysis at 125 μM | Fish | Synthetic Short Amps | right-handed α-Helical | Non-hemolytic | ||
| 33316868 | 2020 | RRWYRRWYRRWY{ct:Amid} | RY12WY | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antifungal | 10 % Hemolysis at 250 μM | Fish | Synthetic Short Amps | right-handed α-Helical | Non-hemolytic | ||
| 33291521 | 2020 | FLQRIIGALGRLF | GHaR | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 10 % Hemolysis at 13.6 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 10 % Hemolysis at 156 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 10 % Hemolysis at 11.6 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 10 % Hemolysis at 22.3 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGARGRLF | GHaR9R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 10 % Hemolysis at >200 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | NA | Low hemolytic | ||
| 33291521 | 2020 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 10 % Hemolysis at 32.8 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGALGRLF | GHaR | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 46.4 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 50 % Hemolysis at >200 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | Low hemolytic | ||
| 33291521 | 2020 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 50 % Hemolysis at 10.9 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 50 % Hemolysis at 167.6 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGARGRLF | GHaR9R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | NA | Low hemolytic | ||
| 33291521 | 2020 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 50 % Hemolysis at 86.3 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291782 | 2020 | SPRVCIRVCRNGVCYRRCWG | Capitellacin | Free | Free | Linear | L | None | 20 | Antibacterial, Anti-infective | 0 % Hemolysis at 64 μM | Human | Marine Polychaeta Capitella Teleta | membrane mimicking media = β-Hairpin | Non-hemolytic | ||
| 33291782 | 2020 | SPRVCIRVCRNGVCYRRCWG | Capitellacin | Free | Free | Linear | L | None | 20 | Antibacterial, Anti-infective | ≥2 % Hemolysis at 128 μM | Human | Marine Polychaeta Capitella Teleta | membrane mimicking media = β-Hairpin | Non-hemolytic | ||
| 33291782 | 2020 | KWCFRVCYRGICYRRCR | Tachyplesin-1 | Free | Free | Linear | L | None | 17 | Antibacterial, Anti-infective | 50 % Hemolysis at 128 μM | Human | Horseshoe Crab Tachypleus Tridentatus | membrane mimicking media = β-Hairpin right-handed twist | NA | ||
| 33236874 | 2020 | FKRLKKLISWIKRKRQQC{ct:Amid} | HnMc | Amidation | Free | Linear | L | None | 18 | Antibacterial | ≥10 % Hemolysis at 1 mg/mL | Rat | Analogue Helicobacter Pylori Ribosomal Protein L1 (Hpa3Nt3) | NA | Low hemolytic | ||
| 33205989 | 2020 | LKKLLKLLKKLLKL{nt:Acet}{ct:Amid} | LK | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 5 μM | Human | Proline Hinged Amphipathic Α‑Helical Peptide | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | LKKLLPLLKKLLKL{nt:Acet}{ct:Amid} | LK-K6P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 1.25 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | LKKLLKLLPKLLKL{nt:Acet}{ct:Amid} | LK-K9P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 5 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | LKKLLKLLKPLLKL{nt:Acet}{ct:Amid} | LK-K10P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 5 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | LKKPLKLGKKLLKL{nt:Acet}{ct:Amid} | LK-L4P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 160 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | Low hemolytic | ||
| 33205989 | 2020 | LKKLPKLSKKLLKL{nt:Acet}{ct:Amid} | LK-L5P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 80 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | LKKLLKPLKKLLKL{nt:Acet}{ct:Amid} | LK-L7P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 160 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | Low hemolytic | ||
| 33205989 | 2020 | LKKLLKLLKKLPKL{nt:Acet}{ct:Amid} | LK-L12P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 40 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | LKKLLKLPKKLLKL{nt:Acet}{ct:Amid} | LK-L8P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 640 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | Non-hemolytic | ||
| 33205989 | 2020 | LKKLLKLLKKPLKL{nt:Acet}{ct:Amid} | LK-L11P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 320 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | Non-hemolytic | ||
| 33205989 | 2020 | KLLKLLKKLLKLLK{nt:Acet}{ct:Amid} | KL | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 0.625 μM | Human | Proline Hinged Amphipathic Α‑Helical Peptide | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KPLKLLKKLLKLLK{nt:Acet}{ct:Amid} | KL-L2P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 5 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLPKLLKKLLKLLK{nt:Acet}{ct:Amid} | KL-L3P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 10 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKLLPKLLKLLK{nt:Acet}{ct:Amid} | KL-K7P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 5 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKLLKPLLKLLK{nt:Acet}{ct:Amid} | KL-K8P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 2.5 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKPLKKLLKLLK{nt:Acet}{ct:Amid} | KL-L5P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 80 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKLLKKLPKLLK{nt:Acet}{ct:Amid} | KL-L10P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 80 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKLLKKLLKPLK{nt:Acet}{ct:Amid} | KL-L12P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 40 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKLLKKLLKLPK{nt:Acet}{ct:Amid} | KL-L13P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 40 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKLPKKLLKLLK{nt:Acet}{ct:Amid} | KL-L6P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 640 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | Non-hemolytic | ||
| 33205989 | 2020 | KLLKLLKKPLKLLK{nt:Acet}{ct:Amid} | KL-L9P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at >1280 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | Non-hemolytic | ||
| 32798369 | 2021 | AIPWIWIWRLLRKG | WWW | Free | Free | Linear | L | None | 14 | Antibacterial | 100 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | NA | ||
| 32798369 | 2021 | AIPYIWIYRLLRKG | YWY | Free | Free | Linear | L | None | 14 | Antibacterial | ~2 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | Low hemolytic | ||
| 32798369 | 2021 | AIPFIWIFRLLRKG | FWF | Free | Free | Linear | L | None | 14 | Antibacterial | ~80 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | NA | ||
| 32798369 | 2021 | AIPYIYIYRLLRKG | YYY | Free | Free | Linear | L | None | 14 | Antibacterial | ~2 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | Low hemolytic | ||
| 32798369 | 2021 | AIPFIFIFRLLRKG | FFF | Free | Free | Linear | L | None | 14 | Antibacterial | ~2 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | Low hemolytic | ||
| 32798369 | 2021 | AIPYIYIWRLLRKG | YYW | Free | Free | Linear | L | None | 14 | Antibacterial | ~5 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | NA | ||
| 32798369 | 2021 | AIPFIFIWRLLRKG | FFW | Free | Free | Linear | L | None | 14 | Antibacterial | ~40 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | NA | ||
| 32798369 | 2021 | AIPWIYIYRLLRKG | WYY | Free | Free | Linear | L | None | 14 | Antibacterial | ~40 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | NA | ||
| 32798369 | 2021 | AIPWIFIFRLLRKG | WFF | Free | Free | Linear | L | None | 14 | Antibacterial | ~60 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | NA | ||
| 33398076 | 2021 | R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid} | D-11 | Amidation | Free | Linear | D | None | 11 | Antibacterial | 10 % Hemolysis at 1200 μM | Human | Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ) | NA | Non-hemolytic | ||
| 33398076 | 2021 | R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid} | D-11 | Amidation | Free | Linear | D | None | 11 | Antibacterial | 0 % Hemolysis at 500 μM | Human | Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ) | NA | Non-hemolytic | ||
| 33398076 | 2021 | R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid} | D-11 | Amidation | Free | Linear | D | None | 11 | Antibacterial | 0 % Hemolysis at 600 μM | Human | Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ) | NA | Non-hemolytic | ||
| 33049300 | 2021 | CGWKYCGWKYCGWKHCGWKY | Gj-CATH3-(23–42)-peptide | Free | Free | Linear | L | None | 20 | Antioxidant | 7.75 ± 0.89 % Hemolysis at 80 μM | Sheep | Gj-Cath3 Analogues | NA | NA | ||
| 33049300 | 2021 | CGWKHCGWKY | Gj-CATH3-(33–42)-peptide | Free | Free | Linear | L | None | 10 | Antioxidant, Wound healing | 1.05 ± 0.23 % Hemolysis at 80 μM | Sheep | Gj-Cath3 Analogues | NA | Non-hemolytic | ||
| 33442249 | 2021 | RADARADARADARADA{nt:Acet}{ct:Amid} | RADA16-I | Amidation | Acetylation | Linear | L | None | 16 | Antitumor, self-assembling peptide | <5 % Hemolysis at 9 mg/mL | Rabbit | Synthetic Pepetide | NA | NA | ||
| 33469079 | 2021 | RK{d}RW{d}WV{d}VK{d}RK{d}WW{d}V{ct:Amid} | AS01 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 7.24 % Hemolysis at 8 µM | Human | Synthetic Syndiotactic Polypeptides | Helical | NA | ||
| 33469079 | 2021 | RK{d}RW{d}LW{d}LK{d}RK{d}WL{d}W{ct:Amid} | AS02 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µM | Human | Synthetic Syndiotactic Polypeptides | Helical | Non-hemolytic | ||
| 33469079 | 2021 | KK{d}KW{d}WV{d}KK{d}KW{d}WV{d}V{ct:Amid} | AS03 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µM | Human | Synthetic Syndiotactic Polypeptides | Helical | Non-hemolytic | ||
| 33469079 | 2021 | WW{d}KK{d}KV{d}WV{d}KK{d}KW{d}W{ct:Amid} | AS04 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 0.25 % Hemolysis at 8 µM | Human | Synthetic Syndiotactic Polypeptides | Helical | Non-hemolytic | ||
| 33469079 | 2021 | KK{d}KV{d}VV{d}KK{d}KV{d}VW{d}K{ct:Amid} | AS06 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial | 0 % Hemolysis at 8 µM | Human | Synthetic Syndiotactic Polypeptides | Helical | Non-hemolytic | ||
| 33469079 | 2021 | WL{d}WL{d}WL{d}WV{d}KK{d}AK{d}AK{d}K{ct:Amid} | AS08 | Amidation | Free | Linear | Mix | None | 15 | Antimicrobial | 1.46 % Hemolysis at 8 µM | Human | Synthetic Syndiotactic Polypeptides | Helical | NA | ||
| 33532575 | 2021 | KYKKALKKLAKLL | L-SB1 | Free | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm | MHC at >2000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | K{d}Y{d}K{d}K{d}A{d}L{d}K{d}K{d}L{d}A{d}K{d}L{d}L{d} | D-SB1 | Free | Free | Linear | D | None | 13 | Antibacterial. Antibiofilm | MHC at >2000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | VQWRAIRVRVIR | L-DJK5 | Free | Free | Linear | L | None | 12 | Antibacterial. Antibiofilm | MHC at >2000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | V{d}Q{d}W{d}R{d}A{d}I{d}R{d}V{d}R{d}V{d}I{d}R{d} | D-DJK5 | Free | Free | Linear | D | None | 12 | Antibacterial. Antibiofilm | MHC at 1000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | ILPWKWPWWPWRR | L-Indo | Free | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm | MHC at 125 μg/mL | Human | Derived From Bovin | PB and 20%TFE = α-Helical | NA | ||
| 33532575 | 2021 | I{d}L{d}P{d}W{d}K{d}W{d}P{d}W{d}W{d}P{d}W{d}R{d}R{d} | D-Indo | Free | Free | Linear | D | None | 13 | Antibacterial. Antibiofilm | MHC at 125 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | NA | ||
| 33532575 | 2021 | OFOFOFOFKBLKBLKKLK{ct:C10} | L-TNS18 | Free | Free | Branched | L | None | 18 | Antibacterial. Antibiofilm | MHC at 1000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | O{d}F{d}O{d}F{d}O{d}F{d}O{d}F{d}K{d}B{d}L{d}K{d}B{d}L{d}K{d}K{d}L{d}K{d}{ct:C10} | D-TNS18 | Free | Free | Branched | D | None | 18 | Antibacterial. Antibiofilm | MHC at 500 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Low hemolytic | ||
| 33175610 | 2021 | IWLTALKFLGKNLGK{nt:H}{ct:Amid} | LyeTx I mn | Amidation | H | Linear | L | None | 15 | Antibacterial, Antifungal | 50 % Hemolysis at 381.4 µM | Rabbit | Lyetx I Analogs | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 33175610 | 2021 | IWLTKALKFLGKNLGK{nt:H}{ct:Amid} | LyeTx I mnΔK | Amidation | H | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 506.5 µM | Rabbit | Lyetx I Analogs | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 33175610 | 2021 | IWLTKALKFLGKNLGK{nt:Acet}{ct:Amid} | LyeTx I mnΔKAc | Amidation | Acetylation | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 207.5 µM | Rabbit | Lyetx I Analogs | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 33175610 | 2021 | IWLTALKFLGKNLGK{nt:H}{ct:Amid} | LyeTx I mn | Amidation | H | Linear | L | None | 15 | Antibacterial, Antifungal | 1 % Hemolysis at 48.06 µM | Rabbit | Lyetx I Analogs | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 33175610 | 2021 | IWLTKALKFLGKNLGK{nt:H}{ct:Amid} | LyeTx I mnΔK | Amidation | H | Linear | L | None | 16 | Antibacterial, Antifungal | 1 % Hemolysis at 44.67 µM | Rabbit | Lyetx I Analogs | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 33175610 | 2021 | IWLTKALKFLGKNLGK{nt:Acet}{ct:Amid} | LyeTx I mnΔKAc | Amidation | Acetylation | Linear | L | None | 16 | Antibacterial, Antifungal | 1 % Hemolysis at 27.44 µM | Rabbit | Lyetx I Analogs | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 33271197 | 2021 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 50 μg/mL | Human | Southern Bell Frog Litoria Aurea And Litoria Raniformis | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFDIIKKIWESF{ct:Amid} | Aurein M1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 25 μg/mL | Human | Aurein 1.2 Analogs | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFKIIKKIAKSF{ct:Amid} | Aurein M2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 100 μg/mL | Human | Aurein 1.2 Analogs | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFKIIKKIWKSF{ct:Amid} | Aurein M3 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 25 μg/mL | Human | Aurein 1.2 Analogs | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 39.96 % Hemolysis at 200 μg/mL | Human | Southern Bell Frog Litoria Aurea And Litoria Raniformis | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFDIIKKIWESF{ct:Amid} | Aurein M1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~50 % Hemolysis at 200 μg/mL | Human | Aurein 1.2 Analogs | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFKIIKKIAKSF{ct:Amid} | Aurein M2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 15.48 % Hemolysis at 200 μg/mL | Human | Aurein 1.2 Analogs | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFKIIKKIWKSF{ct:Amid} | Aurein M3 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 43.86 % Hemolysis at 200 μg/mL | Human | Aurein 1.2 Analogs | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33807972 | 2021 | LARLRRLCFLWAAAWPWPWR | ZM-804 | Free | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 256 µM | Mouse | Plant Maize Zea Mays B73 | α-Helix | Low hemolytic | ||
| 33809374 | 2021 | AIPWIWIWRLLRKG | WWW | Free | Free | Linear | L | None | 14 | Antibacterial | ~34 % Hemolysis at 15 µM | Sheep | Bucathl4B Peptides | phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical | NA | ||
| 33809374 | 2021 | AIPWIWIWRLLRKG | WWW | Free | Free | Linear | L | None | 14 | Antibacterial | ~15 % Hemolysis at 7.5 µM | Sheep | Variants Of Bucathl-4B | phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical | NA | ||
| 33809374 | 2021 | AIPZIWIWRLLRKG | Z4 | Free | Free | Linear | L | AzAla = Azulenyl-Alanine | 14 | Antibacterial | ~9 % Hemolysis at 15 µM | Sheep | Variants Of Bucathl-4B | phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical | NA | ||
| 33809374 | 2021 | AIPWIZIWRLLRKG | Z6 | Free | Free | Linear | L | AzAla = Azulenyl-Alanine | 14 | Antibacterial | ~14 % Hemolysis at 15 µM | Sheep | Variants Of Bucathl-4B | phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical | NA | ||
| 33809374 | 2021 | AIPWIWIZRLLRKG | Z8 | Free | Free | Linear | L | AzAla = Azulenyl-Alanine | 14 | Antibacterial | ~9 % Hemolysis at 15 µM | Sheep | Variants Of Bucathl-4B | phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical | NA | ||
| 32889698 | 2021 | A({nnr:Nle})WKK({nnr:Nle})({nnr:Nle})KK({nnr:Nle})({nnr:Nle})KSAKK({nnr:Nle})G | C18G-Nle | Free | Free | Linear | L | Nle = Norleucine | 18 | Antibacterial | 24 % Hemolysis at 10 µM | Human | Variants Of C18G (Human Platelet Factor Iv Protein) | PBS = Disordered, TFE = α-Helix | NA | ||
| 32889698 | 2021 | A({nnr:Nva})WKK({nnr:Nva})({nnr:Nva})KK({nnr:Nva})({nnr:Nva})KSAKK({nnr:Nva})G | C18G-Nva | Free | Free | Linear | L | Nva = Norvaline | 18 | Antibacterial | <5 % Hemolysis at 10 µM | Human | Variants Of C18G (Human Platelet Factor Iv Protein) | PBS = Disordered, TFE = α-Helix | NA | ||
| 32889698 | 2021 | A({nnr:Cha})WKK({nnr:Cha})({nnr:Cha})KK({nnr:Cha})({nnr:Cha})KSAKK({nnr:Cha})G | C18G-Cha | Free | Free | Linear | L | Cha = Cyclohexylalanine | 18 | Antibacterial | 65 % Hemolysis at 10 µM | Human | Variants Of C18G (Human Platelet Factor Iv Protein) | PBS = Disordered, TFE = α-Helix | NA | ||
| 32889698 | 2021 | A({nnr:Abu})WKK({nnr:Abu})({nnr:Abu})KK({nnr:Abu})({nnr:Abu})KSAKK({nnr:Abu})G | C18G-Abu | Free | Free | Linear | L | Abu = Aminobutyric | 18 | Antibacterial | <5 % Hemolysis at 10 µM | Human | Variants Of C18G (Human Platelet Factor Iv Protein) | PBS = Disordered, TFE = α-Helix | NA | ||
| 32889698 | 2021 | AAWKKAAKKAAKSAKKAG | C18G-Ala | Free | Free | Linear | L | None | 18 | Antibacterial | <5 % Hemolysis at 10 µM | Human | Variants Of C18G (Human Platelet Factor Iv Protein) | PBS = Disordered, TFE = α-Helix | NA | ||
| 33506605 | 2021 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Solitary Wasp Anoplius Samariensis | PBS = Random Coil, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLLKIIKKLL{ct:Amid} | Ano 1-F | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLLKIIKKLL{nt:C8 = octanoic acid}{ct:Amid} | Ano 1-C8 | Amidation | C8 = octanoic acid | Linear | L | C8 = Octanoic Acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Anoplin Analogs | PBS = Helical, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLLKIIKKLL{nt:C10 = decanoic acid}{ct:Amid} | Ano 1-C10 | Amidation | C10 = decanoic acid | Linear | L | C10 = decanoic acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at 44.6 μg/ml | Human | Anoplin Analogs | PBS = Helical, SDS = α-Helix | NA | ||
| 33506605 | 2021 | #ERROR! | Ano 2-F | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLKKIIKKLL{nt:C8 = octanoic acid}{ct:Amid} | Ano 2-C8 | Amidation | C8 = octanoic acid | Linear | L | C8 = Octanoic Acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at 80.8 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | NA | ||
| 33506605 | 2021 | GLKKIIKKLL{nt:C10 = decanoic acid}{ct:Amid} | Ano 2-C10 | Amidation | C10 = decanoic acid | Linear | L | C10 = decanoic acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at 75.5 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | NA | ||
| 33506605 | 2021 | GLLKFIKRLL{ct:Amid} | Ano 3-F | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLLKFIKRLL{nt:C10 = decanoic acid}{ct:Amid} | Ano 3-C10 | Amidation | C10 = decanoic acid | Linear | L | C10 = decanoic acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at 175.2 μg/ml | Human | Anoplin Analogs | PBS = Helical, SDS = α-Helix | NA | ||
| 33506605 | 2021 | GLLKKIKRLL{ct:Amid} | Ano 4-F | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLLKKIKRLL{nt:C10 = decanoic acid}{ct:Amid} | Ano 4-C10 | Amidation | C10 = decanoic acid | Linear | L | C10 = decanoic acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at 44.2 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | NA | ||
| 33506605 | 2021 | GLLKIIKRLL{ct:Amid} | Ano 5-F | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Anoplin Analogs | PBS = Helical, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLLKIIKRLL{nt:C10 = decanoic acid}{ct:Amid} | Ano 5-C10 | Amidation | C10 = decanoic acid | Linear | L | C10 = decanoic acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at 68.1 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | NA | ||
| 33917850 | 2021 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 50 % Hemolysis at 163 µM | Human | Combines The Sequence Of Melittin And Cecropin A | α-Helical | NA | ||
| 33917850 | 2021 | {conj:Naphthalimide}AAKKLFKKILKYL{ct:Amid} | NAPHT-BP100 | Amidation | Naphthalimide | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 23 µM | Human | Naphthalimide-Conjugated Bp10 Peptide | aqueous = Random/flexible structure, POPG = α-Helix | NA | ||
| 33920239 | 2021 | GANAAKKFATIAKKFINYLW | GW-Q4 | Free | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 128 μg/ml | NA | Synthetic Peptide | NA | NA | ||
| 33920239 | 2021 | GANAAKKFATIAKKFINYLW{ct:Amid} | GW-Q4a | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 32 μg/ml | NA | Analogs Gw-Q4 | NA | NA | ||
| 33920239 | 2021 | KKFATIAKKFINYLW | Q4-15 | Free | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 128 μg/ml | NA | Derived From Truncation Of Gw-Q4 | NA | NA | ||
| 33920239 | 2021 | KKFATIAKKFINYLW{ct:Amid} | Q4-15a | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 16 μg/ml | NA | C-Terminal Amide Derivative Of Q4-15 | NA | NA | ||
| 33920239 | 2021 | KKFATIAKKFINKLW | Q4-15-1 | Free | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 256 μg/ml | NA | Derived From Q4-15 With A Substitution | NA | Low hemolytic | ||
| 33920239 | 2021 | KKFATIAKKFINKLW{ct:Amid} | Q4-15a-1 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 256 μg/ml | NA | C-Terminal Amide Derivative Of Q4-15-1 | NA | Low hemolytic | ||
| 33920239 | 2021 | KKFATIAKKFINWLW | Q4-15-2 | Free | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 32 μg/ml | NA | Derived From Q4-15 With A Substitution | NA | NA | ||
| 33920239 | 2021 | KKFATIAKKFINWLW{ct:Amid} | Q4-15a-2 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 16 μg/ml | NA | C-Terminal Amide Derivative Of Q4-15-2 | NA | NA | ||
| 33244888 | 2021 | INWLKLGKAIIDAL{ct:Amid} | agelaia-MPI | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antinociceptive | 50 % Hemolysis at 11.5 ± 1.1 µM | Human | Wasp Parachartergus Fraternus | α-Helical | NA | ||
| 33244888 | 2021 | IFWLFRGKADVAL{ct:Amid} | neuroVAL | Amidation | Free | Linear | L | None | 13 | Anticancer, Antimicrobial | 50 % Hemolysis at >64 µM | Human | Agelaia-Mpi Analogues | 30% TFE = α-Helical | Low hemolytic | ||
| 33244888 | 2021 | ILGTILGLLKGL{ct:Amid} | protonectin | Amidation | Free | Linear | L | None | 12 | Anticancer, Antimicrobial | 50 % Hemolysis at >64 µM | Human | Wasp Parachartergus Fraternus | 30% TFE = α-Helical | Low hemolytic | ||
| 33244888 | 2021 | IFGTILGFLKGL{ct:Amid} | protonectin-F | Amidation | Free | Linear | L | None | 12 | Anticancer, Antimicrobial | 50 % Hemolysis at >64 µM | Human | Protonectin Analogues | 30% TFE = α-Helical | Low hemolytic | ||
| 33676184 | 2021 | KWKLFKKIKF | CMt1 | Free | Free | Linear | L | None | 10 | Antifungal | 10 % Hemolysis at 500 μg/ml | Human | C-Terminal Truncated Derivatives | α-Helix | Low hemolytic | ||
| 33676184 | 2021 | KWKLFKKIKFLHSAKKF | CE-MA | Free | Free | Linear | L | None | 17 | Antibacterial, Antiviral, Antiparasitic, Antifungal, Anticancer | >20 % Hemolysis at 500 μg/ml | Human | Synthetic Peptide Consisting Of Cecropin A And Magenin B | α-Helix | NA | ||
| 33830736 | 2021 | LRKSEEEVAARRARVVW | LP-1 | Free | Free | Linear | L | None | 17 | NA | 0 % Hemolysis at 100 µM | Human | Human Lactoferrin | α-Helical and β-Sheet | Non-hemolytic | ||
| 33830736 | 2021 | RKVRGPPVSCIKRDSPIQ | LP-2 | Free | Free | Linear | L | None | 18 | Anti-osteoclastogenic | 0 % Hemolysis at 100 µM | Human | Fragment From The N-Terminus Of The N-Lobe Of Human Lactoferrin | aqueous environmen = nano-globular assembly Helical and β-Sheet | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.22 % Hemolysis at 21.875 µM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.26 % Hemolysis at 43.75 µM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.31 % Hemolysis at 87.5 µM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.32 % Hemolysis at 175 µM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.33 % Hemolysis at 350 µM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.33 % Hemolysis at 700 µM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.4 % Hemolysis at 1.4 mM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.56 % Hemolysis at 2.8 mM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33981626 | 2021 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 10 % Hemolysis at 45 μM | Human | Synthetic Peptide | micelles and lipid bilayers = α-Helix | NA | ||
| 33981626 | 2021 | KLALKLALKALKAALKLA{ct:Amid} | MAP | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 2 μM | Human | Synthetic Peptide | Helical | NA | ||
| 33981626 | 2021 | GRKKRRQRRRPPQ | TAT | Free | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at >>100 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 34093476 | 2021 | FKFLARTGKFL | PN5 | Free | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at 200 μg/ml | Mouse | Pinus Densiflora | α-Helical | Low hemolytic | ||
| 34073939 | 2021 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 49.2 % Hemolysis at 50 µM | Mouse | Scorpion Heterometrus Petersii | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | NA | ||
| 34073939 | 2021 | GILGKLWEGVKSIA{ct:Amid} | Hp1404-A | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 50 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 34073939 | 2021 | GILGKLWEGVKSIK{ct:Amid} | Hp1404-K | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 50 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 34073939 | 2021 | GILGKLWEGVKSIV{ct:Amid} | Hp1404-V | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 50 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 34073939 | 2021 | GILGKLWEGVKSIL{ct:Amid} | Hp1404-L | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 45.8 % Hemolysis at 50 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | NA | ||
| 34073939 | 2021 | GILGKLWEGVKSIL{ct:Amid} | Hp1404-L | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 21.3 % Hemolysis at 25 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | NA | ||
| 34073939 | 2021 | GILGKLWEGVKSII{ct:Amid} | Hp1404-I | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 25 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 34073939 | 2021 | GILGKLWEGVKSIW{ct:Amid} | Hp1404-W | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 15.9 % Hemolysis at 50 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | NA | ||
| 34073939 | 2021 | GILGKLWEGVKSIW{ct:Amid} | Hp1404-W | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 1.7 % Hemolysis at 25 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | Low hemolytic | ||
| 34070683 | 2021 | {nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}{nt:Acet}{ct:Amid} | Subclass I-1 | Amidation | Acetylation | Linear | NA | hArg = homoarginine, βNPhe = N-benzyl-β-alanine | 16 | Antibacterial | 6.1 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Low hemolytic | ||
| 34070683 | 2021 | {nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}{nt:Acet}{ct:Amid} | Subclass I-2 | Amidation | Acetylation | Linear | NA | hArg = homoarginine, βNsce = N-(S)-1-cyclohexylethyl-β-alanine | 12 | Antibacterial | 98.4 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | NA | ||
| 34070683 | 2021 | {nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}{nt:SpermineAc = H2N(CH2)3NH(CH2)4NH(CH2)3NHCH2(C=O)-}{ct:Amid} | Subclass II-3 | Amidation | SpermineAc = H2N(CH2)3NH(CH2)4NH(CH2)3NHCH2(C=O)- | Linear | L | hArg = homoarginine, βNspe = N-(S)-1-phenylethyl-β-alanine | 13 | Antibacterial | 0.6 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Non-hemolytic | ||
| 34070683 | 2021 | {nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}{nt:H}{ct:Amid} | Subclass II-4 | Amidation | H | Linear | L | hArg = homoarginine, βNspe = N-(S)-1-phenylethyl-β-alanine | 16 | Antibacterial | 2.6 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Non-hemolytic | ||
| 34070683 | 2021 | {nnr:hArg}-{nnr:βNsce}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNsce}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNsce}-K-{nnr:βNspe}{nt:Acet}{ct:Amid} | Subclass II-5 | Amidation | Acetylation | Linear | L | hArg = homoarginine, βNspe = N-(S)-1-phenylethyl-β-alanine, βNsce = N-(S)-1-cyclohexylethyl-β-alanine | 12 | Antibacterial | 9.4 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Low hemolytic | ||
| 34070683 | 2021 | {nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}{nt:Cinn = cinnamoyl}{ct:Amid} | Subclass II-6 | Amidation | Cinn = cinnamoyl | Linear | L | hArg = homoarginine, βNspe = N-(S)-1-phenylethyl-β-alanine | 13 | Antibacterial | 15.7 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Low hemolytic | ||
| 34070683 | 2021 | K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}{nt:H}{ct:Amid} | Subclass III-7 | Amidation | H | Linear | L | βNPhe(F) = N-(4-fluorobenzyl)-β-alanine | 16 | Antibacterial | 1.5 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Non-hemolytic | ||
| 34070683 | 2021 | K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}{nt:H}{ct:Amid} | Subclass III-8 | Amidation | H | Linear | L | βNPhe(F3) = N-(3,4,5-trifluorobenzyl)-β-alanine | 12 | Antibacterial | 28.8 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Low hemolytic | ||
| 34070683 | 2021 | K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}{nt:H}{ct:Amid} | Subclass III-9 | Amidation | H | Linear | L | βNCha = N-cyclohexylmethyl-β-alanine | 16 | Antibacterial | 23 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Low hemolytic | ||
| 34070683 | 2021 | K-{nnr:βNspe}-K-{nnr:βNspe}-K-{nnr:βNspe}-K-{nnr:βNspe}-K-{nnr:βNspe}-K-{nnr:βNspe}{nt:Oct = octanoyl}{ct:Amid} | Subclass III-10 | Amidation | Oct = octanoyl | Linear | L | βNspe = N-(S)-1-phenylethyl-β-alanine | 13 | Antibacterial | 6.9 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Low hemolytic | ||
| 34070683 | 2021 | K-{nnr:βNPhe}-K-{nnr:βNPhe}-K-{nnr:βNPhe}-K-{nnr:βNPhe}-K-{nnr:βNPhe}-K-{nnr:βNPhe}{nt:Lau = lauroyl}{ct:Amid} | Subclass III-11 | Amidation | Lau = lauroyl | Linear | L | βNPhe = N-benzyl-β-alanine | 13 | Antibacterial | 95.6 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | NA | ||
| 34198776 | 2021 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 3 ± 3.5 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34198776 | 2021 | RINSAKDDAAGLQIA{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antibacterial | 0 ± 0 % Hemolysis at 375 μM | Horse | Bacterial Flagellin | NA | Non-hemolytic | ||
| 33890759 | 2021 | KRIWQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 50 % Hemolysis at >340 μM | Human | Fragement Of Ll-37 | NA | Low hemolytic | ||
| 33890759 | 2021 | KRIWQRIKDF{nt:C14}{ct:Amid} | C14-KR10 | Amidation | C14 | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at <25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDFLR{nt:C12}{ct:Amid} | C12-KR12 | Amidation | C12 | Linear | L | None | 12 | Antibacterial | 50 % Hemolysis at <25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDF{nt:C12}{ct:Amid} | C12-KR10 | Amidation | C12 | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at <25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDFLR{nt:C10}{ct:Amid} | C10-KR12 | Amidation | C10 | Linear | L | None | 12 | Antibacterial | 50 % Hemolysis at <25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDF{nt:C10}{ct:Amid} | C10-KR10 | Amidation | C10 | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDFLR{nt:C8}{ct:Amid} | C8-KR12 | Amidation | C8 | Linear | L | None | 12 | Antibacterial | 50 % Hemolysis at <25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDF{nt:C8}{ct:Amid} | C8-KR10 | Amidation | C8 | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 250 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 33890759 | 2021 | K{d}R{d}I{d}W{d}Q{d}R{d}I{d}K{d}D{d}F{d}{nt:C8}{ct:Amid} | C8-KR10d | Amidation | C8 | Linear | D | None | 10 | Antibacterial | 50 % Hemolysis at 150 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDFLR{nt:C6}{ct:Amid} | C6-KR12 | Amidation | C6 | Linear | L | None | 12 | Antibacterial | 50 % Hemolysis at 25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDF{nt:C6}{ct:Amid} | C6-KR10 | Amidation | C6 | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >200 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | WKKLKKLLKKLKKL{nt:Acet}{ct:Amid} | pepD2 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 9.6 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | WKKLKKLLKKL{nt:Acet}{ct:Amid} | pepD3 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 3.15 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | PE/PG liposomes = α-Helical | Low hemolytic | ||
| 34220763 | 2021 | WKKVKKVVKKVKKV{nt:Acet}{ct:Amid} | pepV2 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0.31 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Non-hemolytic | ||
| 34220763 | 2021 | WKKIKKIIKKIKKI{nt:Acet}{ct:Amid} | pepI2 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0.27 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Non-hemolytic | ||
| 34220763 | 2021 | WRRLRRLLRRLRRL{nt:Acet}{ct:Amid} | pepR2 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 105.65 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | W{nnr:O}{nnr:O}L{nnr:O}{nnr:O}LL{nnr:O}{nnr:O}L{nnr:O}{nnr:O}L{nt:Acet}{ct:Amid} | pepO2 | Amidation | Acetylation | Linear | L | O = L-Ornithine | 14 | Antibacterial, Antibiofilm | 0.23 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Non-hemolytic | ||
| 34220763 | 2021 | WK{d}K{d}L{d}K{d}K{d}L{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}{nt:Acet}{ct:Amid} | pepdD2 | Amidation | Acetylation | Linear | Mix | None | 14 | Antibacterial, Antibiofilm | 2.9 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | MY{d}R{d}-WKKLKKLLKKLKKL{nt:Myr = myristyl}{ct:Amid} | pepD2M | Amidation | Myr = myristyl | Linear | L | None | 14 | Antibacterial, Antibiofilm | 93.63 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | PA{d}L{d}-WKKLKKLLKKLKKL{nt:Pal = palmitoyl}{ct:Amid} | pepD2P | Amidation | Pal = palmitoyl | Linear | L | None | 14 | Antibacterial, Antibiofilm | 83.45 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | ST{d}E{d}-WKKLKKLLKKLKKL{nt:Ste = stearyl}{ct:Amid} | pepD2S | Amidation | Ste = stearyl | Linear | L | None | 14 | Antibacterial, Antibiofilm | 60.7 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | OC{d}T{d}-WKKLKKLLKKL{nt:Oct = octanoyl}{ct:Amid} | pepD3O | Amidation | Oct = octanoyl | Linear | L | None | 11 | Antibacterial, Antibiofilm | 86.03 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | HE{d}X{d}-WKKLKKLLKKL{nt:Hex = hexanoyl}{ct:Amid} | pepD3H | Amidation | Hex = hexanoyl | Linear | L | None | 11 | Antibacterial, Antibiofilm | 54.07 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | BU{d}T{d}-WKKLKKLLKKL{nt:But = butanoyl}{ct:Amid} | pepD3B | Amidation | But = butanoyl | Linear | L | None | 11 | Antibacterial, Antibiofilm | 7.89 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34205705 | 2021 | KKLF{d}KKILKYL{nt:C5H11CO}{ct:Amid} | BP472 | Amidation | C5H11CO | Linear | Mix | None | 11 | Antifungal, Antibacterial | 78 ± 5 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KK({nnr:COC3H7})IL{d}KYL{d}{nt:Acet}{ct:Amid} | BP473 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 84 ± 11 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKIK({nnr:COC3H7})KYL{d}{nt:Acet}{ct:Amid} | BP474 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 0 ± 0 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}KK({nnr:COC3H7})L{d}{nt:Acet}{ct:Amid} | BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 0 ± 0 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | α-Helical | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}KYK({nnr:COC11H23}){nt:Acet}{ct:Amid} | BP476 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 94 ± 10 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}k({nnr:COC5H11})KKIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP484 | Amidation | Acetylation | Linear | Mix | COC5H11 = hexanoyl | 11 | Antifungal, Antibacterial | 10 ± 2 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}{d}KKIL{d}KYL{d}{nt:C3H7CO}{ct:Amid} | BP485 | Amidation | C3H7CO | Linear | Mix | None | 11 | Antifungal, Antibacterial | 24 ± 9 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KK({nnr:COC3H7})L{d}F{d}KKIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP486 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 14 ± 5 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}k({nnr:COC11H23})KKIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP488 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 86 ± 14 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKK({nnr:COC11H23})L{d}KYL{d}{nt:Acet}{ct:Amid} | BP489 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 100 ± 6 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKIK({nnr:COC11H23})KYL{d}{nt:Acet}{ct:Amid} | BP490 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 100 ± 6 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKK({nnr:COC5H11})L{d}KYL{d}{nt:Acet}{ct:Amid} | BP494 | Amidation | Acetylation | Linear | Mix | COC5H11 = hexanoyl | 11 | Antifungal, Antibacterial | 0.2 ± 0.2 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}KYK({nnr:COC5H11}){nt:Acet}{ct:Amid} | BP495 | Amidation | Acetylation | Linear | Mix | COC5H11 = hexanoyl | 11 | Antifungal, Antibacterial | 0.6 ± 1 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}KYK({nnr:COC3H7}){nt:Acet}{ct:Amid} | BP496 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 1 ± 1 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}K({nnr:COC11H23})YL{d}{nt:Acet}{ct:Amid} | BP497 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 100 ± 2 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}K({nnr:COC3H7})KIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP498 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 21 ± 3 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}K({nnr:COC3H7})YL{d}{nt:Acet}{ct:Amid} | BP499 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 11 ± 1 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKK({nnr:COC11H23})F{d}KKIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP500 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 71 ± 8 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 33862164 | 2021 | FWSTLLSIGKSLL{ct:Amid} | VpCT1 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 10.5±0.4 μM | Human | Scorpion Mesomexovis Variegatu | 60 % aqueous TFE = α-Helix | NA | ||
| 33862164 | 2021 | FWSTIWNAAKSLI{ct:Amid} | VpCT2 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 10.8±0.4 μM | Human | Scorpion Mesomexovis Variegatu | 60 % aqueous TFE = α-Helix | NA | ||
| 33862164 | 2021 | FLQGIIDTVGKWL{ct:Amid} | VpCT3 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 83.7±1.8 μM | Human | Scorpion Mesomexovis Variegatu | 60 % aqueous TFE = α-Helix | NA | ||
| 33862164 | 2021 | FLQGIWDTVGKWL{ct:Amid} | VpCT3W | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 37.9±0.4 μM | Human | Scorpion Mesomexovis Variegatu | 60 % aqueous TFE = α-Helix | NA | ||
| 33862164 | 2021 | FLSKIWDGVKSLL{ct:Amid} | VpCTConsensus | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 4.8±0.7 μM | Human | Scorpion Mesomexovis Variegatu | 60 % aqueous TFE = α-Helix | NA | ||
| 33862164 | 2021 | LWGALLGLGSTLLSKL{ct:Amid} | VpCT4 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 39.9±0.4 μM | Human | Scorpion Mesomexovis Variegatu | 60 % aqueous TFE = α-Helix | NA | ||
| 33972716 | 2021 | IWLTKALKFLGKNLGK{nt:H}{ct:Amid} | LyeTx I mnΔK | Amidation | H | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 55.31 ± 5 μM | Human | Lycosa Erythrognatha Spider Venom | NA | NA | ||
| 34335511 | 2021 | FIGAIARLLSKIF | BmKn2 | Free | Free | Linear | L | None | 13 | Antibacterial | 91.8 % Hemolysis at 25 μg/mL | Human | Scorpion Mesobuthus Martensii Karsch | α-Helical | NA | ||
| 34335511 | 2021 | FIKAIARLLSKIF | Kn2(G3K) | Free | Free | Linear | L | None | 13 | Antibacterial | 69 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | NA | NA | ||
| 34335511 | 2021 | FIGRIARLLSKIF | Kn2(A4R) | Free | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | NA | NA | ||
| 34335511 | 2021 | FIGAIARLLRKIF | Kn2(S10R) | Free | Free | Linear | L | None | 13 | Antibacterial | 50.9 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | NA | NA | ||
| 34335511 | 2021 | FIKRIARLLSKIF | Kn2(G3K_A4R) | Free | Free | Linear | L | None | 13 | Antibacterial | 8.3 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | NA | NA | ||
| 34335511 | 2021 | FIKAIARLLRKIF | Kn2(G3K_S10R) | Free | Free | Linear | L | None | 13 | Antibacterial | 77.5 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | NA | NA | ||
| 34335511 | 2021 | FIGRIARLLRKIF | Kn2(A4R_S10R) | Free | Free | Linear | L | None | 13 | Antibacterial | 18 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | NA | NA | ||
| 34335511 | 2021 | FIKRIARLLRKIF | BmKn2-7 | Free | Free | Linear | L | None | 13 | Antibacterial | 6.9 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | aqueous = Random coil, 30% or 70% TFE solutions = α-Helical | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 50 % Hemolysis at 886.5 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 1 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 2 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0.4 % Hemolysis at 4 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0.7 % Hemolysis at 8 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 1.4 % Hemolysis at 16 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 1.5 % Hemolysis at 32 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 1.8 % Hemolysis at 64 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 2.4 % Hemolysis at 128 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 10.6 % Hemolysis at 256 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 50 % Hemolysis at 16.77 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0.1 % Hemolysis at 1 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0.3 % Hemolysis at 2 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 2 % Hemolysis at 4 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 2.5 % Hemolysis at 8 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 5.4 % Hemolysis at 16 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 16.9 % Hemolysis at 32 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 40.3 % Hemolysis at 64 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 99.3 % Hemolysis at 128 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 99.5 % Hemolysis at 256 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 50 % Hemolysis at 33.26 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 1 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 2 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0.4 % Hemolysis at 4 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0.5 % Hemolysis at 8 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0.9 % Hemolysis at 16 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 2.5 % Hemolysis at 32 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 8.7 % Hemolysis at 64 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 23.6 % Hemolysis at 128 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 65.6 % Hemolysis at 256 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 50 % Hemolysis at 0.99 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 6.1 % Hemolysis at 1 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 15 % Hemolysis at 2 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 33.7 % Hemolysis at 4 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 61.6 % Hemolysis at 8 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 96.2 % Hemolysis at 16 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 97.6 % Hemolysis at 32 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 97.9 % Hemolysis at 64 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 99.8 % Hemolysis at 128 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 100 % Hemolysis at 256 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34021418 | 2021 | RKPRPHQFIGLM | RM12 | Free | Free | Linear | L | None | 12 | Antioxidant | 15-20 % Hemolysis at 320 μM | Fish | Muscle Transcriptome Of A Freshwater Murrel Channa Striatus | Random coil | Low hemolytic | ||
| 34022355 | 2021 | GILGKLWEGVKSIF | Hp1404 | Free | Free | Linear | L | None | 14 | Anti-Acinetobacter baumannii, Anti-Carbapenem-resistant Acinetobacter baumannii (CRAB | 10 % Hemolysis at 32.3 μM | Human | Scorpion Heterometrus Petersii | α-Helical | NA | ||
| 34022355 | 2021 | FLWGLIPGAISAVTSLIKK | ctriporin | Free | Free | Linear | L | None | 19 | Anti-Acinetobacter baumannii | 10 % Hemolysis at 14.9 μM | Human | Scorpion Chaerilus Tricostatus | NA | NA | ||
| 34058259 | 2021 | HVSAKDKNSGKEQKITIK | DP4 | Free | Free | Linear | L | None | 18 | Anti-Salmonella | 1 % Hemolysis at 100 µg/ml | Human | Synthetic Multi-Epitope Dnak Peptides | NA | Non-hemolytic | ||
| 34129853 | 2021 | INWKGIAAMGKKLL | Vp1a | Free | Free | Linear | L | None | 14 | Antioxidant | 2.37 % Hemolysis at 120 μM | mouse | Asian Hornet Vespa Velutina | NA | Non-hemolytic | ||
| 34129853 | 2021 | INWKGIAAMAKRLL | Vp1b | Free | Free | Linear | L | None | 14 | Antioxidant, Antibacterial | 4.08 % Hemolysis at 120 μM | mouse | Asian Hornet Vespa Velutina | NA | Non-hemolytic | ||
| 34129853 | 2021 | FFPIIAKLLGGFLGKK | Vp2a | Free | Free | Linear | L | None | 16 | Antioxidant, Antibacterial | 3.46 % Hemolysis at 120 μM | mouse | Asian Hornet Vespa Velutina | NA | Non-hemolytic | ||
| 34129853 | 2021 | FLPIIDKLLGGLLGKK | Vp2b | Free | Free | Linear | L | None | 16 | Antioxidant | 2.12 % Hemolysis at 120 μM | mouse | Asian Hornet Vespa Velutina | NA | Non-hemolytic | ||
| 34180670 | 2021 | GLLKRIKTLL | anoplin | Free | Free | Linear | L | None | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at ≥512 μM | Human | Venom Of Wasps (Anoplius Samariensis) | α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GAAKRAKTAA | A-1 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GAAKRAKTAL | A-2 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GALKRAKTAL | A-3 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GLAKRAKTLL | A-4 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GLLKRLKTLA | A-5 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GLLKRFKTLL | A-6 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GWFKRIKTFW | A-7 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 384 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Low hemolytic | ||
| 34180670 | 2021 | GWWKRWKTWW | A-8 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 40.79 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | NA | ||
| 34180670 | 2021 | GFLKRFKTLF | A-9 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 384 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Low hemolytic | ||
| 34180670 | 2021 | GLLKRWKTLL | A-10 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GFFKRWKTFF | A-11 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GWLKRWKTLW | A-12 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 320 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Low hemolytic | ||
| 34180670 | 2021 | GWWKRIKTWW | A-13 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 102.54 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | NA | ||
| 34180670 | 2021 | GIRWKFWKFT | A-14 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | KWFKRIKTFW | A-15 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GLWKRWKKFW | A-16 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 83.63 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | NA | ||
| 34180670 | 2021 | KWWKRWKKWW | A-17 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 77.65 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | NA | ||
| 34180670 | 2021 | GFFRRIKTFF | A-18 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GFFKRIRTFF | A-19 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GFFRRIRTFF | A-20 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | KWWKKWKKWW | A-21 | Free | Free | Linear | L | None | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 134.38 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | NA | ||
| 34180670 | 2021 | RWWRRWRRWW | A-22 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 43.67 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | NA | ||
| 34227804 | 2021 | {nnr:NLys}-F-{nnr:NLys}-F-{nnr:NLys}-F-{nnr:NLys}-F-{nnr:NLys}-F-{nnr:NLys}-F{nt:H}{ct:Amid} | CEP-124 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine | 12 | Antibacterial | 2.7 % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Low hemolytic | ||
| 34227804 | 2021 | {nnr:NLys}-L-{nnr:NLys}-L-{nnr:NLys}-L-{nnr:NLys}-L-{nnr:NLys}-L-{nnr:NLys}-L{nt:H}{ct:Amid} | CEP-126 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine | 12 | Antibacterial | 1.5 % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Low hemolytic | ||
| 34227804 | 2021 | {nnr:NLys}-Y-{nnr:NLys}-Y-{nnr:NLys}-Y-{nnr:NLys}-Y-{nnr:NLys}-Y-{nnr:NLys}-Y{nt:H}{ct:Amid} | CEP-129 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine | 12 | Antibacterial | 1.6 % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Low hemolytic | ||
| 34227804 | 2021 | {nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}{nt:H}{ct:Amid} | CEP-130 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine, Tyr(Me) = Tyr(Me) | 12 | Antibacterial | 3 % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Low hemolytic | ||
| 34227804 | 2021 | {nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}{nt:H}{ct:Amid} | CEP-136 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine, tBuAla = tBuAla | 12 | Antibacterial | 3.9 (±2.0) % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Low hemolytic | ||
| 34227804 | 2021 | {nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}{nt:H}{ct:Amid} | CEP-140 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine, Phe(4-NH2) = Phe(4-NH2) | 12 | Antibacterial | 0.1 % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Non-hemolytic | ||
| 34227804 | 2021 | {nnr:NOrn}-F-{nnr:NOrn}-F-{nnr:NOrn}-F-{nnr:NOrn}-F-{nnr:NOrn}-F-{nnr:NOrn}-F{nt:H}{ct:Amid} | CEP-144 | Amidation | H | Linear | L | NOrn = NOrn | 12 | Antibacterial | 5.5 (±2.5) % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Low hemolytic | ||
| 34577539 | 2021 | CRFKFRIVIC | mCA4-5 | Free | Free | Linear | L | None | 10 | Antibacterial | <6 % Hemolysis at 100 µM | Chicken | Chicken Angiogenin 4 (Chang4) | NA | Low hemolytic | ||
| 34564152 | 2021 | FFKRLKNAFKSARQAWRDYK | β-Pte20 | Free | Free | Linear | L | None | 20 | Antibacterial | <5 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | Low hemolytic | ||
| 34564152 | 2021 | FFKRLKNAFKSARQAWR | β-Pte17 | Free | Free | Linear | L | None | 17 | Antibacterial | <5 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | Low hemolytic | ||
| 34564152 | 2021 | FFKRLKNAFKSAR | β-Pte13 | Free | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | Low hemolytic | ||
| 34564152 | 2021 | FFKRLKNAFK | β-Pte10 | Free | Free | Linear | L | None | 10 | Antibacterial | <5 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | NA | Low hemolytic | ||
| 34564152 | 2021 | FFRHLKSLWKGAKAAFRGAR | γ-Pte20 | Free | Free | Linear | L | None | 20 | Antibacterial | <10 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | Low hemolytic | ||
| 34564152 | 2021 | FFRHLKSLWKGAKAAFR | γ-Pte17 | Free | Free | Linear | L | None | 17 | Antibacterial | <10 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | Low hemolytic | ||
| 34564152 | 2021 | FFRHLKSLWKGAK | γ-Pte13 | Free | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | Low hemolytic | ||
| 34564152 | 2021 | FFRHLKSLWK | γ-Pte10 | Free | Free | Linear | L | None | 10 | Antibacterial | <10 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | NA | Low hemolytic | ||
| 34564152 | 2021 | FFRHLKSLWKGAKAAFRGAR | γ-Pte20 | Free | Free | Linear | L | None | 20 | Antibacterial | 19 % Hemolysis at 200 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | NA | ||
| 34564152 | 2021 | FFRHLKSLWKGAKAAFR | γ-Pte17 | Free | Free | Linear | L | None | 17 | Antibacterial | 43 % Hemolysis at 200 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | NA | ||
| 34159664 | 2021 | RGGRLCYCRRRFCVCVGR{nt:H}{ct:Amid} | PG-1 | Amidation | H | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at 6.3±1.6 µM | Human | Wild Boar Porcine Leukocytes (Sus Scrofa) | antiparallel β-Sheet | NA | ||
| 34526600 | 2021 | KRIVQRIKDWLRKLCKKW | CaD23 | Free | Free | Linear | L | None | 18 | Antibacterial | 7.1 % Hemolysis at 200 μg/ml | Human | 2Nd Generation Hyhdps (Human-Derived Hybrid Host Defense Peptides) | NA | Low hemolytic | ||
| 34576320 | 2021 | SWKSMAKKLKEYMEKLKQRA{ct:Amid} | Ltc3a | Amidation | Free | Linear | L | None | 20 | Antibacterial | 16 % Hemolysis at 256 μg/ml | Human | Spider Lachesana Tarabaevi | vesicles composed of DMPC/DMPG (7/3) = α-Helix | Low hemolytic | ||
| 34033840 | 2021 | KLQVVPAIHLVWLQK{ct:Amid} | Psacotheasin-2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antiseptic, Anti-inflammatory | 0 % Hemolysis at 100 μg/ml | Mouse | Transcriptome Of Beetle Psacothea Hilaris | NA | Non-hemolytic | ||
| 34037941 | 2021 | GFRKFMRRLKKFF{ct:Amid} | Pb2-1 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Mutant Of Cathpb2 | α-Helical | Non-hemolytic | ||
| 34037941 | 2021 | GFRKFMRRLKK{ct:Amid} | Pb2-2 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Mutant Of Cathpb2 | NA | Non-hemolytic | ||
| 34037941 | 2021 | FFRKFFRRFKK{ct:Amid} | Pb2-3F | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Mutant Of Cathpb2 | NA | Non-hemolytic | ||
| 34037941 | 2021 | GFRKFWRRWKK{ct:Amid} | Pb2-2W | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Mutant Of Cathpb2 | NA | Non-hemolytic | ||
| 34037941 | 2021 | GWRKWWRRWKK{ct:Amid} | Pb2-4W | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Mutant Of Cathpb2 | NA | Non-hemolytic | ||
| 34037941 | 2021 | WWRKWWRRWKK{ct:Amid} | Pb2-5W | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Mutant Of Cathpb2 | NA | Non-hemolytic | ||
| 34482475 | 2021 | GRVPDNPKAPP | BPP-Bax11 | Free | Free | Linear | L | None | 11 | Antibacterial | 1.8 % Hemolysis at 250 μg/mL | Human | Snake Venom Of Bothrops Atrox | NA | Non-hemolytic | ||
| 34680789 | 2021 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF-OR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 100 % Hemolysis at 100 μg/mL | Human | Wasp Eumenine Anterhynchium Flavomarginatum Micado | water = 17.73% Helical, 50% TFE = Helical | NA | ||
| 34680789 | 2021 | INKLVIKVGKIVSL{ct:Amid} | EMP-AF-KV | Amidation | Free | Linear | L | None | 14 | Antifungal | >50 % Hemolysis at 100 μg/mL | Human | Emp-Af Analog | 50% TFE = Helical | NA | ||
| 34680789 | 2021 | FDI{nnr:M*}GLIKKVAGAL{ct:Amid} | EMP-ER-OR | Amidation | Free | Linear | L | M* = Methionine in sulfoxide form | 14 | Antifungal | 0 % Hemolysis at 100 μg/mL | Human | Wasp Eumenes Rubrofemoratus | 50% TFE = Helical | Non-hemolytic | ||
| 34680789 | 2021 | FDI{nnr:M*}GLIEEVAGAL{ct:Amid} | EMP-ER-KE | Amidation | Free | Linear | L | M* = Methionine in sulfoxide form | 14 | Antifungal | >30 % Hemolysis at 100 μg/mL | Human | Emp-Er Analog | water = Random, 50% TFE = Helical | NA | ||
| 34680789 | 2021 | FKI{nnr:M*}GLIKKVAGAL{ct:Amid} | EMP-ER-D2K2 | Amidation | Free | Linear | L | M* = Methionine in sulfoxide form | 14 | Antibacterial, Antifungal | ~50 % Hemolysis at 100 μg/mL | Human | Emp-Er Analog | 50% TFE = Helical | NA | ||
| 34680789 | 2021 | FDI{nnr:M*}GLIKKVA{ct:Amid} | EMP-ER-C3 | Amidation | Free | Linear | L | M* = Methionine in sulfoxide form | 11 | Antifungal | ~50 % Hemolysis at 100 μg/mL | Human | Emp-Er Analog | 50% TFE = Helical | NA | ||
| 34721331 | 2021 | VKKLVKKAVKKLVKKA{ct:Amid} | VL1 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKLVKKLVKKAVKKA{ct:Amid} | VL2 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKLVKKLVKKLVKKA{ct:Amid} | VL3 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKLVKKLVKKAVKKL{ct:Amid} | VL4 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKLVKKLVKKLVKKL{ct:Amid} | VL5 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKWVKKAVKKWVKKA{ct:Amid} | VW1 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKWVKKWVKKAVKKA{ct:Amid} | VW2 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKWVKKWVKKAVKKW{ct:Amid} | VW3 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKWVKKWVKKWVKKA{ct:Amid} | VW4 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKWVKKWVKKWVKKW{ct:Amid} | VW5 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | sodium phosphate buffer = unordered, 50% TFE = α-Helical | Low hemolytic | ||
| 34738013 | 2021 | FIPLVSGLFSKLL{ct:Amid} | Temporin-FL | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 157.4 μM | Horse | Frog Pelophylax Nigromaculatus | 50%TFE/NH4Ac = Helix | NA | ||
| 34738013 | 2021 | FIPLVSGLFKLL{ct:Amid} | Temporin-FLa | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 74.02 μM | Horse | Temporin-Fl Truncated Analogues | 50%TFE/NH4Ac = Helix | NA | ||
| 34738013 | 2021 | FIPVSGLFKLL{ct:Amid} | Temporin-FLb | Amidation | Free | Linear | L | None | 11 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 356 μM | Horse | Temporin-Fl Truncated Analogues | 50%TFE/NH4Ac = Helix | Low hemolytic | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:OH} | RR4-OH | OH | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 3.2 ± 1.0 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | WIRRIKKWIRRVHK{ct:Amid} | RR2-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 13.0 ± 1.7 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRKRK{ct:Amid} | RR3-NH2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 19.0 ± 3.3 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:Amid} | RR4-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 64.3 ± 5.4 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VFWRRIRVWVIR{ct:Amid} | LJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 28.4 ± 1.9 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 35.1 ± 8.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RIVWVRIRRWFV{ct:Amid} | RJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 19.2 ± 3.1 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm, Anti-inflammatory | 79.0 ± 0.6 % Hemolysis at 150 μM | Horse | Ll-37 Derivatives Synthetic Peptide | α-Helical | NA | ||
| 34819923 | 2021 | WKKIRVRLSA{ct:Amid} | SB056 | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 1.7 ± 0.2 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | GILGKLWEGVKSIF{ct:Amid} | HP1404 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 100.0 ± 0.5 % Hemolysis at 150 μM | Horse | Scorpion Heterometrus Petersii | NA | NA | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid} | HP1404 T1-D | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial, Antibiofilm | 0.3 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid} | HP1404 T1-E | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 0.8 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | FLFSLIPHAIGGLISAFK{ct:Amid} | AamAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.00 ± 1.3 % Hemolysis at 150 μM | Horse | Scorpion Venom Antimicrobial Peptide | NA | NA | ||
| 34819923 | 2021 | FLFSLIPKAIGGLISAFK{ct:Amid} | AamAP-S1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.00 ± 4.9 % Hemolysis at 150 μM | Horse | Aamap1 Analog | NA | NA | ||
| 34819923 | 2021 | FLFSLIPRAIGGLISAFK{ct:Amid} | AamAP-R | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.00 ± 4.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAK{ct:Amid} | Magainin 2(1-10) | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0.0 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 95.1 ± 5.0 % Hemolysis at 150 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid} | BP525 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 3.1 ± 1.0 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid} | BP526 | Amidation | C3H7CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 8.3 ± 0.7 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid} | BP527 | Amidation | C5H11CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 62.2 ± 4.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid} | BP528 | Amidation | C11H23CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 92.1 ± 5.7 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid} | BP529 | Amidation | HOC11H22CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 7.2 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 35.6 ± 4.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRVIRK{ct:Amid} | HH15 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 2.3 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQWRIRVRVIKK{ct:Amid} | 1026 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 7.6 ± 0.8 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQFRIRVRIVIRK{ct:Amid} | 1036 | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 6.5 ± 0.6 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV7-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 6.3 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA-OH{ct:OH} | RR4-OH | OH | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 9.8 ± 3.7 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | WIRRIKKWIRRVHK{ct:Amid} | RR2-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 14.0 ± 1.8 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRKRK{ct:Amid} | RR3-NH2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 30.8 ± 4.2 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:Amid} | RR4-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 85.0 ± 5.7 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VFWRRIRVWVIR{ct:Amid} | LJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 43.9 ± 3.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 64.4 ± 9.4 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RIVWVRIRRWFV{ct:Amid} | RJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 29.6 ± 2.2 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm, Anti-inflammatory | 96.1 ± 1.8 % Hemolysis at 250 μM | Horse | Ll-37 Derivatives Synthetic Peptide | α-Helical | NA | ||
| 34819923 | 2021 | WKKIRVRLSA{ct:Amid} | SB056 | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 1.8 ± 0.3 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | GILGKLWEGVKSIF{ct:Amid} | HP1404 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 100.0 ± 3.9 % Hemolysis at 250 μM | Horse | Scorpion Heterometrus Petersii | NA | NA | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid} | HP1404 T1-D | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial, Antibiofilm | 0.8 ± 1.1 % Hemolysis at 250 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid} | HP1404 T1-E | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 0.7 ± 0.4 % Hemolysis at 250 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | FLFSLIPHAIGGLISAFK{ct:Amid} | AamAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 4.1 % Hemolysis at 250 μM | Horse | Scorpion Venom Antimicrobial Peptide | NA | NA | ||
| 34819923 | 2021 | FLFSLIPKAIGGLISAFK{ct:Amid} | AamAP-S1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 2.1 % Hemolysis at 250 μM | Horse | Aamap1 Analog | NA | NA | ||
| 34819923 | 2021 | FLFSLIPRAIGGLISAFK{ct:Amid} | AamAP-R | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 10.5 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAK{ct:Amid} | Magainin 2(1-10) | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0.0 ± 0.2 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 100.0 ± 4.4 % Hemolysis at 250 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid} | BP525 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 3.8 ± 0.8 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid} | BP526 | Amidation | C3H7CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 20.4 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid} | BP527 | Amidation | C5H11CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 73.6 ± 1.1 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid} | BP528 | Amidation | C11H23CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 96.6 ± 3.1 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid} | BP529 | Amidation | HOC11H22CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 12.5 ± 0.6 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 43.0 ± 0.2 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRVIRK{ct:Amid} | HH15 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 4.5 ± 1.9 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQWRIRVRVIKK{ct:Amid} | 1026 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 10.8 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQFRIRVRIVIRK{ct:Amid} | 1036 | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 11.0 ± 1.6 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV7-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 8.0 ± 1.3 % Hemolysis at 250 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:OH} | RR4-OH | OH | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 17.8 ± 0.3 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WIRRIKKWIRRVHK{ct:Amid} | RR2-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 17.9 ± 0.4 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRKRK{ct:Amid} | RR3-NH2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 37.3 ± 4.4 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:Amid} | RR4-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 100.0 ± 5.4 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VFWRRIRVWVIR{ct:Amid} | LJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 72.4 ± 8.9 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 71.0 ± 7.1 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RIVWVRIRRWFV{ct:Amid} | RJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 50.2 ± 5.4 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm, Anti-inflammatory | 100.0 ± 1.7 % Hemolysis at 375 μM | Horse | Ll-37 Derivatives Synthetic Peptide | α-Helical | NA | ||
| 34819923 | 2021 | WKKIRVRLSA{ct:Amid} | SB056 | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 2.3 ± 0.7 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | GILGKLWEGVKSIF{ct:Amid} | HP1404 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 100.0 ± 0.7 % Hemolysis at 375 μM | Horse | Scorpion Heterometrus Petersii | NA | NA | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid} | HP1404 T1-D | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial, Antibiofilm | 1.3 ± 0.2 % Hemolysis at 375 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid} | HP1404 T1-E | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 1.5 ± 0.3 % Hemolysis at 375 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | FLFSLIPHAIGGLISAFK{ct:Amid} | AamAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 4.4 % Hemolysis at 375 μM | Horse | Scorpion Venom Antimicrobial Peptide | NA | NA | ||
| 34819923 | 2021 | FLFSLIPKAIGGLISAFK{ct:Amid} | AamAP-S1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 2.9 % Hemolysis at 375 μM | Horse | Aamap1 Analog | NA | NA | ||
| 34819923 | 2021 | FLFSLIPRAIGGLISAFK{ct:Amid} | AamAP-R | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 3.1 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAK{ct:Amid} | Magainin 2(1-10) | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0.0 ± 0.7 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 100.0 ± 2.5 % Hemolysis at 375 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid} | BP525 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 10.0 ± 5.9 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid} | BP526 | Amidation | C3H7CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 46.8 ± 3.3 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid} | BP527 | Amidation | C5H11CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 100.0 ± 2.6 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid} | BP528 | Amidation | C11H23CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 99.1 ± 8.0 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid} | BP529 | Amidation | HOC11H22CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 39.0 ± 1.1 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 45.9 ± 4.9 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRVIRK{ct:Amid} | HH15 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 4.0 ± 0.4 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQWRIRVRVIKK{ct:Amid} | 1026 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 14.5 ± 5.5 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VQFRIRVRIVIRK{ct:Amid} | 1036 | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 17.3 ± 1.3 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV7-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 9.7 ± 0.6 % Hemolysis at 375 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34508563 | 2021 | FFPLIFGALSSILPKIL | Temporin-HLa | Free | Free | Linear | L | None | 17 | Antimicrobial, Anticancer, Antibiofilm | 50 % Hemolysis at 31.4 ± 0.7 μM | Horse | Broad-Folded Frog, Hylarana Latouchii | aqueous = Random coil, 50% TFE = α-Helical | NA | ||
| 34508563 | 2021 | FLQHIIGALSHIF | Temporin-HLb | Free | Free | Linear | L | None | 13 | Antimicrobial, Anticancer, Antibiofilm | 50 % Hemolysis at 18.6 ± 10.0 mM | Horse | Broad-Folded Frog, Hylarana Latouchii | aqueous = Random coil, 50% TFE = α-Helical | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | 13.03±0.00 % Hemolysis at 400 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | 11.44±0.25 % Hemolysis at 200 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | 10.74±0.75 % Hemolysis at 100 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | 9.15±1.99 % Hemolysis at 50 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | 6.34±4.98 % Hemolysis at 25 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | 4.58±4.48 % Hemolysis at 12.5 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | -0.18±0.75 % Hemolysis at 6.25 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 11.44±1.24 % Hemolysis at 400 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 9.33±1.74 % Hemolysis at 200 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 8.63±3.24 % Hemolysis at 100 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 7.22±3.73 % Hemolysis at 50 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 5.99±3.98 % Hemolysis at 25 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 4.05±3.24 % Hemolysis at 12.5 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 0.35±0.50 % Hemolysis at 6.25 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | 10.56±1.99 % Hemolysis at 400 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | 9.68±2.74 % Hemolysis at 200 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | 8.27±3.73 % Hemolysis at 100 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | 7.04±3.98 % Hemolysis at 50 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | 5.81±3.73 % Hemolysis at 25 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | 3.52±4.98 % Hemolysis at 12.5 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | -0.53±0.75 % Hemolysis at 6.25 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 22.18±1.99 % Hemolysis at 400 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 18.13±0.25 % Hemolysis at 200 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 15.85±1.49 % Hemolysis at 100 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 12.15±0.25 % Hemolysis at 50 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 8.27±1.74 % Hemolysis at 25 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 4.93±2.49 % Hemolysis at 12.5 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 0.7±0.50 % Hemolysis at 6.25 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34867843 | 2021 | FLLKIVALLKKKLL | PHNX-1 | Free | Free | Linear | L | None | 14 | Antibacterial | ~40 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | Helical | NA | ||
| 34867843 | 2021 | FLLKLGLGKKKLL | PHNX-4 | Free | Free | Linear | L | None | 13 | Antibacterial | ~10 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | Random coil | NA | ||
| 34867843 | 2021 | FLIKILKGGKGGK | PHNX-5 | Free | Free | Linear | L | None | 13 | Antibacterial | ~10 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | Random coil | NA | ||
| 34867843 | 2021 | FIGAIASYLKKFR | PHNX-6 | Free | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | Random coil Helical | Low hemolytic | ||
| 34867962 | 2021 | FLPLLISALTSLFPKLGK | SSTP1 | Free | Free | Linear | L | None | 18 | Anticancer | 0.25 % Hemolysis at 5 μM | Human | Frog Indosylvirana Aurantiaca Host Defense Peptide | NA | Low hemolytic | ||
| 34959645 | 2021 | GIKEFKRIVQRIKDFLRNLV{ct:Amid} | GI-20 | Amidation | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 50 % Hemolysis at ~160 μM | Human | Ll-37 Derived Peptide | PBS, 60mMSDS = Helical | NA | ||
| 34959645 | 2021 | GFKRIVQRIKDFLRNLV{ct:Amid} | GF-17 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 50 % Hemolysis at 175 μM | Human | Ll-37 Derived Peptide | PBS, 60mMSDS = Helical | NA | ||
| 34959645 | 2021 | G{nnr:X}KRlVQRlKD{nnr:X}LRNLV{ct:Amid} | 17BIPHE2 | Amidation | Free | Linear | Mix | X = biphenylalanines | 17 | Antibacterial, Antibiofilm | 50 % Hemolysis at ~200 μM | Human | Ll-37 Derived Peptide | PBS = distorted, 60mMSDS = Helical | NA | ||
| 34959645 | 2021 | RIVQRIKDFL{ct:Amid} | RI-10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | <25 % Hemolysis at 200 μM | Human | Ll-37 Derived Peptide | PBS = distorted, 60mMSDS = Helical | Low hemolytic | ||
| 34977576 | 2021 | {nnr:B}KKLLKCLKCL{cyc:7-10} | bp3 | Free | Free | Bicyclic | L | B = 3,5-bis(methylene)toluoyl | 11 | Antibacterial | MHC at 500 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | Low hemolytic | ||
| 34977576 | 2021 | {nnr:B}KKLLKCLKCLL{cyc:7-10} | bp65 | Free | Free | Bicyclic | L | B = 3,5-bis(methylene)toluoyl | 12 | Antibacterial | MHC at 16.6 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | NA | ||
| 34977576 | 2021 | {nnr:B}K{d}KL{d}LK{d}CL{d}KC{d}LL{d}{cyc:7-10} | bp67 | Free | Free | Bicyclic | Mix | B = 3,5-bis(methylene)toluoyl | 12 | Antibacterial | MHC at >2000 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | Low hemolytic | ||
| 34977576 | 2021 | {nnr:B}KKLLKC{d}LKC{d}LL{cyc:7-10} | bp68 | Free | Free | Bicyclic | Mix | B = 3,5-bis(methylene)toluoyl | 12 | Antibacterial | MHC at 16.6 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | NA | ||
| 34977576 | 2021 | {nnr:B}K{d}K{d}LLK{d}CLK{d}CLL{cyc:7-10} | bp69 | Free | Free | Bicyclic | Mix | B = 3,5-bis(methylene)toluoyl | 12 | Antibacterial | MHC at 16.6 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | NA | ||
| 34977576 | 2021 | KKLLKLLKLLL | ln65 | Free | Free | Linear | L | None | 12 | Antibacterial | MHC at 125 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | NA | ||
| 34977576 | 2021 | {nnr:Tol}-KKLLK-{nnr:Cm}-LK-{nnr:Cm}-LL | ln65b | Free | Free | Linear | L | Tol = toluoyl group, Cm = S-methyl cysteine | 12 | Antibacterial | MHC at 16.6 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | NA | ||
| 34977576 | 2021 | K{d}K{d}LLK{d}LLK{d}LLL | ln69 | Free | Free | Linear | Mix | None | 12 | Antibacterial | MHC at 1000 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | Low hemolytic | ||
| 34977576 | 2021 | {nnr:Tol}-K{d}K{d}LLK{d}-{nnr:Cm}-LK{d}-{nnr:Cm}-LL | ln69b | Free | Free | Linear | Mix | Tol = toluoyl group, Cm = S-methyl cysteine | 12 | Antibacterial | MHC at 1000 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | Low hemolytic | ||
| 34966279 | 2021 | VRKPPYLPRPRPRPL{ct:Amid} | consP1 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at >139 μM | Human | Consensus Sequence Derived From Multiple Alignment | NA | Low hemolytic | ||
| 34966279 | 2021 | RWRRPIRRRPIRPPFWR{ct:Amid} | Bac5-v291 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 50 % Hemolysis at >278 μM | Human | Optimized Bac5(1–17) Variant 291 | NA | Low hemolytic | ||
| 34941705 | 2021 | ASIGALIQKAIALIKAKAA{nt:Amid}{ct:Amid} | LVTX-9 | Amidation | Amidation | Linear | L | None | 19 | Anticancer | 0 % Hemolysis at 200 μM | Human | Venom Gland Of The Spider Lycosa Vittata | ultrapure water = Random coil, SDS = α-Helical | Non-hemolytic | ||
| 34966367 | 2021 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial | 2.3 % Hemolysis at 64 μM | Sheep | Venom Sac Of The Solitary Wasp | phosphate buffer = Random coil, membrane-mimicking environments = α-Helical | Low hemolytic | ||
| 34966367 | 2021 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial | 0.6 % Hemolysis at 32 μM | Sheep | Venom Sac Of The Solitary Wasp | phosphate buffer = Random coil, membrane-mimicking environments = α-Helical | Low hemolytic | ||
| 34966367 | 2021 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial | 0.7 % Hemolysis at 16 μM | Sheep | Venom Sac Of The Solitary Wasp | phosphate buffer = Random coil, membrane-mimicking environments = α-Helical | Low hemolytic | ||
| 34966367 | 2021 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial | 1.3 % Hemolysis at 8 μM | Sheep | Venom Sac Of The Solitary Wasp | phosphate buffer = Random coil, membrane-mimicking environments = α-Helical | Low hemolytic | ||
| 34966367 | 2021 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial | 0.5 % Hemolysis at 4 μM | Sheep | Venom Sac Of The Solitary Wasp | phosphate buffer = Random coil, membrane-mimicking environments = α-Helical | Low hemolytic | ||
| 34796903 | 2021 | PARDVLNTTSG{ct:Amid} | P264-G274 | Amidation | Free | Linear | L | None | 11 | Anticancer | 12.2 % Hemolysis at 150 μM | Sheep | Toxin Ps2Aa1 Parasporin-2Aa1 | α-Helix | NA | ||
| 34796903 | 2021 | NNETYFNAVKP{ct:Amid} | Loop1-PS2Aa | Amidation | Free | Linear | L | None | 11 | Anticancer | 18.1 % Hemolysis at 150 μM | Sheep | Toxin Ps2Aa1 Parasporin-2Aa1 | α-Helix | NA | ||
| 34796903 | 2021 | TYFNAVKPPITA{ct:Amid} | Loop2-PS2Aa | Amidation | Free | Linear | L | None | 12 | Anticancer | 9.4 % Hemolysis at 150 μM | Sheep | Toxin Ps2Aa1 Parasporin-2Aa1 | α-Helix | NA | ||
| 34796903 | 2021 | FKPQSGGGKCF{ct:Amid} | Loop1-HCoV-229E | Amidation | Free | Linear | L | None | 11 | Anticancer | 9.2 % Hemolysis at 150 μM | Sheep | Spike Protein Of The Alphacoronavirus Hcov-229E | β-lSheet | NA | ||
| 34796903 | 2021 | FLGWLFKVASK{ct:Amid} | A4W-GGN5 | Amidation | Free | Linear | L | None | 11 | Antimicrobial, Anticancer | 23 % Hemolysis at 150 μM | Sheep | Na | NA | NA | ||
| 34825276 | 2022 | INWLKLGKMVIDAL{ct:Amid} | MPII | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 100 % Hemolysis at 256 μM | Mouse | Social Wasp Polybia Paulista | α-Helix | NA | ||
| 34825276 | 2022 | INWLHLGHMVIDAL{ct:Amid} | HMPII | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | >30 % Hemolysis at 256 μM | Mouse | Mpii Analogs | 10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical | NA | ||
| 34825276 | 2022 | INWLRLGRMVIDAL{ct:Amid} | RMPII | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 100 % Hemolysis at 256 μM | Mouse | Mpii Analogs | 10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical | NA | ||
| 34825276 | 2022 | INWL{nnr:O}LG{nnr:O}MVIDAL{ct:Amid} | OMPII | Amidation | Free | Linear | L | O = L-Ornithine | 14 | Antibacterial, Antifungal | 100 % Hemolysis at 256 μM | Mouse | Mpii Analogs | 10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical | NA | ||
| 34825276 | 2022 | INWL-{nnr:Dab}-LG-{nnr:Dab}-MVIDAL{ct:Amid} | BMPII | Amidation | Free | Linear | L | Dab = L-2, 4-Diamino butyric acids | 14 | Antibacterial, Antifungal | 100 % Hemolysis at 256 μM | Mouse | Mpii Analogs | 10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical | NA | ||
| 34825276 | 2022 | INWL-{nnr:Dap}-LG-{nnr:Dap}-MVIDAL{ct:Amid} | PMPII | Amidation | Free | Linear | L | Dap = L-2,3-Diamino-propionic | 14 | Antibacterial, Antifungal, Antibiofilm | 0 % Hemolysis at 256 μM | Mouse | Mpii Analogs | 10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical | Non-hemolytic | ||
| 35013238 | 2022 | KK WRK WLK WLA KK | W3_p1 | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 5 % Hemolysis at 120 μg/ml | Human | Synthetic Peptide | Helical | NA | ||
| 35013238 | 2022 | KK WLK WLK WLK KK | W3_p2 | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 5 % Hemolysis at 90 μg/ml | Human | Synthetic Peptide | Helical | NA | ||
| 35013238 | 2022 | KK WKC WAR WRL KK | W3_db5 | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 5 % Hemolysis at >>240 μg/ml | Human | Synthetic Peptide | Helical | Non-hemolytic | ||
| 35056876 | 2022 | INLKAIAAFAKKLI | MpVT | Free | Free | Linear | L | None | 14 | Antibacterial | <10 % Hemolysis at 50 μg/ml | Human | Vespa Tropica, The Greater Banded Horne | Water = unordered, 40% TFE, = α-Helix | Low hemolytic | ||
| 35056876 | 2022 | INLKAIAAFAKKFI | MpVT1 | Free | Free | Linear | L | None | 14 | Antibacterial | <10 % Hemolysis at 50 μg/ml | Human | Mpvt Analog | Water = unordered, 40% TFE, = α-Helix | Low hemolytic | ||
| 35056876 | 2022 | INLKAIAAFAKALI | MpVT3 | Free | Free | Linear | L | None | 14 | Antibacterial | 50 % Hemolysis at 100 μg/ml | Human | Mpvt Analog | Water = unordered, 40% TFE, = α-Helix | NA | ||
| 35056876 | 2022 | KAIAAFAKKFI | MpVT4 | Free | Free | Linear | L | None | 11 | Antibacterial | <10 % Hemolysis at 50 μg/ml | Human | Mpvt Analog | Water = unordered, 40% TFE, = Random coil | Low hemolytic | ||
| 35056876 | 2022 | KAIAAFAKKFFI | MpVT5 | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 50 μg/ml | Human | Mpvt Analog | Water = unordered, 40% TFE, = Random coil | Low hemolytic | ||
| 35056876 | 2022 | KAIAAFAKALFI | MpVT6 | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 50 μg/ml | Human | Mpvt Analog | Water = unordered, 40% TFE, = Random coil | Low hemolytic | ||
| 35056876 | 2022 | KAIAAFAAKLFI | MpVT7 | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 50 μg/ml | Human | Mpvt Analog | Water = unordered, 40% TFE, = Random coil | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{ct:Amid} | RW-BP-100 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal, Antibiofilm | 3.10 ± 0.77 % Hemolysis at 50 μg/mL | Sheep | Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues | NA | NA | ||
| 35145500 | 2022 | R{d}RLFRRILRWL{ct:Amid} | RW-BP100-1D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 4.61 ± 0.47 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RR{d}LFRRILRWL{ct:Amid} | RW-BP100-2D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 4.83 ± 1.08 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRL{d}FRRILRWL{ct:Amid} | RW-BP100-3D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 3.49 ± 0.76 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLF{d}RRILRWL{ct:Amid} | RW-BP100-4D* | Amidation | Free | Linear | Mix | None | 11 | Antibacterial, Antifungal, Antibiofilm | 0.11 ± 0.19 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFR{d}RILRWL{ct:Amid} | RW-BP100-5D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 1.26 ± 0.54 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRR{d}ILRWL{ct:Amid} | RW-BP100-6D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 2.33 ± 1.51 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRI{d}LRWL{ct:Amid} | RW-BP100-7D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 0.53 ± 1.12 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRIL{d}RWL{ct:Amid} | RW-BP100-8D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 0.91 ± 0.38 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILR{d}WL{ct:Amid} | RW-BP100-9D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 0.63 ± 0.24 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRW{d}L{ct:Amid} | RW-BP100-10D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 0.31 ± 0.37 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{d}{ct:Amid} | RW-BP100-11D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 0.65 ± 0.60 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid} | RW-BP100-All-D | Amidation | Free | Linear | D | None | 11 | Antibacterial | 1.94 ± 0.94 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{cyc:N-C}{ct:Amid} | RW-BP100-cycle | Amidation | Free | Cyclic | L | None | 11 | Antibacterial | 0.47 ± 0.61 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{ct:Amid} | RW-BP-100 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal, Antibiofilm | 4.70 ± 0.49 % Hemolysis at 100 μg/mL | Sheep | Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues | NA | NA | ||
| 35145500 | 2022 | R{d}RLFRRILRWL{ct:Amid} | RW-BP100-1D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 5.49 ± 0.23 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RR{d}LFRRILRWL{ct:Amid} | RW-BP100-2D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 5.99 ± 0.79 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRL{d}FRRILRWL{ct:Amid} | RW-BP100-3D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 4.04 ± 0.20 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLF{d}RRILRWL{ct:Amid} | RW-BP100-4D* | Amidation | Free | Linear | Mix | None | 11 | Antibacterial, Antifungal, Antibiofilm | 3.69 ± 0.01 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFR{d}RILRWL{ct:Amid} | RW-BP100-5D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 2.49 ± 0.72 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRR{d}ILRWL{ct:Amid} | RW-BP100-6D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 3.25 ± 0.23 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRI{d}LRWL{ct:Amid} | RW-BP100-7D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 1.11 ± 0.19 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRIL{d}RWL{ct:Amid} | RW-BP100-8D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 1.38 ± 0.58 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILR{d}WL{ct:Amid} | RW-BP100-9D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 1.53 ± 0.09 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRW{d}L{ct:Amid} | RW-BP100-10D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 1.28 ± 0.19 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{d}{ct:Amid} | RW-BP100-11D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 1.42 ± 0.15 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid} | RW-BP100-All-D | Amidation | Free | Linear | D | None | 11 | Antibacterial | 2.75 ± 0.23 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{cyc:N-C}{ct:Amid} | RW-BP100-cycle | Amidation | Free | Cyclic | L | None | 11 | Antibacterial | 1.19 ± 0.05 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{ct:Amid} | RW-BP-100 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal, Antibiofilm | 41.82 ± 2.27 % Hemolysis at 150 μg/mL | Sheep | Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues | NA | NA | ||
| 35145500 | 2022 | R{d}RLFRRILRWL{ct:Amid} | RW-BP100-1D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 39.81 ± 0.20 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RR{d}LFRRILRWL{ct:Amid} | RW-BP100-2D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 39.16 ± 1.75 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRL{d}FRRILRWL{ct:Amid} | RW-BP100-3D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 38.13 ± 3.12 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLF{d}RRILRWL{ct:Amid} | RW-BP100-4D* | Amidation | Free | Linear | Mix | None | 11 | Antibacterial, Antifungal, Antibiofilm | 18.75 ± 0.42 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFR{d}RILRWL{ct:Amid} | RW-BP100-5D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 29.72 ± 0.94 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRR{d}ILRWL{ct:Amid} | RW-BP100-6D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 32.57 ± 1.20 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRI{d}LRWL{ct:Amid} | RW-BP100-7D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 16.17 ± 3.36 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRIL{d}RWL{ct:Amid} | RW-BP100-8D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 26.19 ± 0.10 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILR{d}WL{ct:Amid} | RW-BP100-9D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 18.14 ± 0.20 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRW{d}L{ct:Amid} | RW-BP100-10D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 19.20 ± 2.16 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRWL{d}{ct:Amid} | RW-BP100-11D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 17.36 ± 1.92 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid} | RW-BP100-All-D | Amidation | Free | Linear | D | None | 11 | Antibacterial | 30.39 ± 2.11 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRWL{cyc:N-C}{ct:Amid} | RW-BP100-cycle | Amidation | Free | Cyclic | L | None | 11 | Antibacterial | 17.23 ± 3.08 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRWL{ct:Amid} | RW-BP-100 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal, Antibiofilm | 56.67 ± 6.33 % Hemolysis at 300 μg/mL | Sheep | Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues | NA | NA | ||
| 35145500 | 2022 | R{d}RLFRRILRWL{ct:Amid} | RW-BP100-1D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 52.88 ± 3.06 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RR{d}LFRRILRWL{ct:Amid} | RW-BP100-2D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 62.12 ± 6.27 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRL{d}FRRILRWL{ct:Amid} | RW-BP100-3D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 55.73 ± 5.27 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLF{d}RRILRWL{ct:Amid} | RW-BP100-4D* | Amidation | Free | Linear | Mix | None | 11 | Antibacterial, Antifungal, Antibiofilm | 48.55 ± 2.53 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFR{d}RILRWL{ct:Amid} | RW-BP100-5D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 51.41 ± 4.64 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRR{d}ILRWL{ct:Amid} | RW-BP100-6D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 55.81 ± 2.87 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRI{d}LRWL{ct:Amid} | RW-BP100-7D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 45.65 ± 5.13 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRIL{d}RWL{ct:Amid} | RW-BP100-8D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 50.11 ± 3.17 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILR{d}WL{ct:Amid} | RW-BP100-9D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 45.18 ± 2.41 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRW{d}L{ct:Amid} | RW-BP100-10D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 45.08 ± 4.70 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRWL{d}{ct:Amid} | RW-BP100-11D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 46.97 ± 6.45 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid} | RW-BP100-All-D | Amidation | Free | Linear | D | None | 11 | Antibacterial | 51.40 ± 1.94 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRWL{cyc:N-C}{ct:Amid} | RW-BP100-cycle | Amidation | Free | Cyclic | L | None | 11 | Antibacterial | 48.67 ± 2.17 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35100952 | 2022 | KFVRSRRPRTASCALAFVN | ARF (26-44) | Free | Free | Linear | L | None | 19 | Antibacterial, Anticancer | 5 % Hemolysis at 250 μM | Mouse | Arf(Alternative Reading Frame) Proteins Are P19Arf In Mice | phosphate buffer = Random coil, 50% v/v TFE = α-Helix | Low hemolytic | ||
| 36358242 | 2022 | WLKKWLKKLL{ct:Amid} | WALK244.01 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 16 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | KWLLKWLKKL{ct:Amid} | WALK244.02 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 32 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | LKWLLKWLKK{ct:Amid} | WALK244.03 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 64 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | Low hemolytic | ||
| 36358242 | 2022 | LLKWLKKWLK{ct:Amid} | WALK244.04 | Amidation | Free | Linear | L | None | 10 | Antibacterial, Anti-inflammatory | 5 % Hemolysis at 64 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | Low hemolytic | ||
| 36358242 | 2022 | KLLKWLKKWL{ct:Amid} | WALK244.05 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 32 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | KKLLKWLLKW{ct:Amid} | WALK244.06 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 32 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | LKKWLKWLLK{ct:Amid} | WALK244.07 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 32 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | WLKKLLKWLK{ct:Amid} | WALK244.08 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 8 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | KWLKKLLKWL{ct:Amid} | WALK244.09 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 8 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | LKWLKKLLKW{ct:Amid} | WALK244.10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 32 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36430320 | 2022 | (CGKKWWGWKC)KL{cyc:N-C}{ct:Amid} | cTurg-2 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >1045 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGKKWGWWKC)KL{cyc:N-C}{ct:Amid} | cTurg-3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 849 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGKKPWWWKC)KL{cyc:N-C}{ct:Amid} | cTurg-4 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >1065 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGRRWWGWRC)RL{cyc:N-C}{ct:Amid} | cTurg-5 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >1101 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGRRWGWWRC)RL{cyc:N-C}{ct:Amid} | cTurg-6 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 1101 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGRRPWWWRC)RL{cyc:N-C}{ct:Amid} | cTurg-7 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 197 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | CGKKPGGWKCKL{nt:C8}{ct:Amid} | C8-Turg-1 | Amidation | C8 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >943 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | CGKKPGGWKCKL{nt:C10}{ct:Amid} | C10-Turg-1 | Amidation | C10 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >957 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | CGKKPGGWKCKL{nt:C12}{ct:Amid} | C12-Turg-1 | Amidation | C12 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >971 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | CGKKWWGWKCKL{nt:C8}{ct:Amid} | C8-Turg-2 | Amidation | C8 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 198 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | CGKKWWGWKCKL{nt:C10}{ct:Amid} | C10-Turg-2 | Amidation | C10 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 64 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | CGKKWWGWKCKL{nt:C12}{ct:Amid} | C12-Turg-2 | Amidation | C12 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 55 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | CGRRWGWWRCRL{nt:C8}{ct:Amid} | C8-Turg-6 | Amidation | C8 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 54 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | CGRRWGWWRCRL{nt:C10}{ct:Amid} | C10-Turg-6 | Amidation | C10 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 21 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | CGRRWGWWRCRL{nt:C12}{ct:Amid} | C12-Turg-6 | Amidation | C12 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 39 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | (CGKKPGGWKC)KL{cyc:N-C}{nt:C8}{ct:Amid} | C8-cTurg-1 | Amidation | C8 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >942 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGKKPGGWKC)KL{cyc:N-C}{nt:C10}{ct:Amid} | C10-cTurg-1 | Amidation | C10 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >956 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGKKPGGWKC)KL{cyc:N-C}{nt:C12}{ct:Amid} | C12-cTurg-1 | Amidation | C12 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 219 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | (CGKKWWGWKC)KL{cyc:N-C}{nt:C8}{ct:Amid} | C8-cTurg-2 | Amidation | C8 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 439 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGKKWWGWKC)KL{cyc:N-C}{nt:C10}{ct:Amid} | C10-cTurg-2 | Amidation | C10 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 106 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | (CGKKWWGWKC)KL{cyc:N-C}{nt:C12}{ct:Amid} | C12-cTurg-2 | Amidation | C12 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 32 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | (CGRRWGWWRC)RL{cyc:N-C}{nt:C8}{ct:Amid} | C8-cTurg-6 | Amidation | C8 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 30 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | (CGRRWGWWRC)RL{cyc:N-C}{nt:C10}{ct:Amid} | C10-cTurg-6 | Amidation | C10 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 16 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | (CGRRWGWWRC)RL{cyc:N-C}{nt:C12}{ct:Amid} | C12-cTurg-6 | Amidation | C12 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 9 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36432731 | 2022 | TGLGKIGYLMKKLLSKAKV | LS-AMP-F1 | Free | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm | 17 % Hemolysis at 200 μM | Mouse | Spider Lycosa Sinensis | α-Helical | Low hemolytic | ||
| 36432731 | 2022 | AGMKNIIDAIKKKLGGKL | LS-AMP-E1 | Free | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | <37.5 % Hemolysis at 200 μM | Mouse | Spider Lycosa Sinensis | α-Helical | Low hemolytic | ||
| 36559073 | 2022 | GWFSLVRKVVGGVGSL{ct:Amid} | Ramosin | Amidation | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 128 μM | Human | Colombian Salamander Bolitoglossa Ramosi | TFE 30% = α-Helical, water = Random coil | Non-hemolytic | ||
| 36500545 | 2022 | VVVNVLVKVLPPPVV{nt:Amid} | P1 | Free | Amidation | Linear | L | None | 15 | Anti-MRSA, Antibacterial | 3.40 ± 0.29 % Hemolysis at 2 μg/mL | Human | Soil Bacterium Brevibacillus Sp. Spr-20 | H2O = β-Strand and Random coil, 50 mM SDS = β-Strand, Random coil and α-Helical | NA | ||
| 36500545 | 2022 | VVVNVLVKVLPPPVV{nt:Amid} | P1 | Free | Amidation | Linear | L | None | 15 | Anti-MRSA, Antibacterial | 62.23 ± 0.69 % Hemolysis at 64 μg/mL | Human | Soil Bacterium Brevibacillus Sp. Spr-20 | H2O = β-Strand and Random coil, 50 mM SDS = β-Strand, Random coil and α-Helical | NA | ||
| 36500545 | 2022 | VVVNVLVKVLPPPVV{nt:Amid} | P1 | Free | Amidation | Linear | L | None | 15 | Anti-MRSA, Antibacterial | 1.64 ± 0.17 % Hemolysis at 0.25 μg/mL | Human | Soil Bacterium Brevibacillus Sp. Spr-20 | H2O = β-Strand and Random coil, 50 mM SDS = β-Strand, Random coil and α-Helical | NA | ||
| 36500545 | 2022 | VVVNVLVKVLPPPVV{nt:Amid} | P1 | Free | Amidation | Linear | L | None | 15 | Anti-MRSA, Antibacterial | 5.52 ± 0.92 % Hemolysis at 32 μg/mL | Human | Soil Bacterium Brevibacillus Sp. Spr-20 | H2O = β-Strand and Random coil, 50 mM SDS = β-Strand, Random coil and α-Helical | NA | ||
| 36548751 | 2022 | AGLGKIGAFIKKAAIKAKAA{ct:Amid} | M-lycotoxin-Lp5a | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36548751 | 2022 | AGLGKIGALIKKAAIKAKAA{ct:Amid} | M-lycotoxin-Lp5b | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36548751 | 2022 | SKWKAFLAKMKEIASEAL{ct:Amid} | M-lycotoxin-Lp6 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36442155 | 2022 | RRRWWWWWWW{cyc:N-C} | 3e | Free | Free | Cyclic | L | None | 10 | Antibacterial | 50 % Hemolysis at 60 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRWWWWWW{cyc:N-C} | 4c | Free | Free | Cyclic | L | None | 10 | Antibacterial | 50 % Hemolysis at 75 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRWWWWWWW{cyc:N-C} | 4d | Free | Free | Cyclic | L | None | 11 | Antibacterial | 50 % Hemolysis at 60 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRWWWWW{cyc:N-C} | 5b | Free | Free | Cyclic | L | None | 10 | Antibacterial | 50 % Hemolysis at 230 μg/mL | Human | Synthetic Cyclic Peptide | NA | Low hemolytic | ||
| 36442155 | 2022 | RRRRRWWWWWW{cyc:N-C} | 5c | Free | Free | Cyclic | L | None | 11 | Antibacterial | 50 % Hemolysis at 140 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRWWWWWWW{cyc:N-C} | 5d | Free | Free | Cyclic | L | None | 12 | Antibacterial | 50 % Hemolysis at 115 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRRWWWW{cyc:N-C} | 6a | Free | Free | Cyclic | L | None | 10 | Antibacterial | 50 % Hemolysis at 265 μg/mL | Human | Synthetic Cyclic Peptide | NA | Low hemolytic | ||
| 36442155 | 2022 | RRRRRRWWWWW{cyc:N-C} | 6b | Free | Free | Cyclic | L | None | 11 | Antibacterial | 50 % Hemolysis at 255 μg/mL | Human | Synthetic Cyclic Peptide | NA | Low hemolytic | ||
| 36442155 | 2022 | RRRRRRWWWWWW{cyc:N-C} | 6c | Free | Free | Cyclic | L | None | 12 | Antibacterial | 50 % Hemolysis at 170 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRRWWWWWWW{cyc:N-C} | 6d | Free | Free | Cyclic | L | None | 13 | Antibacterial | 50 % Hemolysis at 85 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRRRWWWW{cyc:N-C} | 7a | Free | Free | Cyclic | L | None | 11 | Antibacterial | 50 % Hemolysis at 190 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRRRWWWWW{cyc:N-C} | 7b | Free | Free | Cyclic | L | None | 12 | Antibacterial | 50 % Hemolysis at 175 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRRRWWWWWW{cyc:N-C} | 7c | Free | Free | Cyclic | L | None | 13 | Antibacterial | 50 % Hemolysis at 170 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRRRWWWWWWW{cyc:N-C} | 7d | Free | Free | Cyclic | L | None | 14 | Antibacterial | 50 % Hemolysis at 140 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36551443 | 2022 | RGGRLCYCRRRFCVCVGR | PG-1 | Free | Free | Linear | L | None | 18 | Antimycobacterial | 100 % Hemolysis at 1000 µg/mL | Human | Sus Domesticus | NA | NA | ||
| 36551443 | 2022 | AVKKLLRWWSRWWKK | AK 15-6 | Free | Free | Linear | L | None | 15 | Antimycobacterial | 33.57 % Hemolysis at 1000 µg/mL | Human | Mycobac Teriophage | NA | NA | ||
| 36551443 | 2022 | GRRRRSVQWCA | hLF 1-11(L-form) | Free | Free | Linear | L | None | 11 | Antimycobacterial | <1 % Hemolysis at 4000 µg/mL | Human | Homo Sapiens | NA | Non-hemolytic | ||
| 36551443 | 2022 | G{d}R{d}R{d}R{d}R{d}S{d}V{d}Q{d}W{d}C{d}A{d} | hLF 1-11(D-form) | Free | Free | Linear | D | None | 11 | Antimycobacterial | <1 % Hemolysis at 4000 µg/mL | Human | Homo Sapiens | NA | Non-hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 10.19 ± 2.29 % Hemolysis at 160 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 1.96 ± 0.13 % Hemolysis at 80 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.44 ± 0.44 % Hemolysis at 40 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.15 ± 0.23 % Hemolysis at 20 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.65 ± 0.22 % Hemolysis at 10 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.34 ± 0.31 % Hemolysis at 5 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.06 ± 0.08 % Hemolysis at 2.5 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.22 ± 0.20 % Hemolysis at 1.2 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.13 ± 0.23 % Hemolysis at 0.6 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.09 ± 0.16 % Hemolysis at 0.3 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36044968 | 2022 | MQLESAITHTLFK | rtVWF | Free | Free | Linear | L | None | 13 | Antimicrobial | ~1.5 % Hemolysis at 45.4 μM | Fish | Rainbow Trout (Oncorhynchus Mykiss) | NA | Non-hemolytic | ||
| 36044968 | 2022 | MQLESAITHTLFK | rtVWF | Free | Free | Linear | L | None | 13 | Antimicrobial | ~1.5 % Hemolysis at 11.3 μM | Fish | Rainbow Trout (Oncorhynchus Mykiss) | NA | Non-hemolytic | ||
| 36044968 | 2022 | MQLESAITHTLFK | rtVWF | Free | Free | Linear | L | None | 13 | Antimicrobial | ~1.5 % Hemolysis at 2.8 μM | Fish | Rainbow Trout (Oncorhynchus Mykiss) | NA | Non-hemolytic | ||
| 36336133 | 2022 | GLFWIIKKTIGKLR | Aurein N2 | Free | Free | Linear | L | None | 14 | Antifungal | <15 % Hemolysis at 500 μg/mL | Human | Modified Peptide Based On Aurein 1.2 | Random coil | Low hemolytic | ||
| 36336133 | 2022 | ILFWIKKLTIGKKR | Aurein N3 | Free | Free | Linear | L | None | 14 | Antifungal | <15 % Hemolysis at 500 μg/mL | Human | Modified Peptide Based On Aurein N2 | Random coil | Low hemolytic | ||
| 36336133 | 2022 | GLFDIIKKIAESF | Aurein 1.2 | Free | Free | Linear | L | None | 13 | Antimicrobial, Anticancer | >20 % Hemolysis at 500 μg/mL | Human | Skin Of Australian Bell Frogs, Ranoidea Aurea (Formerly Litoria Aurea) And R. Raniformis (Formerly L. Raniformis) | α-Helix | NA | ||
| 36336133 | 2022 | GLFWIIKKTIGKLR | Aurein N2 | Free | Free | Linear | L | None | 14 | Antifungal | <30 % Hemolysis at 1000 μg/mL | Human | Modified Peptide Based On Aurein 1.2 | Random coil | Low hemolytic | ||
| 36336133 | 2022 | ILFWIKKLTIGKKR | Aurein N3 | Free | Free | Linear | L | None | 14 | Antifungal | <20 % Hemolysis at 1000 μg/mL | Human | Modified Peptide Based On Aurein N2 | Random coil | Low hemolytic | ||
| 36336133 | 2022 | GLFDIIKKIAESF | Aurein 1.2 | Free | Free | Linear | L | None | 13 | Antimicrobial, Anticancer | <35 % Hemolysis at 1000 μg/mL | Human | Skin Of Australian Bell Frogs, Ranoidea Aurea (Formerly Litoria Aurea) And R. Raniformis (Formerly L. Raniformis) | α-Helix | NA | ||
| 36555393 | 2022 | GIGAVLKVLTTGLP{nt:(FITC)-Ahx = Fluorescein isothiocyanate} | FITC-melittin 1-14 | Free | (FITC)-Ahx = Fluorescein isothiocyanate | Linear | L | None | 14 | NA | <25 % Hemolysis at 40 μM | Mouse | Modified Melittin | NA | NA | ||
| 36555393 | 2022 | GIGAVLKVLTTGLPALISWI{nt:(FITC)-Ahx = Fluorescein isothiocyanate} | FITC-melittin 1-20 | Free | (FITC)-Ahx = Fluorescein isothiocyanate | Linear | L | None | 20 | NA | <25 % Hemolysis at 40 μM | Mouse | Modified Melittin | NA | NA | ||
| 36555393 | 2022 | VLTTGLPALISWI{nt:(FITC)-Ahx = Fluorescein isothiocyanate} | FITC-melittin 8-20 | Free | (FITC)-Ahx = Fluorescein isothiocyanate | Linear | L | None | 13 | NA | <25 % Hemolysis at 40 μM | Mouse | Modified Melittin | NA | NA | ||
| 36555393 | 2022 | VLTTGLPALISWIKR{nt:(FITC)-Ahx = Fluorescein isothiocyanate} | FITC-melittin 8-22 | Free | (FITC)-Ahx = Fluorescein isothiocyanate | Linear | L | None | 15 | NA | <25 % Hemolysis at 40 μM | Mouse | Modified Melittin | NA | NA | ||
| 36555393 | 2022 | VLTTGLPALISWIKRKRQQ{nt:(FITC)-Ahx = Fluorescein isothiocyanate} | FITC-melittin 8-26 | Free | (FITC)-Ahx = Fluorescein isothiocyanate | Linear | L | None | 19 | NA | <25 % Hemolysis at 40 μM | Mouse | Modified Melittin | NA | NA | ||
| 36555393 | 2022 | TTGLPALISWIKRKRQQ{nt:(FITC)-Ahx = Fluorescein isothiocyanate} | FITC-melittin 10-26 | Free | (FITC)-Ahx = Fluorescein isothiocyanate | Linear | L | None | 17 | NA | <25 % Hemolysis at 40 μM | Mouse | Modified Melittin | NA | NA | ||
| 36555393 | 2022 | GLPALISWIKRKRQQ{nt:(FITC)-Ahx = Fluorescein isothiocyanate} | FITC-melittin 12-26 | Free | (FITC)-Ahx = Fluorescein isothiocyanate | Linear | L | None | 15 | NA | <25 % Hemolysis at 40 μM | Mouse | Modified Melittin | NA | NA | ||
| 36555393 | 2022 | ALISWIKRKRQQ{nt:(FITC)-Ahx = Fluorescein isothiocyanate} | FITC-melittin 15-26 | Free | (FITC)-Ahx = Fluorescein isothiocyanate | Linear | L | None | 12 | NA | <25 % Hemolysis at 40 μM | Mouse | Modified Melittin | NA | NA | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 5 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 10 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 20 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 40 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 60 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 80 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 100 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36668862 | 2023 | LLKKVLALLKKVL{nt:Amid} | Hp-MAP3 | Free | Amidation | Linear | L | None | 13 | Antibacterial, Antibiofilm, Antifungal, Anticancer | ~15 % Hemolysis at 10.8 μM | mouse | Temporin-Pta Analog | 50% TFE or SDS = α-Helix | NA | ||
| 36668862 | 2023 | LLKKVLALLKKVL{nt:Amid} | Hp-MAP3 | Free | Amidation | Linear | L | None | 13 | Antibacterial, Antibiofilm, Antifungal, Anticancer | 25 % Hemolysis at 21.6 μM | mouse | Temporin-Pta Analog | 50% TFE or SDS = α-Helix | NA | ||
| 36668862 | 2023 | LLKKVLALLKKVL{nt:Amid} | Hp-MAP3 | Free | Amidation | Linear | L | None | 13 | Antibacterial, Antibiofilm, Antifungal, Anticancer | ~85 % Hemolysis at 43.3 μM | mouse | Temporin-Pta Analog | 50% TFE or SDS = α-Helix | NA | ||
| 36760504 | 2023 | VNFKLLSHSLLVTLRSHL | HJH-3 | Free | Free | Linear | L | None | 18 | Antibacterial | 7.31 % Hemolysis at 100 μg/mL | Chicken | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 36760504 | 2023 | VNFKLLSHSLLVTLRSHL | HJH-3 | Free | Free | Linear | L | None | 18 | Antibacterial | 13.37 % Hemolysis at 400 μg/mL | Chicken | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 36327032 | 2023 | RNCKWLFKTWLKLPK{nt:Amid} | RN15m4 | Free | Amidation | Linear | L | None | 15 | Antibacterial | <12 % Hemolysis at 200 μg/mL | Human | Analog Of Rn15 (Cathelin Domain Of Crocodylus Siamensis) | 73.33% α-Helix | Low hemolytic | ||
| 36769243 | 2023 | MKRKKKILIKKVLKLKSSAY | AMP 2 | Free | Free | Linear | L | None | 20 | Antibacterial | 14.9 ± 14.9 % Hemolysis at 100 µM | Mouse | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MKRKKKILIKKVLKLKSSAY | AMP 2 | Free | Free | Linear | L | None | 20 | Antibacterial | 5.2 ± 1.9 % Hemolysis at 100 µM | Rat | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MKRKKKILIKKVLKLKSSAY | AMP 2 | Free | Free | Linear | L | None | 20 | Antibacterial | 4.6 ± 0.7 % Hemolysis at 100 µM | Rabbit | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MKRKKKILIKKVLKLKSSAY | AMP 2 | Free | Free | Linear | L | None | 20 | Antibacterial | 8.5 ± 1.4 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | NA | ||
| 36837754 | 2023 | INLKAIAALAKKLF{ct:Amid} | Mastoparan-AF | Amidation | Free | Linear | L | None | 14 | Antibacterial | <5 % Hemolysis at 256 μg/mL | Sheep | Hornet Venom Of Vespa Affinis | Water = Disordered, SDS = Helical | Low hemolytic | ||
| 36837754 | 2023 | INLKAIAALAKKLF{ct:Amid} | Mastoparan-AF | Amidation | Free | Linear | L | None | 14 | Antibacterial | >35 % Hemolysis at 256 μg/mL | Chicken | Hornet Venom Of Vespa Affinis | Water = Disordered, SDS = Helical | NA | ||
| 36910465 | 2023 | KLWCKSSQVPQSR | ALA‐A2 | Free | Free | Linear | L | None | 13 | Anticancer | 7.8 ± 10.2 % Hemolysis at 200 µM | Human | Synthetic Peptide Sequence Of Alphalactalbumin | Helix–coil | Low hemolytic | ||
| 36910465 | 2023 | LFQISNKLWCKSSQVPQSRN | ALA‐A4 | Free | Free | Linear | L | None | 20 | NA | 0.7 ± 0.6 % Hemolysis at 200 µM | Human | Synthetic Peptide Sequence Of Alphalactalbumin | coil | Low hemolytic | ||
| 36979401 | 2023 | KWKWRPLKRKLVLRM | PAM-5 | Free | Free | Linear | L | None | 15 | Antibacterial | <1 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36914718 | 2023 | LGIKILWSAYKHRKTI{ct:CH3-(CH2)3-CONH} | L-6-C5 | CH3-(CH2)3-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at > 100 µM | Human | Synthetic Lippopeptide | NA | Low hemolytic | ||
| 36914718 | 2023 | LGIKILWSAYKHRKTI{ct:CH3-(CH2)3-CONH} | D-6-C5 | CH3-(CH2)3-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at > 100 µM | Human | Synthetic Lippopeptide | NA | Low hemolytic | ||
| 36914718 | 2023 | LGLKLLWSAYKHRKTL{ct:CH3-(CH2)3-CONH} | L-6-C5-Leu | CH3-(CH2)3-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at > 100 µM | Human | Synthetic Lippopeptide | NA | Low hemolytic | ||
| 36914718 | 2023 | LGLKLLWSAYKHRKTL{ct:CH3-(CH2)3-CONH} | D-6-C5-Leu | CH3-(CH2)3-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at > 100 µM | Human | Synthetic Lippopeptide | NA | Low hemolytic | ||
| 36914718 | 2023 | LGIKILWSAYKHRKTI{ct:CH3-(CH2)4-CONH} | L-6-C6 | CH3-(CH2)4-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at > 100 µM | Human | Synthetic Lippopeptide | NA | Low hemolytic | ||
| 36914718 | 2023 | LGIKILWSAYKHRKTI{ct:CH3-(CH2)4-CONH} | D-6-C6 | CH3-(CH2)4-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at > 100 µM | Human | Synthetic Lippopeptide | NA | Low hemolytic | ||
| 36914718 | 2023 | LGLKLLWSAYKHRKTL{ct:CH3-(CH2)4-CONH} | L-6-C6-Leu | CH3-(CH2)4-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 60 µM | Human | Synthetic Lippopeptide | NA | NA | ||
| 36914718 | 2023 | LGLKLLWSAYKHRKTL{ct:CH3-(CH2)4-CONH} | D-6-C6-Leu | CH3-(CH2)4-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 65 µM | Human | Synthetic Lippopeptide | NA | NA | ||
| 36914718 | 2023 | LGIKILWSAYKHRKTI{ct:CH3-(CH2)5-CONH} | L-6-C7 | CH3-(CH2)5-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 80 µM | Human | Synthetic Lippopeptide | NA | NA | ||
| 36914718 | 2023 | LGIKILWSAYKHRKTI{ct:CH3-(CH2)5-CONH} | D-6-C7 | CH3-(CH2)5-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 65 µM | Human | Synthetic Lippopeptide | NA | NA | ||
| 36914718 | 2023 | LGLKLLWSAYKHRKTL{ct:CH3-(CH2)5-CONH} | L-6-C7-Leu | CH3-(CH2)5-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 30 µM | Human | Synthetic Lippopeptide | NA | NA | ||
| 36914718 | 2023 | LGLKLLWSAYKHRKTL{ct:CH3-(CH2)5-CONH} | D-6-C7-Leu | CH3-(CH2)5-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 35 µM | Human | Synthetic Lippopeptide | NA | NA | ||
| 36982579 | 2023 | KRIVQRIKDFLR{ct:Amid} | KR12-NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Ll-37-Derived Peptide Fragment | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C8}{ct:Amid} | C8α-KR12-NH2 | Amidation | C8 | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 64 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | K({nnr:C8})RIVQRIKDFLR{ct:Amid} | C8ε-KR12-NH2 | Amidation | Free | Linear | L | C8 = C8 | 12 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | KKRIVQRIKDFLR{nt:C8}{ct:Amid} | C8α-Lys-KR12-NH2 | Amidation | C8 | Linear | L | C8 = C8 | 13 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | K({nnr:C8})KRIVQRIKDFLR{ct:Amid} | C8ε-Lys-KR12-NH2 | Amidation | Free | Linear | L | C8 = C8 | 13 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLRK({nnr:C8}){ct:Amid} | KR12-Lysε(C8)-NH2 | Amidation | Free | Linear | L | C8 = C8 | 13 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLK({nnr:C8}){ct:Amid} | [Lysε(C8)]12KR12-NH2 | Amidation | Free | Linear | L | C8 = C8 | 12 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | KRIVQRIK({nnr:C8})DFLR{ct:Amid} | [Lysε(C8)]8KR12-NH2 | Amidation | Free | Linear | L | C8 = C8 | 12 | Antibacterial | 5 % Hemolysis at 64 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | K({nnr:C8})RIVQRIKDFLR{nt:C8}{ct:Amid} | C8α,C8ε-KR12-NH2 | Amidation | C8 | Linear | L | C8 = C8 | 12 | Antibacterial | 5 % Hemolysis at 8 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | K({nnr:C4})RIVQRIKDFLR{nt:C4}{ct:Amid} | C4α, C4ε-KR12-NH2 | Amidation | C4 | Linear | L | C4 = C4 | 12 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | RLFDKIRQVIRK({nnr:C8}){ct:Amid} | retro-KR12-C8ε-NH2 | Amidation | Free | Linear | L | C8 = C8 | 12 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | RLFDKIRQVIRK{nt:C8}{ct:Amid} | C8α-retro-KR12-NH2 | Amidation | C8 | Linear | L | C8 = C8 | 12 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:CH3-(CH2)5-CH(C4H9)-CO}{ct:Amid} | 2-Buthyloctanoic acid-KR12-NH2 | Amidation | CH3-(CH2)5-CH(C4H9)-CO | Linear | L | CH3-(CH2)5-CH(C4H9)-CO | 12 | Antibacterial | 5 % Hemolysis at 16 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:CH3-(CH2)3-CH(C2H5)-CO}{ct:Amid} | 2-Ethylhexanoic acid-KR12-NH2 | Amidation | CH3-(CH2)3-CH(C2H5)-CO | Linear | L | CH3-(CH2)3-CH(C2H5)-CO | 12 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-CO}{ct:Amid} | Benzoic acid-KR12-NH2 | Amidation | C6H5-CO | Linear | L | C6H5-CO | 12 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-CH2-CO}{ct:Amid} | Phenylacetic acid-KR12-NH2 | Amidation | C6H5-CH2-CO | Linear | L | C6H5-CH2-CO | 12 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-CH2-CH2-CO}{ct:Amid} | 3-Phenylpropionic acid- KR12-NH2 | Amidation | C6H5-CH2-CH2-CO | Linear | L | C6H5-CH2-CH2-CO | 12 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-(CH2)3-CO}{ct:Amid} | 4-Phenylbutanoic acid-KR12-NH2 | Amidation | C6H5-(CH2)3-CO | Linear | L | C6H5-(CH2)3-CO | 12 | Antibacterial | 5 % Hemolysis at 128 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-CH=CH-CO}{ct:Amid} | trans-cinnamic acid-KR12-NH2 | Amidation | C6H5-CH=CH-CO | Linear | L | C6H5-CH=CH-CO | 12 | Antibacterial | 5 % Hemolysis at 128 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-C≡C-CO}{ct:Amid} | Phenylpropiolic acid-KR12-NH2 | Amidation | C6H5-C≡C-CO | Linear | L | C6H5-C≡C-CO | 12 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-C6H4-CO}{ct:Amid} | 4-Phenylbenzoic acid- KR12-NH2 | Amidation | C6H5-C6H4-CO | Linear | L | C6H5-C6H4-CO | 12 | Antibacterial | 5 % Hemolysis at 32 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C24H39O3}{ct:Amid} | Deoxycholic acid- KR12-NH2 | Amidation | C24H39O3 | Linear | L | C24H39O3 | 12 | Antibacterial | 5 % Hemolysis at 8 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 37007486 | 2023 | VFRLKKWIQKVI | FD10 | Free | Free | Linear | L | None | 12 | Antibacterial, Antifungal | 0.31 % Hemolysis at 256 μg/mL | Mouse | Protaetia Brevitarsis Lewis Larvae | α-Helix | Non-hemolytic | ||
| 37007486 | 2023 | KIYVLLRRQA | FD12 | Free | Free | Linear | L | None | 10 | Antibacterial | 0.4 % Hemolysis at 256 μg/mL | Mouse | Protaetia Brevitarsis Lewis Larvae | α-Helix | Non-hemolytic | ||
| 37007486 | 2023 | STLHLVLRLR{ct:Amid} | FD15 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 0.55 % Hemolysis at 256 μg/mL | Mouse | Protaetia Brevitarsis Lewis Larvae | α-Helix | Non-hemolytic | ||
| 36426386 | 2023 | GIFDVLKNLAKGVITSLAS{ct:Amid} | OCN-3N | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolysis at 56 ± 7 µM | Mouse | Caribbean Frog Leptodactylus Nesiotus | α-Helix | NA | ||
| 36426386 | 2023 | GIFKVLKNLAKGVITSLAS{ct:Amid} | [D4K]OCN-3N | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolysis at 107 ± 8 µM | Mouse | Ocellatin-3N Analogs | NA | NA | ||
| 36426386 | 2023 | GIFDVLKNLAKGVITSLKS{ct:Amid} | [A18K]OCN-3N | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolysis at >128 µM | Mouse | Ocellatin-3N Analogs | NA | NA | ||
| 36426386 | 2023 | GIFKVLKNLAKGVITSLKS{ct:Amid} | [D4K,A18K]OCN-3N | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolysis at >128 µM | Mouse | Ocellatin-3N Analogs | NA | NA | ||
| 37242633 | 2023 | VRLIVAVRIWRR{ct:Amid} | IDR1018 | Amidation | Free | Linear | L | None | 12 | Wound healing, Antibiofilm, Antibacterial | 20 % Hemolysis at 128 μg/mL | Human | Cationic Host Defense Peptides | NA | NA | ||
| 37242633 | 2023 | VRLIVAVRIWRR{nt:PEG6}{ct:Amid} | PEG6-IDR1018 | Amidation | PEG6 | Linear | L | None | 12 | Wound healing, Antibiofilm, Antibacterial | 0 % Hemolysis at 128 μg/mL | Human | Cationic Host Defense Peptides | NA | Non-hemolytic | ||
| 37242633 | 2023 | T({nnr:GlcNAc})VRLIVAVRIWRR{ct:Amid} | Glc-IDR1018 | Amidation | Free | Linear | L | GlcNAc = N-acetyl glucosamine | 13 | Wound healing, Antibiofilm, Antibacterial | 0 % Hemolysis at 128 μg/mL | Human | Cationic Host Defense Peptides | NA | Non-hemolytic | ||
| 36951612 | 2023 | AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5} | GLP6 | C6H12NO5 | C8H15O | Linear | L | None | 14 | Antibacterial, Antibiofilm | 5.15 % Hemolysis at 8 µM | mouse | Synthetic Glycosylated Lp6 Lipopeptide | SDS = 67.5% α-Helical, pure water =7 .38% α-Helical | NA | ||
| 36951612 | 2023 | AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5} | GLP6 | C6H12NO5 | C8H15O | Linear | L | None | 14 | Antibacterial, Antibiofilm | 15.6 % Hemolysis at 16 µM | mouse | Synthetic Glycosylated Lp6 Lipopeptide | SDS = 67.5% α-Helical, pure water =7 .38% α-Helical | NA | ||
| 36951612 | 2023 | AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5} | GLP6 | C6H12NO5 | C8H15O | Linear | L | None | 14 | Antibacterial, Antibiofilm | 60.67 % Hemolysis at 64 µM | mouse | Synthetic Glycosylated Lp6 Lipopeptide | SDS = 67.5% α-Helical, pure water =7 .38% α-Helical | NA | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 2.78 % Hemolysis at 4 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 2.98 % Hemolysis at 8 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 3.15 % Hemolysis at 16 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 3.83 % Hemolysis at 32 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 5.79 % Hemolysis at 64 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 6.64 % Hemolysis at 128 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 15.5 % Hemolysis at 256 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 24.53 % Hemolysis at 512 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 36868141 | 2023 | FLPLIAGKIFCAISKKC | Des(8–14)brevinin-1PMa | Free | Free | Linear | L | None | 17 | Antibacterial | 50 % Hemolysis at >200 µM | Mouse | Amazon River Frog Lithobates Palmipes | NA | Low hemolytic | ||
| 36868141 | 2023 | FLPFLGKLLSGIF{ct:Amid} | Temporin-PMa | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 8 µM | Mouse | Amazon River Frog Lithobates Palmipes | NA | NA | ||
| 36868141 | 2023 | FLPFLGKLLSGIF | Temporin-PMa non-amidated | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 110 µM | Mouse | Amazon River Frog Lithobates Palmipes | NA | NA | ||
| 37446618 | 2023 | YA{d}FGYPSGHFM | LENART01 | Free | Free | Linear | Mix | a = D-alanine | 11 | Antibacterial | 4.8 % Hemolysis at 200 µM (1 hour) | Human | Opioid–Ranatensin Hybrid Peptide | NA | Low hemolytic | ||
| 37446618 | 2023 | YA{d}FGYPSGHFM | LENART01 | Free | Free | Linear | Mix | a = D-alanine | 11 | Antibacterial | 8.3 % Hemolysis at 200 µM (2 hour) | Human | Opioid–Ranatensin Hybrid Peptide | NA | Low hemolytic | ||
| 37446618 | 2023 | YA{d}FGYPSGHFM | LENART01 | Free | Free | Linear | Mix | a = D-alanine | 11 | Antibacterial | 16.4 % Hemolysis at 200 µM (4 hour) | Human | Opioid–Ranatensin Hybrid Peptide | NA | Low hemolytic | ||
| 37300579 | 2023 | HIDWKKLLDAAKQIL{ct:Amid} | MP1 | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm, Antifungal | 50 % Hemolysis at 221.4 µM | Human | Mastoparan Family | α-Helix | Low hemolytic | ||
| 37300579 | 2023 | HIDWKKLLDAAKKIL{ct:Amid} | MP1-Q12K | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm, Antifungal | 50 % Hemolysis at 187.4 µM | Human | Mp1 Analog | α-Helix | Low hemolytic | ||
| 37631261 | 2023 | RGGRLCYCRRRFCVCVGR | Protegrin-1 (PG-1) | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 0.7 µM | Human | Porcine (Sus Scrofa) Leukocytes | β-Hairpin | NA | ||
| 37631261 | 2023 | RGG-LCYCRGRFCVCVGR | Iseganan | Free | Free | Linear | L | None | 17 | Antibacterial | 2 % Hemolysis at 1 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 37631261 | 2023 | RGGRRCYCRRRFCVCVGR | [L5R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 4.1 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 37631261 | 2023 | RGGRACYCRRRFCVCVGR | [L5A] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 4.1 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 37631261 | 2023 | RGGRLCYCRRRFCVCRGR | [V16R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 49.2 µM | Human | Protegrin-1 Analogs | β-Hairpin | Low hemolytic | ||
| 37631261 | 2023 | RGGRLCYCRRRFCVCAGR | [V16A] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 4.3 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 37631261 | 2023 | RGGRLCYCRRRFCRCVGR | [V14R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at >64 µM | Human | Protegrin-1 Analogs | NA | Low hemolytic | ||
| 37631261 | 2023 | RGGRLCYCRRRFCACVGR | [V14A] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 5.5 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 37631261 | 2023 | RGGRLCRCRRRFCVCVGR | [Y7R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 61.4 µM | Human | Protegrin-1 Analogs | NA | Low hemolytic | ||
| 37631261 | 2023 | RGGRLCTCRRRFCVCVGR | [Y7T] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 33.5 µM | Human | Protegrin-1 Analogs | NA | Low hemolytic | ||
| 37631261 | 2023 | RGGRLCTCRRRFCVCRGR | [Y7T,V16R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at >64 µM | Human | Protegrin-1 Analogs | NA | Low hemolytic | ||
| 37631261 | 2023 | RGGRLCYCRRRFCACRGR | [V14A,V16R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at >64 µM | Human | Protegrin-1 Analogs | NA | Low hemolytic | ||
| 37631261 | 2023 | RGGRACYCRRRFCVCRGR | [L5A, V16R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at >64 µM | Human | Protegrin-1 Analogs | NA | Low hemolytic | ||
| 37631261 | 2023 | RGGRACYCRRRFCACVGR | [L5A, V14A] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 18.8 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 37631261 | 2023 | RGGRACYCRRRFCVCAGR | [L5A,V16A] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 11.9 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 36857655 | 2023 | KLLPSVVGLFKKKKQ{ct:Amid} | At1 | Amidation | Free | Linear | L | None | 15 | Antifungal | 10 % Hemolysis at 32 µM | Human | Derived Amp Ponericin-W1 | water and DPPC SUVs = Random coil, SDS = α-Helical, DPPG SUVs = α-Helical | NA | ||
| 36857655 | 2023 | KLLKKVVKLFKKKKK{ct:Amid} | At2 | Amidation | Free | Linear | L | None | 15 | Antifungal | 10 % Hemolysis at 4 µM | Human | Modified Sequence Of At1 | water and DPPC SUVs = Random coil, SDS = α-Helical, DPPG SUVs = α-Helical | NA | ||
| 36857655 | 2023 | KLLKKVVKLFKKLLK{ct:Amid} | At3 | Amidation | Free | Linear | L | None | 15 | Antifungal | 10 % Hemolysis at 31.3 µM | Human | Modified Sequence Of At1 | water and DPPC SUVs = Random coil, SDS = α-Helical, DPPG SUVs = α-Helical | NA | ||
| 36857655 | 2023 | KLLKKLLKLLKKLLK{ct:Amid} | At4 | Amidation | Free | Linear | L | None | 15 | Antifungal | 10 % Hemolysis at 0.2 µM | Human | Modified Sequence Of At1 | water = Random coil, α-Helical, DPPC SUVs = Random coil, SDS = α-Helical, DPPG SUVs = α-Helical | NA | ||
| 36857655 | 2023 | KIIKKIIKIIKKIIK{ct:Amid} | At5 | Amidation | Free | Linear | L | None | 15 | Antifungal | 10 % Hemolysis at 31.3 µM | Human | Modified Sequence Of At1 | water and DPPC SUVs = Random coil, SDS = α-Helical, DPPG SUVs = α-Helical | NA | ||
| 36857655 | 2023 | KVVKKVVKVVKKVVK{ct:Amid} | At6 | Amidation | Free | Linear | L | None | 15 | Antifungal | 10 % Hemolysis at 16 µM | Human | Modified Sequence Of At1 | water = Random coil, α-Helical, DPPC SUVs = Random coil, SDS = α-Helical, DPPG SUVs = α-Helical | NA | ||
| 36857655 | 2023 | KIIKKIKKKIKKIIK{ct:Amid} | At7 | Amidation | Free | Linear | L | None | 15 | Antifungal | 10 % Hemolysis at 16 µM | Human | Modified Sequence Of At1 | water and DPPC SUVs = Random coil, SDS = α-Helical, DPPG SUVs = α-Helical | NA | ||
| 36857655 | 2023 | KLLKKLKKKLKKLLK{ct:Amid} | At8 | Amidation | Free | Linear | L | None | 15 | Antifungal | 10 % Hemolysis at 16 µM | Human | Modified Sequence Of At1 | water and DPPC SUVs = Random coil, SDS = α-Helical, DPPG SUVs = Helical | NA | ||
| 36857655 | 2023 | KVVKKVKKKVKKVVK{ct:Amid} | At9 | Amidation | Free | Linear | L | None | 15 | Antifungal | 10 % Hemolysis at 8 µM | Human | Modified Sequence Of At1 | water and DPPC SUVs = Random coil, SDS = α-Helical, DPPG SUVs = Helical | NA | ||
| 36857655 | 2023 | IKKIIKIIKKIIKKI{ct:Amid} | At10 | Amidation | Free | Linear | L | None | 15 | Antifungal | 10 % Hemolysis at 16.1 µM | Human | Modified Sequence Of At1 | water and DPPC SUVs = Random coil, SDS = α-Helical, DPPG SUVs = α-Helical | NA | ||
| 36857655 | 2023 | IIIKKIKKKIKKIII{ct:Amid} | At11 | Amidation | Free | Linear | L | None | 15 | Antifungal | 10 % Hemolysis at 16 µM | Human | Modified Sequence Of At1 | water and DPPC SUVs = Random coil, SDS = α-Helical, DPPG SUVs = α-Helical | NA | ||
| 36857655 | 2023 | KIIIKIKKKIKIIIK{ct:Amid} | At12 | Amidation | Free | Linear | L | None | 15 | Antifungal | 10 % Hemolysis at 1 µM | Human | Modified Sequence Of At1 | water and DPPC SUVs = Random coil, SDS = α-Helical, DPPG SUVs = β-Sheet | NA | ||
| 36870201 | 2023 | FVQWFSKFLGRIL{ct:Amid} | Temporin L | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 50 % Hemolysis at 15 µM | Human | European Frog Rana Temporaria | PC/PG (3:1 w/w) = 70.1% Helical, PC/Chol (8:1 w/w) vesicles = 61.7% Helical | NA | ||
| 36870201 | 2023 | FVQWFSKF(βL)RIL{ct:Amid} | L9βl-TL | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antibiofilm | 50 % Hemolysis at 33.3 µM | Human | Tl-Analogue | PC/PG (3:1 w/w) = 13.8% Helical, PC/Chol (8:1 w/w) vesicles = 7.2% Helical | NA | ||
| 37167720 | 2023 | RRWQWRP{d}PRWQWRR{ct:Amid} | Lf6-pP | Amidation | Free | Linear | L | p = D-Proline | 14 | Antibacterial, Antibiofilm, Anti-inflammatory | 10 % Hemolysis at >512 µM | Sheep | Synthetic Amps | Phosphate buffer and 50% TFE = typical TrpZip Hairpin, 30 mM SDS = α-Helical | Low hemolytic | ||
| 37167720 | 2023 | RRWQWRGGRWQWRR{ct:Amid} | Lf6-GG | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 10 % Hemolysis at >512 µM | Sheep | Synthetic Amps | Phosphate buffer and 50% TFE = typical TrpZip Hairpin, 30 mM SDS = α-Helical | Low hemolytic | ||
| 37336295 | 2023 | FVDLKKIANIINSIFGK{ct:Amid} | Temporin-1CEa | Amidation | Free | Linear | L | None | 17 | Antimycobacterial | 50 % Hemolysis at 95.74 µM | Human | Chinese Brown Frog Rana Chensinensis | NA | NA | ||
| 37336295 | 2023 | FVDLKKIANIINSIFKK{ct:Amid} | LK1 | Amidation | Free | Linear | L | None | 17 | Antimycobacterial | 50 % Hemolysis at 1467 µM | Human | Analog Of Temporin-1Cea | NA | NA | ||
| 37336295 | 2023 | FVKLKKILNIILSIFKK{ct:Amid} | LK2(6)AN(2L) | Amidation | Free | Linear | L | None | 17 | Antimycobacterial | 50 % Hemolysis at 28.34 µM | Human | Analog Of Temporin-1Cea | NA | NA | ||
| 37336295 | 2023 | IKKILSKIKKLLK{ct:Amid} | LK6 | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Temporin-1Ceb | NA | Low hemolytic | ||
| 37336295 | 2023 | IWLSKIKKLLK{ct:Amid} | I4W | Amidation | Free | Linear | L | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | IKKWWSKIKKLLK{ct:Amid} | I4WL5W | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | IKKIWSKIKKLLK{ct:Amid} | L5W | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | IKKILSKIKKWLK{ct:Amid} | L11W | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | IKKILSKIKKLWK{ct:Amid} | L12W | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | WKKIWSKIKKLLK{ct:Amid} | I1WL5W | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | WKKILSKIKKLLK{ct:Amid} | I1W | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | SAVGRHGRRFGLRKHRKH{ct:Amid} | Chensinin-1 | Amidation | Free | Linear | L | None | 18 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Frog Rana Chensinensis | NA | Low hemolytic | ||
| 37336295 | 2023 | SKVWRHWRRFWHRAHRKL{ct:Amid} | Chensinin-1b | Amidation | Free | Linear | L | None | 18 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Chensinin-1 | NA | Low hemolytic | ||
| 37336295 | 2023 | SKVWRHWRRFWHRAHRK({nnr:C8})L | OA-C1b | Free | Free | Linear | L | C8 = C8 | 19 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Lipidated Analog Of Chensinin-1B | NA | Low hemolytic | ||
| 37336295 | 2023 | SKVWRHWRRFWHRAHRK({nnr:C12})L | LA-C1b | Free | Free | Linear | L | C12 = C12 | 19 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Lipidated Analog Of Chensinin-1B | NA | Low hemolytic | ||
| 37336295 | 2023 | SKVWRHWRRFWHRAHRK({nnr:C16})L | PA-C1b | Free | Free | Linear | L | C16 = C16 | 19 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Lipidated Analog Of Chensinin-1B | NA | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{ct:Amid} | D-W3R6 | Amidation | Free | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of W3R6 | NA | Low hemolytic | ||
| 37336295 | 2023 | VWRRWRRFWRR{ct:Amid} | W3R6 | Amidation | Free | Linear | L | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Chensinin-1 | 40% H2O/TFE-d3 = Random coil, 50%H2O/TFE-d3 = α-Helical | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{ct:Amid} | D-Arg-W3R6 | Amidation | Free | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Diastereomer Of W3R6 | NA | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:Acetylation(CH3COOH)}{ct:Amid} | AC-D-W3R6 | Amidation | Acetylation(CH3COOH) | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Lipidated Analog Of D-W3R6 (Acetyl) | NA | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:butanoyl = CH3(CH2)2COOH}{ct:Amid} | BA-D-W3R6 | Amidation | butanoyl = CH3(CH2)2COOH | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Lipidated Analog Of D-W3R6 (Butanoyl) | NA | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:octanoyl = C8H16O2}{ct:Amid} | OA-D-W3R6 | Amidation | octanoyl = C8H16O2 | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at 100 µM | Human | Lipidated Analog Of D-W3R6 (Octanoyl) | NA | NA | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:lauric acyl = C12H24O2}{ct:Amid} | LA-D-W3R6 | Amidation | lauric acyl = C12H24O2 | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at 25 µM | Human | Lipidated Analog Of D-W3R6 (Lauric Acid) | NA | NA | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:palmitic acyl = C16H32O2}{ct:Amid} | PA-D-W3R6 | Amidation | palmitic acyl = C16H32O2 | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at 25 µM | Human | Lipidated Analog Of D-W3R6 (Palmitic Acid) | NA | NA | ||
| 37336295 | 2023 | ILPILSLIGGLL{ct:Amid} | Temporin-1CEb | Amidation | Free | Linear | L | None | 12 | Antimycobacterial | 50 % Hemolysis at 122 µM | Human | Rana Chensinensis | NA | NA | ||
| 37336295 | 2023 | IIPLPLGYFAKKT{ct:Amid} | Temporin-1CEc | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Rana Chensinensis | NA | Low hemolytic | ||
| 37336295 | 2023 | IIPLPLKKFAKKT{ct:Amid} | 2 K | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Temporin-1Cec | NA | Low hemolytic | ||
| 37336295 | 2023 | KIPKPLKKFAKKT{ct:Amid} | 4 K | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Temporin-1Cec | NA | Low hemolytic | ||
| 37336295 | 2023 | IIPLPLKKFLKKL{ct:Amid} | 2 K2L | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Temporin-1Cec | NA | Low hemolytic | ||
| 37336295 | 2023 | KIPKPLKKFLKKL{ct:Amid} | 4 K2L | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Temporin-1Cec | NA | Low hemolytic | ||
| 37336295 | 2023 | IILLLLKKFLKKL{ct:Amid} | 2 K4L | Amidation | Free | Linear | L | None | 14 | Antimycobacterial | 50 % Hemolysis at 62.5 µM | Human | Analog Of Temporin-1Cec | NA | NA | ||
| 37336295 | 2023 | KILKLLKKFLKKL{ct:Amid} | 4 K4L | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Temporin-1Cec | NA | Low hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C2} | PE-2C-C2-DH | Free | C2 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C3} | PE-2C-C3-DH | Free | C3 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C4} | PE-2C-C4-DH | Free | C4 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C5} | PE-2C-C5-DH | Free | C5 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C6} | PE-2C-C6-DH | Free | C6 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C7} | PE-2C-C7-DH | Free | C7 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C8} | PE-2C-C8-DH | Free | C8 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:6-MC7} | PE-2C-6-MC7-DH | Free | 6-MC7 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:6-MC8} | PE-2C-6-MC8-DH | Free | 6-MC8 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:LB-8} | PE-2C-LB-8-DH) | Free | LB-8 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at 1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 31608030 | 2019 | FKRIVQRIKDFLRNLV | FK16 | Free | Free | Linear | L | None | 16 | Antibacterial | <10% (1 hr) % Hemolysis at 256 μg/mL | Human | Cathelicidin-Derived Peptides | NA | Low hemolytic | ||
| 23409125 | 2013 | RLLFRKIRRLKR | EC5 | Free | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 500 μg/mL | Chicken | Peptide Synergists From Phage Display | NA | Low hemolytic | ||
| 19451300 | 2009 | FFSLLPSLIGGLVSAIK | imcroporin | Free | Free | Linear | L | None | 17 | Antibacterial | <50 % Hemolysis at 50 μg/ml | Human | Scorpion Isometrus Maculates | α-Helix | NA | ||
| 25626077 | 2015 | FLFSLIPSVIAGLVSAIRN{ct:Amid} | AaeAP1 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 100 % Hemolysis at 16 μg/ml | Horse | Scorpion Androctonus Aeneas | 21.05 % α-Helix | NA | ||
| 25626077 | 2015 | FLFSLIPSAIAGLVSAIRN{ct:Amid} | AaeAP2 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 100 % Hemolysis at 64 μg/ml | Horse | Scorpion Androctonus Aeneas | 21.05 % α-Helix | NA | ||
| 25626077 | 2015 | FLFKLIPKVIKGLVKAIRK{ct:Amid} | AaeAP1a | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal. Anticancer, Antiproliferative | 100 % Hemolysis at 32 μg/ml | Horse | Aaeap1 Analogues | 31.58% α-Helix | NA | ||
| 25626077 | 2015 | FLFKLIPKAIKGLVKAIRK{ct:Amid} | AaeAP2a | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal. Anticancer, Antiproliferative | 100 % Hemolysis at 64 μg/ml | Horse | Aaeap2 Analogues | 31.58% α-Helix | NA | ||
| 25633390 | 2015 | ARDGYIVDEKGCKFACFIN | Cm38 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 64 µM | Human | Scorpion Centruroides Margaritatus | NA | Non-hemolytic | ||
| 34971943 | 2022 | FLFSAGKAIHRLIRRRRR | ZN-6 | Free | Free | Linear | L | None | 18 | Antibacterial | 2.02 % Hemolysis at 64 µg/mL | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 35216177 | 2022 | FVQWFSKFLGRIL | Temporin L | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼70 % Hemolysis at 100 µM | Human | Rana Temporaria (Red Frog) | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3 , DLeu9 ] TL | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial, Antibiofilm | ∼50 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVQWFSKFLGRIL | Temporin L | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼43 % Hemolysis at 50 µM | Human | Rana Temporaria (Red Frog) | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3 , DLeu9 ] TL | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial, Antibiofilm | ∼25 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3,DLeu9] TL (TL1) | Amidation | Free | Linear | Mix | l=D-Leu | 13 | Antibacterial, Antibiofilm | 60 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}PRIL{ct:Amid} | [Pro3,DLeu9,Pro10] TL (TL2) | Amidation | Free | Linear | Mix | l=D-Leu | 14 | Antibacterial, Antibiofilm | 60 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}P{d}RIL{ct:Amid} | [Pro3,DLeu9,DPro10] TL (TL3) | Amidation | Free | Linear | Mix | l=D-Leu, p = D-Pro | 14 | Antibacterial, Antibiofilm | 20 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}{nnr:O}RIL{ct:Amid} | [Pro3,DLeu9,Hyp10] TL (TL4) | Amidation | Free | Linear | Mix | l=D-Leu, O = Hyp = hydroxyproline | 14 | Antibacterial, Antibiofilm | 80 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}{nnr:o}RIL{ct:Amid} | [Pro3,DLeu9,DHyp10] TL (TL5) | Amidation | Free | Linear | Mix | l=D-Leu, o = D-Hyp = hydroxyproline | 14 | Antibacterial, Antibiofilm | 20 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}{nnr:N=Nle}RIL{ct:Amid} | [Pro3,DLeu9,Nle10] TL (TL6) | Amidation | Free | Linear | Mix | l=D-Leu, N = Nle | 14 | Antibacterial, Antibiofilm | 60 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}{nnr:n=D-Nle}RIL{ct:Amid} | [Pro3,DLeu9,DNle10] TL (TL7) | Amidation | Free | Linear | Mix | l=D-Leu, n = D-Nle | 14 | Antibacterial, Antibiofilm | 40 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}KRIL{ct:Amid} | [Pro3,DLeu9,Lys10] TL (TL8) | Amidation | Free | Linear | Mix | l=D-Leu | 14 | Antibacterial, Antibiofilm | 80 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}K{d}RIL{ct:Amid} | [Pro3,DLeu9,DLys10] TL (TL9) | Amidation | Free | Linear | Mix | l=D-Leu, k = D-Lys | 14 | Antibacterial, Antibiofilm | 40 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}WRIL{ct:Amid} | [Pro3,DLeu9,Trp10] TL (TL10) | Amidation | Free | Linear | Mix | l=D-Leu | 14 | Antibacterial, Antibiofilm | 60 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}W{d}RIL{ct:Amid} | [Pro3,DLeu9,DTrp10] TL (TL11) | Amidation | Free | Linear | Mix | l=D-Leu, w = D-Trp | 14 | Antibacterial, Antibiofilm | 80 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFl{nnr:Aic}RIL{ct:Amid} | [Pro3,DLeu9,Aic10] TL (TL12) | Amidation | Free | Linear | Mix | Aic = 2-aminoindane-2-carboxylic acid | 14 | Antibacterial, Antibiofilm | 100 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216297 | 2022 | WFGKLYRGITK | Pep-A | Free | Free | Linear | L | None | 11 | Antibacterial | ∼3 % Hemolysis at 50 µM | Rabbit | Synthetic | α-Helix | Non-hemolytic | ||
| 35216297 | 2022 | WRGITKVVKKV | Pep-B | Free | Free | Linear | L | None | 11 | Antibacterial | ∼7 % Hemolysis at 50 µM | Rabbit | Synthetic | α-Helix | Non-hemolytic | ||
| 35216297 | 2022 | WVVKKVKGLLK | Pep-C | Free | Free | Linear | L | None | 11 | Antibacterial | ∼2 % Hemolysis at 50 µM | Rabbit | Synthetic | α-Helix | Non-hemolytic | ||
| 35216297 | 2022 | WFGKLYRGITK{nt:myristic acid} | Myr-A | Free | myristic acid | Linear | L | None | 11 | Antibacterial | ∼5.5 % Hemolysis at 50 µM | Rabbit | Synthetic | α-Helix | Non-hemolytic | ||
| 35216297 | 2022 | WRGITKVVKKV{nt:myristic acid} | Myr-B | Free | myristic acid | Linear | L | None | 11 | Antibacterial | ∼2.5 % Hemolysis at 50 µM | Rabbit | Synthetic | α-Helix | Non-hemolytic | ||
| 35216297 | 2022 | WVVKKVKGLLK{nt:myristic acid} | Myr-C | Free | myristic acid | Linear | L | None | 11 | Antibacterial | 28.5 % Hemolysis at 50 µM | Rabbit | Synthetic | α-Helix | NA | ||
| 35203875 | 2022 | RRLFRRILRWL | L6 | Free | Free | Linear | L | None | 11 | Antibacterial | 50 % Hemolysis at 50 µM | Sheep | Synthetic | α-Helix | NA | ||
| 35203875 | 2022 | RR{nnr:S5}FRR{nnr:S5}LRWL | L6S1 | Free | Free | Macrocyclized | L | (R8) and (S5) indicate stapled using 8- and 5-atom linkers, respectively. | 11 | Antibacterial | ∼5 % Hemolysis at 50 µM | Sheep | Synthetic | NA | Non-hemolytic | ||
| 35203875 | 2022 | RRLFRR{nnr:S5}LRW{nnr:S5} | L6S2 | Free | Free | Macrocyclized | L | (S5) and (S5) indicate stapled using 5- and 5-atom linkers, respectively. | 11 | Antibacterial | ∼55 % Hemolysis at 50 µM | Sheep | Synthetic | NA | NA | ||
| 35203875 | 2022 | RRL{nnr:R8}RRILRW{nnr:S5} | L6S3 | Free | Free | Macrocyclized | L | (R8) and (S5) indicate stapled using 8- and 5-atom linkers, respectively. | 11 | Antibacterial | <5 % Hemolysis at 50 µM | Sheep | Synthetic | NA | Non-hemolytic | ||
| 35203875 | 2022 | KRIVQRIKKWLR | L8 | Free | Free | Linear | L | None | 12 | Antibacterial | ∼1 % Hemolysis at 50 µM | Sheep | Synthetic | α-Helix | Non-hemolytic | ||
| 35203875 | 2022 | KR{nnr:S5}VQR{nnr:S5}KKWLR | L8S1 | Free | Free | Linear | L | macrocyclized, (S5) and (S5) indicate stapled using 5- and 5-atom linkers, respectively | 12 | Antibacterial | 0 % Hemolysis at 50 µM | Sheep | Synthetic | NA | Non-hemolytic | ||
| 35203875 | 2022 | KRIVQR{nnr:S5}KKW{nnr:S5}R | L8S2 | Free | Free | Linear | L | macrocyclized, (S5) and (S5) indicate stapled using 5- and 5-atom linkers, respectively | 12 | Antibacterial | 0 % Hemolysis at 50 µM | Sheep | Synthetic | NA | Non-hemolytic | ||
| 35203875 | 2022 | KRI{nnr:R8}QRIKKW{nnr:S5}R | L8S3 | Free | Free | Macrocyclized | L | (R8) and (S5) indicate stapled using 8- and 5-atom linkers, respectively | 12 | Antibacterial | ∼20 % Hemolysis at 50 µM | Sheep | Synthetic | NA | Non-hemolytic | ||
| 35323465 | 2022 | SPRVCIRVCRNGVCYRRCWG | Capitellacin | Free | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 128 µM | Human | Capitella Teleta | NA | Low hemolytic | ||
| 35323465 | 2022 | SPRVCIRVCRNGVCYRRCW | CT3 | Free | Free | Linear | L | None | 19 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35323465 | 2022 | RVCIRVCRNGVCYRRCW | CT4 | Free | Free | Linear | L | None | 17 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35323465 | 2022 | KWCI RVCRNGVCYRRCR | CT5 | Free | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | <2.5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35323465 | 2022 | RVC FRVCRNGVCYRRCW | CT6 | Free | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | <2.5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35323465 | 2022 | RVCIRVCYRGVCYRRCW | CT7 | Free | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 50 % Hemolysis at 128 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35323465 | 2022 | KWCFRVCYRGICYRRCR | Tachyplesin-1 | Free | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | <5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35335979 | 2022 | FVDLKKIANILNSIF{ct:Amid} | Temporin-1CEh | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 50 % Hemolysis at 152.6 µM | Horse | Rana Chensinensis | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANILNSIF{ct:Amid} | Temporin-1CEh | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 92.3 % Hemolysis at 256 µM | Horse | Rana Chensinensis | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANIINSIF{ct:Amid} | Temporin-1CEa | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 50 % Hemolysis at 160 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANIL{ct:Amid} | T1CEh-t | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antibiofilm | <5 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANII{ct:Amid} | T1CEa-t | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antibiofilm | 0 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKFVDLKKIANIL{ct:Amid} | T1CEh-KK | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKFVPLKKIANIL{ct:Amid} | T1CEh-KKP | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼1 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKWVPLKKIANIL{ct:Amid} | T1CEh-KKPW | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | <10 % Hemolysis at 256 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKWVPWKKIANIL{ct:Amid} | T1CEh-KKPWW | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 6 % Hemolysis at 256 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKWVPWKKKWVPWKKIANIL{ct:Amid} | T1CEh-KKPWW2 | Amidation | Free | Branched | L | None | 20 | Antibacterial, Antibiofilm | 63 % Hemolysis at 256 µM | Horse | Synthetic | α-Helix | NA | ||
| 35290038 | 2022 | LKLLKKLLKKLLKLL{ct:Amid} | Amp1L | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | ∼55 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | NA | ||
| 35290038 | 2022 | L{nnr:k}LLKKLLKKLLKLL{ct:Amid} | Amp1EP2 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | ∼35 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLL{nnr:k}KLLKKLLKLL{ct:Amid} | Amp1EP5 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | <10 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLLK{nnr:k}LLKKLLKLL{ct:Amid} | Amp1EP6 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | <5 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLLKKLL{nnr:k}KLLKLL{ct:Amid} | Amp1EP9 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | <5 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35290038 | 2022 | LKLLKKLLK{nnr:k}LLKLL{ct:Amid} | Amp1EP10 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | <5 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35290038 | 2022 | LKLLKKLLKKLL{nnr:k}LL{ct:Amid} | Amp1EP13 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | < 10 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLLKKLLKKLLKLL{ct:Amid} | Amp1L | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | 100 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | NA | ||
| 35290038 | 2022 | L{nnr:k}LLKKLLKKLLKLL{ct:Amid} | Amp1EP2 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | 100 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLL{nnr:k}KLLKKLLKLL{ct:Amid} | Amp1EP5 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | ∼85 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLLK{nnr:k}LLKKLLKLL{ct:Amid} | Amp1EP6 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | ∼60 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLLKKLL{nnr:k}KLLKLL{ct:Amid} | Amp1EP9 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | >35 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35290038 | 2022 | LKLLKKLLK{nnr:k}LLKLL{ct:Amid} | Amp1EP10 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | <10 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35290038 | 2022 | LKLLKKLLKKLL{nnr:k}LL{ct:Amid} | Amp1EP13 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | < 10 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 3.1 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 6.2 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 12.5 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 200 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | >85 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | NA | ||
| 35538042 | 2022 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 50 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | NA | ||
| 35538042 | 2022 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | >100 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35538042 | 2022 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼1 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | <10 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | <25 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | <50 % Hemolysis at 200 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 12.5 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼10 % Hemolysis at 37.5 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 62.5 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35538042 | 2022 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | >100 % Hemolysis at 200 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSGIVGMLGKLF{ct:Amid} | SHa | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 50 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 2.812 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 2.812 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 2.812 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 1±0.62 % Hemolysis at 5.625 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 5.625 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 5.625 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 7±0.55 % Hemolysis at 11.25 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 11.25 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 1.8±0.9 % Hemolysis at 11.25 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 52.74 ± 5.94 % Hemolysis at 22.5 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 2.88 ± 1.24 % Hemolysis at 22.5 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 2 ± 0.94 % Hemolysis at 22.5 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 55.07 ± 5.23 % Hemolysis at 45 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 18.18 ± 7.65 % Hemolysis at 45 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 7.49 ± 1.20 % Hemolysis at 45 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 58.93 ± 6.02 % Hemolysis at 90 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 42.93 ± 4.75 % Hemolysis at 90 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 44.69 ± 3.73 % Hemolysis at 90 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 61.64 ± 13.83 % Hemolysis at 180 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 47.60 ± 7.88 % Hemolysis at 180 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 57.01 ± 8.50 % Hemolysis at 180 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 64.71 ± 11.34 % Hemolysis at 360 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 51.15 ± 10.41 % Hemolysis at 360 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 58.97 ± 5.51 % Hemolysis at 360 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35464194 | 2022 | VKRFKKFFRKLKKSV{ct:Amid} | B1 | Amidation | Free | Linear | L | None | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | VKRFKKFFRKLKKLV{ct:Amid} | B1-Leu | Amidation | Free | Linear | L | None | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | V{nnr:S5}RFK{nnr:S5}FFRKLKKLV{ct:Amid} | B1-L-1 | Amidation | Free | Linear | L | S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | VKRF{nnr:S5}KFF{nnr:S5}KLKKLV{ct:Amid} | B1-L-2 | Amidation | Free | Stapled | L | S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | VKRFK{nnr:S5}FFR{nnr:S5}LKKLV{ct:Amid} | B1-L-3 | Amidation | Free | Stapled | L | S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | VKRFKKFF{nnr:S5}KLK{nnr:S5}LV{ct:Amid} | B1-L-4 | Amidation | Free | Stapled | L | S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | V{nnr:R8}RFKKFF{nnr:S5}KLKKLV{ct:Amid} | B1-L-5 | Amidation | Free | Stapled | L | S5 = (S)-2-(4-pentenyl) alanine, stapled b/w R8 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | VKRF{nnr:R8}KFFRKL{nnr:S5}KLV{ct:Amid} | B1-L-6 | Amidation | Free | Stapled | L | R8 = (R)-2-(7-octenyl) alanine, S5 = (S)-2-(4-pentenyl) alanine, stapled b/w R8 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | VKRFK{nnr:R8}FFRKLK{nnr:S5}LV{ct:Amid} | B1-L-7 | Amidation | Free | Stapled | L | R8 = (R)-2-(7-octenyl) alanine, S5 = (S)-2-(4-pentenyl) alanine, stapled b/w R8 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKVARRTVAKYRE{nnr:NIe}L{nt:Acet}{ct:Amid} | WT | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 0.12 ± 0.07 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKV{nnr:X}RRT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid} | 2 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 6.6 ± 0.3 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKVARR{nnr:X}VAK{nnr:X}RE{nnr:NIe}L{nt:Acet}{ct:Amid} | 10 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 10.7 ± 0.3 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKV{nnr:X}RRT{nnr:X}AKYRE{nnr:NIe}|{nt:Acet}{ct:Amid} | 14 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 35.0 ± 0.5 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKV{nnr:X}KRT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid} | 17 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 3.3 ± 0.7 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKV{nnr:X}RKT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid} | 18 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 3.3 ± 0.05 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKV{nnr:X}RRT{nnr:X}GKYRE{nnr:NIe}L{nt:Acet}{ct:Amid} | 31 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 0.53 ± 0.05 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FRV{nnr:X}RRT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid} | 33 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 1.5 ± 0.03 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | <5 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | ∼1 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | <5 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Hairpin | Low hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | <1 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | <1 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVL | Nigrocin-M2 | Free | Free | Linear | L | None | 14 | Antimicrobial, Anticancer | 0 % Hemolysis at 10 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVL | Nigrocin-M2 | Free | Free | Linear | L | None | 14 | Antimicrobial, Anticancer | 0 % Hemolysis at 100 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35740884 | 2022 | FLPLIIGALSSLLPKIF{ct:Amid} | Temporin-PKE | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 6.58 µM | Horse | Pelophylax Kl. Esculentus | Random coils | NA | ||
| 35740884 | 2022 | FLPLIIGKLSSLLPKIF{ct:Amid} | Temporin-PKE-2K | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 19.87 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | NA | ||
| 35740884 | 2022 | FLPLIIGALSSKLPKIF{ct:Amid} | Temporin-PKE-K12 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 122.7 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Low hemolytic | ||
| 35740884 | 2022 | FLPKIIGKLSSLLPKIF{ct:Amid} | Temporin-PKE-3K | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 87.47 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Low hemolytic | ||
| 35740884 | 2022 | FLPKIIGKLSSKLPKIF{ct:Amid} | Temporin-PKE-4K | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 1671 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Non-hemolytic | ||
| 35740884 | 2022 | FLPLIIGALSSLLPKI{d}F{ct:Amid} | Temporin-PKE-i | Amidation | Free | Linear | Mix | i = D-Isoleucine | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 68.37 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Low hemolytic | ||
| 35740884 | 2022 | FLPLI{d}I{d}GALSSLLPKI{d}F{ct:Amid} | Temporin-PKE-3i | Amidation | Free | Linear | Mix | i = D-Isoleucine | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 64 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Low hemolytic | ||
| 35740895 | 2022 | FLSGIVGMLGKLF | Temporin SHa | Free | Free | Linear | L | None | 13 | Antimicrobial, Antiproliferative | 50 % Hemolysis at 266.20 ± 41.27 µM | Human | Pelophylax Saharicus | α-Helix | Low hemolytic | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a] SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antimicrobial, Antiproliferative | 50 % Hemolysis at 43.66 ± 1.01 µM | Human | Analog Of Temporin-Sha | α-Helix | NA | ||
| 35740895 | 2022 | FLSGIVGMLGKLF | Temporin SHa | Free | Free | Linear | L | None | 13 | Antimicrobial, Antiproliferative | 24.54 ± 1.88 % Hemolysis at 100 µM | Human | Pelophylax Saharicus | α-Helix | Low hemolytic | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a] SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antimicrobial, Antiproliferative | 102.03 ± 6.18 % Hemolysis at 100 µM | Human | Analog Of Temporin-Sha | α-Helix | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA-OH{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antimicrobial | 0 ± 0 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVL{ct:Amid} | BP13 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5 ± 0.2 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE-OH{ct:OH} | Pep13 | OH | Free | Linear | L | None | 13 | Antimicrobial | 0 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 2 ± 1 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4 ± 0.5 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYL{ct:Amid}{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 11 | Antimicrobial | 3 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK({nnr:COC3H7})KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 13 | Antimicrobial | 4 ± 0.9 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK({nnr:COC3H7})L{nt:Acet}{ct:Amid} | BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antimicrobial | 0 ± 0 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK{ct:Amid} | KSL-W | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 4 ± 1 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | PIP1-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 4 ± 0.4 % Hemolysis at 50 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid} | BP475-PIP1 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 9 ± 1.0 % Hemolysis at 50 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKVVFWVKFK{ct:Amid} | PIP1-KSLW | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 7 ± 0.8 % Hemolysis at 50 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKYGIHTH{ct:Amid} | KSLW-PIP1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 8 ± 1.3 % Hemolysis at 50 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antimicrobial | 0 ± 0 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVL{ct:Amid} | BP13 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 13 ± 2 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE{ct:OH} | Pep13 | OH | Free | Linear | L | None | 13 | Antimicrobial | 0 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 1 ± 0.6 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4 ± 0.5 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYL{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 11 | Antimicrobial | 7 ± 2 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK({nnr:COC3H7})KYL{ct:Acet} | BP387 | Acetylation | Free | Linear | L | COC3H7 = butanoyl | 13 | Antimicrobial | 4 ± 0.6 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{nnr:COC3H7}L{ct:Acet}{ct:Acet} | BP475 | Acetylation | Free | Linear | Mix | COC3H7 = butanoyl | 11 | Antimicrobial | 11 ± 5 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK{ct:Amid} | KSL-W | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 5 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | PIP1-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 11 ± 0.5 % Hemolysis at 150 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid} | BP475-PIP1 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 18 ± 1.4 % Hemolysis at 150 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKVVFWVKFK{ct:Amid} | PIP1-KSLW | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 7 ± 1.1 % Hemolysis at 150 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKYGIHTH{ct:Amid} | KSLW-PIP1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 3 ± 2.1 % Hemolysis at 150 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antimicrobial | 0 ± 0 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVL{ct:Amid} | BP13 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 27 ± 3 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE{nt:OH}{ct:OH} | Pep13 | OH | OH | Linear | L | None | 13 | Antimicrobial | 2 ± 0.1 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 1 ± 0.4 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 6 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYL{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 11 | Antimicrobial | 6 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 13 | Antimicrobial | 14 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antimicrobial | 0 ± 0 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK{ct:Amid} | KSL-W | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 6 ± 1 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | PIP1-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 18 ± 0.1 % Hemolysis at 250 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid} | BP475-PIP1 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 26 ± 2.8 % Hemolysis at 250 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTKKVVFWVKFK{ct:Amid} | PIP1-KSLW | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 6 ± 0.4 % Hemolysis at 250 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKYGIHTH{ct:Amid} | KSLW-PIP1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 3 ± 1.2 % Hemolysis at 250 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antimicrobial | 0 ± 0 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVL{ct:Amid} | BP13 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 42 ± 3 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE{ct:OH} | Pep13 | OH | Free | Linear | L | None | 13 | Antimicrobial | 0 ± 0.1 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 3 ± 3 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 11 ± 0.9 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYL{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 11 | Antimicrobial | 7 ± 0.3 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 13 | Antimicrobial | 18 ± 1 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antimicrobial | 0 ± 0 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK{ct:Amid} | KSL-W | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 20 ± 2 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | PIP1-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 24 ± 0.5 % Hemolysis at 375 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid} | BP475-PIP1 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 39 ± 2.0 % Hemolysis at 375 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKVVFWVKFK{ct:Amid} | PIP1-KSLW | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 6 ± 0.4 % Hemolysis at 375 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKYGIHTH | KSLW-PIP1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 5 ± 4.9 % Hemolysis at 375 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35377553 | 2022 | FFGSVLKLIPKIL | temporin-PTa | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 13 % Hemolysis at 87 µM | Mus musculus | Hylarana Picturata | α-Helix | NA | ||
| 35377553 | 2022 | AAGKVLKLLKKLL | Hp-MAP1 | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | Hemolytic | Mus musculus | Synthetic; Temporin-Pta | α-Helix | NA | ||
| 35377553 | 2022 | AAKKVLKLLKKLL | Hp-MAP2 | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | Hemolytic | Mus musculus | Synthetic; Temporin-Pta | α-Helix | NA | ||
| 35311294 | 2022 | IRIRCRRRFCRIRI | C(RI)2 | Free | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | IRIRRRRFRIRI | F(RI)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | RIRIRRRFIRIR | F(IR)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | FRFRRRRFRFRF | F(RF)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | WRWRRRRFRWRW | F(RW)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at 237 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | VRVRRRRFRVRV | F(RV)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | ARARRRRFRARA | F(RA)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | WKWKRRRFKWKW | F(KW)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | IKIKRRRFKIKI | F(KI)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | LKLKRRRFKLKL | F(KL)2 | Free | Free | Linear | L | None | 12 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | RIRIRRRRFRIRIR | F(RI)2R | Free | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | IRIRIRRRRFRIRIRI | F(RI)3 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at 56 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | KWKWKRRRFKWKWK | F(KW)2K | Free | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | WKWKWKRRRFKWKWKW | F(KW)3 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | RFRFRRRRFRFRFR | F(RF)2R | Free | Free | Linear | L | None | 14 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | FRFRFRRRRFRFRFRF | F(RF)3 | Free | Free | Linear | L | None | 16 | Antimicrobial | 10 % Hemolysis at >256 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35311294 | 2022 | RGGRLCYCRRRFCVCVGR | PG-1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 10 % Hemolysis at 20 µM | mouse | Synthetic | β-Hairpin | NA | ||
| 35378215 | 2022 | MDKLQLKGMSYSMCTGKF | PD1 CD44 | Free | Free | Linear | L | None | 18 | Antiviral | 8 % Hemolysis at 196.3 µM | Human | Human | α-Helix | NA | ||
| 35500455 | 2022 | KPIINIIKNIIKNKIK | KK16 | Free | Free | Linear | L | None | 16 | Antimicrobial, Antifungal | 50 % Hemolysis at 2250 µM | Fish | Synthetic | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPSLVGGLISAFK{ct:Amid} | Stig (stigmurin) | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 0 % Hemolysis at 150–1.17 µM | Human | Tityus Stigmurus | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPKLVGKLISAFK{ct:Amid} | StigA8 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 11.5 % Hemolysis at 9.17 µM | Human | Synthetic; Analog Of Stigmurin | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPKLVGKLIKAFK{ct:Amid} | StigA18 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 14 % Hemolysis at 9.17 µM | Human | Synthetic; Analog Of Stigmurin | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPKLVGKLISAFK{ct:Amid} | StigA8 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 15 % Hemolysis at 150 µM | Human | Synthetic; Analog Of Stigmurin | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPKLVGKLIKAFK{ct:Amid} | StigA18 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 22 % Hemolysis at 150 µM | Human | Synthetic; Analog Of Stigmurin | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPSLVKKLIKAFK{ct:Amid} | StigA25 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 100 % Hemolysis at 150 µM | Human | Synthetic; Analog Of Stigmurin | NA | NA | ||
| 35526666 | 2022 | FFKLIPKLVKKLIKAFK{ct:Amid} | StigA31 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 80 % Hemolysis at 150 µM | Human | Synthetic; Analog Of Stigmurin | NA | NA | ||
| 35526666 | 2022 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 5 % Hemolysis at 160 µM | Human | T. Serrulatus Scorpion | NA | NA | ||
| 35526666 | 2022 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 86 % Hemolysis at 40 µM | Human | T. Serrulatus Scorpion | NA | NA | ||
| 35283164 | 2022 | IFKRIKAMWRGAKQAWKDYK | Ss-piscidins1 | Free | Free | Linear | L | None | 20 | Antimicrobial | No Hemolysis | Fish | Sebastes Schlegelii | α-Helix | Non-hemolytic | ||
| 35283164 | 2022 | FIHHIFGAIKRIFGDKQRD | Ss-piscidins2 | Free | Free | Linear | L | None | 19 | Antimicrobial | 16.4 % Hemolysis at 30 µM | Fish | Sebastes Schlegelii | α-Helix | NA | ||
| 35283164 | 2022 | FIHHIFGAIKRIFGDKQRD | Ss-piscidins2 | Free | Free | Linear | L | None | 19 | Antimicrobial | 93.2 % Hemolysis at 60 µM | Fish | Sebastes Schlegelii | α-Helix | NA | ||
| 35806412 | 2022 | KTMMOSGGTFGTMAIGMGIR | AMPR-11 | Free | Free | Linear | L | None | 20 | Antimicrobial | low hemolytic | mouse | Synthetic | NA | Low hemolytic | ||
| 35806412 | 2022 | KKMMKKGGKFTFMAIGGIR | AMPR-22 | Free | Free | Linear | L | None | 19 | Antimicrobial | low hemolytic | mouse | Synthetic | NA | Low hemolytic | ||
| 35832307 | 2022 | GLFKWHPRCGEEQSMWT{ct:Amid} | OA-GL17d | Amidation | Free | Linear | L | None | 17 | Cell proliferation | 6.26 ± 0.14 % Hemolysis at 100 μg/mL | mouse | Odorrana Andersonii Frog Skin | α-Helix | Non-hemolytic | ||
| 35832307 | 2022 | GLFKWHPRCGEEQSMWT{ct:Amid} | OA-GL17d | Amidation | Free | Linear | L | None | 17 | Cell proliferation | 6.99 ± 0.28 % Hemolysis at 500 μg/mL | mouse | Odorrana Andersonii Frog Skin | α-Helix | Non-hemolytic | ||
| 35832307 | 2022 | GLFKWHPRCGEEQSMWT{ct:Amid} | OA-GL17d | Amidation | Free | Linear | L | None | 17 | Cell proliferation | 8.49 ± 0.46 % Hemolysis at 1 mg/mL | mouse | Odorrana Andersonii Frog Skin | α-Helix | Non-hemolytic | ||
| 35847280 | 2022 | QR{d}W{d}GL{d}SL{d}APYK{d}NFR{d}R{d}L{d}S | ASU2056 | Free | Free | Linear | Mix | Lower-case letters signify D-amino acids | 17 | Antimicrobial | <1 % Hemolysis at 32 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35847280 | 2022 | QR{d}W{d}GL{d}SL{d}APYK{d}NFR{d}R{d}L{d}S | ASU2056 | Free | Free | Linear | Mix | Lower-case letters signify D-amino acids | 17 | Antimicrobial | <1 % Hemolysis at 64 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35847280 | 2022 | QR{d}W{d}GL{d}SL{d}APYK{d}NFR{d}R{d}L{d}S | ASU2056 | Free | Free | Linear | Mix | Lower-case letters signify D-amino acids | 17 | Antimicrobial | <1 % Hemolysis at 128 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35847280 | 2022 | VGR{d}W{d}SAR{d}YNFR{d}W{d}R{d}K{d}SGL{d} | ASU2060 | Free | Free | Linear | Mix | Lower-case letters signify D-amino acids | 17 | Antimicrobial | <0.1 % Hemolysis at 8 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35847280 | 2022 | VGR{d}W{d}SAR{d}YNFR{d}W{d}R{d}K{d}SGL{d} | ASU2060 | Free | Free | Linear | Mix | Lower-case letters signify D-amino acids | 17 | Antimicrobial | <0.1 % Hemolysis at 16 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35847280 | 2022 | VGR{d}W{d}SAR{d}YNFR{d}W{d}R{d}K{d}SGL{d} | ASU2060 | Free | Free | Linear | Mix | Lower-case letters signify D-amino acids | 17 | Antimicrobial | <0.1 % Hemolysis at 32 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35834028 | 2022 | GLLSVFKGVLKTAGK | B2-N15 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | B2Ce Analogs | α-Helix | Low hemolytic | ||
| 35834028 | 2022 | GLLSVFKKVLKTAGK | B2-N15-G8K | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | B2Ce Analogs | α-Helix | Low hemolytic | ||
| 35835842 | 2022 | RFGRFLRKIRRFRPK | N-15 Cath-2 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 97.76 μg/mL | Murine | N-Terminal Fragment Of Chicken Cathelicidin-2 | α-Helix | NA | ||
| 35835842 | 2022 | RFGRFLRKILRFLKK | DP1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 216 μg/mL | Murine | Synthetic; N-15 Cath-2 Analogs | α-Helix | NA | ||
| 35835842 | 2022 | RFGRFLRKILRFLRK | DP2 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 145 μg/mL | Murine | Synthetic; N-15 Cath-2 Analogs | α-Helix | NA | ||
| 35835842 | 2022 | RFGRFLRKILRFLLK | DP3 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 24.62 μg/mL | Murine | Synthetic | α-Helix | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N{nt:Acet} | LBF127 | Free | Acetylation | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 50 µM | mouse | Synthetic | α-Helix | NA | ||
| 35700987 | 2022 | W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W | oLBF127 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 10 | Antifungal | Hemolysis at 50 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | dLBF127 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 6.25 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N{nt:Acet} | Ac-LBF127 | Free | Acetylation | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 6.25 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Abz}-{nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | Abz-LBF127 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 100 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:DG}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W | DG-oLBF127 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 10 | Antifungal | Hemolysis at 12.5 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:DG}-{nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | DG-LBF127 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 6.25 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | A-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | AJ-1 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 12.5 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-A-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | AJ-2 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at >200 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-A-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | AJ-3 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at >100 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-A-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | AJ-4 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 25 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-A-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | AJ-5 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 12.5 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-A-R-W-W-{nnr:Dpr}-N | AJ-6 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 200 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | AJ-7 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 50 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-A-W-{nnr:Dpr}-N | AJ-8 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 50 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-A-{nnr:Dpr}-N | AJ-9 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 200 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-A-N | AJ-10 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 50 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-A | AJ-11 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 50 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | AJ-12 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 12 | Antifungal | Hemolysis at 6.25 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35700987 | 2022 | K-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W | K-oLBF127 | Free | Free | Linear | L | DG = dansylglycine, Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 10 | Antifungal | Hemolysis at 100 µM | mouse | Synthetic | α-Helix | NA | ||
| 35700987 | 2022 | {nnr:DG}-K-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W | DG-K-oLBF127 | Free | Free | Linear | Mix | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 10 | Antifungal | Hemolysis at 25 µM | mouse | Synthetic; K-Olbf127 Analogs | α-Helix | NA | ||
| 35700987 | 2022 | K{d}-W{d}-W{d}-{nnr:orn}-N{d}-{nnr:nva}-{nnr:Aib}-R{d}-W{d}-W{d} | ki-oLBF127 | Free | Free | Linear | Mix | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid, Lower-case letters signify D-amino acids | 10 | Antifungal | Hemolysis at 20 µM | mouse | Synthetic; K-Olbf127 Analogs | α-Helix | NA | ||
| 35700987 | 2022 | K{d}-W{d}-W{d}-R{d}-{nnr:Aib}-{nnr:nva}-N{d}-{nnr:orn}-W{d}-W{d} | kri-oLBF127 | Free | Free | Linear | Mix | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid, Lower-case letters signify D-amino acids | 10 | Antifungal | Hemolysis at >200 µM | mouse | Synthetic; K-Olbf127 Analogs | α-Helix | NA | ||
| 35700987 | 2022 | K-W{d}-W{d}-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W{d}-W{d} | kw-oLBF127 | Free | Free | Linear | Mix | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid, Lower-case letters signify D-amino acids | 10 | Antifungal | Hemolysis at 80 µM | mouse | Synthetic; K-Olbf127 Analogs | α-Helix | NA | ||
| 35700987 | 2022 | W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | LBF127-tr10 | Free | Free | Linear | L | Orn = Ornithine, Nva = Norvaline, Dpr = Dpr, Dap = 2,3-Diaminopropionic acid, Aib = Alpha-Amino isobutyric acid, Lower-case letters signify D-amino acids | 10 | Antifungal | Hemolysis at 200 µM | mouse | Synthetic | α-Helix | NA | ||
| 35700987 | 2022 | W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | LBF127-tr11 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid, Lower-case letters signify D-amino acids | 11 | Antifungal | Hemolysis at 100 µM | mouse | Synthetic | α-Helix | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | LBF127 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid, Lower-case letters signify D-amino acids | 12 | Antifungal | Hemolysis at 100 µM | mouse | Synthetic | α-Helix | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr} | LBF127-ctr1 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid, Lower-case letters signify D-amino acids | 11 | Antifungal | Hemolysis at 6.25 µM | mouse | Synthetic | α-Helix | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W | LBF127-ctr2 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid, Lower-case letters signify D-amino acids | 10 | Antifungal | Hemolysis at 6.25 µM | mouse | Synthetic | α-Helix | NA | ||
| 35887160 | 2022 | AGDKKIKIGINGFGRIGRL | NP-6 | Free | Free | Linear | L | None | 19 | Antibacterial | 2.39 ± 0.13 % Hemolysis at 512 µg/mL | Mouse | Synthetic | NA | Non-hemolytic | ||
| 35887325 | 2022 | WDNDTGODDADGD | Daptomycin | Free | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >512 µg/mL | Sheep | Synthetic | α-Helix | NA | ||
| 35561952 | 2022 | IFGAILPLALGALKNLIK{ct:Amid} | Hylin a1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 94 % Hemolysis at 50 μM | Sheep | Hypsiboas Albopunctatus | α-Helix | NA | ||
| 35561952 | 2022 | IAGAILPLALGALKNLIK{ct:Amid} | Hylin a1-2A | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 3 % Hemolysis at 50 μM | Sheep | Synthetic; Hylin A1 Analog | α-Helix | NA | ||
| 35561952 | 2022 | IAKAILPLALGALKNLIK{ct:Amid} | Hylin a1-3K | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 15 % Hemolysis at 50 μM | Sheep | Synthetic; Hylin A1 Analog | α-Helix | NA | ||
| 35561952 | 2022 | IAKAILPLALKALKNLIK{ct:Amid} | Hylin a1-11K | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 30 % Hemolysis at 50 μM | Sheep | Synthetic; Hylin A1 Analog | α-Helix | NA | ||
| 35561952 | 2022 | IAKAILPLALKALKKLIK{ct:Amid} | Hylin a1-15K | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 28 % Hemolysis at 50 μM | Sheep | Synthetic; Hylin A1 Analog | α-Helix | NA | ||
| 36009917 | 2022 | LFVNVLDKIR{ct:Amid} | LF-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | No Hemolysis detected | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | LFVNVLDKIR{ct:Amid} | LF-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | ∼10 % Hemolysis at 512 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{ct:Amid} | BP214 | Amidation | Free | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 41 % Hemolysis at 150 μM | Human | Synthetic | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C4)}{ct:Amid} | 1 | Amidation | lipidated (C4) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp214 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C6)}{ct:Amid} | 2 | Amidation | lipidated (C6) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp215 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C8)}{ct:Amid} | 3 | Amidation | lipidated (C8) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp216 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C10)}{ct:Amid} | 4 | Amidation | lipidated (C10) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp217 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C12)}{ct:Amid} | 5 | Amidation | lipidated (C12) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp218 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C14)}{ct:Amid} | 6 | Amidation | lipidated (C14) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp219 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{ct:Amid} | 7 | Amidation | Free | Linear | D | Lower-case letters signify D-amino acids | 11 | Antimicrobial | 3 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp220 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{ct:Amid} | 8 | Amidation | Free | Linear | D | Lower-case letters signify D-amino acids | 11 | Antimicrobial | 3 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp221 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{ct:Amid} | 9 | Amidation | Free | Linear | D | Lower-case letters signify D-amino acids | 11 | Antimicrobial | 3 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp222 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C10)}{ct:Amid} | 10 | Amidation | lipidated (C10) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 81 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp223 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C12)}{ct:Amid} | 11 | Amidation | lipidated (C12) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 96 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp224 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C14)}{ct:Amid} | 12 | Amidation | lipidated (C14) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 95 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp225 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C10)}{ct:Amid} | 13 | Amidation | lipidated (C10) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 36 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp226 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C12)}{ct:Amid} | 14 | Amidation | lipidated (C12) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 98 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp227 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C14)}{ct:Amid} | 15 | Amidation | lipidated (C14) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 83 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp228 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C10)}{ct:Amid} | 16 | Amidation | lipidated (C10) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 59 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp229 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C12)}{ct:Amid} | 17 | Amidation | lipidated (C12) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp230 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C14)}{ct:Amid} | 18 | Amidation | lipidated (C14) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 94 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp231 | NA | NA | ||
| 35978681 | 2022 | KWKLFKKIGAVLKVL{ct:Amid} | CAM (CA(1–7)M(2–9)) | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 690 μg/mL | Sheep | Synthetic | NA | NA | ||
| 35978681 | 2022 | RWKLFKKIGAVLKVL{ct:Amid} | R1-CAM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 450 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | KWRLFKKIGAVLKVL{ct:Amid} | R3-CAM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 750 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | KWKLFRKIGAVLKVL{ct:Amid} | R6-CAM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 935 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | KWKLFKRIGAVLKVL{ct:Amid} | R7-CAM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at >1000 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | KWKLFKKIGAVLRVL{ct:Amid} | R13-CAM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 280 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | RWRLFRRIGAVLRVL{ct:Amid} | R-CAM | Amidation | Free | Linear | L | No subscript indicates that all Lys residues were replaced by either Arg or Orn | 15 | Antibacterial | 50 % Hemolysis at 230 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | {nnr:O}W{nnr:O}LF{nnr:O}{nnr:O}IGAVL{nnr:O}VL{ct:Amid} | O-CAM | Amidation | Free | Linear | L | O = L-Ornithine, No subscript indicates that all Lys residues were replaced by either Arg or Orn | 15 | Antibacterial | 50 % Hemolysis at >1000 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | CKWKLFKKIGAVLKVL{cyc:N-C}{ct:Amid} | Cyc-CAM | Amidation | Free | Cyclic | L | None | 16 | Antibacterial | 50 % Hemolysis at >1000 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at 47 μg/mL | Human | Synthetic | β-Sheets | Non-hemolytic | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 50 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | Non-hemolytic | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis at >256 μg/mL | Human | Synthetic | β-Sheets | Non-hemolytic | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 50 % Hemolysis at 3 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 50 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 9 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at <1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 50 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 50 % Hemolysis at <1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 11 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 5 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 9 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 9 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 47 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 29 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 37 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 33 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 56 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 58 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 12 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 8 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 19 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 22 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 86 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 55 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 59 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 80 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 77 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 87 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 16 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 10 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 31 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 33 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 96 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 74 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 59 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 95 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 80 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 87 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 20 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 9 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 48 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 46 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 96 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 86 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 69 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 95 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 76 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 77 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 28 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 12 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 72 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 64 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 95 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 93 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 68 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 90 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 59 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 53 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 40 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 15 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 86 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 81 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 94 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 94 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 51 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 82 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 37 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 49 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 59 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 20 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 94 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 90 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 94 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 97 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 41 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 79 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 30 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 49 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 81 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 29 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 98 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 93 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 91 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 97 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 35 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 78 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 29 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 50 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 94 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLK{ct:Amid} | LK10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 43 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLK{ct:Amid} | KL11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 100 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKL{ct:Amid} | LK11 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 100 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKL{ct:Amid} | KL12 | Amidation | Free | Linear | L | None | 12 | Antimicrobial | 89 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLK{ct:Amid} | KL13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 99 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKL{ct:Amid} | LK13 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 32 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 78 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLK{ct:Amid} | KL15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 0 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | LKLKLKLKLKLKLKL{ct:Amid} | LK15 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 31 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKL{ct:Amid} | KL16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 48 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL20 | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 35812346 | 2022 | RRRRRRRRRRRRRRRRRR{nt:H}{ct:OH} | R18 (acetate) | OH | H | Linear | L | None | 18 | Mast cell degranulation inducer | low Hemolysis at 16 μM | Human | Synthetic | NA | Low hemolytic | ||
| 35812346 | 2022 | RRRRRRRRRRRRRRRRRR{nt:H}{ct:OH} | R18 (HCl) | OH | H | Linear | L | None | 18 | Mast cell degranulation inducer | No Hemolysis at 16 μM | Human | Synthetic | NA | Non-hemolytic | ||
| 35812346 | 2022 | R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}{nt:H}{ct:OH} | R18D (acetate) | OH | H | Linear | D | Lower case r = d-arginine | 18 | Mast cell degranulation inducer | No Hemolysis at 16 μM | Human | Synthetic | NA | Non-hemolytic | ||
| 35812346 | 2022 | GRKKRRQRRRKLSSIESDV{nt:H}{ct:OH} | Tat-NR2B9c (TFA) | OH | H | Linear | L | TFA = Trifluoroacetic acid | 19 | Mast cell degranulation inducer | No Hemolysis at 16 μM | Human | Synthetic | NA | Non-hemolytic | ||
| 35852614 | 2022 | FLGAVLKVAGKLV | BR-1GHa-1 | Free | Free | Linear | L | None | 11 | Antimicrobial | 12 % Hemolysis at 128 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | Non-hemolytic | ||
| 35852614 | 2022 | FLGAVLKVLGKLV{ct:Amid} | BR-1GHa-2 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 20.7 % Hemolysis at 16 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | NA | ||
| 35852614 | 2022 | FLGLVLKVLGKLV{ct:Amid} | BR-1GHa-3 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 48.2 % Hemolysis at 16 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | NA | ||
| 35852614 | 2022 | FLPLVLKVLGKLV{ct:Amid} | BR-1GHa-4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 13.4 % Hemolysis at 64 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | NA | ||
| 35852614 | 2022 | FLPLVLKVLGKLV{ct:Amid} | BR-1GHa-4 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 69.4 % Hemolysis at 128 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | NA | ||
| 35852614 | 2022 | FLPLVLKVLGKLL{ct:Amid} | BR-1GHa-5 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 0 % Hemolysis at 32 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | NA | ||
| 35861280 | 2022 | KLLPSVVGLFKKKKQ{ct:Amid} | At1 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 4 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KLLKKVVKLFKKKKK{ct:Amid} | At2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 4 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KLLKKVVKLFKKLLK{ct:Amid} | At3 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 32 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KLLKKLLKLLKKLLK{ct:Amid} | At4 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 0.4 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KIIKKIIKIIKKIIK{ct:Amid} | At5 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 32.3 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KVVKKVVKVVKKVVK{ct:Amid} | At6 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 4 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KIIKKIKKKIKKIIK{ct:Amid} | At7 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 32 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KLLKKLKKKLKKLLK{ct:Amid} | At8 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 129 μM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35861280 | 2022 | KVVKKVKKKVKKVVK{ct:Amid} | At9 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 4 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | IKKIIKIIKKIIKKI{ct:Amid} | At10 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | ~30 % Hemolysis at 200 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | IKKIIKIIKKIIKKI{ct:Amid} | At10 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 32.3 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | IIIKKIKKKIKKIII{ct:Amid} | At11 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 32.3 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35861280 | 2022 | KIIIKIKKKIKIIIK{ct:Amid} | At12 | Amidation | Free | Linear | L | None | 15 | Antimicrobial | 10 % Hemolysis at 32 μM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 36144584 | 2022 | FRIMRILRVLKL | pept_1 | Free | Free | Linear | L | None | 12 | Antimicrobial | 30 % Hemolysis at 50 μM | Human | Synthetic | NA | NA | ||
| 36144584 | 2022 | FRIMRILRVLK | pept_2 | Free | Free | Linear | L | None | 11 | Antimicrobial | <10 % Hemolysis at 50 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | RWRLVCFLCRRKKV | pept_3 | Free | Free | Linear | L | None | 14 | Antimicrobial | 22 % Hemolysis at 50 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | KFKKVIWKSFL | pept_4 | Free | Free | Linear | L | None | 11 | Antimicrobial | ∼5 % Hemolysis at 50 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | RPILIRVRRIRVI | pept_5 | Free | Free | Linear | L | None | 13 | Antimicrobial | ∼15 % Hemolysis at 50 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | FRIMRILRVLKL | pept_1 | Free | Free | Linear | L | None | 12 | Antimicrobial | 80 % Hemolysis at 100 μM | Human | Synthetic | NA | NA | ||
| 36144584 | 2022 | FRIMRILRVLK | pept_2 | Free | Free | Linear | L | None | 11 | Antimicrobial | ∼15 % Hemolysis at 100 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | RWRLVCFLCRRKKV | pept_3 | Free | Free | Linear | L | None | 14 | Antimicrobial | ∼30 % Hemolysis at 100 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | KFKKVIWKSFL | pept_4 | Free | Free | Linear | L | None | 11 | Antimicrobial | ∼15 % Hemolysis at 100 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36144584 | 2022 | RPILIRVRRIRVI | pept_5 | Free | Free | Linear | L | None | 13 | Antimicrobial | ∼35 % Hemolysis at 100 μM | Human | Synthetic | NA | Low hemolytic | ||
| 36145681 | 2022 | GFLFKLIPKAIKKLISKFK | GK-19 | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal | <5 % Hemolysis at 100 μM | Rat | Synthetic | NA | Low hemolytic | ||
| 36145681 | 2022 | GFLFKLIPKAIKKLISKFK | GK-19 | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 15 % Hemolysis at 200 μM | Rat | Synthetic | NA | Low hemolytic | ||
| 36145681 | 2022 | GFLFKLIPKAIKKLISKFK | GK-19 | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 40 % Hemolysis at 400 μM | Rat | Synthetic | NA | Low hemolytic | ||
| 36299717 | 2022 | GWGAKRWGKRGWKWKRHW{ct:Amid} | GW18 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | No Hemolysis at 1.32–169.01 μM | Human | Synthetic | NA | Non-hemolytic | ||
| 36287965 | 2022 | IKGIMSIVKAFLGNLR | Ca-MAP1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 91.09 % Hemolysis at 72.7 μM | Human | Synthetic | NA | NA | ||
| 36287965 | 2022 | IKGIMSIVKAFLGNLR | Ca-MAP1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 71.95 % Hemolysis at 36.3 μM | Human | Synthetic | NA | NA | ||
| 36287965 | 2022 | IKGIMSIVKAFLGNLR | Ca-MAP1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 32.25 % Hemolysis at 18.1 μM | Human | Synthetic | NA | NA | ||
| 36287965 | 2022 | IKGIMSIVKAFLGNLR | Ca-MAP1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 5 % Hemolysis at 9.1 μM | Human | Synthetic | NA | NA | ||
| 36287965 | 2022 | IKGIMSIVKAFLGNLR | Ca-MAP1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 0 % Hemolysis at 4.5 μM | Human | Synthetic | NA | NA | ||
| 35972429 | 2022 | RRRLCFVRP{d}KFVVCVRRP{d} | PLP-3 | Free | Free | Linear | Mix | None | 18 | Antimicrobial | 50 % Hemolysis at 48.5 mg/L | Human | Protegrin-1 (Pg-1) Analog | β-Hairpin | Non-hemolytic | ||
| 36364155 | 2022 | PTECQVGTTCVESS{nt:Amid} | PS14 | Free | Amidation | Linear | L | None | 14 | Anticancer, Anti-inflammatory | 25.45 ± 1 % Hemolysis at 5 μM | Human | Aphanomyces Invadans | NA | NA | ||
| 36364155 | 2022 | PTECQVGTTCVESS{nt:Amid} | PS14 | Free | Amidation | Linear | L | None | 14 | Anticancer, Anti-inflammatory | 39.21 ± 1.5 % Hemolysis at 10 μM | Human | Aphanomyces Invadans | NA | NA | ||
| 36364155 | 2022 | PTECQVGTTCVESS{nt:Amid} | PS14 | Free | Amidation | Linear | L | None | 14 | Anticancer, Anti-inflammatory | 49.10 ± 1.89 % Hemolysis at 15 μM | Human | Aphanomyces Invadans | NA | NA | ||
| 36364155 | 2022 | PTECQVGTTCVESS{nt:Amid} | PS14 | Free | Amidation | Linear | L | None | 14 | Anticancer, Anti-inflammatory | 69 ± 1.3 % Hemolysis at 20 μM | Human | Aphanomyces Invadans | NA | NA | ||
| 36364155 | 2022 | PTECQVGTTCVESS{nt:Amid} | PS14 | Free | Amidation | Linear | L | None | 14 | Anticancer, Anti-inflammatory | 77 ± 2.8 % Hemolysis at 25 μM | Human | Aphanomyces Invadans | NA | NA | ||
| 2317508 | 1990 | FLPLIAGLLGKLF{ct:Amid} | Hemolytic protein B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | 4 % Hemolysis at 1nmol/ml | Human | Rana Esculenta (Edible Frog) (Pelophylax Esculentus) | α-Helix | NA | ||
| 2317508 | 1990 | FLPLIAGLLGKLF{ct:Amid} | Hemolytic protein B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | 5 % Hemolysis at 1.5nmol/ml | Human | Rana Esculenta (Edible Frog) (Pelophylax Esculentus) | α-Helix | NA | ||
| 2317508 | 1990 | FLPLIAGLLGKLF{ct:Amid} | Hemolytic protein B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | 17 % Hemolysis at 2nmol/ml | Human | Rana Esculenta (Edible Frog) (Pelophylax Esculentus) | α-Helix | NA | ||
| 2317508 | 1990 | FLPLIAGLLGKLF{ct:Amid} | Hemolytic protein B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | 20 % Hemolysis at 2.5nmol/ml | Human | Rana Esculenta (Edible Frog) (Pelophylax Esculentus) | α-Helix | NA | ||
| 2317508 | 1990 | FLPLIAGLLGKLF{ct:Amid} | Hemolytic protein B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | 35 % Hemolysis at 3nmol/ml | Human | Rana Esculenta (Edible Frog) (Pelophylax Esculentus) | α-Helix | NA | ||
| 2317508 | 1990 | FLPLIAGLLGKLF{ct:Amid} | Hemolytic protein B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | 90 % Hemolysis at 3.5nmol/ml | Human | Rana Esculenta (Edible Frog) (Pelophylax Esculentus) | α-Helix | NA | ||
| 25561178 | 2015 | {nnr:x}ISQ{d}I{d}IST{d}A{nnr:X}I | Teixobactin | Free | Free | Linear | Mix | x = NmPhe(N-methylated phenylalanine), X = End (Enduracididine) | 11 | Anticancer, Antibacterial | No Hemolysis | Human | Eleftheria Terrae | NA | Non-hemolytic | ||
| 25329706 | 2014 | RFPGLMMKLLV | LBP/BPI (324334), ofLBP1N | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 45 % Hemolysis at 100μg/mL | Human | Synthetic Construct | NA | NA | ||
| 25329706 | 2014 | RFPKLMMKLLV | LBP/BPI (324334)[G4K], ofLBP2A | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 30 % Hemolysis at 100μg/mL | Human | Synthetic Construct | NA | NA | ||
| 25329706 | 2014 | KLVKTQLKVLK | LBP/BPI (450460), ofLBP4N | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 0 % Hemolysis at 100μg/mL | Human | Synthetic Construct | NA | Non-hemolytic | ||
| 25329706 | 2014 | KLVKTWLKVLK | LBP/BPI (450460)[Q6W], ofLBP5A | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 0 % Hemolysis at 100μg/mL | Human | Synthetic Construct | NA | Non-hemolytic | ||
| 25329706 | 2014 | MKLVKTWLKVLK | LBP/BPI (449460)[Q7W], ofLBP6A | Free | Free | Linear | L | None | 12 | Antibacterial, Antifungal | 28 % Hemolysis at 100μg/mL | Human | Synthetic Construct | NA | NA | ||
| 25485686 | 2015 | TR{d}SG{nnr:x}LR{d}EQ{d}W{d}IT | Lysocin E | Free | Free | Linear | Mix | x = D-N-Methylphenylalanine | 12 | Antibacterial, Antifungal | <1 % Hemolysis at 100μg/mL | Sheep | Lysobacter | NA | Non-hemolytic | ||
| 25485686 | 2015 | TR{d}SG{nnr:x}LR{d}EQ{d}W{d}IT | Lysocin E | Free | Free | Linear | Mix | x = D-N-Methylphenylalanine | 12 | Antibacterial, Antifungal | <1 % Hemolysis at 100μg/mL | Horse | Lysobacter | NA | Non-hemolytic | ||
| 21884742 | 2011 | IKWKAILDAVKKVI{ct:Amid} | Mastoparan-A | Amidation | Free | Linear | L | None | 14 | Antibacterial | 4 % Hemolysis at 32μg/mL | Sheep | Vespa Analis | 40%TFE= α-Helix | NA | ||
| 21884742 | 2011 | INLKAIAALAKKLL{ct:Amid} | Mastoparan M | Amidation | Free | Linear | L | None | 14 | Antibacterial | 7 % Hemolysis at 64μg/mL | Sheep | Vespa Mandarinia | 40%TFE= α-Helix | NA | ||
| 21884742 | 2011 | INLKAIAALAKKLF{ct:Amid} | Mastoparan-AF | Amidation | Free | Linear | L | None | 14 | Antibacterial | 2.5 % Hemolysis at 32μg/mL | Sheep | Vespa Affinis | 40%TFE= α-Helix | NA | ||
| 28002968 | 2016 | WGEAFSAGVHRLANGGNG{ct:Amid} | Leucocin A (18-35)/ WG18 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >71.15μM | Human | Synthetic Construct | TFE = α-Helix | NA | ||
| 28002968 | 2016 | WGRAFSAGVHRLANGGNG{ct:Amid} | WR1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >70.09μM | Human | Synthetic Construct | TFE = Random coil | NA | ||
| 28002968 | 2016 | WGRAFSAGVHRLARGGRG{ct:Amid} | WR3 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >67.01μM | Human | Synthetic Construct | TFE = α-Helix | NA | ||
| 28002968 | 2016 | WGRAFSRGVRRLARGGRG{ct:Amid} | WR5 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >63.54μM | Human | Synthetic Construct | TFE = Random coil | NA | ||
| 28002968 | 2016 | WGRAFRRGVRRLARGGRR{ct:Amid} | WR7 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >58.64μM | Human | Synthetic Construct | TFE = Random coil | NA | ||
| 28002968 | 2016 | WGRAFRRLVRRLARGLRR{ct:Amid} | WRL2 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >55.78μM | Human | Synthetic Construct | TFE = α-Helix | NA | ||
| 28002968 | 2016 | WLRAFRRLVRRLARGLRR{ct:Amid} | WRL3 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at 27.22μM | Human | Synthetic Construct | TFE = α-Helix | NA | ||
| 28002968 | 2016 | WLRAFRRLVRRLARLLRR{ct:Amid} | WRL4 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at 53.18μM | Human | Synthetic Construct | TFE = α-Helix | NA | ||
| 11600395 | 2001 | KNIRRIIRKIIHIIKKYG | OV-5 | Free | Free | Linear | L | None | 18 | Antibacterial | 76 % Hemolysis at 100μM | Human | Synthetic Construct | NA | NA | ||
| 28741926 | 2017 | {nnr:Z}CRRLCYKQRCVTYCRGR{ct:Amid} | Gomesin | Amidation | Free | Linear | L | Z = pyroglutamic acid | 18 | Antibacterial, Antifungal | 47.2±6 % Hemolysis at 64μM | Human | Acanthoscurria Gomesiana [Tarantula Spider] | NA | NA | ||
| 24269514 | 2014 | GLLKKWLKKWKEFKRIVGY{ct:Amid} | peptide2 | Amidation | Free | Linear | L | None | 19 | Antibacterial | 20 % Hemolysis at 160μg/mL | Human | Synthetic Construct | α-Helix | NA | ||
| 28433718 | 2017 | FFFHIVKGLFHAGRMIHGLV | Piscidin-2 (1-20), ecPis-2 (1-20) | Free | Free | Linear | L | None | 20 | Antibacterial, Antiparasitic, Antifungal | 5.12±0.37 % Hemolysis at 2.5μM | Rabbit | Synthetic Construct | α-Helix | NA | ||
| 15019209 | 2003 | GIFSKLAGKKLKNLLISGL{ct:Amid} | Esculentin-1B (1-18) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 7 % Hemolysis at 15μM | Human | Synthetic Construct | NA | NA | ||
| 8223491 | 1993 | I{nnr:l}GPVLGLVGSALGGLLKKI | Bombinin H4 | Free | Free | Linear | Mix | l = D-aILe(D-alloisoleucine) | 20 | Antibacterial, hemolytic, Antifungal, candidacidal, Antiparasitic | Hemolysis at 14.6μM | Human | Yellow-Bellied Toad, Bombina Variegata L, Europe | Helix | NA | ||
| 2578459 | 1985 | IKITTMLAKLGKVLAHV{ct:Amid} | Bombolitin I | Amidation | Free | Linear | L | None | 17 | hemolytic | 50 % Hemolysis at 4μg/mL | Pig | American Common Bumblebee, Megabombus Pennsylvanicus | Helix | NA | ||
| 2578459 | 1985 | SKITDILAKLGKVLAHV{ct:Amid} | Bombolitin II | Amidation | Free | Linear | L | None | 17 | Antifungal, hemolytic | 50 % Hemolysis at 3.9μg/mL | Pig | American Common Bumblebee, Megabombus Pennsylvanicus | Helix | NA | ||
| 2578459 | 1985 | IKIMDILAKLGKVLAHV{ct:Amid} | Bombolitin III | Amidation | Free | Linear | L | None | 17 | hemolytic | 50 % Hemolysis at 2.8μg/mL | Pig | American Common Bumblebee, Megabombus Pennsylvanicus | Helix | NA | ||
| 2578459 | 1985 | INIKDILAKLVKVLGHV{ct:Amid} | Bombolitin IV | Amidation | Free | Linear | L | None | 17 | hemolytic | 50 % Hemolysis at 1.8μg/mL | Pig | American Common Bumblebee, Megabombus Pennsylvanicus | NA | NA | ||
| 2578459 | 1985 | INVLGILGLLGKALSHL{ct:Amid} | Bombolitin V | Amidation | Free | Linear | L | None | 17 | hemolytic | 50 % Hemolysis at 0.7μg/mL | Pig | American Common Bumblebee, Megabombus Pennsylvanicus | NA | NA | ||
| 17698251 | 2004 | VWPLGLVICKALKIC | Dybowskin-4 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal, candidacidal, Hemolytic | 47.58 % Hemolysis | Human | Frog Rana Dybowskii , Asia | NA | NA | ||
| 17698251 | 2004 | FLPLLLAGLPLKLCFLFKKC | Dybowskin-6 | Free | Free | Linear | L | None | 20 | Antibacterial Gram+, Antifungal, candidacidal, Hemolytic | 59.39 % Hemolysis | Human | Frog Rana Dybowskii , Asia | NA | NA | ||
| 2317508 | 1990 | FLPLIAGLIGKLF{ct:Amid} | Peptide B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | Hemolytic | Human | Frog Rana Esculenta, Europe | NA | NA | ||
| 9022710 | 1993 | I{nnr:l}GPVLGMVGSALGGLLKKI | Bombinin H3 | Free | Free | Linear | Mix | l = D-alloisoleucine | 20 | Antibacterial, Hemolytic | Hemolytic at 15.7µM | Human | Toad, Bombina Variegata, Europe | NA | NA | ||
| 19022312 | 2009 | FFPLVLGALGSILPKIF{ct:Amid} | Temporin-LTa | Amidation | Free | Linear | L | None | 17 | Antibacterial Gram+, Hemolytic | 50 % Hemolytic at 9µg/ml | Rabbit | Chinese Broad-Folded Frog, Hylarana Latouchii (Anura:Ranidae), China, Asia | NA | NA | ||
| 15556063 | 2004 | FLPIIAGMAAKVICAITKKC | Brevinin-1SPb | Free | Free | Linear | L | None | 20 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 25µM | Human | Frog Rana Septentrionalis , North America | NA | NA | ||
| 15556063 | 2004 | FFPIIAGMAAKVICAITKKC | Brevinin-1SPd | Free | Free | Linear | L | None | 20 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 8µM | Human | Frog Rana Septentrionalis , North America | NA | NA | ||
| 20451254 | 2010 | FLSLIPHIVSGVASIAKHF{ct:Amid} | Phylloseptin-1 (PSN-1) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Antiparasitic, Hemolytic, Antibiofilm | 6.7 % Hemolytic at 5µM | Horse | The Waxy Monkey Frog, Phyllomedusa Sauvagei, South America | Helix | NA | ||
| 21295070 | 2011 | FLPIITNLLGKLL{ct:Amid} | Temporin-PRb | Amidation | Free | Linear | L | None | 13 | Antibacterial Gram+, Hemolytic | 50 % Hemolytic at 35µM | Human | Frog North America, The Oregon Spotted Rana Pretiosa | NA | NA | ||
| 21338048 | 2011 | ILGPVLGLVGNALGGLIKKL{ct:Amid} | Maximin H39 | Amidation | Free | Linear | L | None | 20 | Antibacterial Gram+, Hemolytic | 50 % Hemolytic at 100µg/ml | Human | Toad Brain, Bombina Maxima, China, Asia | NA | NA | ||
| 19778602 | 2010 | FLPLVLGALSGILPKIL{ct:Amid} | Temporin-RN1 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 6.69±1.51 % Hemolytic at 100µg/ml | Rabbit | Frog Skin Secretions, Rana Nigrovittata , China, Asia | NA | NA | ||
| 19778602 | 2010 | FFPLLFGALSSHLPKLF{ct:Amid} | Temporin-RN3 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | Hemolytic | Rabbit | Frog Skin Secretions, Rana Nigrovittata , China, Asia | NA | NA | ||
| 20308076 | 2010 | FLPAALAGIGGILGKLF | Temporin-SHd (Temp-SHd) | Free | Free | Linear | L | None | 17 | Antibacterial, Antiparasitic, Anti-MRSA, Hemolytic | 50 % Hemolytic at 44µM | Human | Skin, Pelophylax Saharica, Africa | Helix | NA | ||
| 22342498 | 2012 | FLSTLWNAAKSIF{ct:Amid} | VmCT2 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Hemolytic | 50 % Hemolytic at 35µM | Human | Scorpions Vaejovis Mexicanus Smithi | Helix | NA | ||
| 22426384 | 2012 | FLAGLIGGLAKML | Temporin-LTe | Free | Free | Linear | L | None | 13 | Antibacterial Gram+, Hemolytic | 50 % Hemolytic at 40µM | Human | Broad-Folded Frog, Hylarana Latouchii, China, Asia | NA | NA | ||
| 22484288 | 2012 | FLFSLIPSAISGLISAF{ct:Amid} | AamAP2 | Amidation | Free | Linear | L | None | 17 | Antibacterial Gram+,Antifungal, candidacidal, Hemolytic | ~50 % Hemolytic at 100µM | Horse | Scorpion Venom, The North African Scorpion, Androctonus Amoreuxi | NA | NA | ||
| 25066917 | 2014 | FLPLLVGAISSILPKIF{ct:Amid} | Temporin-TP2 | Amidation | Free | Linear | L | None | 17 | Antibacterial Gram+, Hemolytic | 50 % Hemolytic at 59.4µM | Human | Frog Skin Secretions, Hylarana Taipehensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPLLFGALSTLLPKIF{ct:Amid} | Temporin-TP3 | Amidation | Free | Linear | L | None | 17 | Antibacterial Gram+, Hemolytic | 50 % Hemolytic at 94.6µM | Human | Frog Skin Secretions, Hylarana Taipehensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPFVGKLLSGLL{ct:Amid} | Temporin-LF1 | Amidation | Free | Linear | L | None | 13 | Antibacterial Gram+, Antifungal, Hemolytic | 50 % Hemolytic at 34.2µM | Human | Frog Skin Secretions, Amolops Lifanensis, China, Asia | NA | NA | ||
| 30802593 | 2019 | FIVPSIFLLKKAFCIALKKC | Japonicin-2LF | Free | Free | Linear | L | None | 20 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm | >80 % Hemolytic at 64µM | Horse | Fujian Large-Headed Frog Skin Secretion, Limnonectes Fujianensis, China, Asia | Helix | NA | ||
| 32933215 | 2020 | FLPALAGIAGLLGKIF{ct:Amid} | Temporin-SHe | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal, Antiparasitic, Hemolytic | 84 % Hemolytic at 25µM | Human | Sahara Frog, Pelophylax Saharicus, Africa | Helix | NA | ||
| 31386688 | 2019 | LKMLGMLFHNIRNILKTV{ct:Amid} | Hs01 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at >128µM | Human | Human Prame Family Member 20 | Helix | NA | ||
| 31386688 | 2019 | KWAVRIIRKFIKGFIS{ct:Amid} | Hs02 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at >128µM | Human | Human Unconventional Myosin-Ih | Helix | NA | ||
| 31386688 | 2019 | FLREFHKWIERVVGWLGKVF{ct:Amid} | Hs03 | Amidation | Free | Linear | L | None | 20 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at >128µM | Human | Human Anaphase-Promoting Complex Subunit 2 | Helix | NA | ||
| 31386688 | 2019 | LFNNYITAALKLLEKLYKV{ct:Amid} | Hs04 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 64µM | Human | Human Unconventional Myosin 1H Protein, Intragenic Antimicrobial Peptide, Homo Sapiens (Probable E3 Ubiquitin-Protein Ligase Herc3 Isoform 1) | Helix | NA | ||
| 28161291 | 2017 | FWRIVRWIKRWLR{ct:Amid} | FK13-a2 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-inflammatory, Hemolytic | 50 % Hemolytic at 14µM | Human | Human Cathelicidin Analog | Helix | NA | ||
| 28161291 | 2017 | FWRIVRRIWRWLR{ct:Amid} | FK13-a3 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-inflammatory, Hemolytic | 50 % Hemolytic at 12.5µM | Human | Human Cathelicidin Analog | Helix | NA | ||
| 9010936 | 1996 | GFFALIAKTISSPLFKTL{ct:Amid} | 18A | Amidation | Free | Linear | L | None | 18 | Antibacterial Gram+, Hemolytic | 100 % Hemolytic at 33µg/ml | Human | Synthetic Peptide | NA | NA | ||
| 38360076 | 2024 | KWIRRIIRDYKKFFIKFII | KWI-19 | Free | Free | Linear | L | None | 19 | Antifungal, Hemolytic, Antibiofilm | 50 % Hemolytic at 10µM | Human | Synthetic Peptide | Helix | NA | ||
| 36249542 | 2022 | FLSKILSTLRILL | YZ106 | Free | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 50µM | Human | Synthetic Peptide | NA | NA | ||
| 36249542 | 2022 | FLSKILSTLRILF | YZ107 | Free | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 25µM | Human | Synthetic Peptide | NA | NA | ||
| 36138742 | 2022 | FLKIIGKLLSGLL | VM-3K | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 11.2µM | Horse | Synthetic Peptide | Helix | NA | ||
| 36138742 | 2022 | FLGIIGKLLSGLL | VM-3G | Free | Free | Linear | L | None | 13 | Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 9.7µM | Horse | Synthetic Peptide | Helix | NA | ||
| 36138742 | 2022 | FLWIIGKLLSGLL | VM-3W | Free | Free | Linear | L | None | 13 | Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 9.7µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39141008 | 2024 | GLLKKLLKKLLKKLLKKI | LK4 | Free | Free | Linear | L | None | 18 | Antibacterial, Hemolytic | 50 % Hemolytic at 64µM | Human | Synthetic Peptide | Helix | NA | ||
| 39141008 | 2024 | GLLKKLLKKLLKKLLKKI | LK4 | Free | Free | Linear | L | None | 18 | Antibacterial, Hemolytic | 10 % Hemolytic at 5.42µM | Human | Synthetic Peptide | Helix | NA | ||
| 39141008 | 2024 | GFFKKFFKKFFKKFFKKI | FK4 | Free | Free | Linear | L | None | 18 | Antibacterial, Hemolytic | 50 % Hemolytic at 32-64µM | Human | Synthetic Peptide | Helix | NA | ||
| 39141008 | 2024 | GFFKKFFKKFFKKFFKKI | FK4 | Free | Free | Linear | L | None | 18 | Antibacterial, Hemolytic | 10 % Hemolytic at 4.02µM | Human | Synthetic Peptide | Helix | NA | ||
| 39141008 | 2024 | GWWKKWWKKWWKKI | WK3 | Free | Free | Linear | L | None | 14 | Antibacterial, Hemolytic | 50 % Hemolytic at 32-64µM | Human | Synthetic Peptide | Helix | NA | ||
| 39141008 | 2024 | GWWKKWWKKWWKKI | WK3 | Free | Free | Linear | L | None | 14 | Antibacterial, Hemolytic | 10 % Hemolytic at 55.52µM | Human | Synthetic Peptide | Helix | NA | ||
| 39141008 | 2024 | GWWKKWWKKWWKKWWKKI | WK4 | Free | Free | Linear | L | None | 18 | Antibacterial, Hemolytic | 10 % Hemolytic at 4.38µM | Human | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPHAISAVSALAKHL | Phylloseptin-TO2 | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 64µM | Horse | Skin Secretion, Super Tiger Leg Monkey Tree Frog, Phyllomedusa Tomopterna, Central America, South America | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAISAVSALAKHL | PSTO2 7K | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 32-64µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAISAVSALAKKL | PSTO2 18K | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 64µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAIKAVSALAKKL | PSTO2 SR (Phylloseptin-TO2 analog) | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 64µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAIKAVKALAKKL | PSTO2 SR2 (Phylloseptin-TO2 analog) | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39138237 | 2024 | FLPFLASLALKIL{ct:Amid} | Temporin-WY2 (Natural AMPs, Leu-rich, frog, amphibians, animals, XXA, UCLL1c) | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 32-64µM | Horse | Cutaneous Secretion, The Ranidae Frog, Amolops Wuyiensis, China, Asia | Helix | NA | ||
| 39138237 | 2024 | FLPKLLSALAKIL{ct:Amid} | QUB-1426 (Synthetic AMPs, Temporin-WY2 analog, Leu-rich, XXA, UCLL1c | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 16-32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39138237 | 2024 | KKKKKKFLPFLASLALKIL{ct:Amid} | 6K-WY2 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39138237 | 2024 | KKKKKKFLPKLLSALAKIL{ct:Amid} | 6K-1426 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39427973 | 2025 | FLPFLGKLFSGIF{ct:Amid} | Temporin-PMb | Amidation | Free | Linear | L | None | 13 | Antibacterial, Hemolytic, Anticancer | 50 % Hemolytic at 32-64µM | Human | Skin Secretion, The Amazon River Frog, Lithobates Palmipes (Ranidae), Brazil, South America | NA | NA | ||
| 39357847 | 2025 | FLKLIGKVLSGIL{ct:Amid} | Temporin F P3K analog | Amidation | Free | Linear | L | None | 13 | Antibacterial, Hemolytic | 50 % Hemolytic at 70µM | Human | Synthetic Peptide | Helix | NA | ||
| 39357847 | 2025 | FLKLIGKVLSKIL{ct:Amid} | Temporin F P3K,G11K analog | Amidation | Free | Linear | L | None | 13 | Antibacterial, Hemolytic | 50 % Hemolytic at 30µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | IILLLLKKFLKKL{ct:Amid} | 2K4L | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 62.5µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | WILLLLKKFLKKL{ct:Amid} | 2K4L_W1 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 12.5µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | IWLLLLKKFLKKL{ct:Amid} | 2K4L_W2 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 50µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | IILLLLKKFWKKL{ct:Amid} | 2K4L_W10 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 12.5µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | IILLLLKKFLKKW{ct:Amid} | 2K4L_W13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 12.5µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | IILLLLKKFWKKW{ct:Amid} | 2K4L_2W | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 25µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | IWLLLLKKFWKKW{ct:Amid} | 2K4L_3W (Temporin-1CEc analog) | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 6.25µM | Human | Synthetic Peptide | Helix | NA | ||
| 22100226 | 2011 | VNWKKILGKIIKVVK{nt:H}{ct:Amid} | Lasioglossin-3 (LL-III) | Amidation | H | Linear | L | None | 15 | Antimicrobial | 50 % Hemolytic at >200µM | Rat | Lasioglossum Laticeps (Bee) | Alphα-Helix | Low hemolytic | ||
| 23967105 | 2013 | FLSLIPHIVSGVASIAKHF{ct:Amid} | Phylloseptin-S1 (PLS-S1) (Phylloseptin-1) (PSN-1) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 % Hemolytic at 39µM | Human | Phyllomedusa Sauvagei (Sauvage'S Leaf Frog) | NA | NA | ||
| 23967105 | 2013 | FLSLIPHIVSGVASLAKHF{ct:Amid} | Phylloseptin-S2 (PLS-S2) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 % Hemolytic at 25µM | Human | Phyllomedusa Sauvagei (Sauvage'S Leaf Frog) | NA | NA | ||
| 23967105 | 2013 | FLSMIPHIVSGVAALAKHL{ct:Amid} | Phylloseptin-S4 (PLS-S4) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | LC50 % Hemolytic at 33µM | Human | Phyllomedusa Sauvagei (Sauvage'S Leaf Frog) | NA | NA | ||
| 31295915 | 2019 | SAEVAGAVIEGAKLTFNVLQ | FraA | Free | Free | Linear | L | None | 20 | actinoporins | HC(50) % Hemolytic at 0.4 ± 0.02nM | Sheep | Actinia Fragacea (Strawberry Anemone) | β-sandwich flanked by two α-helices | NA | ||
| 31295915 | 2019 | SAEVAGAIIDGASLTFDVLQ | FraB | Free | Free | Linear | L | None | 20 | actinoporins | HC(50) % Hemolytic at 0.3 ± 0.02nM | Sheep | Actinia Fragacea (Strawberry Anemone) | β-sandwich flanked by two α-helices | NA | ||
| 31295915 | 2019 | SADVAGAVIDGAGLG | FraC d | Free | Free | Linear | L | None | 15 | actinoporins | HC(50) % Hemolytic at 1.6 ± 0.3nM | Sheep | Actinia Fragacea (Strawberry Anemone) | β-sandwich flanked by two α-helices | NA | ||
| 31295915 | 2019 | SVAVAGAVIKGAALTFNILQ | FraD | Free | Free | Linear | L | None | 20 | actinoporins | HC(50) % Hemolytic at 0.4 ± 0.3nM | Sheep | Actinia Fragacea (Strawberry Anemone) | β-sandwich flanked by two α-helices | NA | ||
| 31295915 | 2019 | SADVAGAVIDGAGLGFDVLK | FraE | Free | Free | Linear | L | None | 20 | actinoporins | HC(50) % Hemolytic at 1.6 ± 0.2nM | Sheep | Actinia Fragacea (Strawberry Anemone) | β-sandwich flanked by two α-helices | NA | ||
| 18584916 | 2008 | FLSGIVGMLGKLF{ct:Amid} | Temporin-SHa (Temporin-1Sa) (Temp-1Sa) | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LC50 % Hemolytic at 25µM | Human | Pelophylax Saharicus (Sahara Frog) (Rana Saharica) | NA | NA | ||
| 18584916 | 2008 | FLSHIAGFLSNLF{ct:Amid} | Temporin-SHc (Temporin-1Sc) (Temp-1Sc) | Amidation | Free | Linear | L | None | 13 | Antimicrobial | LC50 % Hemolytic at >80µM | Human | Pelophylax Saharicus (Sahara Frog) (Rana Saharica) | NA | Non-hemolytic | ||
| 19591185 | 2009 | VNWKKVLGKIIKVAK{ct:Amid} | Lasioglossin-1 (LL-I) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | >200 % Hemolytic at 50µM | Rat | Lasioglossum Laticeps (Bee) | Alpha Helix | Non-hemolytic | ||
| 19591185 | 2009 | VNWKKILGKIIKVAK{ct:Amid} | Lasioglossin-2 (LL-II) | Amidation | Free | Linear | L | None | 15 | Antimicrobial | >200 % Hemolytic at 50µM | Rat | Lasioglossum Laticeps (Bee) | Alpha Helix | Non-hemolytic | ||
| 30734396 | 2019 | FFSMIPKIATGIASLVKNL{ct:Amid} | Phylloseptin-3.1TR (PLS-3.1TR) (Phylloseptin-3.3TR) | Amidation | Free | Linear | L | None | 19 | cytotoxic | LC50 % Hemolytic at 12µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | NA | NA | ||
| 15142548 | 2004 | ADVRNPLEEFRETDYEVL | L-amino-acid oxidase (Balt-LAAO-I) (LAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 18 | Antibacterial | Hemolytic | NA | Bothrops Alternatus (Urutu) (Rhinocerophis Alternatus) | NA | NA | ||
| 22091349 | 2011 | NLFQFARMINGKLGAFSV | Acidic phospholipase A2 Drs-PLA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) | Free | Free | Linear | L | None | 18 | Antimicrobial | Hemolytic | Human | Daboia Siamensis (Eastern Russel'S Viper) (Daboia Russelii Siamensis) | NA | NA | ||
| 22014884 | 2011 | KIAKVALKAL | PYLa/PGLa A [Cleaved into: PYLa; PGLa; PGLa-H] | Free | Free | Linear | L | None | 10 | Antimicrobial | 7.95 % Hemolytic at 200μg/mL | Rabbit | Xenopus Laevis (African Clawed Frog) | NA | Low hemolytic | ||
| 24371568 | 2012 | IIIQYEGHKH | Rondonin | Free | Free | Linear | L | None | 10 | Antifungal | 0 % Hemolytic at 67µM | Human | Acanthoscurria Rondoniae (Spider) | NA | Non-hemolytic | ||
| 30734396 | 2019 | FLSLIPKIAGGIASLVKNL{ct:Amid} | Phylloseptin-1.1TR (PLS-1.1TR) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolytic at 28µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | Helical | NA | ||
| 30734396 | 2019 | FLSLIPKIAGGIASLVKDL{ct:Amid} | Phylloseptin-1.2TR (PLS-1.2TR) (Phylloseptin-1.3TR) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolytic at 75µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | NA | NA | ||
| 30734396 | 2019 | FLSLIPHIATGIAALAKHL{ct:Amid} | Phylloseptin-2.1TR (PLS-2.1TR) (Phylloseptin-2.2TR) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolytic at 41µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | Helical | NA | ||
| 30734396 | 2019 | FFSMIPKIATGIASLVKDL{ct:Amid} | Phylloseptin-3.2TR (PLS-3.2TR) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal, Anti-inflammatory | 50 % Hemolytic at 110µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | NA | NA | ||
| 30734396 | 2019 | LLGMIPVAITAISALSKL{ct:Amid} | Medusin-TR1 (MDS-TR1) (Phylloseptin-4TR) (PLS-4TR) | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal, Anti-inflammatory, Antibiofilm | 50 % Hemolytic at 65µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | Helical | NA | ||
| 18312859 | 2008 | NILSSIVNGINRALSFFG | Amolopin-P1 | Free | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 3 % Hemolytic at 200μg/mL | Rabbit | Amolops Loloensis (Lolokou Sucker Frog) (Staurois Loloensis) | β-Sheet | Non-hemolytic | ||
| 22450466 | 2012 | AILTTLANWARKFL{ct:Amid} | temporin-HN1 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 50 % Hemolytic at 75µM | Human | Odorrana Hainanensis (Odor Frog) (Rana Hainanensis) | Helical | NA | ||
| 22450466 | 2012 | NILNTIINLAKKIL{ct:Amid} | temporin-HN2: | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 50 % Hemolytic at 300µM | Human | Odorrana Hainanensis (Odor Frog) (Rana Hainanensis) | Helical | Low hemolytic | ||
| 22342498 | 2012 | FLKGIIDTVSNWL{ct:Amid} | Amphipathic peptide CT1 (VsCT1) (Non-disulfide-bridged peptide 5.11) (NDBP-5.11) | Amidation | Free | Linear | L | None | 13 | hemolytic | 6 % Hemolytic at 50µM | Human | Mesomexovis Subcristatus (Scorpion) (Vaejovis Subcristatus) | Alpha Helix | Low hemolytic | ||
| 22342498 | 2012 | FLKGIIDTVSKLF{ct:Amid} | Amphipathic peptide CT2 (VsCT2) (Non-disulfide-bridged peptide 5.12) (NDBP-5.12) | Amidation | Free | Linear | L | None | 13 | hemolytic | 2 % Hemolytic at 50µM | Human | Mesomexovis Subcristatus (Scorpion) (Vaejovis Subcristatus) | Alpha Helix | Low hemolytic | ||
| 16330062 | 2006 | FLPIIAKLLGGLL | Vespid chemotactic peptide 5e (VCP 5e) | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | Hemolytic at 50μg/mL | Rabbit | Vespa Magnifica (Hornet) | NA | NA | ||
| 21549739 | 2011 | FDVMGIIKKIAGAL{ct:Amid} | Eumenine mastoparan-EF (EMP-EF) | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 50 % Hemolytic at 181.1µM | Mouse | Eumenes Fraterculus (Solitary Wasp) | Alphα-Helical | Low hemolytic | ||
| 12236591 | 2002 | NLFQFAEMIVKMTGKEAVH | Neutral phospholipase A2 RVV-PFIIc' (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) | Free | Free | Linear | L | None | 19 | Hemolytic, Anticoagulant | 31 % Hemolytic at 2µg | Rabbit | Daboia Russelii (Russel'S Viper) (Vipera Russelii) | NA | NA | ||
| 15556063 | 2004 | FLSAITSLLGKLL{ct:Amid} | Temporin-1SPb | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolytic at 60µM | Human | Lithobates Septentrionalis (Mink Frog) (Rana Septentrionalis) | NA | NA | ||
| 19463738 | 2009 | ILGKLLSTAAGLLSNL{ct:Amid} | Alyteserin-2a | Amidation | Free | Linear | L | None | 16 | Antibacterial | 50 % Hemolytic at 135µM | Human | Alytes Obstetricans (Common Midwife Toad) (Bufo Obstetricans) | NA | NA | ||
| 34941722 | 2021 | ISEALKSIIVG{ct:Amid} | Annulatin (Linear alpha-helical peptide) | Amidation | Free | Linear | L | None | 11 | Histamine releasing activity from mast cells | 15.4 % Hemolytic at 12.5µmol/l | Human | Campsomeriella Annulata (Wasp) (Campsomeris Annulata) | Alpha Helix | Low hemolytic | ||
| 10691983 | 2000 | LLPIVGNLLNSLL{ct:Amid} | Temporin-1Td (TD) (Temporin-D) | Amidation | Free | Linear | L | None | 13 | NA | 80 % Hemolytic at 20µM | Human | Rana Temporaria (European Common Frog) | α-Helical | NA | ||
| 15638808 | 2005 | FIGAILPAIAGLVHGLINR{ct:Amid} | Hylin-b1 (Hy-b1) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | Hemolytic | Human | Boana Lundii (Brazilian Tree Frog) (Hypsiboas Lundii) | NA | NA | ||
| 15638808 | 2005 | FIGAILPAIAGLVGGLINR{ct:Amid} | Hylin-b2 (Hy-b2) | Amidation | Free | Linear | L | None | 19 | Antimicrobial | Hemolytic | Human | Boana Lundii (Brazilian Tree Frog) (Hypsiboas Lundii) | NA | NA | ||
| 16076139 | 2005 | LPSDATLVLDQTGKELDARL{nt:Amid} | Antifungal protein J (AFP-J) | Free | Amidation | Linear | L | None | 20 | Antifungal | 0 % Hemolytic at 25µg | Human | Solanum Tuberosum (Potato) | NA | Non-hemolytic | ||
| 21736910 | 2011 | LMCTHPLDCSN | Antifungal peptide 1 (Tn-AFP1) | Free | Free | Linear | L | None | 11 | Antifungal | 10 % Hemolytic at 32μg/mL(60min) | Mouse | Trapa Natans (Water Chestnut) | NA | Non-hemolytic | ||
| 18312859 | 2008 | NVLSSVANGINRALSFFG | Amolopin-P2 | Free | Free | Linear | L | None | 18 | Antibacterial | 3 % Hemolytic at 200μg/mL | Rabbit | Amolops Loloensis (Lolokou Sucker Frog) (Staurois Loloensis) | NA | Non-hemolytic | ||
| 15777955 | 2005 | IGGIISFFKRLF | Grammistin Gs B | Free | Free | Linear | L | None | 12 | Antibacterial | Hemolytic at <10HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | Non-hemolytic | ||
| 15777955 | 2005 | FIGGIISFFKRLF | Grammistin Gs D | Free | Free | Linear | L | None | 13 | Antibacterial | Hemolytic at 79HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | NA | ||
| 15777955 | 2005 | FIGGIISFIKKLF | Grammistin Gs E | Free | Free | Linear | L | None | 13 | Antibacterial | Hemolytic at 63HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | NA | ||
| 9784389 | 1998 | FLPIASLLGKYL | Ranatuerin-5 (Temporin) | Free | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 9784389 | 1998 | FISAIASMLGKFL | Ranatuerin-6 (Temporin) | Free | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 9784389 | 1998 | FLSAIASMLGKFL | Ranatuerin-7 (Temporin) | Free | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 9784389 | 1998 | FISAIASFLGKFL | Ranatuerin-8 (Temporin) | Free | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 9784389 | 1998 | FLFPLITSFLSKVL | Ranatuerin-9 (Temporin) | Free | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 19807165 | 2009 | QGIGVGDNDGKRGKR | Antifungal protein Pr-2 | Free | Free | Linear | L | None | 15 | Antifungal | Hemolytic at 160µM | Human | Cucurbita Maxima (Pumpkin) (Winter Squash) | NA | Low hemolytic | ||
| 21520894 | 2011 | PVVDTTGNNPLQQQEEYYV | Kunitz-type serine protease inhibitor 1 (Xb-KTI) | Free | Free | Linear | L | None | 19 | Antibacterial, trypsin inhibitor | 0 % Hemolytic at 250μg/mL | Human | Xanthosoma Sagittifolium (Arrowleaf Elephant'S Ear) (Arum Sagittifolium) | NA | Non-hemolytic | ||
| 31209048 | 2019 | GLLSLLSLLGKLL{ct:Amid} | DFTamP1 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at <3.1µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GALSLLSLLGKLL{ct:Amid} | DFT506 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 4µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLASLLSLLGKLL{ct:Amid} | DFT507 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at <3.1µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSALSLLGKLL{ct:Amid} | DFT508 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 6µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLASLLGKLL{ct:Amid} | DFT509 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 4µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLLSALGKLL{ct:Amid} | DFT510 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 19µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLLSLAGKLL{ct:Amid} | DFT511 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 14µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLLSLLGKAL{ct:Amid} | DFT512 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 4µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLLSLLGKLA{ct:Amid} | DFT513 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at <3.1µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSALKALGKLL{ct:Amid} | DFT514 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 36µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSAL{nnr:O}ALGKLL{ct:Amid} | DFT515 | Amidation | Free | Linear | L | O = L-Ornithine | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 36µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSAL{nnr:O}ALG{nnr:O}LL{ct:Amid} | DFT516 | Amidation | Free | Linear | L | O = L-Ornithine | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 36µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSALKAAGKLL{ct:Amid} | DFT521 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at > 50µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GALSALKALGKLL{ct:Amid} | DFT528 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at > 50µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSALKALGKAL{ct:Amid} | DFT529 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at > 50µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSAAKAAGKLL{ct:Amid} | DFT522 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 50µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GALSALKALGKAL{ct:Amid} | DFT530 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >100µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLSLLGKLL{ct:Amid} | DFT523 | Amidation | Free | Linear | L | None | 12 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >50µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLSLGKLL{ct:Amid} | DFT524 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >300µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLSSLGKLL{ct:Amid} | DFT526 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >300µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLSLLLSLLGKLL{ct:Amid} | DFT502 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 3.1µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLSLLLSLGLKLL{ct:Amid} | DFT503 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >300µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLSLLLSLLLGKL{ct:Amid} | DFT504 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 8µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSSLLLLGKLL{ct:Amid} | DFT505 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 20µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GKLLSLLSLLGLL{ct:Amid} | DFT527 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 20µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLLSLGLKLL{ct:Amid} | DFT531 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 7µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | LLGSLLSLGLKLL{ct:Amid} | DFT532 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 13µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | G{d}L{d}S{d}L{d}L{d}L{d}S{d}L{d}G{d}L{d}K{d}L{d}L{d}{ct:Amid} | DFT503d | Amidation | Free | Linear | D | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >300µM | Human | Synthetic Peptide | NA | NA |